Clustering O 0 3.22641113825739e-07
of O 0 5.15886500185303e-11
missense O 0 2.1648679648933467e-06
mutations O 0 1.1545418487912684e-07
in O 0 1.799504989463685e-10
the O 0 6.119300337559253e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 1.0839462447620463e-05
in O 0 4.180909438100677e-11
a O 0 6.515626371772498e-10
sporadic B-Disease 0 0.440182626247406
T I-Disease 1 0.9998661279678345
- I-Disease 0 0.030976030975580215
cell I-Disease 0 0.018722262233495712
leukaemia I-Disease 1 0.5135595798492432
. O 0 2.9299215498213016e-08

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.0014272830449044704
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 3.6455272828250784e-11
is O 0 3.6052812211334606e-12
a O 0 4.1572426924540995e-12
recessive B-Disease 0 3.387488686712459e-05
multi I-Disease 0 0.00427516084164381
- I-Disease 1 0.8705918788909912
system I-Disease 0 3.4315580705879256e-05
disorder I-Disease 1 0.7246735692024231
caused O 0 2.5041202444953115e-09
by O 0 3.2435295768684647e-12
mutations O 0 7.603549789791941e-09
in O 0 2.870677003399824e-12
the O 0 3.5568954465797775e-12
ATM O 0 1.2906102853094126e-08
gene O 0 5.0979704901976675e-09
at O 0 8.653875394060151e-10
11q22 O 0 9.036608616952435e-08
- O 0 1.6802985101094237e-06
q23 O 0 1.0156954743933966e-07
( O 0 3.7095170685175205e-11
ref O 0 8.354037390745361e-07
. O 0 1.5662360297596933e-11
3 O 0 1.2269258525821058e-11
) O 0 2.0040104992125052e-11
. O 0 1.408783228962207e-10

The O 0 1.0489821233861107e-09
risk O 0 9.660072208816928e-08
of O 0 6.275207350275869e-12
cancer B-Disease 0 1.1089738336522714e-06
, O 0 6.663410101470646e-11
especially O 0 4.499822389703034e-11
lymphoid B-Disease 0 6.906968792463886e-07
neoplasias I-Disease 0 1.4114661098574288e-05
, O 0 1.882422412391449e-10
is O 0 8.967915299251672e-11
substantially O 0 2.720812375400783e-08
elevated O 0 2.3154662187607755e-07
in O 0 2.7602859997699625e-09
A B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 2.8166627998871263e-06
and O 0 4.6051645830047505e-10
has O 0 2.254263886669605e-09
long O 0 1.888460360310873e-10
been O 0 1.2717564501496526e-10
associated O 0 5.159943139432244e-09
with O 0 6.4464180660195325e-09
chromosomal O 1 1.0
instability O 1 0.9999998807907104
. O 0 9.25125618778111e-07

By O 0 1.054808462797041e-09
analysing O 0 3.082369403273333e-06
tumour B-Disease 1 0.9999996423721313
DNA O 0 3.105944301751151e-07
from O 0 3.1162347008395486e-11
patients O 0 8.05516348068025e-11
with O 0 4.363172583649044e-12
sporadic B-Disease 0 0.06228872016072273
T I-Disease 1 0.9999363422393799
- I-Disease 0 0.08964026719331741
cell I-Disease 0 0.006001354195177555
prolymphocytic I-Disease 0 0.029202088713645935
leukaemia I-Disease 1 0.8527867794036865
( O 0 1.058177656609871e-09
T B-Disease 0 0.0016955246683210135
- I-Disease 0 1.5435148270626087e-07
PLL I-Disease 0 4.073919512848079e-08
) O 0 1.767702629239254e-12
, O 0 1.6810134556045908e-13
a O 0 3.970939245825922e-13
rare O 0 5.984422679627954e-11
clonal B-Disease 0 7.325778028643981e-08
malignancy I-Disease 0 1.1480807415864547e-06
with O 0 2.7965292841852785e-12
similarities O 0 1.5468384906291988e-10
to O 0 3.743568822989207e-12
a O 0 6.592690976470195e-11
mature B-Disease 0 4.7009316972435045e-07
T I-Disease 0 0.08227140456438065
- I-Disease 0 1.9216608052374795e-05
cell I-Disease 0 3.5349439713172615e-05
leukaemia I-Disease 0 0.0024153543636202812
seen O 0 2.2608328436035663e-06
in O 0 3.908054158063834e-10
A B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999994039535522
T I-Disease 1 1.0
, O 0 4.284908539098353e-11
we O 0 1.2504520856271295e-11
demonstrate O 0 1.539866216308805e-12
a O 0 1.71043544995933e-13
high O 0 2.463737764149543e-12
frequency O 0 2.7763891186083356e-10
of O 0 3.4943716756968835e-12
ATM O 0 1.3675473553576012e-07
mutations O 0 5.464110497399588e-09
in O 0 1.2433701290781585e-10
T B-Disease 0 0.0006246336852200329
- I-Disease 0 5.158655312698102e-06
PLL I-Disease 0 2.720374322962016e-05
. O 0 1.424706042030266e-08

In O 0 2.0266328892848406e-10
marked O 0 1.3668055576232518e-09
contrast O 0 1.2577315577910753e-10
to O 0 1.460638250974644e-12
the O 0 4.608654495356912e-13
ATM O 0 5.98970686382927e-08
mutation O 0 1.935233528982394e-09
pattern O 0 1.3028238754486665e-07
in O 0 8.46331449366744e-10
A B-Disease 1 0.9999994039535522
- I-Disease 1 0.9999990463256836
T I-Disease 1 1.0
, O 0 6.257127455056022e-11
the O 0 1.3311334185524965e-13
most O 0 8.808077422810257e-14
frequent O 0 2.6611896714046068e-11
nucleotide O 0 7.110121519326995e-11
changes O 0 7.337692953246489e-12
in O 0 6.681028885506535e-13
this O 0 6.463842048415325e-12
leukaemia B-Disease 0 1.2161517588538118e-06
were O 0 1.440118996276496e-10
missense O 0 6.8687711518578e-07
mutations O 0 7.197621698651346e-08
. O 0 2.1615953471609828e-09

These O 0 7.539670554557176e-10
clustered O 0 7.1642297427843e-08
in O 0 7.125975157173947e-12
the O 0 7.069681211974155e-13
region O 0 1.3689911704251045e-10
corresponding O 0 1.1200559577040359e-11
to O 0 1.3787221147740225e-12
the O 0 8.02173160795866e-13
kinase O 0 3.299821216273813e-08
domain O 0 2.5190856067780487e-09
, O 0 9.222066686687125e-12
which O 0 4.069989137378549e-12
is O 0 3.0782011054691916e-12
highly O 0 1.102768375747798e-12
conserved O 0 2.9277108515302075e-11
in O 0 2.641949809964461e-12
ATM O 0 1.2778701830029604e-06
- O 0 6.313420897186006e-08
related O 0 1.489522727382564e-09
proteins O 0 1.1010812053791064e-11
in O 0 1.3887829688336017e-12
mouse O 0 4.73433715342253e-07
, O 0 2.056870819500123e-11
yeast O 0 2.1725734544730813e-09
and O 0 6.034661659271023e-11
Drosophila O 0 5.494261046123938e-09
. O 0 5.329119368013835e-10

The O 0 9.490071228857033e-11
resulting O 0 2.872711790669058e-10
amino O 0 4.1378492299237735e-10
- O 0 1.8396976164680723e-09
acid O 0 4.1713013251842845e-12
substitutions O 0 3.0022698736809073e-12
are O 0 9.994366038977923e-14
predicted O 0 4.41331650044563e-12
to O 0 8.440567445281918e-14
interfere O 0 1.864727261491339e-09
with O 0 2.809724458305296e-12
ATP O 0 1.2228992263274563e-09
binding O 0 1.75484320408259e-08
or O 0 4.491749194812655e-09
substrate O 0 6.578387115041551e-07
recognition O 0 7.089355769096528e-09
. O 0 7.1090981990096225e-09

Two O 0 4.824680099879686e-10
of O 0 3.754509290271324e-12
seventeen O 0 4.11383416221156e-09
mutated O 0 4.5272315674083075e-07
T B-Disease 0 0.0005215239361859858
- I-Disease 0 3.1766174402036995e-07
PLL I-Disease 0 1.9690062345034676e-06
samples O 0 5.6525584213318325e-09
had O 0 5.316506956898337e-11
a O 0 3.1603476346314663e-12
previously O 0 1.950984485077356e-09
reported O 0 0.0028905386570841074
A B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999979734420776
T I-Disease 1 0.9999995231628418
allele O 0 8.161464961631282e-07
. O 0 3.198923348435301e-09

In O 0 1.536300531235213e-10
contrast O 0 7.613050745369776e-10
, O 0 1.010977499632526e-11
no O 0 1.5505270678506378e-11
mutations O 0 1.583562864171384e-10
were O 0 4.06293878749131e-12
detected O 0 2.407059218612062e-09
in O 0 5.705163988803386e-14
the O 0 2.095132606901723e-14
p53 O 0 6.975801880582111e-12
gene O 0 3.482582625058406e-11
, O 0 4.0983346273962273e-13
suggesting O 0 1.6638567260085502e-11
that O 0 8.734470937320216e-13
this O 0 1.0705806900712656e-11
tumour B-Disease 1 1.0
suppressor O 0 1.748220711306203e-05
is O 0 1.680084071864485e-09
not O 0 3.446640889359642e-11
frequently O 0 1.550900519120546e-10
altered O 0 2.691673106625103e-09
in O 0 1.0383511758749187e-11
this O 0 2.3115315217481225e-10
leukaemia B-Disease 0 0.00015783488925080746
. O 0 1.843012964464208e-09

Occasional O 0 1.1072218512708787e-05
missense O 0 2.789663449220825e-05
mutations O 0 1.8814807845046744e-07
in O 0 2.777023229427744e-11
ATM O 0 2.5738236786310154e-07
were O 0 1.4741355358616204e-10
also O 0 9.586378565962228e-12
found O 0 2.0535387626474666e-11
in O 0 1.471146121589939e-11
tumour B-Disease 1 1.0
DNA O 0 2.6892685127677396e-06
from O 0 1.4292136918392373e-11
patients O 0 1.410764977061163e-10
with O 0 2.171642423179354e-12
B B-Disease 0 2.0120500266784802e-05
- I-Disease 0 1.5532281395280734e-05
cell I-Disease 0 0.00474252924323082
non I-Disease 0 0.0003954357234761119
- I-Disease 1 0.9999449253082275
Hodgkins I-Disease 1 0.9999992847442627
lymphomas I-Disease 1 0.9992682337760925
( O 0 6.346451364436234e-09
B B-Disease 0 4.3114006984978914e-05
- I-Disease 0 9.582864777257782e-07
NHL I-Disease 0 2.4431923151269075e-10
) O 0 2.1620045163872614e-12
and O 0 1.4136106564824336e-12
a O 0 3.1931655236627776e-11
B B-Disease 0 1.722136886428416e-07
- I-Disease 0 1.1310147485232847e-08
NHL I-Disease 0 1.4431498218669958e-09
cell O 0 9.795105171406249e-08
line O 0 9.299544672103366e-07
. O 0 4.277580067935105e-09

The O 0 6.533253538859585e-12
evidence O 0 4.8068212604723826e-11
of O 0 2.1697355419509137e-14
a O 0 3.726568749765069e-13
significant O 0 1.0365069913476077e-11
proportion O 0 5.0166221871039696e-11
of O 0 6.068370632383857e-13
loss O 0 1.1255486320749242e-08
- O 0 2.015972768276697e-06
of O 0 3.7892664700445167e-11
- O 0 3.884259058395401e-06
function O 0 1.587820008808194e-08
mutations O 0 7.969454429712641e-09
and O 0 1.0959834602364271e-11
a O 0 9.942697706821768e-12
complete O 0 7.335601015512339e-10
absence O 0 1.3547904464950022e-10
of O 0 3.800777102986111e-14
the O 0 2.1727888585565402e-13
normal O 0 7.628556120131691e-11
copy O 0 6.220115533750459e-09
of O 0 8.729441323442055e-13
ATM O 0 8.066149526086974e-09
in O 0 6.985890815477958e-13
the O 0 3.9558804908017275e-13
majority O 0 3.172288820518787e-11
of O 0 3.6017482399341993e-12
mutated O 0 9.215368481818587e-05
tumours B-Disease 1 0.9999998807907104
establishes O 0 7.06643561443343e-08
somatic O 0 4.739258763208909e-09
inactivation O 0 2.6714868539556846e-08
of O 0 2.8831865822760705e-13
this O 0 2.5867697740766804e-13
gene O 0 1.1206548189424126e-10
in O 0 9.428533800058536e-14
the O 0 5.616884520974648e-14
pathogenesis O 0 2.2346900718783758e-10
of O 0 4.713124964091098e-13
sporadic B-Disease 0 0.11912485212087631
T I-Disease 1 0.9882060289382935
- I-Disease 0 3.532284381435602e-06
PLL I-Disease 0 5.619569378723099e-07
and O 0 1.0846517260743038e-11
suggests O 0 2.492252931807215e-11
that O 0 4.908751898881347e-13
ATM O 0 4.1428420693989665e-09
acts O 0 4.196898939490268e-10
as O 0 7.885991339107168e-12
a O 0 6.208141778429876e-10
tumour B-Disease 1 0.9999998807907104
suppressor O 0 0.0005651278770528734
. O 0 8.294784237250497e-08

As O 0 3.7349287551613486e-10
constitutional O 0 1.7430359933179318e-10
DNA O 0 3.805313397720056e-09
was O 0 3.501453849086289e-10
not O 0 2.263497765955802e-12
available O 0 1.1322751547124255e-12
, O 0 1.2488997466406082e-12
a O 0 1.7974803936948724e-11
putative O 0 7.629891740634775e-08
hereditary O 0 3.9019982068566605e-05
predisposition O 0 6.29235728411004e-05
to O 0 1.0733978150767598e-08
T B-Disease 1 0.5210049152374268
- I-Disease 0 1.2881138218290289e-06
PLL I-Disease 0 6.961240046621242e-07
will O 0 6.672567359755632e-11
require O 0 5.116929883280941e-12
further O 0 5.588763393044038e-12
investigation O 0 2.789542485892582e-10
. O 0 2.6400317695851605e-11
. O 0 3.1846761339160423e-10

Myotonic B-Disease 1 0.9999995231628418
dystrophy I-Disease 1 0.9999995231628418
protein O 0 4.136069037485868e-06
kinase O 0 1.0122971616510767e-06
is O 0 4.3501948571167404e-11
involved O 0 7.439779695084248e-12
in O 0 1.8894833411103353e-14
the O 0 4.661907981911217e-15
modulation O 0 9.103680483069088e-12
of O 0 7.676784961841918e-14
the O 0 2.7881035154220246e-12
Ca2 O 0 1.6060219820701604e-08
+ O 0 1.3820296373978636e-07
homeostasis O 0 5.1420538511592895e-06
in O 0 1.5024276267538994e-10
skeletal O 0 0.0021417050156742334
muscle O 0 8.05750005383743e-06
cells O 0 1.410132028922817e-07
. O 0 1.0348886192446116e-08

Myotonic B-Disease 1 0.9999986886978149
dystrophy I-Disease 1 0.9999997615814209
( O 0 1.804745693334553e-06
DM B-Disease 1 1.0
) O 0 3.822131056097078e-09
, O 0 1.5091330962668792e-11
the O 0 2.0630137951681976e-13
most O 0 2.9549687349805787e-12
prevalent O 0 8.164347775618808e-08
muscular B-Disease 0 4.2524494347162545e-05
disorder I-Disease 0 0.0006671561277471483
in O 0 6.98164486293007e-12
adults O 0 3.6559757443654917e-09
, O 0 3.011108723471878e-11
is O 0 9.208712958841403e-11
caused O 0 6.257596663061804e-10
by O 0 4.470750592650008e-12
( O 0 1.3404495395608063e-11
CTG O 0 1.5388790188808343e-06
) O 0 6.26106735901466e-11
n O 0 2.585539107258228e-07
- O 0 9.20447575936123e-08
repeat O 0 1.9955679331218334e-09
expansion O 0 2.1778944966910352e-11
in O 0 2.2078672711704078e-14
a O 0 1.7040855488856255e-13
gene O 0 3.4474104126935856e-11
encoding O 0 1.7514366693061056e-11
a O 0 8.626494484020863e-12
protein O 0 1.6361266785835937e-09
kinase O 0 2.14101504525388e-07
( O 0 1.5151279120217964e-09
DM B-Disease 1 1.0
protein O 0 1.35297170800186e-07
kinase O 0 5.8113840850637644e-08
; O 0 1.862791518258966e-11
DMPK O 0 3.1610596806785907e-08
) O 0 1.1119220778496586e-12
and O 0 3.703045086279194e-13
involves O 0 1.1445234950752115e-12
changes O 0 9.10412804172589e-13
in O 0 8.09838253314904e-13
cytoarchitecture O 0 8.692958886058477e-08
and O 0 3.65925290068958e-10
ion O 0 3.6779607626158395e-07
homeostasis O 0 1.5106065802683588e-05
. O 0 3.341362386777291e-08

To O 0 1.1125406151890616e-10
obtain O 0 1.7237052063467928e-10
clues O 0 1.2241337943308395e-09
to O 0 6.336354184399706e-12
the O 0 8.271098107630326e-13
normal O 0 2.753348937734046e-10
biological O 0 4.7244301804028055e-09
role O 0 1.2804335369764885e-10
of O 0 4.61534944377201e-13
DMPK O 0 5.601826913448349e-08
in O 0 3.890691588348538e-12
cellular O 0 2.4449287039374212e-08
ion O 0 3.686282923354156e-08
homeostasis O 0 1.0432639783175546e-06
, O 0 3.232872303193801e-10
we O 0 3.4367633738874304e-10
have O 0 7.224149121791423e-13
compared O 0 5.212222146944168e-12
the O 0 2.6538471940840136e-13
resting O 0 4.158200450632421e-09
[ O 0 7.122826634065049e-11
Ca2 O 0 3.8902872590007576e-10
+ O 0 1.1138475031202688e-08
] O 0 8.78935413339832e-09
i O 0 2.0902215069895647e-08
, O 0 1.7093950224495585e-13
the O 0 4.347863740453107e-15
amplitude O 0 1.2287168895189216e-12
and O 0 1.5123423346974363e-12
shape O 0 4.974879952435174e-10
of O 0 5.611415195352909e-13
depolarization O 0 5.607147191000195e-09
- O 0 1.5217792679322883e-05
induced O 0 2.23313327296637e-05
Ca2 O 0 1.6941187652719236e-07
+ O 0 1.2303777907618496e-07
transients O 0 1.1784312619056436e-06
, O 0 2.1989915444109442e-10
and O 0 2.1381045805374255e-12
the O 0 2.6671461534569924e-14
content O 0 8.886164373778094e-12
of O 0 6.605910344561691e-14
ATP O 0 5.786966461585052e-10
- O 0 2.521827191515058e-08
driven O 0 4.510140527713702e-08
ion O 0 8.813695551168621e-09
pumps O 0 3.5017295729744546e-09
in O 0 1.9844171878641292e-12
cultured O 0 2.1848585163297685e-08
skeletal O 0 1.8472463125362992e-05
muscle O 0 4.6567524947249694e-08
cells O 0 4.629665817379447e-10
of O 0 7.935295216060512e-13
wild O 0 2.0893395902277234e-09
- O 0 2.090155248879455e-06
type O 0 9.923740435624495e-06
and O 0 5.633010724537257e-10
DMPK O 0 4.4592115955310874e-07
[ O 0 4.034927059137772e-09
- O 0 7.424045520565414e-07
/ O 0 0.00013395030691754073
- O 0 9.266494089388289e-06
] O 0 3.6134117920028075e-08
knockout O 0 5.321324181295495e-08
mice O 0 3.709700422405149e-07
. O 0 4.079749427177148e-09

In O 0 6.919305128860742e-10
vitro O 0 8.347336006409023e-06
- O 0 4.880558481090702e-05
differentiated O 0 6.661601332780265e-07
DMPK O 0 5.919794148212532e-06
[ O 0 2.4433669310042205e-08
- O 0 1.034168349178799e-06
/ O 0 1.3918261174694635e-05
- O 0 2.9951041824460845e-07
] O 0 2.776983754060325e-09
myotubes O 0 3.783810598179116e-09
exhibit O 0 1.8564008663624065e-10
a O 0 4.976042147775139e-12
higher O 0 9.221714537821502e-12
resting O 0 4.677723541846035e-09
[ O 0 1.994535647753537e-10
Ca2 O 0 5.0711359556032676e-09
+ O 0 4.3989540898792256e-08
] O 0 1.0775475622892827e-08
i O 0 9.557528102277502e-09
than O 0 8.049277390453913e-12
do O 0 1.8935991663582286e-11
wild O 0 1.5096110125845108e-11
- O 0 6.752696180001294e-09
type O 0 1.935843485512123e-08
myotubes O 0 1.7479418801258362e-08
because O 0 1.229756053933162e-11
of O 0 8.160770270540605e-15
an O 0 5.241676708021663e-14
altered O 0 7.430257520368855e-10
open O 0 1.919655961968303e-10
probability O 0 2.5835970515752926e-11
of O 0 2.908052271211048e-12
voltage O 0 1.1917817488438232e-07
- O 0 1.1967320006078808e-06
dependent O 0 6.82246579231105e-08
l O 0 1.0356546908951714e-06
- O 0 9.412924661944544e-09
type O 0 2.360854800542711e-08
Ca2 O 0 3.6450651386132904e-09
+ O 0 4.549902854478205e-08
and O 0 7.092111342643648e-10
Na O 0 6.953338242965401e-07
+ O 0 1.6156747051354614e-07
channels O 0 4.600051397574134e-07
. O 0 5.6786015889542796e-09

The O 0 2.553362243862267e-10
mutant O 0 4.260854336024522e-09
myotubes O 0 1.4120289826280441e-08
exhibit O 0 7.005609425903003e-10
smaller O 0 5.997403962343384e-11
and O 0 5.117203102228407e-12
slower O 0 2.0009581547242306e-08
Ca2 O 0 7.61651435254862e-08
+ O 0 1.565899907518542e-07
responses O 0 3.6252145729775975e-09
upon O 0 1.2718747929851837e-11
triggering O 0 2.5539367842775107e-10
by O 0 1.1728188949525209e-12
acetylcholine O 0 8.931650086196896e-09
or O 0 8.886940960906031e-09
high O 0 2.6664014995958496e-08
external O 0 1.3805161813706945e-07
K O 0 7.509575880249031e-06
+ O 0 1.7636975258028542e-07
. O 0 3.252188518487742e-09

In O 0 9.79518549604208e-11
addition O 0 2.5770807363101333e-11
, O 0 1.0852512465076014e-12
we O 0 2.4400170469188187e-13
observed O 0 5.406202287054629e-13
that O 0 5.880026148060921e-14
these O 0 1.8483002942829702e-13
Ca2 O 0 2.1680699457959918e-09
+ O 0 7.749689956426664e-08
transients O 0 1.6699689240340376e-06
partially O 0 9.483480312155734e-08
result O 0 5.1584591632958254e-12
from O 0 5.5138046770519464e-14
an O 0 1.882756036036652e-14
influx O 0 3.0512244206942762e-12
of O 0 9.552565173338162e-14
extracellular O 0 7.356478204378902e-10
Ca2 O 0 7.000270585422186e-09
+ O 0 1.0735821120988476e-08
through O 0 1.7053780262954454e-11
the O 0 5.082437942727225e-12
l O 0 3.724680652794632e-08
- O 0 5.143003800611723e-09
type O 0 2.4165920819996245e-08
Ca2 O 0 1.3045764468699872e-08
+ O 0 1.8846235150249413e-07
channel O 0 3.6916060253133764e-06
. O 0 1.248325975922171e-08

Neither O 0 1.0983544029841141e-07
the O 0 2.7228120799693833e-11
content O 0 2.0262436173368314e-09
nor O 0 1.2737551013941584e-09
the O 0 4.020092906568268e-13
activity O 0 6.639536698216375e-10
of O 0 9.979660191760872e-14
Na O 0 5.605631869798344e-08
+ O 0 6.445313971426003e-08
/ O 0 1.0025321444118163e-06
K O 0 2.2653254916349397e-07
+ O 0 3.1099098407594283e-08
ATPase O 0 3.914410172001226e-06
and O 0 9.917668908343558e-10
sarcoplasmic O 0 3.691176516440464e-06
reticulum O 0 1.0108655033036484e-06
Ca2 O 0 5.621059244731441e-07
+ O 0 1.5553210914731608e-06
- O 0 2.5313988771813456e-06
ATPase O 0 4.235103915561922e-05
are O 0 1.4786381841158658e-10
affected O 0 1.0325379440345728e-09
by O 0 3.337382800672195e-11
DMPK O 0 2.5966686735046096e-05
absence O 0 1.1935330057610827e-08
. O 0 7.358582632122079e-10

In O 0 1.8274493029935002e-10
conclusion O 0 4.93164571679916e-11
, O 0 1.4094060120373175e-11
our O 0 5.0606155550803056e-12
data O 0 1.0923291784981082e-11
suggest O 0 1.2247047126434651e-11
that O 0 9.207140258538082e-13
DMPK O 0 9.693105873509467e-09
is O 0 1.0426015519676701e-12
involved O 0 2.4766425889277688e-12
in O 0 4.775869912217179e-14
modulating O 0 7.690664771686784e-10
the O 0 9.020555027765276e-13
initial O 0 9.995448219113356e-11
events O 0 9.193457627121315e-12
of O 0 1.7777370287658245e-13
excitation O 0 1.2562912932168047e-09
- O 0 1.3248396726339706e-06
contraction O 0 1.4238075891626067e-06
coupling O 0 1.783664949073227e-08
in O 0 1.7469924812330007e-11
skeletal O 0 8.406992128584534e-05
muscle O 0 5.418758064479334e-07
. O 0 1.741407712474441e-10
. O 0 1.6987798945322652e-09

Constitutional O 0 4.814766043637064e-07
RB1 O 0 0.0005866560968570411
- O 0 1.4404097328224452e-06
gene O 0 1.0931690752613576e-07
mutations O 0 3.190126562913065e-08
in O 0 1.8074571353499103e-11
patients O 0 1.6435989236285309e-09
with O 0 1.4679291115982096e-10
isolated O 0 0.005091545637696981
unilateral B-Disease 1 0.9842717051506042
retinoblastoma I-Disease 1 0.5915897488594055
. O 0 3.6540541259455495e-07

In O 0 7.451457506579828e-11
most O 0 1.00728401314365e-11
patients O 0 5.097936309206297e-11
with O 0 2.1841957496132602e-12
isolated O 0 0.0004202599811833352
unilateral B-Disease 1 0.805213987827301
retinoblastoma I-Disease 0 0.0021399524994194508
, O 0 2.1182292031518557e-10
tumor B-Disease 0 3.435990834077529e-07
development O 0 6.824407705607882e-11
is O 0 2.8790446589266327e-12
initiated O 0 1.3781811629420826e-11
by O 0 4.0952403143959537e-13
somatic O 0 1.7147171182951837e-10
inactivation O 0 2.9823404190665315e-08
of O 0 2.140895750610272e-12
both O 0 6.950090242902052e-12
alleles O 0 1.6962793669694776e-10
of O 0 3.0821020648857944e-12
the O 0 1.6238269062718302e-10
RB1 O 0 1.3997877431393135e-05
gene O 0 2.4142337906596367e-07
. O 0 1.5082664006627056e-08

However O 0 5.038872652463056e-10
, O 0 7.46530875311846e-12
some O 0 1.777984633436966e-13
of O 0 5.395362365971483e-14
these O 0 3.261204500892845e-11
patients O 0 1.5551007703784592e-10
can O 0 3.479860496979903e-11
transmit O 0 3.117850064882077e-05
retinoblastoma B-Disease 0 0.00105060706846416
predisposition O 0 0.0005056767840869725
to O 0 4.0478620455530745e-09
their O 0 3.449624141893537e-09
offspring O 0 1.1147341894002238e-07
. O 0 4.319409718789302e-09

To O 0 2.6885200662962738e-11
determine O 0 1.7462795098843742e-11
the O 0 3.62240104448755e-13
frequency O 0 6.263641605386283e-09
and O 0 9.707749881737726e-11
nature O 0 9.730074523872645e-10
of O 0 4.1266512776361175e-13
constitutional O 0 2.3685662320360734e-09
RB1 O 0 0.0001289888023165986
- O 0 2.6037154654545702e-08
gene O 0 1.381457259697072e-08
mutations O 0 1.2995714504526745e-09
in O 0 8.315943419989758e-13
patients O 0 6.053059442567843e-11
with O 0 7.57148250346562e-12
isolated O 0 0.00014337261382024735
unilateral B-Disease 0 0.037329915910959244
retinoblastoma I-Disease 0 6.646055408054963e-05
, O 0 2.1493797019989103e-10
we O 0 2.2978549618635213e-11
analyzed O 0 2.1822729387444006e-11
DNA O 0 1.1433420876727496e-10
from O 0 9.241854243696723e-13
peripheral O 0 4.9506432731050154e-08
blood O 0 1.5560251753754528e-08
and O 0 8.706602799835039e-11
from O 0 2.740845918280943e-11
tumor B-Disease 0 3.7954490835545585e-05
tissue O 0 2.1361995095503516e-05
. O 0 3.3631014417778715e-08

The O 0 8.594653461146962e-11
analysis O 0 5.080602050178129e-10
of O 0 9.73890690314505e-11
tumors B-Disease 1 1.0
from O 0 2.405286247952887e-10
54 O 0 4.833303535178857e-09
( O 0 1.129577247710456e-11
71 O 0 3.5424254640759045e-09
% O 0 9.707666528274705e-13
) O 0 4.384761325727793e-13
of O 0 3.431681479780513e-13
76 O 0 1.3316796554363464e-09
informative O 0 2.3769361234826647e-07
patients O 0 1.0198241362502358e-08
showed O 0 2.495615092357184e-08
loss O 0 2.921698716296106e-10
of O 0 1.1050234078463506e-12
constitutional O 0 6.1356772995679876e-09
heterozygosity O 0 2.6047440769616514e-05
( O 0 5.6292787320444404e-08
LOH O 1 0.9999954700469971
) O 0 1.3985033131547198e-09
at O 0 9.64706980965957e-09
intragenic O 0 8.491082894579449e-07
loci O 0 7.590642070454123e-08
. O 0 4.271123010823885e-09

Three O 0 9.535545686389924e-10
of O 0 5.497030348272647e-12
13 O 0 1.2693113227157937e-10
uninformative O 0 4.0059643652057275e-05
patients O 0 2.9111001254022995e-07
had O 0 9.286383217954608e-09
constitutional O 0 2.12123429932376e-09
deletions O 0 4.29118290412589e-06
. O 0 4.057812219571133e-08

For O 0 7.620546971232045e-10
39 O 0 2.1896717772307284e-09
randomly O 0 1.7634957938383877e-09
selected O 0 7.296101500742225e-09
tumors B-Disease 1 1.0
, O 0 9.714848925312936e-10
SSCP O 0 6.6282073021284305e-06
, O 0 1.5483792026316223e-10
hetero O 0 2.0219637519858225e-07
- O 0 1.2685648087540358e-08
duplex O 0 3.263599523961602e-07
analysis O 0 3.1767272840044214e-11
, O 0 2.0601588197975002e-13
sequencing O 0 3.992600954710879e-12
, O 0 6.247664603546699e-13
and O 0 4.1179237211981523e-13
Southern O 0 2.171378181425876e-11
blot O 0 2.1511438319521403e-07
analysis O 0 3.6695393251795494e-11
were O 0 1.3975999177406884e-12
used O 0 4.2842666263601115e-13
to O 0 1.3382061301095427e-12
identify O 0 1.5706921319136313e-09
mutations O 0 3.2013055317747785e-08
. O 0 3.087566868842373e-09

Mutations O 0 1.3214112186687998e-06
were O 0 1.575483743465611e-09
detected O 0 1.801065785400624e-08
in O 0 7.1403833366845415e-12
21 O 0 1.0988536469636045e-10
( O 0 2.4246112929893204e-12
91 O 0 4.994341606945341e-10
% O 0 1.842574270244368e-12
) O 0 2.6399247371466927e-12
of O 0 1.6666454674685305e-11
23 O 0 3.200022774763056e-06
tumors B-Disease 1 1.0
with O 0 6.123758794274181e-06
LOH O 1 0.9999990463256836
. O 0 1.1168277751494315e-06

In O 0 1.1332405014385927e-09
6 O 0 1.5110866724565852e-10
( O 0 2.7712862386841675e-12
38 O 0 1.4578563356515417e-10
% O 0 4.563537048252186e-13
) O 0 1.068550304662852e-12
of O 0 8.495053618884363e-12
16 O 0 2.937975409622595e-07
tumors B-Disease 1 1.0
without O 0 3.11161857098341e-05
LOH O 1 0.9999997615814209
, O 0 3.8429256998817607e-10
one O 0 1.8038227161953913e-12
mutation O 0 2.6511584594324233e-11
was O 0 4.72549811780798e-11
detected O 0 2.305083768305849e-08
, O 0 5.058511769184815e-12
and O 0 2.118401981610063e-11
in O 0 1.6395917826553252e-12
9 O 0 1.1228201007851268e-10
( O 0 1.7397792191273243e-12
56 O 0 1.1582280273758627e-10
% O 0 1.2900901321614283e-13
) O 0 2.1374144587495841e-13
of O 0 6.365374265009105e-13
the O 0 1.1246365616557341e-08
tumors B-Disease 1 1.0
without O 0 4.13392590417061e-05
LOH O 1 0.9999995231628418
, O 0 7.580391314654378e-10
both O 0 5.073063063382177e-12
mutations O 0 8.709563625863836e-10
were O 0 9.607250411880486e-11
found O 0 1.1096927821085956e-09
. O 0 9.673708500912426e-10

Thus O 0 1.4504462075848323e-09
, O 0 2.112462461900666e-11
a O 0 3.78014026330975e-12
total O 0 1.749616944379806e-11
of O 0 4.922027412382346e-13
45 O 0 8.490862180021708e-11
mutations O 0 2.1104429315244033e-09
were O 0 1.5464844682622214e-10
identified O 0 9.898250397100128e-08
in O 0 5.620625076474539e-10
tumors B-Disease 1 1.0
of O 0 5.046564555133415e-11
36 O 0 1.9583973553949363e-08
patients O 0 6.653992912220019e-09
. O 0 2.251625330629281e-09

Thirty O 0 2.3754358835503808e-07
- O 0 2.9684192668355536e-06
nine O 0 2.4881410820576377e-10
of O 0 1.0425810740991373e-13
the O 0 2.2464903472619452e-13
mutations O 0 7.825882719636468e-10
- O 0 1.5032375344503635e-08
including O 0 1.0515231047003581e-11
34 O 0 6.4867399646173496e-12
small O 0 3.5986168472196267e-12
mutations O 0 2.4168753109954366e-10
, O 0 1.1066093787842624e-12
2 O 0 2.653968624727332e-13
large O 0 9.131940863216226e-12
structural O 0 4.068003178758772e-08
alterations O 0 2.622786325900961e-07
, O 0 1.8568789561523857e-10
and O 0 2.0354060450977762e-11
hypermethylation O 0 1.428840391781705e-06
in O 0 1.6528564628082165e-10
3 O 0 1.717678088652974e-08
tumors O 1 1.0
- O 0 0.0017978717805817723
were O 0 6.310553413158004e-09
not O 0 5.505427017049591e-11
detected O 0 1.983701203300825e-09
in O 0 1.0605719861361829e-13
the O 0 1.3086478786467765e-13
corresponding O 0 6.083338000006933e-11
peripheral O 0 4.032871459003218e-07
blood O 0 1.6130183411178223e-08
DNA O 0 9.450273807942722e-08
. O 0 2.694585665707905e-09

In O 0 1.003472749339096e-09
6 O 0 6.299318289215705e-10
( O 0 6.63213841484156e-12
17 O 0 9.315574700519136e-11
% O 0 5.5764376813037184e-14
) O 0 1.8810475705820402e-14
of O 0 1.7447521766657086e-14
the O 0 5.508205111644238e-13
36 O 0 5.3908030817062524e-11
patients O 0 8.219581265622722e-12
, O 0 8.189183651943072e-14
a O 0 3.947536470882279e-13
mutation O 0 1.4126497194233423e-10
was O 0 1.6115898893165337e-10
detected O 0 1.7357059789446794e-08
in O 0 2.5831607360950193e-13
constitutional O 0 4.2368599947884e-12
DNA O 0 8.86126461097092e-09
, O 0 1.3115577200684125e-11
and O 0 3.201402684616106e-12
1 O 0 1.3873898232520665e-13
of O 0 2.0268724239681617e-14
these O 0 1.3095648697392104e-12
mutations O 0 1.6149745429849816e-10
is O 0 3.2656034994194005e-12
known O 0 1.2369545492052492e-11
to O 0 3.5898144266216514e-12
be O 0 3.493840286528105e-11
associated O 0 9.389322652708643e-10
with O 0 2.010550892439511e-10
reduced O 0 6.081525327772397e-08
expressivity O 0 0.0003820786077994853
. O 0 5.206628728160467e-08

The O 0 9.839207226747249e-11
presence O 0 1.0460331489881014e-09
of O 0 1.1724200440783178e-13
a O 0 8.408583725139085e-12
constitutional O 0 1.0847805292923951e-10
mutation O 0 9.804297818050145e-09
was O 0 3.763649392141133e-09
not O 0 1.4334315852349011e-11
associated O 0 3.005245011178381e-11
with O 0 3.6387294002557247e-13
an O 0 8.046629362172888e-14
early O 0 4.2314755865913156e-11
age O 0 3.202914600208828e-10
at O 0 2.343758520595429e-10
treatment O 0 2.6178863521408857e-09
. O 0 3.4671088222637536e-10

In O 0 3.091253919507153e-10
1 O 0 7.335723001267169e-11
patient O 0 8.121818773076939e-09
, O 0 3.640883601552236e-12
somatic O 0 4.262496577922548e-09
mosaicism O 0 3.3669577987893717e-06
was O 0 2.882670102621887e-09
demonstrated O 0 5.0372369470030876e-11
by O 0 5.873479599818182e-14
molecular O 0 1.0060085360238946e-12
analysis O 0 2.4874932842700037e-12
of O 0 5.906868960972589e-14
DNA O 0 7.69323627025642e-09
and O 0 1.9093100364631077e-11
RNA O 0 5.677818770699616e-10
from O 0 2.281193896974676e-12
peripheral O 0 7.105020358721958e-07
blood O 0 7.557357406540177e-08
. O 0 2.9151481228950615e-09

In O 0 4.359633209993774e-10
2 O 0 7.624531006555912e-10
patients O 0 1.5772276817926922e-09
without O 0 1.8635626028440377e-11
a O 0 7.68067831558028e-11
detectable O 0 3.650689677670016e-06
mutation O 0 1.6982591333203345e-08
in O 0 1.455827125518283e-11
peripheral O 0 0.00010325009498046711
blood O 0 3.4256942171850824e-07
, O 0 3.4768618539793295e-11
mosaicism O 0 1.6801273261535243e-07
was O 0 3.227119904636311e-09
suggested O 0 5.3573319114263995e-09
because O 0 2.2146442665849086e-11
1 O 0 1.1963925672636017e-13
of O 0 3.771019480296352e-14
the O 0 5.96072496916733e-12
patients O 0 8.066114443039396e-10
showed O 0 4.024897407362005e-06
multifocal O 1 0.9999891519546509
tumors B-Disease 1 1.0
and O 0 2.395571812030539e-07
the O 0 4.566029412206296e-12
other O 0 1.31699425670595e-12
later O 0 2.5989035576379216e-11
developed O 0 1.016762563033069e-09
bilateral B-Disease 0 6.489029402700908e-08
retinoblastoma I-Disease 0 6.440462584578199e-06
. O 0 1.4690398231209656e-08

In O 0 2.8188848477661566e-10
conclusion O 0 6.087853138270205e-11
, O 0 7.714310093498433e-12
our O 0 2.3863701813231497e-12
results O 0 3.075834400546873e-13
emphasize O 0 2.2783556291594564e-11
that O 0 6.54809594134026e-13
the O 0 4.322439623024796e-14
manifestation O 0 1.2891034073536645e-10
and O 0 6.9575048847192456e-12
transmissibility O 0 2.087288342167426e-09
of O 0 1.7487210681246812e-13
retinoblastoma B-Disease 0 4.6299595268806115e-09
depend O 0 5.46879694307556e-11
on O 0 2.08048960004259e-11
the O 0 1.396927685288693e-13
nature O 0 4.5435655238179606e-11
of O 0 1.2862639996353859e-14
the O 0 8.09606220497465e-14
first O 0 4.879449708866668e-13
mutation O 0 1.0011623474692755e-11
, O 0 2.7946400618997225e-13
its O 0 2.4025088017111396e-13
time O 0 1.4548076285314515e-12
in O 0 6.987205952713182e-14
development O 0 3.1496662916685736e-12
, O 0 9.807962818644822e-13
and O 0 1.0800598696653063e-12
the O 0 3.9011128989728874e-14
number O 0 1.2665417326029882e-11
and O 0 1.158461607891903e-11
types O 0 1.2955343742238057e-10
of O 0 3.707375457518737e-14
cells O 0 2.604381987847404e-11
that O 0 3.3776618654779433e-12
are O 0 1.98209070684241e-12
affected O 0 1.5524306840042357e-10
. O 0 1.4466346523467344e-11
. O 0 6.742821301308766e-10

Hereditary B-Disease 1 0.9999939203262329
deficiency I-Disease 1 0.9999982118606567
of I-Disease 0 3.73808567433187e-10
the I-Disease 0 2.0883864082499315e-10
fifth I-Disease 0 6.72181688088358e-09
component I-Disease 0 5.0924434447097155e-08
of I-Disease 0 1.4873032276249698e-12
complement I-Disease 0 1.4877964416015743e-09
in O 0 7.373655158682269e-11
man O 0 2.2314219449981465e-07
. O 0 6.790095152808817e-10

I O 0 0.0004093362367711961
. O 0 3.1176185188996897e-08

Clinical O 0 1.2034099654556485e-06
, O 0 5.554550153163973e-10
immunochemical O 0 4.3832183109770995e-06
, O 0 5.781792267178787e-10
and O 0 1.302340041364758e-10
family O 0 6.250680861796809e-09
studies O 0 6.6156202738199e-10
. O 0 1.2457540554677848e-09

The O 0 2.071569304984422e-10
first O 0 4.8887241477224563e-11
recognized O 0 6.213081160666434e-10
human O 0 2.528920850508598e-09
kindred O 0 5.5854019592516124e-05
with O 0 3.637385859178721e-08
hereditary B-Disease 1 0.9999918937683105
deficiency I-Disease 1 0.9999942779541016
of I-Disease 0 1.0608609130047242e-10
the I-Disease 0 1.0442265108157045e-10
fifth I-Disease 0 7.1143611002355556e-09
component I-Disease 0 1.040992501089022e-07
of I-Disease 0 5.7936862772611786e-12
complement I-Disease 0 1.2014762518219868e-09
( O 0 1.9089532038440993e-11
C5 O 0 1.0198202282651891e-08
) O 0 9.407113109316523e-12
is O 0 5.151421997307004e-11
described O 0 3.874183640562023e-09
. O 0 1.4594929709232929e-09

The O 0 5.850034900944934e-10
proband O 0 9.74805175246729e-07
, O 0 7.57726520417279e-11
a O 0 1.8883512808987035e-11
20 O 0 5.2148105278426726e-11
- O 0 2.3523774927980412e-08
year O 0 5.200784941594705e-11
- O 0 1.9418823882233482e-08
old O 0 3.1009994572173127e-09
black O 0 3.184048857907129e-11
female O 0 3.192752728864434e-10
with O 0 5.753640341943367e-10
systemic B-Disease 1 0.9999998807907104
lupus I-Disease 1 0.9997239708900452
erythematosus I-Disease 1 0.9999985694885254
since O 0 1.5296872390990757e-07
age O 0 3.002190567258367e-07
11 O 0 1.1345488992731134e-09
, O 0 1.7766922655315653e-10
lacked O 0 6.471108093819566e-08
serum O 0 3.234837322452222e-07
hemolytic O 0 1.4964816728024743e-05
complement O 0 5.698453930946812e-10
activity O 0 1.525040715932846e-07
, O 0 2.440643173673429e-11
even O 0 2.213098801440161e-11
during O 0 2.811549604242458e-10
remission O 0 4.8594657187095436e-08
. O 0 7.192674789102682e-10

C5 O 0 0.0008185839396901429
was O 0 1.4246224964153953e-05
undetectable O 0 0.0004133178445044905
in O 0 2.1546048278864305e-10
her O 0 5.267273839315578e-10
serum O 0 1.9803254591721497e-09
by O 0 1.2387624563278687e-12
both O 0 6.17695347995828e-12
immunodiffusion O 0 1.1882991657330422e-06
and O 0 3.931307279714247e-09
hemolytic O 0 0.0007547630229964852
assays O 0 7.266453394549899e-07
. O 0 1.680344574594983e-08

Other O 0 2.6354296522868026e-10
complement O 0 8.689104435966044e-10
components O 0 7.221518494304746e-09
were O 0 8.198541845416685e-11
normal O 0 1.762832380070023e-10
during O 0 3.8846200561826194e-11
remission O 0 1.098324098336434e-09
of O 0 7.182163392661922e-13
lupus O 0 1.2146040262450697e-07
, O 0 4.730457692225798e-11
but O 0 2.2216345429981743e-10
C1 O 0 2.1173876518787438e-07
, O 0 9.197351213963145e-12
C4 O 0 1.4747548737759075e-09
, O 0 1.6718358641920616e-10
C2 O 0 9.232679332171756e-08
, O 0 8.90836640565773e-11
and O 0 1.0517748894045553e-09
C3 O 0 1.1778080988733564e-05
levels O 0 1.2456050413334196e-08
fell O 0 1.7799286524677882e-06
during O 0 8.659394978849377e-09
exacerbations O 0 0.00015536042337771505
. O 0 2.028967216460842e-08

A O 0 2.981873947760505e-08
younger O 0 5.845041339824775e-09
half O 0 1.7487646886138464e-09
- O 0 1.4128247130429372e-05
sister O 0 9.310849236499052e-06
, O 0 7.758911846345029e-10
who O 0 1.1464763582935689e-09
had O 0 5.165536443030305e-09
no O 0 1.2945549521248267e-08
underlying O 0 2.7656792553898413e-06
disease O 0 5.6431596021866426e-05
, O 0 3.692779415587211e-11
was O 0 1.9697784736649737e-08
also O 0 3.9173680965731705e-10
found O 0 1.0605150091436144e-10
to O 0 8.637875137385009e-11
lack O 0 3.622760758048571e-09
immunochemically O 0 0.00014474130875896662
detectable O 0 0.00012566482473630458
C5 O 0 4.936090135743143e-06
. O 0 2.208172844575529e-08

By O 0 1.098054447368213e-08
hemolytic O 0 0.15021303296089172
assay O 0 3.176962763973279e-07
, O 0 1.0329476163306595e-09
she O 0 3.699478778873555e-10
exhibited O 0 2.9152762426321033e-09
1 O 0 4.333747596896309e-11
- O 0 1.002877297651139e-06
2 O 0 1.0625086747928503e-11
% O 0 2.750248217098933e-13
of O 0 6.223399074724301e-14
the O 0 6.739741577332925e-12
normal O 0 4.2494615826171867e-08
serum O 0 1.7950984698700267e-08
C5 O 0 1.0220575497044138e-08
level O 0 1.624545636902397e-10
and O 0 1.2690727375225253e-12
normal O 0 4.125506186669625e-11
concentrations O 0 2.4205970561297363e-11
of O 0 8.939057176762799e-14
other O 0 6.142412099785499e-12
complement O 0 5.136785441450797e-10
components O 0 3.343791377119487e-08
. O 0 1.3898822093239005e-09

C5 O 0 4.78049369121436e-05
levels O 0 2.045052127641611e-08
of O 0 8.308222816319488e-13
other O 0 9.954494910660583e-13
family O 0 1.3485179639616263e-10
members O 0 7.45159196933326e-13
were O 0 1.1169029243141004e-11
either O 0 5.129398641945393e-12
normal O 0 4.269784803501153e-10
or O 0 6.049424156051586e-11
approximately O 0 2.516097608040724e-10
half O 0 3.3708320579250994e-09
- O 0 1.6025175000322633e-06
normal O 0 2.9559217296082352e-08
, O 0 1.127287239249819e-11
consistent O 0 6.335187929806807e-10
with O 0 4.15061084460544e-12
autosomal O 0 2.8883680442959303e-06
codominant O 0 2.927690729848109e-07
inheritance O 0 2.451460145991291e-09
of O 0 1.4431641645606952e-12
the O 0 4.708311431705914e-12
gene O 0 2.241074980702251e-06
determining O 0 0.000150248859426938
C5 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
. O 0 1.1942393030039966e-07

Normal O 0 3.729139643837698e-05
hemolytic O 1 0.9931430816650391
titers O 0 0.0010286567267030478
were O 0 7.235333221444762e-09
restored O 0 3.900328593431368e-08
to O 0 7.304992027945545e-11
both O 0 3.7143688125240715e-10
homozygous O 0 0.38099727034568787
C5 B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999986886978149
deficient I-Disease 1 1.0
( O 0 1.1140412681243106e-07
C5D B-Disease 1 0.9999998807907104
) O 0 1.98567232101432e-10
sera O 0 1.6198155208257958e-06
by O 0 7.263844473831549e-13
addition O 0 5.235537697823034e-12
of O 0 4.517153795111084e-13
highly O 0 4.0176767468480534e-10
purified O 0 8.625733904921162e-09
human O 0 2.505104346184339e-09
C5 O 0 6.507162311208958e-07
. O 0 3.3016138711872145e-09

In O 0 5.279504611266361e-10
specific O 0 3.214323918143691e-09
C5 O 0 3.884189538894134e-07
titrations O 0 6.065631623641821e-07
, O 0 4.36769578837648e-11
however O 0 1.3372161451058462e-12
, O 0 6.687926579727888e-13
it O 0 1.3933626388101805e-12
was O 0 8.391428524268107e-11
noted O 0 5.526236759867409e-11
that O 0 5.379961341873962e-13
when O 0 2.415332745007298e-13
limited O 0 5.164718479278019e-13
amounts O 0 4.600627604572916e-13
of O 0 5.485904157158383e-13
C5 O 0 1.1608300987120401e-08
were O 0 2.060429188377455e-10
assayed O 0 1.0517573478807662e-08
in O 0 7.070004846322642e-13
the O 0 1.3224104699737643e-13
presence O 0 2.8083970912695655e-11
of O 0 2.9378268481122793e-13
low O 0 7.095818932434383e-10
dilutions O 0 3.6105853862267168e-09
of O 0 9.540775287864012e-12
either O 0 1.953152484190923e-08
C5D B-Disease 1 0.9999997615814209
serum O 0 4.985105661603484e-08
, O 0 2.634773692625214e-12
curving O 0 1.019265449819784e-09
rather O 0 6.6305073410932724e-12
than O 0 1.080076349538328e-12
linear O 0 1.0301826752767695e-10
dose O 0 8.58348114807228e-11
- O 0 1.3491032291312877e-08
response O 0 1.7789709982896085e-10
plots O 0 1.6732029095578582e-08
were O 0 7.571919480309219e-11
consistently O 0 2.2823669343363662e-10
obtained O 0 5.067742015960053e-13
, O 0 6.612704904051386e-14
suggesting O 0 2.5211679532261e-12
some O 0 2.1550537504695655e-13
inhibitory O 0 5.562670879477594e-10
effect O 0 1.971803609279732e-09
. O 0 1.6853926032567301e-09

Further O 0 3.386166902430432e-10
studies O 0 1.7371042104752377e-11
suggested O 0 9.179585563900972e-11
that O 0 4.8866427397598056e-12
low O 0 7.878936614247323e-09
dilutions O 0 2.020881538555841e-06
of O 0 1.75696579507445e-09
C5D B-Disease 1 0.9999998807907104
serum O 0 1.7488346770733187e-07
contain O 0 7.149886238622116e-11
a O 0 4.1065996089773016e-12
factor O 0 5.137743355754232e-11
( O 0 5.477999239118791e-13
or O 0 9.553084885649543e-12
factors O 0 4.633371377543716e-12
) O 0 5.425021868364632e-13
interfering O 0 1.098778734665018e-09
at O 0 2.487049732824431e-10
some O 0 1.0290995486328391e-12
step O 0 1.960406142975657e-10
in O 0 2.5818998089684186e-13
the O 0 1.8367707528554877e-12
hemolytic O 0 1.0467607353348285e-05
assay O 0 1.3810719234896851e-09
of O 0 1.1348155488227762e-12
C5 O 0 3.391326552915075e-09
, O 0 1.6391102884705244e-12
rather O 0 5.236753413719042e-13
than O 0 1.6450078061877593e-12
a O 0 6.9320851142640194e-12
true O 0 1.325435872168157e-09
C5 O 0 1.8400709222987643e-07
inhibitor O 0 2.814450184018824e-08
or O 0 1.4370602485769268e-09
inactivator O 0 1.0941386108243023e-06
. O 0 3.2589071441435635e-09

Of O 0 3.13090414705286e-10
clinical O 0 1.720534754667824e-07
interest O 0 4.622230154183171e-09
are O 0 2.0822323032465562e-11
( O 0 1.1864580498621713e-12
a O 0 5.612221624928804e-12
) O 0 4.520170316605482e-13
the O 0 1.1820144201531851e-13
documentation O 0 7.664603174362128e-09
of O 0 4.7102721029146366e-11
membranous O 0 0.4288225471973419
glomerulonephritis B-Disease 1 1.0
, O 0 1.1044239727198146e-05
vasculitis B-Disease 1 1.0
, O 0 3.569663533653511e-07
and O 0 3.837543408735655e-05
arthritis B-Disease 1 1.0
in O 0 3.5727415470532264e-10
an O 0 1.9539554696468286e-10
individual O 0 4.828141220158955e-10
lacking O 0 3.0545945772786354e-09
C5 O 0 5.0347853886023586e-08
( O 0 2.2264608559585675e-11
and O 0 3.3472578875315406e-11
its O 0 5.873732056294045e-12
biologic O 0 2.6376134609762403e-09
functions O 0 1.8784833064056095e-11
) O 0 1.5089538776477673e-12
, O 0 3.7928371381112935e-12
and O 0 1.7983307551427963e-11
( O 0 3.0298942608336654e-12
b O 0 6.933880580817231e-09
) O 0 3.125755947477882e-13
a O 0 1.7519536169019467e-12
remarkable O 0 4.812823473088201e-10
propensity O 0 3.4464301279513165e-07
to O 0 6.877309832731271e-09
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 6.348409020695556e-10
the O 0 1.4018750570110594e-11
proband O 0 1.972214960233032e-07
, O 0 1.7076695960072108e-11
even O 0 2.3953400027365568e-12
during O 0 1.8746310927186816e-12
periods O 0 6.127297974556356e-11
of O 0 4.040910943532705e-13
low O 0 1.0837847952416269e-08
- O 0 4.1989128618524774e-08
dose O 0 3.6418387749925785e-10
or O 0 5.250139906154416e-11
alternate O 0 3.037186474541542e-11
- O 0 1.210858613376331e-08
day O 0 2.3251686687153494e-10
corticosteroid O 0 9.929711275447062e-09
therapy O 0 5.403882674670513e-09
. O 0 2.0403125022827595e-10

Other O 0 2.4798390771407774e-11
observations O 0 1.1866182481057308e-09
indicate O 0 3.8060080087554127e-10
that O 0 2.7441451888599033e-12
the O 0 1.1812217870499353e-12
C5D B-Disease 1 0.9999996423721313
state O 0 1.9931349973245638e-11
is O 0 4.869086037140313e-12
compatible O 0 2.0817805812534118e-10
with O 0 1.4122362133883737e-12
normal O 0 5.370424660533502e-10
coagulation O 0 3.1889022533704292e-09
function O 0 5.560785609759478e-09
and O 0 3.165483153377835e-11
the O 0 3.78269843833573e-13
capacity O 0 5.898771748835685e-11
to O 0 9.581460624907834e-12
mount O 0 1.1184755521753686e-06
a O 0 4.212678206272358e-08
neutrophilic O 1 0.9164378046989441
leukocytosis O 0 0.009879874996840954
during O 0 2.6547203901827743e-07
pyogenic B-Disease 1 0.7621129155158997
infection I-Disease 0 0.01977998949587345
. O 0 1.1113322484490595e-09
. O 0 2.4311352930794783e-09

Susceptibility O 0 0.0009443418821319938
to O 0 4.695872917181987e-07
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 1.4785177882004064e-06
twins O 0 3.7032918953627814e-06
: O 0 4.903196338529314e-12
the O 0 1.0165589344694054e-13
role O 0 6.697120288889913e-12
of O 0 1.5585867015402433e-14
genes O 0 2.487432829156866e-11
, O 0 1.4806403715941774e-12
HLA O 0 3.2619004741718527e-07
, O 0 1.165977037143051e-10
and O 0 3.0076306029025446e-11
the O 0 8.3244539733629e-12
environment O 0 9.29949894867832e-09
. O 0 9.375954457269131e-10

OBJECTIVE O 0 1.0757982948916833e-07
To O 0 2.7665765511830642e-11
determine O 0 1.6373177119666238e-11
the O 0 1.700416744259206e-13
relative O 0 1.188241588456762e-10
effects O 0 2.525208375736554e-10
of O 0 3.6716340552763946e-14
genetic O 0 1.2254209869055899e-09
and O 0 2.849320605846639e-12
environmental O 0 1.1377853520455616e-11
factors O 0 8.321469381622482e-12
in O 0 3.983776850069454e-12
susceptibility O 0 8.403215360885952e-06
to O 0 7.406899385387078e-06
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 0.0001253623777301982
AS B-Disease 1 0.9999992847442627
) O 0 1.9215105062642124e-09
. O 0 1.7362281612420816e-09

METHODS O 0 1.523524417734734e-07
Twins O 0 1.351062053345231e-07
with O 0 1.4786805113686796e-10
AS B-Disease 1 0.9998499155044556
were O 0 7.03715766214863e-11
identified O 0 1.033393037808139e-09
from O 0 3.763806757581256e-13
the O 0 9.485122106148158e-13
Royal O 0 4.480657789240894e-10
National O 0 1.9413212704044724e-10
Hospital O 0 1.5975339806573174e-07
for O 0 2.106460561535073e-10
Rheumatic B-Disease 1 0.9993926286697388
Diseases I-Disease 0 0.0004152890178374946
database O 0 1.5866717149037868e-06
. O 0 2.876646121308113e-08

Clinical O 0 1.0475009730726015e-06
and O 0 1.9427930375570668e-09
radiographic O 0 2.8890877729281783e-05
examinations O 0 1.3464451775746511e-08
were O 0 1.3125744935393868e-10
performed O 0 2.608713522977979e-10
to O 0 1.2881729103547679e-12
establish O 0 5.401345481992337e-10
diagnoses O 0 1.1173411621712148e-05
, O 0 9.791169958139889e-11
and O 0 6.630299087539981e-10
disease O 0 3.05282483168412e-05
severity O 0 1.0241323877835384e-07
was O 0 2.2067614402487834e-09
assessed O 0 2.835132573153487e-09
using O 0 9.625702318549756e-11
a O 0 2.3980487040553555e-10
combination O 0 2.362969819813543e-10
of O 0 2.884623529625374e-12
validated O 0 1.299956498002075e-08
scoring O 0 5.840818051439101e-09
systems O 0 1.6520723988833197e-07
. O 0 1.716671693685612e-09

HLA O 0 0.0014298473251983523
typing O 0 1.3519669664674439e-05
for O 0 3.3775493513132915e-10
HLA O 0 1.786172106221784e-05
- O 0 3.6897336030961014e-07
B27 O 0 4.6950489718255994e-08
, O 0 2.8683467059864576e-11
HLA O 0 2.2018187451067206e-07
- O 0 1.9326522604501406e-08
B60 O 0 9.890697150183314e-09
, O 0 2.676745327126473e-12
and O 0 6.350752389250314e-12
HLA O 0 1.652866558288224e-06
- O 0 5.109284870741249e-07
DR1 O 0 0.0006128866225481033
was O 0 4.857088620191519e-10
performed O 0 1.6678061709463066e-11
by O 0 6.62123689752249e-14
polymerase O 0 6.705307975529706e-10
chain O 0 4.833875077991934e-09
reaction O 0 4.178796891851633e-11
with O 0 1.3706116591075818e-13
sequence O 0 6.230902599435595e-11
- O 0 6.643755545709951e-10
specific O 0 6.6214581560808394e-12
primers O 0 5.738712838265769e-10
, O 0 1.968414797479112e-12
and O 0 1.0935168786099791e-12
zygosity O 0 2.6146527165593625e-09
was O 0 1.2138148819396122e-10
assessed O 0 3.5567634948385773e-10
using O 0 8.727839562183703e-10
microsatellite O 0 1.4060959983908106e-05
markers O 0 9.609344488126226e-06
. O 0 3.230638156992427e-08

Genetic O 0 9.285516284762707e-07
and O 0 1.1325462789812946e-10
environmental O 0 2.9126388800815306e-11
variance O 0 1.199822186048749e-10
components O 0 2.881357730188938e-08
were O 0 8.623619179859432e-11
assessed O 0 1.771739088773927e-09
with O 0 1.4468132638126296e-12
the O 0 1.1490775778805196e-12
program O 0 3.060454112358002e-10
Mx O 0 5.963305937939367e-08
, O 0 7.767750201739809e-14
using O 0 2.624725794781596e-13
data O 0 1.6658254636814362e-11
from O 0 1.0440855401387325e-13
this O 0 7.948504593228989e-13
and O 0 9.57855583044731e-12
previous O 0 1.784785340352979e-11
studies O 0 3.1953938193357567e-12
of O 0 2.263660586017055e-13
twins O 0 7.733768292439436e-09
with O 0 1.5871158554059406e-10
AS B-Disease 1 0.9999923706054688
. O 0 5.282005499651632e-09

RESULTS O 0 1.87808893770125e-07
Six O 0 1.1935550325858912e-09
of O 0 8.14228025280972e-12
8 O 0 1.304381713751468e-09
monozygotic O 0 9.788005854716175e-07
( O 0 1.4966623496093234e-09
MZ O 1 0.9998488426208496
) O 0 7.959048531347435e-09
twin O 0 0.007647433318197727
pairs O 0 1.1764844209949388e-08
were O 0 1.0317622312072672e-09
disease O 0 2.9421588010336563e-07
concordant O 0 5.1863693784071074e-08
, O 0 1.3670413759325761e-11
compared O 0 3.2013633410876707e-10
with O 0 1.0761553974336646e-11
4 O 0 1.0408575910891837e-11
of O 0 1.0035861031099103e-12
15 O 0 2.401499832327403e-10
B27 O 0 1.4371026679782517e-07
- O 0 1.4680140338896308e-06
positive O 0 1.055688514384201e-08
dizygotic O 0 9.513989596143801e-08
( O 0 9.373016945923851e-11
DZ O 0 2.4034554371610284e-05
) O 0 2.7736685170864916e-10
twin O 0 1.0568509196673403e-06
pairs O 0 1.1262969723535576e-10
( O 0 2.9557072935004758e-12
27 O 0 3.5266196213301626e-11
% O 0 1.0429033531949086e-13
) O 0 2.097380835631643e-13
and O 0 7.869432536167231e-12
4 O 0 5.969485756401882e-12
of O 0 3.761511935262973e-12
32 O 0 5.6679780868762464e-08
DZ O 1 0.9489812254905701
twin O 0 0.0006705683772452176
pairs O 0 5.30018862132664e-10
overall O 0 2.0901397279615708e-10
( O 0 2.5155192599074505e-12
12 O 0 3.3081838050202927e-12
. O 0 6.931486092563721e-13
5 O 0 6.472650974226335e-12
% O 0 1.7270502519414754e-12
) O 0 9.548203373788144e-12
. O 0 3.69813818457132e-10

Nonsignificant O 0 9.438775123271625e-06
increases O 0 1.0984922305112832e-08
in O 0 2.3815866813381437e-12
similarity O 0 1.2059249432372354e-10
with O 0 6.350433959072255e-13
regard O 0 2.2497257529119352e-11
to O 0 3.621152423055607e-12
age O 0 5.993736063025779e-10
at O 0 2.2355139961405257e-09
disease O 0 2.1901591935602482e-06
onset O 0 6.718166645214296e-08
and O 0 7.254579159621244e-10
all O 0 2.6015953714236817e-12
of O 0 1.796875229989267e-13
the O 0 1.5156525340342952e-11
disease O 0 5.475899342854973e-06
severity O 0 3.520126767853071e-08
scores O 0 1.7273206864842905e-08
assessed O 0 5.591245244573884e-09
were O 0 2.0445976856020565e-10
noted O 0 6.018698317511451e-10
in O 0 6.428620136222918e-11
disease O 0 0.00019289582269266248
- O 0 0.16471722722053528
concordant O 1 0.9776026606559753
MZ O 1 0.9998375177383423
twins O 0 1.9438984963926487e-06
compared O 0 5.353061993673691e-09
with O 0 7.682923741647585e-10
concordant O 0 0.00024301426310557872
DZ O 1 0.5383049845695496
twins O 0 3.0148714813549304e-06
. O 0 9.998966987723179e-09

HLA O 0 0.0035275137051939964
- O 0 4.6224795369198546e-05
B27 O 0 1.0093540367961396e-06
and O 0 2.5037560913432344e-10
B60 O 0 7.288520897930084e-09
were O 0 1.264699803216196e-11
associated O 0 1.072469613117022e-10
with O 0 1.672223232281056e-12
the O 0 5.52228315159331e-12
disease O 0 1.6200100390051375e-06
in O 0 4.864906220924947e-13
probands O 0 3.9424759279427235e-07
, O 0 2.22310000269621e-11
and O 0 1.73126519630723e-12
the O 0 5.993212111483903e-13
rate O 0 3.8093961762797335e-08
of O 0 8.336222879525013e-13
disease O 0 1.4011558846505068e-07
concordance O 0 6.584375267237874e-10
was O 0 3.0150182350752175e-10
significantly O 0 8.393929440408954e-10
increased O 0 1.9784753835239144e-09
among O 0 7.096793708250004e-10
DZ O 1 0.9949749708175659
twin O 0 0.06695979088544846
pairs O 0 9.972374037658938e-10
in O 0 3.69529276969538e-12
which O 0 4.4542491223209524e-11
the O 0 1.5375249684534964e-11
co O 0 7.107378792170493e-07
- O 0 1.2636138535526698e-06
twin O 0 3.9501710489275865e-06
was O 0 1.4957548533089948e-09
positive O 0 3.3197080501201626e-11
for O 0 3.2418146400821357e-13
both O 0 1.9005309478958843e-12
B27 O 0 1.4104758250255145e-08
and O 0 1.5049924639853884e-09
DR1 O 0 0.0009041696903295815
. O 0 4.385974694542938e-09

Additive O 0 1.7877904667784605e-07
genetic O 0 1.6533183710976118e-08
effects O 0 5.370099476209589e-09
were O 0 1.0843951604722069e-11
estimated O 0 1.9332502612656732e-11
to O 0 3.212956430857089e-13
contribute O 0 3.688077621077923e-11
97 O 0 1.919268965977494e-09
% O 0 2.4755232586048947e-12
of O 0 1.3885889508548355e-13
the O 0 3.2002610197284787e-12
population O 0 8.903949105798503e-11
variance O 0 2.715264013630758e-09
. O 0 7.492052311874886e-09

CONCLUSION O 0 4.515061657883734e-09
Susceptibility O 0 5.233721367403632e-07
to O 0 7.304619131787149e-10
AS B-Disease 1 0.9999673366546631
is O 0 2.8058699461097625e-11
largely O 0 2.7304610395600948e-12
genetically O 0 2.6516438350610017e-11
determined O 0 8.025080044937738e-10
, O 0 9.301294977281938e-12
and O 0 3.868994100791889e-12
the O 0 1.2344172992811986e-13
environmental O 0 6.632343979573463e-11
trigger O 0 1.8544342728077368e-09
for O 0 2.58297983696254e-12
the O 0 4.918465981718079e-11
disease O 0 6.217576446942985e-05
is O 0 4.0772657472487595e-10
probably O 0 1.4797343794725748e-08
ubiquitous O 0 3.11044118461723e-07
. O 0 3.726917441326805e-09

HLA O 0 0.0043349782936275005
- O 0 6.27647023065947e-05
B27 O 0 9.28613587802829e-07
accounts O 0 3.6520868551548347e-09
for O 0 1.242629154955821e-12
a O 0 4.380516782642729e-12
minority O 0 8.812241908406904e-11
of O 0 4.171909671023266e-14
the O 0 4.47400464928787e-14
overall O 0 1.7501743110326373e-11
genetic O 0 3.7240683870010116e-09
susceptibility O 0 3.358588784863059e-08
to O 0 1.101685764837157e-08
AS B-Disease 1 0.9999986886978149
. O 0 2.4625446570780696e-08

Cell O 0 1.7375648894812912e-05
cycle O 0 4.043695753352949e-06
- O 0 2.5479268970229896e-06
dependent O 0 3.626903932740788e-08
colocalization O 0 1.5711430023657158e-07
of O 0 9.211045121082506e-12
BARD1 O 0 7.325907972699497e-06
and O 0 8.557163311273541e-11
BRCA1 O 0 2.5939588255141643e-09
proteins O 0 4.686656011193557e-12
in O 0 3.069885654276988e-13
discrete O 0 1.5269741027168493e-08
nuclear O 0 0.00010100648069055751
domains O 0 1.2951765882007749e-07
. O 0 2.569583656963914e-09

Germ O 0 0.0032301791943609715
- O 0 0.0006212506559677422
line O 0 1.6310227692883927e-06
mutations O 0 2.2429851753713592e-08
of O 0 1.052034110868294e-12
the O 0 2.2821384539073453e-12
BRCA1 O 0 1.7409412578217598e-08
gene O 0 2.2178676672979236e-09
predispose O 0 6.896234694409031e-10
women O 0 3.0463223089916003e-12
to O 0 1.4843077938628269e-12
early O 0 2.07328199053336e-09
- O 1 0.9517210125923157
onset O 1 0.9997071623802185
breast B-Disease 1 0.9999998807907104
and I-Disease 1 0.9999966621398926
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
by O 0 9.82484232858738e-11
compromising O 0 5.185687541597872e-07
the O 0 5.144330274264863e-12
genes O 0 1.6384500423072268e-09
presumptive O 0 9.242563692168915e-08
function O 0 1.9755037605762027e-09
as O 0 6.88954882727133e-12
a O 0 8.645852783706331e-11
tumor B-Disease 0 8.876744686858729e-06
suppressor O 0 3.0234401492634788e-05
. O 0 7.767685161752524e-08

Although O 0 3.198976639140483e-10
the O 0 1.726928387617288e-12
biochemical O 0 2.5113140456056726e-09
properties O 0 1.5609097658852988e-07
of O 0 9.068465596506758e-12
BRCA1 O 0 9.44447222650524e-08
polypeptides O 0 2.440119661883955e-09
are O 0 1.4267160369785259e-11
not O 0 4.8022007377579445e-12
understood O 0 1.5403371286804024e-11
, O 0 3.069668813842491e-13
their O 0 1.6724489360683131e-13
expression O 0 4.206954923313688e-11
pattern O 0 5.079638043525847e-08
and O 0 1.3216308603070104e-10
subcellular O 0 5.397498057391203e-07
localization O 0 1.0085754453825757e-08
suggest O 0 1.6945848890781434e-10
a O 0 5.942107916823147e-12
role O 0 3.59728774546042e-11
in O 0 7.026474671198435e-13
cell O 0 9.172562442927301e-08
- O 0 4.223807991365902e-06
cycle O 0 6.410214155039284e-07
regulation O 0 6.558458665040234e-09
. O 0 2.684428901389424e-09

When O 0 4.599829406259914e-09
resting O 0 2.4720492319829646e-07
cells O 0 6.415467046494427e-10
are O 0 2.2811637561542808e-12
induced O 0 2.4918753727121157e-09
to O 0 3.511348330154096e-12
proliferate O 0 2.504169138717316e-08
, O 0 2.5130110666016225e-12
the O 0 4.859082428955441e-13
steady O 0 8.45519068093381e-08
- O 0 7.610847951866617e-09
state O 0 1.2493625925480423e-11
levels O 0 6.695971034587078e-12
of O 0 1.682979080261989e-14
BRCA1 O 0 1.458078796590101e-10
increase O 0 1.5907783987648139e-12
in O 0 1.5870196324631325e-13
late O 0 1.3422207789659524e-10
G1 O 0 2.2390254628135153e-07
and O 0 2.300863492787908e-11
reach O 0 1.1822794479532384e-11
a O 0 6.726436681953052e-12
maximum O 0 1.418159756294557e-10
during O 0 1.0116634197032681e-09
S O 0 1.1896114301634952e-05
phase O 0 1.160566664992757e-08
. O 0 1.6215065956615149e-09

Moreover O 0 3.73560915534199e-08
, O 0 7.335541202246887e-11
in O 0 1.4299491495409211e-12
S O 0 3.576526751203346e-06
phase O 0 6.402586461007331e-09
cells O 0 1.4029891692857177e-09
, O 0 1.1651716050331551e-11
BRCA1 O 0 2.2689214951299164e-09
polypeptides O 0 3.704082041089407e-10
are O 0 3.190613138276399e-12
hyperphosphorylated O 0 1.1620351791918893e-08
and O 0 2.3785690431155082e-11
accumulate O 0 1.5701708822035698e-09
into O 0 5.145330776029633e-12
discrete O 0 2.343009875005464e-08
subnuclear O 0 1.2906965821457561e-05
foci O 0 1.73268961134454e-06
termed O 0 4.918032914247306e-07
" O 0 3.522497493690935e-08
BRCA1 O 0 1.9722799606824992e-06
nuclear O 0 5.251595212030225e-07
dots O 0 1.9744395274301496e-07
. O 0 1.1007742273250187e-08

" O 0 2.72058997552449e-07
BRCA1 O 0 2.935613338195253e-06
associates O 0 1.7139447550107434e-07
in O 0 3.9879809524134835e-12
vivo O 0 5.7097154240182135e-06
with O 0 4.467034381283597e-12
a O 0 3.354870201088822e-11
structurally O 0 1.0932311624856084e-06
related O 0 2.6348041970436498e-08
protein O 0 5.1234543718692294e-08
termed O 0 2.2699066448694794e-06
BARD1 O 0 9.751108154887334e-05
. O 0 2.1028979446668927e-08

Here O 0 5.055799334741096e-09
we O 0 2.3276301025498825e-11
show O 0 6.490456089247587e-11
that O 0 1.207463084596308e-13
the O 0 3.227714590828962e-14
steady O 0 7.056573547714606e-09
- O 0 3.319534203072294e-09
state O 0 7.637943229277244e-12
levels O 0 7.614974623093573e-12
of O 0 1.3201743707556488e-14
BARD1 O 0 3.144227100904118e-09
, O 0 7.806515850417028e-14
unlike O 0 2.4939243920864274e-13
those O 0 6.332227900666607e-14
of O 0 4.912907984621663e-14
BRCA1 O 0 2.5786519586290524e-09
, O 0 4.317179426449602e-12
remain O 0 2.5597341954397557e-11
relatively O 0 1.058170651796475e-11
constant O 0 1.0221292701118045e-09
during O 0 8.572457188549265e-10
cell O 0 2.5177671432174975e-06
cycle O 0 2.0512889022938907e-06
progression O 0 1.2196793250041083e-05
. O 0 1.9060783174040807e-08

However O 0 1.653172487792176e-09
, O 0 7.304281485209785e-11
immunostaining O 0 7.882682950821618e-08
revealed O 0 4.605386738631978e-09
that O 0 5.45029230081262e-11
BARD1 O 0 3.606035534176044e-06
resides O 0 1.7038299660043776e-08
within O 0 1.74175222855677e-11
BRCA1 O 0 8.152910169201277e-08
nuclear O 0 5.701797434198852e-08
dots O 0 2.075837945980652e-09
during O 0 1.102569563427025e-10
S O 0 3.494745897114626e-07
phase O 0 1.1632403373873501e-10
of O 0 7.120506576941202e-14
the O 0 1.4305649221647843e-13
cell O 0 2.0860306815251306e-09
cycle O 0 5.119573653900034e-09
, O 0 7.12994507184872e-12
but O 0 1.894642429056681e-12
not O 0 3.3022749031802467e-13
during O 0 4.380965804972464e-13
the O 0 9.803567463037566e-13
G1 O 0 3.719654273481865e-08
phase O 0 2.6875794922887053e-09
. O 0 9.31163535167201e-10

Nevertheless O 0 3.7804943531227764e-07
, O 0 7.527198309098537e-10
BARD1 O 0 6.115951691754162e-07
polypeptides O 0 7.001859536615029e-09
are O 0 6.619475800828667e-12
found O 0 1.420676185200087e-12
exclusively O 0 6.225210017613003e-12
in O 0 6.08478220066877e-13
the O 0 5.533139593207059e-13
nuclear O 0 1.6764029053817353e-09
fractions O 0 1.1747823850868921e-12
of O 0 3.3021349055747246e-14
both O 0 3.3674191907140383e-13
G1 O 0 1.7769551163837605e-08
- O 0 3.1057602711825893e-08
and O 0 1.987536663028422e-10
S O 0 1.5411643516927143e-06
- O 0 1.9357095926153534e-09
phase O 0 6.645669570204404e-10
cells O 0 9.541167855786625e-10
. O 0 3.1500357877689567e-10

Therefore O 0 1.996496745704235e-09
, O 0 3.828577038733627e-11
progression O 0 8.929520234346455e-09
to O 0 2.7031592242376945e-11
S O 0 9.0394505605218e-06
phase O 0 3.0193014755042213e-09
is O 0 1.501747858012603e-11
accompanied O 0 5.02745588215614e-11
by O 0 1.5062126892950722e-13
the O 0 8.8961945991263e-14
aggregation O 0 1.971731111716224e-10
of O 0 3.354279961426121e-12
nuclear O 0 4.5141163695916475e-07
BARD1 O 0 5.318077000993071e-08
polypeptides O 0 1.0410471373845098e-09
into O 0 8.346286856086849e-11
BRCA1 O 0 8.082677993570542e-08
nuclear O 0 1.3857726344213006e-07
dots O 0 6.739779934150647e-08
. O 0 3.0958107188894246e-09

This O 0 5.7604896547269746e-11
cell O 0 1.990593290202014e-07
cycle O 0 7.590003292534675e-07
- O 0 1.2986821502636303e-06
dependent O 0 1.471698318766812e-08
colocalization O 0 3.663433290057583e-07
of O 0 1.1615192314906597e-11
BARD1 O 0 3.458794526522979e-05
and O 0 7.160234627434647e-10
BRCA1 O 0 6.550834541485528e-08
indicates O 0 1.0601529376597085e-10
a O 0 2.486459172237887e-12
role O 0 1.6373583044959616e-11
for O 0 1.008852398322324e-12
BARD1 O 0 1.5056599522722536e-07
in O 0 1.0564644645216781e-11
BRCA1 O 0 1.420746229996439e-06
- O 0 5.026829967391677e-06
mediated O 0 1.5814412108738907e-05
tumor B-Disease 0 0.0006143313948996365
suppression O 0 4.1483745008008555e-06
. O 0 2.4508397089562095e-08

Ethnic O 0 1.0336536888644332e-06
differences O 0 1.6556384707655525e-07
in O 0 4.9719648537172034e-11
the O 0 5.1499679520894404e-11
HFE O 0 7.1115127866505645e-06
codon O 0 3.769937606534768e-08
282 O 0 6.912475924991668e-09
( O 0 1.347178479882416e-10
Cys O 0 2.8077589377062395e-05
/ O 0 6.068818493076833e-06
Tyr O 0 6.5452024955448e-07
) O 0 1.7278956043753624e-10
polymorphism O 0 1.0919521287178213e-07
. O 0 3.3690901179994626e-09

Recent O 0 4.780813078752999e-09
studies O 0 2.7068905450455816e-10
have O 0 3.155638944596362e-11
shown O 0 1.91315074893339e-09
that O 0 1.0389553750655978e-07
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 4.1024891288543586e-06
HH B-Disease 1 0.9999991655349731
) O 0 3.133431292212663e-10
is O 0 4.463433789236859e-11
likely O 0 1.559975065790198e-11
to O 0 9.329114087144874e-13
be O 0 9.467142347840962e-12
caused O 0 4.0739522866317657e-11
by O 0 1.2830237089769825e-12
homozygosity O 0 4.113459439736289e-08
for O 0 5.255707761359085e-12
a O 0 5.372080905119425e-11
Cys282Tyr O 0 9.742059603468078e-08
mutation O 0 3.2583150066933797e-10
in O 0 1.1150483748140205e-12
the O 0 2.5169590803925113e-12
HFE O 0 3.741670582257939e-07
gene O 0 1.8398738532710013e-08
located O 0 5.7383687135370565e-08
4 O 0 2.4585731228654595e-09
. O 0 5.9818043851578295e-09

5 O 0 9.034643966288058e-08
Mb O 0 5.785647772427183e-06
telomeric O 0 8.95526900421828e-05
to O 0 7.844388250077827e-09
HLA O 0 0.0022905729711055756
- O 0 4.022732173325494e-05
A O 0 1.496574597581457e-08
. O 0 2.54570919899777e-09

Population O 0 3.2194946708585803e-10
studies O 0 2.7254828602329972e-11
of O 0 2.0397869659083585e-14
this O 0 6.559881218955177e-14
polymorphism O 0 8.591903855048599e-10
are O 0 2.852897497233886e-13
facilitated O 0 1.9907795897888825e-11
by O 0 4.3753878558455694e-13
the O 0 1.2767686755933705e-13
fact O 0 4.451452227660635e-12
that O 0 6.643821235351177e-13
the O 0 2.738361024479802e-13
Cys282Tyr O 0 3.682719551534319e-08
mutation O 0 9.225366026655024e-10
creates O 0 8.034771459275447e-11
a O 0 3.092656339354072e-11
Rsal O 0 7.950858815775064e-08
restriction O 0 1.7391522888487998e-08
site O 0 1.0636578053890844e-06
. O 0 6.723650525231051e-09

We O 0 2.7524539092382838e-08
have O 0 1.538085284136237e-11
studied O 0 1.0135744674122371e-11
the O 0 4.2730535364417233e-13
codon O 0 4.40936798185021e-09
282 O 0 3.8216789732814505e-09
( O 0 6.923328577101984e-11
Cys O 0 2.6507423172006384e-05
/ O 0 3.31230558003881e-06
Tyr O 0 6.940287278212054e-08
) O 0 7.42189296132345e-12
polymorphism O 0 6.598959712000863e-10
in O 0 9.323670308036824e-13
different O 0 9.493339274413426e-13
ethnic O 0 2.1541898820309768e-10
groups O 0 2.565488099737223e-10
. O 0 3.7500472171991817e-10

In O 0 1.4101945999822618e-10
agreement O 0 1.1517007486583353e-10
with O 0 1.647255899392408e-12
previous O 0 1.001422555990672e-10
observations O 0 7.01352798060384e-09
the O 0 4.150333722530153e-12
Tyr O 0 2.7200444563391102e-08
allele O 0 6.840976118915876e-10
appeared O 0 1.290626217009816e-10
to O 0 9.717113181803572e-13
be O 0 4.711743582103134e-12
rare O 0 6.20951276508741e-11
or O 0 1.3169887402852964e-09
absent O 0 1.291042939222109e-09
in O 0 3.903029809071423e-12
Asiatic O 0 5.56427348641364e-10
( O 0 2.5158167649835805e-12
Indian O 0 1.055411140427065e-11
, O 0 5.187959437047418e-13
Chinese O 0 4.340890982171969e-13
) O 0 5.933328372891011e-13
populations O 0 1.7635487514766623e-10
. O 0 1.392824605650489e-10

The O 0 4.619733207089638e-10
highest O 0 8.238676407756884e-10
allele O 0 1.127404503087348e-09
frequency O 0 1.8019892245035862e-09
( O 0 1.8634445115434106e-12
7 O 0 8.908531898277339e-12
. O 0 9.152058451367129e-13
5 O 0 1.1837297635153288e-12
% O 0 1.1042684507685946e-13
) O 0 1.6024074428466761e-13
was O 0 3.818587668291684e-10
found O 0 4.623821464599942e-11
in O 0 4.086089973320828e-12
Swedes O 0 4.670475561852072e-09
. O 0 7.677855018428659e-10

Saamis O 0 1.3317991033545695e-05
( O 0 1.2775701607736778e-09
2 O 0 1.5202884784404347e-10
% O 0 6.513532335022942e-12
) O 0 2.3563334443366113e-12
and O 0 3.071376486474264e-11
Mordvinians O 0 2.9123933487085196e-08
( O 0 1.0619935920247459e-12
1 O 0 3.909189053193096e-13
. O 0 2.5555995037188084e-13
8 O 0 1.4642503789324968e-12
% O 0 4.3864319457503215e-14
) O 0 1.0753397006397006e-13
had O 0 2.496092221804247e-11
significantly O 0 3.7628563459568554e-11
lower O 0 1.5807256545374848e-11
frequencies O 0 2.18342330327026e-10
of O 0 1.982181562984464e-12
the O 0 1.461241544431502e-10
Tyr O 0 6.822569389441924e-07
allele O 0 1.0402283834309856e-07
. O 0 3.477409027397016e-09

Comparisons O 0 1.5582942936021027e-08
with O 0 3.004579918197692e-11
allele O 0 6.701894039728984e-10
frequencies O 0 1.5420781318553622e-10
based O 0 2.624553005481367e-11
on O 0 1.0814873996345398e-10
prevalence O 0 5.085930752102286e-07
estimates O 0 3.3978140301371695e-09
of O 0 3.055372621574293e-11
HH B-Disease 1 0.9999914169311523
showed O 0 1.5815353435755242e-06
some O 0 1.2360912640674293e-11
disagreements O 0 7.896177933730542e-09
with O 0 1.4553432244046594e-12
the O 0 4.203654026431469e-13
RFLP O 0 4.76656358827654e-09
data O 0 1.2112916225603954e-10
, O 0 1.2652974371377135e-12
particularly O 0 3.510350647314975e-12
in O 0 3.1696925899965533e-12
Finns O 0 1.0555496032793599e-08
. O 0 1.2286085482315912e-09

The O 0 3.3563456458551855e-09
newly O 0 1.811871008783328e-08
described O 0 6.628231119520933e-08
HFE O 0 9.75217844825238e-05
marker O 0 4.096300472156145e-06
provides O 0 6.552225428890779e-11
a O 0 2.795729142981984e-12
new O 0 1.674559579542545e-12
approach O 0 5.221598153859475e-11
to O 0 7.717750050151295e-13
the O 0 5.19084693848329e-14
screening O 0 7.310901883883503e-11
of O 0 1.1876127251758684e-12
HH B-Disease 1 0.9998706579208374
as O 0 6.465250557141644e-11
well O 0 8.339837501147862e-12
as O 0 9.548630197078398e-14
studies O 0 4.746845820059742e-14
of O 0 2.765431494436703e-15
the O 0 1.9756733141834681e-13
relationship O 0 2.7379262745874655e-10
between O 0 1.6776134301177414e-11
the O 0 2.790993998413871e-11
HFE O 0 0.00011406559497117996
Tyr O 0 3.3954066225305723e-07
allele O 0 1.968933283080787e-08
and O 0 5.878453973595654e-11
different O 0 6.498656474063225e-11
disorders O 0 2.9394707325991476e-06
including O 0 9.675724221835935e-09
cancer B-Disease 0 0.0012343127746134996

Autosomal B-Disease 1 0.9999310970306396
dominant I-Disease 1 0.9984629154205322
neurohypophyseal I-Disease 1 0.999958872795105
diabetes I-Disease 1 0.9999979734420776
insipidus I-Disease 1 0.999758780002594
associated O 0 1.3722769836022053e-06
with O 0 1.6020827720009123e-10
a O 0 1.6673457059468433e-10
missense O 0 1.3516088301912532e-06
mutation O 0 3.188026509448605e-09
encoding O 0 4.757190641413445e-09
Gly23 O 0 5.97265716351103e-06
- O 0 0.00031366964685730636
- O 0 0.0006061369203962386
> O 0 5.1255359068136386e-08
Val O 0 6.895132537465543e-05
in O 0 3.979938045794995e-10
neurophysin O 0 8.022568181331735e-06
II O 0 1.3728458725381643e-05
. O 0 6.583524836401011e-09

Autosomal B-Disease 1 0.9998761415481567
dominant I-Disease 1 0.9977320432662964
neurohypophyseal I-Disease 1 0.9999390840530396
diabetes I-Disease 1 0.9999980926513672
insipidus I-Disease 1 0.9994922876358032
( O 0 1.7611705871445338e-08
ADNDI B-Disease 0 9.432004299014807e-05
) O 0 2.9869484663436197e-10
is O 0 1.885646749855141e-09
an O 0 4.07544886726896e-09
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 4.416004685481312e-06
by O 0 1.735687704673694e-10
progressive O 0 2.9592188184324186e-06
degeneration O 0 0.06220443919301033
of O 0 1.7461298032483974e-11
the O 0 1.8078606320304225e-11
magnocellular O 0 1.146022583498052e-07
neurons O 0 4.431957023598443e-09
of O 0 7.46450806981408e-13
the O 0 9.767341015848308e-13
hypothalamus O 0 4.682436660630174e-09
leading O 0 5.761096599776749e-10
to O 0 1.1311597492014158e-11
decreased O 0 1.349256848470759e-07
ability O 0 2.6337765302031357e-10
to O 0 1.4376941477600713e-12
produce O 0 1.953851108682514e-10
the O 0 1.2662293089049648e-12
hormone O 0 2.5460283881173496e-10
arginine O 0 2.1597397481532e-10
vasopressin O 0 4.27309299055878e-10
( O 0 2.0021881722009915e-11
AVP O 0 3.463503617240349e-08
) O 0 1.4789258706571218e-10
. O 0 4.678559761828183e-10

Affected O 0 7.813077331775276e-07
individuals O 0 2.4507063045575705e-10
are O 0 1.3119630382085745e-11
not O 0 8.450917916846823e-12
symptomatic O 0 5.564753546849488e-09
at O 0 2.7114031020403218e-09
birth O 0 5.288800064562338e-09
, O 0 1.983237532532378e-11
but O 0 5.778084607999112e-11
usually O 0 8.479310587006239e-10
develop O 0 5.991078211309286e-08
diabetes B-Disease 0 7.3435359809082e-05
insipidus I-Disease 0 0.00038564205169677734
at O 0 1.6886892240108864e-07
1 O 0 7.84947662424429e-09
- O 0 0.4354783594608307
6 O 0 6.24111748948053e-08
yr O 0 2.016529833781533e-05
of O 0 3.851670718479916e-11
age O 0 2.2228405782698246e-08
. O 0 7.839119353647561e-10

The O 0 6.541985703156783e-11
genetic O 0 7.969743087699044e-09
locus O 0 7.713541805287605e-09
of O 0 1.3661525903596594e-11
the O 0 1.4077142229673711e-10
disease O 0 0.0014036173233762383
is O 0 3.3212299577201065e-10
the O 0 2.094552482845291e-11
AVP O 0 1.276333841815358e-05
- O 0 1.3330495676200371e-05
neurophysin O 0 2.3602797227795236e-06
II O 0 1.135727075052273e-06
( O 0 2.3794809872468292e-11
NPII O 0 1.2415277694799443e-08
) O 0 6.779939023399129e-13
gene O 0 1.4098018585873007e-10
, O 0 5.665783380653933e-12
and O 0 8.114807437120675e-12
mutations O 0 1.5341519166156559e-09
that O 0 3.613294125709432e-12
cause O 0 1.6539002112292422e-10
ADNDI B-Disease 0 5.104024580759869e-07
have O 0 8.572027809794491e-11
been O 0 3.392216021969041e-11
found O 0 2.45911450924563e-11
in O 0 1.7283411843631996e-13
both O 0 3.1998687553824734e-13
the O 0 1.2297313774917162e-13
signal O 0 8.808565543638736e-10
peptide O 0 2.6268518610317315e-11
of O 0 2.6413272339719657e-14
the O 0 6.672878395674875e-13
prepro O 0 4.4063860116239084e-08
- O 0 1.2827929651848535e-07
AVP O 0 1.0150897651328705e-06
- O 0 5.8641397515657445e-08
NPII O 0 5.810508696413308e-08
precursor O 0 5.248600998264408e-10
and O 0 2.1452053675097282e-11
within O 0 2.681953964467354e-11
NPII O 0 4.040347505451791e-07
itself O 0 4.018398946925572e-09
. O 0 9.244917609230185e-10

An O 0 5.176679085394653e-10
affected O 0 1.5970815070431854e-07
girl O 0 0.00027876405511051416
who O 0 8.5654300319149e-10
presented O 0 2.4352027339080706e-11
at O 0 2.83765205777442e-10
9 O 0 5.128050761804559e-11
months O 0 5.5167901497066296e-11
of O 0 3.96009315834292e-13
age O 0 2.2457420811861084e-08
and O 0 1.6488080900600721e-09
her O 0 2.0118868793161937e-09
similarly O 0 1.407814309573041e-09
affected O 0 1.5433058164759927e-09
younger O 0 7.718262140521404e-10
brother O 0 7.876115404314987e-08
and O 0 4.332543213081408e-10
father O 0 1.1418330281287581e-08
were O 0 8.460405293009288e-11
all O 0 8.491241564045904e-13
found O 0 3.4197325960577674e-12
to O 0 1.2849043660653758e-12
have O 0 1.3252145041053875e-11
a O 0 9.85542593714972e-13
novel O 0 2.1072964206947375e-10
missense O 0 1.4051329344511032e-07
mutation O 0 1.151262085663518e-09
( O 0 1.0196669029960415e-11
G1758 O 0 4.2078038831050435e-08
- O 0 1.5367467085525277e-06
- O 0 1.1376545216990053e-06
> O 0 2.5474093945376808e-09
T O 0 1.2871859134122587e-08
) O 0 3.443067974283863e-14
encoding O 0 4.741491487630922e-13
the O 0 1.1753660416095272e-14
amino O 0 1.0312092840877515e-13
acid O 0 7.587025727454327e-15
substitution O 0 3.004577110114065e-13
Gly23 O 0 4.318157831306735e-09
- O 0 9.890418084523844e-08
- O 0 1.1227118648093892e-06
> O 0 1.6470989905315037e-08
Val O 0 5.400879217631882e-06
within O 0 1.4776888601630844e-09
NPII O 0 4.116946911381092e-06
. O 0 1.2510091851325456e-09

The O 0 9.981294263328166e-11
mutation O 0 3.2336877620053883e-09
was O 0 2.306488749992397e-10
confirmed O 0 1.0521956916864639e-10
by O 0 3.0335759945709917e-13
restriction O 0 3.7301728372796106e-10
endonuclease O 0 7.790891686454415e-06
analysis O 0 1.973038443736641e-08
. O 0 5.999697627601108e-09

A O 0 5.661279445234868e-08
T1 O 0 7.19325544196181e-06
- O 0 7.876592711397734e-09
weighted O 0 7.912828725586962e-11
magnetic O 0 4.411273429871798e-11
resonance O 0 2.6046068080098905e-10
imaging O 0 9.253235333517296e-08
of O 0 3.4607163055394574e-12
the O 0 1.0894791319104868e-10
fathers O 0 3.818253446752351e-07
pituitary O 0 1.1222120519960299e-05
gland O 0 1.2826404827137594e-06
demonstrates O 0 2.8564112852791368e-08
an O 0 9.373606751905683e-11
attenuated O 0 0.004763957113027573
posterior O 0 0.001456255093216896
pituitary O 1 0.5382057428359985
bright O 0 3.2999964787450153e-06
spot O 0 2.2877140963828424e-06
. O 0 3.047328078764622e-08

This O 0 1.4630653633052049e-10
mutation O 0 4.2411274492337725e-09
may O 0 5.924965379433544e-11
be O 0 1.8225557781720303e-13
valuable O 0 8.446368604531074e-13
for O 0 1.997064080945521e-13
developing O 0 1.9540223605840623e-10
models O 0 1.753060274722884e-08
of O 0 1.4222982167022558e-11
dominantly B-Disease 0 0.0004604039422702044
inherited I-Disease 1 0.8302246928215027
neurodegeneration I-Disease 1 1.0
, O 0 6.017140563585599e-09
as O 0 3.0066368231912444e-12
the O 0 6.403974979430835e-14
early O 0 1.5682927179128114e-11
age O 0 6.063668317457527e-11
of O 0 1.5925413386023296e-13
onset O 0 1.8359604325723922e-07
of O 0 1.6805053876245424e-11
symptoms O 0 7.20684568022989e-07
suggests O 0 6.757804732471229e-11
that O 0 1.6524228816858222e-12
this O 0 3.2875687849126534e-13
mutation O 0 1.0990234416974332e-10
may O 0 3.334804004120895e-12
be O 0 4.966538790472652e-13
particularly O 0 8.443018419818094e-13
deleterious O 0 2.1843937769716604e-10
to O 0 4.1206617978906124e-11
the O 0 3.959303718215068e-11
magnocellular O 0 8.498941497236956e-07
neuron O 0 8.981259611573478e-07
. O 0 7.407744417875506e-10
. O 0 2.625642370190917e-09

Frequent O 0 1.8727320139078074e-06
inactivation O 0 2.2363801690516993e-06
of O 0 8.291024117257351e-11
PTEN O 0 7.831270340830088e-05
/ O 0 0.002341244835406542
MMAC1 O 0 0.0004552444734144956
in O 0 8.235286230728889e-09
primary O 0 0.14021971821784973
prostate B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 0 8.611713155914913e-07

Sporadic B-Disease 1 0.9998769760131836
prostate I-Disease 1 0.9999977350234985
carcinoma I-Disease 1 1.0
is O 0 6.299167694123753e-07
the O 0 2.487603525946902e-11
most O 0 4.0037521908953266e-11
common O 0 2.338774729437887e-10
male B-Disease 0 1.633819834978567e-08
cancer I-Disease 0 3.149522598278054e-08
in O 0 2.9553237027718504e-12
the O 0 3.641577924623496e-12
Western O 0 3.229355005629486e-09
world O 0 2.0341768547371686e-10
, O 0 6.344698638000024e-12
yet O 0 5.213256475816719e-12
many O 0 1.3317575463093513e-14
of O 0 2.2182499045763195e-15
the O 0 7.209358300229105e-15
major O 0 1.3056616334980453e-12
genetic O 0 3.387392796816435e-11
events O 0 1.5142386042971134e-12
involved O 0 1.5811659273556877e-11
in O 0 1.4321292903744093e-13
the O 0 5.5555769538787395e-14
progression O 0 5.158781846148486e-09
of O 0 5.339730597248536e-14
this O 0 4.330051942003088e-12
often O 0 8.337460721818957e-10
fatal O 0 7.60841089686437e-07
cancer B-Disease 0 2.439470790704945e-06
remain O 0 2.264191945045013e-09
to O 0 7.185910894103031e-11
be O 0 2.9494493514192754e-09
elucidated O 0 2.0943334675394e-06
. O 0 8.022069231117257e-09

Numerous O 0 2.6739748193449486e-08
cytogenetic O 0 0.0002491427294444293
and O 0 1.5175601886241452e-09
allelotype O 0 1.0438694886261146e-07
studies O 0 1.0242422882056346e-10
have O 0 6.701158725141987e-12
reported O 0 1.0515467607774553e-08
frequent O 0 1.953879014138238e-08
loss O 0 3.7594598545354074e-09
of O 0 3.6807952519257725e-12
heterozygosity O 0 1.4878518186378642e-06
on O 0 1.2840494889587717e-08
chromosomal O 1 0.9526928067207336
arm O 0 0.028565963730216026
10q O 0 1.218260990754061e-06
in O 0 2.7624771359313627e-09
sporadic B-Disease 1 0.9998506307601929
prostate I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 1.7644379113335162e-07

Deletion O 0 2.8185331757413223e-06
mapping O 0 6.228131610441778e-07
studies O 0 2.6003292852294635e-09
have O 0 1.3044183788668562e-10
unambiguously O 0 4.1952304741244006e-07
identified O 0 6.668960494948806e-09
a O 0 2.3860118741891867e-11
region O 0 6.444410560746405e-10
of O 0 5.63088584006749e-13
chromosome O 0 1.2171706202934729e-06
10q23 O 0 4.084314042529513e-08
to O 0 7.034071242140172e-11
be O 0 1.232447043725271e-11
the O 0 2.5952848268888384e-13
minimal O 0 1.0197340749584782e-09
area O 0 8.757091940481132e-09
of O 0 1.0415088930182392e-11
loss O 0 7.435978233161222e-08
. O 0 9.934675304634766e-09

A O 0 1.2049415909487493e-09
new O 0 4.805721098843918e-11
tumor B-Disease 0 1.5227749372570543e-07
suppressor O 0 1.878217972262064e-07
gene O 0 6.272384212024917e-08
, O 0 1.4538105441719296e-10
PTEN O 0 6.065185971237952e-07
/ O 0 1.485571192461066e-05
MMAC1 O 0 1.502095165051287e-05
, O 0 1.4891669841698985e-10
was O 0 5.190382013076089e-10
isolated O 0 4.251513132658147e-07
recently O 0 4.969564315615571e-08
at O 0 1.8026310999452733e-10
this O 0 3.932694285242039e-13
region O 0 7.449013628146872e-11
of O 0 7.934247063610261e-14
chromosome O 0 1.5328868130382034e-07
10q23 O 0 1.4142607973610666e-08
and O 0 1.6642217118278957e-11
found O 0 5.6874813018914505e-12
to O 0 6.274270924859493e-13
be O 0 9.261988962241952e-13
inactivated O 0 1.0251184345833053e-09
by O 0 1.6556935401694506e-13
mutation O 0 2.413590716177083e-10
in O 0 2.06630025589849e-11
three O 0 1.295584297622554e-07
prostate B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
cell O 0 5.4439085943158716e-05
lines O 0 4.0660750528331846e-05
. O 0 5.886866460969031e-08

We O 0 1.1654671538963157e-07
screened O 0 8.759783440837055e-07
80 O 0 4.019206869543268e-07
prostate B-Disease 1 0.9686445593833923
tumors I-Disease 1 1.0
by O 0 2.5396168501501393e-10
microsatellite O 0 6.08297568760463e-07
analysis O 0 1.9823811481245457e-09
and O 0 6.075233371927169e-11
found O 0 3.675521345614108e-11
chromosome O 0 7.421511583061147e-08
10q23 O 0 1.0628832924908238e-08
to O 0 3.475018883758452e-11
be O 0 3.5726987340778393e-11
deleted O 0 8.348954416703691e-09
in O 0 3.408826346196214e-11
23 O 0 4.743298531728612e-10
cases O 0 4.088557825632222e-10
. O 0 5.386920909344894e-10

We O 0 7.85175302553398e-09
then O 0 5.75559955598437e-12
proceeded O 0 1.112779746820225e-11
with O 0 2.5904222479078767e-14
sequence O 0 1.2954242713247854e-12
analysis O 0 6.590295800398827e-13
of O 0 7.074502608213221e-15
the O 0 9.060260815251311e-14
entire O 0 6.377852690420127e-10
PTEN O 0 1.2726345630653668e-06
/ O 0 1.6805693121568765e-06
MMAC1 O 0 1.4990478121035267e-06
coding O 0 3.4571746709843865e-07
region O 0 5.3967781354913313e-08
and O 0 7.304814531039483e-10
tested O 0 2.1905239844244306e-09
for O 0 2.9065313524034853e-13
homozygous O 0 3.002858628420313e-09
deletion O 0 8.175715660030392e-10
with O 0 2.6658417227182207e-12
new O 0 8.71872973123855e-12
intragenic O 0 5.5676128596360286e-08
markers O 0 1.897548855822606e-07
in O 0 3.5156304950545447e-12
these O 0 3.406608111919396e-12
23 O 0 1.4679396587169435e-11
cases O 0 6.442794214800429e-12
with O 0 5.872343410151526e-12
10q23 O 0 4.434386013940639e-08
loss O 0 1.1116825682222498e-08
of O 0 1.0513210441098764e-10
heterozygosity O 0 1.6447527741547674e-05
. O 0 5.656217538785313e-08

The O 0 1.5975231554277158e-11
identification O 0 1.1533934224372544e-10
of O 0 2.8563111077739567e-13
the O 0 6.168896773614541e-13
second O 0 1.0979668563226852e-11
mutational O 0 3.4012398941740685e-07
event O 0 1.4425196592782186e-09
in O 0 4.559319501801218e-12
10 O 0 5.495153811152509e-12
( O 0 8.235253841706869e-13
43 O 0 1.8824869441047554e-10
% O 0 1.499555341011316e-11
) O 0 8.691226627277615e-10
tumors B-Disease 1 1.0
establishes O 0 1.0513671213630005e-06
PTEN O 0 1.4364040907821618e-05
/ O 0 7.10101958247833e-05
MMAC1 O 0 8.59692954691127e-06
as O 0 7.199712354077903e-11
a O 0 2.3143230387656644e-11
main O 0 1.8318927486049574e-09
inactivation O 0 7.221190401196509e-08
target O 0 1.813176941922734e-09
of O 0 2.6996886171894163e-13
10q O 0 8.016929342602452e-09
loss O 0 1.554060879982444e-09
in O 0 4.2654627052662875e-10
sporadic B-Disease 1 0.9999964237213135
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.734061504445663e-09
. O 0 3.838305229209027e-09

Risk O 0 3.833585196844069e-06
reversals O 0 3.796115777277009e-08
in O 0 9.341404386131735e-12
predictive O 0 2.3218920830458956e-07
testing O 0 1.4292545813532342e-07
for O 0 2.5604445230698047e-09
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 6.154878917641327e-08

The O 0 2.3023034867453163e-11
first O 0 2.4816928026472063e-12
predictive O 0 8.367367243522494e-09
testing O 0 1.0274032291590629e-08
for O 0 1.1399451521620918e-10
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 4.9510891914072985e-11
HD B-Disease 0 0.002008191542699933
) O 0 3.675353077436938e-11
was O 0 1.2946475835828863e-10
based O 0 1.5879501489776682e-12
on O 0 3.778265894593957e-12
analysis O 0 3.861709996916263e-12
of O 0 3.595388892749067e-14
linked O 0 4.2965342395007156e-09
polymorphic O 0 7.241915400690857e-10
DNA O 0 1.7512379324458038e-09
markers O 0 1.4666089453996278e-09
to O 0 8.574668210713232e-13
estimate O 0 1.9577679755133914e-10
the O 0 6.128927660525862e-13
likelihood O 0 2.0141396883666118e-10
of O 0 5.181540960186304e-13
inheriting O 0 1.352576362023683e-08
the O 0 5.488963016747617e-12
mutation O 0 2.964302969754584e-10
for O 0 3.476589849338296e-11
HD B-Disease 0 0.00027651144773699343
. O 0 2.588355663135644e-08

Limits O 0 2.490953443512467e-09
to O 0 4.124670223426552e-12
accuracy O 0 1.0124510119169372e-09
included O 0 3.2138345804066937e-12
recombination O 0 1.5301038214232676e-10
between O 0 2.027841002755215e-12
the O 0 4.454624196641513e-14
DNA O 0 1.1950015421646754e-09
markers O 0 1.39366571616506e-08
and O 0 4.3776605604395336e-12
the O 0 1.0825238275224969e-13
mutation O 0 1.8403950585721418e-10
, O 0 3.883225772188803e-12
pedigree O 0 4.034126810381622e-09
structure O 0 7.351512176789754e-10
, O 0 3.189128648661832e-12
and O 0 5.262606756623045e-13
whether O 0 1.4447230304442948e-12
DNA O 0 2.3213667099675206e-10
samples O 0 7.191930384564671e-11
were O 0 6.4665551559317525e-12
available O 0 1.969688084510479e-12
from O 0 1.4145222536690594e-12
family O 0 9.130452505168307e-10
members O 0 4.159782934776146e-11
. O 0 2.8449304023681066e-10

With O 0 2.9163535475440483e-10
direct O 0 4.483070803473765e-09
tests O 0 4.114320439896346e-09
for O 0 2.540572190557616e-13
the O 0 4.654432221584681e-13
HD B-Disease 0 7.055525657051476e-06
mutation O 0 2.92397883683293e-10
, O 0 9.199873935578085e-13
we O 0 4.289681890951025e-12
have O 0 6.104029093160004e-14
assessed O 0 2.150017360327827e-12
the O 0 8.604252157767486e-14
accuracy O 0 3.275403415159417e-08
of O 0 3.663129912248597e-13
results O 0 1.5720960991338906e-11
obtained O 0 4.92205798688361e-12
by O 0 6.140980193976298e-13
linkage O 0 2.454534131501873e-09
approaches O 0 4.1053976884697363e-10
when O 0 8.061737909181854e-12
requested O 0 1.0858086998966066e-11
to O 0 4.9599525875354544e-12
do O 0 5.171665318215446e-10
so O 0 2.000992253836653e-12
by O 0 1.295104838259717e-13
the O 0 8.881449178529954e-13
test O 0 1.0580525344749958e-09
individuals O 0 2.2677771119306023e-11
. O 0 1.555157252974837e-10

For O 0 2.7532703894550536e-10
six O 0 2.8499961071681845e-11
such O 0 1.103039751551571e-12
individuals O 0 3.795970482389777e-12
, O 0 2.2379381334203252e-12
there O 0 2.100938346905057e-11
was O 0 3.2410404915417246e-10
significant O 0 2.979424693072552e-11
disparity O 0 6.531986063151862e-11
between O 0 1.8425507647412687e-11
the O 0 2.369987366079851e-11
tests O 0 4.3536858562731595e-09
. O 0 1.258160936545849e-10

Three O 0 1.9408448181934546e-09
went O 0 5.946082515251305e-10
from O 0 4.4275542433747095e-13
a O 0 4.228552837742816e-12
decreased O 0 1.0734309086046778e-07
risk O 0 8.513602045567836e-10
to O 0 3.800764499135856e-13
an O 0 8.661756208117044e-13
increased O 0 3.376520174569464e-09
risk O 0 2.0903058839394362e-07
, O 0 1.782108141612504e-11
while O 0 1.5303687136980493e-11
in O 0 4.840471556563641e-13
another O 0 1.5723001026146655e-11
three O 0 1.4353269007366665e-12
the O 0 2.4220783798739598e-12
risk O 0 4.04784605834152e-09
was O 0 1.3488921979387669e-08
decreased O 0 8.073353683357709e-07
. O 0 1.9443573417987636e-09

Knowledge O 0 1.6727362828206083e-09
of O 0 1.1839690469347963e-12
the O 0 8.772788810500198e-13
potential O 0 2.509841293130144e-11
reasons O 0 1.9712476009153823e-12
for O 0 1.9369270117387642e-14
these O 0 5.984985049873812e-14
changes O 0 2.0670756772922516e-12
in O 0 8.392876237744984e-13
results O 0 8.866530426532293e-11
and O 0 5.397621585800927e-12
impact O 0 1.0584067476615555e-11
of O 0 1.3714904049683813e-13
these O 0 2.9964344807481558e-12
risk O 0 6.185704726213714e-11
reversals O 0 1.8908138943452002e-10
on O 0 5.386550649966182e-10
both O 0 1.844678056139859e-11
patients O 0 1.0633566943640815e-10
and O 0 2.0889939084112186e-12
the O 0 3.2151817558161155e-13
counseling O 0 1.403178406800265e-10
team O 0 5.69071211594524e-13
can O 0 2.0072219710995376e-13
assist O 0 4.594769660234976e-13
in O 0 2.6661049127955916e-13
the O 0 1.449588604533758e-13
development O 0 7.849854447017357e-12
of O 0 2.2339609681435238e-14
strategies O 0 4.252041774233106e-11
for O 0 5.125853084000931e-14
the O 0 1.189003729458113e-13
prevention O 0 2.767359119637547e-10
and O 0 1.4190709371475485e-11
, O 0 9.324880277661318e-13
where O 0 1.7954405323594713e-12
necessary O 0 2.893119988370274e-12
, O 0 2.368809900836488e-13
management O 0 6.711161140704469e-12
of O 0 8.63110564329429e-15
a O 0 1.2534225393712184e-11
risk O 0 1.091517987106272e-09
reversal O 0 5.147358650425815e-10
in O 0 8.642266589864445e-13
any O 0 1.2089159534545146e-11
predictive O 0 5.560255367242917e-09
testing O 0 8.615473667816786e-09
program O 0 2.6446750345243686e-10
. O 0 3.5297945122358954e-12
. O 0 5.3658140430901113e-11

A O 0 5.551078707810575e-09
novel O 0 2.7636364308136763e-09
common O 0 4.38023728399628e-10
missense O 0 5.188700242797495e-07
mutation O 0 8.14494871548277e-09
G301C O 0 1.0064789002228736e-08
in O 0 7.2110603079045266e-12
the O 0 5.168899596535992e-12
N O 0 4.165838163316948e-06
- O 0 2.160602662115707e-06
acetylgalactosamine O 0 5.011595203541219e-05
- O 0 1.618600799702108e-05
6 O 0 2.11166684138675e-09
- O 0 3.3541530797265295e-07
sulfate O 0 7.063053431011213e-08
sulfatase O 0 1.8057546924410417e-07
gene O 0 6.150041809149798e-09
in O 0 2.8674606092349286e-11
mucopolysaccharidosis B-Disease 0 6.421946181944804e-06
IVA I-Disease 0 0.0007150671444833279
. O 0 1.0985952769715368e-07

Mucopolysaccharidosis B-Disease 0 0.17248913645744324
IVA I-Disease 1 0.9972301125526428
( O 0 6.47357665002346e-05
MPS B-Disease 1 0.9999997615814209
IVA I-Disease 1 0.9999998807907104
) O 0 1.2852814368358167e-09
is O 0 1.330702104063164e-09
an O 0 1.1369730712473824e-09
autosomal B-Disease 1 0.9999995231628418
recessive I-Disease 1 0.9999994039535522
lysosomal I-Disease 1 0.9999992847442627
storage I-Disease 1 0.9999909400939941
disorder I-Disease 1 0.9999954700469971
caused O 0 1.909155145085606e-07
by O 0 4.875073608689995e-11
a O 0 2.1442922104597528e-08
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 2.1659078974778367e-09
N O 0 0.0007701467839069664
- O 0 0.00011673998960759491
acetylgalactosamine O 0 0.000623079133220017
- O 0 0.0003815609961748123
6 O 0 1.668594507009402e-08
- O 0 1.373086888634134e-05
sulfate O 0 2.3405855245073326e-06
sulfatase O 0 5.320681339071598e-06
( O 0 2.388544917408808e-10
GALNS O 0 1.8682102620459773e-07
) O 0 1.1488682921667603e-10
. O 0 2.764457551762689e-10

In O 0 3.2334149246970867e-10
previous O 0 2.4058002812132884e-10
studies O 0 1.7245496697348983e-11
, O 0 4.1766113137442495e-12
we O 0 2.2105421659812663e-11
have O 0 3.451393901579558e-13
found O 0 4.963186437355327e-13
two O 0 1.5687749832364074e-14
common O 0 1.946865520359442e-13
mutations O 0 1.4457877603457625e-11
in O 0 2.1759531025969392e-13
Caucasians O 0 1.4777387646880413e-10
and O 0 8.396807554822416e-11
Japanese O 0 1.208634348159876e-08
, O 0 1.2118224826385138e-11
respectively O 0 2.3758181533217737e-10
. O 0 1.419841244576503e-09

To O 0 4.662418229273158e-10
characterize O 0 1.3204785886955506e-07
the O 0 3.0959911717642896e-11
mutational O 0 1.6088065990516043e-07
spectrum O 0 8.260925277170372e-10
in O 0 1.0269034971324698e-12
various O 0 3.6044883982948306e-13
ethnic O 0 3.261589956449207e-11
groups O 0 9.930586734874236e-12
, O 0 6.838473472388362e-13
mutations O 0 1.993747181239236e-11
in O 0 4.411628465425706e-14
the O 0 2.543141749706407e-13
GALNS O 0 2.062468063002143e-08
gene O 0 2.2922539422154387e-09
in O 0 5.631589292121042e-11
Colombian O 0 5.158832664164947e-06
MPS B-Disease 1 0.9999988079071045
IVA I-Disease 1 0.9999998807907104
patients O 0 1.8758264275220426e-07
were O 0 1.4121917524256844e-10
investigated O 0 2.3199834942033704e-08
, O 0 2.698306508785997e-11
and O 0 1.2625980989888763e-11
genetic O 0 1.2520547931771375e-09
backgrounds O 0 1.3381205865581336e-10
were O 0 3.81712716990279e-12
extensively O 0 9.383516880179243e-11
analyzed O 0 8.39219735371266e-11
to O 0 7.230269443055104e-13
identify O 0 1.8166100568262067e-10
racial O 0 1.0743470002516631e-10
origin O 0 2.16388677809487e-11
, O 0 1.1027220803150328e-12
based O 0 5.493767333414334e-13
on O 0 2.092203797363079e-12
mitochondrial O 0 3.840765927520806e-09
DNA O 0 5.173483419440572e-09
( O 0 1.5911214403321883e-12
mtDNA O 0 2.3125104609000857e-10
) O 0 1.0121486981873318e-11
lineages O 0 9.547885815308632e-10
. O 0 9.908479592368735e-10

Three O 0 2.9856455086019196e-09
novel O 0 1.3370963003467295e-08
missense O 0 2.0815281459363177e-05
mutations O 0 2.089671937710591e-07
never O 0 6.589680801027953e-09
identified O 0 2.0153050339644096e-09
previously O 0 7.262563467280714e-11
in O 0 8.483568665271224e-13
other O 0 1.8942304322311365e-12
populations O 0 4.077709281347097e-10
and O 0 5.682897555314703e-11
found O 0 4.349434146178055e-10
in O 0 2.338892751349575e-12
16 O 0 2.6020631829770657e-11
out O 0 1.1265182536801532e-10
of O 0 2.6900111912281366e-12
19 O 0 9.112432586277919e-09
Colombian O 0 7.138516139093554e-06
MPS B-Disease 1 0.9999903440475464
IVA I-Disease 1 0.9999966621398926
unrelated O 0 8.286323804895801e-08
alleles O 0 9.853076576860076e-09
account O 0 2.649568786594614e-09
for O 0 9.37264155176365e-11
84 O 0 1.2326675680185417e-08
. O 0 2.0797932265281815e-09

2 O 0 5.87227422244041e-09
% O 0 5.161109040141554e-11
of O 0 9.636384572242473e-13
the O 0 1.5047749287941392e-12
alleles O 0 3.5017259925052e-11
in O 0 5.287528769860883e-13
this O 0 6.308518160982879e-13
study O 0 1.2688555935114199e-11
. O 0 1.405876109972226e-10

The O 0 6.292305010369148e-10
G301C O 0 1.0212668399844915e-07
and O 0 1.2586554021254415e-10
S162F O 0 6.136660513078596e-09
mutations O 0 1.404952043593255e-09
account O 0 1.6255158330480413e-10
for O 0 2.578329563740489e-11
68 O 0 2.5901732314537185e-08
. O 0 4.563172062432841e-09

4 O 0 1.6931004154230322e-08
% O 0 7.587088179938917e-10
and O 0 6.377572914217922e-10
10 O 0 6.811783914706382e-10
. O 0 1.8817125635450793e-09

5 O 0 3.0367433012656875e-09
% O 0 3.2603586497259585e-11
of O 0 2.241491226569886e-13
mutations O 0 3.05936431743703e-09
, O 0 2.9546264740387684e-11
respectively O 0 6.948277370133482e-11
, O 0 4.504938522914559e-12
whereas O 0 1.93671224890668e-11
the O 0 8.562835770303812e-13
remaining O 0 6.022519288828576e-11
F69V O 0 1.460304929423728e-06
is O 0 4.8742739011675695e-11
limited O 0 4.664141295407376e-11
to O 0 2.0102613150496662e-12
a O 0 4.4003488353094866e-11
single O 0 3.5039009471660165e-09
allele O 0 1.2038078978093836e-07
. O 0 3.4071787613498827e-09

The O 0 2.7391644508156787e-10
skewed O 0 3.449046914738574e-08
prevalence O 0 4.789184799847135e-07
of O 0 1.0526222905468674e-12
G301C O 0 8.019269692738362e-09
in O 0 4.577164168517722e-12
only O 0 5.1863595883216984e-12
Colombian O 0 7.218209918669061e-10
patients O 0 1.3680561891660226e-11
and O 0 4.786412423091885e-14
haplotype O 0 2.5260368796686805e-10
analysis O 0 3.734561271340198e-12
by O 0 4.4711318523439625e-13
restriction O 0 5.166755912000554e-10
fragment O 0 3.519742053370578e-09
length O 0 1.2793356374274367e-09
polymorphisms O 0 2.0542627154895854e-08
in O 0 3.3061335787121227e-12
the O 0 7.621640406470231e-13
GALNS O 0 1.3154604516785184e-08
gene O 0 2.2380299002922044e-10
suggest O 0 1.5750382942325558e-10
that O 0 1.167355383364932e-12
G301C O 0 6.032651045373427e-10
originated O 0 5.922740076158561e-11
from O 0 2.287471427553367e-13
a O 0 3.768858922864604e-12
common O 0 1.349412595552657e-11
ancestor O 0 2.4353352667816353e-09
. O 0 2.376893348809972e-09

Investigation O 0 2.8507221028206686e-09
of O 0 5.050498322507757e-13
the O 0 2.4526292997407995e-13
genetic O 0 2.7871029928405733e-09
background O 0 9.554297353275842e-10
by O 0 3.2227044383797976e-12
means O 0 2.382973679493361e-11
of O 0 4.635558565691325e-14
mtDNA O 0 4.860462587963355e-10
lineages O 0 7.79648429150015e-11
indicate O 0 9.172274051394425e-10
that O 0 1.2021925122063237e-11
all O 0 6.883664645240817e-12
our O 0 1.1930378907010208e-10
patients O 0 3.520132752996008e-12
are O 0 3.043752248399305e-14
probably O 0 1.3386457740904856e-11
of O 0 2.947181344456484e-14
native O 0 1.4835226103127042e-10
American O 0 3.2668481253494974e-09
descent O 0 0.0002023872802965343

Low O 0 4.977437839670529e-08
frequency O 0 2.1105647007857442e-08
of O 0 1.5904850353409827e-11
BRCA1 O 0 1.0358863988813027e-07
germline O 0 1.803695681701356e-08
mutations O 0 7.688058190069569e-09
in O 0 1.1212508352342887e-11
45 O 0 1.2314854913597628e-08
German O 0 0.24346496164798737
breast B-Disease 1 0.9999996423721313
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.5415877189516323e-06
. O 0 1.9161133124612206e-08

In O 0 4.5708589690995893e-11
this O 0 3.978186324197358e-13
study O 0 4.1180492175996175e-13
we O 0 2.1630108728437625e-12
investigated O 0 4.857625968135437e-10
45 O 0 1.9937529405211762e-09
German O 0 0.04448510706424713
breast B-Disease 1 0.9999992847442627
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.9259328293562703e-09
for O 0 4.398517140791203e-12
germline O 0 3.582216123731996e-08
mutations O 0 2.3742519061897838e-09
in O 0 1.125404673965602e-12
the O 0 6.175858002083201e-12
BRCA1 O 0 8.774668458499946e-08
gene O 0 8.35462827808442e-08
. O 0 6.652812967189448e-09

We O 0 1.629525137047949e-08
identified O 0 3.947597360109967e-09
four O 0 4.207378369314174e-12
germline O 0 1.9315688604137904e-08
mutations O 0 6.335327640272226e-08
in O 0 2.48503804339828e-11
three O 0 6.196075319486738e-10
breast B-Disease 0 0.008106223307549953
cancer I-Disease 0 3.8017085898900405e-05
families O 0 1.1529871501991806e-09
and O 0 3.4165612006198387e-10
in O 0 2.5712443285641484e-10
one O 0 0.00031117338221520185
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 3.378903272732714e-07
. O 0 6.114172102639204e-12
among O 0 6.01245832634878e-13
these O 0 4.390820389568728e-13
were O 0 2.309353402951686e-11
one O 0 2.4894974970379735e-11
frameshift O 0 4.176787342657917e-07
mutation O 0 3.5241068396807407e-10
, O 0 3.967580170655127e-12
one O 0 1.8139153373786243e-11
nonsense O 0 1.8955336145154433e-06
mutation O 0 1.4150047800143284e-09
, O 0 1.1137269058381083e-11
one O 0 2.6179924113994835e-12
novel O 0 2.2441297431452512e-10
splice O 0 2.3013731151877437e-06
site O 0 6.97503594437876e-07
mutation O 0 9.101090547858348e-09
, O 0 1.2711671992793327e-10
and O 0 7.798521550750337e-11
one O 0 1.1282083600683279e-10
missense O 0 3.2243824534816667e-06
mutation O 0 7.038456573127405e-08
. O 0 3.5906420059461652e-09

The O 0 1.3244351171337598e-09
missense O 0 4.357902071205899e-06
mutation O 0 3.116310764994523e-08
was O 0 5.693850724242111e-09
also O 0 9.852690885381321e-11
found O 0 5.5433914403213436e-11
in O 0 6.200679726620084e-12
2 O 0 5.407189695993964e-10
. O 0 2.1186383758475813e-09

8 O 0 1.3017380062763095e-08
% O 0 3.130610007340273e-11
of O 0 4.222384974213872e-13
the O 0 6.837247781832367e-13
general O 0 5.917971408059275e-12
population O 0 8.374523297050018e-12
, O 0 9.488216419148432e-13
suggesting O 0 1.3149198396789075e-10
that O 0 4.925880450062925e-12
it O 0 1.679162885126484e-11
is O 0 2.962560752273191e-11
not O 0 1.7177255451361617e-10
disease O 0 3.1656149701575487e-08
associated O 0 3.6815099857534506e-09
. O 0 8.80259065638711e-09

The O 0 3.07053410475433e-10
average O 0 2.25148912846862e-08
age O 0 1.3852243796463881e-09
of O 0 7.536931148632853e-12
disease O 0 0.001073317602276802
onset O 0 9.051442248164676e-06
in O 0 1.334180682599495e-10
those O 0 4.0130967993157185e-10
families O 0 7.525360889992783e-10
harbouring O 0 0.00017274064884986728
causative O 0 2.8639386073336937e-05
mutations O 0 1.0989788279403001e-07
was O 0 1.678297678608942e-08
between O 0 1.9081461410941358e-10
32 O 0 1.0699658936630385e-08
. O 0 3.809161874812617e-09

3 O 0 5.939083891348673e-08
and O 0 1.767836765864672e-09
37 O 0 1.3774578810910043e-08
. O 0 2.0446455639699934e-09

4 O 0 2.8818838426758475e-09
years O 0 2.1139306971562632e-10
, O 0 6.051013422964102e-12
whereas O 0 7.756566222649752e-12
the O 0 1.2371757264484362e-12
family O 0 2.9352620334321955e-09
harbouring O 0 1.8589293176773936e-05
the O 0 1.163246408919516e-11
missense O 0 9.97529383539586e-08
mutation O 0 1.4728096520144618e-09
had O 0 2.48637610500424e-10
an O 0 5.237892368101238e-13
average O 0 2.8112618899456265e-09
age O 0 5.448413942232833e-10
of O 0 1.0771590867528213e-12
onset O 0 1.5653520222258521e-06
of O 0 1.7765500182065352e-10
51 O 0 1.4219946251614601e-06
. O 0 3.339527410162191e-08

2 O 0 6.791526629967848e-08
years O 0 3.4445348795486552e-09
. O 0 1.4378636059575456e-09

These O 0 3.0304811438064405e-10
findings O 0 2.29110772020924e-10
show O 0 1.2599201681950944e-08
that O 0 3.510753840418879e-11
BRCA1 O 0 2.48844731487452e-08
is O 0 2.892211123373123e-11
implicated O 0 4.69410399439596e-10
in O 0 9.099591604310939e-14
a O 0 3.327756093688544e-13
small O 0 6.6089794227564e-12
fraction O 0 5.402087110972786e-10
of O 0 1.527810233881155e-08
breast B-Disease 1 0.9999998807907104
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 5.514638967696328e-09
suggesting O 0 5.438156591708321e-10
the O 0 9.854579175253009e-13
involvement O 0 7.990135220126149e-10
of O 0 1.8028692416998532e-13
another O 0 1.0694031597757725e-11
susceptibility O 0 1.4358609412568057e-08
gene O 0 7.145955578380381e-07
( O 0 7.955937242343225e-09
s O 0 0.002001454122364521
) O 0 1.716103810167624e-07

Paternal O 0 0.005140888504683971
transmission O 0 0.0632297471165657
of O 0 1.477639557379007e-07
congenital B-Disease 1 0.9999998807907104
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 1.1022722901543602e-05

We O 0 9.188772409629564e-09
report O 0 5.009432105240741e-11
a O 0 1.4677371731192101e-12
rare O 0 1.0423574330065133e-11
case O 0 4.350842255917975e-11
of O 0 1.260798063174029e-11
paternally O 1 0.7449522614479065
transmitted O 1 0.9999829530715942
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 3.1071820558281615e-05
DM B-Disease 1 1.0
) O 0 1.6849602957336174e-07
. O 0 2.250647668233796e-08

The O 0 5.055006413456908e-10
proband O 0 1.7658480828686152e-06
is O 0 4.547460463744102e-10
a O 0 2.860173903274088e-11
23 O 0 1.4298143224955595e-10
year O 0 9.806303338799616e-12
old O 0 2.912526724685449e-06
, O 0 1.2603912580289034e-08
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 7.360081508522853e-05
who O 0 9.083578333957121e-08
suffers O 1 0.8635654449462891
severe O 0 0.0003239950747229159
muscular B-Disease 1 0.9811925888061523
weakness I-Disease 1 0.9984349608421326
. O 0 2.867799651085079e-07

He O 0 8.531031880920636e-09
presented O 0 1.1369166719177315e-09
with O 0 1.0502393399391963e-09
respiratory O 0 0.3255751430988312
and O 0 1.164313534474104e-08
feeding O 0 8.792791049927473e-05
difficulties O 0 5.547418595597264e-07
at O 0 9.852213267436127e-09
birth O 0 4.832642375163232e-08
. O 0 3.347823129828953e-09

His O 0 8.469507406516641e-08
two O 0 5.9240337080268546e-09
sibs O 1 0.6644564867019653
suffer O 0 6.162732461234555e-05
from O 0 5.066792541086329e-10
childhood O 0 0.00015379114483948797
onset O 1 0.997914731502533
DM B-Disease 1 1.0
. O 0 9.185829185298644e-06

Their O 0 3.7782627027027615e-10
late O 0 4.1840783615576527e-10
father O 0 1.1978478653418279e-08
had O 0 6.551325454351442e-11
the O 0 2.7528602973016757e-14
adult O 0 3.965743358702589e-11
type O 0 1.7236445160051517e-08
of O 0 8.900893216923222e-11
DM B-Disease 1 1.0
, O 0 1.0291330454492709e-08
with O 0 1.5154738575162696e-10
onset O 0 1.9568334153063915e-07
around O 0 1.512741363285386e-07
30 O 0 4.766709249537371e-09
years O 0 8.280139351946048e-10
. O 0 1.0190691623890302e-09

Only O 0 6.354320958301685e-10
six O 0 6.354217933074446e-12
other O 0 1.3124297113496775e-13
cases O 0 5.047255148549201e-12
of O 0 1.0638748996344427e-12
paternal O 0 0.00018114082922693342
transmission O 1 0.9676827788352966
of O 0 9.906519160551852e-09
congenital B-Disease 1 0.9999998807907104
DM I-Disease 1 1.0
have O 0 2.042187588813249e-05
been O 0 3.252680258469809e-08
reported O 0 6.154835773486411e-06
recently O 0 1.6321541806973983e-07
. O 0 1.80919035308591e-09

We O 0 1.5688685905956845e-09
review O 0 1.666887114448734e-11
the O 0 1.3217825813906237e-13
sex O 0 2.219626982213896e-10
related O 0 3.555818486877804e-11
effects O 0 4.3774978086830174e-10
on O 0 5.599588570603942e-10
transmission O 0 0.0025639201048761606
of O 0 3.674711868129066e-09
congenital B-Disease 1 0.9999984502792358
DM I-Disease 1 1.0
. O 0 1.7794733139453456e-05

Decreased O 0 1.1660607924568467e-05
fertility O 0 6.495852744592412e-08
of O 0 9.130403681376076e-13
males O 0 1.5911684470015786e-10
with O 0 2.094396878149496e-11
adult O 0 2.0981107695661194e-07
onset O 0 0.37624114751815796
DM B-Disease 1 1.0
and O 0 4.319148274589679e-07
contraction O 0 3.1680540359957376e-06
of O 0 2.7473396821409146e-12
the O 0 2.351493565838636e-12
repeat O 0 9.952270119129025e-10
upon O 0 1.7566581869687958e-12
male O 0 2.3180173058801046e-10
transmission O 0 3.238522694459789e-08
contribute O 0 9.168805992221252e-11
to O 0 1.8443579996585413e-11
the O 0 5.0119335764930995e-12
almost O 0 1.4993788155504006e-10
absent O 0 4.0989894811716e-10
occurrence O 0 4.727161329043383e-09
of O 0 2.1908048292162974e-12
paternal O 0 3.2468215067638084e-06
transmission O 0 0.004686757456511259
of O 0 1.5205248615757228e-08
congenital B-Disease 1 0.9999995231628418
DM I-Disease 1 1.0
. O 0 7.835341966710985e-05

Also O 0 1.1317355053108713e-08
the O 0 3.65511960975784e-12
fathers O 0 1.3928751207981094e-10
of O 0 7.203781435304382e-14
the O 0 1.8568876904850873e-12
reported O 0 2.411123386991676e-05
congenitally O 0 0.00017422357632312924
affected O 0 3.205485370472161e-07
children O 0 2.9983486804496806e-09
showed O 0 2.4194884318262666e-08
, O 0 4.914338033734644e-12
on O 0 5.5740006360549543e-11
average O 0 3.1896747465509634e-09
, O 0 8.843201344810314e-12
shorter O 0 4.4022923084696686e-09
CTG O 0 2.790381131489994e-06
repeat O 0 1.8155276393372333e-08
lengths O 0 6.154712295369791e-09
and O 0 1.4046726282135324e-10
hence O 0 2.1152737894603035e-10
less O 0 1.8056732498106243e-10
severe O 0 1.4535714853991522e-07
clinical O 0 4.7789194468350615e-06
symptoms O 0 5.635528214043006e-05
than O 0 9.315686000377355e-10
the O 0 1.0161068514369376e-10
mothers O 0 4.466444547546189e-09
of O 0 3.3882678563898483e-13
children O 0 1.3088701233954225e-09
with O 0 7.250612554798863e-09
congenital B-Disease 1 0.9999992847442627
DM I-Disease 1 1.0
. O 0 0.00016497370961587876

We O 0 7.877073215922792e-09
conclude O 0 1.5163306166243729e-09
that O 0 1.0173920733658193e-11
paternal O 0 1.5580096146550204e-07
transmission O 0 0.00019787607016041875
of O 0 6.235768568174649e-10
congenital B-Disease 1 0.9999998807907104
DM I-Disease 1 1.0
is O 0 6.817587063778774e-07
rare O 0 8.891756664297645e-09
and O 0 3.00928310048576e-11
preferentially O 0 2.426622902618192e-09
occurs O 0 7.285595043926563e-11
with O 0 1.7656942531349418e-12
onset O 0 8.949418095482997e-09
of O 0 1.669153010253055e-10
DM B-Disease 1 1.0
past O 0 4.022041321150027e-05
30 O 0 5.437754246884197e-09
years O 0 1.7733769314132175e-11
in O 0 8.829511557659209e-13
the O 0 7.735906641832824e-13
father O 0 1.2799921123018976e-09
. O 0 2.733363231935404e-12
. O 0 6.927448892302124e-11

The O 0 6.020983711607641e-10
RB1 O 0 1.877499198599253e-05
gene O 0 5.97849876271539e-08
mutation O 0 4.4766790274763935e-09
in O 0 1.964686443048369e-12
a O 0 4.175553999785642e-11
child O 0 6.564042109857837e-07
with O 0 4.106843221052259e-08
ectopic B-Disease 1 0.9999990463256836
intracranial I-Disease 1 0.9999980926513672
retinoblastoma I-Disease 1 0.9992734789848328
. O 0 1.014464669424342e-05

The O 0 1.0119181048651171e-09
RB1 O 0 1.732820601318963e-05
gene O 0 3.6991863794355595e-08
mutation O 0 3.820177507662947e-09
was O 0 8.388483657695289e-11
investigated O 0 5.008612968815385e-10
in O 0 3.505203668551643e-13
a O 0 3.9582014749184324e-11
child O 0 4.762213848152896e-06
with O 0 2.179771918520146e-08
ectopic B-Disease 1 0.9999985694885254
intracranial I-Disease 1 0.9999839067459106
retinoblastoma I-Disease 0 6.529654638143256e-05
using O 0 2.8059368162303144e-09
DNA O 0 1.978793306989246e-08
obtained O 0 6.201416463680332e-11
from O 0 2.6974407950353108e-12
both O 0 7.827364516092838e-13
the O 0 5.939589640437115e-13
pineal B-Disease 0 3.0396196848414547e-07
and I-Disease 0 8.42975689252512e-10
retinal I-Disease 0 0.00010203388228546828
tumours I-Disease 1 1.0
of O 0 6.511188116453681e-11
the O 0 5.573185246632306e-10
patient O 0 5.396682354330551e-06
. O 0 5.604859243391047e-09

A O 0 4.3680774552967705e-08
nonsense O 0 1.269169388251612e-06
mutation O 0 4.092374883413186e-09
in O 0 3.2224832611366105e-12
exon O 0 6.908903671387634e-09
17 O 0 1.6425428794875074e-09
( O 0 4.774955170844253e-12
codon O 0 6.749215630819094e-10
556 O 0 1.8295522041800183e-10
) O 0 1.090779593385105e-12
of O 0 3.004816176693098e-14
the O 0 2.259592794991161e-13
RB1 O 0 5.958531801297795e-08
gene O 0 2.2603938165666193e-10
was O 0 5.433042210567507e-11
found O 0 3.4749770335545938e-12
to O 0 4.0950370264886127e-13
be O 0 2.5463658959168356e-12
present O 0 4.624524721497103e-12
homozygously O 0 2.3589509012822418e-08
in O 0 2.1501689317915407e-12
both O 0 4.557274154402824e-13
the O 0 4.43392637059295e-13
retinal B-Disease 0 7.058485351763011e-09
and I-Disease 0 1.4355562294454671e-09
the I-Disease 0 2.8416061170766227e-10
pineal I-Disease 0 0.005154607817530632
tumours I-Disease 1 0.9999995231628418
. O 0 7.497774134890278e-08

The O 0 4.953006407792948e-11
same O 0 1.7207579111611082e-11
mutation O 0 2.2560132928450827e-10
was O 0 7.828059034320489e-11
present O 0 2.2432299073837925e-11
heterozygously O 0 7.507561150532638e-08
in O 0 9.063394024004523e-13
the O 0 3.8037430735542166e-14
DNA O 0 3.767274270316534e-10
from O 0 1.0988834218657664e-13
the O 0 4.440017282872702e-14
constitutional O 0 2.729179946273086e-12
cells O 0 2.928146614067373e-11
of O 0 3.240014186849452e-14
the O 0 1.6277417781707104e-12
patient O 0 2.7894177634379957e-08
, O 0 2.2942364154288075e-12
proving O 0 2.1418374018811193e-10
it O 0 1.220139440871737e-11
to O 0 3.2645884693455196e-12
be O 0 9.131662440098332e-12
of O 0 1.2829495766534388e-13
germline O 0 9.587160398893957e-09
origin O 0 1.2828249573715311e-09
. O 0 1.2758242240451523e-09

The O 0 9.606462847422392e-11
initial O 0 6.971325738902578e-10
mutation O 0 5.819930093409198e-10
was O 0 8.311860921761394e-11
shown O 0 2.7655001552662206e-11
to O 0 1.7463486169308484e-12
have O 0 3.960638674666006e-12
occurred O 0 7.987144279297809e-11
in O 0 1.8190620721964673e-13
the O 0 1.1402398122917212e-12
paternally O 0 5.726046481413505e-08
derived O 0 5.565114591377096e-09
RB1 O 0 8.717566743143834e-06
allele O 0 2.4788172936496267e-07
. O 0 4.860019497954227e-09

The O 0 1.466370358471636e-10
mutation O 0 2.3775372781642545e-09
is O 0 1.1066817601212975e-11
in O 0 1.2554071822899748e-13
an O 0 1.0364881289403119e-13
area O 0 3.4317213515322464e-09
of O 0 9.90286750713644e-14
the O 0 9.97891751327272e-14
gene O 0 2.983833735648034e-10
that O 0 7.269069786201843e-13
encodes O 0 6.267731559456147e-12
the O 0 4.631434125101919e-13
protein O 0 3.075569243726761e-10
- O 0 1.7673489338676518e-08
binding O 0 5.613490228206786e-10
region O 0 4.201408110304783e-10
known O 0 3.7178421452566113e-10
as O 0 2.0534173320041482e-11
the O 0 1.4444750734074474e-12
pocket O 0 5.662473540724022e-06
region O 0 1.0871723787886367e-07
and O 0 1.9359940317542623e-09
has O 0 3.363001821465872e-10
been O 0 6.099112100782511e-12
detected O 0 2.356128903091559e-10
in O 0 1.3822463003831595e-14
other O 0 8.75716532166941e-15
cases O 0 4.4885885915231516e-13
of O 0 8.882461145732698e-14
retinoblastoma B-Disease 0 2.5231551958881937e-08
. O 0 1.1075692446516072e-10
. O 0 2.2920878528509547e-09

Low O 0 7.356165042438079e-06
levels O 0 3.2923572756971e-09
of O 0 1.0320185461418219e-12
beta O 0 7.294632953236402e-11
hexosaminidase O 0 1.7121436712841387e-08
A O 0 6.629890386689041e-11
in O 0 2.1429058614380603e-12
healthy O 0 2.3908157675833763e-09
individuals O 0 8.539353252290383e-12
with O 0 3.339828066883932e-11
apparent O 0 1.0496076356503181e-05
deficiency O 0 0.2774531841278076
of O 0 5.510369721281605e-13
this O 0 4.211836435175087e-11
enzyme O 0 1.8134683088533166e-08
. O 0 1.0182492626853445e-09

Appreciable O 0 5.297725692798849e-06
beta O 0 2.384928734500136e-07
hexosaminidase O 0 2.3280833829630865e-06
A O 0 2.7463378238223868e-09
( O 0 4.111944725687655e-12
hex O 0 8.840663756615186e-10
A O 0 1.0666869948092184e-12
) O 0 1.7621531133143326e-14
activity O 0 2.2402209254313021e-10
has O 0 2.212641745172328e-12
been O 0 1.1667389060096567e-12
detected O 0 2.0518679810788143e-10
in O 0 4.232542661079981e-14
cultured O 0 9.955193336352863e-10
skin O 0 4.1686297436172026e-07
fibroblasts O 0 4.2036725744765135e-07
and O 0 2.668259071469947e-07
melanoma B-Disease 1 0.8342260122299194
tissue O 0 2.7819751267088577e-05
from O 0 2.7873567343128514e-10
healthy O 0 3.013995240053191e-07
individuals O 0 8.295863995755326e-11
previously O 0 3.176160667806016e-09
reported O 0 2.2965647076489404e-05
as O 0 3.7325662560760975e-09
having O 0 2.5825424927461427e-06
deficiency B-Disease 0 0.20309412479400635
of I-Disease 0 1.4222540246217052e-12
hex I-Disease 0 9.513681220596482e-08
A I-Disease 0 2.2647653197260809e-10
activity O 0 2.1779683834211028e-08
indistinguishable O 0 5.641544870149673e-11
from O 0 1.2023817000644116e-13
that O 0 1.8726251831743118e-13
of O 0 6.842109886474879e-14
patients O 0 1.8711429627948917e-10
with O 0 3.292509731522841e-08
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 0.9873663187026978
( O 0 1.7831266463375073e-09
TSD B-Disease 0 3.876510163536295e-05
) O 0 1.4975275464124138e-09
. O 0 3.727521846741411e-09

Identification O 0 5.590672813582387e-08
and O 0 3.4858410602467416e-10
quantitation O 0 1.2112701597288833e-07
of O 0 7.13893961307166e-12
hex O 0 3.468626985636547e-08
A O 0 2.253252445738596e-10
, O 0 4.37245335424552e-12
amounting O 0 5.1622806723772285e-11
to O 0 4.025511694816242e-12
3 O 0 5.5557763251057324e-11
. O 0 8.002122298123027e-10

5 O 0 3.2819386319715704e-08
% O 0 2.15129603020614e-09
- O 0 0.00014557121903635561
6 O 0 1.4577492990497376e-08
. O 0 4.069708126053229e-09

9 O 0 6.666889618145433e-08
% O 0 8.288715547255521e-11
of O 0 1.4080135711871944e-12
total O 0 9.52419879074462e-11
beta O 0 1.5070110437331863e-10
hexosaminidase O 0 4.5721300523382524e-08
activity O 0 2.89828278710047e-07
, O 0 9.12041796252705e-12
has O 0 8.34055394194344e-12
been O 0 1.4178879424731061e-12
obtained O 0 3.1374406111311925e-12
by O 0 1.6802802638854475e-12
cellulose O 0 3.7450088257173775e-06
acetate O 0 1.3337779591893195e-07
gel O 0 1.0383412529790803e-07
electrophoresis O 0 5.266533431580456e-09
, O 0 5.0161246684110594e-11
DEAE O 0 1.4002181103478506e-07
- O 0 2.2416935863134313e-08
cellulose O 0 3.454682584447255e-08
ion O 0 2.2016250156298156e-08
- O 0 2.1411089790035476e-07
exchange O 0 5.43858125201524e-10
chromatography O 0 5.113403034329167e-10
, O 0 1.5323422869126246e-12
radial O 0 1.2236576196755777e-09
immunodiffusion O 0 1.7212759217954954e-08
, O 0 4.5927241176801914e-11
and O 0 1.1866924110037758e-10
radioimmunoassay O 0 1.5423170225403737e-06
. O 0 3.977723928016985e-09

Previous O 0 5.645062728376615e-08
family O 0 2.4360180539417797e-09
studies O 0 1.3924759782735219e-11
suggested O 0 4.979968659668543e-10
that O 0 1.8523563759254014e-12
these O 0 2.4646013311799275e-13
individuals O 0 1.1648533700114871e-12
may O 0 2.089256719017829e-12
be O 0 2.3311656424662708e-12
compound O 0 1.0134755257240613e-08
heterozygotes O 0 7.3588397597745825e-09
for O 0 6.571567834172398e-13
the O 0 8.565253541148454e-13
common O 0 2.0626694796632705e-11
mutant O 0 6.339530678189931e-09
TSD B-Disease 0 1.461307732597561e-07
gene O 0 5.834404515070446e-09
and O 0 1.895203438628812e-11
a O 0 1.2786219999449955e-11
rare O 0 2.2927687526319573e-10
( O 0 1.9959959032811447e-11
allelic O 0 9.132913092457784e-09
) O 0 4.2069712297143624e-11
mutant O 0 2.2857893355876513e-08
gene O 0 2.1040699493823922e-07
. O 0 1.0568429686941272e-08

Thus O 0 7.143592384295516e-10
, O 0 2.6329815064340956e-11
the O 0 8.577465994419331e-13
postulated O 0 2.898133955042681e-09
rate O 0 1.5623766724814914e-09
mutant O 0 8.229189552011462e-10
gene O 0 2.42208186840287e-09
appears O 0 3.051617292193498e-10
to O 0 8.611512653140807e-13
code O 0 4.388796184112698e-12
for O 0 2.764558872624112e-13
the O 0 1.883903054172506e-13
expression O 0 4.6714063173247666e-11
of O 0 4.0505568192107655e-13
low O 0 1.645659941651445e-09
amounts O 0 3.854118066359824e-11
of O 0 4.557345820166425e-12
hex O 0 1.7834139498518198e-07
A O 0 4.482779925041314e-09
. O 0 1.4314004426196902e-09

Heterozygotes O 0 1.9609749415394617e-06
for O 0 3.544314147729821e-11
the O 0 1.1814989091252226e-12
rare O 0 5.678942385789476e-11
mutant O 0 6.503402971702599e-08
may O 0 4.812043541413402e-10
be O 0 4.75856290135801e-12
indistinguishable O 0 6.933239399264934e-11
from O 0 1.5902840025741605e-12
heterozygotes O 0 3.1680775780529302e-09
for O 0 9.686580964424207e-13
the O 0 3.6089273930395294e-12
common O 0 3.9403585949671083e-10
TSD B-Disease 0 2.1127373202034505e-06
mutant O 0 2.3492617629017332e-07
. O 0 9.844135284708955e-09

However O 0 4.755355553776042e-10
, O 0 6.942935375925385e-12
direct O 0 1.02356456643804e-10
visualization O 0 5.83564272460535e-08
and O 0 6.230775340121397e-10
quantitation O 0 8.336958217114443e-07
of O 0 1.0437640335370091e-11
hex O 0 2.0494489660904947e-08
A O 0 1.5649549364726845e-11
by O 0 1.1105396116595223e-13
the O 0 3.2837258303122785e-14
methods O 0 2.9665641471110504e-11
described O 0 5.36439448417525e-10
may O 0 1.2608413445247546e-11
prevent O 0 2.5933441505365806e-10
false O 0 2.9789957167736247e-09
- O 0 2.9534149348364735e-07
positive O 0 1.3294464418223129e-09
prenatal O 0 1.1133491852888255e-06
diagnosis O 0 2.859115397768619e-07
of O 0 1.016315070295759e-12
TSD B-Disease 0 6.056462552805897e-06
in O 0 7.193289019991056e-11
fetuses O 0 1.48400289390338e-07
having O 0 1.2575851471297028e-10
the O 0 5.239883180130356e-12
incomplete O 0 6.365122118268118e-08
hex B-Disease 0 1.9818658074655104e-06
A I-Disease 0 2.8894751480379455e-08
deficiency I-Disease 0 0.0006048393552191556
of O 0 5.400368737265571e-13
the O 0 2.7372344842124807e-12
type O 0 3.002104733695887e-07
described O 0 1.0193534905056367e-08
in O 0 1.705570060184236e-11
the O 0 4.763575384841845e-12
four O 0 6.652792899908277e-11
healthy O 0 5.8699363592040754e-08
individuals O 0 5.658620683135496e-09

The O 0 2.0737198069831209e-10
tumor B-Disease 0 3.573335334294825e-07
suppressor O 0 5.472143129736651e-07
gene O 0 2.9561368819486233e-07
Smad4 O 0 6.884511094540358e-06
/ O 0 0.00010487266990821809
Dpc4 O 0 5.576504008786287e-06
is O 0 4.358328142828327e-10
required O 0 6.970548270535115e-12
for O 0 3.135154082959529e-13
gastrulation O 0 8.460611411464924e-08
and O 0 5.264177982411411e-11
later O 0 1.8424452935539293e-11
for O 0 4.777522236328047e-13
anterior O 0 2.3301867102532015e-09
development O 0 5.203185798885457e-11
of O 0 7.641053723994942e-14
the O 0 4.2168503931738766e-12
mouse O 0 1.4091790490056155e-06
embryo O 0 3.298211197488854e-07
. O 0 9.703390979609594e-09

Mutations O 0 4.7043221229614574e-07
in O 0 4.0080921220875254e-11
the O 0 2.7045669523384497e-11
SMAD4 O 0 0.000102472651633434
/ O 0 0.00046599353663623333
DPC4 O 0 3.0881434213370085e-05
tumor B-Disease 0 7.08640982338693e-06
suppressor O 0 1.3179649727135256e-07
gene O 0 3.206469401106915e-08
, O 0 4.0859284705652144e-11
a O 0 1.0915419609847099e-11
key O 0 4.123559271818067e-09
signal O 0 1.9095024228477087e-08
transducer O 0 3.7271611574851704e-08
in O 0 6.282201321650138e-12
most O 0 1.7158972159814212e-11
TGFbeta O 0 3.251965608797036e-06
- O 0 1.8988916963280644e-06
related O 0 1.6286518800257e-08
pathways O 0 9.930520850076618e-10
, O 0 1.3997234361157185e-12
are O 0 2.6641005617918448e-14
involved O 0 3.4564731177071095e-13
in O 0 2.4409990630365475e-13
50 O 0 6.107240407837722e-11
% O 0 6.069577132561399e-12
of O 0 2.1972253877455827e-11
pancreatic B-Disease 1 0.9969111084938049
cancers I-Disease 1 0.5200819373130798
. O 0 1.4134333525817055e-07

Homozygous O 0 0.0001722618326311931
Smad4 O 0 6.407466571545228e-05
mutant O 0 7.786219612171408e-06
mice O 0 0.00012376908853184432
die O 0 4.931709554512054e-06
before O 0 3.5887570692949566e-10
day O 0 2.5659985247727946e-09
7 O 0 6.408215069697576e-10
. O 0 4.160356226190487e-10

5 O 0 1.3581422209085758e-08
of O 0 3.728030037453145e-11
embryogenesis O 0 1.2188920663902536e-06
. O 0 3.1321373938908437e-08

Mutant O 0 2.0221564511757606e-07
embryos O 0 2.2096939389371073e-08
have O 0 3.4117143138390205e-11
reduced O 0 1.9957256333635875e-11
size O 0 2.422798184298358e-09
, O 0 5.561684446320214e-10
fail O 0 1.3977468071857402e-08
to O 0 1.7494967280429208e-11
gastrulate O 0 1.106069339584792e-05
or O 0 9.482048035636126e-09
express O 0 5.635019673100317e-10
a O 0 4.4876923357972665e-12
mesodermal O 0 8.622776448419245e-08
marker O 0 4.101772901776712e-06
, O 0 1.2685877348594943e-10
and O 0 3.70900081481107e-11
show O 0 1.470987598395368e-07
abnormal O 0 2.106910415022867e-06
visceral O 0 1.2350331246580026e-07
endoderm O 0 1.8472849205863895e-06
development O 0 4.711123935408068e-08
. O 0 5.275521353098611e-09

Growth B-Disease 1 0.9999997615814209
retardation I-Disease 1 1.0
of O 0 7.986260958103841e-11
the O 0 1.0731183303080982e-10
Smad4 O 0 0.00022259178513195366
- O 0 0.0006170019041746855
deficient O 0 3.480413943179883e-05
embryos O 0 2.521075570527387e-09
results O 0 3.1312428344643095e-11
from O 0 6.656315039085814e-13
reduced O 0 2.5896158481475418e-11
cell O 0 1.4206737120048274e-08
proliferation O 0 1.8111028055045608e-07
rather O 0 2.384747087302852e-11
than O 0 1.329632584590179e-11
increased O 0 1.7369261584576634e-10
apoptosis O 0 2.3536969706583477e-08
. O 0 6.469205171555359e-09

Aggregation O 0 1.0102643699383407e-07
of O 0 1.052920389765788e-10
mutant O 0 7.017839607215137e-07
Smad4 O 0 2.8367536287987605e-05
ES O 0 6.680917294943356e-07
cells O 0 1.482697187249471e-09
with O 0 1.2593415893435989e-11
wild O 0 1.0226367308519002e-08
- O 0 1.3403117918642238e-05
type O 0 4.610038558894303e-06
tetraploid O 0 7.720712460468349e-07
morulae O 0 2.751559577518492e-06
rescues O 0 4.0953841562441085e-07
the O 0 1.300875240861643e-10
gastrulation B-Disease 0 4.0077069570543244e-05
defect I-Disease 0 6.17287223576568e-05
. O 0 3.201328313551244e-09

These O 0 2.5818150395373607e-10
results O 0 7.8873935160928e-11
indicate O 0 4.3859474385676833e-10
that O 0 2.607691189718264e-12
Smad4 O 0 2.3384737701803715e-08
is O 0 9.121913294163342e-12
initially O 0 1.3131321550952091e-11
required O 0 2.4144943856774237e-13
for O 0 1.7760415737372824e-14
the O 0 2.8385937534975564e-14
differentiation O 0 9.685722363039773e-11
of O 0 1.162688516428631e-13
the O 0 7.309778867273242e-13
visceral O 0 6.194113555402225e-10
endoderm O 0 1.5101834449637863e-08
and O 0 1.0995707122596343e-10
that O 0 2.8561330817772346e-12
the O 0 3.797069267081482e-13
gastrulation B-Disease 0 2.5624399313528556e-07
defect I-Disease 0 4.897952976534725e-07
in O 0 4.678303100816295e-13
the O 0 5.335131750446032e-13
epiblast O 0 5.778733225270116e-08
is O 0 1.6516683853939895e-10
secondary O 0 6.527207108142363e-10
and O 0 1.0475340039839409e-10
non O 0 8.59718696233358e-09
- O 0 1.4286061741586309e-05
cell O 0 1.2402716492943e-05
autonomous O 0 1.858816176536493e-07
. O 0 9.61760004969392e-09

Rescued O 0 2.3103232251742156e-06
embryos O 0 6.019679403834743e-07
show O 0 7.593328973598545e-06
severe O 0 1.644431358727161e-05
anterior O 0 0.00016540827346034348
truncations O 0 2.5437386739213252e-06
, O 0 3.497644396333044e-09
indicating O 0 2.1021520524300286e-08
a O 0 3.4872223164672533e-11
second O 0 4.391417351284899e-12
important O 0 6.1046870683534316e-12
role O 0 5.135225231156504e-11
for O 0 1.7279267209777127e-12
Smad4 O 0 1.5332990699334914e-07
in O 0 1.7983307551427963e-11
anterior O 0 1.595052481206949e-07
patterning O 0 5.778015861324093e-07
during O 0 8.39409430852811e-09
embryogenesis O 0 7.076726546983991e-07
. O 0 4.910503559329982e-09

Prevalence O 0 0.00011168342462042347
of O 0 5.423589355402214e-11
p16 O 0 3.4443306162756926e-07
and O 0 4.423036936707092e-10
CDK4 O 0 9.047781759363716e-07
germline O 0 5.349176035451819e-08
mutations O 0 9.880703366604848e-09
in O 0 1.2538648938575925e-11
48 O 0 3.728903053001886e-08
melanoma B-Disease 1 0.9998753070831299
- O 1 0.9999682903289795
prone O 1 0.9999145269393921
families O 0 2.476440386089962e-07
in O 0 7.981513783228422e-10
France O 0 2.615412995510269e-06
. O 0 1.8170172921827543e-08

The O 0 5.282368320536079e-09
French O 0 2.44277180172503e-06
Familial B-Disease 1 0.6180317401885986
Melanoma I-Disease 1 0.972044825553894
Study O 0 8.55240678276914e-09
Group O 0 2.1410063055782302e-08
. O 0 6.389325513111999e-09

Germline O 0 1.3930983186583035e-05
mutations O 0 1.4354179711517645e-07
in O 0 1.736690131981522e-11
the O 0 1.4922959786292656e-12
p16 O 0 2.2159911239327812e-08
and O 0 5.914476547408398e-11
CDK4 O 0 9.129171729682639e-08
genes O 0 3.91282756195821e-10
have O 0 5.743010234038337e-12
been O 0 1.5017192350752495e-11
reported O 0 1.2040921149036876e-08
in O 0 2.0727716147205671e-13
a O 0 1.3071765891936593e-12
subset O 0 5.216265197560688e-10
of O 0 9.098733051715602e-12
melanoma B-Disease 0 0.0013014473952353
pedigrees O 0 6.276141562011617e-07
, O 0 1.531578336377848e-10
but O 0 4.8513273259720435e-11
their O 0 5.5127586523484595e-12
prevalence O 0 3.510445765186887e-07
is O 0 1.22720500428386e-10
not O 0 2.878255446481237e-11
well O 0 2.0115931489983474e-11
known O 0 1.7416602882125432e-10
. O 0 3.4698080519923735e-10

We O 0 1.889971068536056e-09
searched O 0 2.1441028952295937e-09
for O 0 2.5991836179010963e-13
such O 0 2.758185661203699e-13
germline O 0 6.4060068361015965e-09
mutations O 0 4.2385153165014344e-09
in O 0 1.2101456121904608e-11
48 O 0 8.637970694280739e-08
French O 0 6.433205271605402e-05
melanoma B-Disease 1 0.9999994039535522
- O 1 0.9999850988388062
prone O 1 0.9957805871963501
families O 0 1.191880705242454e-09
selected O 0 4.343957485386518e-12
according O 0 1.7146467622478068e-12
to O 0 2.0253826827493215e-12
two O 0 1.3179616903044589e-12
major O 0 1.3250357755456577e-10
criteria O 0 2.7789359355323562e-11
families O 0 8.420953279304755e-13
with O 0 1.7889994498830608e-13
at O 0 2.1953371065475125e-10
least O 0 6.164575100386926e-11
three O 0 1.7596929772698e-12
affected O 0 3.1734223582269294e-10
members O 0 2.0152163358183595e-13
( O 0 5.628147687480878e-13
n O 0 1.7630098625431856e-07
= O 0 6.40709671984041e-08
20 O 0 7.7577687329633e-11
) O 0 1.4766721916428804e-12
or O 0 3.518953184400431e-11
families O 0 1.4342985132920205e-11
with O 0 3.5200705197913074e-13
two O 0 6.726510082440129e-13
affected O 0 7.013855468640529e-11
members O 0 2.4273120948110904e-13
, O 0 7.067092679287346e-13
one O 0 1.746937420025671e-13
of O 0 1.5558067394073546e-14
them O 0 1.342296174385027e-12
affected O 0 2.920059333222369e-11
before O 0 2.3529695986762578e-12
the O 0 2.1983969007190185e-13
age O 0 1.0743588310657692e-11
of O 0 3.528787708545998e-14
50 O 0 2.237290561146743e-11
( O 0 3.9977062459006785e-12
n O 0 4.95604751904466e-07
= O 0 1.692523312613048e-07
28 O 0 5.610439335335116e-10
) O 0 1.7303144594221775e-12
, O 0 1.903193531591074e-12
and O 0 2.0113773927660228e-12
one O 0 1.240105240718492e-12
additional O 0 1.8612856048094706e-11
minor O 0 6.394287765942863e-09
criterion O 0 8.600077450182653e-08
. O 0 1.9829039743513022e-08

Sixteen O 0 1.5221964133615984e-08
different O 0 1.0553874441043831e-10
p16 O 0 5.186053186889694e-08
germline O 0 3.8088153075932496e-08
mutations O 0 8.682516039471011e-09
were O 0 3.2503121721871864e-11
found O 0 1.7870403073994012e-11
in O 0 7.894038070790921e-13
21 O 0 1.0179070086824282e-10
families O 0 2.4569533907392582e-11
, O 0 3.4277322733672344e-12
while O 0 8.310398376398798e-12
one O 0 3.5659639303908808e-12
germline O 0 1.737205490570659e-09
mutation O 0 4.03501759782543e-10
, O 0 2.2328005330057854e-12
Arg24His O 0 7.923998346370809e-09
, O 0 1.302677323650192e-11
was O 0 3.5413025289976474e-10
detected O 0 4.6233786576976854e-08
in O 0 2.0958623291739142e-12
the O 0 2.528617940034117e-12
CDK4 O 0 2.995841441588709e-07
gene O 0 2.3526288472908163e-08
. O 0 1.3037723123332512e-09

The O 0 4.957325522303435e-11
frequency O 0 4.0082237529048825e-10
of O 0 2.0927693172162476e-13
p16 O 0 6.2206613193893645e-09
gene O 0 2.9981657156952224e-09
mutation O 0 5.719851814411925e-10
in O 0 4.790444950442119e-12
our O 0 2.4405826318241175e-11
sample O 0 5.225982147027963e-11
( O 0 1.3821713955655679e-12
44 O 0 1.4584925281391214e-11
% O 0 1.2569453941221886e-13
) O 0 1.9856542083328266e-13
is O 0 4.821758877587845e-12
among O 0 1.8264464376679945e-13
the O 0 7.664831632890265e-14
highest O 0 7.872860002811066e-11
rates O 0 3.1906970399120382e-09
yet O 0 8.305633264482637e-11
reported O 0 2.959411915526289e-07
and O 0 1.1832855875693049e-11
the O 0 3.2557940718436207e-13
CDK4 O 0 2.3653665692791037e-08
mutation O 0 8.482800573084148e-11
is O 0 2.560841295962124e-12
the O 0 4.084434206868062e-14
second O 0 1.1211070049740868e-12
mutation O 0 6.404069635701504e-11
detected O 0 1.2988032871419364e-09
in O 0 8.971922055116266e-14
this O 0 1.652854014679711e-13
gene O 0 1.3033073509305382e-09
worldwide O 0 9.024475056129688e-10
. O 0 1.5674329612025417e-09

In O 0 1.3873131532449179e-09
summary O 0 3.882078942751832e-07
, O 0 7.198315832290803e-10
our O 0 1.1182463982573054e-10
results O 0 1.228518155260705e-11
show O 0 1.8028728510088854e-09
frequent O 0 7.106397137413012e-10
involvement O 0 4.351707327820975e-10
of O 0 7.747951992443866e-14
the O 0 2.1983799600600734e-13
p16 O 0 9.781206955494781e-10
gene O 0 1.9463832767740996e-09
in O 0 4.462418715794891e-12
familial B-Disease 0 5.113447332405485e-05
melanoma I-Disease 1 0.9197389483451843
and O 0 3.849838670078043e-09
confirm O 0 5.749147931055631e-07
the O 0 2.270719202945859e-12
role O 0 1.6720688722493549e-10
of O 0 2.1550084850288642e-13
the O 0 4.835027777455592e-13
CDK4 O 0 9.752021412623435e-09
gene O 0 7.596022144618075e-10
as O 0 3.65606806981833e-12
a O 0 4.508112286250032e-11
melanoma B-Disease 0 0.00029731346876360476
- O 0 7.422268595291825e-07
predisposing O 0 3.2555109896748036e-07
gene O 0 5.654890600226281e-08
. O 0 2.2728575965746955e-10
. O 0 9.8144714577586e-10

Progression O 0 2.8755273433489492e-06
of O 0 5.935338331930495e-11
somatic O 0 5.707367449758749e-07
CTG O 0 0.00024234072770923376
repeat O 0 3.2151845630323805e-07
length O 0 9.634326225693712e-09
heterogeneity O 0 1.232613477952782e-08
in O 0 6.139437049024199e-12
the O 0 3.4761373467195877e-12
blood O 0 1.1832619328799865e-09
cells O 0 4.0594727579446044e-10
of O 0 2.4465685033447926e-10
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 0.9999998807907104
patients O 0 7.801322681189049e-06
. O 0 1.8442621652070557e-08

The O 0 4.036385461980707e-11
genetic O 0 4.59830307164566e-09
basis O 0 6.93525292749797e-10
of O 0 3.387950198163736e-10
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 4.985220130038215e-07
DM B-Disease 1 1.0
) O 0 1.188768083970615e-09
is O 0 2.301548188143876e-11
the O 0 6.217727342109486e-14
expansion O 0 2.2965842769173683e-11
of O 0 1.1630921106873388e-13
an O 0 3.990727887037693e-12
unstable O 0 3.052079409826547e-05
CTG O 0 3.623376687755808e-05
repeat O 0 4.551360888171985e-08
in O 0 2.0728358265942326e-12
the O 0 4.597969682947067e-13
34 O 0 2.1506334907384073e-11
UTR O 0 1.6946721803634546e-10
of O 0 1.0645563613574313e-13
the O 0 2.00431633096132e-11
DM B-Disease 1 1.0
protein O 0 5.955222537323834e-09
kinase O 0 7.742874785776621e-09
gene O 0 2.370871499124405e-09
on O 0 1.0592136057141488e-09
chromosome O 0 1.1638711839623284e-05
19 O 0 1.0682165907383023e-07
. O 0 1.3188369507588504e-08

One O 0 2.155321254804221e-09
of O 0 1.2256810150157449e-12
the O 0 1.2131354948374806e-12
principal O 0 3.5029568135058753e-10
features O 0 3.3278754751897566e-10
of O 0 4.59206240741028e-13
the O 0 9.572350551101394e-11
DM B-Disease 1 1.0
mutation O 0 6.835686150452602e-08
is O 0 5.962683818916403e-11
an O 0 2.926603837744013e-12
extraordinarily O 0 7.240275490261183e-09
high O 0 5.008538916939642e-09
level O 0 1.705447311151076e-10
of O 0 2.0621796371217416e-13
somatic O 0 2.8323381418005056e-09
mosaicism O 0 4.049192625643627e-07
, O 0 1.0198730748811613e-11
due O 0 3.0736017030130736e-12
to O 0 4.290301837753252e-13
an O 0 9.798109589301274e-13
extremely O 0 1.8649335409293144e-09
high O 0 1.7006041019840268e-10
degree O 0 7.075377176507525e-12
of O 0 1.4032707287836566e-12
somatic O 0 4.3270475202916714e-08
instability O 0 1.6228769936788012e-06
both O 0 4.741550554965279e-11
within O 0 3.258717254372989e-11
and O 0 8.17328010827012e-11
between O 0 1.3243630150872043e-11
different O 0 4.3421786999342515e-11
tissues O 0 3.36913643650405e-08
. O 0 1.0854288579054128e-09

This O 0 4.5990200536749626e-10
instability O 0 2.3752269484589306e-08
appears O 0 3.5826974720265525e-10
to O 0 1.0042160245721243e-12
be O 0 2.654707779558424e-13
biased O 0 3.4906164764203496e-11
towards O 0 4.3049662142372047e-13
further O 0 4.594462831020163e-13
expansion O 0 3.587899768953129e-11
and O 0 1.6508791946326373e-12
continuous O 0 1.3433860968081746e-10
throughout O 0 1.096520790833111e-11
the O 0 4.0589555913399245e-13
life O 0 1.0264966827933097e-11
of O 0 2.459298498354301e-14
an O 0 2.1020904743436486e-13
individual O 0 2.927506598682933e-13
, O 0 4.813881498283434e-13
features O 0 9.64441526640769e-10
that O 0 2.992684988711858e-10
could O 0 3.1633601293989955e-10
be O 0 4.0555991724644525e-12
associated O 0 2.0031708236611934e-10
with O 0 3.3833615162986996e-12
the O 0 1.404949941108402e-12
progressive O 0 6.9858652196330695e-09
nature O 0 8.000039031230699e-08
of O 0 4.218265927530274e-12
the O 0 3.516747726362013e-10
disease O 0 1.935288673848845e-05
. O 0 1.7824600684335223e-09

Although O 0 1.4677646875682626e-09
increasing O 0 6.705819233232546e-10
measured O 0 1.163922824787278e-08
allele O 0 6.128846763431284e-09
size O 0 4.740659864665986e-09
between O 0 4.289702759674441e-10
patients O 0 2.1415649253953006e-09
clearly O 0 7.585829742140504e-10
correlates O 0 6.218736636753874e-10
with O 0 2.467749312187739e-12
an O 0 2.0677932022900025e-12
increased O 0 6.150945086602633e-09
severity O 0 1.3873365787731018e-05
of O 0 1.8751049324361446e-10
symptoms O 0 0.003516691504046321
and O 0 1.18342169397323e-10
an O 0 2.0351333465673527e-12
earlier O 0 9.890810837021036e-09
age O 0 2.5603956732567212e-09
of O 0 2.547520842281076e-13
onset O 0 4.949602061543601e-09
, O 0 4.3807652275705544e-13
this O 0 1.2067324339760065e-14
correlation O 0 3.435221551661982e-11
is O 0 1.668552991086758e-12
not O 0 9.85978768248963e-13
precise O 0 1.2019529815887608e-09
and O 0 8.139054707978488e-11
measured O 0 4.583437274163771e-08
allele O 0 1.918855296878519e-09
length O 0 4.32217062140694e-09
cannot O 0 1.2441446983757487e-08
be O 0 1.0557609474159957e-12
used O 0 1.3404872914804522e-12
as O 0 4.3486972378138644e-13
an O 0 1.4895253270825332e-13
accurate O 0 3.4909344748257354e-08
predictor O 0 1.316761313319148e-07
of O 0 6.3941438949166596e-12
age O 0 2.9210092122866627e-09
of O 0 3.1086178770012296e-11
onset O 0 1.0304656825610436e-05
. O 0 1.0319694432325832e-08

In O 0 1.7428099241545425e-10
order O 0 1.6930333870956993e-11
to O 0 1.4510436038492336e-13
further O 0 7.666209789376766e-13
characterize O 0 2.2854742542932627e-09
the O 0 2.2967320319894347e-12
dynamics O 0 8.665672623919818e-09
of O 0 3.438599127658648e-10
DM B-Disease 1 1.0
CTG O 0 0.006207186728715897
repeat O 0 4.4944769683752384e-07
somatic O 0 8.896373770994614e-08
instability O 0 6.63100010456219e-08
, O 0 2.1642377126540602e-11
we O 0 2.1872026759184315e-11
have O 0 3.6044059989297217e-13
studied O 0 1.4900945061180337e-12
repeat O 0 6.146505526771762e-11
length O 0 2.395501158547475e-11
changes O 0 1.0911526023005269e-11
over O 0 8.607773348268122e-12
time O 0 1.2604253578352154e-11
in O 0 6.255370353647205e-12
111 O 0 2.719598910516652e-07
myotonic B-Disease 1 0.9999997615814209
dystrophy I-Disease 1 0.9999997615814209
patients O 0 1.1053570148078506e-07
with O 0 6.969803206802183e-12
varying O 0 1.2235992219444825e-09
clinical O 0 1.8060595152746828e-07
severity O 0 2.8099821065552533e-06
and O 0 3.5468741277355775e-09
CTG O 0 2.718569157877937e-05
repeat O 0 1.1856894843731425e-07
size O 0 2.2476102756741057e-08
over O 0 2.6130821950687277e-09
time O 0 6.436168265011588e-10
intervals O 0 5.199193076066422e-09
of O 0 6.355547598618783e-13
1 O 0 3.593227798637244e-11
- O 0 4.0842797943696496e-07
7 O 0 2.333961912626137e-10
years O 0 5.3919344683572845e-11
. O 0 7.902105358947864e-11

We O 0 3.187237496149464e-08
have O 0 1.4693458255665703e-11
found O 0 1.043357457722327e-12
a O 0 2.1581633778255255e-13
direct O 0 6.329062274268438e-11
progression O 0 2.433377801480674e-07
of O 0 3.4787155252756496e-13
the O 0 3.4150441263931797e-13
size O 0 2.2591913062530722e-10
heterogeneity O 0 2.258402631571954e-10
over O 0 3.2424608137349153e-11
time O 0 1.1633595128901497e-11
related O 0 4.280481177842965e-11
to O 0 1.95323813546866e-12
initial O 0 2.8026619913745776e-10
CTG O 0 2.8035691457262146e-07
repeat O 0 3.2298479446524198e-09
size O 0 2.7834055060793617e-09
and O 0 1.3235201823391662e-10
the O 0 2.0271759531426126e-12
time O 0 2.937521753620942e-11
interval O 0 2.566535595160957e-10
and O 0 1.6526026424060203e-12
always O 0 5.5072938397182636e-12
biased O 0 2.012859670608158e-11
towards O 0 3.6024488513780595e-12
further O 0 3.243326787694123e-11
expansion O 0 1.5237991979333287e-09
. O 0 1.0831291419322042e-09

Attempts O 0 1.02526399814451e-07
to O 0 3.896279965331928e-10
mathematically O 0 1.0575844644478138e-09
model O 0 2.7355004927898108e-09
the O 0 1.1243876923278107e-12
dynamics O 0 8.09898921261265e-08
have O 0 3.819432548013424e-10
proved O 0 6.646264649745603e-10
only O 0 1.4405770847047972e-11
partially O 0 2.927657893891933e-09
successful O 0 1.904320277856808e-11
suggesting O 0 8.137072682323776e-10
that O 0 1.056784434266822e-12
individual O 0 6.19374682293318e-14
specific O 0 3.507385788054096e-12
genetic O 0 6.4485208284281725e-09
and O 0 5.158375948610683e-10
/ O 0 0.00010902366921072826
or O 0 2.1636907820976603e-09
environmental O 0 3.571351547826396e-10
factors O 0 1.8220613906549943e-10
also O 0 1.3283152355825223e-10
play O 0 2.6961304716577317e-11
a O 0 9.934299910474564e-12
role O 0 9.11426559224715e-11
in O 0 1.7392483937436753e-12
somatic O 0 2.1911841230348728e-09
mosaicism O 0 1.244574860947978e-07
. O 0 7.110962513268149e-11
. O 0 1.2022006723455547e-09

Aspartylglucosaminuria B-Disease 1 0.9997923970222473
among O 0 3.314689678290961e-08
Palestinian O 0 8.369898978344281e-07
Arabs O 0 2.1190763277445512e-07
. O 0 1.1046378034507143e-08

Aspartylglucosaminuria B-Disease 1 0.9999986886978149
( O 0 2.429786491120467e-06
AGU B-Disease 1 0.999995231628418
) O 0 2.5193150343660875e-10
is O 0 5.1402792612675885e-12
a O 0 2.6326336943771622e-12
rare O 0 1.176966302196547e-09
disorder B-Disease 0 0.0022960102651268244
of I-Disease 0 2.0043470355668447e-11
glycoprotein I-Disease 0 0.006567337550222874
metabolism I-Disease 0 5.822415550937876e-05
caused O 0 4.427363009540386e-08
by O 0 4.488995633544768e-11
the O 0 1.0842722275583583e-09
deficiency B-Disease 1 0.716721773147583
of I-Disease 0 4.665989816743377e-12
the I-Disease 0 1.4664570946454347e-10
lysosomal I-Disease 0 0.0005458419327624142
enzyme I-Disease 0 1.0683756102025654e-07
aspartylglucosaminidase I-Disease 0 6.168218646962487e-07
( O 0 1.860523540786474e-10
AGA O 0 2.0437184389265894e-08
) O 0 4.931300368049563e-10
. O 0 1.4645039625449385e-09

AGU B-Disease 1 0.9999955892562866
is O 0 4.099689832059994e-08
inherited O 0 1.1014169103873428e-05
as O 0 3.330127840150965e-11
an O 0 2.566788968871858e-11
autosomal O 1 0.9997206330299377
recessive O 1 0.9966069459915161
trait O 0 0.004654041025787592
and O 0 4.130021657999805e-09
occurs O 0 3.379011792592479e-10
with O 0 8.14482379110637e-13
a O 0 2.794060555838529e-12
high O 0 9.053538474468326e-11
frequency O 0 1.987326214702989e-08
in O 0 5.957662141398146e-10
Finland O 0 7.888202446793002e-08
because O 0 3.3417543732205957e-10
of O 0 2.101777817542158e-13
a O 0 3.534471673671824e-11
founder O 0 5.1413167057035025e-09
effect O 0 2.4209458882040735e-09
. O 0 1.542696637102381e-09

While O 0 1.601216048641163e-09
very O 0 1.1078692130350731e-10
few O 0 5.5507026058831954e-11
patients O 0 1.2271278437836486e-10
with O 0 2.950042640725847e-11
AGU B-Disease 1 0.9999998807907104
have O 0 1.6811643188674452e-09
been O 0 3.521795077787715e-10
reported O 0 8.875426260601671e-08
from O 0 2.8514027076986803e-12
non O 0 6.5251937186872055e-09
- O 0 4.204562742415874e-07
Finnish O 0 7.051703221350181e-09
origin O 0 6.877434038932151e-11
, O 0 1.1659007093101081e-11
we O 0 1.8605979257291239e-10
diagnosed O 0 3.738237275285883e-09
the O 0 5.44350317859682e-13
disorder O 0 1.1085119240306085e-06
in O 0 2.1280713736332446e-12
8 O 0 4.123966446112348e-10
patients O 0 5.127610835931051e-11
originating O 0 5.0865239104025406e-11
from O 0 3.31430347576267e-12
3 O 0 9.364471004191799e-12
unrelated O 0 7.215594233223044e-10
families O 0 1.3872383797242094e-10
, O 0 5.677726084424295e-12
all O 0 2.0411471991776953e-12
Palestinian O 0 1.1715959757907513e-08
Arabs O 0 5.66898861187326e-10
from O 0 9.031112663260288e-12
the O 0 3.2134607474976207e-12
region O 0 3.5021952005109824e-10
of O 0 5.7654883471591756e-12
Jerusalem O 0 6.264624244067818e-05
. O 0 2.5760870769886424e-08

The O 0 2.0245398690832417e-09
clinical O 0 4.811461167264497e-07
diagnosis O 0 0.0005526395980268717
of O 0 1.004354199807267e-08
AGU B-Disease 1 1.0
is O 0 3.739950571457484e-08
often O 0 2.527169307153798e-10
difficult O 0 5.495431887325708e-10
, O 0 9.099162395775906e-13
in O 0 1.4548312641388117e-14
particular O 0 1.0187877017703295e-12
early O 0 1.757188491935402e-11
in O 0 5.383471446407384e-13
the O 0 3.4763343462543284e-13
course O 0 1.3307300816833845e-09
of O 0 2.902806982415726e-14
the O 0 4.4349750651442865e-13
disease O 0 1.6522559320719665e-08
, O 0 9.047849275356512e-13
and O 0 3.4114720597056003e-12
most O 0 3.212025101190924e-13
of O 0 2.5724360114927e-14
the O 0 4.6289018625078615e-12
patients O 0 2.269154031342424e-10
are O 0 5.316829008311652e-12
diagnosed O 0 3.231408385317991e-08
after O 0 2.7627164445043206e-11
the O 0 5.714622351715715e-12
age O 0 1.5557839461166623e-09
of O 0 4.5399659509212653e-13
5 O 0 7.5902839569153e-11
years O 0 9.66424718029657e-10
. O 0 8.665503870020075e-10

However O 0 4.302928569011044e-10
, O 0 1.6653806805821958e-11
since O 0 3.523686550876981e-12
these O 0 1.2392185801818334e-12
patients O 0 1.5972299437921889e-12
excrete O 0 6.8474830840214995e-12
early O 0 1.1737004597389689e-12
large O 0 2.819817513169398e-12
amounts O 0 7.894690109977454e-12
of O 0 1.322610423959425e-12
aspartylglucosamine O 0 8.776448225944478e-07
in O 0 3.9265372203667326e-11
urine O 0 1.419559692017458e-09
, O 0 2.2692210523839185e-12
biochemical O 0 2.1501300739856788e-10
screening O 0 4.815532417268287e-10
is O 0 1.0691201396406669e-10
easy O 0 4.667293773685799e-10
by O 0 6.4459037066311176e-12
urine O 0 4.932334540797001e-10
chromatography O 0 1.3402515763871747e-09
. O 0 7.268952800787432e-11
. O 0 6.903657090440163e-10

Detection O 0 8.164472831140301e-08
of O 0 6.979731376199894e-11
heterozygous O 0 3.434237427768494e-08
carriers O 0 1.7377521643879845e-09
of O 0 1.6357380727693993e-11
the O 0 3.3460360100434627e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 5.187148488516868e-09
ATM O 0 1.2973907814739505e-07
) O 0 1.6019039393577739e-12
gene O 0 4.042309889595863e-11
by O 0 9.568398590814597e-13
G2 O 0 7.51446371793918e-09
phase O 0 8.151487818075509e-10
chromosomal O 0 9.126913028012495e-06
radiosensitivity O 0 8.558201329833537e-07
of O 0 1.613822964152689e-10
peripheral O 0 0.005440970417112112
blood O 0 3.8183716242201626e-05
lymphocytes O 0 3.975594154326245e-05
. O 0 2.992608116869633e-08

In O 0 2.1356658180593513e-05
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.00012114176934119314
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 5.103270028783413e-10
patients O 0 2.7144870795581255e-09
, O 0 8.879942137510199e-13
mutations O 0 3.744886623024968e-10
in O 0 3.053103288849085e-13
a O 0 2.3369305622578107e-12
single O 0 1.8229782267065175e-11
gene O 0 1.2490850576085677e-09
, O 0 8.510151784657527e-12
ATM O 0 7.634429977088075e-09
, O 0 1.0193844466460655e-12
result O 0 4.938147113442426e-12
in O 0 3.427348335693914e-11
an O 0 9.847273759078234e-06
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 2.1426448881811666e-07
embraces O 0 9.333816564094377e-08
a O 0 3.732334580286434e-11
variety O 0 1.7886474246164852e-10
of O 0 8.868973264131164e-13
clinical O 0 2.434666468431601e-09
features O 0 7.781399631312524e-07
and O 0 1.6433803651239032e-08
manifests O 0 2.31510348669417e-08
extreme O 0 3.613010113312498e-09
radiosensitivity O 0 3.108450300715049e-06
and O 0 8.319283456570403e-11
a O 0 6.302292021587164e-12
strong O 0 2.213622167512863e-11
pre O 0 9.001504395200755e-07
- O 0 2.4142338588717394e-05
disposition O 0 4.8380743464804254e-06
to O 0 1.0309970654986955e-09
malignancy B-Disease 0 5.844924089615233e-05
. O 0 5.88877302476476e-09

Heterozygotes O 0 1.4825673133600503e-06
for O 0 4.695166824775221e-11
the O 0 5.7624204886919106e-12
ATM O 0 1.8869393159093306e-08
gene O 0 8.969378129108918e-09
have O 0 2.1653245863006987e-10
no O 0 7.502801713243912e-10
clinical O 0 1.1036137559372605e-09
expression O 0 1.6185340845353835e-09
of O 0 3.48759660040443e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 8.777765003742388e-08
may O 0 1.7664043561183007e-09
be O 0 2.3169387242116812e-10
cancer B-Disease 0 1.1371778896318574e-07
prone O 0 1.4902403222549765e-07
with O 0 1.3444125370257187e-12
a O 0 2.1411910439139703e-11
moderate O 0 1.9420749453047392e-08
increase O 0 3.4849370611489405e-10
in O 0 1.1478032933831539e-11
in O 0 2.436076167178225e-11
vitro O 0 2.4009609660424758e-06
radiosensitivity O 0 2.2646809156867675e-05
. O 0 6.671504682032037e-09

We O 0 6.306726696436726e-09
performed O 0 8.947263485659107e-10
a O 0 1.727436596543619e-11
blind O 0 1.7840110499989237e-09
chromosomal O 0 1.142257474384678e-06
analysis O 0 1.7518826389562037e-09
on O 0 1.047654518693264e-09
G2 O 0 7.452845807165431e-07
- O 0 4.72765080417048e-08
phase O 0 3.9887555480788706e-09
lymphocytes O 0 3.28326592580197e-08
from O 0 3.798990635961452e-12
7 O 0 4.264590069968932e-11
unrelated O 0 8.221447700407225e-08
A B-Disease 1 0.9999969005584717
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
patients O 0 8.924065468818299e-07
, O 0 4.400986519659256e-11
13 O 0 2.722496672546981e-10
obligate O 0 1.5974000007190625e-06
A B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
heterozygotes O 0 3.353418605911429e-06
( O 0 1.5483078361078206e-11
parents O 0 2.1898200266989853e-11
of O 0 3.39698904314005e-14
the O 0 3.3559036083895266e-13
patients O 0 5.932233437117018e-12
) O 0 2.5057920690664537e-13
, O 0 5.202518537500422e-12
and O 0 2.7410237274372307e-11
14 O 0 7.436971177776641e-12
normal O 0 3.265425985166104e-10
controls O 0 3.6912928180754534e-07
following O 0 9.467346351321737e-11
X O 0 2.7966659672529204e-06
- O 0 2.641022867067022e-08
irradiation O 0 5.0737871681860724e-09
with O 0 7.009812869052112e-12
1 O 0 5.612146164457599e-12
Gy O 0 1.4867731934486983e-08
in O 0 2.1709039730796742e-13
order O 0 7.392898142624671e-13
to O 0 1.299628265248598e-13
evaluate O 0 2.7872223626324022e-11
this O 0 4.281323966138714e-14
cytogenetic O 0 9.71652180936644e-09
method O 0 1.6504046393417404e-11
as O 0 1.0085138019838569e-12
a O 0 3.319229927804118e-13
tool O 0 3.5150958532792487e-11
for O 0 4.890609672878604e-14
detection O 0 4.595037197963059e-11
of O 0 5.050799188610622e-12
ATM O 0 2.322900854778709e-06
carriers O 0 4.872784487019999e-08
. O 0 3.409772686424617e-09

Both O 0 1.9499853465276829e-07
A B-Disease 1 0.9999724626541138
- I-Disease 1 0.9999984502792358
T I-Disease 1 0.9999998807907104
homozygotes O 0 3.363192445249297e-05
and O 0 1.7651977102239869e-10
heterozygotes O 0 5.631853206011783e-09
showed O 0 1.6293627558283674e-09
significantly O 0 1.2414909378311023e-10
increased O 0 5.1781575555187587e-11
levels O 0 1.9023853672917035e-11
of O 0 6.257037531327836e-13
radiation O 0 1.5411819731525611e-06
- O 0 0.0009012371301651001
induced O 0 0.003424786264076829
chromatid O 0 0.011679175309836864
damage O 0 5.5079872254282236e-05
relative O 0 8.022145614461351e-09
to O 0 6.223927623283387e-12
that O 0 6.2152440312435164e-12
of O 0 3.9923703991188997e-13
normal O 0 4.9530775036998875e-09
controls O 0 4.727722625830211e-05
. O 0 3.040465657022651e-08

These O 0 1.4475240450728677e-10
results O 0 2.2980126482274876e-11
show O 0 5.633203903343542e-10
that O 0 7.631648134623359e-13
the O 0 2.1623990846628832e-13
G2 O 0 5.678420222920977e-08
- O 0 2.1061975274960787e-08
phase O 0 1.2200482402136004e-08
chromosomal O 0 0.00030605163192376494
radiosensitivity O 0 1.4469660527538508e-06
assay O 0 5.5912989793682755e-09
can O 0 1.117358896379761e-11
be O 0 7.332676810580321e-14
used O 0 9.743983099769551e-14
for O 0 6.5810940579763295e-15
the O 0 1.789336264064207e-14
detection O 0 8.334308243540534e-11
of O 0 1.510478027377804e-11
A B-Disease 1 0.9999991655349731
- I-Disease 1 0.9999990463256836
T I-Disease 1 0.9999998807907104
heterozygotes O 0 3.6607445508707315e-05
. O 0 1.1016122236640058e-08

In O 0 3.588091282424877e-11
combination O 0 1.7539414365330686e-10
with O 0 8.781259682073828e-13
molecular O 0 1.322679882287403e-10
genetic O 0 1.0589253029991141e-08
analyses O 0 4.469301728704522e-08
, O 0 1.9619649654911697e-11
this O 0 2.421505704286453e-12
test O 0 1.435682239758762e-09
may O 0 4.4048224269455094e-12
be O 0 3.3216176120384744e-13
of O 0 6.886254194367163e-15
value O 0 2.072876592595918e-11
in O 0 6.711409992208109e-14
studies O 0 1.3258180360867233e-12
of O 0 5.614185196378338e-14
familial B-Disease 0 1.3862920411611412e-07
and I-Disease 0 5.014685111603967e-09
sporadic I-Disease 0 0.0013935487950220704
cancers I-Disease 0 1.3142465832061134e-05
aimed O 0 1.3390130781942844e-08
at O 0 1.011121764094014e-08
determination O 0 8.228593362247238e-10
of O 0 5.138607706120686e-14
the O 0 1.4903382076613542e-13
potential O 0 7.198664841306934e-12
involvement O 0 1.4307091622534074e-10
of O 0 6.111126145055823e-13
ATM O 0 1.7369188753946219e-07
mutations O 0 3.2361990864870904e-09
in O 0 2.7504489571311685e-12
tumor B-Disease 0 0.00014513697533402592
risk O 0 2.703550592286774e-07
or O 0 6.671921348733179e-10
development O 0 3.54454604556409e-10
. O 0 8.680420271467426e-11
. O 0 7.832364756765742e-10

Ataxia B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 1.0
: O 0 1.8858562711443483e-08
identification O 0 1.4143712867564773e-08
and O 0 3.346243074298094e-11
detection O 0 1.335237059807426e-10
of O 0 2.0427935601766145e-13
founder O 0 9.587709293157332e-09
- O 0 8.164470273186453e-07
effect O 0 6.621932446826406e-10
mutations O 0 2.754132921722885e-09
in O 0 7.895513669947674e-13
the O 0 7.776931225736416e-13
ATM O 0 8.564128073373922e-09
gene O 0 6.977112776418437e-10
in O 0 1.5497427559990617e-12
ethnic O 0 7.914282007526197e-10
populations O 0 9.716503157619627e-09
. O 0 5.495644384012621e-09

To O 0 1.174637886958152e-10
facilitate O 0 2.1973479980008648e-10
the O 0 3.3982755845429757e-12
evaluation O 0 1.1085223711182479e-10
of O 0 3.749340519044325e-13
ATM O 0 1.1387092513359676e-07
heterozygotes O 0 6.270239882866235e-09
for O 0 6.525180244222606e-13
susceptibility O 0 2.851167968387358e-09
to O 0 7.921689346157557e-12
other O 0 6.587082008319145e-12
diseases O 0 3.727140267528739e-07
, O 0 3.306524542015521e-12
such O 0 3.5003503567887506e-11
as O 0 2.2327665050170253e-08
breast B-Disease 0 0.0028048239182680845
cancer I-Disease 0 8.804609933577012e-06
, O 0 2.0758053609348792e-10
we O 0 1.235804902854909e-09
have O 0 1.4773541548093738e-12
attempted O 0 8.923432825991284e-11
to O 0 1.1063625059495874e-12
define O 0 1.8442322669010025e-10
the O 0 2.4736010223631866e-13
most O 0 2.3437726911178236e-13
common O 0 4.831505746698272e-13
mutations O 0 1.1539627760293047e-11
and O 0 4.338650098911767e-12
their O 0 1.6467248571683246e-12
frequencies O 0 1.3875625981540907e-08
in O 0 5.772529902969836e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 5.4407588322646916e-05
A B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
) O 0 1.3124266950992336e-10
homozygotes O 0 4.663383279535083e-08
from O 0 4.244091189598009e-12
10 O 0 1.2915933080004383e-11
ethnic O 0 6.330377888552619e-11
populations O 0 1.5045189538653858e-09
. O 0 7.692455006313992e-10

Both O 0 3.179935759156649e-10
genomic O 0 7.603595975069766e-08
mutations O 0 1.8922739286608703e-07
and O 0 3.046894958558255e-10
their O 0 1.2138529114150143e-12
effects O 0 1.9334393808190242e-10
on O 0 3.344736987376251e-11
cDNA O 0 2.6062580982255668e-09
were O 0 3.7214531456442046e-10
characterized O 0 4.902043659882338e-09
. O 0 9.066866146767438e-10

Protein O 0 7.29899980456139e-08
- O 0 1.2658003356591507e-07
truncation O 0 2.4901755324435726e-08
testing O 0 1.1683824574504342e-08
of O 0 3.831012655546029e-13
the O 0 2.6302785362079806e-13
entire O 0 5.0496076070549734e-11
ATM O 0 1.33434929772136e-09
cDNA O 0 2.4340568449687794e-10
detected O 0 2.5166222439310104e-09
92 O 0 4.194248073852158e-11
( O 0 7.270581164030288e-13
66 O 0 1.1957966561393363e-10
% O 0 5.098008603807158e-13
) O 0 3.9824073943053873e-13
truncating O 0 8.574195575761223e-09
mutations O 0 3.0329228017933474e-09
in O 0 2.6809964838447886e-12
140 O 0 5.402066571846831e-10
mutant O 0 1.5396351216168114e-07
alleles O 0 7.849391181480314e-08
screened O 0 2.3209631763165817e-06
. O 0 1.775599933750982e-08

The O 0 6.256997003850628e-11
haplotyping O 0 1.7514801697871007e-07
of O 0 1.463458174089105e-11
patients O 0 6.68633282074893e-09
with O 0 2.1311841180704505e-11
identical O 0 2.16227658711432e-06
mutations O 0 1.1649865427898476e-06
indicates O 0 8.394898287633623e-08
that O 0 3.974150175611868e-10
almost O 0 4.673378350972257e-10
all O 0 2.296219638042718e-12
of O 0 2.4239707870033975e-14
these O 0 2.1303973667639864e-13
represent O 0 9.082915084120124e-13
common O 0 8.349626545722799e-12
ancestry O 0 5.31669508418986e-09
and O 0 3.2638072799962004e-10
that O 0 1.861747214726428e-11
very O 0 1.50317206598638e-11
few O 0 4.5906396739514577e-11
spontaneously O 0 4.2685227574779105e-10
recurring O 0 2.234961584690609e-07
ATM O 0 1.0371657481300645e-05
mutations O 0 6.879358807054814e-07
exist O 0 4.049500645919579e-08
. O 0 9.127774980299819e-09

Assays O 0 3.526094474182173e-07
requiring O 0 7.862299145067198e-10
minimal O 0 1.4777112866681819e-09
amounts O 0 3.68979430342975e-11
of O 0 1.385633686783183e-13
genomic O 0 9.514979915081767e-10
DNA O 0 1.247247816138497e-08
were O 0 9.140375088756425e-12
designed O 0 2.2997447696182505e-11
to O 0 2.6991172426445165e-13
allow O 0 4.920790771384409e-12
rapid O 0 2.0119626797932e-10
screening O 0 7.218843300904609e-10
for O 0 2.3999680281300284e-12
common O 0 7.632703497018056e-11
ethnic O 0 1.4380390211954364e-09
mutations O 0 8.815549534801903e-08
. O 0 3.040574236834459e-09

These O 0 4.396458475053322e-10
rapid O 0 6.37913366574594e-09
assays O 0 4.138358633554162e-08
detected O 0 7.893858899876705e-09
mutations O 0 1.2033752883056081e-09
in O 0 3.2327519567526553e-12
76 O 0 2.737698068244754e-09
% O 0 1.1236935860969854e-11
of O 0 3.303145734365187e-12
Costa O 0 8.348432345428591e-08
Rican O 0 8.272219353955279e-09
patients O 0 9.349400142966147e-10
( O 0 4.5195238610601374e-13
3 O 0 8.749927865592255e-13
) O 0 7.049954153445781e-13
, O 0 3.4525674420110564e-12
50 O 0 2.383055558441427e-11
% O 0 7.690477486603509e-13
of O 0 8.647460460371736e-13
Norwegian O 0 2.8477583327912726e-05
patients O 0 1.0615440970696e-08
( O 0 8.669475185484055e-13
1 O 0 1.2610883474636903e-12
) O 0 2.0719782226757966e-12
, O 0 4.993545507647745e-12
25 O 0 6.76016014000691e-12
% O 0 4.4863461903799084e-13
of O 0 3.3027096682514134e-13
Polish O 0 5.8921459640259854e-06
patients O 0 7.3311285930799386e-09
( O 0 1.1536057482539053e-12
4 O 0 8.81798800644873e-12
) O 0 7.385966838135971e-12
, O 0 3.6951466192425286e-11
and O 0 2.243637498011708e-10
14 O 0 5.269984795774896e-11
% O 0 1.9699773496500983e-12
of O 0 9.668123506639814e-13
Italian O 0 1.9963738395745168e-06
patients O 0 5.75777070466188e-09
( O 0 2.0200739952319635e-12
1 O 0 8.51222911602001e-12
) O 0 7.591626112468663e-12
, O 0 7.290707100537919e-12
as O 0 2.2171450873159637e-12
well O 0 4.5223980810193964e-12
as O 0 6.969162118057592e-13
in O 0 2.305847570174824e-13
patients O 0 4.09436764006732e-12
of O 0 6.083456356937092e-14
Amish O 0 1.3073517379780242e-07
/ O 0 5.8104462368646637e-05
Mennonite O 0 9.722750746732345e-07
and O 0 1.4618199983829072e-08
Irish O 0 1.263339566293098e-08
English O 0 2.435330603844932e-09
backgrounds O 0 2.559048306594036e-09
. O 0 8.817810925876302e-10

Additional O 0 4.1597627564726736e-09
mutations O 0 8.368196802166494e-09
were O 0 2.634051483874078e-11
observed O 0 3.0610319834423194e-10
in O 0 1.0685115986452942e-12
Japanese O 0 4.014000243302007e-10
, O 0 1.0240668312259602e-13
Utah O 0 2.868962120823604e-13
Mormon O 0 2.8634037415459224e-12
, O 0 1.1133907381125074e-12
and O 0 2.926927580512717e-12
African O 0 2.9181425071495015e-12
American O 0 3.250634830753718e-11
patients O 0 3.8698466653386276e-10
. O 0 5.155887383700986e-10

These O 0 1.399383248168462e-10
assays O 0 4.669843178817246e-09
should O 0 1.2311031534484318e-11
facilitate O 0 1.015009951088608e-11
screening O 0 1.3547316601858483e-09
for O 0 4.6029693945293104e-10
A B-Disease 1 0.9999971389770508
- I-Disease 1 0.9999992847442627
T I-Disease 1 1.0
heterozygotes O 0 3.82089410777553e-07
in O 0 3.2198965715934946e-12
the O 0 4.63701180317827e-13
populations O 0 3.265200609892105e-11
studied O 0 2.905181824275349e-11
. O 0 9.606072881584993e-12
. O 0 2.358835904381351e-10

The O 0 8.311567434304834e-09
von B-Disease 1 0.9252015352249146
Hippel I-Disease 1 0.9985771179199219
- I-Disease 1 0.9968923926353455
Lindau I-Disease 1 0.9942951798439026
tumor I-Disease 0 0.006219570990651846
suppressor O 0 1.8508062566979788e-06
gene O 0 1.9146708041262173e-07
is O 0 1.2153322792585186e-10
required O 0 9.516894217131977e-12
for O 0 1.0962629458724504e-12
cell O 0 1.3938895904175297e-07
cycle O 0 6.495258162431128e-07
exit O 0 7.422728742767504e-08
upon O 0 5.203893427285777e-10
serum O 0 1.929717114990126e-07
withdrawal O 0 1.3045312243775697e-06
. O 0 8.39409430852811e-09

The O 0 1.3859001446459018e-10
inactivation O 0 2.022195104700586e-07
of O 0 1.415813126459664e-11
the O 0 4.084325655462351e-10
von B-Disease 1 0.999846339225769
Hippel I-Disease 1 0.9999583959579468
- I-Disease 1 0.9999511241912842
Lindau I-Disease 1 0.9995203018188477
( I-Disease 0 2.5484505172812533e-08
VHL I-Disease 0 6.70375493427855e-06
) I-Disease 0 1.4787480961953037e-10
tumor I-Disease 0 5.747284035351186e-07
suppressor O 0 3.272113531238574e-07
gene O 0 7.612186436745105e-08
predisposes O 0 5.979189268146001e-07
affected O 0 2.2323108694877192e-08
individuals O 0 6.765438903544307e-11
to O 0 1.2654598723071953e-11
the O 0 1.9123398697917793e-10
human O 0 7.913403533166274e-05
VHL B-Disease 1 0.9999734163284302
cancer I-Disease 1 0.9999837875366211
syndrome I-Disease 1 0.9999972581863403
and O 0 2.005170057772787e-10
is O 0 1.0728665178483254e-10
associated O 0 2.4745840931927887e-08
with O 0 2.2212088168771515e-08
sporadic B-Disease 1 0.9999990463256836
renal I-Disease 1 0.9999997615814209
cell I-Disease 1 0.9999988079071045
carcinomas I-Disease 1 1.0
( O 0 1.4543717270498746e-06
RCC B-Disease 0 0.06687365472316742
) O 0 5.145152748298187e-09
and O 0 6.074706071501623e-09
brain B-Disease 0 3.5616893001133576e-05
hemangioblastomas I-Disease 0 0.00020551869238261133
. O 0 5.5920160946243413e-08

VHL O 0 0.0005300051998347044
- O 0 3.036703674297314e-05
negative O 0 7.448745691363001e-07
786 O 0 1.6203917994062067e-06
- O 0 7.003306382102892e-05
0 O 0 1.3547005739411588e-09
RCC B-Disease 0 1.8902084093497251e-06
cells O 0 2.661898035327681e-09
are O 0 5.0860457338763876e-12
tumorigenic O 0 2.795042348679999e-07
in O 0 1.350703437985601e-10
nude O 1 0.9632688164710999
mice O 0 3.0386849175556563e-05
which O 0 2.643146812530972e-10
is O 0 2.115095251720156e-11
suppressed O 0 1.000992899680142e-10
by O 0 2.5710000534778787e-13
the O 0 3.5409593009474993e-13
reintroduction O 0 7.093775011846049e-10
of O 0 3.713276214289962e-11
VHL B-Disease 0 1.3945692671768484e-06
. O 0 2.1259003446516544e-09

Remarkably O 0 5.631086992252676e-07
, O 0 1.888592580934212e-11
this O 0 6.304389654635326e-14
occurs O 0 2.8261158062196923e-13
without O 0 1.1326131547396978e-14
affecting O 0 3.164557808507662e-12
the O 0 2.296634562214128e-13
growth O 0 2.1849835718512622e-08
rate O 0 7.987826222688454e-08
and O 0 1.522501916206842e-11
cell O 0 3.009247606655663e-08
cycle O 0 7.761020270891095e-08
profile O 0 6.127093499230796e-09
of O 0 3.931501933902848e-13
these O 0 1.9512050395548153e-12
cells O 0 1.9183484661899897e-11
in O 0 2.8185216747328434e-12
culture O 0 4.732411795771441e-09
. O 0 4.044095724964336e-09

The O 0 5.146072457051787e-10
786 O 0 1.0171145703452567e-07
- O 0 1.3761623449681792e-05
0 O 0 3.0043753596054046e-10
cell O 0 2.997876151766832e-07
line O 0 9.081444432013086e-07
, O 0 3.3496638622565467e-12
like O 0 2.181631177794463e-12
many O 0 1.0178782052254129e-13
cancer B-Disease 0 4.0443846188731314e-11
cells O 0 8.566891987471514e-12
, O 0 9.8794644340372e-12
fails O 0 2.1490733637108406e-09
to O 0 5.152205485164929e-12
exit O 0 2.134783727569811e-08
the O 0 1.0555138360568428e-11
cell O 0 3.15690869001628e-07
cycle O 0 4.099736372609186e-08
upon O 0 1.0835687208610167e-10
serum O 0 3.7972526456542255e-08
withdrawal O 0 3.1885821272226167e-07
. O 0 4.172118650558332e-09

Here O 0 8.054004574375995e-09
, O 0 4.369685602939599e-12
it O 0 4.2479599482100894e-13
is O 0 2.8112774152870557e-13
shown O 0 1.1774046364612656e-12
that O 0 2.5968829070097642e-14
reintroduction O 0 5.481001503354621e-12
of O 0 2.960127396022319e-14
the O 0 2.1918275842306573e-13
wild O 0 4.2809242262187297e-10
- O 0 6.179204774525715e-07
type O 0 2.667053138338815e-07
VHL B-Disease 0 1.8848062666165788e-08
gene O 0 2.7868742868975005e-09
restores O 0 1.3467071013906207e-08
the O 0 8.238069948429683e-12
ability O 0 8.035981602372289e-11
of O 0 1.453931051074997e-12
VHL O 0 3.26651866089378e-06
- O 0 1.7751463019521907e-05
negative O 0 5.064796368969837e-06
RCC B-Disease 0 0.00022756264661438763
cancer I-Disease 0 2.0411695800248708e-07
cells O 0 1.3645673480056075e-10
to O 0 4.910945348296503e-12
exit O 0 3.452085728383736e-09
the O 0 2.924226616060621e-12
cell O 0 1.3721557223789205e-08
cycle O 0 3.8560504123097417e-08
and O 0 2.4345015586790808e-11
enter O 0 3.8546271730055537e-10
G0 O 0 8.45382601255551e-07
/ O 0 8.195940495170362e-07
quiescence O 0 1.2340129842414171e-06
in O 0 1.1519539766524645e-09
low O 0 8.826011708151782e-07
serum O 0 2.2863132187467272e-07
. O 0 1.0638846470456542e-09

Both O 0 1.1986568182464907e-08
VHL O 0 1.1353394256730098e-05
- O 0 4.3125028241775e-06
positive O 0 3.736134512877243e-09
and O 0 1.1546811423679415e-10
VHL O 0 7.167126909735089e-07
- O 0 3.051545434118452e-07
negative O 0 4.420477495159503e-08
RCC B-Disease 0 9.565608252160018e-07
cells O 0 1.7189027978758986e-09
exit O 0 1.1979430780684197e-09
the O 0 2.5096198990465224e-12
cell O 0 7.962966286356732e-09
cycle O 0 7.926991507645198e-09
by O 0 1.9744848117619895e-11
contact O 0 4.953760708303889e-07
inhibition O 0 3.5855799751516315e-07
. O 0 7.191471418366291e-09

The O 0 5.482554410463081e-10
cyclin O 0 4.808769153896719e-05
- O 0 1.9177532522007823e-06
dependent O 0 1.0875103839680378e-07
kinase O 0 5.869342203368433e-07
inhibitor O 0 1.2065543231187803e-08
, O 0 3.6091615807087862e-12
p27 O 0 1.2330361176537963e-09
, O 0 1.4193381712990227e-12
accumulates O 0 9.78135142326586e-11
upon O 0 2.512345149627282e-12
serum O 0 9.841052417414176e-10
withdrawal O 0 6.393641616142531e-09
, O 0 1.21684389994825e-11
only O 0 7.573673676056214e-13
in O 0 7.803478729081353e-14
the O 0 1.7078732091752036e-13
presence O 0 3.928441738576538e-10
of O 0 3.6413819008707105e-13
VHL B-Disease 0 1.4796919245441131e-08
, O 0 3.718398419033653e-12
as O 0 4.116415867026768e-13
a O 0 2.4655887683085187e-13
result O 0 5.590764938674664e-13
of O 0 1.4753812998787377e-14
the O 0 2.0949858330326226e-13
stabilization O 0 1.1575506109195999e-09
of O 0 2.3334554232444515e-13
the O 0 3.423380936368181e-12
protein O 0 4.550115284551737e-10
. O 0 1.7195152246518575e-10

We O 0 2.3767845469535587e-09
propose O 0 6.889345760541232e-10
that O 0 2.60412720033687e-12
the O 0 1.2982682691484865e-13
loss O 0 1.9357924985197172e-11
of O 0 1.7246463588846406e-13
wild O 0 4.409872911281809e-09
- O 0 0.0011716014705598354
type O 0 6.357164966175333e-05
VHL B-Disease 0 1.1053064241650645e-07
gene O 0 2.5799851144370223e-09
results O 0 2.8411384356274993e-11
in O 0 1.184241777991285e-13
a O 0 3.79871568229051e-12
specific O 0 1.4962598937628968e-09
cellular O 0 0.00029533758061006665
defect O 0 0.009196896106004715
in O 0 2.874361582083651e-10
serum O 0 1.5822865861991886e-06
- O 0 3.0970170428190613e-06
dependent O 0 6.737363378306327e-08
growth O 0 5.611333975252819e-08
control O 0 1.3679583332759648e-07
, O 0 1.3307945891105621e-11
which O 0 5.660285608277693e-12
may O 0 1.7549108000114444e-11
initiate O 0 2.4619142280357664e-09
tumor B-Disease 0 1.41331088343577e-06
formation O 0 5.4377338187805435e-09
. O 0 6.706641020315374e-09

This O 0 2.601121540379836e-10
is O 0 8.394726580540635e-11
corrected O 0 6.629492954601801e-09
by O 0 2.6434201507406774e-13
the O 0 1.8098864692107225e-14
reintroduction O 0 1.1712634334637428e-11
of O 0 8.026762712614807e-14
wild O 0 5.309325201707793e-10
- O 0 1.4139919585431926e-05
type O 0 4.222489951644093e-05
VHL B-Disease 0 2.853650357792503e-06
, O 0 5.825280535720623e-11
implicating O 0 4.677373510730831e-07
VHL B-Disease 0 8.65619540491025e-08
as O 0 7.2406785428524856e-12
the O 0 3.586922629034671e-14
first O 0 3.0654621094132473e-13
tumor B-Disease 0 5.982990991526549e-09
suppressor O 0 2.2833956947465595e-09
involved O 0 7.924141204318502e-11
in O 0 5.400863133456224e-13
the O 0 1.538855441728451e-13
regulation O 0 1.7513723761172773e-12
of O 0 3.481012136527517e-13
cell O 0 9.547965618139642e-08
cycle O 0 3.817179390352976e-07
exit O 0 1.4096144695940893e-07
, O 0 2.020129029334239e-11
which O 0 9.510633600107177e-12
is O 0 1.2357094514303668e-11
consistent O 0 7.120738443333607e-10
with O 0 3.1528941783764974e-12
its O 0 6.025058230108016e-11
gatekeeper O 0 1.3515530383756413e-07
function O 0 5.665324320780485e-10
in O 0 1.7694398463802274e-12
the O 0 6.877758779166854e-12
kidney O 0 1.1702384483669448e-07
. O 0 7.207475588577594e-11
. O 0 1.4688036342747068e-09

Piebaldism B-Disease 1 0.9999998807907104
with O 0 0.0005691280821338296
deafness B-Disease 1 1.0
: O 0 3.901783063309239e-10
molecular O 0 2.284396560803259e-10
evidence O 0 1.1902580310252375e-10
for O 0 4.1063879727132324e-12
an O 0 2.2178410497009082e-10
expanded O 0 0.02530856430530548
syndrome O 1 0.9999933242797852
. O 0 1.017978235040573e-07

In O 0 1.7435945742771963e-10
a O 0 2.54293197610167e-10
South O 0 1.6155885518287505e-09
African O 0 3.320328734179867e-11
girl O 0 2.5352877131012974e-08
of O 0 4.125911309653396e-13
Xhosa O 0 2.1516383696962293e-07
stock O 0 1.9879773383024713e-09
with O 0 1.437238999688062e-12
severe O 0 5.484000364930353e-09
piebaldism B-Disease 0 1.5763518604217097e-05
and O 0 4.623799565450781e-09
profound O 0 5.102467639517272e-07
congenital O 1 0.9999996423721313
sensorineural B-Disease 1 0.9999986886978149
deafness I-Disease 1 1.0
we O 0 0.000214027488254942
identified O 0 3.3783521757868584e-07
a O 0 2.1293068003247484e-11
novel O 0 1.1397321281192418e-10
missense O 0 6.104882821489355e-09
substitution O 0 3.407207849193128e-11
at O 0 4.2658106214066294e-11
a O 0 5.635000929413159e-13
highly O 0 1.339999075242182e-12
conserved O 0 1.925970320726389e-11
residue O 0 5.264923497172447e-10
in O 0 3.3595411066782155e-13
the O 0 2.5862076152502467e-13
intracellular O 0 1.23061838497307e-09
kinase O 0 1.2095936696709941e-08
domain O 0 4.90649409989885e-10
of O 0 1.1544773383803664e-12
the O 0 1.0729499753947547e-11
KIT O 0 5.485111387315555e-07
proto O 0 6.141686981209205e-07
- O 0 2.426227410978754e-06
oncogene O 0 2.3070593613283563e-07
, O 0 3.6669661751531635e-10
R796G O 0 1.1597825988474142e-07
. O 0 2.3426063311404732e-09

Though O 0 5.402542857524395e-09
auditory B-Disease 0 3.265042991529299e-08
anomalies I-Disease 0 4.540255758911371e-06
have O 0 8.990144739762229e-11
been O 0 6.413564557911089e-12
observed O 0 8.892442338037654e-11
in O 0 1.931969260135849e-13
mice O 0 1.651531356117175e-08
with O 0 7.615831576490706e-12
dominant O 0 1.2103302537980198e-07
white O 0 2.6661776786340852e-08
spotting O 0 1.2276167581148911e-05
( O 0 4.8544773756376e-10
W O 0 0.2785296142101288
) O 0 2.2455242526531194e-11
due O 0 6.650053424595015e-11
to O 0 5.0939415879858174e-11
KIT O 0 7.940966315800324e-05
mutations O 0 2.426014589218539e-06
, O 0 1.4986312635301147e-08
deafness B-Disease 1 1.0
is O 0 5.188794105492889e-08
not O 0 4.864338931653833e-10
typical O 0 2.5353297239405492e-09
in O 0 8.029512818530371e-12
human O 0 1.6803148872313045e-09
piebaldism B-Disease 0 2.9770887977065286e-06
. O 0 6.651937223267623e-09

Thus O 0 1.4120875579948233e-09
, O 0 1.388481864206259e-11
the O 0 4.762246911919898e-13
occurrence O 0 5.616641818306789e-09
of O 0 1.8823784544985678e-11
sensorineural B-Disease 1 0.9999878406524658
deafness I-Disease 1 1.0
in O 0 1.757793688383913e-09
this O 0 2.5116431157101715e-10
patient O 0 8.761122671785415e-08
extends O 0 3.6900231759062763e-09
considerably O 0 1.0417443574439744e-09
the O 0 1.7386777781402962e-12
phenotypic O 0 1.5466040892420096e-08
range O 0 2.1711661801759874e-08
of O 0 1.522628919649327e-12
piebaldism B-Disease 0 1.0936024530394661e-08
due O 0 2.0964391680977634e-11
to O 0 2.3568232868781402e-12
KIT O 0 3.914220059186846e-08
gene O 0 1.7574450783541806e-09
mutation O 0 7.120436185115153e-11
in O 0 1.1910692701219694e-13
humans O 0 1.2570497594233121e-11
and O 0 3.2564305418869566e-11
tightens O 0 3.569187356333714e-06
the O 0 7.438872434706312e-12
clinical O 0 6.340447056274456e-10
similarity O 0 2.6715962775369917e-10
between O 0 1.8194386969261345e-11
piebaldism B-Disease 0 1.4193175275067915e-06
and O 0 5.6582911966973626e-11
the O 0 1.7986573534289722e-14
various O 0 1.7451291063272367e-13
forms O 0 2.0207852058362619e-10
of O 0 2.4152588817827336e-09
Waardenburg B-Disease 1 0.9999916553497314
syndrome I-Disease 1 0.9998179078102112
. O 0 3.7104813666033465e-10
. O 0 3.0649305315932907e-09

Cycloheximide O 0 2.196727336922777e-06
facilitates O 0 4.869855185773986e-09
the O 0 8.974938847661207e-13
identification O 0 1.1424461376918771e-10
of O 0 6.041254193948908e-13
aberrant O 0 3.795906309278507e-07
transcripts O 0 9.576747572737077e-08
resulting O 0 4.0562994629844695e-10
from O 0 6.460674443348191e-12
a O 0 5.95420587834461e-11
novel O 0 3.523503711022613e-09
splice O 0 3.63777216989547e-05
- O 0 1.094114622901543e-06
site O 0 4.815757961296185e-07
mutation O 0 1.144047190315689e-09
in O 0 8.363839677262563e-13
COL17A1 O 0 5.461956575913973e-08
in O 0 9.60392464340043e-13
a O 0 3.54849448436223e-11
patient O 0 1.0461533861416683e-08
with O 0 8.947259599878521e-11
generalized O 0 0.00021133734844624996
atrophic B-Disease 1 0.9999735355377197
benign I-Disease 1 0.9999192953109741
epidermolysis I-Disease 1 0.9978199005126953
bullosa I-Disease 1 0.9704346656799316
. O 0 1.5247542251017876e-06

Patients O 0 1.7776893628251855e-06
with O 0 1.5104016926059671e-09
generalized O 0 0.0002899158571381122
atrophic B-Disease 1 0.9999769926071167
benign I-Disease 1 0.9999648332595825
epidermolysis I-Disease 1 0.9986629486083984
bullosa I-Disease 0 0.4248618483543396
often O 0 5.5686641076135857e-08
show O 0 1.403464153781897e-07
decreased O 0 2.3162213835803414e-07
expression O 0 2.4676719001526237e-10
of O 0 1.4347383957974413e-12
type O 0 3.7800004974997137e-06
XVII O 0 5.534261049433553e-07
collagen O 0 1.7690133972791955e-05
, O 0 9.11194120156722e-10
a O 0 3.698124029227756e-10
transmembrane O 0 3.543528848126698e-08
hemidesmosomal O 0 6.772485505734949e-08
protein O 0 6.29134522256436e-10
encoded O 0 9.25195198231421e-11
by O 0 2.6196668098665832e-11
COL17A1 O 0 2.5977833502111025e-06
. O 0 2.9571891602131473e-09

This O 0 1.126965326614382e-10
report O 0 1.63816502030123e-10
documents O 0 8.914451121722067e-11
a O 0 2.6686307677548093e-11
novel O 0 2.0993502491961635e-09
splice O 0 0.00010861473128898069
- O 0 4.265367806510767e-06
site O 0 9.577886430633953e-07
mutation O 0 1.875739119583386e-09
in O 0 6.469956406567057e-13
COL17A1 O 0 5.0268209150772236e-08
in O 0 5.421464058935621e-13
a O 0 2.8040883850999343e-11
patient O 0 8.395823591911267e-09
with O 0 5.4688281680981277e-11
generalized O 0 9.681933443062007e-05
atrophic B-Disease 1 0.9999781847000122
benign I-Disease 1 0.9999396800994873
epidermolysis I-Disease 1 0.9984374642372131
bullosa I-Disease 1 0.8116524815559387
, O 0 4.188849800357275e-08
and O 0 7.84466450132193e-11
applies O 0 1.6930203766696295e-11
a O 0 3.5952810823955406e-13
new O 0 3.12260362966138e-13
methodology O 0 7.167920337142197e-12
to O 0 4.615181934536361e-13
define O 0 2.758163697436089e-10
and O 0 1.784758105194406e-11
characterize O 0 3.205044407650348e-08
the O 0 2.5111807164940325e-12
resulting O 0 1.6370592381687032e-10
mRNA O 0 1.4918827284660097e-09
splice O 0 6.275842565628409e-07
variants O 0 6.426936494108304e-08
. O 0 1.8470529550285164e-09

Mutational O 0 1.0777041097753681e-05
analysis O 0 2.3669495252676143e-09
of O 0 3.2109565006877006e-11
COL17A1 O 0 1.0168862900172826e-05
identified O 0 1.597111420892361e-08
a O 0 1.5571725853202878e-10
maternally O 0 4.849937340623001e-06
inherited O 0 0.00017709938401822
G O 0 9.140599286183715e-05
- O 0 1.552878529764712e-05
to O 0 5.745298015114031e-09
- O 0 0.00018139697203878313
T O 0 9.336910807178356e-06
transversion O 0 1.3167784196355115e-08
at O 0 1.9692691921591177e-10
the O 0 6.996665074567032e-13
- O 0 4.2402863442703165e-09
1 O 0 7.374997422655849e-13
position O 0 8.328313733096948e-12
of O 0 1.8009170001630215e-13
exon O 0 4.3314631881230525e-09
32 O 0 2.919538610868244e-09
. O 0 5.318812057453215e-10

This O 0 6.911703848144768e-11
acceptor O 0 1.20400656111741e-09
splice O 0 2.73469964895412e-07
- O 0 6.014159481537718e-08
site O 0 5.7830771282851856e-08
mutation O 0 1.1571289482148472e-09
led O 0 1.2819943891184682e-11
to O 0 3.5636841784827955e-13
the O 0 5.448247037439895e-14
formation O 0 6.407548536896401e-12
of O 0 1.485768566554871e-13
aberrant O 0 5.659743340657997e-09
transcripts O 0 5.774675404524032e-09
present O 0 5.29836896578928e-10
at O 0 1.8980379490329824e-09
extremely O 0 1.2018779749212172e-08
low O 0 2.461587200741633e-07
levels O 0 1.067888266703676e-08
. O 0 1.7111436712013983e-09

Based O 0 8.400180107059896e-09
on O 0 6.213875525240553e-10
our O 0 6.626148935096055e-11
recent O 0 2.3159214129764294e-11
finding O 0 1.6288545165443757e-11
that O 0 2.2677066387893907e-12
cycloheximide O 0 1.3767375151019223e-07
stabilized O 0 6.577554813702591e-06
mutant O 0 4.320754598552412e-08
COL17A1 O 0 2.0362251973438106e-07
transcripts O 0 4.178075219130051e-09
in O 0 5.74571683634173e-12
keratinocytes O 0 1.4379411439335854e-08
homozygous O 0 9.803250655693319e-09
for O 0 4.8496228734207225e-12
a O 0 9.760087182897337e-11
frameshift O 0 3.9538117562187836e-06
mutation O 0 2.5957505034313044e-09
, O 0 3.5759281820368916e-12
the O 0 9.449940016701547e-14
effects O 0 5.287405513421106e-10
of O 0 5.521784743854619e-13
the O 0 9.37521154459331e-12
splice O 0 4.558330147119705e-06
- O 0 1.270572766998157e-07
site O 0 4.305264411641474e-08
mutation O 0 1.7585373435213825e-10
on O 0 3.25583310312183e-12
splicing O 0 1.493131729368713e-10
of O 0 2.0463591758612676e-12
COL17A1 O 0 2.3148915673232295e-08
transcripts O 0 3.894742028887066e-10
were O 0 1.4565401836030833e-12
determined O 0 3.920264286805253e-12
using O 0 3.971161073590412e-12
reverse O 0 4.761475214110078e-09
transcriptase O 0 2.3416744454607397e-07
polymerase O 0 1.2148536399081422e-08
chain O 0 5.1972892656237946e-09
reaction O 0 3.421306640771782e-11
of O 0 2.137687542171779e-13
total O 0 8.86456359705523e-12
RNA O 0 5.613297049400501e-10
from O 0 1.5306714229446072e-12
keratinocytes O 0 3.904738477000791e-10
incubated O 0 3.143098004088074e-10
for O 0 1.3745996528535809e-12
2 O 0 7.373485849671013e-11
. O 0 3.527556580174007e-10

5 O 0 1.0334664679589878e-08
h O 0 3.829649415365566e-07
in O 0 5.83928305014636e-12
the O 0 9.420449446559398e-13
presence O 0 1.7929076001621524e-09
or O 0 3.2573890806908423e-10
absence O 0 5.6754337340869654e-11
of O 0 5.267949704929054e-13
10 O 0 8.349563228315926e-12
microg O 0 1.3757932570968023e-08
cycloheximide O 0 8.93656135758647e-08
per O 0 2.900844009445791e-09
ml O 0 2.2248609639063943e-06
. O 0 6.702932431323916e-09

Using O 0 3.296282691245267e-10
this O 0 2.9330355418716314e-12
approach O 0 1.6225893961774318e-09
, O 0 1.3101525940528713e-11
an O 0 1.7176057668169542e-12
abnormally O 0 6.302099109234405e-08
spliced O 0 3.4886081266449764e-05
transcript O 0 5.687731027137488e-05
was O 0 1.776417093424243e-07
identified O 0 6.538050101312365e-09
that O 0 5.940677637317204e-13
contains O 0 1.7113956736133917e-12
an O 0 1.1465746971653368e-13
extra O 0 9.505029575918034e-12
264 O 0 4.497662520197565e-10
bases O 0 2.2813586575409772e-09
upstream O 0 3.0769833903043775e-10
from O 0 7.451534506618118e-13
exon O 0 3.235592627159889e-10
32 O 0 3.7858299828386066e-10
, O 0 1.4244802169424697e-12
resulting O 0 2.8304652458649437e-12
in O 0 6.048910287589915e-13
a O 0 3.915946733545894e-11
premature O 0 8.035590859378772e-09
termination O 0 3.746231769241604e-09
codon O 0 1.3170095236603174e-08
27 O 0 4.023643362938145e-10
bp O 0 1.0737029043639268e-08
downstream O 0 1.1248484366177536e-09
from O 0 1.617827833505503e-12
the O 0 3.98971567588946e-12
cryptic O 0 1.7373553262700625e-08
splice O 0 1.1674401321215555e-06
site O 0 1.6236664350799401e-06
. O 0 6.1393530259579165e-09

Three O 0 1.4799962366751629e-09
other O 0 9.998322482440702e-12
splice O 0 1.0690278173797196e-07
variants O 0 1.9770984849287743e-09
, O 0 3.6896395660956927e-11
including O 0 4.33422481932455e-12
one O 0 1.1071499619874636e-12
derived O 0 2.524448206898955e-13
from O 0 1.2908237304563863e-13
the O 0 5.922629194802381e-14
skipping O 0 5.901686084275326e-11
of O 0 7.806427081364156e-14
exon O 0 1.197992816059923e-10
32 O 0 9.894711716640359e-10
, O 0 2.8387604766866303e-11
were O 0 5.392890994881938e-11
also O 0 2.5445720530647975e-10
identified O 0 1.0738872013860146e-08
. O 0 5.23430465637631e-10

These O 0 1.9439556908640299e-10
results O 0 1.0407309736226722e-10
indicate O 0 3.1012939438745946e-10
the O 0 3.820410242501293e-13
usefulness O 0 1.3149800692779934e-10
of O 0 6.583068915292853e-14
cycloheximide O 0 1.1471330552126346e-08
treatment O 0 3.0597305245017026e-10
in O 0 5.470416261361792e-14
evaluating O 0 8.300708037589644e-11
the O 0 3.225285435861508e-13
abnormal O 0 2.7616129383289945e-09
processing O 0 1.7331246437990444e-09
of O 0 2.6082817004315084e-13
mRNA O 0 2.685614231001665e-11
due O 0 1.4078961087238273e-11
to O 0 3.535622532593874e-12
splice O 0 1.088746898858517e-06
- O 0 1.3300599732701812e-07
site O 0 2.2491053641715553e-07
mutations O 0 1.4348398025276765e-08
, O 0 1.641833370646939e-11
because O 0 4.0632254505457155e-12
( O 0 9.412259383348442e-13
i O 0 1.1688723322578198e-09
) O 0 3.2121294556500257e-13
aberrant O 0 4.91015450521104e-10
splicing O 0 9.098221620540414e-10
often O 0 3.086121289075372e-11
generates O 0 2.1337516475927742e-10
a O 0 3.176945165273004e-11
premature O 0 1.0303507380626797e-08
termination O 0 2.4357997840951384e-09
codon O 0 1.000219107538669e-08
, O 0 7.501282234256834e-11
( O 0 9.872414300990395e-13
ii O 0 4.423646782214519e-09
) O 0 1.567524061940606e-11
transcripts O 0 7.526211653896553e-09
with O 0 2.138529978101822e-11
premature O 0 4.475406711890173e-09
termination O 0 6.790121798161408e-10
codons O 0 1.0165377428705824e-09
can O 0 1.9673760884297842e-11
occur O 0 9.450148129308555e-12
at O 0 3.770674883440961e-10
low O 0 5.477333502312831e-07
or O 0 6.31221666935744e-07
undetectable O 0 1.6659076209180057e-05
levels O 0 5.2249454762787195e-11
due O 0 7.872045029722052e-12
to O 0 2.3256155681772306e-11
nonsense O 0 3.1631298043066636e-05
- O 0 8.629125431980356e-07
mediated O 0 4.746977921854523e-08
mRNA O 0 1.9315991514612385e-11
decay O 0 1.1900355700866783e-10
, O 0 9.612885574356023e-13
and O 0 1.3848885688401424e-13
( O 0 7.962517127038053e-15
iii O 0 2.998202727755306e-11
) O 0 2.8876788113474383e-12
the O 0 1.5400953082278512e-12
levels O 0 4.872897918506425e-11
of O 0 1.7228306251775884e-14
these O 0 6.507779883556386e-13
transcripts O 0 2.737811366504417e-10
can O 0 1.7444653360731976e-11
be O 0 2.4117108050197844e-12
increased O 0 1.2989110655114988e-11
by O 0 2.362770222530397e-11
cycloheximide O 0 2.4207638489315286e-06
. O 0 5.236464151181508e-09

A O 0 1.802674098883017e-08
deletion O 0 1.9399303141653945e-07
mutation O 0 2.0722550786445026e-08
in O 0 2.128458347072648e-11
COL17A1 O 0 2.842812364178826e-06
in O 0 3.326471390008301e-11
five O 0 1.7711424341038118e-11
Austrian O 0 1.150428463603248e-08
families O 0 1.2744907906814262e-10
with O 0 1.5653967705420158e-11
generalized O 0 8.820660696073901e-06
atrophic B-Disease 1 0.99997878074646
benign I-Disease 1 0.9999510049819946
epidermolysis I-Disease 1 0.9988429546356201
bullosa I-Disease 0 0.4855951964855194
represents O 0 3.3447612679538e-08
propagation O 0 1.0211515188984777e-08
of O 0 6.411962107100155e-12
an O 0 6.19026080395102e-11
ancestral O 0 4.171555701759644e-05
allele O 0 7.02202942193253e-06
. O 0 1.881394062763775e-08

Patients O 0 1.3684153827853152e-06
with O 0 1.8477153140850078e-09
generalized O 0 0.0003154053119942546
atrophic B-Disease 1 0.9999922513961792
benign I-Disease 1 0.99998939037323
epidermolysis I-Disease 1 0.9998385906219482
bullosa I-Disease 1 0.9947299957275391
, O 0 1.069614796733731e-08
a O 0 1.0176468695499707e-10
usually O 0 2.8082577929744446e-11
nonlethal O 0 3.5114273710945554e-09
form O 0 1.331292853734567e-10
of O 0 7.159247500387877e-11
junctional B-Disease 1 0.8308349251747131
epidermolysis I-Disease 1 0.982883632183075
bullosa I-Disease 0 0.15945065021514893
, O 0 6.540282981859491e-09
have O 0 4.379115473018835e-11
generalized O 0 8.301729081949816e-09
blistering B-Disease 0 7.71225768403383e-06
, O 0 1.0736040945147352e-09
nail B-Disease 1 0.9991210103034973
dystrophy I-Disease 1 0.6255782842636108
, O 0 4.046804225055212e-09
patchy B-Disease 0 0.011301054619252682
alopecia I-Disease 1 0.9997602105140686
, O 0 9.1104164212652e-09
and O 0 8.0333883545336e-08
dental B-Disease 0 0.04506542906165123
abnormalities I-Disease 1 0.9979573488235474
. O 0 2.057547447975594e-07

Skin B-Disease 1 0.947081446647644
fragility I-Disease 0 0.00015729341248515993
in O 0 1.401813561063836e-11
most O 0 2.9708995680222117e-12
cases O 0 3.191618844211597e-11
is O 0 9.488600877238795e-12
due O 0 7.90047367804636e-12
to O 0 1.0635462779559623e-12
mutations O 0 1.0534573213760723e-09
in O 0 1.1949967924917981e-13
the O 0 9.264422182967552e-14
gene O 0 5.634493427386644e-10
encoding O 0 5.287768556350159e-10
type O 0 2.933326868514996e-06
XVII O 0 2.5403468839613197e-07
collagen O 0 2.2183692180988146e-06
( O 0 3.888442012822679e-09
COL17A1 O 0 5.249514742899919e-06
) O 0 5.532979074907018e-10
. O 0 1.4474006437836806e-09

Recently O 0 7.326853506128828e-07
, O 0 1.7531354146171907e-10
we O 0 1.8243810628870705e-10
reported O 0 1.7723314371664856e-08
five O 0 1.200396119310776e-11
Austrian O 0 4.5828931760638625e-09
families O 0 8.574645160575045e-11
with O 0 2.8875261556815524e-11
generalized O 0 7.866536179790273e-06
atrophic B-Disease 1 0.9999200105667114
benign I-Disease 1 0.9999032020568848
epidermolysis I-Disease 1 0.9967267513275146
bullosa I-Disease 1 0.7656458616256714
who O 0 4.0462202832713956e-07
share O 0 1.0548567574986123e-09
the O 0 6.065434612900766e-12
same O 0 2.4906765538901254e-10
COL17A1 O 0 4.74881653644843e-06
mutation O 0 5.1000736078776754e-08
. O 0 1.874916444322139e-09

Affected O 0 7.568088449261268e-07
individuals O 0 7.153450054531163e-10
in O 0 3.5269612751187562e-12
three O 0 1.2157651621547139e-11
families O 0 2.962492751112933e-11
are O 0 7.108486976131756e-13
homozygous O 0 2.9106464460859627e-10
for O 0 4.2016978546617623e-13
4003delTC O 0 5.783118428581702e-09
, O 0 3.786815479245309e-12
whereas O 0 6.2856174258552056e-12
those O 0 8.031744215021563e-13
in O 0 2.4998487438074313e-13
two O 0 8.539675043495176e-13
others O 0 6.318468318000647e-12
are O 0 2.1779140990663137e-12
compound O 0 1.0466862931934884e-08
heterozygotes O 0 1.315398350243413e-07
. O 0 1.5741981052030951e-09

To O 0 9.969421121969191e-11
determine O 0 1.0167194863797135e-10
if O 0 2.5217449656222968e-12
the O 0 6.856114390411602e-14
occurrence O 0 7.337560559150802e-10
of O 0 2.0090643016411336e-13
4003delTC O 0 9.237679066131932e-09
in O 0 5.706298064275805e-13
these O 0 5.852001825831787e-13
unrelated O 0 1.203826760498572e-10
families O 0 9.182207078017868e-12
signifies O 0 4.0220295843829135e-11
propagation O 0 1.6550963377603978e-10
of O 0 8.990187067015043e-13
an O 0 5.086191016967501e-12
ancestral O 0 3.6261960758565692e-06
allele O 0 2.264994947154264e-07
or O 0 4.139682818760093e-09
a O 0 5.248120271694745e-10
mutational O 0 2.3084219719748944e-05
hot O 0 1.2546129255497362e-06
spot O 0 1.349529696881291e-07
, O 0 2.8945953273185054e-11
haplotypes O 0 8.705909881889795e-10
were O 0 1.8557485409465002e-11
determined O 0 8.270097107132557e-11
for O 0 5.783415196400354e-13
polymorphisms O 0 1.528885817947412e-08
both O 0 2.5982344747932373e-11
within O 0 1.362790713610451e-10
and O 0 2.4867521375426804e-09
flanking O 0 0.0001492480660090223
COL17A1 O 0 5.4238858865574e-05
. O 0 7.089599129983526e-09

Five O 0 1.1426411816728432e-08
intragenic O 0 2.464843646521331e-06
polymorphisms O 0 2.2800118415489123e-07
were O 0 3.5936545406123344e-10
chosen O 0 5.242694819940219e-11
based O 0 5.036429953642063e-11
on O 0 5.769894007023879e-10
their O 0 2.9737884377212254e-10
informativeness O 0 1.019144406200212e-06
. O 0 1.6939492031298187e-09

One O 0 9.868625916453766e-10
of O 0 1.069596342918866e-12
these O 0 1.5479259584186278e-12
, O 0 1.876197764857923e-12
not O 0 1.1653355147175914e-12
previously O 0 7.311822675104551e-11
reported O 0 1.4148051832307829e-06
, O 0 1.0428526965589047e-11
was O 0 1.5390757557298684e-09
2988 O 0 1.3048203406640368e-08
A O 0 1.3321006797628598e-10
or O 0 1.5448982371157882e-10
C O 0 4.353137406098995e-09
that O 0 3.513994867657133e-12
introduces O 0 2.271322366298456e-11
a O 0 1.2907528778444144e-12
new O 0 1.2630935793817022e-12
restriction O 0 1.0002906142281276e-10
site O 0 2.6121003138257493e-09
for O 0 2.079111839289882e-12
Eco0109 O 0 7.730557172180852e-08
I O 0 3.721596158356988e-06
. O 0 8.202769019582945e-10

All O 0 5.445505157908315e-10
the O 0 7.34194822993306e-12
4003delTC O 0 3.214325161593479e-08
alleles O 0 1.2701838469908466e-09
showed O 0 1.9849237808955422e-09
the O 0 5.486937130778219e-14
same O 0 5.418693380283834e-13
haplotype O 0 4.6167383804807116e-10
for O 0 2.5471565503511207e-13
these O 0 7.320857245071699e-13
five O 0 4.5912761439947936e-12
polymorphic O 0 6.938524421684633e-09
markers O 0 8.492864367326547e-07
. O 0 1.195223298111614e-08

Fourteen O 0 1.9178396826191602e-07
microsatellite O 0 1.6025420563892112e-06
polymorphisms O 0 1.4413492976927955e-07
were O 0 4.3293851142989226e-11
selected O 0 1.4077261491912685e-12
based O 0 2.1564529675832667e-12
on O 0 9.287667163127011e-11
their O 0 3.0072749845899693e-11
high O 0 3.137743398440307e-10
heterozygosity O 0 4.355465321737029e-08
and O 0 5.8149568493703896e-11
their O 0 1.1993085561115557e-12
location O 0 1.0327472210747146e-08
within O 0 8.645589799627373e-11
10q23 O 0 9.52395780018378e-08
- O 0 5.010777499592223e-07
q25 O 0 2.966546617244603e-07
near O 0 6.802519010307151e-07
COL17A1 O 0 6.286388270382304e-06
. O 0 6.264800678223992e-09

Three O 0 5.505151889906301e-08
families O 0 7.59310037068417e-09
shared O 0 7.490191245018707e-10
microsatellite O 0 1.4242218639992643e-06
polymorphisms O 0 7.75779312789382e-07
covering O 0 1.4478355581104552e-07
at O 0 8.769611703485225e-09
most O 0 3.234733314538829e-11
19 O 0 6.057252616153974e-11
cM O 0 5.781505829638434e-10
, O 0 5.064023853029731e-12
whereas O 0 3.9646768507095587e-11
the O 0 2.3636073567118165e-12
others O 0 5.330570013173386e-11
shared O 0 3.618356265652767e-12
smaller O 0 1.1930810506211031e-10
regions O 0 4.115011442706873e-09
consistent O 0 1.0763360336341066e-07
with O 0 6.84708123532829e-11
cross O 0 5.213266973669306e-08
- O 0 5.727428060708917e-07
over O 0 1.5389722829439734e-10
events O 0 4.0267272155558587e-11
during O 0 7.548180830374562e-12
passage O 0 1.1318929734466243e-12
of O 0 1.6730830249326277e-14
this O 0 8.24384641497436e-14
mutation O 0 1.2130295899692722e-11
through O 0 1.9711714357127652e-13
several O 0 8.645056892575553e-12
generations O 0 1.544503552830534e-10
. O 0 2.959907319244337e-10

These O 0 3.9511810490111543e-10
results O 0 1.0170549818999675e-10
indicate O 0 2.2518131803650476e-10
that O 0 2.299673472483388e-12
4003delTC O 0 2.13351363242964e-08
occurs O 0 7.377101013394949e-11
on O 0 1.800695530185248e-11
a O 0 2.463466410029813e-11
single O 0 4.3922679382468743e-10
ancestral O 0 4.4643093133345246e-07
allele O 0 2.6500401872908697e-08
. O 0 1.1078396533470425e-10
. O 0 5.772822220251328e-10

The O 0 1.6986048123612818e-09
haptoglobin O 0 4.852638994634617e-06
- O 0 4.2221543594678224e-07
gene O 0 2.558293132892686e-08
deletion O 0 8.894456726693534e-08
responsible O 0 2.4607230031392646e-08
for O 0 1.321575349155779e-10
anhaptoglobinemia B-Disease 0 7.449743861798197e-06
. O 0 9.539716572248835e-09

We O 0 1.5180473766918112e-08
have O 0 3.0418573476048705e-12
found O 0 3.426991763283427e-13
an O 0 4.715766487159087e-14
allelic O 0 2.0050756610601184e-09
deletion O 0 1.6757612186779625e-08
of O 0 7.58682006107847e-12
the O 0 2.8356055351008713e-11
haptoglobin O 0 3.3778559327402036e-07
( O 0 1.2729644595366185e-11
Hp O 0 2.1166098040925618e-10
) O 0 3.951687609950183e-13
gene O 0 1.0827237023613989e-10
from O 0 1.5137736984055516e-12
an O 0 5.919089003658673e-12
individual O 0 2.9604818596595806e-11
with O 0 3.4933086978661265e-10
anhaptoglobinemia B-Disease 0 0.00014693199773319066
. O 0 6.498046190017703e-08

The O 0 4.985290513737084e-10
Hp O 0 3.0485256985457454e-08
gene O 0 2.747057159524502e-08
cluster O 0 8.572008880491921e-08
consists O 0 1.8618759312083455e-10
of O 0 4.687898940564095e-12
coding O 0 2.0578765997925075e-06
regions O 0 2.0379108178758543e-08
of O 0 1.3149818040014694e-11
the O 0 1.5419273496908303e-11
alpha O 0 1.6573266370389916e-10
chain O 0 1.3223450423538452e-07
and O 0 4.468039653537925e-12
beta O 0 5.8346847318924144e-12
chain O 0 6.760862980570437e-10
of O 0 5.330460329860606e-14
the O 0 4.2990009338841895e-13
haptoglobin O 0 3.1281239820657447e-09
gene O 0 4.5439488283172125e-10
( O 0 1.3807326592826796e-12
Hp O 0 2.328563730724653e-10
) O 0 4.707413712307096e-12
and O 0 6.448477168907729e-11
of O 0 4.896763333359089e-13
the O 0 2.2371570741752667e-12
alpha O 0 5.509933828640179e-11
chain O 0 6.396473395398061e-08
and O 0 7.762900565422282e-12
beta O 0 4.663943710403462e-12
chain O 0 1.161480578382168e-09
of O 0 3.607540427410377e-14
the O 0 7.359400090202473e-13
haptoglobin O 0 7.323012596316403e-08
- O 0 2.251815445220018e-08
related O 0 3.204162712933112e-09
gene O 0 7.48274064932275e-09
( O 0 5.44833579294024e-12
Hpr O 0 2.994350012386349e-08
) O 0 1.4502427037044185e-11
, O 0 9.512393477073555e-12
in O 0 1.2023318538695316e-12
tandem O 0 7.128707579795446e-07
from O 0 6.143853654994036e-12
the O 0 3.4932605419424334e-11
5 O 0 5.15109011001158e-10
side O 0 1.330403733845742e-07
. O 0 7.132037183055218e-09

Southern O 0 1.5166298794611066e-07
blot O 0 8.390818948100787e-06
and O 0 1.297609103501074e-10
PCR O 0 6.857243217694986e-09
analyses O 0 3.366975032115249e-10
have O 0 1.3297866497188893e-12
indicated O 0 4.264297248646187e-11
that O 0 2.442610729565947e-13
the O 0 2.447711426449041e-14
individual O 0 2.0624706098797824e-13
with O 0 3.054798167895223e-13
anhaptoglobinemia B-Disease 0 1.4566737149834807e-08
was O 0 5.649710144162157e-10
homozygous O 0 5.58983526133261e-10
for O 0 1.2559341045458028e-13
the O 0 7.229382836728554e-14
gene O 0 3.9151643038692896e-10
deletion O 0 4.938284225985967e-10
and O 0 9.173144188689974e-11
that O 0 1.2575646904031124e-12
the O 0 1.9453463498278825e-14
gene O 0 6.650268530306036e-11
deletion O 0 2.4749263749512806e-10
was O 0 1.2013250394460329e-09
included O 0 2.7578887090706772e-11
at O 0 6.429051735423741e-10
least O 0 2.0302221709345147e-11
from O 0 1.8367347031332526e-13
the O 0 1.1231567433912792e-13
promoter O 0 8.923650796077709e-08
region O 0 2.3133190918400715e-09
of O 0 1.4990283320193143e-12
Hp O 0 8.746320334651614e-10
to O 0 8.470201970367519e-12
Hpr O 0 7.25913977817072e-08
alpha O 0 1.4708879947367137e-11
but O 0 4.180460665137442e-12
not O 0 1.0092277491144386e-12
to O 0 3.990362727746e-12
Hpr O 0 1.4988705743235187e-07
beta O 0 5.935952285263113e-10
( O 0 1.2442710056737027e-11
Hpdel O 0 8.200853329753954e-08
) O 0 2.0637173914206386e-10
. O 0 6.885352288321656e-10

In O 0 9.446602527996006e-11
addition O 0 7.310874128307887e-11
, O 0 2.0395060640332474e-11
we O 0 1.210997534889513e-11
found O 0 1.7434265836557827e-12
seven O 0 5.275510930879967e-13
individuals O 0 2.1249716125170542e-13
with O 0 8.792416800055061e-14
hypohaptoglobinemia B-Disease 0 1.3578935309510598e-08
in O 0 6.346707881466074e-12
three O 0 2.1485015155864318e-11
families O 0 2.805629166491297e-11
, O 0 6.289107255808002e-12
and O 0 1.794363095608542e-11
the O 0 1.38225563807437e-12
genotypes O 0 6.447816169874443e-10
of O 0 8.658105157301199e-13
six O 0 3.0063802142210605e-11
of O 0 3.831093157557336e-13
the O 0 1.6235342063797287e-12
seven O 0 8.427513895070682e-12
individuals O 0 1.3299845166153679e-12
were O 0 2.1206565149756162e-12
found O 0 8.287493954983738e-12
to O 0 2.6863350953421072e-12
be O 0 1.1276705264018361e-10
Hp2 O 0 3.7749032344436273e-07
/ O 0 6.906174530740827e-05
Hpdel O 0 9.20519232749939e-06
. O 0 2.477044347415358e-08

The O 0 9.6372065883088e-10
phenotypes O 0 9.073817182070343e-07
and O 0 7.377414790177284e-10
genotypes O 0 8.747309543366555e-09
in O 0 3.9408658628059534e-12
one O 0 1.607021633820427e-11
of O 0 1.0328942697890656e-13
these O 0 1.2300721422345284e-12
three O 0 1.2946313942760468e-12
families O 0 4.094976961688257e-12
showed O 0 7.2360788472281e-09
the O 0 5.656494153280511e-13
father O 0 1.2485658062999505e-09
to O 0 6.6897412089039765e-12
be O 0 3.535159318057701e-11
hypohaptoglobinemic B-Disease 0 8.283002728148858e-09
( O 0 2.1613240711038095e-12
Hp2 O 0 6.3808252015462585e-09
) O 0 4.967479119016849e-12
and O 0 1.9456129415895695e-11
Hp2 O 0 5.878675679582557e-08
/ O 0 1.246698161594395e-06
Hpdel O 0 6.082888717173773e-07
, O 0 1.045083325434959e-10
the O 0 8.204634346052619e-13
mother O 0 7.910372912256491e-10
to O 0 9.33035983544106e-13
be O 0 8.628057469872719e-12
Hp2 O 0 9.468532624623549e-08
- O 0 4.768203325511422e-07
1 O 0 6.400146905505277e-12
and O 0 2.273502393290716e-11
Hp1 O 0 7.442661598133782e-08
/ O 0 1.55510008426063e-07
Hp2 O 0 9.252917720914411e-08
, O 0 2.6588658358361883e-11
one O 0 1.8337777043381243e-12
of O 0 7.351217345356181e-14
the O 0 1.213480271128331e-12
two O 0 1.857291447374121e-12
children O 0 6.148953308332539e-12
to O 0 1.1142213453968486e-12
be O 0 2.8499961071681845e-11
hypohaptoglobinemic B-Disease 0 7.713055971692029e-09
( O 0 2.0686098233663186e-12
Hp2 O 0 4.515681606420685e-09
) O 0 4.158757106048627e-12
and O 0 1.6690504880956247e-11
Hp2 O 0 4.2272628064665696e-08
/ O 0 9.721082960822969e-07
Hpdel O 0 3.1829188174015144e-07
, O 0 1.0087419094473304e-10
and O 0 5.876914840191594e-12
the O 0 2.995911827538382e-14
other O 0 1.224381246346315e-13
child O 0 6.408456404427554e-11
to O 0 2.9881975257932403e-13
be O 0 5.581306684182552e-12
Hp1 O 0 1.7196285284626356e-08
and O 0 2.61657570610474e-11
Hp1 O 0 1.5950480758419872e-07
/ O 0 4.625390374712879e-06
Hpdel O 0 5.340226039152185e-07
, O 0 1.1666615590266716e-11
showing O 0 3.0969919961876258e-09
an O 0 2.8958126586757504e-13
anomalous O 0 4.5703054674106625e-09
inheritance O 0 1.7520639161716645e-08
of O 0 4.5152378363999546e-11
Hp O 0 1.9154030894696916e-07
phenotypes O 0 2.0841941505977957e-08
in O 0 1.713960917637536e-11
the O 0 1.504339361413365e-11
child O 0 2.7625267762232397e-07
with O 0 9.782619159182104e-11
Hp1 O 0 9.78221396508161e-06
. O 0 1.1926068133050194e-08

The O 0 1.1936234223242081e-09
Hp2 O 0 1.9550702745618764e-06
/ O 0 8.788368177192751e-06
Hpdel O 0 3.335452220198931e-06
individuals O 0 8.809741824933326e-10
had O 0 7.798733880903796e-10
an O 0 2.7311536279078785e-12
extremely O 0 7.6772437296313e-09
low O 0 1.3592220682312472e-07
level O 0 7.313067373893034e-10
of O 0 8.954352016810052e-13
Hp O 0 3.2502270319589854e-10
( O 0 4.917748066407546e-13
mean O 0 3.509590951189523e-10
+ O 0 6.836596622150637e-09
/ O 0 1.2209338819957338e-06
- O 0 1.1204783731955104e-06
SD O 0 1.6181326145670027e-06
= O 0 1.7929666640270625e-08
0 O 0 1.5784719017974957e-11
. O 0 1.5797421964308667e-12
049 O 0 1.4833542394399046e-08
+ O 0 2.837713175551926e-09
/ O 0 1.3576442370322184e-07
- O 0 2.960723577416502e-08
0 O 0 2.8711547028770212e-11
. O 0 3.0254475140434334e-12
043 O 0 9.615729545942031e-09
mg O 0 3.1879352491159807e-09
/ O 0 8.59292459409744e-09
ml O 0 1.771459423594024e-08
; O 0 1.631447581196266e-11
n O 0 3.343912879927302e-08
= O 0 7.988904648925654e-09
6 O 0 4.132718472993346e-12
) O 0 8.137521418424137e-14
, O 0 4.692357884628767e-14
compared O 0 4.0362218775569225e-12
with O 0 5.689821985961629e-13
the O 0 1.964386769567894e-12
level O 0 3.268085108087959e-11
( O 0 3.677717784716754e-14
1 O 0 1.1236238990023489e-13
. O 0 3.844371381563766e-13
64 O 0 2.465323084566151e-11
+ O 0 8.514089433475647e-10
/ O 0 2.043163789267055e-07
- O 0 8.547225149868609e-08
1 O 0 4.301233848258423e-12
. O 0 1.0264217861072344e-12
07 O 0 1.0810748823919525e-10
mg O 0 3.180681829029197e-10
/ O 0 5.078337306230196e-09
ml O 0 1.5892067661837928e-09
) O 0 6.147144425427964e-13
obtained O 0 1.4790316324106434e-12
from O 0 4.852978912825434e-13
52 O 0 4.449960885888338e-11
healthy O 0 1.0642901143720351e-10
volunteers O 0 9.153197297329108e-12
having O 0 1.74543712816444e-11
phenotype O 0 1.00725239260413e-09
Hp2 O 0 3.455071251323716e-08
, O 0 1.0531870514585151e-11
whereas O 0 2.061458122259996e-11
the O 0 5.2791777026273135e-12
serum O 0 5.8957634330170094e-09
Hp O 0 2.0570221082039097e-09
level O 0 1.5960377464097064e-10
of O 0 5.348415056650145e-14
an O 0 1.0080407645760014e-12
individual O 0 1.7342032757744485e-12
with O 0 1.0157381012676492e-11
Hp1 O 0 1.7677756432021852e-06
/ O 0 0.00011722366616595536
Hpdel O 0 1.1188361895619892e-05
was O 0 1.0704479080914098e-07
0 O 0 2.584378266945464e-09
. O 0 1.2807271909665019e-09

50 O 0 9.221714947216242e-08
mg O 0 5.558095139690522e-08
/ O 0 6.778299734833126e-07
ml O 0 5.779316438747628e-07
, O 0 1.2975003016446607e-10
which O 0 8.355075312160842e-12
was O 0 1.1450333736728879e-10
approximately O 0 1.9561694278302788e-11
half O 0 8.203230629499902e-12
the O 0 8.258675861239073e-13
level O 0 9.407310867792784e-12
of O 0 2.084283470100111e-14
Hp O 0 5.918945195082514e-11
in O 0 3.838239134076188e-13
control O 0 2.424690705993271e-07
sera O 0 0.0003764514112845063
from O 0 7.895020574799627e-12
the O 0 1.90343682655858e-12
Hp1 O 0 1.6140832670430427e-08
phenotype O 0 6.29372165494857e-10
( O 0 6.943527783992431e-13
1 O 0 2.5613970037856315e-13
. O 0 4.769727906910048e-13
26 O 0 1.7885476086276775e-11
+ O 0 1.0721756815712524e-09
/ O 0 5.369210498429311e-07
- O 0 1.319066456062501e-07
0 O 0 5.596635568178021e-12
. O 0 7.295223453107624e-13
33 O 0 2.4080119842562198e-11
mg O 0 1.4643553036819412e-10
/ O 0 2.7905495691982196e-09
ml O 0 8.368915338508032e-09
; O 0 1.5730710137273896e-11
n O 0 5.78069503376355e-08
= O 0 6.00123151173193e-09
9 O 0 3.480822921564375e-11
) O 0 1.2760430732894346e-13
, O 0 9.569232748861053e-14
showing O 0 4.154153410151906e-11
a O 0 3.7392085955323395e-12
gene O 0 4.248989604604958e-09
- O 0 8.335877765830446e-08
dosage O 0 1.9389628391763836e-07
effect O 0 8.482615498905943e-09
. O 0 1.1660087340104042e-09

The O 0 1.1760972751240217e-10
other O 0 1.1956318747563532e-11
allele O 0 1.6141409320269418e-09
( O 0 5.132921865325102e-12
Hp2 O 0 3.3110736374908356e-09
) O 0 1.4364524110119237e-12
of O 0 1.161939197202172e-13
individuals O 0 4.328689750393577e-12
with O 0 2.686827106287981e-12
Hp2 O 0 2.9920147426309995e-06
/ O 0 7.453185389749706e-05
Hpdel O 0 3.8052937725296943e-06
was O 0 5.321504126243326e-09
found O 0 3.90245093184749e-11
to O 0 3.6175695685564113e-12
have O 0 1.2268650505242729e-11
, O 0 9.19727618717281e-13
in O 0 3.112227814870694e-13
all O 0 1.9650687327343874e-12
exons O 0 3.1873864658749085e-10
, O 0 5.115495266966308e-12
no O 0 1.696317392108071e-11
mutation O 0 3.3598440869753166e-12
, O 0 7.12759929202833e-14
by O 0 6.283453033058273e-14
DNA O 0 1.4930490177533784e-10
sequencing O 0 5.499216637616655e-10
. O 0 1.0564614738584055e-09

On O 0 4.025095812210111e-09
the O 0 1.753223976587448e-12
basis O 0 5.1147659024808334e-11
of O 0 5.519560435335129e-14
the O 0 9.941550485398007e-14
present O 0 2.1119297716892804e-12
study O 0 6.420390477948623e-13
, O 0 7.905545521599139e-14
the O 0 1.8056487633756092e-14
mechanism O 0 8.287730744738209e-12
of O 0 2.5100384824002647e-14
anhaptoglobinemia B-Disease 0 1.1993796178444427e-08
and O 0 9.187305430313764e-12
the O 0 6.850101811738812e-14
mechanism O 0 6.242474419326793e-12
of O 0 1.2831887618170845e-14
anomalous O 0 2.1840231012593136e-10
inheritance O 0 8.279333885141682e-10
of O 0 2.1798934185524033e-11
Hp O 0 4.2890199836165266e-08
phenotypes O 0 1.788747994169171e-08
were O 0 1.9185368849150564e-09
well O 0 1.3042249502603909e-09
explained O 0 7.15535293238645e-08
. O 0 1.1030729663019656e-09

However O 0 1.974610058796955e-10
, O 0 4.006248024296388e-12
the O 0 8.27759559572476e-14
mechanism O 0 5.776079267660883e-11
of O 0 2.7397415933161362e-12
hypohaptoglobinemia B-Disease 0 5.639286246150732e-05
remains O 0 8.955737939686514e-06
unknown O 0 2.0431164102774346e-06

ATM O 0 2.3612801669514738e-05
mutations O 0 8.258268735517049e-07
and O 0 1.9685979513184293e-09
phenotypes O 0 6.936046702321619e-05
in O 0 1.8316337673240923e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 3.376796666998416e-05
in O 0 9.683339546873171e-11
the O 0 2.6563617624986158e-11
British O 0 7.401946078289257e-08
Isles O 0 2.665512397470593e-07
: O 0 3.280987027204363e-12
expression O 0 2.415140136491356e-12
of O 0 1.9741014243212715e-14
mutant O 0 7.390470457835363e-10
ATM O 0 1.3745893312488988e-08
and O 0 7.0194462221950804e-12
the O 0 2.4764240137697957e-13
risk O 0 1.407293392929887e-09
of O 0 4.595928672357363e-12
leukemia B-Disease 0 0.3869834542274475
, O 0 1.403107035002904e-06
lymphoma B-Disease 1 1.0
, O 0 4.2969256242031406e-07
and O 0 6.959043730603298e-06
breast B-Disease 1 0.9949474334716797
cancer I-Disease 0 0.002854554448276758
. O 0 4.509899653726279e-08

We O 0 1.4578466434045367e-08
report O 0 7.420283137937744e-11
the O 0 3.035428353982683e-13
spectrum O 0 9.179969978623248e-11
of O 0 8.43719137524207e-13
59 O 0 1.2297338702893512e-09
ATM O 0 5.019003523898391e-08
mutations O 0 2.8724356226916825e-08
observed O 0 8.734059520065784e-08
in O 0 1.8793539879879972e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.0005534772062674165
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.885666705587653e-10
patients O 0 3.7889941184587883e-10
in O 0 5.847795121402544e-13
the O 0 1.4833009820414134e-11
British O 0 1.5345835890911985e-07
Isles O 0 3.254398052376928e-06
. O 0 4.5433012907381e-09

Of O 0 1.1960207269012813e-09
51 O 0 1.508689990714629e-07
ATM O 0 2.6020134100690484e-06
mutations O 0 1.7614719638459064e-07
identified O 0 1.691667250725004e-08
in O 0 2.855909519289268e-12
families O 0 6.5722731076856e-12
native O 0 9.992603099140407e-12
to O 0 9.784705164161966e-12
the O 0 2.8739982615988424e-11
British O 0 4.0799037037686503e-07
Isles O 0 1.9147159946442116e-06
, O 0 1.9260118500064038e-10
11 O 0 8.244515313504674e-12
were O 0 2.9690644474250627e-12
founder O 0 1.894473466990121e-11
mutations O 0 3.7337653802094195e-11
, O 0 2.7460614077795542e-12
and O 0 2.7559311169961243e-12
2 O 0 1.6233112944130657e-12
of O 0 1.2034762021575357e-13
these O 0 4.24437637813746e-11
11 O 0 3.762446951216525e-11
conferred O 0 7.730336336331245e-12
a O 0 1.0483410146922001e-11
milder O 0 7.643568977755422e-08
clinical O 0 1.2162889362343776e-08
phenotype O 0 2.467418935836463e-09
with O 0 3.4902948586879035e-12
respect O 0 2.780733629470511e-11
to O 0 1.5843808903737155e-11
both O 0 2.3655671865796535e-10
cerebellar B-Disease 0 2.853361002053134e-05
degeneration I-Disease 0 0.0029976333025842905
and O 0 1.1348438633262958e-08
cellular O 0 7.796221325406805e-06
features O 0 1.0128464055014774e-05
. O 0 7.670280410820851e-08

We O 0 8.11428151337168e-08
report O 0 1.0181462339886593e-09
, O 0 3.3870549594194888e-12
in O 0 5.434197471350377e-13
two O 0 2.006409621779781e-10
A B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
families O 0 2.426613576744785e-09
, O 0 1.6355563821693342e-12
an O 0 4.083836404895208e-13
ATM O 0 2.5017822480322138e-08
mutation O 0 2.3219290379294932e-10
( O 0 3.1865931334612574e-12
7271T O 0 2.172251534204861e-08
- O 0 1.0147336979571264e-05
- O 0 1.3281388419272844e-05
> O 0 1.6164115601569051e-09
G O 0 2.606064253285467e-09
) O 0 2.838140150413643e-13
that O 0 2.32150046798954e-13
may O 0 3.3973277207936803e-13
be O 0 4.357388202428508e-14
associated O 0 3.841990961483965e-12
with O 0 2.4436407216298084e-13
an O 0 7.826766578594713e-13
increased O 0 1.8631212128639163e-08
risk O 0 1.0465784043844906e-06
of O 0 7.677207480849546e-11
breast B-Disease 0 0.4523574113845825
cancer I-Disease 0 3.1337473046733066e-05
in O 0 7.708371441150774e-11
both O 0 2.554988998149099e-10
homozygotes O 0 1.801098846954119e-06
and O 0 9.296994285534765e-10
heterozygotes O 0 2.0786560028795975e-08
( O 0 1.582082902185089e-11
relative O 0 6.991943912737497e-09
risk O 0 1.335350496844967e-08
12 O 0 8.63927158978317e-12
. O 0 1.6100887983983014e-12
7 O 0 3.9198772699977624e-11
; O 0 7.364462512038372e-11
P O 0 0.0012467085616663098
= O 0 5.265528901787775e-09
. O 0 3.773282467728345e-12
0025 O 0 2.121100628471595e-09
) O 0 2.2843237175960984e-13
, O 0 2.878898630446526e-14
although O 0 4.0416952960418626e-14
there O 0 1.7063492274965036e-13
is O 0 1.659718640734803e-13
a O 0 7.547198001105204e-13
less O 0 2.761167856857316e-11
severe O 0 2.3908046387077775e-06
A B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 1.0116049452335574e-05
in O 0 2.2924660433853994e-11
terms O 0 1.4603826828385458e-11
of O 0 7.127314011331695e-14
the O 0 7.305347190893208e-13
degree O 0 1.921321782227814e-11
of O 0 4.6511534207427374e-11
cerebellar B-Disease 0 0.0006227953126654029
degeneration I-Disease 0 0.07951967418193817
. O 0 2.0654134402775526e-07

This O 0 6.356136450502703e-11
mutation O 0 8.270747975380743e-10
( O 0 6.865098333558306e-12
7271T O 0 3.626973210657525e-08
- O 0 2.2138183339848183e-05
- O 0 1.1393286513339262e-05
> O 0 2.568672163860697e-09
G O 0 3.0645095350223528e-09
) O 0 7.543614170824053e-13
also O 0 2.7290328200382796e-13
allows O 0 4.675118256934618e-13
expression O 0 6.494502418491477e-12
of O 0 9.825389742264268e-14
full O 0 1.301237589901305e-10
- O 0 5.169106742641816e-08
length O 0 2.3400075210844307e-09
ATM O 0 8.98859386921913e-09
protein O 0 1.9489779581882694e-11
at O 0 1.987721445773083e-11
a O 0 2.8759709457676363e-12
level O 0 1.4193036503018508e-11
comparable O 0 4.774711875876747e-11
with O 0 2.789804249159894e-13
that O 0 2.599165023833838e-12
in O 0 5.51668216317025e-12
unaffected O 0 5.464863193083147e-07
individuals O 0 1.5571398337410614e-10
. O 0 5.992558116396651e-10

In O 0 1.3467134352129762e-10
addition O 0 7.865715023758213e-11
, O 0 1.5503201153399537e-11
we O 0 3.033695170073791e-11
have O 0 5.421360517628149e-13
studied O 0 4.4108779129192754e-11
18 O 0 6.307905753288878e-09
A B-Disease 1 0.9999994039535522
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
patients O 0 8.689848414178414e-07
, O 0 1.284312066418547e-11
in O 0 9.770620727420076e-13
15 O 0 9.02183276002555e-12
families O 0 4.745800540745249e-12
, O 0 3.678962950254272e-12
who O 0 9.83292267053848e-11
developed O 0 5.6682267768337624e-08
leukemia B-Disease 0 0.07442237436771393
, O 0 1.4953126026284735e-07
lymphoma B-Disease 1 1.0
, O 0 2.2001378496838697e-09
preleukemic O 0 0.0031817227136343718
T O 1 0.9522250890731812
- O 0 2.9756420190096833e-05
cell O 0 7.670823106309399e-05
proliferation O 0 0.48222294449806213
, O 0 3.791699842992102e-09
or O 0 0.001424715155735612
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 2.226289907980572e-08
mostly O 0 1.2864603826656662e-10
in O 0 3.47725320759551e-11
childhood O 0 1.5096944707693183e-06
. O 0 4.883240034558867e-09

A O 0 2.138361843151415e-08
wide O 0 2.1924018156482816e-08
variety O 0 2.4244115603977434e-09
of O 0 5.604561953420628e-12
ATM O 0 1.3820523463436984e-06
mutation O 0 3.086201072477479e-09
types O 0 3.000723003410144e-09
, O 0 4.442393935349953e-12
including O 0 4.867786295575938e-12
missense O 0 1.6241992852883413e-06
mutations O 0 7.629964215993823e-08
and O 0 7.245465893923608e-10
in O 0 5.0580612614981035e-11
- O 0 1.1822860869870055e-05
frame O 0 1.6413479897892103e-05
deletions O 0 6.604178537372718e-08
, O 0 3.285348659787246e-10
were O 0 2.4634710937831983e-11
seen O 0 3.7565923705074056e-09
in O 0 5.773672013577313e-13
these O 0 9.342331595829645e-12
patients O 0 5.39615262196147e-11
. O 0 7.286873188183662e-11

We O 0 1.5681186127380897e-08
also O 0 1.983388973891831e-11
show O 0 1.6924570633847225e-09
that O 0 3.866412398578767e-12
25 O 0 2.0163976825054997e-12
% O 0 1.1291797575099793e-13
of O 0 2.3273792832192997e-13
all O 0 2.711663249499452e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
patients O 0 1.9735992395908397e-08
carried O 0 1.7428707366207163e-09
in O 0 3.945844952862876e-12
- O 0 1.498298871638326e-07
frame O 0 2.8751653644576436e-06
deletions O 0 2.431691257243074e-07
or O 0 8.919341709656692e-09
missense O 0 1.816103178953199e-07
mutations O 0 2.185315706171309e-09
, O 0 2.6989124910642426e-12
many O 0 8.629364990587682e-14
of O 0 9.002772689121162e-15
which O 0 3.0788017968408354e-11
were O 0 9.988435772934068e-11
also O 0 2.605519792975297e-11
associated O 0 5.914239237236885e-11
with O 0 6.73508612162449e-13
expression O 0 5.0360840497809534e-11
of O 0 1.3070071283940998e-12
mutant O 0 1.133037272893489e-07
ATM O 0 3.5790202446150943e-07
protein O 0 1.2857430675694559e-08
. O 0 1.82633164147461e-09

The O 0 4.0987313543183745e-10
DMPK O 0 3.389027085631824e-07
gene O 0 2.480249605696372e-08
of O 0 6.586934470087513e-11
severely O 0 0.002341019921004772
affected O 0 0.0013596726348623633
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 6.79822733218316e-06
is O 0 2.3052926234612414e-10
hypermethylated O 0 1.579307706833788e-07
proximal O 0 1.0662212162060314e-06
to O 0 1.3649715802088735e-09
the O 0 2.5243741125224872e-11
largely O 0 1.4021357408466883e-09
expanded O 0 1.704414920311592e-08
CTG O 0 6.255121115827933e-05
repeat O 0 7.797921739438607e-07
. O 0 2.5753585930488043e-09

Using O 0 2.1606708089372262e-10
methylation O 0 1.846740360633703e-08
- O 0 3.151926932787319e-07
sensitive O 0 4.713074304163456e-07
restriction O 0 1.48100420815922e-09
enzymes O 0 6.112332862073799e-11
, O 0 2.9408599036898075e-13
we O 0 4.139801023685108e-13
characterized O 0 1.9107662500850164e-12
the O 0 1.3382403976744568e-14
methylation O 0 6.24784057823291e-10
pattern O 0 5.956804471907162e-08
on O 0 5.6557264427326e-10
the O 0 1.7928912477913062e-12
5 O 0 4.7031779512596295e-12
side O 0 3.5810102105848785e-10
of O 0 1.3845717107552336e-13
the O 0 4.299667392959616e-12
CTG O 0 1.0428879022583715e-06
repeat O 0 1.6178334227845426e-09
in O 0 3.574576344558128e-13
the O 0 9.884562108706738e-14
DMPK O 0 1.3797711861940343e-09
gene O 0 6.980090810904116e-11
of O 0 4.9231699581842384e-14
normal O 0 2.5621874066850125e-10
individuals O 0 4.182768020832839e-11
and O 0 9.50024520857129e-12
of O 0 6.21232557583562e-13
patients O 0 1.6490501186794404e-09
affected O 0 1.0284678886307574e-08
with O 0 2.5811285553345442e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 2.8003055430048107e-10
showing O 0 7.923409484078547e-09
expansions O 0 4.722358060149645e-09
of O 0 3.6332441504145774e-13
the O 0 1.3577871466052827e-12
repetitive O 0 5.710307959816419e-07
sequence O 0 2.497738904594371e-08
. O 0 1.7133187091289415e-09

The O 0 6.725490997450123e-11
gene O 0 4.435948497416575e-09
segment O 0 7.59375229364423e-09
analyzed O 0 6.028268439983719e-10
corresponds O 0 6.331307700335742e-11
to O 0 3.9438508882272405e-12
the O 0 6.033849635211919e-13
genomic O 0 3.232437961742107e-08
SacI O 0 8.15450130176032e-06
- O 0 3.1189870242087636e-07
HindIII O 0 1.283479491576145e-07
fragment O 0 6.370816763023868e-09
carrying O 0 2.583042890691445e-09
exons O 0 4.716083967792883e-09
11 O 0 8.455328104339799e-10
- O 0 2.650847079621599e-07
15 O 0 7.809451418872015e-10
. O 0 3.158253936152988e-10

There O 0 1.587931230950801e-09
is O 0 9.573441865640131e-12
constitutive O 0 3.362584932720125e-10
methylation O 0 7.4134440808393265e-09
in O 0 1.568765430060015e-11
intron O 0 1.0395335721113952e-06
12 O 0 8.255376937604808e-11
at O 0 1.4251332752790447e-11
restriction O 0 5.759731580567973e-11
sites O 0 8.480184332526619e-10
of O 0 3.7467885781808374e-13
SacII O 0 2.212650507260605e-08
and O 0 2.7667507174200523e-11
HhaI O 0 1.4726587949098757e-08
, O 0 1.4706122604402072e-12
localized O 0 1.0661150851021262e-09
1 O 0 1.0252248702768973e-11
, O 0 1.8689412864536514e-11
159 O 0 1.558623341502141e-09
- O 0 8.888131475259797e-08
1 O 0 1.7400711947723746e-12
, O 0 1.1591837515909087e-12
232 O 0 4.369479084109784e-11
bp O 0 9.273457557412712e-10
upstream O 0 1.2173785590707809e-10
of O 0 3.238372027133951e-13
the O 0 4.7818637070873304e-12
CTG O 0 7.446444101333327e-07
repeat O 0 4.328002844999901e-09
, O 0 1.0692211005469687e-12
whereas O 0 1.5724792344976035e-12
most O 0 3.601588428533975e-13
, O 0 2.823082750642164e-13
if O 0 3.2551064708258304e-12
not O 0 2.0118069536667615e-12
all O 0 1.239182503354544e-13
, O 0 1.049510277946128e-13
of O 0 1.6067914312717802e-15
the O 0 1.0154421554097685e-14
other O 0 2.3339127193920152e-14
sites O 0 4.366223771423705e-10
of O 0 9.681570324084066e-14
SacII O 0 2.9337843265864194e-09
, O 0 7.1777020091423616e-12
HhaI O 0 4.864795677406164e-09
, O 0 6.950170040181947e-12
and O 0 4.8389230990208976e-12
HpaII O 0 3.2573410635450273e-09
in O 0 2.645150266357421e-13
this O 0 4.0700570084345467e-13
region O 0 1.25209953516503e-10
are O 0 1.558255477776549e-12
unmethylated O 0 1.7535475649310683e-07
, O 0 6.778856555950119e-12
in O 0 6.636637311756288e-14
normal O 0 6.457868961806668e-11
individuals O 0 4.283533597271294e-12
and O 0 4.083698223328325e-12
most O 0 4.520653328673324e-13
of O 0 9.005284988842718e-14
the O 0 1.9169730039458877e-11
patients O 0 4.528193930930513e-10
. O 0 2.459022152567769e-10

In O 0 2.386195130377189e-10
a O 0 3.6327212071807224e-11
number O 0 1.1889550975696661e-11
of O 0 2.292940414361927e-13
young O 0 7.784240613206705e-11
and O 0 3.2149949369397746e-11
severely O 0 3.010579121109913e-06
affected O 0 2.99967730654771e-08
patients O 0 4.134954045831307e-10
, O 0 4.2769349802192214e-13
however O 0 4.2126675411924275e-13
, O 0 8.304859214604624e-14
complete O 0 1.5598255109425252e-12
methylation O 0 1.5292321853266344e-09
of O 0 1.0187696904617391e-13
these O 0 9.207435161528998e-14
restriction O 0 2.377417013255112e-11
sites O 0 3.20396109643184e-09
was O 0 4.84382201015876e-10
found O 0 1.1763456528313121e-11
in O 0 1.2884131424511364e-13
the O 0 8.026996493708249e-13
mutated O 0 3.634533563001696e-09
allele O 0 1.2614975730684819e-08
. O 0 1.2232118651311907e-09

In O 0 4.1183282478707284e-11
most O 0 1.833428157557715e-12
of O 0 4.992017473763426e-14
these O 0 4.2150653627170964e-12
patients O 0 5.1816950036309706e-11
, O 0 5.099185505265391e-13
the O 0 2.4773640170533406e-13
onset O 0 8.844125432005967e-09
of O 0 3.359837798602716e-12
the O 0 5.438560712889284e-10
disease O 0 0.14038705825805664
was O 0 1.7655112969805487e-05
congenital O 1 0.9999516010284424
. O 0 1.8941480561807111e-07

Preliminary O 0 1.7264740748146323e-08
in O 0 1.0905352315626615e-10
vivo O 0 5.960718681308208e-06
footprinting O 0 3.402538368391106e-06
data O 0 1.0704673814032617e-09
gave O 0 5.5941626331268424e-11
evidence O 0 2.2312306516281133e-11
for O 0 2.1491017515931632e-13
protein O 0 7.932095258400551e-11
- O 0 1.075153743812507e-08
DNA O 0 2.8888525349657357e-08
contact O 0 1.9786121185916272e-08
in O 0 1.312197637874657e-12
normal O 0 1.824161655061829e-10
genes O 0 9.73913505397661e-10
at O 0 2.471666482595225e-10
an O 0 2.432453327302908e-12
Sp1 O 0 2.8798304185784218e-08
consensus O 0 2.4901706131147394e-12
binding O 0 1.1373910147050026e-10
site O 0 3.2684202011523666e-08
upstream O 0 1.1526705145925575e-09
of O 0 6.128121014109533e-13
the O 0 1.922552395061672e-12
CTG O 0 3.3236671015401953e-07
repeat O 0 1.4081122934328505e-09
and O 0 6.977967466001433e-13
for O 0 9.393813072517635e-15
a O 0 3.6233111644487156e-14
significant O 0 3.6371475492860683e-13
reduction O 0 7.32474410986006e-12
of O 0 5.990189050895153e-15
this O 0 5.36192862029064e-14
interaction O 0 2.373790834037104e-12
in O 0 1.3213540504819488e-13
cells O 0 1.8370343440876624e-11
with O 0 3.387195038340174e-13
a O 0 3.6317854973377806e-11
hypermethylated O 0 4.760451872698468e-07
DMPK O 0 1.423098723307703e-07
gene O 0 8.912725668608346e-09
. O 0 8.868288742247543e-11
. O 0 8.193528078237478e-10

The O 0 9.757361141282672e-09
hemochromatosis B-Disease 1 0.9999889135360718
gene O 0 4.461010973955126e-07
product O 0 1.3423142597446258e-08
complexes O 0 1.0944475548058108e-08
with O 0 1.0035234795924275e-11
the O 0 1.793712097256095e-12
transferrin O 0 6.333137569924929e-09
receptor O 0 2.1187827881075094e-10
and O 0 1.2749819255919448e-10
lowers O 0 3.3483164685321753e-08
its O 0 3.1352993118405337e-12
affinity O 0 4.551161097293699e-12
for O 0 1.3724978998371634e-13
ligand O 0 5.312249598543595e-11
binding O 0 4.882131587891081e-09
. O 0 1.2702662255392738e-09

We O 0 2.7255909529344535e-08
recently O 0 4.406047526828161e-09
reported O 0 2.618131045295513e-09
the O 0 1.75334329303653e-13
positional O 0 1.2615426481232817e-09
cloning O 0 3.367400358555983e-09
of O 0 3.231356968027427e-13
a O 0 5.339634550488581e-12
candidate O 0 3.151045535609853e-10
gene O 0 2.957552567295352e-07
for O 0 3.035016788999201e-07
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 0 0.39555561542510986
HFE O 1 0.6541383862495422
. O 0 2.8877076374556054e-07

The O 0 4.085375093776378e-11
gene O 0 3.99154087560305e-09
product O 0 2.0261634148255325e-08
, O 0 2.2290867068841536e-11
a O 0 9.140514733996241e-12
member O 0 3.1881251111309794e-12
of O 0 2.099510073173133e-13
the O 0 8.318613159419286e-12
major O 0 1.2504270952007346e-09
histocompatibility O 0 3.608529084431211e-07
complex O 0 4.557780997060945e-08
class O 0 3.3629972140403197e-09
I O 0 8.591557616455248e-07
- O 0 6.417685938231443e-09
like O 0 2.0354214841367124e-11
family O 0 1.0368317315823106e-10
, O 0 6.2288645378758e-13
was O 0 2.1652327500398805e-11
found O 0 6.153493947030908e-12
to O 0 1.4434753305841985e-12
have O 0 3.2440181183673866e-12
a O 0 1.1977631343348949e-12
mutation O 0 8.452469280051389e-11
, O 0 2.977633547715519e-12
Cys O 0 6.880500222905539e-07
- O 0 3.013371667748288e-07
282 O 0 1.0566498787056844e-07
- O 0 2.0221836166456342e-05
- O 0 4.79287700727582e-06
> O 0 4.221934357673263e-09
Tyr O 0 8.18762657672778e-09
( O 0 1.2414968142068772e-12
C282Y O 0 9.124963284978804e-11
) O 0 2.1192200555172902e-13
, O 0 6.604486651583946e-14
in O 0 1.7559360608880754e-14
85 O 0 1.0803982708473825e-11
% O 0 8.161650066722259e-13
of O 0 3.0195501047464157e-12
patient O 0 5.8116717127632e-07
chromosomes O 0 2.1114450987624878e-07
. O 0 2.7918021672235227e-08

This O 0 6.35389379999296e-11
mutation O 0 4.452011204136852e-09
eliminates O 0 2.7902569144089284e-09
the O 0 3.2305342428928796e-11
ability O 0 5.0533288664667e-10
of O 0 1.9988789269620444e-12
HFE O 0 4.773189630213892e-06
to O 0 7.159889348073989e-11
associate O 0 1.0061190075516535e-10
with O 0 8.576570877105727e-12
beta2 O 0 5.291666184348287e-06
- O 0 3.511843897285871e-05
microglobulin O 0 2.501215249139932e-06
( O 0 3.188509872797951e-11
beta2m O 0 1.7540802588200677e-08
) O 0 2.181864064421113e-12
and O 0 2.237212585326498e-12
prevents O 0 1.2498517498737982e-10
cell O 0 1.1898352880734819e-07
- O 0 9.457895430386998e-06
surface O 0 1.5042325685499236e-05
expression O 0 2.359986552846749e-07
. O 0 7.463327733603364e-09

A O 0 7.296449666682747e-09
second O 0 3.755263461302505e-11
mutation O 0 6.892316162243617e-10
that O 0 1.5525363980528617e-11
has O 0 3.577610152571964e-10
no O 0 1.1059120980094761e-10
effect O 0 4.0324917016665296e-11
on O 0 7.043647332061198e-10
beta2m O 0 4.8134256758203264e-06
association O 0 1.2073927795064332e-11
, O 0 8.214483780688564e-13
H63D O 0 1.3362677186989913e-08
, O 0 7.134461424418426e-12
was O 0 3.685322880198072e-10
found O 0 6.992203344102776e-11
in O 0 1.2295255959193785e-12
eight O 0 7.1543704120713425e-12
out O 0 3.1560844215849926e-11
of O 0 1.9522091462918084e-13
nine O 0 4.2047247628129725e-11
patients O 0 1.119462161858209e-11
heterozygous O 0 1.26981272718929e-10
for O 0 1.3249358207789719e-12
the O 0 1.4645612847474787e-11
C282Y O 0 7.977396876412968e-08
mutant O 0 3.321126200717117e-07
. O 0 1.622973933024241e-08

In O 0 1.7006462904589625e-10
this O 0 1.9449292436996e-12
report O 0 9.167407111210224e-11
, O 0 5.485370187588434e-13
we O 0 1.265688508861329e-12
demonstrate O 0 2.820355277446951e-12
in O 0 8.527137600623097e-14
cultured O 0 1.479372402357626e-09
293 O 0 5.093603872019514e-10
cells O 0 1.2852978403810056e-10
overexpressing O 0 2.8278160257855234e-08
wild O 0 5.373897993266041e-10
- O 0 4.557389843284909e-07
type O 0 2.3494462766393553e-06
or O 0 5.352814302916897e-10
mutant O 0 1.021590207983536e-07
HFE O 0 6.54973518976476e-07
proteins O 0 2.8508277336025678e-11
that O 0 4.368002053806164e-12
both O 0 3.8262150609327805e-13
the O 0 1.494166390007129e-13
wild O 0 4.949515242103075e-10
- O 0 4.686147804022767e-06
type O 0 4.937030826113187e-05
and O 0 6.868527080428066e-09
H63D O 0 7.264067244250327e-05
HFE O 0 1.3662136552738957e-05
proteins O 0 4.081724402915654e-10
form O 0 5.491562760084889e-11
stable O 0 1.1699970769996071e-08
complexes O 0 3.659813119227806e-09
with O 0 4.4527602091615215e-12
the O 0 4.568677467592375e-12
transferrin O 0 5.787281409652678e-08
receptor O 0 1.015192929720854e-09
( O 0 3.48306106179308e-11
TfR O 0 5.862272018930526e-07
) O 0 1.1607757116616213e-10
. O 0 4.129145081410712e-10

The O 0 8.093670178510592e-10
C282Y O 0 6.084193842070817e-07
mutation O 0 5.963465810054913e-08
nearly O 0 1.69971337005137e-09
completely O 0 4.519489671395149e-09
prevents O 0 6.9147271242187e-10
the O 0 2.6514907890823336e-12
association O 0 2.407748913441088e-12
of O 0 2.6182642208841256e-14
the O 0 6.927336308748533e-13
mutant O 0 6.034267130416993e-08
HFE O 0 2.1599000774585875e-06
protein O 0 1.4593259933803893e-09
with O 0 5.433692558398651e-12
the O 0 8.996096922953001e-11
TfR O 0 4.606756556313485e-05
. O 0 4.206493819935986e-09

Studies O 0 1.042125941097538e-09
on O 0 7.389352324471687e-11
cell O 0 1.9389851502182864e-07
- O 0 1.6786326568762888e-06
associated O 0 9.49924494619836e-09
transferrin O 0 1.9139728024697433e-08
at O 0 7.641419164094998e-10
37 O 0 1.5919425500054984e-10
degrees O 0 9.119970056925553e-11
C O 0 1.285526574079654e-09
suggest O 0 7.408658408980529e-11
that O 0 4.2747329656069033e-13
the O 0 5.724107711262139e-14
overexpressed O 0 1.227232004907819e-08
wild O 0 1.4053191943474985e-09
- O 0 1.878620651041274e-06
type O 0 3.3704143334034598e-06
HFE O 0 3.3253331821470056e-06
protein O 0 2.624085171376578e-09
decreases O 0 6.024199472598468e-10
the O 0 6.652164713169539e-13
affinity O 0 1.60211253985576e-11
of O 0 9.50718236775172e-13
the O 0 1.3704771692490958e-11
TfR O 0 2.521457872717292e-06
for O 0 6.598905449850534e-11
transferrin O 0 9.545635748509085e-08
. O 0 1.5973421474413385e-09

The O 0 7.855329164918601e-10
overexpressed O 0 6.3200386648532e-06
H63D O 0 1.0007915989262983e-06
protein O 0 1.124968562749018e-09
does O 0 1.0423838181505829e-10
not O 0 9.021638687836675e-13
have O 0 5.969798765569079e-14
this O 0 3.3986591380021514e-15
effect O 0 3.3873908452525248e-12
, O 0 2.970954916543117e-13
providing O 0 2.344313708001894e-13
the O 0 2.315652721928286e-14
first O 0 2.3221737575386536e-13
direct O 0 1.1084267184657826e-11
evidence O 0 4.1912828763202015e-10
for O 0 1.606545734118836e-12
a O 0 2.455416772684238e-11
functional O 0 2.3480011268617318e-09
consequence O 0 2.7797539270402183e-10
of O 0 1.2311353108848677e-12
the O 0 4.78581688168056e-11
H63D O 0 3.285676712039276e-06
mutation O 0 4.006745157880687e-08
. O 0 1.6025115678885982e-09

Addition O 0 6.880231939732084e-10
of O 0 3.29557518427559e-12
soluble O 0 2.0753234686310407e-09
wild O 0 5.5791966602214416e-09
- O 0 4.453978908713907e-05
type O 0 0.0003740360261872411
HFE O 0 0.002637219149619341
/ O 0 0.00039887172169983387
beta2m O 0 4.181827534921467e-06
heterodimers O 0 2.3642391155931364e-08
to O 0 8.243980151312336e-12
cultured O 0 2.062569226524147e-09
cells O 0 6.411944308837292e-10
also O 0 1.616320445541053e-11
decreased O 0 3.0689197849653738e-09
the O 0 3.210928701743998e-13
apparent O 0 1.5495787986097298e-10
affinity O 0 5.619076384744126e-12
of O 0 1.5511200722288787e-13
the O 0 3.437415499810137e-12
TfR O 0 2.5123745217570104e-07
for O 0 3.2436206498509534e-13
its O 0 5.23557488595755e-13
ligand O 0 4.74174692566276e-12
under O 0 4.7390797883184455e-12
steady O 0 4.401917053087345e-08
- O 0 2.1249730863814875e-08
state O 0 4.25553862981598e-11
conditions O 0 3.896640521361405e-08
, O 0 8.205604706996994e-13
both O 0 2.2827717499488212e-14
in O 0 3.167066692992375e-14
293 O 0 4.341555327053159e-12
cells O 0 1.9920356596897504e-12
and O 0 1.9675890691045472e-12
in O 0 1.912264834327826e-12
HeLa O 0 4.1928308291971916e-07
cells O 0 2.609550797672e-09
. O 0 4.10749656509779e-10

Furthermore O 0 6.76816913625089e-09
, O 0 6.424562271067913e-11
at O 0 2.4187382652307576e-10
4 O 0 1.6059736873685893e-11
degrees O 0 1.44678791169639e-09
C O 0 1.432432696901742e-07
, O 0 1.8533291221145554e-11
the O 0 1.4638175654252406e-12
added O 0 3.9286965347606895e-10
soluble O 0 4.7536549349636026e-12
complex O 0 1.7922354572652566e-11
of O 0 1.157334753205952e-12
HFE O 0 6.368551112245768e-06
/ O 0 1.2237513828949886e-06
beta2m O 0 1.0361491575849868e-07
inhibited O 0 1.204851995950662e-09
binding O 0 2.9149299640707227e-10
of O 0 8.512972228189031e-13
transferrin O 0 2.4674520204825967e-09
to O 0 1.690806522569588e-11
HeLa O 0 1.668491677264683e-06
cell O 0 8.049306075008644e-07
TfR O 0 1.5962881434461451e-06
in O 0 2.500608444269692e-12
a O 0 3.1899208968733106e-11
concentration O 0 7.222526932082474e-08
- O 0 5.0164280764875e-06
dependent O 0 1.5706605438481347e-07
manner O 0 8.456559612568526e-07
. O 0 5.554234849824979e-09

Scatchard O 0 2.0477767975535244e-05
plots O 0 7.920841085251595e-07
of O 0 6.465383783904599e-12
these O 0 1.1927726601551614e-12
data O 0 3.068589132793065e-11
indicate O 0 4.501144595936424e-11
that O 0 4.977444780125684e-13
the O 0 6.312490677742866e-13
added O 0 4.780755791244928e-10
heterodimer O 0 4.668477826541562e-10
substantially O 0 2.1928647786495503e-09
reduced O 0 4.187741126093769e-11
the O 0 4.731824741061041e-13
affinity O 0 2.297513221338754e-11
of O 0 2.331076737888127e-12
TfR O 0 5.433744263427798e-07
for O 0 2.924551920080454e-11
transferrin O 0 8.620474289955382e-08
. O 0 1.6770105304431127e-09

These O 0 7.240382737805362e-10
results O 0 1.1231456736870982e-10
establish O 0 1.1517248960091209e-10
a O 0 6.050413642322283e-12
molecular O 0 5.938942115868429e-10
link O 0 9.902080364554422e-07
between O 0 1.957802586716184e-09
HFE O 0 0.00043571690912358463
and O 0 1.1147714973347433e-09
a O 0 4.2332515964860207e-11
key O 0 1.0272146466761e-09
protein O 0 3.629297817137056e-12
involved O 0 7.594681827871597e-12
in O 0 6.078610921902983e-13
iron O 0 1.061781063071976e-08
transport O 0 7.199399965074349e-10
, O 0 3.2348490205946767e-12
the O 0 7.356087852565529e-13
TfR O 0 3.580898066957161e-07
, O 0 7.911814432770559e-12
and O 0 3.2230364210850126e-12
raise O 0 1.9668546305529055e-11
the O 0 2.9017329446386075e-14
possibility O 0 4.286378110091027e-12
that O 0 1.421635026496379e-13
alterations O 0 2.1206587874633698e-10
in O 0 2.6556651300767287e-13
this O 0 3.7677646376119145e-13
regulatory O 0 2.081867872538723e-10
mechanism O 0 3.294975403633771e-10
may O 0 3.720493357839416e-11
play O 0 4.528388081181944e-12
a O 0 2.4311685477285128e-12
role O 0 2.0244026940896553e-11
in O 0 2.808093926658095e-13
the O 0 1.4401340363290327e-12
pathogenesis O 0 6.047540779263727e-08
of O 0 1.6357553089818566e-09
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 4.7636626732128207e-07
. O 0 1.1731433602335528e-08

Genomic O 0 6.635782483499497e-07
organization O 0 7.30307636587213e-09
of O 0 2.03024923262074e-11
the O 0 2.2940276414584737e-11
UBE3A O 0 1.8615106455399655e-05
/ O 0 7.065855243126862e-06
E6 O 0 6.518068857985782e-07
- O 0 2.7335383492754772e-05
AP O 0 4.06128975782849e-07
gene O 0 1.2751241840192051e-08
and O 0 7.647567995539006e-11
related O 0 7.210920305311674e-09
pseudogenes O 0 1.2469645298551768e-06
. O 0 2.1932759608489505e-08

The O 0 4.0547989965666886e-10
UBE3A O 0 3.1893409868644085e-06
gene O 0 7.52929807390501e-09
encodes O 0 6.332059321323413e-10
the O 0 2.913772348400734e-11
E6 O 0 2.2899224916272942e-07
- O 0 7.744277536403388e-05
AP O 0 2.8503268367785495e-06
ubiquitin O 0 1.414910943964287e-08
- O 0 3.4208810006930435e-08
protein O 0 5.14270431795083e-11
ligase O 0 2.6972685196469115e-10
and O 0 1.5032267097758734e-11
has O 0 1.2092665410690095e-11
recently O 0 7.670401119819203e-11
been O 0 3.1668524139855103e-12
shown O 0 3.5976013834648768e-12
to O 0 3.036626939484366e-13
be O 0 1.3260058849551282e-11
mutated O 0 6.242872814254952e-07
in O 0 8.305167398248159e-07
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 3.77005671907682e-05
who O 0 1.52346202320075e-09
lack O 0 3.174790430549024e-10
15q11 O 0 2.895384909606946e-07
- O 0 7.557078788522631e-06
q13 O 0 4.814513658857322e-07
deletions O 0 6.766938440705417e-07
or O 0 2.3101725332708156e-07
chromosome O 0 0.0008253601845353842
15 O 0 3.048031516073024e-08
paternal O 0 0.00013343300088308752
uniparental B-Disease 0 0.09587440639734268
disomy I-Disease 0 0.003152630291879177
. O 0 1.6925781665122486e-07

Previous O 0 4.548098075929374e-08
UBE3A O 0 1.5153995036598644e-06
cDNA O 0 5.4364481805180276e-09
analysis O 0 5.469540376168425e-10
has O 0 4.77773653972946e-11
shown O 0 1.1517506566527391e-11
a O 0 3.787667662152883e-12
coding O 0 2.020640721411837e-08
region O 0 1.5867414049353101e-09
of O 0 3.226948439363775e-12
approximately O 0 2.66184208008724e-09
2 O 0 1.1960435974955885e-09
. O 0 4.293838617996926e-09

6 O 0 9.735614270311999e-08
kb O 0 1.089908619178459e-05
and O 0 6.072620628572167e-09
a O 0 2.55043319796755e-09
3 O 0 3.966573558500386e-08
- O 1 0.9662308096885681
untranslated O 0 0.019082648679614067
region O 0 1.5891311022642185e-06
( O 0 6.923697726257672e-11
UTR O 0 3.248400659572326e-09
) O 0 7.900259222856643e-13
of O 0 2.756506604733016e-14
< O 0 2.400822041170869e-10
50 O 0 3.252326359615143e-12
bp O 0 3.0231836478655794e-10
, O 0 2.0580772871515995e-13
whereas O 0 6.286153238568848e-13
Northern O 0 1.0249238090176416e-11
analysis O 0 6.60225485393795e-11
has O 0 5.744297815191146e-10
indicated O 0 3.947595306197371e-10
mRNA O 0 2.167318191234613e-12
sizes O 0 1.899517348968871e-11
of O 0 1.5858153549000442e-13
5 O 0 7.764000553578398e-11
- O 0 8.52184894029051e-06
8 O 0 3.4041973684395543e-09
kb O 0 2.4237390334747033e-06
. O 0 4.044520274248953e-09

We O 0 1.7622054926391684e-08
have O 0 3.641189346564877e-12
analyzed O 0 1.0904784887577623e-11
additional O 0 2.482534306163381e-13
cDNA O 0 2.959845146754958e-10
clones O 0 3.936982295726921e-08
and O 0 7.629672935105525e-12
provide O 0 4.574316728352124e-13
evidence O 0 2.130735908892345e-12
for O 0 2.2119558992068043e-14
an O 0 8.316050213903747e-14
additional O 0 3.132204565159391e-11
0 O 0 8.814246554855742e-10
. O 0 9.64304014416939e-09

5 O 0 2.1755850454496795e-08
kb O 0 8.866066991686239e-07
of O 0 1.667911919689402e-10
5 O 0 6.1755258684570435e-09
- O 0 0.0002008928422583267
UTR O 0 2.8771296456397977e-07
and O 0 1.26494648089448e-10
> O 0 3.150636973536791e-10
2 O 0 1.83003300013862e-11
kb O 0 2.6364983085613858e-08
of O 0 1.748983076421684e-11
3 O 0 4.42186687266144e-09
- O 0 0.00030229680123738945
UTR O 0 5.385114945966052e-06
. O 0 5.067490871368818e-09

We O 0 1.3401108844846021e-07
have O 0 2.0945406867256544e-11
established O 0 9.459449282905874e-13
the O 0 7.473818079987895e-15
genomic O 0 5.827202609332005e-11
organization O 0 2.5383451850852223e-12
of O 0 4.048098526309926e-14
UBE3A O 0 8.364753512069001e-08
and O 0 3.554325020069249e-12
the O 0 2.247234821459946e-14
sequence O 0 4.068522428679611e-12
of O 0 6.862973730981103e-13
intron O 0 6.230234816939628e-07
- O 0 5.885440828024002e-07
exon O 0 1.5843598077935894e-07
borders O 0 6.045615350558364e-07
. O 0 1.585456566033372e-08

We O 0 3.8671426949576926e-08
have O 0 2.993288603092559e-11
also O 0 2.9719198022665205e-12
mapped O 0 2.503863427705255e-08
two O 0 1.6114712645884377e-12
highly O 0 6.7915391192829855e-12
homologous O 0 8.4061022032067e-11
processed O 0 3.912245805093306e-10
pseudogenes O 0 3.9464755907658855e-09
, O 0 1.6354292919906754e-11
UBE3AP1 O 0 4.985552237712909e-08
and O 0 2.6934114660814856e-11
UBE3AP2 O 0 2.764797812915276e-08
, O 0 1.570530923193647e-12
to O 0 2.9078399844256753e-13
chromosomes O 0 1.0740458522562335e-10
2 O 0 1.1655339887672866e-11
and O 0 2.7080060416295737e-10
21 O 0 9.074214990523188e-11
, O 0 2.643799675711156e-12
respectively O 0 7.88764626530325e-12
, O 0 2.0789979113255974e-11
and O 0 5.502015509861735e-11
determined O 0 1.0937853955894639e-09
their O 0 4.5807272905373786e-12
genomic O 0 7.159145720692095e-09
organization O 0 2.016858458020465e-09
. O 0 9.53543688453351e-10

These O 0 1.0389227256268896e-09
results O 0 8.471551238287134e-10
will O 0 3.0950051549405444e-11
form O 0 7.795688465421502e-13
the O 0 1.4743469032435508e-13
basis O 0 8.407813507915751e-12
for O 0 1.41049035989947e-14
studies O 0 3.76490559648307e-13
of O 0 1.8108498844849295e-14
mutation O 0 1.3279174981839503e-10
and O 0 9.093442145113872e-12
imprinting O 0 3.692066741223243e-08
of O 0 1.9694683384141598e-10
UBE3A O 0 0.00017822829249780625
. O 0 2.5310551876600584e-08

Mutation O 0 3.4150795613641094e-07
spectrum O 0 6.111257278007542e-08
and O 0 6.719826362022729e-10
genotype O 0 6.843982873760979e-07
- O 0 6.794014552724548e-06
phenotype O 0 5.981738695481909e-07
analyses O 0 4.7629310273578085e-08
in O 0 3.193001071877255e-11
Cowden B-Disease 0 0.004819675348699093
disease I-Disease 0 0.0008462591795250773
and O 0 6.408230834864526e-09
Bannayan B-Disease 1 0.9993878602981567
- I-Disease 1 0.9999995231628418
Zonana I-Disease 1 0.9999992847442627
syndrome I-Disease 1 0.9999998807907104
, O 0 5.886167997459779e-09
two O 0 1.3117491537428805e-09
hamartoma B-Disease 1 0.9562541842460632
syndromes I-Disease 0 0.016997748985886574
with O 0 1.668250093622703e-09
germline O 0 5.241715916781686e-05
PTEN O 0 0.0012390604242682457
mutation O 0 5.38362610313925e-06
. O 0 3.7900818483649346e-08

The O 0 3.457126140915534e-09
tumour B-Disease 1 0.9999990463256836
suppressor O 0 2.3834993044147268e-05
gene O 0 1.3233949403002043e-06
PTEN O 0 6.005350314808311e-06
, O 0 2.7436664051805337e-10
which O 0 3.487056129958255e-11
maps O 0 2.2018522827238485e-07
to O 0 1.1858173332157662e-09
10q23 O 0 1.4133189552012482e-06
. O 0 5.157709814795908e-09

3 O 0 5.645134582010769e-09
and O 0 3.634529829876776e-11
encodes O 0 9.486036262051911e-11
a O 0 1.6034300623357645e-11
403 O 0 1.1770420749179777e-10
amino O 0 3.4233234302849525e-11
acid O 0 1.627596668551945e-11
dual O 0 3.373074874968296e-10
specificity O 0 3.2710505415423086e-09
phosphatase O 0 1.6621102986391634e-05
( O 0 5.529305138751717e-11
protein O 0 1.5625495342064255e-09
tyrosine O 0 1.5522137175594253e-07
phosphatase O 0 3.5838334042637143e-06
; O 0 1.028676189368527e-11
PTPase O 0 1.003725991211013e-08
) O 0 3.670237724850978e-12
, O 0 9.490821756968915e-13
was O 0 2.6639216874069227e-11
shown O 0 1.3662210252007867e-10
recently O 0 2.0624040253380826e-09
to O 0 1.880310360538595e-12
play O 0 1.3311855957820473e-11
a O 0 1.6429767268899553e-11
broad O 0 4.773840212024538e-10
role O 0 1.1682832479209537e-10
in O 0 7.256813639583415e-12
human O 0 1.7440678901081696e-09
malignancy B-Disease 0 4.171328328084201e-06
. O 0 3.284504446199321e-09

Somatic O 0 9.043408681463916e-06
PTEN O 0 3.1417246646014974e-05
deletions O 0 3.4332427389927034e-07
and O 0 4.942646847361232e-10
mutations O 0 6.757256976186454e-09
were O 0 9.155328405119345e-12
observed O 0 1.8864480810787398e-10
in O 0 3.371302586055447e-12
sporadic B-Disease 0 0.041487425565719604
breast I-Disease 0 0.324463814496994
, I-Disease 0 3.4078222466149555e-09
brain I-Disease 0 0.00022816922864876688
, I-Disease 0 5.934845948019074e-09
prostate I-Disease 1 0.7594134211540222
and I-Disease 0 1.4701052350574173e-05
kidney I-Disease 0 0.322662889957428
cancer I-Disease 0 2.5011913749040104e-05
cell O 0 0.00020873834728263319
lines O 0 0.12499800324440002
and O 0 3.721478236684561e-08
in O 0 1.330728669618475e-11
several O 0 9.117221561050215e-11
primary O 0 4.6260427666311443e-07
tumours B-Disease 1 0.9999998807907104
such O 0 9.70784785891965e-10
as O 0 6.944498665006904e-08
endometrial B-Disease 1 0.9911638498306274
carcinomas I-Disease 1 1.0
, O 1 0.9640620946884155
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9993078708648682
thyroid B-Disease 1 0.9999996423721313
tumours I-Disease 1 1.0
. O 0 2.23415668187954e-06

In O 0 1.3960188560702136e-10
addition O 0 4.0555853814128184e-11
, O 0 1.778139094299469e-11
PTEN O 0 2.610842386729928e-07
was O 0 1.526443305088776e-09
identified O 0 1.4075457466233843e-09
as O 0 4.621541864480161e-13
the O 0 3.0522750939145776e-14
susceptibility O 0 1.2253321690636199e-09
gene O 0 5.3994524407130484e-09
for O 0 5.7030616340547624e-11
two O 0 1.6808382241606523e-08
hamartoma B-Disease 1 0.9996908903121948
syndromes I-Disease 1 0.9998332262039185
Cowden B-Disease 1 0.9998743534088135
disease I-Disease 1 0.9998321533203125
( O 0 5.158939053728773e-09
CD B-Disease 0 0.00023281043104361743
; O 0 1.6631547694601068e-08
MIM O 0 0.0001154401688836515
158350 O 0 1.7079499059491354e-07
) O 0 1.1398234439630173e-10
and O 0 2.176172297918555e-10
Bannayan B-Disease 0 3.1757215765537694e-05
- I-Disease 0 0.05033991113305092
Zonana I-Disease 0 0.0009790512267500162
( I-Disease 0 1.1216518824852528e-09
BZS I-Disease 0 4.378408675620449e-07
) I-Disease 0 2.880040129993322e-11
or I-Disease 0 1.9989686295129871e-10
Ruvalcaba I-Disease 0 1.7339475562039297e-06
- I-Disease 0 2.461437588863191e-06
Riley I-Disease 0 2.939134446933167e-06
- I-Disease 1 0.9544086456298828
Smith I-Disease 0 0.0027989831287413836
syndrome I-Disease 1 0.999580442905426
( O 0 4.1210099221977714e-10
MIM O 0 8.53723831824027e-05
153480 O 0 7.790785616634821e-07
) O 0 6.073497815783924e-10
. O 0 2.285831746107192e-09

Constitutive O 0 2.4481070681758865e-07
DNA O 0 1.8932540513105778e-07
from O 0 1.4037834783486858e-10
37 O 0 1.0587228871372645e-09
CD B-Disease 0 1.2410949068453192e-07
families O 0 3.4314726615747304e-09
and O 0 2.121767345153458e-10
seven O 0 1.2494227874526587e-10
BZS B-Disease 0 4.974515377398347e-07
families O 0 5.170489730810246e-11
was O 0 6.46975389928528e-11
screened O 0 1.7790365847147882e-09
for O 0 7.735188357893552e-12
germline O 0 5.900017754356668e-07
PTEN O 0 9.312811926065478e-06
mutations O 0 4.083504450136388e-07
. O 0 1.3189779046740568e-08

PTEN O 0 0.00016365699411835521
mutations O 0 7.48095942526561e-07
were O 0 2.83241363696618e-09
identified O 0 6.540619601480557e-09
in O 0 6.585725020880062e-12
30 O 0 9.429231700996965e-11
of O 0 1.0688498697231097e-12
37 O 0 7.480083219491007e-10
( O 0 1.9146344232279233e-11
81 O 0 4.637816797270489e-09
% O 0 3.338469908506503e-12
) O 0 2.5869586420951274e-12
CD B-Disease 0 5.215574461203687e-08
families O 0 1.4582735019530446e-10
, O 0 8.148925870025969e-13
including O 0 1.6381414454091914e-12
missense O 0 1.4753302934877865e-07
and O 0 7.518933253791715e-10
nonsense O 0 7.794248517711821e-07
point O 0 3.82948450727838e-10
mutations O 0 6.793489659706609e-10
, O 0 1.6575714325423041e-12
deletions O 0 3.537697079725177e-10
, O 0 8.950703025978335e-12
insertions O 0 6.488952486449762e-09
, O 0 2.504862810226438e-11
a O 0 3.70203902255728e-11
deletion O 0 5.444565687184877e-08
/ O 0 2.8754926461260766e-05
insertion O 0 1.2558491846448305e-07
and O 0 5.023109483914823e-09
splice O 0 1.951426747837104e-05
site O 0 4.7056059884198476e-06
mutations O 0 2.8547998454087065e-07
. O 0 4.6347921056622e-09

These O 0 5.761291790862266e-11
mutations O 0 1.358628654024585e-09
were O 0 3.273518955904109e-11
scattered O 0 2.615720084975237e-09
over O 0 2.427607836974488e-10
the O 0 5.0389349810775474e-12
entire O 0 1.0264507022128555e-09
length O 0 7.197148987891921e-10
of O 0 8.063194751641023e-13
PTEN O 0 8.850187072084736e-08
, O 0 8.905032093664556e-12
with O 0 3.6922263749010475e-13
the O 0 1.8912798302288258e-13
exception O 0 2.3053925088389882e-11
of O 0 1.2393810478773803e-13
the O 0 8.436611869180877e-13
first O 0 4.4099775914352435e-11
, O 0 2.918322181133526e-11
fourth O 0 2.0624345287156842e-10
and O 0 1.4782151891434836e-10
last O 0 5.32003996411845e-10
exons O 0 3.168357309846215e-08
. O 0 2.1261761240509713e-09

A O 0 9.025288072450621e-09
hot O 0 1.7984225664235964e-08
spot O 0 9.038950032902449e-09
for O 0 1.993473441874727e-11
PTEN O 0 3.146513790852623e-06
mutation O 0 1.891889978011818e-09
in O 0 1.6040319029617112e-12
CD B-Disease 0 1.1272974553833137e-08
was O 0 9.02191565899102e-09
identified O 0 1.5897040350765224e-09
in O 0 3.713066909060564e-13
exon O 0 2.0769856667879338e-10
5 O 0 1.126956080538255e-11
that O 0 1.3488946288067738e-12
contains O 0 1.8371184781762473e-11
the O 0 8.073833268618102e-12
PTPase O 0 2.3152453820785013e-07
core O 0 1.3666733522654795e-08
motif O 0 9.010285295651954e-10
, O 0 3.226948439363775e-12
with O 0 1.2187008401141203e-13
13 O 0 1.3824271588580572e-12
of O 0 8.741966840090237e-14
30 O 0 4.951315746293261e-11
( O 0 2.4988774070811015e-12
43 O 0 1.0267993122425878e-09
% O 0 2.4464633877757658e-12
) O 0 1.990159773090916e-12
CD B-Disease 0 1.3379534813395821e-08
mutations O 0 4.222731941894153e-09
identified O 0 1.5456536051061676e-09
in O 0 4.2682234157633003e-13
this O 0 4.494313341624201e-12
exon O 0 5.442021944190856e-08
. O 0 1.24871410989158e-08

Seven O 0 3.287362604353916e-09
of O 0 6.2078272210219776e-12
30 O 0 2.395488807316326e-10
( O 0 2.0819411732792004e-12
23 O 0 4.7058180269177186e-11
% O 0 1.494745082916693e-13
) O 0 1.3873315473852954e-13
were O 0 1.3686250917299692e-11
within O 0 3.8517550694089353e-13
the O 0 1.5962484968806007e-13
core O 0 2.263712772787585e-09
motif O 0 3.481455679299472e-10
, O 0 1.1480610299235972e-12
the O 0 8.110389259057688e-14
majority O 0 3.149636367688613e-12
( O 0 5.108502054533559e-13
five O 0 1.8604434399299707e-12
of O 0 5.870601720676591e-14
seven O 0 6.96642396547098e-13
) O 0 6.936177977465152e-14
of O 0 1.179808729417876e-14
which O 0 1.7694509052423868e-11
were O 0 6.445808470312286e-11
missense O 0 2.3815779570668383e-08
mutations O 0 7.359618470204055e-11
, O 0 2.0801460868472704e-13
possibly O 0 4.917957100586401e-12
pointing O 0 7.082786801504426e-09
to O 0 2.2232779853248452e-11
the O 0 3.704021898226495e-12
functional O 0 7.610146957048869e-10
significance O 0 1.359924256538747e-10
of O 0 9.55544888006643e-13
this O 0 1.7879539862541982e-11
region O 0 1.291053486340843e-08
. O 0 1.5435560607457433e-09

Germline O 0 0.0004368365043774247
PTEN O 0 0.00014400671352632344
mutations O 0 4.2881447370746173e-07
were O 0 1.7951489184042657e-09
identified O 0 2.358334683094654e-08
in O 0 1.0338611911020479e-11
four O 0 1.9057736291849814e-11
of O 0 3.2695486942846408e-12
seven O 0 1.4152441718540132e-10
( O 0 1.897445915666207e-11
57 O 0 2.360052153704828e-09
% O 0 1.1005541963871046e-11
) O 0 4.9989231504232734e-11
BZS B-Disease 0 8.239372846219339e-07
families O 0 1.2475510902110187e-10
studied O 0 8.766914416646898e-10
. O 0 6.970874433243068e-10

Interestingly O 0 3.0683543172926875e-07
, O 0 2.897369844045983e-10
none O 0 3.222300551386503e-11
of O 0 5.572387169749948e-14
these O 0 1.1834452688652686e-12
mutations O 0 4.728962221811628e-10
was O 0 3.451635921525309e-10
observed O 0 7.157940906665772e-10
in O 0 1.2929336420941517e-12
the O 0 4.1335381298357454e-12
PTPase O 0 4.7272538949982845e-07
core O 0 1.2803351978618593e-07
motif O 0 1.36254314497819e-07
. O 0 3.347369714745696e-09

It O 0 3.7221294935108062e-09
is O 0 4.153220545255465e-10
also O 0 1.5313146584094994e-11
worthy O 0 2.4081773034034804e-11
of O 0 1.0326500532497132e-13
note O 0 1.9775198145666195e-10
that O 0 1.910711606295523e-12
a O 0 3.283077802673784e-12
single O 0 3.039302975960112e-10
nonsense O 0 7.32826549665333e-07
point O 0 1.4393830571890476e-10
mutation O 0 4.6742224674156674e-11
, O 0 4.659513335066034e-13
R233X O 0 1.5430018374118504e-10
, O 0 6.594344211310887e-13
was O 0 1.0040001816036259e-11
observed O 0 8.738029050325835e-11
in O 0 9.333095548572784e-14
the O 0 1.8417054990435555e-13
germline O 0 3.85807691349882e-10
DNA O 0 6.138951569312212e-10
from O 0 2.0496705190314185e-13
two O 0 1.2804755628210984e-13
unrelated O 0 1.0374173048388613e-10
CD B-Disease 0 1.4558743544057506e-07
families O 0 2.2152166767597237e-09
and O 0 2.605824167556392e-10
one O 0 7.792667067185732e-10
BZS B-Disease 0 3.82123289455194e-06
family O 0 1.0093124558352429e-08
. O 0 6.080962955401503e-10

Genotype O 0 0.00045097278780303895
- O 0 0.00013812087127007544
phenotype O 0 1.1967246393851383e-07
studies O 0 7.204671581551025e-11
were O 0 1.0297990758745268e-11
not O 0 1.1203673622520172e-12
performed O 0 5.1173128234882626e-11
on O 0 1.2746724682710653e-11
this O 0 4.958426789818116e-13
small O 0 2.6906131836423874e-11
group O 0 3.8701767485216365e-11
of O 0 2.7468366123328813e-12
BZS B-Disease 0 4.776213245349936e-06
families O 0 1.5379665319059654e-09
. O 0 5.895928745225376e-10

However O 0 4.5026407602399843e-10
, O 0 1.0016862339590205e-10
genotype O 0 3.707040008293916e-08
- O 0 2.5021836336236447e-07
phenotype O 0 2.274481936126449e-08
analysis O 0 4.6679146659123205e-11
inthe O 0 9.372972620269593e-09
group O 0 9.681086488022572e-11
of O 0 2.2930802764421776e-13
CD B-Disease 0 2.8474963187363755e-07
families O 0 7.083648667638442e-10
revealed O 0 1.5690488908148836e-08
two O 0 3.440996836426291e-12
possible O 0 1.2799963866605424e-10
associations O 0 4.023024968713429e-12
worthy O 0 1.690567998091641e-11
of O 0 4.109622256213974e-13
follow O 0 1.3642453833284662e-09
- O 0 6.663573003606871e-06
up O 0 1.1678745082122077e-08
in O 0 1.0532914818117689e-11
independent O 0 8.615074764684039e-10
analyses O 0 5.4158967088824284e-08
. O 0 1.0018778029419195e-09

The O 0 1.4766456113424198e-10
first O 0 5.485302490004784e-11
was O 0 9.202186235235388e-10
an O 0 1.1220267336770062e-12
association O 0 3.1553423068819697e-12
noted O 0 2.636671714295602e-10
in O 0 5.093576927427124e-13
the O 0 1.826596193093069e-13
group O 0 6.16106905076963e-12
of O 0 2.24986807748637e-14
CD B-Disease 0 2.13638301715946e-07
families O 0 5.551997195318847e-10
with O 0 2.1258018956249458e-10
breast B-Disease 0 0.02432946488261223
disease I-Disease 0 0.007551607675850391
. O 0 2.1293507401765055e-08

A O 0 1.1643952468887164e-09
correlation O 0 2.1451131981820026e-09
was O 0 7.986626637812577e-11
observed O 0 5.693160526343277e-11
between O 0 2.699714638041556e-13
the O 0 1.6032695190990737e-13
presence O 0 1.0534633165804053e-09
/ O 0 8.084633691396448e-07
absence O 0 5.2356396995634213e-11
of O 0 4.2722041318022166e-14
a O 0 1.1599761082226046e-11
PTEN O 0 1.1336305760778487e-07
mutation O 0 2.0738662176444933e-10
and O 0 9.89868018282103e-13
the O 0 1.7580247424920509e-13
type O 0 1.4100258738380944e-07
of O 0 8.865037176564172e-12
breast O 0 2.050043440249283e-05
involvement O 0 2.796594174014899e-07
( O 0 2.8590027567609866e-10
unaffected O 0 1.1383469882275676e-06
versus O 0 9.613972906663548e-08
benign O 0 0.00443557184189558
versus O 0 7.521758220718766e-07
malignant O 1 0.6919886469841003
) O 0 1.5382989104750777e-08
. O 0 1.138290706137468e-08

Specifically O 0 2.141030996938298e-08
and O 0 1.7224398296544763e-10
more O 0 3.773376142796048e-12
directly O 0 5.564557495341127e-11
, O 0 1.7912581140588912e-11
an O 0 9.523262170171853e-13
association O 0 7.464283531544158e-12
was O 0 2.520373687531219e-09
also O 0 4.88493065442519e-11
observed O 0 1.5392159768978786e-10
between O 0 1.756168181796941e-13
the O 0 7.22125199806127e-14
presence O 0 1.5551148910275536e-11
of O 0 5.872549896455276e-14
a O 0 3.240964788209233e-11
PTEN O 0 1.8366174117545597e-05
mutation O 0 1.8527845213611727e-07
and O 0 1.442141410734621e-07
malignant B-Disease 1 0.9999880790710449
breast I-Disease 1 0.9999403953552246
disease I-Disease 1 0.9994761347770691
. O 0 1.1414305589596552e-07

Secondly O 0 2.0555367882479914e-05
, O 0 6.309875955068378e-10
there O 0 2.165481405302927e-10
appeared O 0 2.764610484984331e-10
to O 0 3.0253091698462242e-12
be O 0 1.8750253086285973e-11
an O 0 1.90581253035893e-12
interdependent O 0 1.216402978343467e-07
association O 0 6.959388794414156e-12
between O 0 2.877255074820728e-12
mutations O 0 7.669311408164958e-09
upstream O 0 1.3837937018479352e-08
and O 0 2.0929961930260532e-10
within O 0 4.346054332388105e-12
the O 0 2.3496016330476488e-12
PTPase O 0 9.219639451885087e-08
core O 0 8.535947060295257e-09
motif O 0 2.942492915991579e-09
, O 0 3.980404547632155e-12
the O 0 3.3820824829958185e-13
core O 0 1.4562506756021776e-09
motif O 0 2.88073925824861e-10
containing O 0 4.303597408994442e-12
the O 0 1.799770185315075e-13
majority O 0 1.9329212709584542e-12
of O 0 5.92085584662401e-14
missense O 0 2.715457014801359e-08
mutations O 0 1.6913631606385593e-09
, O 0 2.2804947166776834e-11
and O 0 1.0352760315690546e-11
the O 0 7.231124878569195e-13
involvement O 0 1.6155115023508415e-09
of O 0 7.283767230852056e-13
all O 0 1.0148821019684284e-11
major O 0 1.6534335012252654e-10
organ O 0 8.528432715593226e-08
systems O 0 1.8587977379525e-08
( O 0 1.7536727278666397e-11
central O 0 1.3631866746521837e-09
nervous O 0 4.16351184640007e-08
system O 0 4.6187667024355505e-09
, O 0 5.537350022954968e-10
thyroid O 0 9.917201532516629e-05
, O 0 1.585866160613847e-10
breast O 0 9.090982348425314e-05
, O 0 5.274668879451383e-08
skin O 1 0.9999231100082397
and O 0 0.0489354133605957
gastrointestinal O 1 0.999913215637207
tract O 1 0.9999880790710449
) O 0 2.159595169359818e-06
. O 0 2.809028956107795e-07

However O 0 5.003428227290385e-10
, O 0 7.975935883974827e-12
these O 0 8.515419408017602e-14
observations O 0 1.1232034746733177e-10
would O 0 9.70258075272401e-12
need O 0 1.506472138874948e-12
to O 0 4.363419890164588e-13
be O 0 1.0653253453007938e-11
confirmed O 0 9.675179407642176e-11
by O 0 1.147084272186405e-13
studying O 0 4.131481181474106e-12
a O 0 6.804891394297796e-13
larger O 0 2.7675884587546884e-12
number O 0 5.173278472270226e-12
of O 0 5.638849847125482e-13
CD B-Disease 0 2.814214212776278e-06
families O 0 1.035844388042051e-08
. O 0 1.478452804626329e-09

Molecular O 0 7.763796929793898e-06
defects O 1 0.9622060060501099
leading O 0 3.824814687192202e-09
to O 0 5.362723806690006e-11
human O 0 1.1656045906249801e-08
complement B-Disease 0 4.074691969435662e-05
component I-Disease 1 0.9999351501464844
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 5.796828642101737e-11
an O 0 4.792464602249025e-12
African O 0 1.1325721610555561e-10
- O 0 3.746576737739815e-07
American O 0 7.134768331695795e-10
family O 0 1.6063436802937758e-08
. O 0 7.146794822610048e-10

Complement B-Disease 0 0.00013840882456861436
component I-Disease 1 0.9959354400634766
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 5.175911255150822e-09
C6D B-Disease 0 2.2555035684490576e-05
) O 0 2.8282015618330547e-10
was O 0 3.694905714723973e-08
diagnosed O 0 3.5635108361020684e-05
in O 0 6.6146415601819886e-12
a O 0 2.055554060298448e-10
16 O 0 5.246959533522499e-10
- O 0 1.86577111094266e-07
year O 0 2.7665147950273195e-10
- O 0 2.909744800660974e-08
old O 0 9.620150898115298e-09
African O 0 1.3574977947294897e-11
- O 0 5.517235002194809e-10
American O 0 7.022700129755144e-12
male O 0 5.919106316198963e-10
with O 0 6.542363317763034e-10
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 4.636421735426666e-08

The O 0 1.5749910264872824e-09
patients O 0 1.1048022052762008e-08
father O 0 1.4593356922887324e-07
and O 0 1.9642021342747285e-09
two O 0 5.036564221239104e-11
brothers O 0 8.030722398189027e-08
also O 0 2.8031751919677106e-10
had O 0 1.1120064868919144e-09
C6D B-Disease 0 3.0090095037849096e-07
, O 0 8.159194674062231e-12
but O 0 3.6228173239116757e-12
gave O 0 2.6076177675471435e-11
no O 0 1.3877517190952204e-10
history O 0 4.337311759750051e-11
of O 0 8.532780038095211e-11
meningitis B-Disease 1 1.0
or O 0 1.9928643624211873e-08
other O 0 5.173431683047625e-10
neisserial B-Disease 0 0.0009572592098265886
infection I-Disease 0 0.009582152590155602
. O 0 1.377429015292364e-08

By O 0 9.664625003069638e-12
using O 0 2.520688519025427e-11
exon O 0 5.713988393551972e-09
- O 0 9.100416775709164e-08
specific O 0 1.7693539688945492e-10
polymerase O 0 1.140805405697165e-08
chain O 0 2.8039909949484354e-08
reaction O 0 4.761343055936784e-11
( O 0 1.8588853600929461e-13
PCR O 0 1.1757451956473375e-10
) O 0 1.421019606238222e-13
/ O 0 3.7311262413020074e-10
single O 0 9.391605548803028e-12
- O 0 1.0065014377502735e-09
strand O 0 6.427458010271891e-10
conformation O 0 1.345427241838948e-10
polymorphism O 0 2.9712243082569145e-11
as O 0 4.2500484604074754e-14
a O 0 6.451063235034596e-14
screening O 0 2.9713191542629636e-12
step O 0 6.337103584941328e-12
and O 0 2.873796781598624e-14
nucleotide O 0 8.997323285714343e-13
sequencing O 0 2.3445160743373883e-12
of O 0 3.896078473947587e-14
target O 0 1.2751447120429305e-10
exons O 0 8.480293550716667e-11
, O 0 2.5492474884508676e-12
we O 0 3.8664340826222166e-12
determined O 0 4.591303032208671e-12
that O 0 2.205528240508542e-13
the O 0 1.215905360337638e-13
proband O 0 8.294717801504703e-09
was O 0 1.482085704163083e-10
a O 0 6.817691376725943e-12
compound O 0 1.1110100617273133e-09
heterozygote O 0 6.393125473458383e-10
for O 0 1.7579888282950873e-12
two O 0 5.555402492196659e-12
C6 O 0 5.542850090023421e-08
gene O 0 2.6176079970241517e-08
mutations O 0 6.269883812137778e-08
. O 0 3.3626894602178936e-09

The O 0 2.9274160873171695e-10
first O 0 1.7334866181384356e-11
, O 0 3.205209101603268e-12
1195delC O 0 1.711711772323099e-09
located O 0 2.0157739921700113e-09
in O 0 1.6555113399943644e-12
exon O 0 1.7208776625921018e-09
7 O 0 9.595003680473724e-10
, O 0 5.324686525032263e-11
is O 0 4.5932143505345024e-11
a O 0 2.3652941584517695e-12
novel O 0 2.582847997978366e-11
mutation O 0 1.2955021777560916e-10
, O 0 4.074004588544566e-12
while O 0 4.3940398194997066e-12
the O 0 2.146005134663273e-13
second O 0 8.819720127839492e-12
, O 0 3.130363373030076e-12
1936delG O 0 8.072409407589021e-10
in O 0 7.312567977361961e-13
exon O 0 1.4766907141527952e-10
12 O 0 1.270410998621685e-10
, O 0 1.988438060041009e-11
has O 0 1.0801103761393094e-10
been O 0 1.5570737407766266e-11
described O 0 1.6380680145644533e-10
before O 0 3.575996486773758e-12
to O 0 2.302732657333273e-12
cause O 0 6.346480979635416e-11
C6D B-Disease 0 9.402342016073817e-08
in O 0 1.1249455143455545e-12
an O 0 9.580743316750517e-13
unrelated O 0 3.349822197407093e-09
African O 0 5.552875936842838e-10
- O 0 5.096092081657844e-07
American O 0 6.025038801205085e-10
individual O 0 2.9457186689896275e-11
. O 0 3.572809825769241e-10

Both O 0 9.056599914458729e-10
mutations O 0 1.4104839074491338e-08
result O 0 2.2010213096557152e-11
in O 0 4.415631488924321e-12
premature O 0 2.4650260499470278e-08
termination O 0 7.857899220198306e-08
codons O 0 4.275975129530707e-07
and O 0 9.199593087316771e-09
C6 O 0 4.256399734003935e-06
null O 0 2.371249138377607e-06
alleles O 0 1.9034484921576222e-07
. O 0 1.7939619567641785e-08

Allele O 0 9.765489039637032e-07
- O 0 1.0344805900786014e-07
specific O 0 2.9431201920004924e-10
PCR O 0 2.2747551398083488e-08
indicated O 0 4.217757254565413e-09
that O 0 4.2001195273491665e-13
the O 0 2.672101906062152e-13
probands O 0 5.224734778153106e-08
two O 0 2.986701858054275e-11
brothers O 0 2.180262725914872e-08
also O 0 3.817369337300036e-11
inherited O 0 4.618467386308112e-09
the O 0 7.958091650939192e-13
1195delC O 0 1.89883540002711e-08
mutation O 0 3.278682048080128e-10
from O 0 1.6428381008001813e-12
their O 0 2.1075847664309144e-11
heterozygous O 0 1.727307541443679e-08
mother O 0 6.005413411003246e-08
and O 0 9.515260107617607e-12
the O 0 9.288721051006754e-13
1936delG O 0 2.8288141606935824e-08
mutation O 0 7.80415010392943e-10
from O 0 4.1430257662067316e-12
their O 0 2.0348236984268908e-11
homozygous O 0 1.9473903378752766e-08
father O 0 3.095895095839296e-08
. O 0 1.8021559938796727e-11
. O 0 2.516385710915614e-10

PAX6 O 0 0.0022263263817876577
mutations O 0 8.542612704331987e-06
reviewed O 0 1.1482591162348399e-06
. O 0 3.461634534573932e-08

Mutations O 0 1.2672608136199415e-06
in O 0 6.84930237526693e-11
PAX6 O 0 4.0621639527671505e-06
are O 0 2.5091758532047592e-11
responsible O 0 8.138003604329924e-10
for O 0 3.1194738632500663e-12
human O 0 7.76879272024189e-09
aniridia B-Disease 1 1.0
and O 0 6.971770716290848e-08
have O 0 1.276108246850427e-10
also O 0 1.957138661204394e-12
been O 0 1.9085883047609276e-12
found O 0 9.692274110031929e-13
in O 0 2.497737531127059e-13
patients O 0 1.1289267264069647e-11
with O 0 1.394575774305018e-11
Peters B-Disease 1 1.0
anomaly I-Disease 1 0.9999997615814209
, O 0 9.225845865046267e-09
with O 0 2.359054462885979e-08
congenital B-Disease 1 0.9999998807907104
cataracts I-Disease 1 0.9999831914901733
, O 0 1.1862363535897202e-08
with O 0 8.181491928382911e-09
autosomal B-Disease 1 0.9973287582397461
dominant I-Disease 0 0.0009471247321926057
keratitis I-Disease 1 0.9976861476898193
, O 0 1.1575261993357344e-07
and O 0 1.0771406877552181e-08
with O 0 2.5335426201422706e-08
isolated B-Disease 1 0.9999107122421265
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 0 1.382764367008349e-06

No O 0 8.556747310706214e-09
locus O 0 4.2551695500492315e-09
other O 0 9.8037229376291e-12
than O 0 3.5843224222009695e-11
chromosome O 0 2.48505239142105e-06
11p13 O 0 5.617211513708753e-07
has O 0 2.187694114752503e-08
been O 0 5.206424735781923e-10
implicated O 0 3.052406682968467e-08
in O 0 1.635826196721979e-10
aniridia B-Disease 1 1.0
, O 0 1.2323213560705426e-09
and O 0 6.845514433084787e-11
PAX6 O 0 9.797345228435006e-07
is O 0 1.4515606772125267e-10
clearly O 0 1.0792702148654243e-10
the O 0 5.5396839052828176e-14
major O 0 3.185276001294035e-11
, O 0 4.051022538253957e-12
if O 0 1.6134251920596476e-11
not O 0 2.8918456171367346e-12
only O 0 3.4652063662064803e-13
, O 0 2.8364086795441834e-13
gene O 0 2.4213187010957427e-10
responsible O 0 3.8739933927445236e-08
. O 0 5.570392591636164e-09

Twenty O 0 6.044381848369085e-07
- O 0 3.105348514509387e-05
eight O 0 4.282919352505132e-09
percent O 0 3.479067700595806e-09
of O 0 8.789236157456803e-13
identified O 0 2.3814914484887595e-08
PAX6 O 0 9.797868187888525e-07
mutations O 0 2.8757794368061695e-08
are O 0 1.1353731149688073e-10
C O 0 8.843792187462896e-08
- O 0 6.2993026404001284e-06
T O 0 7.840530429348291e-07
changes O 0 5.06714774306527e-11
at O 0 5.395473304248277e-11
CpG O 0 4.948396536974542e-08
dinucleotides O 0 1.637113911101551e-08
, O 0 6.011360680069355e-12
20 O 0 1.2895938657220274e-12
% O 0 6.786585860342823e-14
are O 0 2.7185580040367183e-14
splicing O 0 1.3051500158400842e-10
errors O 0 5.563936866792574e-09
, O 0 4.923456607686116e-12
and O 0 6.866456730460213e-13
more O 0 2.336149665643078e-13
than O 0 2.1177020640555932e-12
30 O 0 1.0014793681845102e-11
% O 0 3.98425379060513e-13
are O 0 5.093868577811522e-13
deletion O 0 7.079758446160156e-10
or O 0 8.771091491999172e-11
insertion O 0 1.9967518749552937e-09
events O 0 1.817103978396517e-08
. O 0 1.374523694863683e-08

There O 0 6.888954739991959e-09
is O 0 8.113171245938133e-11
a O 0 2.967045012458591e-11
noticeably O 0 1.383889411954442e-07
elevated O 0 2.1606201983104256e-07
level O 0 6.410293407199674e-10
of O 0 2.8028287698579624e-13
mutation O 0 3.3589697689961895e-10
in O 0 7.341174651682991e-13
the O 0 5.219771012990315e-13
paired O 0 3.66059821343967e-11
domain O 0 1.2155501605271013e-10
compared O 0 1.2224328216348113e-09
with O 0 8.118615155150444e-12
the O 0 8.35449656504117e-13
rest O 0 2.933501705437713e-11
of O 0 5.23889810114149e-14
the O 0 6.56191084542207e-13
gene O 0 8.863089817623404e-09
. O 0 1.0139061812353134e-09

Increased O 0 1.605712718344421e-08
mutation O 0 4.397374908648999e-09
in O 0 2.4416432417573297e-12
the O 0 1.4530688935074365e-12
homeodomain O 0 3.100587164794888e-08
is O 0 1.4433639006217192e-10
accounted O 0 3.641778212326585e-09
for O 0 3.219336147490537e-13
by O 0 1.2882786200665852e-12
the O 0 6.865019403640149e-12
hypermutable O 0 3.65672462976363e-07
CpG O 0 1.990522378036985e-06
dinucleotide O 0 5.44396350221632e-08
in O 0 2.4457972105929038e-11
codon O 0 2.2647892450322615e-08
240 O 0 5.9310889533037425e-09
. O 0 8.685145380660231e-10

Very O 0 6.220400194933973e-09
nearly O 0 5.260246127569701e-10
all O 0 7.811406144316024e-13
mutations O 0 1.4106331380769888e-10
appear O 0 1.3248379823749268e-11
to O 0 2.808497358286477e-12
cause O 0 2.3040804819629557e-09
loss O 0 2.7774936128821537e-08
of O 0 4.8279340594814535e-12
function O 0 5.8190369855992685e-08
of O 0 1.4300473782577483e-12
the O 0 1.7531837526868488e-12
mutant O 0 2.4683179944418043e-09
allele O 0 4.61504806592572e-10
, O 0 2.66060957987424e-12
and O 0 4.175461788390872e-13
more O 0 1.2980874784362245e-13
than O 0 2.163427640158866e-12
80 O 0 1.7226296777916872e-11
% O 0 2.884000547057064e-13
of O 0 3.2928529152508046e-13
exonic O 0 1.1908785779723985e-07
substitutions O 0 3.2078011358294134e-09
result O 0 2.470441073931795e-10
in O 0 1.2708175657627496e-11
nonsense O 0 4.643333397780225e-07
codons O 0 4.6859234714702325e-08
. O 0 7.970985538285902e-10

In O 0 7.641239724298643e-11
a O 0 1.0746744640022232e-11
gene O 0 1.4512596679949752e-09
with O 0 3.4233674922612423e-12
such O 0 1.4170072233643527e-11
extraordinarily O 0 2.1296269636650322e-08
high O 0 4.635727357538144e-10
sequence O 0 2.2646141906168538e-10
conservation O 0 8.53007508377912e-12
throughout O 0 1.6059198513097145e-13
evolution O 0 3.137380980011706e-12
, O 0 8.169032399314713e-13
there O 0 1.512654584923112e-11
are O 0 2.958257944163378e-11
presumed O 0 1.3505713525319152e-07
undiscovered O 0 6.374805820996698e-07
missense O 0 2.6657105536287418e-06
mutations O 0 3.330736220163999e-08
, O 0 2.458293985041493e-11
these O 0 1.0616209517380626e-12
are O 0 4.657913594760532e-13
hypothesized O 0 1.3003388296684015e-11
to O 0 3.3130204309117506e-12
exist O 0 1.9912703430602363e-10
in O 0 1.9778083251015266e-12
as O 0 1.2337460220113172e-10
- O 0 3.16923251375556e-06
yet O 0 1.270107041762003e-08
unidentified O 0 4.216311566551667e-08
phenotypes O 0 4.4556380807136975e-09
. O 0 1.937488017245137e-11
. O 0 2.6558666377241025e-10

Genetic O 0 1.5267810340446886e-06
heterogeneity O 0 7.788187872392882e-08
and O 0 7.17672365979638e-10
penetrance O 0 2.9767886644549435e-07
analysis O 0 2.836239854087097e-10
of O 0 1.4637840635781108e-12
the O 0 2.930968315273397e-11
BRCA1 O 0 5.445828719530255e-06
and O 0 1.8684511715605367e-09
BRCA2 O 0 8.129522939270828e-07
genes O 0 8.232365900084915e-09
in O 0 2.0627492769431655e-10
breast B-Disease 0 0.0429832823574543
cancer I-Disease 0 0.00882473774254322
families O 0 6.662478568841834e-08
. O 0 2.061162440725184e-08

The O 0 5.049383844379918e-07
Breast B-Disease 1 1.0
Cancer I-Disease 1 0.9999996423721313
Linkage O 0 0.0018769848393276334
Consortium O 0 1.4822421690041665e-06
. O 0 1.1467240490503627e-08

The O 0 1.3625458400445822e-11
contribution O 0 2.8036925212027164e-11
of O 0 2.164430527168415e-12
BRCA1 O 0 2.231077814940363e-06
and O 0 5.716429996027728e-09
BRCA2 O 0 0.00028290448244661093
to O 0 1.8582610437078984e-06
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 2.8028789529344067e-06
assessed O 0 4.3594379661726634e-08
by O 0 2.4318701566383716e-11
linkage O 0 6.19651063971105e-06
and O 0 4.769942080207201e-11
mutation O 0 3.790206343223801e-11
analysis O 0 4.506279464161489e-12
in O 0 2.194739209164867e-13
237 O 0 1.2100030699624398e-10
families O 0 4.16489516485985e-11
, O 0 8.990461370164682e-13
each O 0 1.872600110999073e-13
with O 0 1.0136860968679162e-12
at O 0 5.856867768549989e-10
least O 0 8.711270593764198e-11
four O 0 2.6049917431492098e-12
cases O 0 6.555449932887925e-11
of O 0 1.1258131579761077e-11
breast B-Disease 0 0.019128751009702682
cancer I-Disease 0 4.8990032155415975e-06
, O 0 7.373468155491558e-12
collected O 0 1.2597499432498438e-11
by O 0 1.1357500356856676e-10
the O 0 7.340142360590107e-08
Breast B-Disease 1 1.0
Cancer I-Disease 1 0.9999996423721313
Linkage O 0 2.0618250346160494e-05
Consortium O 0 4.6253987306954514e-08
. O 0 2.5889319577032666e-09

Families O 0 4.099423733805452e-08
were O 0 1.3269427223683294e-10
included O 0 1.0889633812738442e-11
without O 0 3.1694024574951962e-12
regard O 0 9.917828711070165e-12
to O 0 5.691743192211274e-13
the O 0 3.4043004960154777e-13
occurrence O 0 2.609806699638284e-07
of O 0 3.1517546905668326e-10
ovarian B-Disease 0 0.00390974385663867
or I-Disease 0 9.60441948194557e-09
other I-Disease 0 1.048666042891e-09
cancers I-Disease 0 2.02841438294854e-05
. O 0 7.3970740643858335e-09

Overall O 0 3.6865785091322323e-07
, O 0 9.636146103275678e-09
disease O 0 7.801062020007521e-05
was O 0 1.8183728300869006e-08
linked O 0 2.002895053010434e-05
to O 0 1.5545759124435676e-10
BRCA1 O 0 1.1737816407730861e-07
in O 0 3.117106833067096e-12
an O 0 2.162082795784115e-12
estimated O 0 6.007140562758195e-09
52 O 0 4.258059682626936e-09
% O 0 5.06567574345973e-12
of O 0 7.354839393763912e-13
families O 0 2.2505465546718284e-10
, O 0 6.112516742762253e-12
to O 0 7.250366106104078e-12
BRCA2 O 0 8.547481833431902e-09
in O 0 3.804755555752992e-12
32 O 0 1.597968979361042e-10
% O 0 9.191524494647774e-13
of O 0 1.5172851039815805e-13
families O 0 2.273000676566994e-10
, O 0 4.318993426788431e-11
and O 0 6.054938668509369e-12
to O 0 1.162964039305714e-12
neither O 0 1.474629619802048e-11
gene O 0 6.057136736625779e-11
in O 0 1.0411012330013847e-12
16 O 0 6.63780835852279e-12
% O 0 5.425704915733298e-13
( O 0 1.2220533829668256e-12
95 O 0 6.746773806298734e-09
% O 0 3.5750591376171315e-10
confidence O 0 1.0771760372563222e-07
interval O 0 2.136975574273947e-08
[ O 0 4.350597659907862e-09
CI O 0 8.291571589325031e-07
] O 0 9.85074133375008e-10
6 O 0 2.2494381357596183e-11
% O 0 6.584620002025865e-12
- O 0 1.4531739225276397e-06
28 O 0 3.90041388076412e-10
% O 0 1.7335841150187964e-13
) O 0 7.918991661417032e-14
, O 0 8.753830044736302e-14
suggesting O 0 3.383602079076731e-11
other O 0 1.3104669259467183e-12
predisposition O 0 8.548757790549644e-08
genes O 0 2.7251230605429555e-08
. O 0 4.736384617842759e-09

The O 0 1.8986270888809997e-10
majority O 0 1.9532958583923232e-10
( O 0 6.4535434288193194e-12
81 O 0 4.0575529047792713e-10
% O 0 3.2272299524578607e-13
) O 0 6.535740102332072e-14
of O 0 2.5287953155095355e-13
the O 0 1.991014109137268e-08
breast B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.3023985445670405e-08
were O 0 9.346114160369012e-11
due O 0 1.686741718520679e-11
to O 0 7.178071938923614e-12
BRCA1 O 0 1.8677679847201034e-08
, O 0 8.418404862098328e-12
with O 0 8.189468526063892e-13
most O 0 3.4838167507073026e-12
others O 0 2.530129578071083e-11
( O 0 9.697913045531026e-13
14 O 0 3.1819484547224164e-11
% O 0 1.1318713978233919e-12
) O 0 1.2349924685337021e-12
due O 0 8.186463312798153e-11
to O 0 1.7573780208834933e-09
BRCA2 O 0 6.784341621823842e-06
. O 0 5.038980788185654e-09

Conversely O 0 2.0160409519576206e-07
, O 0 7.468873436389245e-11
the O 0 1.432888909521507e-13
majority O 0 7.350117042781434e-12
of O 0 1.6125403963507257e-13
families O 0 1.1068427424598681e-10
with O 0 1.3349951699659357e-10
male B-Disease 0 5.708969183615409e-06
and I-Disease 0 2.724900411976705e-07
female I-Disease 0 9.938229368344764e-07
breast I-Disease 0 3.78272270609159e-05
cancer I-Disease 0 1.9856192920997273e-06
were O 0 2.8555094400140035e-10
due O 0 8.645358734460373e-11
to O 0 9.800361910894395e-11
BRCA2 O 0 3.4114339086954715e-07
( O 0 8.521720828991164e-11
76 O 0 3.212057819723668e-08
% O 0 6.157688248187299e-11
) O 0 1.1092562979264642e-10
. O 0 3.41478401111317e-09

The O 0 8.00986013627103e-11
largest O 0 3.71304459401145e-10
proportion O 0 1.0240586156839981e-10
( O 0 3.9774299305517236e-12
67 O 0 7.849562666528698e-10
% O 0 8.680610483896567e-13
) O 0 1.8540944062180043e-13
of O 0 1.6072007006512345e-13
families O 0 1.0232595153147894e-11
due O 0 3.574646438228579e-12
to O 0 2.8248941814218442e-12
other O 0 5.86159755715937e-13
genes O 0 1.4778457624320396e-10
was O 0 6.315715173066394e-10
found O 0 8.616187624488347e-11
in O 0 8.157401078408288e-13
families O 0 3.41662267054621e-12
with O 0 1.2297929601751134e-12
four O 0 2.3516865538253384e-12
or O 0 8.020362846083984e-11
five O 0 1.1352312319357072e-12
cases O 0 3.3825629797146206e-11
of O 0 6.639074272979384e-12
female O 0 2.148957264580531e-06
breast B-Disease 0 0.0016386681236326694
cancer I-Disease 0 2.4310809749295004e-05
only O 0 3.738001908004662e-09
. O 0 5.870896213622245e-09

These O 0 8.923297517560158e-11
estimates O 0 1.6862543583684442e-09
were O 0 2.8513880492853083e-11
not O 0 1.179202460503681e-12
substantially O 0 1.7960005704864557e-10
affected O 0 1.1218909828913937e-10
either O 0 1.2654013037058376e-12
by O 0 1.1930116183139772e-12
changing O 0 2.6364717076177158e-09
the O 0 4.616240983218445e-12
assumed O 0 4.82289763681365e-09
penetrance O 0 3.8178487926643356e-08
model O 0 1.496830770442159e-09
for O 0 1.0397319940777527e-12
BRCA1 O 0 1.2439496099858616e-09
or O 0 1.0580293585693568e-11
by O 0 1.253326327270432e-12
including O 0 4.127458097524794e-11
or O 0 1.9000192530427285e-09
excluding O 0 1.5188169300017762e-07
BRCA1 O 0 4.759035618917551e-07
mutation O 0 7.077777475217317e-09
data O 0 1.1595908233630325e-08
. O 0 5.437215122583439e-09

Among O 0 1.0382926740604148e-09
those O 0 1.917894662528674e-11
families O 0 9.268819739505219e-11
with O 0 2.677251996485719e-11
disease O 0 1.1964595614699647e-05
due O 0 9.966474173728201e-11
to O 0 2.6895166649332225e-10
BRCA1 O 0 2.1810003545397194e-06
that O 0 4.1272793516178297e-10
were O 0 3.9189523848293106e-10
tested O 0 6.623764314817038e-10
by O 0 8.99200080172434e-14
one O 0 1.387125874233175e-12
of O 0 1.7095669362565333e-14
the O 0 2.1697768771587397e-14
standard O 0 2.518687732336322e-12
screening O 0 3.2243400657772092e-12
methods O 0 5.472686106372526e-12
, O 0 1.1700141994575725e-13
mutations O 0 5.977483698987873e-12
were O 0 2.0228270013883387e-12
detected O 0 1.4218928257037078e-09
in O 0 2.48565165845982e-13
the O 0 8.842859712705764e-13
coding O 0 5.583912887630049e-09
sequence O 0 8.042195798196872e-10
or O 0 5.006108028116074e-11
splice O 0 6.288757070649353e-09
sites O 0 2.8415259034630935e-09
in O 0 2.3839353342942904e-13
an O 0 3.75698604171415e-13
estimated O 0 5.028599758816199e-10
63 O 0 1.190374465664945e-09
% O 0 3.0734080645050676e-12
( O 0 1.94871289244114e-12
95 O 0 1.6414309911283453e-09
% O 0 5.055958082755829e-11
CI O 0 2.750629573711194e-05
51 O 0 1.574720585040268e-07
% O 0 3.141492066482954e-10
- O 0 1.6955271348706447e-05
77 O 0 1.1162656576857444e-08
% O 0 1.3252550098985516e-11
) O 0 2.7127038462748665e-11
. O 0 4.422404387138812e-10

The O 0 3.196846259934105e-11
estimated O 0 2.8150698438977884e-10
sensitivity O 0 9.968137426596968e-09
was O 0 5.855418816480551e-09
identical O 0 6.293925935985101e-10
for O 0 8.407115064876236e-14
direct O 0 3.762481212005175e-12
sequencing O 0 9.552653112976373e-11
and O 0 1.7630634799314926e-11
other O 0 4.981272013794558e-13
techniques O 0 1.6150432102790546e-09
. O 0 5.340138886644752e-10

The O 0 1.0659524374290186e-09
penetrance O 0 5.090315426059533e-06
of O 0 1.6116073753291715e-11
BRCA2 O 0 1.177053761125535e-07
was O 0 5.744703601706647e-10
estimated O 0 8.877359958248121e-11
by O 0 1.7655461511181803e-12
maximizing O 0 5.5927174003045366e-09
the O 0 1.00332110675172e-10
LOD O 0 0.00030333237373270094
score O 0 4.665676733850432e-09
in O 0 3.732547951273979e-11
BRCA2 O 0 3.639502779151371e-07
- O 0 7.381122912875071e-08
mutation O 0 2.6612836379058535e-09
families O 0 3.9175756388898364e-11
, O 0 2.4052931955204082e-12
over O 0 1.191286930213309e-10
all O 0 5.520147533522035e-11
possible O 0 5.807093028664667e-09
penetrance O 0 1.4027992847331916e-06
functions O 0 8.98107010982585e-09
. O 0 3.2673279637407404e-09

The O 0 4.3205092281617397e-11
estimated O 0 1.8114416633352448e-09
cumulative O 0 1.0785143444991263e-07
risk O 0 1.5501575489906827e-06
of O 0 1.0714330117567172e-10
breast B-Disease 1 0.9640099406242371
cancer I-Disease 0 0.08665373176336288
reached O 0 5.680255412698898e-07
28 O 0 3.0705533671238072e-09
% O 0 1.3339712147397709e-11
( O 0 7.348449106159283e-12
95 O 0 1.1809448530186728e-08
% O 0 2.1154795970534934e-10
CI O 0 2.3606677132193e-05
9 O 0 2.10070805195528e-09
% O 0 6.71385308459449e-11
- O 0 2.147969780708081e-06
44 O 0 2.3078178257307513e-10
% O 0 1.9158599132065163e-13
) O 0 2.5734224660630724e-14
by O 0 1.2125727939099606e-13
age O 0 1.4973461706646596e-11
50 O 0 3.592622943929258e-12
years O 0 7.99073264154404e-13
and O 0 2.5085001350427794e-12
84 O 0 1.1550593814746435e-11
% O 0 1.8315116946925752e-13
( O 0 3.816368336802267e-13
95 O 0 8.294444575618343e-10
% O 0 4.784749332853444e-11
CI O 0 1.8110474684362998e-06
43 O 0 2.7704922800353415e-09
% O 0 2.031081899889209e-11
- O 0 8.240583611041075e-07
95 O 0 1.1474088346119515e-08
% O 0 2.4386456395908418e-12
) O 0 2.600929183398798e-13
by O 0 4.546684209683072e-12
age O 0 8.104421578281062e-10
70 O 0 4.430011080192031e-10
years O 0 1.1308841363355526e-10
. O 0 4.0034944803757355e-10

The O 0 4.117164209560542e-08
corresponding O 0 0.22702214121818542
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 7.87468088674359e-05
were O 0 1.5225207761204729e-09
0 O 0 5.121543744657231e-10
. O 0 2.945828470046763e-09

4 O 0 7.490937647958162e-09
% O 0 8.970720694057022e-11
( O 0 5.526834632313404e-12
95 O 0 2.0748089912814294e-09
% O 0 9.645201304309126e-11
CI O 0 3.537348675308749e-05
0 O 0 1.6777967903891522e-10
% O 0 4.5282003841018437e-11
- O 0 1.2672802540691919e-06
1 O 0 1.1729848863051284e-11
% O 0 1.2722907850957338e-13
) O 0 2.7935727665048642e-14
by O 0 1.9412554517431874e-13
age O 0 1.848961435346741e-11
50 O 0 5.734778971144827e-12
years O 0 1.5100538007517539e-12
and O 0 3.317959405488291e-12
27 O 0 1.0087143793857667e-11
% O 0 5.047433418491412e-14
( O 0 9.912750009938645e-14
95 O 0 1.0346093426427672e-10
% O 0 1.0534181166255152e-11
CI O 0 6.581844331776665e-07
0 O 0 7.936695745058842e-11
% O 0 6.54670415101144e-11
- O 0 1.1161366728629218e-06
47 O 0 3.822014260634887e-09
% O 0 1.1636585792174081e-12
) O 0 1.6982677200280683e-13
by O 0 2.1143076438939756e-12
age O 0 5.709943629028658e-10
70 O 0 3.587053154507913e-10
years O 0 1.8543271085302848e-10
. O 0 6.20176243693038e-10

The O 0 7.622640296744976e-10
lifetime O 0 2.986398683901825e-08
risk O 0 4.070743386819231e-07
of O 0 9.318950472403387e-11
breast B-Disease 1 0.8258511424064636
cancer I-Disease 0 0.0001315538538619876
appears O 0 5.594541718778601e-09
similar O 0 9.667689565562299e-11
to O 0 1.2766237719730178e-11
the O 0 2.1269404640311684e-11
risk O 0 1.697718232662737e-08
in O 0 3.941113928263018e-12
BRCA1 O 0 3.434460182916155e-08
carriers O 0 2.2677262845327562e-10
, O 0 3.486103549929509e-12
but O 0 3.782469563257118e-12
there O 0 4.880709118110227e-12
was O 0 4.2110169518050355e-11
some O 0 1.3830143898597297e-13
suggestion O 0 2.481466594705939e-11
of O 0 9.333897180554065e-14
a O 0 5.387143856006027e-11
lower O 0 5.012677384286235e-09
risk O 0 1.2685598349548854e-08
in O 0 9.180035204225945e-12
BRCA2 O 0 9.499356679043558e-08
carriers O 0 3.768036160867183e-10
< O 0 1.8930998990640546e-08
50 O 0 6.912695971195149e-10
years O 0 4.313798276922576e-11
of O 0 5.084222539503136e-12
age O 0 7.147166858345599e-09
. O 0 1.628346790738533e-09

Eye B-Disease 0 0.016553791239857674
movement I-Disease 0 1.405688362865476e-05
abnormalities I-Disease 1 0.9418879151344299
correlate O 0 1.1601935057115043e-06
with O 0 3.752623212172068e-10
genotype O 0 8.90521641849773e-06
in O 0 1.7691051956703063e-09
autosomal O 1 0.9999690055847168
dominant O 1 0.9966811537742615
cerebellar B-Disease 1 0.9996819496154785
ataxia I-Disease 1 0.999996542930603
type I-Disease 1 0.999990701675415
I I-Disease 1 0.9962792992591858
. O 0 7.108830146762557e-08

We O 0 4.27334185815198e-08
compared O 0 1.8424023195962036e-08
horizontal O 0 1.492404226155486e-05
eye O 1 0.6314908266067505
movements O 0 0.0021794340573251247
( O 0 1.7867013424321954e-09
visually O 0 3.132126096261345e-07
guided O 0 5.376046274818691e-08
saccades O 0 2.0347802092146594e-06
, O 0 5.674221509321953e-11
antisaccades O 0 2.1642863501369902e-08
, O 0 1.2762975572233604e-11
and O 0 7.552630396090443e-12
smooth O 0 1.779373270949236e-08
pursuit O 0 1.5753043314248316e-08
) O 0 7.462717943607089e-12
in O 0 8.651816242599697e-13
control O 0 4.44745573702221e-08
subjects O 0 1.8183831329565692e-08
( O 0 1.933932528008775e-11
n O 0 1.1560263146748184e-06
= O 0 3.493778777396983e-08
14 O 0 3.6051661655989165e-11
) O 0 1.3760213671623611e-12
and O 0 1.2665585594207052e-11
patients O 0 9.010998544556337e-12
with O 0 8.857760309738047e-14
three O 0 4.010955792759646e-13
forms O 0 3.6826510591003725e-11
of O 0 1.348761553832123e-11
autosomal O 1 0.8849775195121765
dominant O 0 0.00031063862843438983
cerebellar B-Disease 0 5.474880526890047e-05
ataxias I-Disease 0 0.0001221498823724687
type I-Disease 0 0.12345313280820847
I I-Disease 0 0.0002597066340968013
spinocerebellar B-Disease 1 0.9371886849403381
ataxias I-Disease 0 2.7518677597981878e-05
1 I-Disease 0 5.688810533754918e-10
and I-Disease 0 3.258482650370098e-10
2 I-Disease 0 3.9410780194870654e-11
( O 0 3.6278237358633447e-12
SCA1 B-Disease 0 6.197050765877066e-07
, O 0 5.898118798919327e-11
n O 0 1.813247507698179e-07
= O 0 4.650095775105001e-08
11 O 0 5.256953553023358e-11
; O 0 1.0671143873056121e-12
SCA2 B-Disease 0 5.337344077815942e-08
, O 0 2.876159033160519e-11
n O 0 3.8396983370603266e-08
= O 0 1.6028119276256803e-08
10 O 0 2.6674299921647382e-11
) O 0 2.9088953468203727e-12
and O 0 2.6034843725319945e-10
SCA3 B-Disease 1 0.9999998807907104
/ O 0 0.0013260676059871912
Machado B-Disease 0 2.836568171460385e-07
- I-Disease 0 1.8659378838492557e-05
Joseph I-Disease 0 7.133950816751167e-07
disease I-Disease 0 5.131145007908344e-05
( O 0 1.9680938823096739e-10
MJD B-Disease 1 0.9999986886978149
) O 0 3.165702144869442e-10
( O 0 3.725435585022474e-11
n O 0 5.201675890020852e-07
= O 0 2.657816082773934e-07
16 O 0 3.118608427055136e-10
) O 0 2.5426981700715778e-11
. O 0 1.4997335318067684e-10

In O 0 1.3176320035057643e-09
SCA1 B-Disease 0 3.917865853964031e-07
, O 0 1.1497401988802558e-11
saccade O 0 1.0724605203904503e-08
amplitude O 0 2.2376159258818973e-10
was O 0 6.473666741557693e-11
significantly O 0 2.4864792516621215e-11
increased O 0 3.215375188325709e-11
, O 0 4.000437134332735e-12
resulting O 0 4.2400957744881396e-11
in O 0 5.596980517941219e-11
hypermetria B-Disease 0 2.480979856045451e-05
. O 0 1.7408748220759662e-08

The O 0 1.6083562259794348e-10
smooth O 0 1.6942763636507152e-08
pursuit O 0 4.753220395059543e-08
gain O 0 2.514526542540807e-08
was O 0 8.112393601322765e-08
decreased O 0 1.6868074226294993e-06
. O 0 2.0342902917747097e-09

In O 0 4.097998829166727e-09
SCA2 B-Disease 0 3.5748423670156626e-06
, O 0 1.3405065946159311e-10
saccade O 0 1.3600090653653751e-07
velocity O 0 1.339173927306092e-08
was O 0 8.913814575350898e-09
markedly O 0 1.760865728783756e-07
decreased O 0 2.3538929383448703e-07
. O 0 2.256461906213758e-09

The O 0 3.8564582083289167e-10
percentage O 0 3.42876393943925e-09
of O 0 9.78178909399885e-13
errors O 0 2.4503803430775406e-09
in O 0 1.2525185966519303e-12
antisaccades O 0 3.035233575587881e-08
was O 0 1.0296011959676221e-10
greatly O 0 2.478368552050192e-11
increased O 0 1.0151033486005545e-10
and O 0 1.2596395281005979e-11
was O 0 1.351138784189132e-10
significantly O 0 1.109772690410793e-10
correlated O 0 1.8558202197205276e-10
with O 0 8.103732962450039e-12
age O 0 3.3234874852183793e-09
at O 0 4.050304269753724e-08
disease O 0 0.0001194360593217425
onset O 0 6.867979209346231e-06
. O 0 2.357875672487353e-08

In O 0 8.982928983991556e-11
addition O 0 1.8668604856442172e-11
, O 0 1.6541635682737477e-12
a O 0 9.360537518710021e-13
correlation O 0 2.3837204432552994e-10
between O 0 1.6631364688213246e-11
smooth O 0 5.539858420888777e-07
pursuit O 0 1.4940226833459747e-07
gain O 0 4.969147582301048e-08
and O 0 3.861257147352859e-10
the O 0 1.0200204396404455e-12
number O 0 2.428602111081979e-11
of O 0 1.5590997460082634e-12
trinucleotide O 0 7.966401085468533e-07
repeats O 0 6.629893505305517e-07
was O 0 4.553894594749863e-09
found O 0 2.748296312748977e-10
. O 0 2.079720839986976e-10

In O 0 1.3985040681063765e-08
SCA3 B-Disease 1 0.9999985694885254
, O 0 1.1262100585440749e-08
gaze B-Disease 0 1.2110882380511612e-05
- I-Disease 0 7.230175833683461e-05
evoked I-Disease 0 1.1121194347651908e-06
nystagmus I-Disease 0 2.3685690393904224e-05
was O 0 2.569495505255759e-09
often O 0 1.0293180370546384e-11
present O 0 9.74384462004707e-12
as O 0 2.626339467085015e-12
was O 0 9.756792596071762e-11
saccade O 0 3.125483516441818e-08
hypometria O 0 2.259655218495027e-07
and O 0 1.3777036456108505e-10
smooth O 0 1.4821777583051698e-08
pursuit O 0 2.962005751783181e-08
gain O 0 1.883235967170549e-08
was O 0 5.646591461072603e-08
markedly O 0 1.5895977867330657e-06
decreased O 0 2.8444558211049298e-06
. O 0 5.10453768143293e-09

Three O 0 5.899317923052649e-09
major O 0 2.4529100972614515e-09
criteria O 0 2.724247216701059e-10
, O 0 4.213151962723094e-12
saccade O 0 1.0945645279036853e-08
amplitude O 0 2.534381038366007e-10
, O 0 1.4687348559583313e-11
saccade O 0 1.0912771131188492e-08
velocity O 0 1.4942577175602878e-09
, O 0 9.851803400851011e-12
and O 0 3.1416325704108905e-12
presence O 0 1.9138249318650935e-10
of O 0 2.1822303079149785e-12
gaze B-Disease 0 1.1402829841244966e-05
- I-Disease 0 3.461035157670267e-05
evoked I-Disease 0 4.3581084696597827e-07
nystagmus I-Disease 0 1.5559426174149849e-06
, O 0 6.174939466002671e-12
permitted O 0 1.861867951480356e-11
the O 0 8.004731724469902e-14
correct O 0 1.1954164325089778e-09
assignment O 0 1.8717862815265107e-09
of O 0 3.4240383965655763e-13
90 O 0 2.2134322152922437e-11
% O 0 3.355679449590365e-13
of O 0 3.5669397665562264e-14
the O 0 1.1677184826724973e-12
SCA1 B-Disease 0 6.993306556069001e-08
, O 0 5.336193292793112e-12
90 O 0 9.985991200611721e-12
% O 0 1.462962780432453e-13
of O 0 2.98006824566658e-14
the O 0 1.245269946187344e-12
SCA2 B-Disease 0 2.002207111218013e-07
, O 0 1.7033787574893822e-11
and O 0 4.560354698035507e-12
93 O 0 3.6030948190324263e-12
% O 0 5.82991771178043e-14
of O 0 1.170850678374304e-14
the O 0 4.134460569044096e-12
patients O 0 3.067607556861418e-10
with O 0 1.1407368105675886e-10
SCA3 B-Disease 1 1.0
to O 0 2.2165172475219208e-10
their O 0 5.563514492851196e-12
genetically O 0 3.3250710518295534e-10
confirmed O 0 3.9180594768595256e-08
patient O 0 6.876224034613188e-08
group O 0 1.8288265346555477e-10
and O 0 1.5535621400442068e-10
, O 0 6.29185462411308e-12
therefore O 0 4.36087624344772e-12
, O 0 2.797879115890023e-12
may O 0 8.042325486123936e-12
help O 0 2.2194225623994868e-11
orient O 0 8.03817601990886e-06
diagnoses O 0 3.406010728213005e-05
of O 0 3.726075004095719e-11
SCA1 B-Disease 0 9.956215762940701e-06
, O 0 7.499049992087947e-11
SCA2 B-Disease 0 1.0593701915695419e-07
, O 0 1.755801407044011e-11
and O 0 1.6594711715889332e-10
SCA3 B-Disease 1 0.9999996423721313
at O 0 5.138101499824188e-09
early O 0 3.8411815395100746e-10
clinical O 0 3.93828702982546e-09
stages O 0 1.6542883729542268e-10
of O 0 6.288096128861942e-13
the O 0 4.6676124770828054e-11
diseases O 0 1.8272423858434195e-06
. O 0 2.394290841978286e-11
. O 0 1.5157523014508456e-09

Genetic O 0 3.341015712976514e-07
basis O 0 1.381380121401321e-09
and O 0 1.4648908822079143e-11
molecular O 0 1.7578574151855264e-09
mechanism O 0 6.765048965462483e-08
for O 0 3.677910953570063e-08
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 0.9999972581863403
fibrillation I-Disease 1 1.0
. O 0 0.0006317251827567816

Ventricular B-Disease 0 0.09872730076313019
fibrillation I-Disease 0 0.019455693662166595
causes O 0 1.1138585875869467e-07
more O 0 3.998653838599431e-11
than O 0 2.9069722323749048e-11
300 O 0 1.503330654406554e-10
, O 0 3.0057247923237496e-12
000 O 0 9.239078946343682e-11
sudden O 0 7.867039242270835e-10
deaths O 0 3.425484251806665e-08
each O 0 1.1401815255829284e-11
year O 0 8.79689238120207e-11
in O 0 3.426666502631681e-12
the O 0 8.916725864616115e-12
USA O 0 5.4143882266544097e-08
alone O 0 4.3463700194479316e-08
. O 0 1.005657113140046e-09

In O 0 1.743105798590605e-10
approximately O 0 5.014080262100151e-10
5 O 0 4.112843399184385e-10
- O 0 5.538017376238713e-06
12 O 0 7.203105473196914e-11
% O 0 1.222463021652645e-13
of O 0 2.7174007029208847e-15
these O 0 3.021196032064466e-13
cases O 0 5.115271053957038e-12
, O 0 1.7750468521253449e-13
there O 0 3.1221286406896143e-12
are O 0 1.0127082549285515e-12
no O 0 2.0990809090903895e-10
demonstrable O 0 8.948789036367089e-05
cardiac O 0 0.0006124716601334512
or O 0 1.7859738932202163e-07
non O 0 1.735562545945868e-05
- O 0 0.4863734245300293
cardiac O 1 0.6914049386978149
causes O 0 8.658573591446839e-08
to O 0 1.3831009948450657e-10
account O 0 2.7341391373170154e-09
for O 0 2.849603148932789e-12
the O 0 4.81484589611586e-13
episode O 0 2.288331302224833e-09
, O 0 5.933727467710703e-12
which O 0 2.2526227844849034e-12
is O 0 2.378132413216605e-12
therefore O 0 7.2622277115519385e-12
classified O 0 3.3900217744076144e-08
as O 0 7.099900045659524e-08
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 0.9999918937683105
fibrillation I-Disease 1 1.0
( O 0 0.00020503700943663716
IVF B-Disease 1 0.9999997615814209
) O 0 1.1788488762931593e-07
. O 0 4.349081450527592e-08

A O 0 2.583776970155327e-09
distinct O 0 1.222129203393152e-10
group O 0 4.82731042639184e-11
of O 0 2.445203761691772e-12
IVF B-Disease 1 1.0
patients O 0 1.4103285366218188e-06
has O 0 4.54602938626536e-10
been O 0 4.053683083649062e-11
found O 0 5.024884154603004e-12
to O 0 4.224310246221663e-13
present O 0 1.2278810780641525e-11
with O 0 1.9284248677087223e-12
a O 0 5.359206481370116e-11
characteristic O 0 1.7060997947737633e-08
electrocardiographic O 0 2.6330969831178663e-06
pattern O 0 3.2909576930251205e-06
. O 0 9.590050531471661e-09

Because O 0 1.5168223344019793e-09
of O 0 4.187672886409033e-13
the O 0 2.89006313455506e-13
small O 0 6.697095135399511e-12
size O 0 2.398378162737913e-10
of O 0 2.1467747826804662e-13
most O 0 8.051842179113144e-12
pedigrees O 0 1.1540789657260575e-08
and O 0 1.9885289595511502e-11
the O 0 6.492505101249324e-13
high O 0 3.8099373655953173e-10
incidence O 0 1.0250660125166178e-06
of O 0 1.4069423794407787e-12
sudden B-Disease 0 5.99363829678623e-08
death I-Disease 0 2.8625468218024253e-08
, O 0 1.2895282064384617e-11
however O 0 8.015338609848599e-13
, O 0 8.699036499817958e-14
molecular O 0 7.657981779089773e-13
genetic O 0 4.2731561344933056e-11
studies O 0 2.771952155658508e-12
of O 0 2.5865442600248034e-12
IVF B-Disease 1 0.9999997615814209
have O 0 4.5922905478335e-09
not O 0 4.4994105663498374e-11
yet O 0 1.9486471464214006e-11
been O 0 3.620857433328517e-11
done O 0 2.4928354935838115e-09
. O 0 8.347911251149753e-11

Because O 0 6.786786599377592e-08
IVF B-Disease 1 0.9999889135360718
causes O 0 5.6181938816735055e-06
cardiac O 0 0.0003634918248280883
rhythm O 0 0.0014036308275535703
disturbance O 0 0.00011169652862008661
, O 0 1.489135759147331e-10
we O 0 5.492830149056438e-11
investigated O 0 2.3977059226965025e-10
whether O 0 4.181818433202089e-11
malfunction O 0 7.890893698458967e-07
of O 0 1.0387229271158205e-12
ion O 0 5.967778093918241e-08
channels O 0 2.9525858735723887e-06
could O 0 5.4120345538422043e-08
cause O 0 2.1117072535048464e-09
the O 0 2.9069431323885953e-12
disorder O 0 6.790955922042485e-07
by O 0 7.424646970366836e-14
studying O 0 1.9527993805334987e-11
mutations O 0 2.371765839281892e-10
in O 0 6.625396303631959e-13
the O 0 6.309436480222974e-12
cardiac O 0 2.3267466531251557e-07
sodium O 0 1.358082624136614e-08
channel O 0 7.52618097976665e-06
gene O 0 7.057167749735527e-06
SCN5A O 0 3.7962308852002025e-05
. O 0 3.5252732288881816e-08

We O 0 7.156431536259333e-08
have O 0 3.1614526968537504e-11
now O 0 1.9524716912688866e-11
identified O 0 8.402126910889152e-11
a O 0 3.3282528209138684e-12
missense O 0 4.677181664192176e-07
mutation O 0 1.3993518566124408e-09
, O 0 2.2154795359385915e-12
a O 0 9.461167960189698e-12
splice O 0 1.4914894563844427e-05
- O 0 5.0327203098277096e-06
donor O 0 4.13379686037274e-09
mutation O 0 4.7633279542935725e-09
, O 0 3.558213793053433e-11
and O 0 1.570903303271809e-11
a O 0 4.844780479573707e-11
frameshift O 0 2.2132849153422285e-06
mutation O 0 1.3488375971704158e-09
in O 0 3.328684550218952e-12
the O 0 1.6596846509966956e-12
coding O 0 3.110906376946332e-08
region O 0 9.120305066723233e-10
of O 0 1.6197761448094594e-12
SCN5A O 0 1.3778069387626601e-06
in O 0 1.5089315213989707e-11
three O 0 2.1689702811578115e-10
IVF B-Disease 1 0.9999972581863403
families O 0 7.252756173414809e-09
. O 0 5.310125117397035e-10

We O 0 2.87352430738963e-09
show O 0 7.741616236955906e-10
that O 0 5.64210950095706e-13
sodium O 0 5.172489173088657e-12
channels O 0 2.3722407371806753e-10
with O 0 1.3279414460415362e-12
the O 0 1.6348639022417677e-12
missense O 0 2.9941216439510754e-07
mutation O 0 1.4538000803199225e-09
recover O 0 2.2572195224057623e-09
from O 0 1.1055882771782155e-12
inactivation O 0 2.577065139064416e-08
more O 0 5.973699833405899e-12
rapidly O 0 7.263630669163135e-11
than O 0 3.6392798496986956e-12
normal O 0 2.4834614920088427e-10
and O 0 1.2845521521476222e-11
that O 0 1.5276351147605616e-12
the O 0 5.357310732187481e-13
frameshift O 0 9.373205216434144e-07
mutation O 0 2.2407679878266862e-10
causes O 0 1.0519624234206493e-11
the O 0 3.1861416716766344e-13
sodium O 0 5.213099743550664e-11
channel O 0 2.5124123226305528e-08
to O 0 4.720392410284546e-10
be O 0 8.499243531190359e-10
non O 0 3.002852855260585e-09
- O 0 6.065284310352581e-07
functional O 0 5.487257226377551e-08
. O 0 1.3709151591712043e-09

Our O 0 1.7070242108729872e-08
results O 0 9.84519549218632e-11
indicate O 0 1.236573066165647e-10
that O 0 6.710466058691689e-13
mutations O 0 5.452624463053724e-10
in O 0 9.070156192954315e-13
cardiac O 0 8.968046927293472e-08
ion O 0 6.895648425597756e-07
- O 0 6.163661601021886e-05
channel O 0 4.895094207313377e-06
genes O 0 2.5150337368273767e-09
contribute O 0 4.037478684715268e-11
to O 0 9.709665797080769e-13
the O 0 4.3090327855356547e-13
risk O 0 9.058150063356862e-11
of O 0 8.424547680557087e-14
developing O 0 1.9878636514647496e-09
IVF B-Disease 1 0.9999853372573853
. O 0 3.11391301632824e-10
. O 0 6.39710229233259e-10

Molecular O 0 7.367493992660457e-08
heterogeneity O 0 5.617909337729543e-08
in O 0 3.192082986824829e-10
mucopolysaccharidosis B-Disease 0 0.0001807795197237283
IVA I-Disease 0 0.014050719328224659
in O 0 7.413878955198072e-10
Australia O 0 3.421340988296606e-10
and O 0 1.069795294017517e-10
Northern O 0 2.723418823791235e-08
Ireland O 0 1.1543872524555354e-08
: O 0 6.971997198318425e-12
nine O 0 9.37050458928168e-13
novel O 0 3.4085904671715683e-12
mutations O 0 2.376360566658242e-11
including O 0 4.4442051492891987e-13
T312S O 0 1.6538380664954389e-09
, O 0 3.789344272392414e-12
a O 0 1.189190347757052e-12
common O 0 3.5118440273873563e-12
allele O 0 8.149980135208068e-10
that O 0 6.320168347007105e-12
confers O 0 1.8310473137717054e-09
a O 0 7.027665116510207e-10
mild O 0 5.282076472212793e-06
phenotype O 0 5.253731615084689e-06
. O 0 3.426752215318629e-08

Mucopolysaccharidosis B-Disease 0 0.13524430990219116
IVA I-Disease 1 0.9973884224891663
( O 0 6.729459710186347e-05
MPS B-Disease 1 0.9999995231628418
IVA I-Disease 1 0.9999998807907104
) O 0 3.837631989966894e-09
is O 0 1.114784153877224e-09
an O 0 2.3359763012820167e-09
autosomal B-Disease 1 0.9999992847442627
recessive I-Disease 1 0.9999990463256836
lysosomal I-Disease 1 0.9999985694885254
storage I-Disease 1 0.9999582767486572
disorder I-Disease 1 0.9999874830245972
caused O 0 5.416401904767554e-07
by O 0 5.278578685263824e-10
a O 0 1.7094930626626592e-07
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 3.982179919148621e-09
N O 0 0.0005564920720644295
- O 0 7.599971286254004e-05
acetylgalactosamine O 0 0.0022397299762815237
- O 0 0.00029598307446576655
6 O 0 1.195282539612208e-08
- O 0 1.5941590390866622e-05
sulfate O 0 2.1258704236970516e-06
sulfatase O 0 3.656386525108246e-06
( O 0 1.0767164243530303e-10
GALNS O 0 2.2063633764446422e-07
) O 0 1.277301459046143e-10
. O 0 3.106521428986042e-10

Previous O 0 6.7903194178597914e-09
studies O 0 1.4128087588716198e-10
of O 0 1.4114605751541776e-12
patients O 0 5.1622806723772285e-11
from O 0 2.434452379268537e-13
a O 0 4.5356343680857947e-11
British O 0 3.075460952572939e-08
- O 0 2.80067229141423e-06
Irish O 0 5.117032353396667e-10
population O 0 1.4992951324899195e-11
showed O 0 9.092223862694482e-09
that O 0 5.209278104365e-13
the O 0 1.7733876501069452e-14
I113F O 0 1.412377714782309e-10
mutation O 0 1.0792304550033549e-11
is O 0 1.5401620408715677e-13
the O 0 4.4549109172941585e-15
most O 0 5.974833529407558e-14
common O 0 3.3595923352308654e-13
single O 0 1.7847955752214872e-11
mutation O 0 6.3785741133415286e-09
among O 0 4.938192521564133e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 0.0001193367934320122
and O 0 5.173816375325657e-10
produces O 0 8.38308906736529e-08
a O 0 3.857651975636145e-09
severe O 0 6.718551958329044e-06
clinical O 0 1.4862365560475155e-06
phenotype O 0 2.27837390411878e-05
. O 0 4.2810267331105933e-08

We O 0 4.921886898046068e-09
studied O 0 1.2584586150943267e-10
mutations O 0 2.108430235958636e-10
in O 0 3.7545219212266334e-13
the O 0 2.8403120784156743e-13
GALNS O 0 5.6346927124195645e-08
gene O 0 1.9124830608063803e-09
from O 0 1.3174747751087956e-11
23 O 0 6.791494033819845e-10
additional O 0 6.51687486197261e-08
MPS B-Disease 1 0.9999998807907104
IVA I-Disease 1 1.0
patients O 0 1.943511415447574e-05
( O 0 2.9088582237379867e-11
15 O 0 6.055658058334856e-11
from O 0 1.7624776421296118e-12
Australia O 0 2.1460645760473795e-11
, O 0 2.5435213830971026e-12
8 O 0 2.4144540533566072e-12
from O 0 3.7777382133966086e-13
Northern O 0 3.795264658101871e-10
Ireland O 0 5.542450873252669e-11
) O 0 2.0644819404350145e-13
, O 0 5.649202893670546e-14
with O 0 1.0724388330239209e-14
various O 0 5.939589640437115e-13
clinical O 0 2.921872743755216e-09
phenotypes O 0 7.3406156708699655e-09
( O 0 6.88196097331506e-11
severe O 0 9.372776617055933e-07
, O 0 3.138748982944861e-10
16 O 0 1.2076652178283354e-10
cases O 0 9.694390429304534e-11
; O 0 3.2675348971694662e-12
intermediate O 0 5.407517142397289e-11
, O 0 1.5528118721408468e-11
4 O 0 1.7187602036061733e-11
cases O 0 6.514035977289723e-10
; O 0 3.1286656598794593e-10
mild O 0 4.201029696559999e-06
, O 0 4.903444317250205e-10
3 O 0 9.408768902874343e-11
cases O 0 9.300346603957621e-10
) O 0 4.1643177794981057e-10
. O 0 3.937265180553595e-09

We O 0 4.7434301819748725e-08
found O 0 4.264484598781593e-11
two O 0 1.317584144002945e-13
common O 0 4.0116442611391745e-13
mutations O 0 2.8971857898851816e-11
that O 0 8.159594961504313e-13
together O 0 2.5443655429086e-12
accounted O 0 1.5989156665341397e-08
for O 0 1.1686437408064965e-11
32 O 0 2.62000282580388e-10
% O 0 1.1566020493777862e-12
of O 0 2.9736421116276224e-13
the O 0 1.0885957933692847e-11
44 O 0 9.266097611426716e-11
unrelated O 0 2.2396740018137962e-10
alleles O 0 1.0962578067541529e-10
in O 0 3.933956892882007e-12
these O 0 7.994536282973641e-11
patients O 0 8.46751280203506e-10
. O 0 3.129984604832714e-10

One O 0 5.720648399432093e-10
is O 0 2.4899960565649693e-11
the O 0 7.598502990008305e-13
T312S O 0 1.3490003780702864e-08
mutation O 0 2.1232582358976515e-09
, O 0 3.661189840881152e-12
a O 0 1.0937922659617905e-12
novel O 0 5.5655976355373227e-11
mutation O 0 2.4390528485795926e-10
found O 0 6.9390300797000926e-12
exclusively O 0 6.312205098890633e-12
in O 0 3.0536346021237115e-12
milder O 0 2.1824517659752019e-07
patients O 0 2.786822506095632e-08
. O 0 2.2546335909368054e-09

The O 0 7.791206568796838e-11
other O 0 2.0459766693348147e-12
is O 0 4.029698883606381e-12
the O 0 1.7184796879780861e-13
previously O 0 2.5637908462883274e-10
described O 0 2.014574729258811e-09
I113F O 0 5.575814032710014e-09
that O 0 6.326994917565942e-12
produces O 0 5.913328715578814e-10
a O 0 1.7647465433423548e-10
severe O 0 3.721450241300772e-07
phenotype O 0 3.7571999200736172e-06
. O 0 3.609788379321799e-08

The O 0 1.952104033975388e-10
I113F O 0 1.3730412717904983e-07
and O 0 6.153919734908087e-11
T312S O 0 4.72026906450651e-09
mutations O 0 1.4629266686938536e-09
accounted O 0 1.1125989907156963e-08
for O 0 7.725029817218232e-12
8 O 0 5.41667335984819e-11
( O 0 3.0350593999833864e-12
18 O 0 2.32764904573024e-10
% O 0 1.4102980935848386e-12
) O 0 4.139937091057755e-12
and O 0 3.309190421685315e-10
6 O 0 2.232354405495851e-11
( O 0 5.613824292580172e-13
14 O 0 5.1491107384837864e-12
% O 0 4.677461624405174e-14
) O 0 3.123221557137061e-14
of O 0 9.325515620134395e-14
44 O 0 2.148231072196527e-11
unrelated O 0 2.2879328986924463e-10
alleles O 0 4.3696732343612155e-10
, O 0 1.1587959064529585e-10
respectively O 0 1.3361014516988234e-09
. O 0 4.673139653021963e-09

The O 0 4.896630878548081e-10
relatively O 0 5.935703040194085e-10
high O 0 5.511387457524108e-10
residual O 0 9.051012028749028e-08
GALNS O 0 1.3824636653225753e-06
activity O 0 5.938098368574174e-08
seen O 0 1.4331789088828373e-09
when O 0 7.05042469718864e-13
the O 0 7.472481970216896e-14
T312S O 0 1.406989386110169e-10
mutant O 0 2.0636228836856674e-10
cDNA O 0 5.313255391214966e-10
is O 0 6.98223119946495e-12
overexpressed O 0 6.03988414837886e-09
in O 0 1.5225583922980068e-13
mutant O 0 1.937434435106411e-09
cells O 0 3.770413842252296e-11
provides O 0 1.118697474065955e-12
an O 0 8.24579594600576e-14
explanation O 0 1.0601543948274283e-11
for O 0 2.5594203405948646e-12
the O 0 1.964462620351881e-11
mild O 0 2.0031734493386466e-07
phenotype O 0 5.947563508357234e-08
in O 0 5.6384979151002934e-12
patients O 0 4.008558415757868e-11
with O 0 1.904216530550923e-13
this O 0 6.749763074853643e-12
mutation O 0 1.2564787432722824e-08
. O 0 1.966886431503667e-09

The O 0 5.2217577484192645e-11
distribution O 0 9.40319377917831e-10
and O 0 3.895881880988661e-12
relative O 0 8.954031960328734e-12
frequencies O 0 2.0661227936868976e-11
of O 0 1.3184890462411558e-13
the O 0 9.228115233766987e-13
I113F O 0 3.42870487557434e-09
and O 0 8.725500356965288e-12
T312S O 0 8.880514656972593e-10
mutations O 0 1.4568223016819815e-10
in O 0 5.271949868844439e-13
Australia O 0 9.241378278943002e-13
corresponded O 0 6.487968495783036e-11
to O 0 7.1439219557351e-13
those O 0 2.0370352269132724e-13
observed O 0 3.555418459644244e-11
in O 0 5.68448500076757e-13
Northern O 0 2.1341517442152735e-09
Ireland O 0 1.5507800599223742e-09
and O 0 4.1623305496729657e-11
are O 0 1.3673373685466755e-13
unique O 0 1.1839211251987725e-13
to O 0 2.9928918501495594e-13
these O 0 3.5260984128197836e-13
two O 0 7.094477593285256e-14
populations O 0 1.726730737561244e-12
, O 0 1.989934774035071e-13
suggesting O 0 5.156868335132181e-11
that O 0 3.679531505873523e-12
both O 0 1.9641420109274554e-13
mutations O 0 2.398358595057104e-11
were O 0 1.0392744824450073e-11
probably O 0 1.3433366398418745e-11
introduced O 0 1.3655162070524973e-12
to O 0 4.9378079750028725e-12
Australia O 0 8.435522245997529e-12
by O 0 1.0850007958057573e-12
Irish O 0 2.1721913157080053e-10
migrants O 0 3.420282460031565e-11
during O 0 1.8786553909744264e-11
the O 0 9.993990227399885e-13
19th O 0 2.4311710977720224e-10
century O 0 3.2780018699440916e-09
. O 0 1.608240540740269e-09

Haplotype O 0 7.281950615833921e-07
analysis O 0 8.677213947372309e-10
using O 0 4.745189796651061e-10
6 O 0 1.3007586674440574e-10
RFLPs O 0 2.0302833192431535e-08
provides O 0 1.4179156980487218e-11
additional O 0 2.8769148521790022e-12
data O 0 2.3997051568080963e-10
that O 0 1.978947821584809e-12
the O 0 3.0051387268394125e-13
I113F O 0 6.6432139789185385e-09
mutation O 0 1.6329021468308724e-10
originated O 0 7.636093146690115e-12
from O 0 1.743242865597655e-13
a O 0 2.6492766314056837e-12
common O 0 1.2453726418171218e-11
ancestor O 0 3.5118359331676174e-09
. O 0 4.299239186877912e-09

The O 0 3.4154989947410286e-10
other O 0 4.910517131806458e-11
9 O 0 1.347993383582491e-10
novel O 0 1.916115044409139e-10
mutations O 0 8.402872175850007e-09
identified O 0 4.510413376124234e-09
in O 0 8.092900806964953e-13
these O 0 5.386072664259611e-12
23 O 0 1.1404431565775752e-10
patients O 0 4.572908024469413e-11
were O 0 1.826221812661899e-11
each O 0 1.2490402592421623e-12
limited O 0 2.842961421833934e-10
to O 0 1.9611531149044126e-11
a O 0 1.255638926167535e-10
single O 0 5.165703420573209e-09
family O 0 3.442169713707699e-07
. O 0 6.35899199963319e-09

These O 0 2.712943480975838e-10
data O 0 2.3847665509002525e-10
provide O 0 1.3087090439123372e-11
further O 0 2.4780696158271942e-12
evidence O 0 1.9927854505441545e-11
for O 0 4.217016818207353e-13
extensive O 0 1.011702455144814e-08
allelic O 0 4.0454060012962145e-07
heterogeneity O 0 7.982675924722571e-07
in O 0 5.382705126066867e-08
MPS B-Disease 1 0.9999990463256836
IVA I-Disease 1 1.0
in O 0 2.360754480790206e-09
British O 0 8.082883482529724e-07
- O 0 4.017464380012825e-05
Irish O 0 2.2273731303812383e-08
patients O 0 9.205644579957095e-10
and O 0 6.661013971301366e-13
provide O 0 1.3518179631244465e-12
evidence O 0 2.1091933755101877e-11
for O 0 1.1714685211466902e-12
their O 0 1.164198078218437e-12
transmission O 0 6.029137011864805e-07
to O 0 1.663434667786845e-11
Australia O 0 6.5055985772055624e-12
by O 0 1.4139100047022568e-12
British O 0 1.182976028246685e-08
- O 0 5.378373089115485e-07
Irish O 0 1.7468834712097703e-10
migrants O 0 1.9898948808161343e-11
. O 0 6.665131771152466e-13
. O 0 1.340856245479749e-11

Identification O 0 4.3436600094537425e-08
of O 0 3.127249847967306e-11
constitutional O 0 1.3782719410215805e-09
WT1 O 0 2.9563860152848065e-05
mutations O 0 2.8681597541435622e-08
, O 0 1.1591888039730325e-11
in O 0 1.726964599969849e-12
patients O 0 1.1528458743192971e-10
with O 0 4.381697435440479e-11
isolated O 1 0.7876756191253662
diffuse B-Disease 1 0.9997797608375549
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 2.595621717560448e-09
and O 0 5.697861019809958e-12
analysis O 0 1.9511425461415932e-11
of O 0 1.12733401173154e-12
genotype O 0 9.284435691370163e-07
/ O 0 4.447128958418034e-05
phenotype O 0 6.431351096125582e-08
correlations O 0 8.928408568031898e-10
by O 0 9.053407979894845e-13
use O 0 6.9505542814318755e-12
of O 0 1.8518642023492016e-13
a O 0 5.6680125870567366e-11
computerized O 0 9.007645189740288e-07
mutation O 0 7.899269149902466e-08
database O 0 7.224152653861893e-08
. O 0 3.1865490246474337e-09

Constitutional O 0 1.018230300076084e-08
mutations O 0 2.5577223894401868e-08
of O 0 1.4160015391131986e-12
the O 0 1.033428876327791e-12
WT1 O 0 2.203953215484944e-07
gene O 0 2.118597963729485e-09
, O 0 2.410850815856569e-12
encoding O 0 2.1055155882687693e-11
a O 0 5.283430984381887e-11
zinc O 0 4.467810299502162e-07
- O 0 4.2002986333500303e-07
finger O 0 2.8955939797015162e-06
transcription O 0 6.981601963218509e-09
factor O 0 1.083508699428748e-10
involved O 0 1.6929373181095997e-10
in O 0 4.910910567090809e-11
renal O 0 0.1466105431318283
and O 0 2.1693406182521358e-08
gonadal O 0 0.1948736310005188
development O 0 2.1202806621545278e-08
, O 0 2.958122288787557e-11
are O 0 3.2887169550133155e-13
found O 0 3.439564713776655e-13
in O 0 7.471868718363084e-14
most O 0 1.7955227148841457e-12
patients O 0 2.3068618196231405e-11
with O 0 5.2071576217560533e-11
Denys B-Disease 1 0.9999911785125732
- I-Disease 1 0.9999995231628418
Drash I-Disease 1 0.9999985694885254
syndrome I-Disease 1 0.9999997615814209
( O 0 1.1728368498609143e-08
DDS B-Disease 1 0.9999998807907104
) O 0 7.777150590193571e-10
, O 0 1.1503988733840842e-10
or O 0 2.736326365493369e-08
diffuse B-Disease 1 0.9587229490280151
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 3.945943305438959e-08
DMS B-Disease 0 0.026515275239944458
) O 0 2.7335784677506858e-11
associated O 0 5.738417518941219e-10
with O 0 1.2209967759080342e-10
pseudohermaphroditism B-Disease 1 1.0
and O 0 7.819316465429438e-07
/ O 0 0.09310856461524963
or O 0 3.00137708109105e-06
Wilms B-Disease 1 0.8548471927642822
tumor I-Disease 1 0.8522531986236572
( O 0 7.41231573897494e-08
WT B-Disease 1 0.9999974966049194
) O 0 4.00815736156801e-09
. O 0 3.717234298150629e-09

Most O 0 9.823872826331126e-10
mutations O 0 8.850119570524839e-08
in O 0 1.5694552324418964e-09
DDS B-Disease 1 1.0
patients O 0 4.711691144621e-05
lie O 0 3.4626788192326785e-07
in O 0 5.744905853116711e-12
exon O 0 6.210975289633325e-09
8 O 0 7.639757160227134e-10
or O 0 9.445539489449928e-11
exon O 0 1.1240184338845438e-09
9 O 0 4.473612591482379e-10
, O 0 2.5647027904196484e-12
encoding O 0 2.206911736690742e-10
zinc O 0 5.780485139439406e-07
finger O 0 0.0003960692847613245
2 O 0 5.139804137854753e-10
or O 0 9.740235284994014e-09
zinc O 0 1.7094251234084368e-05
finger O 0 0.025497332215309143
3 O 0 1.1085879436656398e-10
, O 0 1.948543063012842e-11
respectively O 0 2.5483009799542877e-11
, O 0 1.0090588087319219e-11
with O 0 3.48022392154812e-12
a O 0 1.566732854563213e-10
hot O 0 8.355137310900318e-07
spot O 0 3.6192889751873736e-07
( O 0 1.6640407801693513e-11
R394W O 0 1.970784424543126e-09
) O 0 1.6980418807155395e-12
in O 0 1.1163827024276984e-12
exon O 0 9.689371971433047e-09
9 O 0 2.0961863356205868e-08
. O 0 3.8689704773275935e-09

We O 0 5.04073982554587e-09
analyzed O 0 4.296039912699001e-10
a O 0 5.970100282193247e-12
series O 0 9.769940412240885e-11
of O 0 6.169355391133502e-13
24 O 0 6.502082205983584e-10
patients O 0 3.905550327587548e-10
, O 0 8.35700345730439e-12
10 O 0 2.162335414890304e-11
with O 0 9.05018907038091e-11
isolated B-Disease 1 0.5516595244407654
DMS I-Disease 1 0.9995570778846741
( O 0 3.01492636411993e-10
IDMS B-Disease 0 1.2203691994727706e-06
) O 0 1.4148224258825337e-11
, O 0 6.0026757869868774e-12
10 O 0 2.488850488549521e-12
with O 0 7.04537339926703e-12
DDS B-Disease 1 1.0
, O 0 2.2273551891771604e-09
and O 0 1.274318151001097e-10
4 O 0 1.4756003710592047e-11
with O 0 4.514462761950888e-11
urogenital B-Disease 0 0.009143989533185959
abnormalities I-Disease 1 0.9998476505279541
and O 0 2.64200110677848e-07
/ O 1 0.9989751577377319
or O 0 0.02779126912355423
WT B-Disease 1 0.9999988079071045
. O 0 1.6605721953055763e-07

We O 0 5.822056792226249e-08
report O 0 5.3756332718535305e-09
WT1 O 0 1.5099066331458744e-05
heterozygous O 0 3.5466297276798286e-07
mutations O 0 3.131910730758136e-08
in O 0 3.991902294830929e-11
16 O 0 5.758064580696498e-10
patients O 0 6.2880372020401865e-09
, O 0 1.5728918167923212e-10
4 O 0 1.4044261587020657e-10
of O 0 2.8723981526646014e-11
whom O 0 7.289914094599226e-08
presented O 0 5.387355006547523e-09
with O 0 9.879610907148617e-09
IDMS B-Disease 0 0.003179418621584773
. O 0 1.6853228146374022e-08

One O 0 2.198419046806066e-08
male O 0 1.431796192719048e-07
and O 0 1.0659116922440148e-09
two O 0 1.293176538075258e-10
female O 0 4.0679871915472177e-08
IDMS B-Disease 0 0.03803751617670059
patients O 0 1.6103840039249917e-08
with O 0 8.651362959355424e-11
WT1 O 0 0.002533529419451952
mutations O 0 4.126042313146172e-06
underwent O 0 4.5660212322218285e-07
normal O 0 7.160779773585091e-07
puberty O 0 1.7439513612771407e-05
. O 0 1.2427881834753407e-08

Two O 0 4.106746942511563e-09
mutations O 0 3.330552544866805e-07
associated O 0 3.2108815162246174e-08
with O 0 5.406251002426643e-10
IDMS B-Disease 0 0.010904687456786633
are O 0 6.688443549007772e-11
different O 0 1.2432953971908134e-12
from O 0 2.989691014285839e-13
those O 0 7.325970342517141e-13
described O 0 5.338631758888823e-10
in O 0 2.2926814613466462e-10
DDS B-Disease 1 1.0
patients O 0 1.2905751134439924e-07
. O 0 2.5410813453419223e-09

No O 0 8.498214043584085e-08
WT1 O 0 5.509024504135596e-06
mutations O 0 2.5852129326153772e-08
were O 0 9.525506772245507e-11
detected O 0 7.798961476623845e-09
in O 0 2.3428262368313524e-12
the O 0 1.6264291346004822e-12
six O 0 2.8771027227314505e-11
other O 0 8.484932374763776e-12
IDMS B-Disease 0 0.00016253262583632022
patients O 0 3.270462511917316e-10
, O 0 4.843620621773626e-13
suggesting O 0 2.3662757864251205e-10
genetic O 0 1.8639447763035832e-09
heterogeneity O 0 1.649242076240398e-09
of O 0 5.49830970683618e-12
this O 0 1.4855251473377962e-09
disease O 0 0.0003305268182884902
. O 0 8.53928572297491e-09

We O 0 2.889381534032509e-08
analyzed O 0 4.912698159387219e-08
genotype O 0 9.921874379870133e-07
/ O 0 3.633542655734345e-05
phenotype O 0 2.1836800101482368e-07
correlations O 0 1.3882402782883219e-08
, O 0 3.179248878049101e-11
on O 0 6.32841001824147e-11
the O 0 4.454040489296901e-13
basis O 0 1.1008823019853509e-10
of O 0 1.4358243869035114e-13
the O 0 1.9972554426289646e-12
constitution O 0 1.7734919435796748e-11
of O 0 8.937438327394007e-14
a O 0 3.6377203332937924e-11
WT1 O 0 3.0754850399716815e-07
mutation O 0 5.126459257098759e-10
database O 0 2.8584465350256494e-10
of O 0 1.5539161754216102e-12
84 O 0 1.2476421007434624e-09
germ O 0 1.7075366486096755e-05
- O 0 2.26079882850172e-05
line O 0 5.297324037201179e-07
mutations O 0 2.8197950641128955e-09
, O 0 5.909475382995244e-13
to O 0 1.1306086004480437e-13
compare O 0 2.690967414176182e-11
the O 0 5.125481067130497e-14
distribution O 0 1.845273794875979e-10
and O 0 2.122940191695566e-11
type O 0 1.893930701157842e-08
of O 0 7.668941436750343e-14
mutations O 0 2.76361405981973e-10
, O 0 8.17804320357024e-13
according O 0 5.990240855430207e-13
to O 0 2.001404467502632e-12
the O 0 2.9243549855978435e-12
different O 0 8.040800247854918e-10
symptoms O 0 6.277494435380504e-07
. O 0 1.4449208496358779e-09

This O 0 5.5374316243472776e-11
demonstrated O 0 3.6277858495026294e-10
( O 0 8.146734697435376e-13
1 O 0 6.483261193526713e-13
) O 0 1.8629138487900876e-13
the O 0 9.747050714291328e-14
association O 0 8.504467746348054e-13
between O 0 4.959496355261273e-13
mutations O 0 5.36055866362517e-10
in O 0 4.1989342233240967e-13
exons O 0 1.6106196376597381e-09
8 O 0 7.705244775557674e-10
and O 0 2.5944624226781343e-10
9 O 0 2.2349129213949936e-09
and O 0 1.6492105459064987e-09
DMS B-Disease 0 0.004302238579839468
; O 0 1.455541243089442e-11
( O 0 7.13685349967158e-13
2 O 0 3.310133851047725e-12
) O 0 1.340898963045345e-12
among O 0 1.4793561341208683e-12
patients O 0 4.698049241302904e-12
with O 0 8.160341976801155e-13
DMS B-Disease 0 7.6313954195939e-05
, O 0 1.2536921370834286e-12
a O 0 6.050987618952397e-13
higher O 0 6.83239814551484e-13
frequency O 0 3.500752743246238e-10
of O 0 1.708538584048458e-12
exon O 0 5.001903780055272e-09
8 O 0 2.378592878216068e-10
mutations O 0 1.993528675470202e-09
among O 0 1.9026790559761864e-11
46 O 0 2.360304396376023e-09
, O 0 4.523929564292928e-10
XY O 0 0.0004525060357991606
patients O 0 1.022047868559639e-08
with O 0 3.112729865528685e-11
female O 0 2.1260868621197915e-09
phenotype O 0 2.1225536883662244e-09
than O 0 1.581073050260784e-10
among O 0 1.511604730275451e-11
46 O 0 2.136004706443373e-09
, O 0 1.5701791256095277e-10
XY O 0 0.0014389738207682967
patients O 0 9.695066083281745e-09
with O 0 4.688974208910679e-11
sexual O 0 6.544078701153921e-07
ambiguity O 0 1.0382080972703989e-06
or O 0 5.871917778677016e-07
male O 0 6.978303446203427e-08
phenotype O 0 2.1749627876488375e-08
; O 0 6.216005488113296e-11
and O 0 2.1855481313615144e-10
( O 0 2.743098500082586e-12
3 O 0 3.375188800322504e-12
) O 0 1.1874428306954399e-12
statistically O 0 1.4840433049112534e-10
significant O 0 7.729347543949938e-12
evidence O 0 1.2403950089279192e-10
that O 0 3.573732889478043e-12
mutations O 0 3.278894655789344e-10
in O 0 5.003640188815106e-13
exons O 0 8.665916872985235e-10
8 O 0 2.336768278876633e-10
and O 0 5.883669940143221e-11
9 O 0 8.719099747755976e-11
preferentially O 0 1.3841177093354418e-09
affect O 0 3.3823777112473863e-10
amino O 0 9.72958172362759e-12
acids O 0 2.1314665256313287e-13
with O 0 1.2671849213116617e-14
different O 0 1.9816274814642154e-14
functions O 0 5.596262168949817e-12
. O 0 3.930776711069672e-12
. O 0 1.490755574540259e-10

The O 0 4.746819048939699e-10
185delAG O 0 3.1779793516761856e-06
BRCA1 O 0 3.5377351537135837e-07
mutation O 0 1.1368624930341298e-09
originated O 0 2.46448625396134e-11
before O 0 1.6391727385156596e-12
the O 0 2.2206215544769842e-14
dispersion O 0 8.63242324844471e-11
of O 0 1.2688205249921508e-13
Jews O 0 3.8487828375732835e-12
in O 0 2.043974662918266e-13
the O 0 5.3832328541668015e-14
diaspora O 0 2.3159654749527192e-11
and O 0 2.8711602539921444e-11
is O 0 1.909404752364896e-11
not O 0 7.623679465496025e-12
limited O 0 3.146953878041536e-11
to O 0 5.214074311199468e-11
Ashkenazim O 0 6.662465921181138e-07
. O 0 1.996283360838902e-09

The O 0 7.954659153597277e-10
185delAG O 0 6.899871891619114e-07
mutation O 0 1.3402676302121108e-08
in O 0 3.864252234170307e-12
BRCA1 O 0 4.646318885193068e-08
is O 0 5.6427071348785773e-11
detected O 0 7.0192429646454e-09
in O 0 9.28540881336981e-13
Ashkenazi O 0 4.464960345895719e-10
Jews O 0 6.599267573376144e-12
both O 0 1.131044802087089e-12
in O 0 1.0659351006025997e-11
familial B-Disease 1 0.9980605244636536
breast I-Disease 1 0.9999996423721313
and I-Disease 1 0.9999996423721313
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.6685055115317482e-08
in O 0 1.3252398310681368e-11
the O 0 3.492199585064526e-12
general O 0 7.385957123684506e-11
population O 0 3.784119129157659e-10
. O 0 2.2528583443204298e-09

All O 0 1.3976907631274571e-08
tested O 0 4.143254983546285e-08
Ashkenazi O 0 1.8816990632331e-08
mutation O 0 1.3125275311054452e-09
carriers O 0 7.12385914147795e-11
share O 0 1.9209883683757312e-11
the O 0 3.740769087719198e-13
same O 0 1.3185155224582079e-11
allelic O 0 1.2811188554451292e-08
pattern O 0 7.772812438133769e-08
at O 0 1.4242597101699062e-09
the O 0 1.0115948009814524e-11
BRCA1 O 0 1.3512257623915502e-07
locus O 0 1.9977591136921546e-07
. O 0 3.602566067684165e-08

Our O 0 1.4004313264592838e-08
previous O 0 1.647989661401894e-10
study O 0 7.836391258120301e-12
showed O 0 5.323968488291086e-10
that O 0 2.3661864026296164e-13
this O 0 6.86231602683822e-14
Ashkenazi O 0 1.0270657657684978e-09
mutation O 0 1.2238973723377455e-10
also O 0 4.905188234760605e-12
occurs O 0 4.0932899431078695e-12
in O 0 2.300593526446959e-13
Iraqi O 0 2.937020404658597e-09
Jews O 0 2.1648032325072286e-11
with O 0 1.2305977634477494e-12
a O 0 6.974990029995354e-12
similar O 0 1.5898912741896254e-10
allelic O 0 1.1313765924114705e-07
pattern O 0 1.862888552750519e-06
. O 0 5.775446343392332e-09

We O 0 1.0973555220061826e-07
extended O 0 1.4379514245987934e-09
our O 0 4.251838811586417e-11
analysis O 0 3.5011897894787758e-12
to O 0 9.093245904520653e-13
other O 0 1.0902928950298763e-12
non O 0 9.84890058397525e-10
- O 0 1.3495490236437035e-07
Ashkenazi O 0 6.014386766395319e-09
subsets O 0 1.139093708246719e-09
354 O 0 8.981374532979203e-10
of O 0 6.263222904721866e-13
Moroccan O 0 1.864730814205018e-09
origin O 0 1.776681232690258e-11
, O 0 2.3734378178097426e-12
200 O 0 9.269716938486994e-12
Yemenites O 0 3.6176028839207675e-09
and O 0 4.478109202898928e-11
150 O 0 1.3183326652566052e-10
Iranian O 0 7.110667610277233e-10
Jews O 0 1.436497726325925e-10
. O 0 3.186316488434926e-10

Heteroduplex O 0 2.8844976895925356e-06
analysis O 0 2.240213348159159e-09
complemented O 0 1.993247344955762e-09
by O 0 1.5913125851751975e-12
direct O 0 2.139721212712775e-11
DNA O 0 9.395808575618503e-10
sequencing O 0 2.3748711330817684e-10
of O 0 1.5242910015797473e-12
abnormally O 0 5.35781974342342e-10
migrating O 0 1.1366292455849969e-11
bands O 0 6.900336552151387e-11
were O 0 7.220616465852814e-11
employed O 0 3.646810631252606e-09
. O 0 5.246559298122122e-10

Four O 0 1.186471143554968e-09
of O 0 1.0214280593209835e-12
Moroccan O 0 3.890920030613643e-09
origin O 0 1.8704603838015643e-11
( O 0 1.2193704704809016e-13
1 O 0 7.244525752946387e-14
. O 0 1.4358216763980802e-13
1 O 0 6.031062964578088e-14
% O 0 3.641685680766914e-14
) O 0 1.1122927665724314e-13
and O 0 1.7193602444565137e-11
none O 0 5.922002905417445e-12
of O 0 1.9087392799134462e-14
the O 0 4.691402973565351e-13
Yemenites O 0 1.2354444134388132e-09
or O 0 1.5390449331631473e-11
Iranians O 0 2.7643769218155256e-11
was O 0 7.069067553544528e-11
a O 0 3.9299366712264305e-12
carrier O 0 1.8850740413078881e-10
of O 0 5.106161262043163e-14
the O 0 5.754523593748395e-12
185delAG O 0 4.0344605167774716e-07
mutation O 0 4.3610015154627035e-08
. O 0 2.6247108930732566e-09

BRCA1 O 0 7.636730879312381e-05
allelic O 0 1.0375290457886877e-06
patterns O 0 1.812481684737577e-07
were O 0 1.890554240935316e-10
determined O 0 9.841651937847473e-10
for O 0 2.3800473310936487e-12
four O 0 1.2036212955132686e-12
of O 0 5.008812781854763e-14
these O 0 1.4239641367083666e-12
individuals O 0 2.6518245065110246e-12
and O 0 8.573675623624322e-12
for O 0 2.2822776654662924e-12
12 O 0 1.261404262292709e-11
additional O 0 7.143834135359128e-11
non O 0 1.1999040339105704e-07
- O 0 1.4097628991294187e-05
Ashkenazi O 0 1.2010214334168268e-07
185delAG O 0 2.473946913994496e-08
mutation O 0 2.3121899950240277e-09
carriers O 0 8.192012068697352e-10
who O 0 1.075346034440372e-09
had O 0 1.2990067261853255e-06
breast B-Disease 1 0.9999927282333374
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.0640441650575667e-07

Six O 0 8.825357866726335e-08
non O 0 4.966120741300983e-07
- O 0 0.00012025200703646988
Ashkenazi O 0 3.3670860375423217e-06
individuals O 0 2.5628974498204116e-09
shared O 0 4.160092062499565e-11
the O 0 3.587068250938963e-13
common O 0 8.107813899427274e-12
Ashkenazi O 0 5.625248045149078e-10
haplotype O 0 1.1001445088254513e-08
, O 0 1.772301749802807e-11
four O 0 2.1444391401503893e-12
had O 0 1.3084518711570237e-11
a O 0 3.4134877541745767e-13
closely O 0 6.55750176381531e-11
related O 0 2.705884127873759e-10
pattern O 0 1.4226118310034508e-06
, O 0 8.431713660606022e-11
and O 0 1.3621248226569627e-11
the O 0 1.2089361629830098e-12
rest O 0 4.121668284451374e-11
( O 0 2.7035598152563844e-12
n O 0 1.2673249329964165e-06
= O 0 4.023732174118777e-07
6 O 0 2.1226173596566866e-10
) O 0 9.193668396023646e-12
displayed O 0 2.257564135632606e-09
a O 0 9.071618456424346e-11
distinct O 0 4.740650538792579e-09
BRCA1 O 0 4.6839397782605374e-07
allelic O 0 2.2068009286613233e-07
pattern O 0 5.357152531360043e-06
. O 0 2.2462218751684304e-08

We O 0 2.911441976394258e-09
conclude O 0 8.551847563431636e-10
that O 0 1.799894543304259e-12
the O 0 7.989041286154963e-13
185delAG O 0 4.642784574571124e-07
BRCA1 O 0 2.817136248722818e-07
mutation O 0 3.6758318611163077e-10
occurs O 0 2.943465133090073e-12
in O 0 4.2001494106715456e-14
some O 0 2.85912526293286e-12
non O 0 3.3260496579146093e-09
- O 0 3.8782306432949554e-07
Ashkenazi O 0 2.280393829323657e-08
populations O 0 5.701933369905987e-10
at O 0 1.791211345913979e-10
rates O 0 4.899470829045072e-10
comparable O 0 5.338985156755349e-11
with O 0 6.310973336802472e-13
that O 0 2.308933860079021e-12
of O 0 3.899033873544511e-12
Ashkenazim O 0 2.0493870067639364e-07
. O 0 2.737729598578653e-09

The O 0 8.511438082114964e-11
majority O 0 1.473101085558426e-10
of O 0 2.8502813173916786e-13
Jewish O 0 5.154717208633031e-10
185delAG O 0 1.1895335205736046e-07
mutation O 0 2.0860784211151895e-09
carriers O 0 2.2812311761821746e-10
have O 0 1.6722710455968626e-12
a O 0 3.811656285740428e-12
common O 0 3.5505730300311455e-11
allelic O 0 1.2495289247738128e-08
pattern O 0 4.567328687699046e-06
, O 0 1.8134631296629067e-10
supporting O 0 8.42430791792026e-10
the O 0 1.4895461166591906e-12
founder O 0 1.2423484463397472e-10
effect O 0 1.0257628080267978e-11
notion O 0 2.01400406768526e-11
, O 0 3.034793119929824e-12
but O 0 1.6154597191203601e-12
dating O 0 7.037940230603112e-10
the O 0 9.41760571978624e-14
mutations O 0 9.305376781620911e-12
origin O 0 5.504266205151598e-13
to O 0 6.652736087714439e-13
an O 0 3.1532410146514755e-13
earlier O 0 1.8447388061559877e-10
date O 0 1.8473734764157257e-09
than O 0 1.0730281940762865e-10
currently O 0 1.0676208805904253e-09
estimated O 0 5.16268006123255e-09
. O 0 3.5827543154454133e-09

However O 0 8.277960539260221e-10
, O 0 5.9503083883749586e-12
the O 0 4.2938197349897886e-14
different O 0 9.501364538894164e-13
allelic O 0 1.972014107565201e-09
pattern O 0 1.4155580174701754e-07
at O 0 1.9650492344425174e-09
the O 0 2.175153503494731e-12
BRCA1 O 0 5.401616043343438e-09
locus O 0 2.172162311131487e-10
even O 0 1.2186701647820541e-10
in O 0 3.4168100206816154e-13
some O 0 3.852056206562343e-13
Jewish O 0 7.61287283213008e-11
mutation O 0 1.0594757710036262e-10
carriers O 0 1.2669741991655492e-11
, O 0 3.2674150928294066e-13
might O 0 5.399011966666922e-12
suggest O 0 3.2018193651950355e-11
that O 0 2.1807573108434397e-12
the O 0 2.5871202424289363e-13
mutation O 0 5.7163915961888634e-11
arose O 0 9.046611550156403e-12
independently O 0 7.626508868874282e-10
. O 0 3.477903035009611e-11
. O 0 8.646319216154552e-10

Crystal O 0 3.2841887787071755e-06
structure O 0 1.3349532146378351e-08
of O 0 6.7914614904074355e-12
the O 0 2.440509461187901e-10
hemochromatosis B-Disease 1 1.0
protein O 0 1.6850567874371336e-07
HFE O 0 5.600113581749611e-06
and O 0 2.5284518923029964e-10
characterization O 0 8.482016866651065e-09
of O 0 1.2408387034881785e-12
its O 0 1.1292541554630553e-11
interaction O 0 3.388077318700056e-11
with O 0 1.1486749051936584e-11
transferrin O 0 3.203822274144841e-08
receptor O 0 2.4627313521818905e-09
. O 0 8.104003579312291e-10

HFE O 0 0.0012849284103140235
is O 0 8.917078631043296e-09
an O 0 1.6141176936712576e-11
MHC O 0 7.23685431580634e-08
- O 0 1.811783505445419e-07
related O 0 6.973085220352004e-09
protein O 0 1.9191799538464949e-10
that O 0 2.709982412085754e-12
is O 0 1.9628398299081917e-12
mutated O 0 1.378145098041017e-10
in O 0 1.2741807392177562e-12
the O 0 6.694263199324979e-11
iron B-Disease 1 0.9526755213737488
- I-Disease 1 0.9999939203262329
overload I-Disease 1 0.9999971389770508
disease I-Disease 1 0.9999997615814209
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 0.00038051139563322067

HFE O 0 3.113052298431285e-05
binds O 0 1.735686083748078e-08
to O 0 9.454967364597167e-11
transferrin O 0 2.8938433871417146e-08
receptor O 0 4.5766185285955885e-10
( O 0 1.2068494641137573e-11
TfR O 0 1.8863838135985134e-07
) O 0 1.7008716483857267e-12
and O 0 1.4197117873676612e-12
reduces O 0 2.7201026153722552e-11
its O 0 9.369629638128485e-13
affinity O 0 2.8186023393744764e-12
for O 0 2.212034158274867e-12
iron O 0 5.952760488980857e-07
- O 0 8.72656357842061e-07
loaded O 0 1.0454153098748975e-08
transferrin O 0 1.3467045256732035e-08
, O 0 1.2994412837419311e-11
implicating O 0 1.4380829327365063e-07
HFE O 0 7.522965461248532e-06
in O 0 2.024125866917359e-10
iron O 0 2.951222995761782e-06
metabolism O 0 1.2402671245581587e-06
. O 0 5.406357139747797e-09

The O 0 2.03691108424664e-09
2 O 0 2.483912853179504e-09
. O 0 1.7567278742802728e-09

6 O 0 3.805808646006881e-08
A O 0 5.438294259363374e-09
crystal O 0 1.1060947144869715e-05
structure O 0 9.541575707316952e-08
of O 0 1.8488309841413475e-11
HFE O 0 1.9293951481813565e-05
reveals O 0 5.387180479488052e-09
the O 0 9.390239237225262e-13
locations O 0 3.1661928634463266e-09
of O 0 6.877971803209704e-11
hemochromatosis B-Disease 1 1.0
mutations O 0 4.3997453758493066e-05
and O 0 6.623953607842736e-10
a O 0 1.37537994882031e-10
patch O 0 0.00021278427448123693
of O 0 1.1233871471949541e-11
histidines O 0 1.6168321508303052e-06
that O 0 1.1186473969360122e-10
could O 0 3.6349943888236425e-11
be O 0 6.017563834379014e-13
involved O 0 7.425107403924436e-12
in O 0 1.270773850731155e-11
pH O 0 2.284772926941514e-05
- O 0 4.164384336036164e-06
dependent O 0 1.2204699828544108e-07
interactions O 0 1.3224415340573614e-08
. O 0 1.4144433402307754e-09

We O 0 1.49365728674411e-08
also O 0 1.3413755349522827e-11
demonstrate O 0 7.907201282630894e-11
that O 0 6.167464976225556e-12
soluble O 0 1.3797877507215617e-08
TfR O 0 1.337348385277437e-05
and O 0 1.7678561392564518e-10
HFE O 0 1.566935338814801e-06
bind O 0 6.690846210410939e-10
tightly O 0 2.202027005182572e-09
at O 0 6.740711877561978e-10
the O 0 1.0775001767562853e-12
basic O 0 2.7556357196090175e-09
pH O 0 2.8551419006817014e-08
of O 0 1.2901738867792528e-13
the O 0 5.904686461999376e-13
cell O 0 4.7209440801054825e-09
surface O 0 2.0933415001422873e-08
, O 0 1.0023068312825512e-11
but O 0 4.460580776272094e-12
not O 0 1.576605599545866e-12
at O 0 2.6980079628757814e-11
the O 0 3.870876275763324e-12
acidic O 0 8.8857412094967e-08
pH O 0 6.156135441415245e-07
of O 0 4.306982548385463e-11
intracellular O 0 1.927557775616151e-07
vesicles O 0 1.482828650978263e-07
. O 0 2.472409121878627e-08

TfR O 0 0.017384091392159462
HFE O 0 0.00017665752966422588
stoichiometry O 0 2.854974070487515e-07
( O 0 3.9884645586241163e-10
2 O 0 1.4859295738300915e-10
1 O 0 8.025133509115268e-12
) O 0 2.9226039990892794e-12
differs O 0 4.149530719033123e-10
from O 0 4.593267086128172e-11
TfR O 0 8.369863280677237e-06
transferrin O 0 4.056378788419579e-09
stoichiometry O 0 4.4494027906516465e-10
( O 0 2.9662795657248164e-12
2 O 0 4.649013379126599e-12
2 O 0 1.8852014133791117e-12
) O 0 1.7957513189122143e-13
, O 0 1.591147732234871e-13
implying O 0 1.633206764273254e-11
a O 0 1.9553952099009286e-13
different O 0 6.650448692181038e-14
mode O 0 6.424072385158297e-11
of O 0 2.983150429155049e-14
binding O 0 2.5858154159563718e-11
for O 0 3.268176961696012e-12
HFE O 0 3.1778731681697536e-06
and O 0 1.1135303790155149e-09
transferrin O 0 1.6889881493398207e-08
to O 0 1.0469028421944415e-10
TfR O 0 5.331510692485608e-06
, O 0 4.4667127635511505e-11
consistent O 0 1.1544835087917704e-09
with O 0 4.182502868349536e-12
our O 0 2.4529591899358216e-11
demonstration O 0 5.292601912287864e-10
that O 0 2.9688040220632317e-12
HFE O 0 1.4679305770926021e-08
, O 0 5.986908451632855e-12
transferrin O 0 7.593791151450091e-10
, O 0 1.558666390399921e-11
and O 0 2.0315325810482676e-10
TfR O 0 1.278931631532032e-05
form O 0 8.117253397221802e-12
a O 0 3.237122028765249e-11
ternary O 0 3.531943093548762e-08
complex O 0 6.598411772529289e-08
. O 0 3.3541440735973538e-09

Identification O 0 3.1258355903673873e-08
of O 0 9.413233213739769e-12
three O 0 8.493546144183739e-12
novel O 0 6.12906253527612e-11
mutations O 0 1.5768847339003855e-09
and O 0 6.336813452439971e-12
a O 0 1.916785740546656e-12
high O 0 1.6255460519309928e-11
frequency O 0 1.138068750350385e-09
of O 0 1.1591373477379263e-12
the O 0 7.84135430198507e-12
Arg778Leu O 0 1.329739092170712e-07
mutation O 0 1.0116865123421803e-09
in O 0 2.3116406358547614e-11
Korean O 0 1.8858369799090724e-07
patients O 0 3.4007605759223125e-11
with O 0 9.259096961367064e-12
Wilson B-Disease 0 2.7905116439796984e-06
disease I-Disease 0 7.905371603555977e-05
. O 0 7.95719667934236e-09

Four O 0 2.7943525271467706e-09
mutations O 0 8.115751626291967e-08
- O 0 7.857920536480378e-06
- O 0 1.57537863287871e-06
R778L O 0 3.943956627949774e-08
, O 0 3.832081787308317e-12
A874V O 0 3.853473096171456e-10
, O 0 6.499269438603461e-13
L1083F O 0 7.354383768642947e-11
, O 0 5.428147623227908e-13
and O 0 4.113229396841833e-13
2304delC O 0 6.000178576215376e-09
- O 0 2.1853091425327875e-07
- O 0 8.996795486382325e-08
in O 0 2.417827223155644e-12
the O 0 4.0916171817860503e-13
copper O 0 1.9294248421175553e-09
- O 0 9.680328760808266e-11
transporting O 0 3.137472226466542e-11
enzyme O 0 9.343257938165817e-12
, O 0 4.0667900362383047e-13
P O 0 3.407160775736884e-08
- O 0 4.283867038878952e-09
type O 0 1.7202788171744032e-07
ATPase O 0 2.4919252155086724e-06
( O 0 5.786378320937757e-11
ATP7B O 0 5.831581262327745e-08
) O 0 3.3511717706380395e-12
, O 0 8.581769734943012e-13
were O 0 8.901325314857045e-13
identified O 0 2.4745155924321693e-10
in O 0 1.6368172008757176e-12
Korean O 0 1.2289324331504758e-06
Patients O 0 1.1035584945862098e-10
with O 0 3.9624067915688954e-12
Wilson B-Disease 0 5.669231768479222e-07
disease I-Disease 0 1.047670502885012e-05
. O 0 3.119746461166528e-09

Arg778Leu O 0 3.5661219044413883e-06
, O 0 2.0811335987858115e-10
the O 0 3.217961108085282e-13
most O 0 4.456122157468073e-13
frequently O 0 1.3710922674992077e-10
reported O 0 1.6087261300867794e-08
mutation O 0 4.53629182828319e-11
of O 0 1.1539698199552941e-14
this O 0 1.4419528396834858e-13
enzyme O 0 1.4293908938423083e-11
, O 0 8.978414799826195e-13
was O 0 1.5482728987770145e-10
found O 0 5.977076472651888e-11
in O 0 1.003283719124004e-12
six O 0 7.885314796951537e-12
of O 0 5.1069208811902606e-14
eight O 0 7.385925204772548e-12
unrelated O 0 2.379482444414549e-10
patients O 0 9.49285441920189e-12
studied O 0 6.17844967895631e-12
, O 0 7.783490648879954e-13
an O 0 3.520015157717875e-14
allele O 0 2.624354344948898e-10
frequency O 0 5.3533484312140445e-09
of O 0 1.468237059709665e-10
37 O 0 4.459151625724189e-08
. O 0 6.909457450632317e-09

5 O 0 6.9688703696613175e-09
% O 0 7.273723290346368e-11
, O 0 1.7146704195392104e-11
which O 0 6.378187041022887e-12
is O 0 2.4508114721683016e-12
considerably O 0 1.0467466303454298e-11
higher O 0 1.3299210907882775e-12
than O 0 3.680542415979149e-12
those O 0 7.780922173933336e-13
in O 0 1.584515125444691e-13
other O 0 1.0314281980589035e-12
Asian O 0 8.865240139210862e-12
populations O 0 2.2237499341937195e-10
. O 0 3.268903481234986e-10

The O 0 9.121708943737872e-11
novel O 0 1.424041717879021e-10
single O 0 4.446838036686884e-11
nucleotide O 0 1.5178699408480156e-09
deletion O 0 3.0465476807961522e-09
, O 0 1.1452337342343633e-11
2304delC O 0 7.472172214306738e-09
, O 0 1.770929757005657e-11
was O 0 4.824219912435979e-10
found O 0 6.071016606101765e-11
in O 0 1.9044718059524346e-12
one O 0 2.907139806662684e-10
patient O 0 1.3210227223225957e-07
. O 0 1.8468063744947472e-09

Since O 0 8.284689045900961e-10
a O 0 1.9834835163212716e-11
mutation O 0 2.739122539896499e-10
at O 0 1.5279420090275053e-11
cDNA O 0 8.227891257206466e-09
nucleotide O 0 5.845713602070646e-08
2302 O 0 1.016374312712287e-06
( O 0 7.67620775971034e-12
2302insC O 0 2.7273421299156553e-09
) O 0 5.989490153845978e-12
had O 0 3.052675473513844e-11
been O 0 4.905216857697958e-12
previously O 0 5.322087215375859e-11
described O 0 7.413128999544938e-10
, O 0 8.732821865815865e-13
this O 0 1.498090117669354e-13
region O 0 3.458910241560531e-11
of O 0 1.0808609324404472e-13
the O 0 9.008003761315497e-13
ATP7B O 0 9.026944525203362e-08
gene O 0 3.327623065985108e-09
may O 0 3.0824565122600234e-11
be O 0 1.778080504014068e-12
susceptible O 0 4.5722389763191984e-10
to O 0 4.273071913668547e-12
gene O 0 1.0188256283072405e-06
rearrangements O 0 0.0002620064187794924
causing O 0 0.00020132640202064067
Wilson B-Disease 0 0.0005252130213193595
disease I-Disease 0 0.19880492985248566
. O 0 8.431420894794428e-08

Disruption O 0 2.485762991000229e-07
of O 0 3.402179796566096e-12
splicing O 0 4.1130339134554106e-09
regulated O 0 9.646291543319307e-10
by O 0 4.0710061190163405e-12
a O 0 8.750705021709493e-11
CUG O 0 4.043504668516107e-05
- O 0 1.1713835874616052e-06
binding O 0 1.9155578456775402e-08
protein O 0 5.351898479943884e-09
in O 0 6.535491037240604e-10
myotonic B-Disease 1 0.9999991655349731
dystrophy I-Disease 1 0.9999988079071045
. O 0 8.890607006151185e-08

Myotonic B-Disease 1 0.9999988079071045
dystrophy I-Disease 1 0.9999998807907104
( O 0 1.5889714632066898e-05
DM B-Disease 1 1.0
) O 0 4.88755391714335e-09
is O 0 3.911387602695271e-10
caused O 0 4.786029350611898e-10
by O 0 4.717289384635615e-13
a O 0 9.18378394165753e-12
CTG O 0 2.7867594099006965e-07
expansion O 0 1.2461557341580942e-09
in O 0 8.290893145634914e-12
the O 0 3.043639125455133e-12
3 O 0 3.465884176878653e-11
untranslated O 0 6.339980984648719e-08
region O 0 5.657671220404836e-09
of O 0 1.363286740441172e-11
the O 0 1.3283260047458612e-09
DM B-Disease 1 0.9999998807907104
gene O 0 2.3298937321669655e-06
. O 0 1.7343690927873467e-08

One O 0 5.906340416750311e-10
model O 0 8.187049260754975e-09
of O 0 5.694919882892613e-11
DM B-Disease 1 1.0
pathogenesis O 0 2.2302122033579508e-06
suggests O 0 4.309008705405404e-09
that O 0 6.1743266749347825e-12
RNAs O 0 7.679265223714538e-09
from O 0 1.4738809131498165e-12
the O 0 2.8480099138403214e-13
expanded O 0 3.088983582810734e-11
allele O 0 1.809086075388322e-10
create O 0 3.0824431548892584e-12
a O 0 3.838966037422731e-12
gain O 0 9.330640704519055e-10
- O 0 4.111859297495357e-08
of O 0 1.1219010963292586e-11
- O 0 5.378199148253771e-07
function O 0 1.053380938031978e-09
mutation O 0 2.396182037511796e-11
by O 0 3.9163289988373637e-14
the O 0 6.803693892998286e-14
inappropriate O 0 3.809074833327486e-09
binding O 0 4.523210972440239e-11
of O 0 2.1653861971733523e-14
proteins O 0 1.166901319495095e-12
to O 0 1.2790237619020317e-12
the O 0 9.736858888609312e-12
CUG O 0 3.082783905483666e-06
repeats O 0 3.9267010265575664e-07
. O 0 2.220585049172996e-09

Data O 0 6.782348549450035e-08
presented O 0 2.4924776131918236e-10
here O 0 4.459731889339125e-11
indicate O 0 8.265681888941501e-11
that O 0 2.8550911092793674e-13
the O 0 1.6902760658146776e-13
conserved O 0 2.101742113680416e-09
heterogeneous O 0 4.976429490710643e-09
nuclear O 0 2.9455446792781004e-07
ribonucleoprotein O 0 2.1368004254895823e-08
, O 0 9.57291190761822e-12
CUG O 0 2.4725866865082935e-07
- O 0 4.6486412941249e-08
binding O 0 1.4518106716820967e-09
protein O 0 8.397993411790594e-11
( O 0 2.3141449694008553e-12
CUG O 0 2.6809916064962636e-08
- O 0 5.342171505162696e-08
BP O 0 1.4767315370534106e-08
) O 0 7.7480009170669e-13
, O 0 6.702995905723264e-13
may O 0 3.8294077110700986e-12
mediate O 0 1.2114124148254746e-09
the O 0 2.2057817811865776e-12
trans O 0 1.8317110050958263e-09
- O 0 1.182406919042478e-07
dominant O 0 4.583548651737601e-09
effect O 0 2.514121133501135e-10
of O 0 3.219256187580316e-13
the O 0 1.4426165340433728e-12
RNA O 0 2.326793646645342e-09
. O 0 1.1337090294327723e-10

CUG O 0 0.00012151350529165938
- O 0 8.051291661104187e-05
BP O 0 3.172568085574312e-06
was O 0 5.644023026718514e-10
found O 0 3.5398465842578775e-12
to O 0 5.535311182395912e-14
bind O 0 1.1616517209961374e-12
to O 0 7.321440410315225e-14
the O 0 3.6728823107901043e-13
human O 0 1.235800128895903e-09
cardiac O 0 2.029208872045274e-06
troponin O 0 0.0008780319476500154
T O 0 0.00010437005403218791
( O 0 2.3945921634460632e-11
cTNT O 0 5.842098804720308e-09
) O 0 1.1157382309723296e-11
pre O 0 1.2576624897064903e-07
- O 0 2.091905173529085e-07
messenger O 0 4.871741232648219e-09
RNA O 0 1.8348640662413374e-10
and O 0 1.260739668045019e-12
regulate O 0 4.152275745461509e-11
its O 0 1.1837681442722348e-12
alternative O 0 3.0235744463702474e-11
splicing O 0 7.007324054342234e-09
. O 0 7.054726802735445e-10

Splicing O 0 2.7023949300541972e-08
of O 0 3.845673432478769e-11
cTNT O 0 6.890613946097801e-08
was O 0 1.608574939915286e-09
disrupted O 0 1.3276977028908732e-07
in O 0 1.2600270826723659e-10
DM B-Disease 1 1.0
striated O 0 0.0019347545458003879
muscle O 0 0.00016620558744762093
and O 0 5.559340210403718e-10
in O 0 4.171420587423258e-12
normal O 0 2.805679910622416e-09
cells O 0 8.732302103631184e-10
expressing O 0 1.6505943833955428e-10
transcripts O 0 3.959164551758931e-09
that O 0 4.45180281527513e-11
contain O 0 8.832005349290739e-09
CUG O 0 2.5662659027148038e-05
repeats O 0 2.741775915637845e-06
. O 0 5.667132096931482e-09

Altered O 0 3.5084840988020005e-07
expression O 0 2.8975757349058995e-09
of O 0 2.830044358581585e-12
genes O 0 1.9514274640641815e-09
regulated O 0 2.0590906757433913e-09
posttranscriptionally O 0 2.2131821708626376e-08
by O 0 1.6809062822198406e-11
CUG O 0 7.302874564629747e-06
- O 0 7.149526481953217e-06
BP O 0 6.614011027750166e-08
therefore O 0 3.000832872121495e-12
may O 0 6.537326561160961e-13
contribute O 0 3.997569202746076e-12
to O 0 2.2697081714095901e-10
DM B-Disease 1 1.0
pathogenesis O 0 3.401836147531867e-05
. O 0 6.793878237765227e-10
. O 0 1.1227350160680771e-09

Identification O 0 1.8627266840098855e-08
of O 0 1.265566037383925e-11
a O 0 6.306648259180037e-11
novel O 0 6.138709096603634e-09
nonsense O 0 3.1187155400402844e-05
mutation O 0 6.349744285927272e-09
and O 0 3.9906667380351646e-12
a O 0 1.511188852006129e-12
missense O 0 1.6350347742388749e-09
substitution O 0 9.339479710435139e-12
in O 0 5.077300884413771e-13
the O 0 2.9874052450556965e-13
vasopressin O 0 1.1937850707965936e-09
- O 0 3.417105531866582e-08
neurophysin O 0 1.2077958899681107e-07
II O 0 1.1224443596802303e-08
gene O 0 3.5068561388129638e-09
in O 0 7.720359941620902e-12
two O 0 8.591338578056718e-12
Spanish O 0 1.0479841439092752e-09
kindreds O 0 1.7785677073334227e-06
with O 0 5.232268507349147e-10
familial B-Disease 0 0.029780671000480652
neurohypophyseal I-Disease 1 0.9992656111717224
diabetes I-Disease 1 0.999914288520813
insipidus I-Disease 1 0.9935862421989441
. O 0 4.0081710039885365e-07

Familial B-Disease 1 0.999699592590332
neurohypophyseal I-Disease 1 0.999895453453064
diabetes I-Disease 1 0.9999979734420776
insipidus I-Disease 1 0.9999486207962036
( O 0 1.1498030971779372e-06
FNDI B-Disease 1 1.0
) O 0 1.076117528420184e-09
is O 0 4.102125861216166e-10
an O 0 1.1837106295153887e-10
autosomal B-Disease 1 0.9999933242797852
dominant I-Disease 1 0.9997928738594055
disease I-Disease 1 0.9999899864196777
caused O 0 1.294501907977974e-05
by O 0 1.8084842068333273e-08
deficiency O 1 0.9999110698699951
in O 0 4.713759244046045e-11
the O 0 1.1207040157001913e-10
antidiuretic O 0 9.509572555543855e-05
hormone O 0 1.6583463491315342e-08
arginine O 0 2.202648730076362e-09
vasopressin O 0 3.902921874576748e-10
( O 0 1.029964134813266e-11
AVP O 0 4.701857125866127e-09
) O 0 7.758337700579376e-13
encoded O 0 1.2303583716080646e-12
by O 0 1.719843885361616e-13
the O 0 1.1885712683165628e-12
AVP O 0 5.10181507706875e-07
- O 0 4.401379953833384e-07
neurophysin O 0 3.6255454460842884e-07
II O 0 3.313122363124421e-07
( O 0 5.290005239411144e-11
AVP O 0 3.576229801183217e-07
- O 0 2.764651014786068e-07
NPII O 0 4.397955777335483e-08
) O 0 2.050789876459347e-12
gene O 0 2.5819529847481704e-10
on O 0 8.700942050188232e-11
chromosome O 0 1.7999809642788023e-06
20p13 O 0 4.116900072403951e-06
. O 0 2.353580264013999e-08

In O 0 2.3593838688329427e-11
this O 0 1.9731726018726303e-13
study O 0 4.777767808120115e-13
, O 0 6.12994518426474e-13
we O 0 3.1784468720180703e-12
analyzed O 0 2.4887283206487254e-11
two O 0 3.41120334019715e-13
families O 0 2.4441312689027495e-12
with O 0 2.406008985794683e-12
FNDI B-Disease 1 0.9999960660934448
using O 0 9.855265908909061e-11
direct O 0 4.459794200606382e-10
automated O 0 1.0382239068462695e-08
fluorescent O 0 6.457317458519185e-10
, O 0 4.933308102306189e-12
solid O 0 8.42799996458865e-11
phase O 0 1.7847147371075067e-10
, O 0 1.9483711519163727e-12
single O 0 3.864637082573452e-11
- O 0 5.207033471066325e-09
stranded O 0 4.085874000248069e-11
DNA O 0 3.809389002157326e-12
sequencing O 0 7.94019017202885e-12
of O 0 6.907278568557551e-14
PCR O 0 9.38062294508768e-10
- O 0 8.185124245052577e-10
amplified O 0 2.3546746774627536e-09
AVP O 0 1.459497127598297e-07
- O 0 5.063030528162926e-08
NPII O 0 2.2028983437394345e-07
DNA O 0 1.1911176933665502e-08
. O 0 4.4204392923852254e-10

In O 0 6.519069728483373e-10
one O 0 1.2395477005933131e-11
of O 0 4.751610549794637e-14
the O 0 4.4957773940278167e-13
families O 0 1.0053990626146536e-11
, O 0 7.866607755827038e-13
affected O 0 4.772310879808117e-10
individuals O 0 4.8895609783272675e-12
presented O 0 2.6718904866385174e-11
a O 0 5.511878106712054e-11
novel O 0 2.0255093158283444e-09
nonsense O 0 1.3089976391711389e-06
mutation O 0 5.172277051102014e-10
in O 0 4.755865840033735e-13
exon O 0 1.108467415078529e-10
3 O 0 1.7460763737653373e-11
of O 0 2.840463595669279e-13
the O 0 5.190760473360034e-13
gene O 0 9.83510273222521e-10
, O 0 2.124680856599448e-12
consisting O 0 2.1374877779214985e-13
in O 0 1.0028201955902122e-13
a O 0 1.030714836397495e-11
G O 0 9.246669208096137e-09
to O 0 4.5369232676284454e-11
T O 0 2.1019491214246955e-06
transition O 0 7.489291409257248e-10
at O 0 1.4615174348531212e-10
nucleotide O 0 1.1026607404929223e-09
2101 O 0 5.298385019614216e-08
, O 0 2.5115402379344287e-12
which O 0 1.4860009923955975e-13
produces O 0 6.8260059063463e-12
a O 0 6.673082225683302e-13
stop O 0 1.113674930053321e-09
signal O 0 6.494785154131932e-09
in O 0 3.865365059280146e-12
codon O 0 7.96190313678835e-09
82 O 0 3.170882667546948e-09
( O 0 1.322288285809936e-11
Glu O 0 2.665537692791986e-07
) O 0 4.366838141089957e-11
of O 0 9.49962851437558e-12
NPII O 0 6.536446562677156e-06
. O 0 3.5206420001543393e-09

The O 0 1.7716468569961563e-10
premature O 0 1.133969718125627e-08
termination O 0 2.471719495744651e-09
eliminates O 0 4.865593705716265e-09
part O 0 1.9831818132143297e-10
of O 0 1.300531622498713e-12
the O 0 2.5344667337057203e-11
C O 0 1.80975959551688e-07
- O 0 6.181679879091462e-08
terminal O 0 6.2943485978905755e-09
domain O 0 1.6347409537154078e-10
of O 0 1.2268591904115306e-13
NPII O 0 4.3763503043692253e-08
, O 0 1.3586835649614937e-12
including O 0 5.091009875495857e-14
a O 0 2.73304382597539e-13
cysteine O 0 3.8677841311673955e-12
residue O 0 4.968609204625274e-11
in O 0 1.775690326114715e-13
position O 0 5.277005221682174e-11
85 O 0 1.645563893482027e-11
, O 0 5.256217011119502e-13
which O 0 2.6192709026012784e-12
could O 0 3.490123814953172e-11
be O 0 6.508735065670346e-13
involved O 0 4.285854657282151e-12
in O 0 5.444271335836026e-13
the O 0 2.1202117752444627e-12
correct O 0 5.874471753486432e-07
folding O 0 2.200051483214338e-07
of O 0 6.0793327837094235e-12
the O 0 1.251407172331298e-10
prohormone O 0 1.0532998203416355e-05
. O 0 1.456015485956641e-08

In O 0 6.098327398618153e-10
the O 0 6.695358243519189e-12
second O 0 8.91116607587561e-12
family O 0 6.862591606093815e-10
, O 0 3.5161383895622456e-13
a O 0 1.749942150821443e-13
G279A O 0 2.7530273200015998e-11
substitution O 0 4.26079917875688e-12
at O 0 1.782092112767586e-10
position O 0 3.6209146792032243e-10
- O 0 3.4518616853773665e-09
1 O 0 1.6623766978859228e-13
of O 0 1.1753122550173765e-14
the O 0 8.196090697408162e-14
signal O 0 4.904716632836426e-10
peptide O 0 8.391311950850522e-12
was O 0 1.3027089173014983e-12
observed O 0 4.23589852430184e-12
in O 0 2.4333742079706358e-14
all O 0 4.3429699398377097e-13
affected O 0 2.09187861477389e-10
individuals O 0 1.5450538418115833e-11
. O 0 3.3365829543718917e-10

This O 0 5.803270086701673e-10
missense O 0 2.0551894976961194e-06
mutation O 0 3.0634943470886355e-08
, O 0 9.3827834390936e-11
which O 0 8.13152878365031e-11
replaces O 0 6.17048883100324e-08
Ala O 0 3.289170535936137e-08
with O 0 5.883868479245047e-12
Thr O 0 5.70153133594431e-06
, O 0 6.00837227193729e-11
is O 0 4.8007191971732865e-11
frequent O 0 2.506568108628926e-08
among O 0 2.0296704317246395e-09
FNDI B-Disease 1 1.0
patients O 0 8.125709314299456e-07
and O 0 2.319289899022081e-11
is O 0 7.349836884940064e-12
thought O 0 5.356649152021831e-12
to O 0 3.3970553149978433e-13
reduce O 0 2.3037793894786773e-11
the O 0 6.736832771324364e-13
efficiency O 0 2.8488778003321613e-10
of O 0 1.1038521442394145e-12
cleavage O 0 5.117330559301081e-08
by O 0 3.3793131487547257e-11
signal O 0 3.144960203371738e-08
peptidases O 0 1.3519579056264774e-07
. O 0 1.266665522470234e-10
. O 0 6.087333415116802e-10

Genetic O 0 4.746824231460778e-07
heterogeneity O 0 1.1721618875526474e-07
of O 0 5.728029162099801e-10
Saethre B-Disease 1 0.9841432571411133
- I-Disease 1 0.9999939203262329
Chotzen I-Disease 1 0.9999896287918091
syndrome I-Disease 1 0.9999996423721313
, O 0 5.262842939224299e-11
due O 0 1.0479871311031008e-11
to O 0 8.15978621476754e-12
TWIST O 0 8.214313993448741e-07
and O 0 3.510798096684198e-09
FGFR O 0 4.4719199649989605e-06
mutations O 0 2.247203134686515e-08
. O 0 1.1535723487554606e-09

Thirty O 0 2.6323786528337223e-07
- O 0 5.855650670127943e-06
two O 0 1.6216564549531576e-11
unrelated O 0 1.3347158933640912e-09
patients O 0 3.062677542131631e-11
with O 0 8.836464546191358e-14
features O 0 2.7547649494863435e-08
of O 0 1.9748699897625954e-10
Saethre B-Disease 1 0.9993546605110168
- I-Disease 1 0.9999914169311523
Chotzen I-Disease 1 0.9999613761901855
syndrome I-Disease 1 0.9999970197677612
, O 0 8.271354955124988e-12
a O 0 1.1842000470496661e-11
common O 0 7.412224167779868e-10
autosomal B-Disease 0 0.2849789559841156
dominant I-Disease 0 0.003224183339625597
condition I-Disease 1 0.5566023588180542
of O 0 3.463255793256792e-10
craniosynostosis B-Disease 1 0.9813108444213867
and O 0 1.9515884019938312e-08
limb B-Disease 1 0.7116571068763733
anomalies I-Disease 0 0.03790709003806114
, O 0 1.7513281935777059e-09
were O 0 1.633821272717384e-10
screened O 0 2.2680821665232997e-09
for O 0 8.052513191837696e-13
mutations O 0 2.392858411415233e-10
in O 0 4.091898261199267e-13
TWIST O 0 7.1342411978037035e-09
, O 0 6.158722143378981e-11
FGFR2 O 0 8.87865923004938e-08
, O 0 5.733196209445346e-11
and O 0 1.8019710723571336e-10
FGFR3 O 0 3.050642135349335e-06
. O 0 3.3945621868980425e-09

Nine O 0 2.2306807068162016e-08
novel O 0 4.741084858039812e-09
and O 0 1.0571609143639193e-09
three O 0 3.9061746892610216e-11
recurrent O 0 2.398189462837763e-05
TWIST O 0 3.4439003115949163e-07
mutations O 0 3.189536457171016e-08
were O 0 9.93523319170464e-11
found O 0 9.939005174430804e-11
in O 0 2.0016906968761683e-12
12 O 0 7.999798740110364e-11
families O 0 2.546936828107249e-10
. O 0 5.931029556371925e-10

Seven O 0 1.325398546470069e-08
families O 0 5.366215805047148e-10
were O 0 9.55552650894198e-12
found O 0 6.79739684678049e-12
to O 0 1.905343938179982e-12
have O 0 7.286508202364317e-12
the O 0 4.316402920853668e-13
FGFR3 O 0 1.5610048365033435e-07
P250R O 0 1.6378814970963163e-09
mutation O 0 7.38259106625172e-11
, O 0 5.507871502635764e-12
and O 0 1.864540466467446e-11
one O 0 8.649642634084298e-12
individual O 0 5.86159755715937e-13
was O 0 4.53022397373104e-10
found O 0 2.681233013390738e-11
to O 0 4.66200428955732e-12
have O 0 2.3522572778489348e-11
an O 0 1.4626621311700228e-12
FGFR2 O 0 7.454651154148451e-07
VV269 O 0 1.239743880887545e-07
- O 0 3.444097274041269e-07
270 O 0 3.208531040854723e-08
deletion O 0 4.162361335602327e-07
. O 0 1.456284870471336e-08

To O 0 4.920823748477687e-10
date O 0 1.3023705447423595e-09
, O 0 1.0971755622091184e-11
our O 0 2.6159107432283113e-12
detection O 0 3.398996709091939e-11
rate O 0 1.739575150594419e-10
for O 0 1.3411464321912148e-13
TWIST O 0 2.2393420451294332e-09
or O 0 2.4368254636364384e-10
FGFR O 0 1.4337290465959995e-08
mutations O 0 2.2834295565488105e-10
is O 0 2.420841652139849e-11
68 O 0 1.3511543273114768e-10
% O 0 1.4000652850607032e-12
in O 0 5.0882193423917865e-12
our O 0 1.2239663504942655e-08
Saethre B-Disease 0 0.014961807988584042
- I-Disease 1 0.9994947910308838
Chotzen I-Disease 1 0.9992677569389343
syndrome I-Disease 1 0.9999897480010986
patients O 0 3.701882533846401e-08
, O 0 2.923503106266878e-11
including O 0 1.250600595303908e-10
our O 0 6.666820429046538e-10
five O 0 5.47128748557002e-12
patients O 0 2.091717944685545e-11
elsewhere O 0 3.6218313070879304e-11
reported O 0 2.837855284099078e-08
with O 0 1.2427625768751671e-11
TWIST O 0 1.1625432705386629e-07
mutations O 0 6.401294427860194e-08
. O 0 3.0494486935594978e-09

More O 0 6.683738285051533e-11
than O 0 1.724861919960574e-11
35 O 0 1.3011103479343422e-11
different O 0 4.819412013565283e-13
TWIST O 0 1.799217663744912e-09
mutations O 0 2.5656852198352453e-09
are O 0 3.605748512269802e-12
now O 0 2.4496722358935408e-11
known O 0 2.043341190693937e-11
in O 0 7.142300531386148e-13
the O 0 3.882549663714041e-13
literature O 0 5.898501131973433e-11
. O 0 4.426741750940266e-10

The O 0 5.936515168336598e-11
most O 0 5.2638340734822986e-12
common O 0 2.8610456018207664e-12
phenotypic O 0 1.5939030095779572e-09
features O 0 4.845971091071988e-08
, O 0 3.530577219468256e-11
present O 0 4.536479698835638e-12
in O 0 9.153031251766391e-14
more O 0 3.1251655993949634e-13
than O 0 1.7056993838193701e-12
a O 0 4.952446439054903e-12
third O 0 2.917793437418048e-11
of O 0 9.504445841468367e-13
our O 0 1.182636988339425e-09
patients O 0 3.7396738483685965e-11
with O 0 1.910641512625072e-13
TWIST O 0 4.949743726001543e-09
mutations O 0 6.409049291278279e-09
, O 0 1.023456753374008e-11
are O 0 1.3174817140026995e-12
coronal B-Disease 0 4.124214569856122e-08
synostosis I-Disease 0 3.5012647003895836e-07
, O 0 1.0775978720456436e-10
brachycephaly B-Disease 0 5.123728215039591e-07
, O 0 2.4780260066137316e-09
low B-Disease 0 0.00033419349347241223
frontal I-Disease 1 0.9999992847442627
hairline I-Disease 1 0.9999997615814209
, O 0 2.2217560058379604e-07
facial B-Disease 1 0.8365867733955383
asymmetry I-Disease 0 2.6315849027014337e-05
, O 0 1.8866225914848656e-08
ptosis B-Disease 1 0.645772397518158
, O 0 4.191900604411103e-09
hypertelorism B-Disease 0 0.00025430135428905487
, O 0 7.5388690845557e-09
broad B-Disease 0 2.2123015241959365e-06
great I-Disease 0 5.751846288148954e-07
toes I-Disease 0 0.4486699104309082
, O 0 9.517847621154374e-10
and O 0 4.30829122377574e-10
clinodactyly B-Disease 0 2.0328852770035155e-06
. O 0 5.498737021270017e-09

Significant O 0 1.175248609541768e-08
intra O 0 5.838631409460504e-07
- O 0 0.00025226271827705204
and O 0 1.1942155042632407e-09
interfamilial O 0 2.700597576676955e-07
phenotypic O 0 5.949764769752619e-08
variability O 0 8.455109679061934e-08
is O 0 2.7405740871122575e-11
present O 0 6.066973312623958e-12
for O 0 5.3444177387654626e-14
either O 0 9.602390931007232e-12
TWIST O 0 2.488328654237648e-08
mutations O 0 7.069752427923959e-08
or O 0 2.2390813647632513e-09
FGFR O 0 2.257011374240392e-06
mutations O 0 1.100978295198729e-07
. O 0 5.073728992499582e-09

The O 0 7.923446621038721e-11
overlap O 0 1.2722156661482131e-09
in O 0 3.944716515241753e-12
clinical O 0 6.164765919969284e-10
features O 0 7.439992799618267e-08
and O 0 7.207973662382017e-10
the O 0 2.0162786371069608e-12
presence O 0 2.7355580023424864e-09
, O 0 8.93681656455314e-12
in O 0 9.822317384357987e-14
the O 0 7.000492850336992e-14
same O 0 2.443222490641772e-12
genes O 0 1.5142770717901932e-11
, O 0 1.1257282676565075e-13
of O 0 1.883466273162925e-15
mutations O 0 4.537301957763251e-12
for O 0 8.32220712699075e-14
more O 0 1.7567151075828513e-12
than O 0 1.942487143358207e-11
one O 0 1.840646905726384e-11
craniosynostotic B-Disease 0 2.9926204092589614e-07
condition I-Disease 0 1.891528313535673e-06
- O 0 1.665754822965937e-08
such O 0 2.4570564333137312e-11
as O 0 3.0690221197726686e-11
Saethre B-Disease 0 1.1290376278338954e-07
- I-Disease 0 2.2595517634727003e-07
Chotzen I-Disease 0 3.721747887652782e-08
, I-Disease 0 7.73186896452227e-12
Crouzon I-Disease 0 6.254342377332023e-09
, I-Disease 0 2.182148212126478e-11
and I-Disease 0 2.1129954730358946e-10
Pfeiffer I-Disease 0 0.020453771576285362
syndromes I-Disease 0 9.566881999489851e-06
- O 0 4.498422470078367e-07
support O 0 1.3133957810218533e-10
the O 0 5.96637485510837e-13
hypothesis O 0 1.7329247412045667e-11
that O 0 4.183353967054937e-13
TWIST O 0 1.7069508306821746e-10
and O 0 5.749521084924547e-12
FGFRs O 0 1.909217450801748e-09
are O 0 8.191952975342143e-13
components O 0 1.2153368589284952e-10
of O 0 1.8790323097939328e-14
the O 0 1.0806609649022594e-13
same O 0 8.941551383860602e-13
molecular O 0 4.6087890448465174e-12
pathway O 0 3.1968568417473087e-12
involved O 0 1.5243112761603728e-12
in O 0 1.009030844447388e-13
the O 0 1.1000409432101663e-13
modulation O 0 1.9680412854938822e-10
of O 0 7.446622311835238e-12
craniofacial O 0 0.00027885017334483564
and O 0 2.7486541931409647e-09
limb O 0 0.000365943560609594
development O 0 8.009344854009726e-10
in O 0 1.6009021365503973e-12
humans O 0 2.524075393139924e-11
. O 0 7.502307802775832e-12
. O 0 3.027245953912683e-10

Mutation O 0 1.0254615290250513e-07
analysis O 0 1.0439940023587724e-09
of O 0 1.1705984792609314e-10
UBE3A O 1 0.9823729991912842
in O 0 6.541539914906025e-05
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 7.367588113993406e-05
. O 0 2.703405499460132e-08

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 4.359040758572519e-06
AS B-Disease 1 0.9999990463256836
) O 0 1.780101344106555e-10
is O 0 7.582599131916723e-11
caused O 0 4.0507713849891047e-10
by O 0 4.8430226842755e-12
chromosome O 0 1.1800118045357522e-05
15q11 O 0 1.3503771469913772e-06
- O 0 9.434413072995085e-07
q13 O 0 3.103084011968349e-08
deletions O 0 1.4725183739017211e-08
of O 0 1.2999172051275654e-11
maternal O 0 1.5115385565422912e-07
origin O 0 7.085049907873398e-11
, O 0 1.8472166504746035e-11
by O 0 5.321975499184006e-11
paternal O 0 2.908393980760593e-05
uniparental B-Disease 0 0.0039756158366799355
disomy I-Disease 0 0.01474708691239357
( O 0 7.168562632386966e-08
UPD B-Disease 1 0.9999992847442627
) O 0 3.254712332978471e-10
15 O 0 2.972057669414774e-11
, O 0 1.838119093782245e-13
by O 0 7.478517046084765e-13
imprinting O 0 0.0010071693686768413
defects O 1 0.9998321533203125
, O 0 8.603970313991738e-11
and O 0 6.433289664875552e-12
by O 0 7.053572136095365e-13
mutations O 0 5.758163945657202e-10
in O 0 2.220624075247035e-12
the O 0 1.1156063052519816e-11
UBE3A O 0 4.646722572942963e-06
gene O 0 5.563154559240502e-08
. O 0 3.122264446986378e-09

UBE3A O 0 0.0009259532671421766
encodes O 0 1.1711473035802555e-07
a O 0 1.5533792030453242e-09
ubiquitin O 0 6.856487999584715e-08
- O 0 1.827721831659801e-07
protein O 0 2.9706023751963073e-10
ligase O 0 7.273615598712979e-10
and O 0 1.2860623156696338e-11
shows O 0 3.5595748570926844e-09
brain O 0 4.331909622123931e-06
- O 0 1.4376142871697084e-06
specific O 0 1.1507204078498035e-08
imprinting O 0 1.300990697927773e-05
. O 0 1.4980626517058226e-08

Here O 0 4.180538581977089e-09
we O 0 1.6285103821012115e-10
describe O 0 3.2702895946812305e-09
UBE3A O 0 3.455787737038918e-05
coding O 0 1.5409190382342786e-05
- O 0 1.5890227587078698e-05
region O 0 1.815593542175975e-08
mutations O 0 6.061120672029574e-08
detected O 0 1.0654752635730347e-08
by O 0 2.490902015900298e-12
SSCP O 0 1.1561279933403057e-08
analysis O 0 1.346389943979176e-10
in O 0 8.393056215305617e-12
13 O 0 7.314685523951425e-10
AS B-Disease 1 0.9999940395355225
individuals O 0 2.404625942808991e-10
or O 0 3.619811339561352e-09
families O 0 3.1092437513535742e-09
. O 0 1.5203908132477295e-09

Two O 0 4.184585478128611e-08
identical O 0 1.94892913896183e-06
de O 0 3.011627541127382e-06
novo O 0 1.4124431118034408e-06
5 O 0 8.230508496964717e-10
- O 0 2.8925256856382475e-07
bp O 0 2.8908756277701286e-08
duplications O 0 1.1765538765473593e-08
in O 0 2.574868486829307e-12
exon O 0 7.613413788298828e-10
16 O 0 2.6160829058596846e-10
were O 0 5.73814086524127e-11
found O 0 2.1090414137336921e-10
. O 0 3.7348998893627083e-10

Among O 0 8.161522568883584e-10
the O 0 4.271646404652163e-12
other O 0 2.9313858198459775e-12
11 O 0 4.570525381775159e-12
unique O 0 4.7937448281742956e-12
mutations O 0 1.7958372566795333e-09
, O 0 1.4092985459179808e-11
8 O 0 2.9750747004841926e-11
were O 0 1.0707808771603933e-11
small O 0 1.0094573614505276e-11
deletions O 0 2.5265536329754923e-09
or O 0 3.123507841262807e-10
insertions O 0 2.37199433428259e-08
predicted O 0 5.635176236751249e-08
to O 0 3.3755123696188605e-11
cause O 0 2.1152708473692883e-09
frameshifts O 0 6.600428150704829e-06
, O 0 6.630273552410415e-10
1 O 0 1.1555397264051415e-11
was O 0 5.88425641545598e-10
a O 0 3.880893436475352e-12
mutation O 0 6.53036652531469e-11
to O 0 2.5433648243033957e-13
a O 0 3.7103432305729545e-12
stop O 0 6.734726998303131e-09
codon O 0 1.0967896590940995e-09
, O 0 7.091671434117375e-12
1 O 0 3.953572224376506e-13
was O 0 1.1119036247286829e-11
a O 0 2.960469109442032e-12
missense O 0 2.2140095978784302e-08
mutation O 0 2.2241020136704037e-10
, O 0 5.496044591657423e-12
and O 0 6.322784743689747e-12
1 O 0 9.15740248387531e-13
was O 0 1.7706376365111964e-09
predicted O 0 3.367960843547735e-08
to O 0 7.609181514045549e-12
cause O 0 8.515026878042065e-11
insertion O 0 4.675972942180806e-10
of O 0 1.0709115018381343e-11
an O 0 8.085564162652048e-11
isoleucine O 0 9.115914144786075e-05
in O 0 1.757724868434174e-11
the O 0 3.295330154584608e-12
hect O 0 2.9793099542985146e-08
domain O 0 1.303814500808187e-09
of O 0 5.024660700535255e-13
the O 0 2.4832362728599566e-12
UBE3A O 0 2.181034801651549e-07
protein O 0 8.614018526253986e-11
, O 0 1.496911318857319e-12
which O 0 3.0761040958372787e-13
functions O 0 3.005736284866778e-12
in O 0 9.742997831045305e-14
E2 O 0 7.048834849143759e-10
binding O 0 1.0616766493720675e-10
and O 0 2.378767538849247e-12
ubiquitin O 0 5.361193156083743e-10
transfer O 0 1.1071094041525953e-09
. O 0 1.3672175613876902e-09

Eight O 0 1.0810610184819325e-09
of O 0 3.228055030311122e-13
the O 0 5.884426518103225e-13
cases O 0 3.187202585186455e-11
were O 0 1.2877861277349467e-10
familial O 0 6.712326126034895e-07
, O 0 9.607126205679606e-10
and O 0 1.3638465357068696e-10
five O 0 4.8903073431028066e-12
were O 0 1.673539640201227e-10
sporadic O 0 8.385571163671557e-06
. O 0 9.590708671680659e-09

In O 0 2.6006058417848976e-10
two O 0 8.005029798752172e-12
familial O 0 2.66057014641774e-07
cases O 0 1.9318846522509148e-09
and O 0 1.522522941055371e-10
one O 0 4.295874073134698e-11
sporadic O 0 9.627313374949154e-06
case O 0 1.6592314189267654e-09
, O 0 7.676383834143152e-12
mosaicism O 0 9.995043370736312e-08
for O 0 6.671876159186629e-12
UBE3A O 0 6.2990502556203865e-06
mutations O 0 7.159118631250294e-09
was O 0 7.351905195740471e-10
detected O 0 7.58576419457313e-08
in O 0 2.5711485891755093e-12
the O 0 5.688435833484107e-12
mother O 0 3.3114483244389703e-07
of O 0 1.5576610097253751e-12
three O 0 3.541790638550424e-09
AS B-Disease 1 1.0
sons O 0 6.55349651879078e-07
, O 0 7.992610913387654e-12
in O 0 1.0900974133781771e-12
the O 0 3.363851731885692e-12
maternal O 0 1.1480715045308898e-07
grandfather O 0 2.3743081101201824e-07
of O 0 5.106809072841223e-12
two O 0 2.157854034345874e-10
AS B-Disease 1 0.9999967813491821
first O 0 3.1738202344033795e-11
cousins O 0 1.628828982802588e-08
, O 0 3.59367362257057e-11
and O 0 2.2890099538042108e-11
in O 0 1.1949928893639772e-12
the O 0 5.036648181855341e-12
mother O 0 2.700860193272092e-07
of O 0 8.574178151331269e-13
an O 0 8.292340702986678e-10
AS B-Disease 1 1.0
daughter O 1 0.8384767174720764
. O 0 4.211119630781468e-08

The O 0 9.817101992437571e-12
frequencies O 0 1.19495080497245e-10
with O 0 2.803589608732504e-12
which O 0 6.230591129835483e-12
we O 0 1.0296792932185106e-11
detected O 0 1.525918558176187e-10
mutations O 0 5.935768543352538e-11
were O 0 1.4393658140376964e-11
5 O 0 2.169551647709933e-12
( O 0 6.481047794791583e-13
14 O 0 1.2056346372635307e-11
% O 0 1.7788666319042828e-13
) O 0 1.0539918953887326e-13
of O 0 7.719453738340085e-14
35 O 0 2.0889550506053567e-11
in O 0 5.915305138076699e-13
sporadic O 0 1.5997226000763476e-05
cases O 0 8.561959674580066e-08
and O 0 3.8759112586106426e-10
8 O 0 5.4198354138002e-11
( O 0 1.2719444638167876e-12
80 O 0 8.008164270600915e-11
% O 0 4.695878560133371e-13
) O 0 1.8233206828047188e-13
of O 0 8.480167252005594e-14
10 O 0 5.800962141200294e-12
in O 0 2.100392342690993e-12
familial O 0 2.1971202102122334e-07
cases O 0 1.4988134067195347e-09
. O 0 1.405280891653149e-10
. O 0 1.566548224474218e-09

The O 0 2.7585032924548614e-08
hemochromatosis B-Disease 1 0.9999778270721436
845 O 0 8.024190719879698e-06
G O 0 8.779369090916589e-05
- O 0 9.56405492615886e-05
- O 0 6.073716576793231e-06
> O 0 3.5509745144324256e-10
A O 0 2.6442547804150784e-11
and O 0 1.6162611613662614e-12
187 O 0 6.644296918212333e-11
C O 0 3.224418732017398e-09
- O 0 1.6654696821660764e-07
- O 0 1.1749121995308087e-06
> O 0 5.146604920014397e-09
G O 0 2.045028679731331e-08
mutations O 0 4.3317269771137035e-09
: O 0 7.732237593260916e-12
prevalence O 0 5.744073661162474e-08
in O 0 5.116890852002731e-12
non O 0 1.6698171734219613e-08
- O 0 1.6138703358592466e-05
Caucasian O 0 9.8383168278815e-07
populations O 0 6.342497016476045e-08
. O 0 1.1007652567229798e-09

Hemochromatosis B-Disease 0 0.24014028906822205
, O 0 2.0734054473336982e-08
the O 0 1.5492139127104565e-08
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 0 3.843739493358811e-10
iron I-Disease 0 0.014946439303457737
metabolism I-Disease 0 6.045019745215541e-06
, O 0 4.388564164847786e-11
leads O 0 2.9898325482058397e-10
, O 0 2.9267002016331034e-11
if O 0 1.9668480732981664e-10
untreated O 0 9.352525864869676e-09
, O 0 1.1240703463519242e-12
to O 0 1.6265291197248288e-11
progressive O 0 4.089606591151096e-06
iron B-Disease 1 0.9880651831626892
overload I-Disease 1 0.5764591097831726
and O 0 1.0450926879457256e-07
premature B-Disease 0 5.249299192655599e-06
death I-Disease 0 1.1661386878358826e-07
. O 0 5.266894920197274e-09

The O 0 3.6158782634743147e-09
hemochromatosis B-Disease 1 0.9999983310699463
gene O 0 1.2909274573758012e-06
, O 0 5.69458646904053e-10
HFE O 0 2.7142716589878546e-06
, O 0 1.639637314809761e-10
recently O 0 1.7632208582085696e-08
has O 0 4.3516992787040465e-10
been O 0 7.329555018475986e-11
identified O 0 7.519453504301055e-09
, O 0 2.5324842049812e-12
and O 0 7.39856851998677e-13
characterization O 0 7.638417121036412e-10
of O 0 7.77782836915283e-15
this O 0 9.254038236660572e-14
gene O 0 6.632018823005126e-10
has O 0 1.2454159925567865e-10
shown O 0 6.268320584812415e-11
that O 0 8.58530640242966e-13
it O 0 6.878227371345802e-13
contains O 0 2.0315459384190326e-12
two O 0 9.729237950223749e-14
mutations O 0 3.1443438130995816e-11
that O 0 3.8744861811067233e-13
result O 0 4.894149321921226e-13
in O 0 3.375726144471715e-14
amino O 0 1.2510431059153948e-12
acid O 0 2.2574519022763168e-13
substitutions O 0 6.536843549093119e-12
- O 0 9.80406381079213e-11
cDNA O 0 8.30309848653954e-11
nucleotides O 0 1.482786289586091e-11
845 O 0 3.8637990029677383e-10
G O 0 6.58483090276718e-09
- O 0 3.7196471680545073e-08
- O 0 6.226433413303312e-08
> O 0 1.1039626851561124e-10
A O 0 6.289563054401315e-12
( O 0 1.8960404264429381e-13
C282Y O 0 4.3886897588274465e-11
) O 0 9.968778867707265e-14
and O 0 1.527847130495391e-13
187 O 0 1.631071146201979e-11
C O 0 1.714106412364913e-09
- O 0 1.1651249565147737e-07
- O 0 6.531633403028536e-07
> O 0 2.1979149611439652e-09
G O 0 9.508997145246667e-09
( O 0 8.520903600761631e-12
H63D O 0 3.224894129516542e-08
) O 0 2.680527154408363e-11
. O 0 8.390003969349635e-11

Although O 0 2.484701440153003e-07
hemochromatosis B-Disease 1 0.9999998807907104
is O 0 7.093572396144054e-10
common O 0 1.1293295291980865e-11
in O 0 2.9698842668977876e-13
Caucasians O 0 9.262338673821091e-10
, O 0 3.059435517427378e-12
affecting O 0 4.098528183504868e-10
> O 0 2.1026320684569555e-09
= O 0 4.619605675770799e-08
1 O 0 3.806674073181249e-11
/ O 0 1.2430257356754737e-07
300 O 0 3.5501346307142967e-10
individuals O 0 1.0388483476231336e-11
of O 0 1.8377474834876256e-13
northern O 0 3.5865008740643134e-09
European O 0 6.564481163512381e-12
origin O 0 5.869431676797099e-12
, O 0 1.0800598696653063e-12
it O 0 3.705435264178547e-12
has O 0 1.807967317524195e-11
not O 0 2.604841526938212e-13
been O 0 9.331783392893533e-13
recognized O 0 4.0789241559022194e-13
in O 0 5.280642256474434e-14
other O 0 4.889763182032436e-13
populations O 0 3.2210670242172057e-10
. O 0 2.6348967452349825e-10

The O 0 2.010266085539225e-11
present O 0 2.003971424566209e-12
study O 0 2.720701810544901e-13
used O 0 4.455170499011174e-13
PCR O 0 1.2620960943010573e-09
and O 0 9.303010835640113e-13
restriction O 0 1.1195525062568379e-10
- O 0 3.995972441828144e-10
enzyme O 0 1.0504186062632037e-11
digestion O 0 3.72752349819816e-12
to O 0 4.643407850606941e-14
analyze O 0 9.416878735124534e-12
the O 0 3.2638131021618666e-14
frequency O 0 1.5734850922211052e-11
of O 0 4.8141266634996877e-14
the O 0 1.0910043484954612e-12
845 O 0 1.637091240347388e-09
G O 0 4.1831171415651625e-08
- O 0 2.8178078537166584e-07
- O 0 3.6951522730532815e-08
> O 0 6.818748343739855e-11
A O 0 1.0276878306680892e-11
and O 0 1.4611091199781545e-12
187 O 0 2.2491763659870934e-11
C O 0 7.600891582804081e-10
- O 0 1.2958643047511487e-08
- O 0 4.426687283398678e-08
> O 0 5.189382257242414e-10
G O 0 1.1315191006389114e-09
mutations O 0 1.4323554842210484e-10
in O 0 7.032776596326007e-13
HLA O 0 6.163913894852158e-07
- O 0 4.442208023647254e-08
typed O 0 2.107185892441521e-08
samples O 0 1.9656441752058385e-10
from O 0 2.39342204909343e-12
non O 0 1.2821889106007234e-09
- O 0 2.180044873512088e-07
Caucasian O 0 8.247830862728733e-09
populations O 0 4.291732524919212e-10
, O 0 1.6495855246004276e-12
comprising O 0 6.507319639734166e-13
Australian O 0 1.154633788753856e-12
Aboriginal O 0 1.1797633182875078e-11
, O 0 2.075422217981751e-13
Chinese O 0 1.0835132297675257e-13
, O 0 1.6127804116066596e-13
and O 0 1.3551584984380916e-12
Pacific O 0 4.461919028697636e-11
Islanders O 0 9.704269332555526e-11
. O 0 5.321795781831895e-10

Results O 0 3.3045136405007725e-08
showed O 0 2.031887191833448e-08
that O 0 2.1661899704539245e-12
the O 0 3.5351287327144154e-13
845 O 0 5.135122993493724e-09
G O 0 4.3091424117847055e-07
- O 0 4.602728949976154e-06
- O 0 2.131243718395126e-06
> O 0 3.244763902010561e-10
A O 0 1.1158701566926776e-11
mutation O 0 1.8582535510347498e-10
was O 0 8.663648271012292e-11
present O 0 2.804573630624252e-12
in O 0 4.832037683389148e-14
these O 0 5.4098090211066735e-14
populations O 0 3.0799494898925417e-13
( O 0 1.1448629452228895e-14
allele O 0 7.1061320890131174e-12
frequency O 0 1.1157302859388096e-10
0 O 0 2.1340058626445613e-12
. O 0 1.082270449474787e-12
32 O 0 4.4687725742065254e-12
% O 0 6.254910733241234e-14
) O 0 9.659178838716809e-14
, O 0 2.6106723120117303e-12
and O 0 3.421182434570902e-11
, O 0 2.1871139881807222e-12
furthermore O 0 5.477803540626658e-12
, O 0 1.081680209812086e-12
it O 0 6.953418309890713e-12
was O 0 5.618848941679744e-09
always O 0 5.67260127759539e-10
seen O 0 3.89213494766949e-10
in O 0 4.3710979388995874e-14
conjunction O 0 2.869018390916356e-12
with O 0 1.9146407549686106e-12
HLA O 0 7.10059680386621e-07
haplotypes O 0 7.706762339410034e-09
common O 0 3.83770133727257e-11
in O 0 1.3112569840698085e-12
Caucasians O 0 1.0232074215688058e-10
, O 0 7.83744813839804e-13
suggesting O 0 3.823760058585535e-11
that O 0 1.1564917860168444e-12
845 O 0 1.2826292250522897e-09
G O 0 8.6182853920036e-07
- O 0 1.7282953194808215e-05
- O 0 5.159211468708236e-06
> O 0 4.937323327958154e-10
A O 0 1.7272563934689344e-10
may O 0 3.289905847747576e-11
have O 0 7.487408588101319e-13
been O 0 1.0023770008471544e-12
introduced O 0 1.6609695389913082e-13
into O 0 4.06254721432419e-14
these O 0 8.160431965581472e-14
populations O 0 1.3169515391403541e-12
by O 0 6.399496275781569e-13
Caucasian O 0 2.7729889495731186e-08
admixture O 0 7.621630260246093e-08
. O 0 7.85193332575318e-09

187 O 0 2.230849389661671e-07
C O 0 2.0537670479825465e-06
- O 0 9.511279131402262e-06
- O 0 4.5892074922448955e-06
> O 0 1.3267333898170364e-09
G O 0 4.412868293002248e-09
was O 0 8.032764037269047e-11
present O 0 1.9661034952878076e-12
at O 0 3.058490309973405e-12
an O 0 1.76454784486281e-14
allele O 0 4.815621859610708e-11
frequency O 0 6.555528342389039e-10
of O 0 1.537844677990119e-11
2 O 0 7.636231647012437e-10
. O 0 2.895255590829038e-09

68 O 0 1.4080721939535579e-06
% O 0 4.742963799486688e-10
in O 0 4.314141925643167e-12
the O 0 2.445143046370113e-12
two O 0 2.7508108638163442e-12
populations O 0 9.741767809101631e-11
analyzed O 0 3.6030708971956926e-10
( O 0 1.972097615418611e-12
Australian O 0 7.403572893638355e-11
Aboriginal O 0 1.0336393962973034e-09
and O 0 4.000111006319251e-11
Chinese O 0 4.321455086137016e-12
) O 0 6.491691299098656e-12
. O 0 8.569003839831169e-11

In O 0 2.2180778047609095e-10
the O 0 2.488214495555141e-12
Australian O 0 6.889469897353173e-12
Aboriginal O 0 1.6736409133577546e-11
samples O 0 1.125422411513144e-11
, O 0 1.2230507947554037e-13
187 O 0 1.0201882741367463e-11
C O 0 8.261445416657409e-10
- O 0 5.055137108911367e-08
- O 0 1.3407692733835574e-07
> O 0 1.548952355268085e-10
G O 0 5.385163981408425e-10
was O 0 2.454868773538177e-11
found O 0 7.439265132733186e-13
to O 0 3.774034239962219e-14
be O 0 1.9290088461038774e-13
associated O 0 1.6471025932052186e-11
with O 0 1.268826623629371e-11
HLA O 0 8.102857100311667e-05
haplotypes O 0 4.156980892844331e-08
common O 0 8.393029327091739e-11
in O 0 1.1001087193984738e-12
Caucasians O 0 1.9948284690762819e-10
, O 0 1.026167323857352e-12
suggesting O 0 4.021531024855918e-11
that O 0 1.653800794226834e-12
it O 0 5.779955940948822e-12
was O 0 1.8734095871830725e-11
introduced O 0 1.3591864179290924e-12
by O 0 5.66250659642803e-13
recent O 0 2.42870529243433e-10
admixture O 0 1.154391604529792e-08
. O 0 3.2014868533991603e-09

In O 0 6.80932532581835e-11
the O 0 7.847335520110021e-13
Chinese O 0 6.823502808790682e-13
samples O 0 2.2909306830048992e-12
analyzed O 0 1.9387486407951293e-11
, O 0 4.5144321766076023e-13
187 O 0 2.1460852192567437e-11
C O 0 1.3082087635396533e-09
- O 0 8.736675738418853e-08
- O 0 2.1804088135013444e-07
> O 0 3.147549720861065e-10
G O 0 1.7622618919688193e-09
was O 0 3.038334861482639e-10
present O 0 3.631148506877402e-11
in O 0 6.252707227850929e-13
association O 0 1.4095504277666926e-12
with O 0 1.0617539697920994e-13
a O 0 4.899400763563877e-12
wide O 0 2.1052395937637414e-10
variety O 0 2.2861312842792358e-10
of O 0 5.72457185821218e-12
HLA O 0 5.942958523519337e-06
haplotypes O 0 1.004626248857221e-08
, O 0 8.009596458302681e-12
showing O 0 9.968342817856524e-10
this O 0 1.7825483114315005e-13
mutation O 0 5.65552682810222e-12
to O 0 2.4002509506869385e-13
be O 0 1.2362179422492625e-12
widespread O 0 5.83191758773971e-11
and O 0 2.5857366595105624e-11
likely O 0 3.263625134031223e-11
to O 0 2.2432447880586098e-13
predate O 0 4.96090390988968e-10
the O 0 1.2884180213609125e-13
more O 0 1.3603113318931548e-13
genetically O 0 7.540583608911522e-12
restricted O 0 1.2192002962763127e-10
845 O 0 2.380423191894465e-09
G O 0 9.588469538357458e-07
- O 0 7.316335540963337e-06
- O 0 3.356819661348709e-06
> O 0 1.9686956509445963e-09
A O 0 1.783282271849984e-10
mutation O 0 7.4379471470820135e-09
. O 0 5.672904368481113e-10

Genotype O 0 0.00025918742176145315
- O 0 0.0005018782685510814
phenotype O 0 1.9825121853500605e-05
correlations O 0 3.3987764709308976e-06
in O 0 3.67490997632558e-08
attenuated B-Disease 1 0.9999673366546631
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 0.9999924898147583
coli I-Disease 1 0.9999988079071045
. O 0 2.8042879876011284e-06

Germ O 0 0.0015859961276873946
- O 0 0.00023099426471162587
line O 0 7.531405117333634e-07
mutations O 0 1.2601099719233844e-08
of O 0 6.003554858108329e-13
the O 0 2.2001009954836226e-12
tumor B-Disease 0 1.0892848649746156e-06
suppressor O 0 1.2637838153750636e-06
APC O 0 7.352332431764808e-08
are O 0 8.274830820553802e-11
implicated O 0 8.936492434941101e-08
in O 0 8.335254264579817e-09
attenuated B-Disease 1 0.9999775886535645
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 0.9999994039535522
coli I-Disease 1 1.0
( O 0 4.302463366911979e-06
AAPC B-Disease 1 0.9999991655349731
) O 0 1.4343766174818029e-09
, O 0 1.7607278482434374e-11
a O 0 3.6820047011332235e-11
variant O 0 7.787437425577082e-06
of O 0 1.1082956064001337e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 0.9999983310699463
polyposis I-Disease 1 1.0
( O 0 4.851621611123846e-07
FAP B-Disease 0 6.200932148203719e-06
) O 0 5.580389039749889e-09
. O 0 4.217934002070933e-09

AAPC B-Disease 1 0.9999862909317017
is O 0 1.9447773169645188e-08
recognized O 0 2.15003972958705e-10
by O 0 9.483259446815828e-13
the O 0 2.283460963717343e-13
occurrence O 0 3.1396603095146247e-09
of O 0 1.9498432816261735e-12
< O 0 1.554404605030868e-07
100 O 0 4.671702469316585e-10
colonic B-Disease 0 8.316315870615654e-06
adenomas I-Disease 0 1.0545280019869097e-05
and O 0 3.8794611967318815e-10
a O 0 5.403093944478243e-11
later O 0 9.385885402224403e-10
onset O 0 5.720760964322835e-05
of O 0 1.779137733137759e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 2.300545531852549e-09
age O 0 1.5232419769972694e-08
> O 0 2.089427297846669e-09
40 O 0 1.5838024225445224e-09
years O 0 1.3128949316598693e-10
) O 0 2.36990149726779e-11
. O 0 2.438155233264183e-10

The O 0 1.9554766139684432e-10
aim O 0 2.2740513916374994e-09
of O 0 8.965370763489022e-14
this O 0 1.3401824409346036e-13
study O 0 2.8196764584667577e-13
was O 0 1.1255168672064109e-11
to O 0 3.242842626371978e-12
assess O 0 1.8091533604547294e-08
genotype O 0 1.2410799854478682e-06
- O 0 2.8734970328514464e-05
phenotype O 0 1.1037469676011824e-06
correlations O 0 4.688802448526985e-07
in O 0 5.269387148842952e-09
AAPC B-Disease 1 0.9999988079071045
families O 0 1.2729292109270318e-07
. O 0 4.6926111885170485e-09

By O 0 3.7945338537959117e-10
protein O 0 3.0888276381091373e-09
- O 0 1.0470481015545374e-07
truncation O 0 1.9950212504227238e-07
test O 0 2.0614928430973123e-08
( O 0 2.319253296356738e-12
PTT O 0 6.370534100241798e-10
) O 0 6.595033763892588e-14
assay O 0 9.097275016634043e-12
, O 0 1.0960826566036933e-13
the O 0 3.2571835446902966e-14
entire O 0 1.0325374583119995e-10
coding O 0 1.1401506405661621e-08
region O 0 9.541912815436149e-10
of O 0 3.5767588435313413e-13
the O 0 2.5026313486831153e-12
APC B-Disease 0 7.729414330803763e-10
gene O 0 2.8295613074824644e-10
was O 0 1.376697505994784e-10
screened O 0 1.7896584214582845e-09
in O 0 4.312948869572564e-12
affected O 0 2.705833779259592e-09
individuals O 0 2.921000594180434e-11
from O 0 8.13262998611286e-11
11 O 0 5.602927544146041e-08
AAPC B-Disease 1 0.9999997615814209
kindreds O 0 0.0012790827313438058
, O 0 1.7950291253399087e-09
and O 0 3.661122099929415e-11
their O 0 1.3040067073019634e-12
phenotypic O 0 5.548602022287241e-09
differences O 0 6.30280672098138e-09
were O 0 9.30680588151489e-10
examined O 0 5.30692112477027e-08
. O 0 1.1432815805179075e-09

Five O 0 1.6361962451583167e-08
novel O 0 4.043835488687364e-08
germ O 0 0.00036909140180796385
- O 0 0.00025011904654093087
line O 0 5.1848746807081625e-06
APC B-Disease 0 5.202171848850412e-08
mutations O 0 3.155786743036515e-09
were O 0 4.6281093540878615e-11
identified O 0 1.3696553891051622e-09
in O 0 6.4809151968658885e-12
seven O 0 1.2513743374853448e-09
kindreds O 0 2.7341177428752417e-06
. O 0 9.798783118242227e-09

Mutations O 0 2.2153452050588385e-07
were O 0 7.535788104640062e-10
located O 0 2.6722718260430156e-08
in O 0 1.5533066152761954e-11
three O 0 1.915890189552183e-12
different O 0 4.651468012845106e-13
regions O 0 5.45023019771218e-11
of O 0 7.44387394064315e-14
the O 0 1.0224592440072344e-12
APC B-Disease 0 2.4405280574235633e-10
gene O 0 7.67600635831478e-11
( O 0 1.91017503464036e-13
1 O 0 1.6794366190699822e-13
) O 0 2.588541902527608e-13
at O 0 7.923476458282508e-11
the O 0 7.398428115805433e-13
5 O 0 9.885816124044489e-12
end O 0 4.635284933662831e-10
spanning O 0 2.3667732218513038e-09
exons O 0 1.5471814940326567e-09
4 O 0 3.502848011649462e-11
and O 0 5.5730968451239704e-11
5 O 0 6.650873862062978e-12
, O 0 6.4888437505128405e-12
( O 0 2.1628240919144975e-13
2 O 0 7.557685488719657e-13
) O 0 1.5043665640458725e-13
within O 0 2.3132746261068926e-13
exon O 0 5.040052403204598e-11
9 O 0 6.534730534468736e-10
, O 0 4.033214734411317e-11
and O 0 1.700347154742765e-11
( O 0 2.7743784917003134e-13
3 O 0 7.969392832284095e-13
) O 0 2.1136290959643256e-13
at O 0 6.879572606033335e-11
the O 0 4.3383913540633035e-13
3 O 0 1.2641589164363864e-12
distal O 0 1.6286053394765077e-08
end O 0 5.092579158372246e-08
of O 0 1.012615555642804e-12
the O 0 2.7746446633336586e-12
gene O 0 4.620555493772827e-09
. O 0 5.600870323085871e-10

Variability O 0 2.215557287854608e-06
in O 0 3.1108657316814003e-11
the O 0 4.6913601475795375e-12
number O 0 5.164587646433461e-10
of O 0 2.849755809108956e-08
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 4.368052032077685e-05
most O 0 6.95997703914486e-11
apparent O 0 4.650197449329596e-10
in O 0 1.5752830897358683e-12
individuals O 0 2.801253586731667e-12
with O 0 4.526883154356426e-13
mutations O 0 1.504897761961388e-09
in O 0 6.114451826799705e-12
region O 0 1.7303104504762246e-09
1 O 0 3.2114342435329846e-11
, O 0 1.5667873665137222e-09
and O 0 1.268196427872681e-07
upper O 0 0.1290173977613449
- O 1 0.9999814033508301
gastrointestinal O 1 0.6804799437522888
manifestations O 0 2.446240614517592e-06
were O 0 1.4201311238082326e-09
more O 0 1.7792517459369606e-11
severe O 0 6.961683229889104e-09
in O 0 7.028985032908608e-12
them O 0 9.389658495173592e-11
. O 0 6.996181967089399e-10

In O 0 3.1966954083806343e-10
individuals O 0 8.000591855683581e-11
with O 0 9.493972448482157e-13
mutations O 0 4.3110475189678255e-09
in O 0 1.266954856998792e-11
either O 0 1.1838761082572091e-09
region O 0 4.631666783438959e-08
2 O 0 1.0493783619835995e-09
or O 0 8.438080811856707e-08
region O 0 1.8335400753244357e-08
3 O 0 2.9410762020232184e-11
, O 0 1.4129508327243023e-11
the O 0 1.199459585474183e-12
average O 0 1.0174143749708264e-09
number O 0 1.543171840312496e-11
of O 0 4.712837108414303e-13
adenomas B-Disease 0 5.3015490664165554e-08
tended O 0 8.11008504797428e-09
to O 0 1.3099077378342372e-11
be O 0 9.374926182581511e-12
lower O 0 1.1109326999991787e-11
than O 0 7.1102399142042305e-12
those O 0 1.5993212613626961e-12
in O 0 1.4714449006036218e-13
individuals O 0 7.178259722739888e-13
with O 0 2.6679155304236424e-13
mutations O 0 4.396181751964434e-10
in O 0 5.767995456262831e-12
region O 0 4.204015358055813e-09
1 O 0 1.6957513518378597e-11
, O 0 1.0524159668734434e-11
although O 0 2.550469731243954e-11
age O 0 1.7491573467420807e-10
at O 0 2.414985988963281e-10
diagnosis O 0 1.518515659881814e-07
was O 0 3.4567899653836776e-09
similar O 0 1.4305816531390292e-09
. O 0 2.6450293066915265e-09

In O 0 2.252605924013551e-08
all O 0 3.609802234905146e-08
AAPC B-Disease 1 0.999997615814209
kindreds O 0 7.601710240123793e-05
, O 0 1.2632395129941187e-10
a O 0 6.8000683209334944e-12
predominance O 0 1.4739569564881094e-08
of O 0 3.0371920256566654e-11
right O 0 0.007657775189727545
- O 1 0.999990701675415
sided O 1 0.9999997615814209
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 0 0.0004985610721632838
rectal B-Disease 1 0.9999256134033203
polyp I-Disease 0 0.42459791898727417
sparing O 0 3.1353897611552384e-07
was O 0 2.0758072594162513e-08
observed O 0 2.050606262571364e-08
. O 0 1.933598836600936e-09

No O 0 5.1864367378584575e-06
desmoid B-Disease 0 0.18431833386421204
tumors I-Disease 1 1.0
were O 0 3.656312586031163e-08
found O 0 3.6651762180817116e-10
in O 0 5.340560892824753e-12
these O 0 1.5133018449464686e-10
kindreds O 0 1.5078513797561754e-06
. O 0 1.9985999522020848e-09

Our O 0 5.367293720581756e-09
data O 0 3.4791189373883924e-10
suggest O 0 8.050080047006247e-11
that O 0 3.0627343109573824e-12
, O 0 3.691305507785847e-12
in O 0 4.8459517648646866e-12
AAPC B-Disease 1 1.0
families O 0 7.320170580804586e-10
, O 0 6.523176638607853e-13
the O 0 1.9576518750790035e-14
location O 0 1.619951617293225e-09
of O 0 6.437852638138675e-13
the O 0 8.2089751662906e-12
APC B-Disease 0 7.775467025794569e-08
mutation O 0 2.7738180641279087e-09
may O 0 1.275424488245136e-10
partially O 0 1.529480897488611e-08
predict O 0 6.685083153712412e-09
specific O 0 9.313198545690682e-10
phenotypic O 0 1.6624211411908618e-06
expression O 0 6.904847964506189e-07
. O 0 5.542469594388422e-08

This O 0 7.351060038462975e-11
should O 0 3.995893893549152e-11
help O 0 3.1761197404750474e-12
in O 0 8.758773329016478e-14
the O 0 7.419309307546418e-14
design O 0 6.875539249051599e-09
of O 0 1.4971082099718425e-12
tailored O 0 9.769409281545904e-09
clinical O 0 4.211923254615613e-08
- O 0 2.797231672957423e-07
management O 0 4.66793492748252e-10
protocols O 0 1.0584309470540454e-11
in O 0 4.657022719387928e-14
this O 0 5.1539301933233375e-14
subset O 0 3.032381984402477e-11
of O 0 5.417577194147261e-13
FAP B-Disease 0 2.784989128201687e-08
patients O 0 4.823300092660077e-10
. O 0 8.228333812920763e-12
. O 0 4.4170175850233306e-10

Wilms B-Disease 0 0.21568545699119568
' I-Disease 0 4.694852577813435e-06
tumor I-Disease 0 9.338406925962772e-06
1 O 0 1.6089239662786525e-10
and O 0 1.1349314543718236e-10
Dax O 0 0.41963109374046326
- O 0 2.569392745499499e-05
1 O 0 2.3214142413907624e-11
modulate O 0 1.2467149979045189e-08
the O 0 1.3249189072250811e-11
orphan O 0 3.717817520509925e-08
nuclear O 0 1.501263291459054e-08
receptor O 0 9.280177321047134e-11
SF O 0 4.3815522076329216e-05
- O 0 2.9046165650470357e-07
1 O 0 1.7864464248174006e-12
in O 0 1.3035011709339878e-13
sex O 0 9.471631257085278e-10
- O 0 3.2293900886770643e-10
specific O 0 1.3283095109950516e-11
gene O 0 1.127548499013642e-09
expression O 0 8.631506620560003e-10
. O 0 3.5258412856009613e-10

Products O 0 3.668592896133305e-08
of O 0 5.286624003147944e-12
steroidogenic O 0 2.841056812030729e-07
factor O 0 9.626502261994574e-09
1 O 0 5.0654470201694224e-11
( O 0 2.1505677447186677e-11
SF O 1 0.9970911741256714
- O 0 0.00011306799569865689
1 O 0 2.499317419690783e-11
) O 0 1.5021768551282122e-12
and O 0 1.4356807409576788e-11
Wilms B-Disease 0 9.688775207905564e-06
tumor I-Disease 0 6.204078999871854e-06
1 O 0 1.368967092463258e-11
( O 0 3.3133428726378478e-12
WT1 O 0 4.251350915751573e-08
) O 0 2.107776843687792e-12
genes O 0 4.5582607133276554e-11
are O 0 1.1177137096722231e-13
essential O 0 7.313488465006401e-13
for O 0 3.095974201289785e-14
mammalian O 0 8.39382938155886e-11
gonadogenesis O 0 5.445455641961416e-09
prior O 0 2.4652854410667224e-11
to O 0 1.0430714451892253e-11
sexual O 0 3.5511928953013694e-09
differentiation O 0 1.0245231152339329e-07
. O 0 1.7507744587419438e-08

In O 0 6.779842659510038e-11
males O 0 1.6441475958473006e-09
, O 0 1.832737572815546e-10
SF O 1 0.9990614056587219
- O 0 0.0023889632429927588
1 O 0 2.3830420275983144e-11
participates O 0 4.437865352979742e-11
in O 0 2.0739264255595358e-13
sexual O 0 7.809447533091429e-11
development O 0 1.0151255920923252e-12
by O 0 9.008274676333347e-14
regulating O 0 6.871287983045704e-10
expression O 0 2.0479776208226497e-10
of O 0 3.200839387377391e-13
the O 0 7.467203938515965e-12
polypeptide O 0 2.465078750901739e-06
hormone O 0 7.990351491571346e-09
Mullerian O 0 3.326266906356068e-08
inhibiting O 0 4.558057042913788e-09
substance O 0 8.78985684238387e-09
( O 0 2.8096308613001497e-10
MIS O 0 5.495667937793769e-05
) O 0 5.374338751806818e-10
. O 0 5.792565316298237e-10

Here O 0 2.01204901628671e-08
, O 0 2.9673791202000643e-11
we O 0 6.416280267512731e-12
show O 0 2.392762654679359e-10
that O 0 1.755446482620826e-11
WT1 O 0 1.2214417438372038e-05
- O 0 1.0080256060973625e-06
KTS O 0 4.373898718768032e-06
isoforms O 0 7.572270033229245e-10
associate O 0 8.445383281596719e-10
and O 0 2.819700722911378e-11
synergize O 0 2.7014138481717964e-07
with O 0 1.6068568697846786e-10
SF O 1 0.9997296929359436
- O 0 0.005724082700908184
1 O 0 4.3448546843682934e-11
to O 0 9.206970255637437e-12
promote O 0 3.924212954586892e-09
MIS O 0 0.0017617378616705537
expression O 0 7.15862702449499e-09
. O 0 7.085634856629497e-10

In O 0 6.283142894858429e-10
contrast O 0 4.91820850712088e-09
, O 0 3.2672328731386813e-10
WT1 O 0 3.114543142146431e-05
missense O 0 3.0191154110070784e-06
mutations O 0 2.792707576304565e-08
, O 0 1.6844976802321554e-11
associated O 0 6.23122720089242e-10
with O 0 2.5138910397792813e-10
male B-Disease 0 4.950274160364643e-06
pseudohermaphroditism I-Disease 1 1.0
in O 0 1.4183932250944054e-07
Denys B-Disease 1 0.9999985694885254
- I-Disease 1 0.9999988079071045
Drash I-Disease 1 0.9999902248382568
syndrome I-Disease 1 0.9999995231628418
, O 0 1.4604230047510214e-09
fail O 0 6.6406933285634295e-09
to O 0 1.4321417315943386e-11
synergize O 0 5.5737550610501785e-06
with O 0 2.169401769336332e-09
SF O 1 0.9999638795852661
- O 1 0.9710002541542053
1 O 0 1.3713969515549707e-08
. O 0 5.029907157449998e-09

Additionally O 0 1.5639754380458726e-08
, O 0 2.3327959008945243e-10
the O 0 4.618750694407314e-12
X O 0 0.014772284775972366
- O 0 0.033850979059934616
linked O 0 0.01579929329454899
, O 0 8.702734366483611e-11
candidate O 0 4.0214026553186955e-10
dosage O 0 3.2399992022646984e-08
- O 0 1.237518088004208e-08
sensitive O 0 2.904899076838774e-07
sex O 0 2.5588935415044034e-08
- O 0 1.2904619595133227e-09
reversal O 0 6.352018910860124e-10
gene O 0 4.949241017015993e-10
, O 0 2.7416391639584203e-12
Dax O 0 5.333910849003587e-06
- O 0 2.2294989321380854e-07
1 O 0 6.7145668365686806e-12
, O 0 4.900905202498418e-12
antagonizes O 0 3.720995422895612e-08
synergy O 0 2.097101159392878e-09
between O 0 6.341362851491894e-11
SF O 1 0.8298973441123962
- O 0 6.018075509928167e-05
1 O 0 3.999767531071008e-11
and O 0 9.913610730938327e-12
WT1 O 0 2.0925671861959927e-08
, O 0 8.041891805254942e-13
most O 0 7.133964236407178e-14
likely O 0 9.62769360762783e-13
through O 0 1.3207611951815065e-14
a O 0 5.412681479237402e-13
direct O 0 2.1611438333346555e-11
interaction O 0 9.391575017669851e-11
with O 0 5.5797338971430577e-11
SF O 1 0.9996048808097839
- O 0 0.02032618597149849
1 O 0 4.4150403333276245e-09
. O 0 3.851020835554664e-09

We O 0 2.9952336166871874e-09
propose O 0 1.3044836322251285e-09
that O 0 9.037539813738782e-12
WT1 O 0 4.4515977037917764e-07
and O 0 3.7478448122740815e-10
Dax O 1 0.8145641684532166
- O 0 0.00018265079415868968
1 O 0 8.039825749595053e-12
functionally O 0 1.9982406007645892e-10
oppose O 0 1.9415545560175218e-10
each O 0 2.891226483486137e-13
other O 0 1.876053701494254e-13
in O 0 3.90240221864388e-13
testis O 0 2.7335669727790446e-08
development O 0 2.355314727975344e-11
by O 0 3.517488383897316e-12
modulating O 0 3.8831519333371034e-08
SF O 1 0.9975883960723877
- O 0 0.0004115774645470083
1 O 0 1.728859055916132e-09
- O 0 7.376562507488416e-07
mediated O 0 4.0748915353105986e-07
transactivation O 0 1.0997690878866706e-05
. O 0 1.4195102038261354e-10
. O 0 2.0554560831165247e-10

A O 0 1.0352301238469863e-08
mouse O 0 2.2634692413703306e-06
model O 0 1.3479299241225817e-06
for O 0 9.441950510336028e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 0.9999995231628418
imprinting O 0 0.04727110266685486
- O 0 0.029704725369811058
centre O 0 4.92538265461917e-06
mutations O 0 3.348462087160442e-06
. O 0 6.156778642463223e-09

Imprinting O 0 3.6442647797230165e-06
in O 0 3.2388031145913487e-10
the O 0 1.1361632988593495e-11
15q11 O 0 9.073552575955546e-08
- O 0 5.112677285978862e-07
q13 O 0 6.299948296373259e-08
region O 0 5.724577478716242e-10
involves O 0 3.792918062961448e-11
an O 0 4.4833180137121564e-13
imprinting O 0 1.6663672397498885e-07
centre O 0 2.657754372137333e-08
( O 0 6.429119389639304e-12
IC O 0 2.6461395297161516e-09
) O 0 1.1201344756253673e-12
, O 0 1.9748104247794412e-13
mapping O 0 1.3024245570925075e-10
in O 0 3.0527829071071155e-13
part O 0 5.2336208283820795e-12
to O 0 1.3444664218736913e-12
the O 0 1.0942819323204664e-13
promoter O 0 8.167010889792437e-08
and O 0 3.4499233331208856e-11
first O 0 2.3642838988674475e-12
exon O 0 4.734593828104039e-10
of O 0 7.563042553337951e-11
SNRPN O 0 1.1110975719930138e-05
. O 0 4.833948796800769e-09

Deletion O 0 6.6213817717653e-07
of O 0 2.9438541881976477e-11
this O 0 4.860978980447683e-11
IC O 0 3.8664427393086953e-07
abolishes O 0 1.6384296941396315e-07
local O 0 6.822117870619593e-11
paternally O 0 4.888150773041389e-09
derived O 0 1.3716827153287259e-11
gene O 0 7.811566948845439e-10
expression O 0 1.2998212228776396e-10
and O 0 4.3717383879648963e-11
results O 0 1.4032006667719088e-09
in O 0 2.9216354846539616e-07
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 8.807967333268607e-07
PWS B-Disease 1 0.9999995231628418
) O 0 8.887263369672382e-09
. O 0 4.862485969425734e-09

We O 0 1.8199759921344594e-08
have O 0 4.376975778347392e-12
created O 0 3.143466606805867e-12
two O 0 5.927412423736844e-13
deletion O 0 1.5698871536073966e-08
mutations O 0 5.428914651162131e-09
in O 0 1.2932641069163253e-12
mice O 0 3.450000818361332e-08
to O 0 7.558845910304868e-11
understand O 0 4.84801432776294e-07
PWS B-Disease 1 1.0
and O 0 8.591756195386324e-10
the O 0 1.3244684212224134e-12
mechanism O 0 4.226716546207321e-11
of O 0 2.1601236153533793e-13
this O 0 2.0064431019428675e-11
IC O 0 1.8787949329635012e-07
. O 0 1.118091175200675e-09

Mice O 0 0.00013047784159425646
harbouring O 0 6.035213664290495e-05
an O 0 2.7436874994180016e-10
intragenic O 0 1.1157600283695501e-06
deletion O 0 1.3410927124368754e-07
in O 0 1.0504592334870111e-10
Snrpn O 0 4.046052708872594e-06
are O 0 1.0087764651389719e-10
phenotypically O 0 2.8933852647128333e-08
normal O 0 2.8912543470482888e-09
, O 0 6.235239321389363e-12
suggesting O 0 1.4435455608641234e-10
that O 0 2.1599683847073337e-12
mutations O 0 2.686594002820897e-10
of O 0 6.533424517542186e-13
SNRPN O 0 1.366386186418822e-06
are O 0 2.396675739813059e-11
not O 0 7.250518328089095e-12
sufficient O 0 1.254747694634517e-11
to O 0 3.1910894066067286e-11
induce O 0 1.3569351722253487e-06
PWS B-Disease 1 0.9999995231628418
. O 0 2.3319937270116498e-07

Mice O 0 8.510787665727548e-06
with O 0 1.582360631413593e-11
a O 0 3.3598505921883515e-12
larger O 0 3.367397333198241e-11
deletion O 0 9.181555071791081e-09
involving O 0 6.529597418314381e-10
both O 0 1.3772325294092447e-11
Snrpn O 0 4.033329048525047e-07
and O 0 2.319662656402599e-10
the O 0 3.643038648526442e-11
putative O 0 3.841292254946893e-06
PWS O 1 0.9999995231628418
- O 0 0.0001405966904712841
IC O 0 3.478937458112341e-07
lack O 0 1.709006547390146e-10
expression O 0 1.0016976831339619e-10
of O 0 1.2357388062041869e-13
the O 0 9.6101360376466e-13
imprinted O 0 1.6986122730600073e-08
genes O 0 3.847453022842728e-09
Zfp127 O 0 2.56627874506421e-08
( O 0 1.1872509052268665e-11
mouse O 0 5.600192309884733e-08
homologue O 0 1.0070399980577349e-07
of O 0 2.0850579943165748e-11
ZNF127 O 0 8.060736718107364e-07
) O 0 4.926596977594677e-11
, O 0 3.4326864267741897e-11
Ndn O 0 1.1250940445961533e-07
and O 0 2.4916969529331645e-11
Ipw O 0 8.94914542470815e-09
, O 0 1.316066422507589e-10
and O 0 2.338068801066573e-11
manifest O 0 8.350622415775888e-10
several O 0 7.639253812863345e-12
phenotypes O 0 7.639455290586739e-09
common O 0 9.222375085826684e-10
to O 0 1.2917227820707922e-07
PWS B-Disease 1 1.0
infants O 0 0.0033156294375658035
. O 0 1.1964504054162717e-08

These O 0 1.7973783572600155e-10
data O 0 4.3965928120393016e-10
demonstrate O 0 3.566328066195723e-10
that O 0 2.7157776895381236e-12
both O 0 4.398448022902707e-13
the O 0 4.395764080424719e-13
position O 0 1.312129516151117e-09
of O 0 1.8932721872460395e-13
the O 0 1.7039759360459872e-12
IC O 0 4.215432891641058e-09
and O 0 2.44436554330818e-11
its O 0 1.5660409167367328e-12
role O 0 9.005123036143203e-12
in O 0 5.1444427466877315e-14
the O 0 3.45827153806072e-14
coordinate O 0 1.0893549395873947e-09
expression O 0 3.0486023427922504e-11
of O 0 6.494780977134643e-14
genes O 0 5.778988398930096e-11
is O 0 1.521548837445097e-12
conserved O 0 6.141478298138381e-11
between O 0 7.484841739457959e-12
mouse O 0 2.7702839361154474e-05
and O 0 4.360098670996848e-10
human O 0 5.5345384525340435e-11
, O 0 3.2544112803928327e-12
and O 0 2.1964864822809904e-12
indicate O 0 9.973015469011415e-11
that O 0 2.610084674434243e-12
the O 0 4.092616545138539e-13
mouse O 0 3.0843318654660834e-07
is O 0 3.8618958725367136e-11
a O 0 2.9534419614812846e-12
suitable O 0 4.243488338495638e-10
model O 0 8.690534514244064e-09
system O 0 9.439668491317832e-11
in O 0 2.348681687504295e-13
which O 0 9.946334120908285e-13
to O 0 7.090369415728437e-13
investigate O 0 7.741583069043045e-11
the O 0 1.7489478019040022e-13
molecular O 0 1.8364526913061674e-11
mechanisms O 0 9.71178259340233e-12
of O 0 7.521170101651431e-14
imprinting O 0 1.9951881924384907e-08
in O 0 1.1804160947315179e-11
this O 0 3.118968191356819e-12
region O 0 2.8288812958798815e-10
of O 0 9.223376999222682e-14
the O 0 9.223311133940704e-13
genome O 0 2.455001202328333e-10
. O 0 2.1652986695319676e-11
. O 0 2.3963434014895313e-10

Mutations O 0 1.374114049212949e-07
of O 0 4.212099419254045e-12
the O 0 4.134531692706611e-12
ATM O 0 2.496695827858275e-08
gene O 0 9.103885645345144e-09
detected O 0 5.455157747746853e-08
in O 0 1.3388994080099081e-10
Japanese O 0 0.13838689029216766
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.7299031019210815
: O 0 2.4633031725507237e-10
possible O 0 3.434718620631827e-10
preponderance O 0 1.880307110013746e-08
of O 0 3.6351104418241853e-12
the O 0 4.989699625701505e-12
two O 0 2.2644865583371088e-12
founder O 0 1.3562984069181994e-09
mutations O 0 8.460312450608853e-10
4612del165 O 0 4.979771706103975e-09
and O 0 3.284039429285457e-10
7883del5 O 0 1.3222415873315185e-07
. O 0 3.332247144882672e-09

The O 0 9.346867724246977e-10
ATM O 0 2.3618197246833006e-06
( O 0 4.642737749804837e-09
A O 1 0.9999963045120239
- O 1 0.9999997615814209
T O 1 1.0
, O 0 3.7454848250684236e-11
mutated O 0 1.3154716205221462e-10
) O 0 3.598732097910562e-13
gene O 0 5.576255082684334e-11
on O 0 2.6889098586613258e-11
human O 0 9.617980856191366e-10
chromosome O 0 9.812355528993066e-06
11q22 O 0 4.263769369572401e-06
. O 0 2.4043441015919598e-08

3 O 0 1.572314367592753e-08
has O 0 4.17005052710806e-09
recently O 0 6.8765886318544744e-09
been O 0 8.735129980452783e-11
identified O 0 3.906086842864198e-10
as O 0 6.270463613405539e-14
the O 0 2.343528830332309e-15
gene O 0 1.3694476108661036e-11
responsible O 0 4.480911822146716e-11
for O 0 1.6657285089021617e-13
the O 0 1.2078436124537961e-12
human O 0 1.7001097418756217e-08
recessive B-Disease 1 0.9999594688415527
disease I-Disease 1 0.9999988079071045
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.29429203271865845
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 3.708452656070449e-09
. O 0 2.3530315473863084e-09

In O 0 5.97512733735428e-11
order O 0 7.2370885326189516e-12
to O 0 3.1096051298154515e-13
define O 0 6.022955745255132e-11
the O 0 7.41888917920458e-13
types O 0 1.102317903622918e-09
of O 0 8.244923840883267e-12
disease O 0 0.0018197724130004644
- O 0 0.00012797315139323473
causing O 0 1.9611227344285e-06
ATM O 0 4.33057539339643e-06
mutations O 0 4.260872898953494e-08
in O 0 6.724836659754985e-11
Japanese O 0 2.901175139413681e-05
A B-Disease 1 0.9999983310699463
- I-Disease 1 0.9999996423721313
T I-Disease 1 1.0
patients O 0 2.3562984097225126e-07
as O 0 8.863346688536833e-12
well O 0 7.726297032717433e-12
as O 0 1.8690961051028715e-13
to O 0 1.0824804594355975e-13
look O 0 2.7841885047452664e-11
for O 0 7.673389376162965e-14
possible O 0 5.71975036778305e-11
mutational O 0 3.014406502188649e-07
hotspots O 0 1.5554397236883233e-07
, O 0 6.227540705339152e-11
reverse O 0 6.106149044171616e-07
- O 0 5.738018899137387e-06
transcribed O 0 3.07331504245667e-07
RNA O 0 1.924896464444714e-09
derived O 0 1.0192702584732594e-11
from O 0 6.202640397828807e-13
ten O 0 5.049508120663626e-12
patients O 0 1.4043123218107634e-12
belonging O 0 3.981559006105417e-12
to O 0 1.6097756808108876e-12
eight O 0 1.0420534227173484e-11
unrelated O 0 3.980912044454499e-09
Japanese O 0 1.815558243833948e-05
A B-Disease 1 0.9999971389770508
- I-Disease 1 0.9999988079071045
T I-Disease 1 1.0
families O 0 1.7790059425593086e-09
was O 0 5.020977730807452e-11
analyzed O 0 5.3474641381612287e-11
for O 0 9.00452875782741e-14
mutations O 0 1.5627745625357292e-11
by O 0 3.578824655245741e-14
the O 0 8.776600323237571e-14
restriction O 0 1.4094093947480957e-10
endonuclease O 0 1.4477319609795813e-07
fingerprinting O 0 1.3362754458512427e-08
method O 0 1.9882351320887892e-09
. O 0 1.530524929016508e-09

As O 0 1.0550056384062145e-09
has O 0 1.0591908600199318e-10
been O 0 1.594387989689583e-11
reported O 0 2.257099174229893e-09
by O 0 4.3295212250396564e-13
others O 0 3.8821519783571734e-12
, O 0 5.319420102426094e-14
mutations O 0 6.548099302366994e-12
that O 0 6.3295831249921e-14
lead O 0 2.76770305892432e-13
to O 0 5.175289450459752e-13
exon O 0 1.5975615275110044e-09
skipping O 0 2.10372675724102e-07
or O 0 1.266239291197735e-08
premature O 0 7.0890315839733375e-09
protein O 0 9.093532871151666e-11
truncation O 0 3.5784377683256707e-09
were O 0 4.1281453255770373e-10
also O 0 1.5931020391768413e-11
predominant O 0 6.399737961793051e-10
in O 0 8.224693495706425e-12
our O 0 2.899492590469066e-10
mutants O 0 1.4234232681431536e-09
. O 0 2.40277381324816e-10

Six O 0 2.0793171628952223e-09
different O 0 6.4189860024543854e-12
mutations O 0 3.012609606223293e-10
were O 0 2.6945676592782242e-11
identified O 0 2.800141452041771e-09
on O 0 7.78253683719754e-10
12 O 0 4.5013076599431656e-11
of O 0 4.750344540470353e-13
the O 0 8.452288348392845e-12
16 O 0 4.521106405919184e-11
alleles O 0 6.10604400375081e-10
examined O 0 2.0374685050228436e-07
. O 0 6.607729030605469e-09

Four O 0 3.8887440489965286e-10
were O 0 9.396712574716304e-12
deletions O 0 6.811342601054093e-10
involving O 0 2.555817779636982e-10
a O 0 5.7727749663838424e-11
loss O 0 1.7458851031548761e-09
of O 0 6.64659679291274e-13
a O 0 4.343239309867464e-11
single O 0 2.775986662761909e-10
exon O 0 3.5173530754661897e-09
exon O 0 1.6095945909455622e-08
7 O 0 2.1501065372575567e-09
, O 0 3.071329301995718e-11
exon O 0 1.2380296787739553e-09
16 O 0 2.4139912291332166e-10
, O 0 7.176634286842898e-12
exon O 0 8.190453648637686e-09
33 O 0 8.465918632794e-09
or O 0 1.228528834218423e-09
exon O 0 1.270650358264902e-07
35 O 0 2.4106356022457476e-07
. O 0 1.2832562568121375e-08

The O 0 1.108490660373107e-10
others O 0 4.7910047457078164e-11
were O 0 1.7270371330951884e-12
minute O 0 6.834030737146168e-12
deletions O 0 1.2701766305411866e-09
, O 0 1.2972620373752353e-11
4649delA O 0 7.143128866182735e-10
in O 0 5.894199516486009e-13
exon O 0 6.05633154737717e-10
33 O 0 3.0238025416906567e-09
and O 0 9.889927418682554e-12
7883del5 O 0 5.200926356252467e-10
in O 0 3.316067906378173e-12
exon O 0 2.3047144637189376e-08
55 O 0 4.637969652776519e-08
. O 0 6.036037447643139e-09

The O 0 1.0851612664009025e-10
mutations O 0 3.6383829282726765e-09
4612del165 O 0 1.0577968723168851e-08
and O 0 3.57560300812132e-11
7883del5 O 0 6.935900742632839e-10
were O 0 1.3168467184743182e-11
found O 0 2.4361910058723346e-12
in O 0 9.344277738729256e-15
more O 0 5.061624269676532e-14
than O 0 3.8429125875406867e-13
two O 0 2.858108376162759e-14
unrelated O 0 1.614351707868167e-11
families O 0 5.586344321156789e-12
; O 0 1.0164643649349103e-12
44 O 0 2.7214310666101582e-11
% O 0 1.5064980513068704e-12
( O 0 1.5827973697327136e-12
7 O 0 1.6052546791822664e-10
of O 0 4.78897390493449e-12
16 O 0 4.907380751761892e-11
) O 0 9.691552031385053e-13
of O 0 7.1236846445593e-14
the O 0 3.2951777157591566e-13
mutant O 0 5.6721716212848605e-09
alleles O 0 1.3378399776886596e-10
had O 0 6.360808546546082e-10
one O 0 1.2527384728525104e-12
of O 0 1.279849757939008e-14
the O 0 6.730385563105679e-13
two O 0 6.849899553823535e-12
mutations O 0 2.6167881195249265e-09
. O 0 4.454820401456061e-10

The O 0 5.8629817667466e-10
4612del165 O 0 9.252211441435065e-08
mutations O 0 1.0162414909586914e-08
in O 0 2.83231229268599e-12
three O 0 2.7940643505461327e-13
different O 0 1.7162654760913276e-13
families O 0 6.36932477246499e-12
were O 0 9.741688358766432e-12
all O 0 7.859359186677614e-14
ascribed O 0 8.23338879712976e-12
to O 0 8.688197188598534e-13
the O 0 4.372909911780354e-13
same O 0 7.766044057833099e-11
T O 0 2.7882904305442935e-06
- O 0 4.339047876555924e-08
- O 0 8.432960996174188e-09
> O 0 8.900651049525976e-12
A O 0 5.950634407968225e-13
substitution O 0 1.1653844122355705e-12
at O 0 6.682370368854551e-12
the O 0 2.6408889791250563e-14
splice O 0 1.5721246526823052e-09
donor O 0 1.8058995271408307e-11
site O 0 9.682882273764903e-10
in O 0 6.866905481739405e-12
intron O 0 1.2975407344129053e-06
33 O 0 2.7410852254661222e-08
. O 0 2.676570742821127e-09

Microsatellite O 0 2.7058022169512697e-05
genotyping O 0 2.73606633527379e-06
around O 0 2.0313370541202858e-08
the O 0 3.9401461260357706e-11
ATM O 0 1.184442908197525e-07
locus O 0 6.302566024629641e-09
also O 0 7.72300445817109e-10
indicated O 0 1.7639710137018483e-08
that O 0 6.797885821960281e-13
a O 0 1.3835771721024126e-12
common O 0 2.9184263512782582e-12
haplotype O 0 9.785208732182582e-08
was O 0 1.2042603714235156e-07
shared O 0 1.3382959671015549e-11
by O 0 4.088465948171721e-13
the O 0 2.515105365728104e-13
mutant O 0 1.0548024675927081e-09
alleles O 0 1.123642706657435e-10
in O 0 2.274633389628966e-12
both O 0 1.2227207094039905e-11
mutations O 0 5.934653213301999e-09
. O 0 1.8949595226303018e-09

This O 0 2.9545362684180176e-11
suggests O 0 3.796379877130107e-10
that O 0 1.934186101212876e-12
these O 0 6.319573770535714e-13
two O 0 4.633465919973156e-13
founder O 0 1.4415376670129376e-09
mutations O 0 4.008447795911252e-09
may O 0 4.707559689287599e-11
be O 0 4.532743104468384e-12
predominant O 0 1.600324539552389e-09
among O 0 2.2093365331654624e-11
Japanese O 0 4.661673269623634e-09
ATM O 0 4.302202682993084e-08
mutant O 0 4.1306304154886675e-08
alleles O 0 1.166863583534905e-08
. O 0 2.2307435898483163e-09

W474C O 0 1.571399366184778e-06
amino O 0 4.243716933416408e-09
acid O 0 1.7883940856000535e-11
substitution O 0 4.331869498525043e-12
affects O 0 1.9406613468997413e-11
early O 0 4.591676973537961e-13
processing O 0 5.403475236698263e-11
of O 0 3.923521663812268e-14
the O 0 3.279469659158915e-14
alpha O 0 8.988283750101245e-13
- O 0 1.5622737478682147e-11
subunit O 0 5.618840462351393e-12
of O 0 8.579670584011809e-14
beta O 0 3.023165051629917e-11
- O 0 1.2026089013517094e-09
hexosaminidase O 0 3.1839550995726995e-09
A O 0 1.0638389474904031e-11
and O 0 7.704336842974391e-13
is O 0 8.034931227307585e-13
associated O 0 6.806144536852798e-11
with O 0 1.803221807983313e-11
subacute O 0 0.000512350641656667
G B-Disease 0 1.5136449292185716e-05
( I-Disease 0 4.897191541175516e-10
M2 I-Disease 0 1.0682339052436873e-05
) I-Disease 0 1.6447562201094001e-09
gangliosidosis I-Disease 0 3.0622261419921415e-06
. O 0 9.358610775223042e-09

Mutations O 0 3.928071805603395e-07
in O 0 4.271680925649335e-11
the O 0 2.3578348475050692e-12
HEXA O 0 4.176677975920029e-06
gene O 0 4.98885022182094e-09
, O 0 3.4755802836433647e-12
encoding O 0 6.8990169480032115e-12
the O 0 1.6722957925114496e-13
alpha O 0 2.628048169708852e-12
- O 0 5.4363697571391256e-11
subunit O 0 6.295732164762757e-12
of O 0 1.4753820452677313e-13
beta O 0 8.861220784917023e-11
- O 0 3.9295098730462996e-08
hexosaminidase O 0 8.154886188549426e-08
A O 0 1.1501136154556946e-10
( O 0 4.704610724430569e-13
Hex O 0 1.0367744163186643e-10
A O 0 1.806408429956552e-12
) O 0 6.796249489831457e-14
, O 0 1.7444758745183142e-14
that O 0 4.153449434970806e-14
abolish O 0 2.1871746080925902e-10
Hex O 0 1.2248133618442125e-09
A O 0 2.8062751775137507e-12
enzyme O 0 1.6817182368900063e-10
activity O 0 3.292327477311119e-08
cause O 0 1.5401770724565722e-05
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 0.9849352836608887
( O 0 1.7310160249639495e-10
TSD B-Disease 0 6.514851065730909e-06
) O 0 7.795874362725996e-11
, O 0 9.846449176842409e-12
the O 0 4.322402678835768e-12
fatal O 0 2.896931255236268e-05
infantile B-Disease 0 0.033958058804273605
form I-Disease 0 3.4525464709389553e-09
of I-Disease 0 6.225830267991839e-11
G I-Disease 0 4.320048446970759e-06
( I-Disease 0 5.8175412404049e-11
M2 I-Disease 0 9.500205919721338e-07
) I-Disease 0 5.121921983763933e-11
gangliosidosis I-Disease 0 3.537930126640276e-08
, I-Disease 0 6.49113679473956e-11
Type I-Disease 0 6.614843783836477e-08
1 I-Disease 0 3.7311478906509876e-10
. O 0 4.854534996212578e-09

Less O 0 9.69865823208238e-08
severe O 0 6.786709946027258e-06
, O 0 1.7644243843761842e-09
subacute O 0 0.0004954625037498772
( O 0 2.607640325891225e-09
juvenile O 0 0.14919953048229218
- O 1 0.9940817952156067
onset O 1 0.6397417783737183
) O 0 2.9437183357572394e-08
and O 0 3.3512179697936517e-07
chronic O 1 0.5826182961463928
( O 0 4.4528750131611616e-10
adult O 0 0.000226463089347817
- O 1 0.848054051399231
onset O 0 0.000900985614862293
) O 0 2.4515138183356378e-11
variants O 0 5.354979237814916e-10
are O 0 1.3588597478145226e-12
characterized O 0 1.5815699444532427e-11
by O 0 2.002510841609545e-13
a O 0 9.180911239581313e-12
broad O 0 3.787606617233763e-10
spectrum O 0 8.046615040946392e-10
of O 0 9.783879435787401e-13
clinical O 0 1.9523282990263624e-09
manifestations O 0 1.5325170021895929e-09
and O 0 3.2924669934875084e-11
are O 0 4.1817027271462415e-13
associated O 0 6.119449391661647e-11
with O 0 1.004423540867938e-11
residual O 0 1.0172005204367451e-05
levels O 0 1.6037477124086763e-08
of O 0 1.000009103302446e-12
Hex O 0 5.9413696185117715e-09
A O 0 2.9136169171772863e-11
enzyme O 0 4.1785197524291107e-10
activity O 0 1.2821357309178438e-08
. O 0 6.891461290514656e-10

We O 0 8.66388827347464e-09
identified O 0 6.055372314683893e-10
a O 0 9.724980369607561e-12
1422 O 0 2.9194742978688737e-07
G O 0 1.6679583495715633e-05
- O 0 0.0026433314196765423
- O 0 0.0006606095703318715
> O 0 5.838337102659352e-08
C O 0 6.215445580437517e-08
( O 0 1.2613794557470026e-12
amino O 0 3.892517384807004e-12
acid O 0 1.8012467331487286e-13
W474C O 0 2.8668083532079613e-12
) O 0 2.0210343764341535e-15
substitution O 0 1.072512524890332e-14
in O 0 4.3584249707559475e-15
the O 0 4.09951876251583e-15
first O 0 2.7696042074337734e-13
position O 0 1.6185200749085915e-11
of O 0 1.9334428264135284e-14
exon O 0 7.76952599479408e-11
13 O 0 2.9602334472578207e-11
of O 0 1.1557772967851765e-12
HEXA O 0 3.850579378195107e-05
of O 0 4.4769114630749396e-12
a O 0 3.888254440642669e-10
non O 0 1.1772431030010466e-08
- O 0 9.742004181134689e-08
Jewish O 0 7.836163717911404e-09
proband O 0 3.0094856811047066e-06
who O 0 4.069923564831157e-10
manifested O 0 6.617866810110229e-10
a O 0 1.6138314642977214e-11
subacute O 0 1.4129726650935481e-06
variant O 0 5.922946115788363e-07
of O 0 7.333218754457249e-11
G B-Disease 0 1.716599399514962e-06
( I-Disease 0 1.4363552014451386e-10
M2 I-Disease 0 1.151722335634986e-05
) I-Disease 0 1.868992960396554e-09
gangliosidosis I-Disease 0 4.93451352667762e-06
. O 0 6.935521046358417e-09

On O 0 8.60299387284158e-09
the O 0 3.411187304847019e-11
second O 0 2.729937664813775e-10
maternally O 0 8.715055628272239e-06
inherited O 0 5.3841395128984004e-06
allele O 0 2.7816341230391117e-08
, O 0 4.36447301910281e-11
we O 0 2.326147954812008e-11
identified O 0 1.621697359732721e-10
the O 0 6.788815928686354e-13
common O 0 1.2439164143174253e-09
infantile O 1 0.7419730424880981
disease O 1 0.9919272661209106
- O 0 0.0016503108199685812
causing O 0 2.1126404590177117e-06
4 O 0 1.3232785978090078e-09
- O 0 1.4957947769289603e-06
bp O 0 5.88358872732897e-08
insertion O 0 2.112662045306024e-09
, O 0 3.516799004787963e-11
+ O 0 2.729522607936019e-09
TATC O 0 6.914799399737603e-08
1278 O 0 1.1448766912280917e-07
, O 0 6.22851492604326e-11
in O 0 2.92381960656507e-12
exon O 0 2.9091674846881688e-08
11 O 0 7.471503415956704e-09
. O 0 3.599480713489811e-09

Pulse O 0 2.2758003979106434e-05
- O 0 1.1506598411870073e-06
chase O 0 1.6850785655719847e-08
analysis O 0 7.150554454105063e-11
using O 0 1.805579470659513e-11
proband O 0 6.859480095045001e-09
fibroblasts O 0 3.024033023990569e-09
revealed O 0 3.533194625759961e-09
that O 0 4.483294378104796e-12
the O 0 2.742280957434423e-13
W474C O 0 1.0906107128505482e-09
- O 0 4.4729642212359977e-10
containing O 0 1.7339726876564043e-11
alpha O 0 5.698589603669868e-12
- O 0 5.458802507241067e-11
subunit O 0 5.551144613424874e-12
precursor O 0 4.237021757752535e-12
was O 0 1.4126005053183288e-11
normally O 0 5.544739472250482e-13
synthesized O 0 1.2505491434056104e-12
, O 0 2.2572623024214034e-13
but O 0 1.3667350942398598e-13
not O 0 5.332219786698643e-14
phosphorylated O 0 3.181054811923767e-12
or O 0 3.873210346200251e-12
secreted O 0 2.045197344813232e-11
, O 0 7.229886828108434e-12
and O 0 1.1648716713441587e-11
the O 0 1.2921421745082373e-12
mature O 0 1.485312650650883e-09
lysosomal O 0 1.6477933684200252e-08
alpha O 0 3.81523666825867e-11
- O 0 1.2830329021440434e-09
subunit O 0 5.3767452296016316e-11
was O 0 3.340677456886709e-10
not O 0 3.263650114049277e-11
detected O 0 1.6888366261014198e-08
. O 0 2.3354848610601664e-10

When O 0 1.8559592751543619e-09
the O 0 5.617083187470229e-12
W474C O 0 6.784325101705235e-09
- O 0 1.7432563170771687e-09
containing O 0 8.428896469681035e-12
alpha O 0 5.9773921923245155e-12
- O 0 1.7680888697579888e-10
subunit O 0 2.1350005097175995e-11
was O 0 1.3002948717755203e-10
transiently O 0 2.4576962687206105e-09
co O 0 7.531941292882038e-09
- O 0 7.583388139664748e-09
expressed O 0 1.8704567408822648e-11
with O 0 1.760081474013256e-13
the O 0 2.7647155398380363e-14
beta O 0 1.1049475136942766e-12
- O 0 1.509049482595337e-11
subunit O 0 9.579903060066841e-13
to O 0 2.718870593075573e-13
produce O 0 4.1747494350374836e-11
Hex O 0 1.5749219706151507e-09
A O 0 2.121224029760782e-11
( O 0 3.296761735133158e-13
alphabeta O 0 4.643656570380017e-10
) O 0 5.256988420965225e-13
in O 0 4.514105018602055e-13
COS O 0 0.00043909260421060026
- O 0 8.17519151041779e-07
7 O 0 5.0975574455991435e-11
cells O 0 5.367820424262426e-11
, O 0 3.780224831079204e-13
the O 0 3.330719557039126e-14
mature O 0 2.2549195149990098e-11
alpha O 0 2.7682537252077255e-12
- O 0 3.5656734509448285e-11
subunit O 0 1.9272261737868224e-12
was O 0 2.922321412635043e-11
present O 0 4.0161784488346175e-12
, O 0 1.4349134944482977e-12
but O 0 1.1380539522917732e-12
its O 0 1.6765985301481212e-12
level O 0 6.213537063343155e-12
was O 0 1.2273049763977806e-11
much O 0 1.8751458719101777e-12
lower O 0 1.067992569381282e-11
than O 0 2.9209935251822694e-12
that O 0 4.3101915266074986e-13
from O 0 2.3573738379650648e-14
normal O 0 2.51064924058908e-12
alpha O 0 1.2594844600848781e-13
- O 0 2.3087589132164688e-11
subunit O 0 4.518345333298646e-12
transfections O 0 2.974032409230887e-10
, O 0 1.9119647813765905e-13
although O 0 1.8715137065409247e-14
higher O 0 4.9691513111325275e-14
than O 0 2.1898846939375632e-13
in O 0 1.1678047309553186e-13
those O 0 1.098320327914959e-12
cells O 0 7.767285079007813e-12
transfected O 0 1.4454363261862113e-09
with O 0 1.0491466636425306e-12
an O 0 6.192025516459088e-13
alpha O 0 2.2853541975509373e-11
- O 0 3.6996639085629113e-09
subunit O 0 3.967780271008081e-10
associated O 0 2.740561111380657e-09
with O 0 2.9177335547636574e-10
infantile O 0 0.03990211710333824
TSD B-Disease 0 0.0036105490289628506
. O 0 4.569017875155623e-08

Furthermore O 0 5.276208270288407e-08
, O 0 6.960905463149203e-11
the O 0 1.6143253997024515e-13
precursor O 0 1.6069395814000131e-10
level O 0 1.9203333367912023e-10
of O 0 6.082307780260615e-14
the O 0 1.9155091738037172e-13
W474C O 0 5.916588885490626e-10
alpha O 0 4.12731437568481e-12
- O 0 2.6319321722034772e-11
subunit O 0 3.461561549553127e-12
was O 0 1.1652338816059427e-11
found O 0 1.8279355893519034e-12
to O 0 1.724833790335209e-13
accumulate O 0 5.981205114524712e-11
in O 0 2.9862017806442376e-14
comparison O 0 6.182811641136654e-12
to O 0 8.22685506957771e-13
the O 0 6.772736532842036e-14
normal O 0 4.753213100894271e-11
alpha O 0 2.2572175031876363e-11
- O 0 1.1021497048346873e-09
subunit O 0 5.122940960333722e-10
precursor O 0 1.0617541290613985e-09
levels O 0 1.2761406376071704e-09
. O 0 2.0373414066909845e-10

We O 0 1.328792986754479e-08
conclude O 0 6.278542685755895e-10
that O 0 6.367571942812733e-13
the O 0 2.385363499605997e-13
1422 O 0 2.3115559244502037e-08
G O 0 9.12528662411205e-07
- O 0 7.108736463123932e-05
- O 0 4.1214989323634654e-05
> O 0 7.759063613832495e-09
C O 0 6.657725037939599e-09
mutation O 0 1.4738429920946317e-10
is O 0 6.807007214837402e-13
the O 0 2.7969315909539064e-14
cause O 0 3.9829507747501935e-11
of O 0 2.298713086199e-12
Hex B-Disease 0 6.249385478440672e-05
A I-Disease 0 2.0764903183589922e-06
enzyme I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.0300942737684338e-10
the O 0 3.108376611660191e-10
proband O 0 2.0395289539010264e-05
. O 0 8.464642320404892e-09

The O 0 4.3435123553425825e-11
resulting O 0 1.0337197070553472e-10
W474C O 0 2.389753506193415e-09
substitution O 0 1.2837690632760967e-10
clearly O 0 1.3565518708347213e-09
interferes O 0 2.990267589098039e-09
with O 0 3.519600789200078e-13
alpha O 0 2.4280913651225644e-12
- O 0 1.4548666958658085e-11
subunit O 0 1.6128212047133994e-12
processing O 0 3.470064166566367e-11
, O 0 2.0021900532917608e-13
but O 0 2.8138402320535862e-14
because O 0 1.7544061499787447e-14
the O 0 3.689054643089395e-15
base O 0 1.007722117557508e-11
substitution O 0 3.250670132376454e-12
falls O 0 4.203774661704074e-09
at O 0 1.5488128141116775e-11
the O 0 4.028380615737383e-14
first O 0 5.0189334025591e-13
position O 0 5.777001706869234e-12
of O 0 2.635982456074791e-14
exon O 0 2.402718857208441e-10
13 O 0 4.252958055173117e-11
, O 0 3.465933323763132e-13
aberrant O 0 1.5771424444199766e-10
splicing O 0 4.2847636549936396e-10
may O 0 7.465256190997138e-11
also O 0 2.0596098611325164e-12
contribute O 0 1.1937405924866695e-11
to O 0 9.686294821786845e-11
Hex B-Disease 0 2.5681607439764775e-05
A I-Disease 0 9.364398323441492e-08
deficiency I-Disease 0 0.0013548627030104399
in O 0 1.518887121111645e-12
this O 0 1.503754239184918e-11
proband O 0 2.3211835298297956e-07
. O 0 9.60457546828053e-11
. O 0 4.344674620071487e-10

Two O 0 1.4883194232595542e-08
frequent O 0 2.5964209271478467e-06
missense O 0 0.0014327234821394086
mutations O 0 0.0001967718271771446
in O 0 1.1930956134165172e-06
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.8295492054676288e-06

Pendred B-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
is O 0 1.6352452121282113e-06
an O 0 2.0835896066273563e-05
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 0.19010750949382782
by O 0 7.097392451527185e-09
early O 0 1.690134240561747e-06
childhood O 1 0.9998396635055542
deafness B-Disease 1 1.0
and O 0 0.27075427770614624
goiter B-Disease 1 1.0
. O 0 8.67970186391176e-07

A O 0 1.50734236203931e-09
century O 0 2.8113245065242154e-10
after O 0 2.4829676509297016e-11
its O 0 1.2646653472711544e-12
recognition O 0 1.2879181228442338e-11
as O 0 4.487546619025284e-12
a O 0 2.309301777581041e-10
syndrome O 0 0.002256248379126191
by O 0 3.977604270261059e-12
Vaughan O 0 1.2816093430956244e-07
Pendred O 0 3.0102583536972816e-07
, O 0 2.2443255587312194e-11
the O 0 7.386344140491996e-13
disease O 0 4.138768971984064e-08
gene O 0 5.98648375316202e-09
( O 0 5.301823910452974e-11
PDS O 0 3.024949251084763e-07
) O 0 1.9452529864683044e-11
was O 0 4.330758529569323e-10
mapped O 0 8.423110386956978e-08
to O 0 3.972685375108753e-11
chromosome O 0 7.531752544309711e-06
7q22 O 0 6.611805929424008e-06
- O 0 7.812042895238847e-05
q31 O 0 7.185055892477976e-06
. O 0 9.072925521991237e-09

1 O 0 3.0674101036964885e-09
and O 0 3.831040484847392e-10
, O 0 2.2344502983995262e-11
recently O 0 3.6285350279996464e-09
, O 0 2.209542011161192e-12
found O 0 1.1115849993942328e-12
to O 0 4.734777023576719e-13
encode O 0 4.824901034261586e-10
a O 0 1.27317628662027e-10
putative O 0 1.0992346233251737e-07
sulfate O 0 4.2947419842676027e-07
transporter O 0 5.981583854008932e-06
. O 0 1.6503662436662125e-08

We O 0 6.004872599163491e-09
performed O 0 1.3767054163338344e-10
mutation O 0 2.3644969662783843e-11
analysis O 0 6.043528091165262e-12
of O 0 9.389751210722372e-14
the O 0 5.773914332762864e-13
PDS B-Disease 0 2.1863343135919422e-08
gene O 0 9.350612506509037e-10
in O 0 2.7676413678207057e-12
patients O 0 2.769475100639074e-11
from O 0 1.2744116742804956e-12
14 O 0 1.1465194765802877e-10
Pendred B-Disease 0 2.2669291865895502e-07
families O 0 1.1769814289852576e-10
originating O 0 8.701207115935361e-11
from O 0 5.197807462220538e-12
seven O 0 1.6865743177052472e-11
countries O 0 1.275698188578367e-12
and O 0 1.5080447741261382e-12
identified O 0 8.336614037984802e-11
all O 0 1.0197151283086736e-12
mutations O 0 6.942532104758925e-10
. O 0 2.3106630497871095e-10

The O 0 1.1014493483951782e-10
mutations O 0 5.004499925576056e-09
include O 0 5.356243226728452e-11
three O 0 7.51235965795738e-12
single O 0 1.0817721718403561e-10
base O 0 2.857346803608607e-09
deletions O 0 3.116471347652805e-08
, O 0 1.2688683437289683e-10
one O 0 9.48865465366655e-12
splice O 0 1.2235862811849074e-07
site O 0 1.1272893374325577e-07
mutation O 0 9.100934228456481e-09
and O 0 1.0724594129429832e-10
10 O 0 5.1574782639063343e-11
missense O 0 7.250082489917986e-07
mutations O 0 3.038830982404761e-07
. O 0 1.017785677959182e-08

One O 0 5.401265656956866e-09
missense O 0 3.4650608995434595e-06
mutation O 0 1.1928274368244729e-08
( O 0 5.831180156790072e-12
L236P O 0 2.7821263071103886e-09
) O 0 1.1089024663790692e-11
was O 0 2.6084745474719284e-10
found O 0 2.1570627228850725e-11
in O 0 2.607267158248605e-13
a O 0 5.394462220670304e-12
homozygous O 0 6.42643227521944e-09
state O 0 3.284451183249715e-11
in O 0 1.5026123791408996e-12
two O 0 2.7429521327893003e-12
consanguineous O 0 9.735094153029422e-08
families O 0 4.630266170480013e-10
and O 0 1.1216551125403651e-11
in O 0 3.034675646624435e-13
a O 0 4.1976309581026605e-12
heterozygous O 0 4.647794649148551e-10
state O 0 4.618081091145587e-12
in O 0 1.440771438786237e-12
five O 0 2.6207350092150028e-12
additional O 0 4.6544549464622165e-11
non O 0 8.045655874866497e-08
- O 0 7.924248347990215e-05
consanguineous O 0 6.473224493674934e-05
families O 0 2.4339991355759594e-08
. O 0 3.492511169156387e-09

Another O 0 2.658368103425346e-08
missense O 0 1.6406687791459262e-05
mutation O 0 4.137663722758589e-08
( O 0 2.4142479682076612e-11
T416P O 0 5.820344206597383e-09
) O 0 8.593009984125821e-12
was O 0 1.39813993715876e-10
found O 0 1.8123454126328653e-11
in O 0 9.768248222016135e-14
a O 0 1.5640618140910778e-12
homozygous O 0 1.0941818562315575e-09
state O 0 9.714820961570503e-12
in O 0 2.3629041431827424e-12
one O 0 1.9677476661983384e-11
family O 0 8.982007915214751e-10
and O 0 2.3653764710807046e-11
in O 0 3.624509004561405e-13
a O 0 8.063829118332144e-12
heterozygous O 0 1.0867275967996193e-09
state O 0 1.397139608866338e-11
in O 0 1.0195113850364201e-11
four O 0 4.9964546389169584e-11
families O 0 2.25243185214552e-10
. O 0 5.00481212029058e-10

Pendred B-Disease 0 0.0005775032914243639
patients O 0 5.776402758783661e-06
in O 0 8.666260070677723e-11
three O 0 1.4874154685706742e-10
non O 0 9.639421705287532e-08
- O 0 5.262857666821219e-05
consanguineous O 0 2.3835718820919283e-05
families O 0 6.328546020561987e-10
were O 0 1.8553309930058326e-11
shown O 0 1.7595697468508753e-11
to O 0 1.654380435813299e-13
be O 0 5.621753063067558e-13
compound O 0 7.929376599769e-10
heterozygotes O 0 9.47602218914767e-10
for O 0 2.31589357066464e-12
L236P O 0 1.2080811906400868e-08
and O 0 2.3848664709724687e-10
T416P O 0 8.265488560255108e-08
. O 0 1.4170654649703351e-09

In O 0 4.4104089824692494e-10
total O 0 1.50534487652898e-10
, O 0 2.6420367629786945e-11
one O 0 7.645464122907342e-12
or O 0 6.975525712604735e-11
both O 0 4.0520711785951846e-13
of O 0 3.445998369468184e-14
these O 0 1.0666686717925034e-12
mutations O 0 8.162311798676214e-11
were O 0 1.1947063130457458e-11
found O 0 9.208906553981322e-11
in O 0 8.757709184584184e-13
nine O 0 1.500007236476808e-11
of O 0 1.7014711308719482e-13
the O 0 3.994215548586144e-12
14 O 0 2.5292140604094016e-10
families O 0 8.447585686521819e-11
analyzed O 0 3.1719895599024994e-09
. O 0 1.6924829315811962e-09

The O 0 1.1284875811590211e-11
identification O 0 2.497193285488919e-10
of O 0 8.533260361341666e-13
two O 0 5.0553866648428425e-12
frequent O 0 1.1196800642210292e-07
PDS B-Disease 0 3.168253670082777e-06
mutations O 0 3.3725620074420704e-09
will O 0 4.898951903864468e-12
facilitate O 0 8.76540073163623e-12
the O 0 7.099706564837882e-13
molecular O 0 1.0208477618789402e-08
diagnosis O 0 0.00012327192234806716
of O 0 2.2185545844877197e-07
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 5.816772841171769e-07

Insertional O 0 3.761921834666282e-05
mutation O 0 1.3704053003493755e-07
by O 0 1.2853763886599978e-10
transposable O 0 7.190390078903874e-07
element O 0 3.9916645988569144e-08
, O 0 2.0662696553763737e-10
L1 O 0 4.6180112178717536e-08
, O 0 6.079518832802222e-12
in O 0 1.100051514181348e-13
the O 0 2.1410102423596866e-12
DMD B-Disease 1 0.999998927116394
gene O 0 1.5295456989861123e-07
results O 0 1.0279711526450797e-09
in O 0 1.0617515200372907e-10
X B-Disease 1 0.999962568283081
- I-Disease 1 0.999997615814209
linked I-Disease 1 0.9999964237213135
dilated I-Disease 1 0.9999779462814331
cardiomyopathy I-Disease 1 1.0
. O 0 1.206855699820153e-06

X B-Disease 1 0.999397873878479
- I-Disease 1 0.9999788999557495
linked I-Disease 1 0.999992847442627
dilated I-Disease 1 0.9999836683273315
cardiomyopathy I-Disease 1 1.0
( O 0 2.844737778673334e-08
XLDCM B-Disease 0 5.926418452872895e-05
) O 0 8.243670329699526e-11
is O 0 4.860459604238976e-11
a O 0 2.637469929955838e-11
clinical O 0 8.091667780263379e-09
phenotype O 0 1.3415720090392824e-08
of O 0 2.0890934381706527e-12
dystrophinopathy B-Disease 0 2.2805256776337046e-06
which O 0 2.0434982872519214e-10
is O 0 2.3205685636962237e-11
characterized O 0 4.2843550929205776e-10
by O 0 6.886685232493361e-12
preferential O 0 3.2387330861638475e-07
myocardial B-Disease 1 0.6247820258140564
involvement I-Disease 0 8.993944788926456e-07
without O 0 1.0839242003957139e-10
any O 0 1.5122168794956536e-10
overt O 0 4.3095365498402316e-08
clinical O 0 7.228963028182989e-08
signs O 0 9.509614642411179e-07
of O 0 1.041661423784035e-08
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 2.417666655674111e-05

To O 0 2.670974830198958e-10
date O 0 9.266773459692956e-10
, O 0 2.8185322999141338e-12
several O 0 3.6874268829339973e-13
mutations O 0 1.4694025163297653e-10
in O 0 1.2014331586887583e-12
the O 0 4.9131591156603704e-11
Duchenne B-Disease 0 0.002177841728553176
muscular I-Disease 0 5.909145784244174e-06
dystrophy I-Disease 0 7.863378414185718e-06
gene O 0 1.4669392385258107e-06
, O 0 1.076430056201616e-08
DMD O 1 0.9999998807907104
, O 0 4.026685651581374e-09
have O 0 3.984652885424822e-11
been O 0 5.344313880328855e-11
identified O 0 5.083725884702517e-09
in O 0 4.721666200385721e-12
patients O 0 1.399271115642975e-10
with O 0 3.1936632158280354e-12
XLDCM B-Disease 0 2.0823938029934652e-05
, O 0 4.9686851855135217e-11
but O 0 7.941958180511521e-13
a O 0 2.3115236395983285e-13
pathogenic O 0 1.6342132508340157e-11
correlation O 0 2.0742846676413684e-11
of O 0 3.082722201423402e-14
these O 0 4.469036685855743e-12
cardiospecific O 0 1.4819747207184264e-07
mutations O 0 1.197758781046332e-08
in O 0 4.2113704884494396e-11
DMD O 1 0.9999997615814209
with O 0 1.9511472992839174e-10
the O 0 7.73585570601476e-11
XLDCM B-Disease 0 5.4516654927283525e-05
phenotype O 0 6.824026854701515e-07
has O 0 1.3209164428928943e-08
remained O 0 1.1166463309564278e-09
to O 0 4.918820125515699e-12
be O 0 1.165118834745016e-10
elucidated O 0 9.938279532661909e-08
. O 0 1.6305657934978512e-09

We O 0 5.958543169981567e-08
report O 0 4.2706485570143116e-10
here O 0 2.665287478567646e-12
the O 0 1.0884881591986112e-14
identification O 0 8.45175578828572e-12
of O 0 8.057825104856517e-14
a O 0 5.39615262196147e-11
unique O 0 1.4941494708153868e-09
de O 0 1.177734066004632e-05
novo O 0 4.090936727152439e-06
L1 O 0 6.055700652041196e-08
insertion O 0 2.0720118676376131e-10
in O 0 7.551705029536226e-13
the O 0 4.0319261601293177e-13
muscle O 0 1.2484728806327894e-09
exon O 0 2.6039523870480252e-09
1 O 0 1.4890050303861813e-10
in O 0 2.1849105857896234e-10
DMD O 1 1.0
in O 0 4.235911066352571e-10
three O 0 1.2048582964663268e-10
XLDCM B-Disease 0 1.0176061550737359e-05
patients O 0 2.27138419184314e-10
from O 0 4.195147376186148e-13
two O 0 1.581074572480634e-12
unrelated O 0 3.5527039088378842e-09
Japanese O 0 4.369544370774747e-08
families O 0 2.0991929028379985e-10
. O 0 1.6980662709276118e-10

The O 0 4.164538158768494e-11
insertion O 0 1.1493510587712308e-09
was O 0 8.317114774669676e-10
a O 0 1.659378537355316e-11
5 O 0 3.20264439968021e-11
- O 0 2.8205386470858684e-08
truncated O 0 3.6469078867895632e-09
form O 0 1.9743040535757928e-11
of O 0 4.0293200091572057e-13
human O 0 8.796204736816193e-11
L1 O 0 6.900224835959534e-09
inversely O 0 2.2112360831272326e-09
integrated O 0 1.3324621406241022e-09
in O 0 8.612438019695023e-12
the O 0 5.234479082821819e-12
5 O 0 4.0400233158877086e-10
- O 0 1.0100028703163844e-05
untranslated O 0 9.887944543152116e-07
region O 0 4.5208783383543505e-09
in O 0 1.1394918212129235e-12
the O 0 3.3510680667002413e-13
muscle O 0 2.818551503303013e-10
exon O 0 7.882866581709891e-11
1 O 0 2.4616194499449406e-12
, O 0 5.163221196077816e-13
which O 0 5.992457506771853e-13
affected O 0 1.3311500339507898e-11
the O 0 1.5288375491799566e-14
transcription O 0 2.2617564765514686e-10
or O 0 1.1626103552098144e-10
the O 0 1.7855607400626972e-12
stability O 0 1.402499560931858e-09
of O 0 4.0970821028364635e-14
the O 0 7.746522607404716e-13
muscle O 0 3.2121725279665725e-09
form O 0 2.83078378446322e-12
of O 0 2.608709689239097e-13
dystrophin O 0 1.9348089796977774e-09
transcripts O 0 4.452204160898532e-10
but O 0 6.8117256626920586e-12
not O 0 8.925313287923287e-13
that O 0 5.2872636824297103e-14
of O 0 7.24483966335664e-15
the O 0 1.9221675032904395e-12
brain O 0 1.9245874227635795e-06
or O 0 5.773970634948e-09
Purkinje O 0 2.098335926348227e-06
cell O 0 1.4477265040113707e-06
form O 0 3.46825290709063e-10
, O 0 1.2444424657420683e-10
probably O 0 1.436755936445877e-09
due O 0 2.524995143526887e-11
to O 0 5.759245077369135e-12
its O 0 1.0744571898868571e-11
unique O 0 1.0209669915051123e-11
site O 0 2.9391795663968878e-08
of O 0 7.110561596988807e-13
integration O 0 8.249258498516099e-10
. O 0 6.235495453310591e-10

We O 0 9.951890422854603e-10
speculate O 0 3.6623951094050256e-10
that O 0 1.207239738948776e-13
this O 0 1.7840746648024527e-14
insertion O 0 4.170523648650004e-11
of O 0 4.2318991193279754e-13
an O 0 5.736070039091823e-12
L1 O 0 2.3038757035465096e-07
sequence O 0 2.9279203506149543e-09
in O 0 6.859394996450163e-11
DMD O 1 0.9999998807907104
is O 0 2.617570327156926e-10
responsible O 0 3.3219776929271916e-10
for O 0 3.9133369396544826e-13
some O 0 2.3905237598459417e-13
of O 0 4.963294586522032e-15
the O 0 5.062020003469489e-14
population O 0 2.5239105510416193e-12
of O 0 2.2596144790346107e-13
Japanese O 0 1.9510599358341096e-08
patients O 0 3.5532084219358495e-11
with O 0 1.17868984971653e-12
XLDCM B-Disease 0 2.1172058950469363e-07
. O 0 6.893548926134585e-11
. O 0 1.2664680415497287e-09

Severe O 0 3.5848968309437623e-06
early O 0 1.2035852137159964e-07
- O 1 0.9992364645004272
onset O 1 0.999984860420227
obesity B-Disease 1 1.0
, O 0 0.023874793201684952
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 1.4907335810221412e-07
red O 0 8.758799907582215e-08
hair O 0 0.0054906150326132774
pigmentation O 0 2.9872968298150226e-05
caused O 0 5.911834932703641e-08
by O 0 1.217901057781745e-10
POMC O 0 9.961800060409587e-06
mutations O 0 2.08543102786507e-08
in O 0 5.222084049905096e-12
humans O 0 7.00401958653174e-10
. O 0 1.5586203438999746e-09

Sequential O 0 7.258875598381564e-07
cleavage O 0 1.7059366655303165e-05
of O 0 5.288219862009669e-11
the O 0 2.675954076380993e-12
precursor O 0 1.0301551972569101e-10
protein O 0 1.0153164420323435e-10
pre O 0 3.7307387401597225e-08
- O 0 7.542531648141448e-07
pro O 0 5.207801336837292e-07
- O 0 1.366542619507527e-06
opiomelanocortin O 0 1.186811715570002e-07
( O 0 6.367915743321628e-12
POMC O 0 1.2252860948080979e-08
) O 0 5.949442869780663e-13
generates O 0 1.8053830999620324e-11
the O 0 6.222250904623639e-13
melanocortin O 0 3.469725484706032e-08
peptides O 0 2.303250035140536e-09
adrenocorticotrophin O 0 1.8401932422307254e-08
( O 0 1.1415633195677177e-11
ACTH O 0 9.546578638719438e-09
) O 0 4.604999649833463e-13
, O 0 1.1376371849766698e-12
melanocyte O 0 6.527163236569322e-07
- O 0 1.0526885034778388e-06
stimulating O 0 2.563622842899349e-07
hormones O 0 2.9159212822094105e-09
( O 0 8.478198069809817e-13
MSH O 0 1.1332951466158647e-08
) O 0 4.37346881800027e-13
alpha O 0 4.61439859846674e-13
, O 0 2.608827596225355e-14
beta O 0 9.270538438473086e-14
and O 0 1.1389300723504362e-14
gamma O 0 3.231763543842109e-13
as O 0 5.6211498400838417e-14
well O 0 4.4341863080638033e-14
as O 0 7.833032047424235e-15
the O 0 4.782558931401646e-15
opioid O 0 1.0882200522643881e-11
- O 0 1.5536391617665402e-10
receptor O 0 1.3698969042463816e-11
ligand O 0 5.156966520480921e-11
beta O 0 4.572177636497088e-10
- O 0 2.7559008231037296e-07
endorphin O 0 1.5792920748936012e-05
. O 0 4.339997250468741e-09

While O 0 4.1848524645615726e-10
a O 0 2.8056078293925424e-11
few O 0 4.6611801224338834e-11
cases O 0 7.642143168284932e-11
of O 0 6.064790336601789e-11
isolated O 1 0.9999681711196899
ACTH B-Disease 1 0.9999905824661255
deficiency I-Disease 1 0.9998732805252075
have O 0 8.8021168132002e-10
been O 0 1.1062714078136082e-09
reported O 0 6.320348688859667e-07
( O 0 3.3993596132431136e-11
OMIM O 0 7.673662366869394e-06
201400 O 0 2.9529802603178723e-08
) O 0 1.561237077118971e-11
, O 0 2.8106195756189e-12
an O 0 4.422399512565844e-12
inherited O 0 0.0005743223009631038
POMC O 1 0.9974178075790405
defect O 1 0.9967888593673706
has O 0 2.5850107832070535e-08
not O 0 3.794698236192495e-11
been O 0 3.3992104270241796e-11
described O 0 9.743389428606974e-10
so O 0 6.225592957820325e-11
far O 0 1.4875914389200773e-10
. O 0 2.1835398766878455e-10

Recent O 0 6.252350637225845e-09
studies O 0 5.2082501506012235e-11
in O 0 6.324855461418977e-13
animal O 0 1.7813921171505598e-10
models O 0 5.802055724757338e-09
elucidated O 0 6.031250610050165e-09
a O 0 3.138795126589322e-11
central O 0 3.879969956432916e-11
role O 0 3.538883075471233e-11
of O 0 1.271948583785043e-13
alpha O 0 7.996804607390828e-12
- O 0 4.266929476415271e-09
MSH O 0 6.024389165304456e-08
in O 0 1.2597102451872982e-13
the O 0 5.081519633651525e-15
regulation O 0 2.1399191012932972e-13
of O 0 8.525182479174245e-15
food O 0 6.39386330339442e-12
intake O 0 2.2093227854819153e-12
by O 0 4.173795843990212e-14
activation O 0 3.891277491202549e-12
of O 0 1.551614197368989e-13
the O 0 8.096436932350515e-13
brain O 0 1.9574637022401475e-08
melanocortin O 0 7.481174435497451e-08
- O 0 1.0723255172706558e-06
4 O 0 8.460942502175328e-10
- O 0 5.8071069730658564e-08
receptor O 0 3.6861386165654153e-10
( O 0 2.181382331711834e-11
MC4 O 0 9.182852522826579e-07
- O 0 2.5957970706258493e-07
R O 0 9.511757781410779e-08
; O 0 4.7465607833085954e-12
refs O 0 4.146953447303758e-09
3 O 0 2.171908486392482e-11
- O 0 8.955343133720817e-09
5 O 0 1.8617889348260253e-12
) O 0 5.087602770168821e-14
and O 0 8.932274136921187e-14
the O 0 4.845435881142227e-15
linkage O 0 1.4274715853801467e-09
of O 0 2.1436160951762012e-13
human O 0 4.684893362139064e-09
obesity B-Disease 1 0.9999984502792358
to O 0 2.645178173721341e-11
chromosome O 0 7.558970764875994e-07
2 O 0 1.1914301489834855e-10
in O 0 1.0372703564132113e-11
close O 0 1.5108634343619087e-08
proximity O 0 7.62277529986477e-09
to O 0 6.386541295810844e-11
the O 0 4.358733166065498e-11
POMC O 0 3.8829821846775303e-07
locus O 0 3.054513086908628e-09
, O 0 3.420706426449094e-11
led O 0 1.0894909974190625e-11
to O 0 6.759151073044978e-13
the O 0 4.663638724332342e-13
proposal O 0 1.0579350590012027e-10
of O 0 6.363295713919179e-14
an O 0 5.485798989547652e-13
association O 0 1.5902717510896114e-12
of O 0 2.308659448509165e-13
POMC O 0 0.00010143958206754178
with O 0 2.632098983212927e-10
human O 0 1.9002236228971014e-07
obesity B-Disease 1 0.9999995231628418
. O 0 2.0736553096867283e-07

The O 0 7.529151191398853e-10
dual O 0 1.5080274806678062e-08
role O 0 1.1113682196750574e-09
of O 0 9.561065047319905e-13
alpha O 0 2.3007375171690825e-10
- O 0 7.58847065185364e-08
MSH O 0 5.772056965724914e-07
in O 0 1.0957299520844566e-12
regulating O 0 8.400176110257007e-10
food O 0 1.906894364633871e-10
intake O 0 3.0241181780965576e-10
and O 0 5.880771997840428e-12
influencing O 0 2.4376682894455826e-09
hair O 0 3.81858080800157e-06
pigmentation O 0 4.437482559183081e-08
predicts O 0 4.6826890809370525e-08
that O 0 7.786345353200108e-12
the O 0 2.9304729758268533e-13
phenotype O 0 1.3829539735610297e-09
associated O 0 4.330353853276847e-10
with O 0 1.1242938871558472e-11
a O 0 7.105488419867356e-10
defect O 0 0.0005822945386171341
in O 0 3.480617183360124e-11
POMC O 0 8.552419785701204e-06
function O 0 3.0362394820571126e-09
would O 0 1.5858903079646325e-10
include O 0 8.430801612391292e-10
obesity B-Disease 1 0.9999998807907104
, O 0 1.1177154340957784e-10
alteration O 0 1.0685100448881713e-07
in O 0 5.113354184516083e-10
pigmentation O 1 0.6999090313911438
and O 0 0.006157189607620239
ACTH B-Disease 1 0.999931812286377
deficiency I-Disease 1 0.9987319111824036
. O 0 1.8287098058067386e-08

The O 0 3.190926411988926e-10
observation O 0 4.642527926534967e-07
of O 0 9.285908847411761e-12
these O 0 1.2595152698580137e-10
symptoms O 0 1.1966540114372037e-07
in O 0 6.978512819694194e-13
two O 0 1.4563123927266441e-12
probands O 0 2.644248731087373e-08
prompted O 0 1.7354227777044429e-10
us O 0 9.580753551619026e-11
to O 0 3.34904901120453e-13
search O 0 6.219587345146493e-11
for O 0 5.655479882148151e-13
mutations O 0 1.4207596210624729e-09
within O 0 9.287344331088132e-12
their O 0 4.247097118437182e-11
POMC O 0 5.460442480398342e-06
genes O 0 2.201259796663635e-08
. O 0 1.867870302874053e-09

Patient O 0 3.38721729349345e-05
1 O 0 3.5488889604806673e-10
was O 0 1.4901678779821736e-09
found O 0 5.436006852987951e-11
to O 0 8.06147249649003e-13
be O 0 4.16974777189133e-13
a O 0 7.059925018725044e-13
compound O 0 5.827005544745134e-10
heterozygote O 0 2.148908412324957e-10
for O 0 1.8392061419854333e-13
two O 0 3.0259364350131157e-13
mutations O 0 3.888267485763208e-11
in O 0 2.6278865151649344e-13
exon O 0 7.409651781031812e-10
3 O 0 1.0795583871292536e-10
( O 0 5.9737228184919555e-12
G7013T O 0 1.037188823715951e-08
, O 0 1.727426708619806e-11
C7133delta O 0 1.7179786482302006e-09
) O 0 5.096589383163375e-13
which O 0 5.102775840759577e-13
interfere O 0 3.808418858053386e-10
with O 0 4.977160177055406e-13
appropriate O 0 1.0394826492621245e-11
synthesis O 0 5.779892536805775e-11
of O 0 1.8544243831492002e-12
ACTH O 0 1.7474975777531654e-07
and O 0 3.8781276801014286e-11
alpha O 0 2.785427444251809e-10
- O 0 5.087298404760077e-07
MSH O 0 1.5894092939561233e-05
. O 0 1.6062877694622557e-09

Patient O 0 8.030304161366075e-05
2 O 0 1.1449750036973683e-09
was O 0 1.1255008036670233e-09
homozygous O 0 3.5307019530250727e-09
for O 0 7.571103032705251e-13
a O 0 7.854977085441917e-12
mutation O 0 3.165031847718325e-10
in O 0 1.63592143304081e-12
exon O 0 3.7486120874064e-09
2 O 0 1.6320865492414072e-10
( O 0 1.5650503462638632e-11
C3804A O 0 1.7594448564750564e-08
) O 0 5.890766346938747e-11
which O 0 1.4875317644325037e-10
abolishes O 0 2.9797813567711273e-06
POMC O 0 1.2663133020396344e-05
translation O 0 6.488707526841608e-08
. O 0 1.596586640673081e-09

These O 0 3.157356598393335e-10
findings O 0 9.321723948296778e-11
represent O 0 1.4704609058169282e-12
the O 0 1.4334902351514217e-13
first O 0 4.110790213004284e-13
examples O 0 6.341529298209414e-12
of O 0 1.9659674008101063e-13
a O 0 1.2421026429620952e-09
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 1.3674333887436774e-10
the O 0 1.6685984191577852e-11
POMC O 0 7.609529006913363e-07
gene O 0 1.4302493411832984e-08
and O 0 1.3687895435154918e-11
define O 0 4.098544004182969e-10
a O 0 6.425714127455961e-11
new O 0 2.2658077636350527e-09
monogenic B-Disease 1 0.7952063679695129
endocrine I-Disease 0 0.006127429194748402
disorder I-Disease 0 0.00016935664461925626
resulting O 0 1.1382243758628618e-10
in O 0 8.842239440642885e-12
early O 0 6.31729974998052e-08
- O 1 0.9998487234115601
onset O 1 0.9999860525131226
obesity B-Disease 1 1.0
, O 0 0.024594822898507118
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 2.623625938724672e-08
red O 0 7.674477053853934e-09
hair O 0 2.5483068384346552e-05
pigmentation O 0 7.74329123487405e-07
. O 0 5.258982138656165e-10
. O 0 1.437770347223477e-09

A O 0 4.282962606794172e-08
European O 0 9.331940775680891e-10
multicenter O 0 4.45685628847059e-07
study O 0 1.558769002762972e-09
of O 0 1.2349361533381398e-08
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 7.620343800418539e-10
classification O 0 4.866974601114293e-10
of O 0 5.265859905241588e-13
105 O 0 9.004719192517996e-10
mutations O 0 1.3089906936158968e-08
and O 0 7.650777927858954e-11
a O 0 2.9481975888367984e-11
general O 0 1.9066316234161995e-11
system O 0 3.792715794204149e-11
for O 0 6.908098767501036e-13
genotype O 0 1.872368482480624e-09
- O 0 5.591288321227239e-09
based O 0 7.060699941385806e-11
prediction O 0 8.931615447238528e-09
of O 0 6.2415693273532025e-12
metabolic O 0 4.767075552081224e-06
phenotype O 0 3.8329051221808186e-07
. O 0 6.905899407882998e-09

Phenylketonuria B-Disease 0 0.0010213367640972137
( O 0 4.132298947467916e-09
PKU B-Disease 0 1.684081212260935e-06
) O 0 3.954302163489132e-10
and O 0 1.9633781267458517e-09
mild B-Disease 0 0.0009686549310572445
hyperphenylalaninemia I-Disease 1 1.0
( O 0 1.6023464013414923e-06
MHP B-Disease 1 1.0
) O 0 1.0226088864584426e-09
are O 0 1.3980359925280794e-10
allelic B-Disease 0 5.474088084156392e-06
disorders I-Disease 0 0.002959669567644596
caused O 0 1.0044570730727287e-09
by O 0 1.5232127625192105e-12
mutations O 0 9.346190488201955e-10
in O 0 5.61646920377995e-13
the O 0 1.5989156613299693e-12
gene O 0 4.7385018575596405e-08
encoding O 0 1.0287291729582648e-07
phenylalanine O 0 0.021911729127168655
hydroxylase O 0 0.007815712131559849
( O 0 4.372151085618725e-09
PAH O 0 2.4119331101246644e-06
) O 0 4.456809088448921e-10
. O 0 1.0598179001064523e-09

Previous O 0 3.2155378359988163e-09
studies O 0 3.8703984461818663e-11
have O 0 6.166508818329641e-13
suggested O 0 6.486171408998098e-12
that O 0 8.38031494242511e-14
the O 0 6.30608507578255e-14
highly O 0 7.001558360864024e-11
variable O 0 1.7259085893783777e-07
metabolic O 0 0.00013233922072686255
phenotypes O 0 1.7630143702263013e-05
of O 0 2.505048257717135e-08
PAH B-Disease 1 0.9998451471328735
deficiency I-Disease 1 0.9996577501296997
correlate O 0 1.9102375517832115e-05
with O 0 1.0035655151341416e-07
PAH O 0 0.03339983895421028
genotypes O 0 1.43041661431198e-05
. O 0 6.628737025948794e-08

We O 0 2.9615028651619468e-08
identified O 0 3.3259988097000814e-09
both O 0 4.578953969464061e-12
causative O 0 4.4579104496733635e-07
mutations O 0 4.7240359180023006e-08
in O 0 6.964225723882222e-11
686 O 0 2.53671578320791e-06
patients O 0 7.609748564618712e-08
from O 0 1.2347087241515453e-10
seven O 0 1.2942185101394443e-09
European O 0 1.3273832033533495e-10
centers O 0 9.833645009393877e-09
. O 0 1.2939321836213935e-09

On O 0 4.966359323788083e-09
the O 0 1.8600140958696665e-12
basis O 0 4.386201905154374e-12
of O 0 4.862807679857466e-14
the O 0 2.4611110133361536e-13
phenotypic O 0 9.760264596536672e-09
characteristics O 0 5.906072964023679e-09
of O 0 1.0708951954374601e-11
297 O 0 1.0109308945516204e-08
functionally O 0 6.95343160828088e-08
hemizygous O 0 1.041123027789581e-06
patients O 0 3.558027206196357e-09
, O 0 2.439669126441668e-12
105 O 0 5.1112943738607086e-11
of O 0 3.8195651069078407e-13
the O 0 2.541872311592752e-12
mutations O 0 2.06673567149096e-09
were O 0 1.3729286804653462e-11
assigned O 0 8.977168834689575e-12
to O 0 8.329579972814194e-13
one O 0 2.254862529332824e-12
of O 0 4.148715198422012e-14
four O 0 5.385066090962676e-12
arbitrary O 0 2.060726167485427e-08
phenotype O 0 2.5564115730958292e-06
categories O 0 2.810071180192608e-07
. O 0 8.5214857392657e-09

We O 0 8.850892463385662e-09
proposed O 0 3.252174363144178e-10
and O 0 2.453007241776106e-10
tested O 0 1.080409650633385e-09
a O 0 9.067405572042719e-13
simple O 0 7.310508101654456e-12
model O 0 2.886448302596989e-10
for O 0 1.6865114448212648e-13
correlation O 0 9.487972213451101e-11
between O 0 4.256104583350018e-12
genotype O 0 8.832927167468085e-10
and O 0 8.380419622144863e-12
phenotypic O 0 2.6233957228782856e-08
outcome O 0 2.583857394711231e-08
. O 0 5.37936672984074e-09

The O 0 1.2968966178750208e-10
observed O 0 3.0431619446602554e-09
phenotype O 0 1.7744048008694335e-08
matched O 0 9.10681641208555e-10
the O 0 1.442822966137014e-12
predicted O 0 2.1289721097161873e-09
phenotype O 0 4.562362487803284e-09
in O 0 1.0950013465405029e-11
79 O 0 4.403913678174831e-09
% O 0 1.9376978320495564e-12
of O 0 6.791584032357981e-14
the O 0 1.3535956210064537e-12
cases O 0 1.4652863367103919e-09
, O 0 4.106304185569343e-11
and O 0 6.274648162163388e-11
in O 0 7.38406243702e-13
only O 0 1.7701047875726128e-12
5 O 0 2.9679362266443743e-13
of O 0 1.916253648001718e-14
184 O 0 2.1736574346009618e-11
patients O 0 4.052260610398761e-11
was O 0 3.093707789947331e-10
the O 0 1.4069986495335307e-12
observed O 0 1.0718076426385892e-09
phenotype O 0 1.4250224611433993e-10
more O 0 1.4441636905435096e-12
than O 0 2.5005858494964173e-11
one O 0 2.7617998166196145e-11
category O 0 7.414387992454863e-10
away O 0 2.8439536836621926e-10
from O 0 2.203666719588493e-12
that O 0 1.8247455629838427e-11
expected O 0 1.3499132922589752e-09
. O 0 6.74139410961061e-10

Among O 0 4.349234861145135e-10
the O 0 1.051919835959314e-12
seven O 0 1.6511155507062392e-12
contributing O 0 1.2810270899610288e-10
centers O 0 4.2629658136839055e-10
, O 0 4.5913550739129505e-12
the O 0 1.629073395278957e-13
proportion O 0 4.745703482966768e-11
of O 0 9.770489538957206e-13
patients O 0 1.2314678443647864e-10
for O 0 6.298827561965203e-13
whom O 0 8.046779909065549e-11
the O 0 3.5801578173420834e-13
observed O 0 7.651642652817259e-10
phenotype O 0 1.4786051272253076e-09
did O 0 1.8831092241100578e-09
not O 0 2.724188583047571e-11
match O 0 5.252952153117496e-12
the O 0 4.291947114549999e-13
predicted O 0 2.820305988748828e-09
phenotype O 0 1.4723519070614088e-09
was O 0 1.3425082157070278e-09
4 O 0 4.599500294522052e-11
% O 0 4.7706154998605754e-11
- O 0 9.722319191496354e-06
23 O 0 8.083953950688283e-09
% O 0 1.8268872525872837e-11
( O 0 1.4069081837042585e-11
P O 0 4.859932232648134e-05
< O 0 4.571901079941654e-09
. O 0 2.098398278055358e-12
0001 O 0 1.6382876166787241e-09
) O 0 2.3496899955247064e-13
, O 0 1.0251358545680309e-13
suggesting O 0 5.637250215240197e-12
that O 0 1.2064340412093477e-13
differences O 0 1.1026190811086467e-12
in O 0 3.269269137836663e-15
methods O 0 1.2895546176033834e-12
used O 0 5.25426219460251e-13
for O 0 6.570286849305607e-14
mutation O 0 2.0882907902919357e-10
detection O 0 1.1817711254025198e-09
or O 0 1.941192762089372e-09
phenotype O 0 8.77076971050883e-08
classification O 0 3.100159906566091e-09
may O 0 8.055813238705412e-10
account O 0 1.9405252404958162e-10
for O 0 1.2907037634860008e-12
a O 0 1.0635995556507183e-11
considerable O 0 5.190359947393475e-11
proportion O 0 5.925545054630277e-10
of O 0 3.0372791087751594e-11
genotype O 0 2.6220230211038142e-05
- O 0 0.002103164792060852
phenotype O 0 2.1648331312462687e-05
inconsistencies O 0 2.705347924347734e-06
. O 0 8.542022200686006e-09

Our O 0 1.2903002222230953e-08
data O 0 8.109168336822847e-10
indicate O 0 4.1507813852703634e-10
that O 0 5.178253659199328e-12
the O 0 7.081682028980962e-12
PAH O 0 3.759952960535884e-06
- O 0 1.9758087432819593e-07
mutation O 0 3.746245980096319e-09
genotype O 0 8.717109256650701e-10
is O 0 5.638099796062557e-12
the O 0 2.0581323104118532e-13
main O 0 5.045874273967854e-10
determinant O 0 3.017015970385728e-09
of O 0 1.558638960084957e-12
metabolic O 0 8.979811809695093e-07
phenotype O 0 1.3776892515693362e-08
in O 0 1.2254851647353071e-11
most O 0 2.0532305022857855e-10
patients O 0 1.8281797409258616e-08
with O 0 3.296506179140124e-08
PAH B-Disease 1 0.999776303768158
deficiency I-Disease 1 0.9978426694869995
. O 0 2.7733062069046355e-08

In O 0 3.9620479119761853e-10
the O 0 1.5506622678615467e-12
present O 0 3.0599199389580445e-12
study O 0 1.322797123573527e-12
, O 0 7.137833618435507e-13
the O 0 5.455796811505362e-14
classification O 0 3.61628123279889e-11
of O 0 8.783001994965012e-13
105 O 0 1.1387923493089147e-08
PAH O 0 8.781783833455847e-08
mutations O 0 1.5083663207349218e-09
may O 0 7.145492531002162e-12
allow O 0 3.4033088847085224e-12
the O 0 4.11170771909275e-13
prediction O 0 6.579171696330377e-08
of O 0 1.5637270395652686e-13
the O 0 2.2816902447292398e-12
biochemical O 0 3.935703762891762e-09
phenotype O 0 1.3270826659805834e-09
in O 0 1.5339183916107668e-12
> O 0 2.942513732673291e-10
10 O 0 8.477592239319875e-11
, O 0 3.179230836924951e-11
000 O 0 7.438169524753846e-10
genotypes O 0 5.131519653645e-09
, O 0 4.465051592350555e-11
which O 0 1.2023697315566295e-10
may O 0 4.461297303803846e-11
be O 0 6.037337513600805e-13
useful O 0 6.616547153920349e-12
for O 0 1.5750328287694043e-13
the O 0 1.632501967809008e-12
management O 0 5.140922132440551e-10
of O 0 6.2388792049228314e-12
hyperphenylalaninemia B-Disease 1 0.9999996423721313
in O 0 2.718341995944229e-09
newborns O 0 3.499855552036024e-07
. O 0 4.879187609496682e-10

Somatic O 0 7.754813850624487e-06
instability O 0 1.2212447018100647e-06
of O 0 7.584682187866676e-11
the O 0 8.041178833906315e-11
CTG O 0 7.060438656480983e-05
repeat O 0 2.307520752253822e-08
in O 0 1.974370753693444e-12
mice O 0 6.132986118956296e-09
transgenic O 0 1.6769401423033514e-09
for O 0 4.2582968401427834e-12
the O 0 4.681880994006349e-10
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 3.0894443625584245e-06
is O 0 1.762268553306967e-09
age O 0 2.5933638569952677e-10
dependent O 0 1.107087685414676e-10
but O 0 2.5403409844443336e-12
not O 0 1.1676087614126418e-13
correlated O 0 1.4822538812672703e-12
to O 0 1.2062913330983943e-13
the O 0 2.8228512734783384e-13
relative O 0 2.407783417091025e-10
intertissue O 0 6.486381920467466e-08
transcription O 0 6.89279602283932e-08
levels O 0 6.2631637653964845e-09
and O 0 1.8583502514601946e-09
proliferative O 0 0.08700741082429886
capacities O 0 1.0823998309206218e-05
. O 0 9.071091433554557e-09

A O 0 2.305290536241955e-08
( O 0 1.2126438742043888e-10
CTG O 0 3.988777166341606e-07
) O 0 9.938791976915606e-12
nexpansion O 0 9.759836494538376e-09
in O 0 5.590042751607571e-12
the O 0 1.3618962728390027e-11
3 O 0 6.763133386655795e-10
- O 0 0.025876810774207115
untranslated O 0 0.00036152746179141104
region O 0 2.8608994284695655e-07
( O 0 1.5662839081276303e-11
UTR O 0 6.673194219430911e-10
) O 0 5.132400038819485e-13
of O 0 7.645339710708049e-14
the O 0 1.5239254302912286e-11
DM O 1 1.0
protein O 0 1.1857301984719015e-07
kinase O 0 5.202281272431719e-08
gene O 0 5.120081247866892e-09
( O 0 5.856906539619677e-12
DMPK O 0 1.7793087891959658e-08
) O 0 8.163611930553372e-13
is O 0 2.2647847139345423e-12
responsible O 0 3.30739852172357e-10
for O 0 2.0006458295585006e-11
causing O 0 8.227734360843897e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 6.190557087393245e-06
DM B-Disease 1 1.0
) O 0 1.32957552523294e-07
. O 0 1.2120370485035892e-08

Major O 0 1.226055701408768e-07
instability O 0 6.918188546478632e-07
, O 0 9.051241700586132e-11
with O 0 6.928935506952949e-13
very O 0 1.3631455990023578e-12
large O 0 2.765135126078788e-12
expansions O 0 1.4815071391893753e-09
between O 0 9.059768560359949e-12
generations O 0 4.192216365717094e-11
and O 0 2.3148042510579003e-11
high O 0 7.199630475129837e-11
levels O 0 3.688075452673578e-12
of O 0 3.922967704264764e-14
somatic O 0 3.204924936550668e-10
mosaicism O 0 5.5725738690171056e-08
, O 0 7.410563482301846e-12
is O 0 4.020608498911393e-12
observed O 0 3.5767303008249485e-10
in O 0 2.0688397175949724e-11
patients O 0 1.7024646137286936e-09
. O 0 1.1169636326968657e-09

There O 0 3.1836877578683698e-09
is O 0 2.32852712805931e-11
a O 0 5.292848624660618e-12
good O 0 7.119349554329801e-11
correlation O 0 3.0855518140526783e-10
between O 0 3.177539481535874e-11
repeat O 0 7.585717831659622e-09
size O 0 1.7885219971702782e-09
( O 0 2.499501907532453e-12
at O 0 1.85239004690807e-10
least O 0 2.2330699789296915e-11
in O 0 5.895728241549214e-13
leucocytes O 0 5.1335362627469294e-09
) O 0 2.1211582837410425e-12
, O 0 9.636384572242473e-13
clinical O 0 1.3704595791530494e-10
severity O 0 3.822577454570819e-08
and O 0 6.124636353632695e-10
age O 0 3.5800695741272648e-09
of O 0 2.422208961183614e-11
onset O 0 7.870400622778106e-06
. O 0 2.1228057534017353e-08

The O 0 1.5494562077833507e-08
trinucleotide O 0 9.291076275985688e-05
repeat O 0 1.0113649295817595e-06
instability O 0 6.177012323860254e-08
mechanisms O 0 2.71043099075996e-09
involved O 0 6.349220593726557e-10
in O 0 2.55890059142061e-10
DM B-Disease 1 1.0
and O 0 1.6652974110797913e-08
other O 0 1.365694016208785e-11
human O 0 3.072763732347994e-08
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 1.2397523008189637e-09
unknown O 0 2.4616243265995763e-08
. O 0 1.3001689724845278e-09

We O 0 1.7496253335025358e-09
studied O 0 2.624879757995302e-10
somatic O 0 8.815848495657974e-09
instability O 0 1.254074977197206e-08
by O 0 1.7621222189734276e-11
measuring O 0 3.793922223849222e-05
the O 0 1.6749192310872019e-10
CTG O 0 7.0492438680958e-05
repeat O 0 2.165756285421594e-08
length O 0 1.5157609611904377e-09
at O 0 2.94198665429235e-10
several O 0 2.292775344581166e-12
ages O 0 5.2267495886937354e-11
in O 0 1.67316681343177e-13
various O 0 1.6849336596097553e-12
tissues O 0 8.20771506315765e-10
of O 0 2.1273075260976743e-13
transgenic O 0 1.9969775166828185e-08
mice O 0 8.963293396391236e-08
carrying O 0 1.672270544261778e-09
a O 0 2.8167926324762504e-11
( O 0 8.013997451761234e-12
CTG O 0 1.2712150976312842e-07
) O 0 9.234123014845164e-12
55expansion O 0 1.3738527648854415e-08
surrounded O 0 7.622615427749224e-09
by O 0 5.4396993853789155e-11
45 O 0 3.4804065185412014e-10
kb O 0 1.0287778628992328e-08
of O 0 4.0846232646218894e-13
the O 0 6.635352423761676e-12
human O 0 1.779625335984747e-07
DM B-Disease 1 1.0
region O 0 2.69023303189897e-07
, O 0 1.0346542199390907e-11
using O 0 1.8125665898760523e-11
small O 0 1.0023499807942926e-09
- O 0 7.630147592863068e-06
pool O 0 4.613345438997385e-08
PCR O 0 1.3485673377999774e-07
. O 0 1.1134158039993736e-09

These O 0 1.1447042203016622e-09
mice O 0 6.798408236363684e-08
have O 0 2.312698990647455e-11
been O 0 7.869522741787982e-12
shown O 0 3.443342833087115e-11
to O 0 1.2640335826652471e-12
reproduce O 0 9.903462228066928e-08
the O 0 4.081797833760392e-12
intergenerational O 0 9.474093509709292e-09
and O 0 2.869238700797805e-11
somatic O 0 6.850350842135811e-10
instability O 0 2.856066494416609e-09
of O 0 3.715114424863303e-13
the O 0 7.742465522875275e-12
55 O 0 1.3965841816343527e-09
CTG O 0 9.015413411361806e-07
repeat O 0 4.145419119083726e-09
suggesting O 0 6.910864103204517e-10
that O 0 8.133770349957881e-13
surrounding O 0 2.5229682926175556e-11
sequences O 0 2.9484129027146366e-10
and O 0 9.495878909582256e-12
the O 0 4.635593802261931e-14
chromatin O 0 1.2051316888861408e-10
environment O 0 2.41622083452242e-10
are O 0 4.4401383069402056e-13
involved O 0 6.200762125985193e-12
in O 0 6.4273538748216286e-12
instability O 0 8.376711946311843e-08
mechanisms O 0 4.196062519667976e-08
. O 0 4.814589171786565e-09

As O 0 9.503475784100601e-11
observed O 0 8.603838475007564e-11
in O 0 1.3119191876517083e-13
some O 0 1.0268129120409586e-13
of O 0 1.6664458441645325e-14
the O 0 3.6157055539713656e-13
tissues O 0 4.821609778105085e-09
of O 0 1.0929258192904356e-10
DM B-Disease 1 1.0
patients O 0 6.618404313485371e-06
, O 0 1.576825996163489e-11
there O 0 4.5080005700581793e-11
is O 0 4.673230552532104e-12
a O 0 1.8152505323540402e-12
tendency O 0 4.083235138896413e-10
for O 0 2.1528527658493113e-12
repeat O 0 4.139272480330192e-09
length O 0 1.6387345924684382e-09
and O 0 3.5374862761283765e-11
somatic O 0 3.111710333847384e-10
mosaicism O 0 7.726986162026606e-09
to O 0 4.280095375341908e-12
increase O 0 5.580032269580926e-11
with O 0 1.0687322554714385e-11
the O 0 6.727154857472106e-12
age O 0 7.44530936902521e-10
of O 0 2.795844881563897e-13
the O 0 1.2259995102459342e-11
mouse O 0 1.180721710625221e-06
. O 0 4.9928963186118835e-09

Furthermore O 0 3.242991652996352e-08
, O 0 7.476826796581904e-11
we O 0 1.4477193749362627e-11
observed O 0 1.3897934018902713e-11
no O 0 2.015578676184404e-12
correlation O 0 1.226612301313823e-11
between O 0 1.425245961831842e-13
the O 0 3.216719764360422e-14
somatic O 0 4.845346901483083e-10
mutation O 0 1.756121581486525e-09
rate O 0 2.4162693179619055e-08
and O 0 8.649250760051075e-11
tissue O 0 9.291377864428796e-06
proliferation O 0 0.000423153571318835
capacity O 0 5.16118596749493e-08
. O 0 4.816325116507869e-09

The O 0 6.072313485372405e-11
somatic O 0 1.7911549576865582e-08
mutation O 0 3.8847151273557756e-08
rates O 0 6.37593444707818e-09
in O 0 3.371165922371605e-13
different O 0 5.157335062483392e-13
tissues O 0 1.4482400834125997e-09
were O 0 8.773500675962609e-11
also O 0 6.888287683304295e-12
not O 0 4.634959950566842e-13
correlated O 0 8.336927502516911e-12
to O 0 7.721932360031658e-13
the O 0 1.7288168509613233e-12
relative O 0 2.3908659496640894e-09
inter O 0 7.83093412337621e-09
- O 0 1.6283340755762765e-06
tissue O 0 9.290556022278906e-07
difference O 0 8.708247317690265e-11
in O 0 2.1370761876717687e-13
transcriptional O 0 6.874880109641879e-10
levels O 0 2.647282740242396e-11
of O 0 3.48559478806007e-14
the O 0 3.396550076785465e-13
three O 0 8.764911539616005e-13
genes O 0 1.3122959316436145e-11
( O 0 2.376281138007086e-13
DMAHP O 0 1.5333744940448923e-08
, O 0 1.1268164352984389e-11
DMPK O 0 5.815830306232783e-08
and O 0 1.174911279377966e-10
59 O 0 1.9042521726131412e-10
) O 0 6.956624946236056e-13
surrounding O 0 3.8773159682925495e-10
the O 0 1.715426065085346e-11
repeat O 0 6.901240823253829e-08
. O 0 9.57468826445762e-11
. O 0 5.33151855997005e-10

A O 0 9.36314581423403e-09
novel O 0 7.47577999504756e-09
missense O 0 6.327927621896379e-06
mutation O 0 1.442817598729107e-08
in O 0 4.988529121036089e-12
patients O 0 2.1086635215716854e-10
from O 0 5.92125361329604e-13
a O 0 4.241610951360997e-10
retinoblastoma B-Disease 0 0.0002470568579155952
pedigree O 0 0.0005551245412789285
showing O 0 1.2261098163435236e-05
only O 0 4.458645674887407e-10
mild O 0 3.848333651745861e-09
expression O 0 4.862907646008274e-11
of O 0 4.5185843998776787e-13
the O 0 4.2563827462593906e-11
tumor B-Disease 0 4.526713746599853e-05
phenotype O 0 1.650209640047251e-07
. O 0 6.172793831638046e-09

We O 0 7.218034614453472e-09
have O 0 4.289772096571776e-12
used O 0 7.264551373648009e-13
single O 0 2.5630500326279115e-12
strand O 0 3.97784361005904e-10
conformation O 0 2.605262672261688e-10
polymorphism O 0 1.900018198330855e-10
analysis O 0 8.60793814699834e-12
to O 0 2.112875304403905e-13
study O 0 7.467527572864452e-13
the O 0 3.4484852582013226e-13
27 O 0 4.32118507642798e-11
exons O 0 9.857070715213467e-11
of O 0 1.333873332967639e-13
the O 0 2.1336801683119466e-12
RB1 O 0 1.8923515199276153e-07
gene O 0 8.014342522955076e-10
in O 0 1.7773141899185552e-12
individuals O 0 1.4580856053797442e-12
from O 0 1.8340635000307914e-13
a O 0 3.0725012811760877e-11
family O 0 3.378016444344212e-08
showing O 0 3.3119908039225265e-05
mild O 0 3.6260473734728293e-06
expression O 0 1.303026464505308e-09
of O 0 2.4628402615911593e-12
the O 0 4.892688684754454e-11
retinoblastoma B-Disease 0 2.76903347184998e-06
phenotype O 0 5.001190857001347e-07
. O 0 5.492332810774769e-09

In O 0 4.395936392675992e-11
this O 0 1.3963449537260364e-12
family O 0 5.312181250438641e-10
affected O 0 9.859576488580046e-10
individuals O 0 1.1219439439991152e-11
developed O 0 6.302568777982742e-08
unilateral B-Disease 1 0.999996542930603
tumors I-Disease 1 1.0
and O 0 3.091116411724215e-07
, O 0 2.8720694225659038e-11
as O 0 5.109223048978262e-13
a O 0 3.5045149291215716e-13
result O 0 2.657296583295776e-13
of O 0 3.313175133009237e-14
linkage O 0 1.991701559234116e-08
analysis O 0 1.0464481503547063e-09
, O 0 1.0259686850089267e-10
unaffected O 0 5.003251857260693e-08
mutation O 0 6.414133668641853e-10
carriers O 0 1.816024552958595e-10
were O 0 4.737012865296819e-11
also O 0 7.232207888119291e-11
identified O 0 2.143228039486189e-09
within O 0 1.237015871680125e-11
the O 0 4.45315312402883e-11
pedigree O 0 9.380679330206476e-06
. O 0 3.476016585679531e-09

A O 0 1.1530046917229697e-09
single O 0 2.7055574794432324e-11
band O 0 2.546988835117059e-11
shift O 0 1.6011084125189257e-10
using O 0 8.2930641520651e-11
SSCP O 0 1.5377831630303263e-07
was O 0 2.4321267222404686e-10
identified O 0 1.217213690951624e-10
in O 0 9.145946668195556e-14
exon O 0 6.777350902709145e-10
21 O 0 2.6296753663501704e-10
which O 0 1.0914107291537523e-11
resulted O 0 2.512164087864477e-11
in O 0 7.064087270865216e-13
a O 0 2.3644383326248963e-11
missense O 0 2.510954288936773e-07
mutation O 0 3.97278598907036e-10
converting O 0 8.342101315284012e-11
a O 0 9.44078426545758e-11
cys O 0 3.879350060742581e-06
- O 0 2.2937567791814217e-06
- O 0 2.0537187594982242e-07
> O 0 5.774188349683129e-10
arg O 0 1.5848540257934474e-09
at O 0 2.2312306516281133e-11
nucleotide O 0 1.258638748780072e-10
position O 0 3.816621740870829e-10
28 O 0 1.951362162133652e-11
in O 0 1.4740178478842014e-13
the O 0 1.333558480656749e-12
exon O 0 2.6757604132399138e-08
. O 0 2.5558775096357067e-09

The O 0 5.964005955760854e-10
mutation O 0 2.3420758665793073e-08
destroyed O 0 2.3316401609463355e-07
an O 0 6.799601246637588e-12
NdeI O 0 1.7402149410372658e-07
restriction O 0 6.3985696741042375e-09
enzyme O 0 7.934645829266174e-09
site O 0 2.4270991616504034e-07
. O 0 3.6492528998621765e-09

Analysis O 0 3.7969032362639155e-09
of O 0 5.949445797126529e-12
all O 0 9.067237412285767e-12
family O 0 2.702583157265792e-10
members O 0 2.1547822933506294e-13
demonstrated O 0 2.5481453752584926e-11
that O 0 3.2047614887363574e-13
the O 0 4.3086546700280004e-13
missense O 0 2.68234515488075e-07
mutation O 0 7.688659486859706e-09
co O 0 8.511905491559446e-08
- O 0 1.1725979476295834e-07
segregated O 0 6.220071213647316e-08
with O 0 2.1895536772564839e-10
patients O 0 1.1551581025059932e-08
with O 0 3.6611675913178487e-09
tumors B-Disease 1 1.0
or O 0 0.00028315652161836624
who O 0 1.5993083479770576e-06
, O 0 3.624713029726223e-11
as O 0 1.9003570418674176e-12
a O 0 1.390781803958796e-12
result O 0 2.0799685758465802e-12
of O 0 1.0321696161620306e-13
linkage O 0 8.360252934380696e-09
analysis O 0 2.4654889241304545e-10
had O 0 8.792636618792926e-10
been O 0 4.102796921645613e-11
predicted O 0 7.919612188267422e-10
to O 0 8.580853042006176e-13
carry O 0 1.2079370836914904e-10
the O 0 9.592853421336311e-12
predisposing O 0 9.70735300143133e-07
mutation O 0 1.9182895982794435e-07
. O 0 5.546020087621173e-09

These O 0 5.51980058882684e-11
observations O 0 7.336132812341134e-10
point O 0 1.0324940902251001e-10
to O 0 1.431018714984078e-12
another O 0 9.306529505370698e-12
region O 0 1.7079636316363889e-10
of O 0 1.9484294819932524e-13
the O 0 1.993153038448714e-12
RB1 O 0 2.999037178597064e-07
gene O 0 3.75310976741261e-10
where O 0 8.226780368048026e-12
mutations O 0 6.72712024973876e-11
only O 0 5.074696088694375e-13
modify O 0 1.0251750559575612e-09
the O 0 9.874146856062027e-13
function O 0 7.117285927282779e-11
of O 0 2.5484670119644767e-14
the O 0 1.6585066382312358e-13
gene O 0 3.7840325317617385e-10
and O 0 2.2153201148511492e-11
raise O 0 1.9613177401622828e-11
important O 0 6.525394807832541e-12
questions O 0 7.0960281921272905e-12
for O 0 1.5678543261853778e-13
genetic O 0 4.020116683989272e-09
counseling O 0 1.1212283324013583e-09
in O 0 3.1981253582891167e-12
families O 0 4.052183241731733e-11
with O 0 3.2529280918208725e-12
these O 0 7.782158598090838e-12
distinctive O 0 1.1381864339909953e-08
phenotypes O 0 2.2728816162498333e-08
. O 0 1.8403283064127862e-10
. O 0 1.268208427163131e-09

Maternal B-Disease 0 0.0033939226996153593
disomy I-Disease 0 0.1819789856672287
and O 0 0.006373078562319279
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 0.9999998807907104
consistent O 0 9.571228929416975e-07
with O 0 7.355211578685683e-11
gamete O 0 5.857689444610514e-08
complementation O 0 2.7235623178967217e-07
in O 0 8.600909155893899e-13
a O 0 6.76304888827528e-12
case O 0 1.6383921996876438e-11
of O 0 4.796778751113562e-13
familial O 0 1.5151668719681766e-07
translocation O 0 3.8565104887311463e-07
( O 0 3.112149427053623e-10
3 O 0 1.4829057426446468e-10
; O 0 3.2610178446468296e-11
15 O 0 2.8045911079632724e-11
) O 0 1.0076332129793641e-12
( O 0 2.9494546453616433e-13
p25 O 0 3.926718949998076e-10
; O 0 8.360171279211959e-13
q11 O 0 2.472501092753987e-10
. O 0 1.5225997546108871e-12
2 O 0 3.7116104460721555e-12
) O 0 1.3241381949247177e-11
. O 0 3.5415390065018926e-10

Maternal B-Disease 0 0.2772074043750763
uniparental I-Disease 1 0.6855221390724182
disomy I-Disease 0 0.11023300886154175
( I-Disease 0 6.847900522188866e-07
UPD I-Disease 1 0.9999990463256836
) I-Disease 0 7.033176263604446e-10
for I-Disease 0 1.9493831895922575e-11
chromosome I-Disease 0 1.0297514563717414e-05
15 I-Disease 0 7.479255548226149e-10
is O 0 4.174224160768958e-11
responsible O 0 2.3123927217483242e-09
for O 0 8.424101802413653e-13
an O 0 7.601836911688697e-13
estimated O 0 9.87327664070392e-10
30 O 0 4.214456214568507e-11
% O 0 2.1403354349275316e-13
of O 0 1.8616636281599402e-13
cases O 0 8.864746270376145e-09
of O 0 8.426932822658273e-07
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 4.091436039743712e-06
PWS B-Disease 1 0.9999996423721313
) O 0 3.959588923407864e-08
. O 0 1.2036145413674149e-08

We O 0 9.857738625385082e-09
report O 0 1.8515387834039387e-10
on O 0 1.7788301213961244e-12
an O 0 4.961196655318273e-14
unusual O 0 4.332202305223909e-11
case O 0 1.3376255658670289e-10
of O 0 3.0336820295434608e-12
maternal B-Disease 0 1.200516749122471e-06
disomy I-Disease 0 3.096341242780909e-05
15 I-Disease 0 2.1863664212418144e-09
in O 0 1.7155775411392682e-10
PWS B-Disease 1 0.9999998807907104
that O 0 2.144907446099964e-10
is O 0 2.043321761791006e-11
most O 0 2.7818551498817734e-13
consistent O 0 2.0462440075696975e-10
with O 0 3.703680699802814e-13
adjacent O 0 1.2111928526792326e-07
- O 0 2.35633046941075e-06
1 O 0 2.516671116295499e-12
segregation O 0 7.794540568539787e-10
of O 0 4.0265926985923184e-13
a O 0 3.531129555423007e-11
paternal O 0 4.010767611362098e-07
t O 0 1.6303866914313403e-06
( O 0 2.9189940395357716e-12
3 O 0 4.806654206601646e-12
; O 0 4.2688361526210805e-12
15 O 0 6.541532940329553e-12
) O 0 2.7019760127228176e-13
( O 0 7.849936114546e-14
p25 O 0 9.372069786905968e-11
; O 0 2.4080002857147786e-13
q11 O 0 1.1737330551930825e-10
. O 0 2.5064374404096257e-13
2 O 0 2.1590074292168054e-13
) O 0 8.885969217387046e-14
with O 0 1.0866472652248937e-12
simultaneous O 0 3.0039085885391614e-08
maternal O 0 3.744530431504245e-06
meiotic O 0 6.048110662959516e-06
nondisjunction O 0 3.947798631998012e-06
for O 0 2.1551885276416272e-10
chromosome O 0 3.2114780879055616e-06
15 O 0 6.567997257178604e-09
. O 0 2.8856128597709585e-09

The O 0 3.773093837367014e-09
patient O 0 3.603150844355696e-07
( O 0 1.9437332299254706e-10
J O 0 0.021373404189944267
. O 0 3.8551933867481125e-10
B O 0 5.331788770490675e-07
. O 0 1.0126136040788936e-12
) O 0 2.780523749613961e-13
, O 0 6.111977243761224e-13
a O 0 2.944183959130431e-12
17 O 0 1.1287249607194738e-10
- O 0 1.3861024328321037e-08
year O 0 1.1594170762352363e-10
- O 0 4.5606679321963384e-08
old O 0 5.648153589277172e-08
white O 0 8.606140244893368e-10
male O 0 4.0157766001414075e-10
with O 0 1.0876347565635935e-11
PWS B-Disease 1 0.9999998807907104
, O 0 3.691856889642686e-11
was O 0 5.217496573672875e-11
found O 0 4.932470664548161e-12
to O 0 2.0996635419906484e-12
have O 0 2.3007406743658088e-11
47 O 0 1.4124962310901878e-10
chromosomes O 0 2.9350027963559455e-10
with O 0 1.3317240539489905e-11
a O 0 5.710694694904817e-10
supernumerary O 0 2.75185607279127e-06
, O 0 1.5373572637145116e-08
paternal O 0 7.975921471370384e-05
der O 1 0.6669119596481323
( O 0 2.4571561452191304e-10
15 O 0 5.934534114127032e-11
) O 0 3.573676456754965e-13
consisting O 0 7.769088107220656e-13
of O 0 1.458582739180883e-13
the O 0 1.27952466330572e-11
short O 0 1.9268037831920992e-08
arm O 0 2.6594017981551588e-05
and O 0 9.297889715098595e-12
the O 0 3.1280937584123036e-13
proximal O 0 7.223739828532416e-08
long O 0 2.5339684839309484e-07
arm O 0 4.31659645983018e-05
of O 0 2.268614983369499e-12
chromosome O 0 4.296011866244953e-07
15 O 0 4.1732309274955526e-10
, O 0 2.3403799731536168e-11
and O 0 1.0751116663598737e-10
distal O 0 0.00015207550313789397
chromosome O 1 0.9529253840446472
arm O 1 0.9927220940589905
3p O 0 0.0002434595226077363
. O 0 9.499392916723082e-08

The O 0 1.8532249068670126e-09
t O 0 1.1029515917471144e-05
( O 0 1.2959167593196153e-11
3 O 0 1.0872593624033922e-11
; O 0 1.0129284563897833e-12
15 O 0 4.4715351213420185e-12
) O 0 3.708261182931022e-13
was O 0 2.388599595892771e-10
present O 0 1.9270690945760727e-11
in O 0 1.172617450188873e-12
the O 0 8.320465627251195e-13
balanced O 0 1.1320927528757352e-10
state O 0 3.710895306319184e-12
in O 0 4.4065429473730267e-13
the O 0 1.1299623346380794e-12
patients O 0 3.191010303216224e-11
father O 0 8.3636930714448e-10
and O 0 2.551686119345309e-11
a O 0 2.4894369898831314e-10
sister O 0 1.0794093213917222e-05
. O 0 6.075748792966351e-09

Fluorescent O 0 5.285391679876739e-09
in O 0 6.115128368955336e-12
situ O 0 9.42993683139548e-10
hybridization O 0 2.3117289332796886e-11
analysis O 0 3.8973407834319573e-11
demonstrated O 0 1.173023622680347e-10
that O 0 1.5237967138093111e-12
the O 0 7.271374908440764e-12
PWS B-Disease 1 0.9999996423721313
critical O 0 3.78065800887839e-09
region O 0 1.1507000907684528e-09
resided O 0 7.126801815360295e-09
on O 0 1.3668700893365582e-10
the O 0 1.5015209128138585e-12
derivative O 0 4.758170746299584e-09
chromosome O 0 2.1073708111885026e-08
3 O 0 3.4124740793534114e-12
and O 0 6.392217484496587e-12
that O 0 6.319601526111329e-12
there O 0 3.519738667190353e-11
was O 0 6.626619808436374e-10
no O 0 1.1577398761897228e-10
deletion O 0 3.6412831083687536e-10
of O 0 2.8534266963142763e-12
the O 0 7.928529499601211e-10
PWS B-Disease 1 1.0
region O 0 2.372320118126936e-08
on O 0 1.6284895654194997e-09
the O 0 4.053990650121353e-12
normal O 0 1.6783352485560954e-09
pair O 0 6.440475236457743e-11
of O 0 2.3113648039800594e-13
15s O 0 1.0482634899000587e-10
present O 0 3.363211792395404e-11
in O 0 3.178527233083095e-11
J O 0 0.00010483786900294945
. O 0 3.4715905705695604e-09

B O 0 0.003193823155015707
. O 0 1.7504382299193821e-07

Methylation O 0 1.2781192992861179e-08
analysis O 0 7.913693589323145e-10
at O 0 8.792463979112597e-11
exon O 0 4.515860185794196e-10
alpha O 0 3.299873221895844e-11
of O 0 1.868629220542345e-13
the O 0 9.56713874789017e-13
small O 0 2.569655876971666e-10
nuclear O 0 1.095487618840707e-06
ribonucleoprotein O 0 3.140513058497163e-07
- O 0 1.4247147817059158e-07
associated O 0 1.0896423319195492e-08
polypeptide O 0 1.844693542807363e-06
N O 0 1.6814962577882397e-07
( O 0 5.42852308244024e-12
SNRPN O 0 4.496806926823638e-09
) O 0 4.391331319842512e-13
gene O 0 6.560028908975113e-11
showed O 0 1.3327867975920782e-10
a O 0 1.9872313430230326e-12
pattern O 0 3.2916620540390795e-08
characteristic O 0 5.8191673701912805e-09
of O 0 1.678172683282353e-12
only O 0 8.270065188220599e-11
the O 0 7.883885384807332e-12
maternal O 0 4.403353273119137e-07
chromosome O 0 3.508280997266411e-06
15 O 0 5.932673019515278e-09
in O 0 6.797326035368201e-10
J O 0 0.11320135742425919
. O 0 1.7269748298076593e-08

B O 0 0.004556857515126467
. O 0 1.1906128349892242e-07

Maternal B-Disease 0 0.0009142581839114428
disomy I-Disease 0 1.9589429939514957e-05
was O 0 1.5000926723018893e-08
confirmed O 0 7.352143338579253e-10
by O 0 5.891119840215064e-13
polymerase O 0 5.060961427716393e-09
chain O 0 2.0143298584685e-08
reaction O 0 4.130868563878565e-11
analysis O 0 6.5896702157453024e-12
of O 0 3.5177752637921555e-13
microsatellite O 0 6.688848230851363e-08
repeats O 0 2.6208953229911458e-08
at O 0 4.5481951538306475e-11
the O 0 3.137133836126488e-13
gamma O 0 1.4512865909033223e-10
- O 0 1.1020955703600066e-08
aminobutyric O 0 5.000532610210939e-08
acid O 0 5.680386161444062e-10
receptor O 0 1.5346486581524488e-10
beta3 O 0 1.0196996136357939e-08
subunit O 0 1.0888896451177743e-09
( O 0 8.468332285405111e-11
GABRB3 O 0 1.351443472685787e-07
) O 0 1.7977828947746133e-10
locus O 0 5.3772151176190164e-08
. O 0 8.665292483556186e-09

A O 0 1.7576344646386133e-07
niece O 0 9.182194480672479e-05
( O 0 1.3694803069341788e-09
B O 0 4.268594693712657e-06
. O 0 1.4135465367659528e-11
B O 0 2.2298756174876644e-09
. O 0 5.494582111346957e-14
) O 0 1.4535193795101042e-14
with O 0 1.500286304694995e-13
45 O 0 2.4016487583378154e-12
chromosomes O 0 5.646238684930971e-11
and O 0 1.78182607557531e-11
the O 0 8.159953290322319e-13
derivative O 0 3.961128758334098e-09
3 O 0 7.509881605471946e-12
but O 0 8.751739610790565e-11
without O 0 1.2629256147811407e-11
the O 0 2.6024044030847904e-12
der O 0 1.4979509614931885e-05
( O 0 1.352932306117327e-12
15 O 0 2.4179011657438076e-12
) O 0 1.2410509902735511e-13
demonstrated O 0 1.769734532530709e-11
a O 0 2.922777037756008e-12
phenotype O 0 3.6646747858526396e-09
consistent O 0 1.176474695441243e-09
with O 0 2.817543507532827e-12
that O 0 3.2932818798403485e-12
reported O 0 3.6551670579143547e-09
for O 0 7.778844842570853e-13
haploinsufficiency O 0 3.857769659276755e-09
of O 0 1.6347766239668826e-12
distal O 0 1.8925044287243509e-06
3 O 0 2.2935218169095606e-07
p O 0 0.0029477218631654978
. O 0 4.4593729597863785e-08

Uniparental B-Disease 1 0.9999793767929077
disomy I-Disease 1 0.9999809265136719
associated O 0 3.806211907431134e-06
with O 0 2.627083550699183e-10
unbalanced O 0 1.6497138858539984e-05
segregation O 0 7.220501174742822e-07
of O 0 2.397484988314602e-11
non O 0 2.3885290190150954e-08
- O 0 8.076295898717945e-07
Robertsonian O 0 5.610123707810999e-07
translocations O 0 5.1546867325669155e-06
has O 0 1.6746204423156996e-08
been O 0 5.872682201646384e-11
reported O 0 6.480467718006366e-09
previously O 0 4.679979181965166e-10
but O 0 6.002359026480164e-11
has O 0 1.3499332207622672e-10
not O 0 3.6281281798333787e-12
, O 0 2.8069376250411393e-13
to O 0 9.227076568085746e-13
our O 0 1.7127452234255713e-11
knowledge O 0 1.8903576620710183e-12
, O 0 1.837666845951047e-13
been O 0 6.69346522652603e-13
observed O 0 6.420638760246122e-12
in O 0 2.545702804644407e-14
a O 0 1.7346466060427779e-12
case O 0 5.546670414635635e-11
of O 0 8.992528249818221e-11
PWS B-Disease 1 0.9999996423721313
. O 0 5.276339365423155e-08

Furthermore O 0 1.1214945772053397e-07
, O 0 5.49061240917581e-10
our O 0 3.329289621767373e-11
findings O 0 3.871734877147759e-11
are O 0 4.688647473743979e-13
best O 0 5.157121257814978e-12
interpreted O 0 3.220721259133974e-11
as O 0 1.359383417463833e-12
true O 0 6.594853829700043e-11
gamete O 0 1.550115413806452e-08
complementation O 0 1.6168786487469333e-07
resulting O 0 6.787208017833279e-10
in O 0 9.905928299858147e-10
maternal B-Disease 1 0.9752050042152405
UPD I-Disease 1 0.9999998807907104
15 I-Disease 0 1.8868886400014162e-05
and O 0 2.56304228969384e-05
PWS B-Disease 1 0.9999954700469971

Schwartz B-Disease 0 0.08941134810447693
- I-Disease 1 0.9992926120758057
Jampel I-Disease 1 0.998128354549408
syndrome I-Disease 1 0.9999678134918213
type I-Disease 0 3.857606498058885e-05
2 I-Disease 0 2.061295134581087e-09
and O 0 4.366178174564084e-08
Stuve B-Disease 1 0.9999072551727295
- I-Disease 1 0.9999998807907104
Wiedemann I-Disease 1 0.9999998807907104
syndrome I-Disease 1 0.9999998807907104
: O 0 1.290141327103811e-10
a O 0 3.501398476712936e-11
case O 0 8.658461447819121e-11
for O 0 1.6887109115584775e-12
" O 0 5.352653875689839e-09
lumping O 0 6.118582973613229e-07
" O 0 4.1904478109699994e-08
. O 0 9.690069857626327e-10

Recent O 0 5.107839928797375e-09
studies O 0 7.299003068617083e-11
demonstrated O 0 5.172038144984903e-11
the O 0 5.751335415945039e-14
existence O 0 1.0560112680135791e-11
of O 0 2.213762281670119e-14
a O 0 1.6078301884325796e-12
genetically O 0 1.6199785957127233e-10
distinct O 0 5.398870239758935e-11
, O 0 7.292486926824271e-12
usually O 0 7.80609257788889e-12
lethal O 0 2.0190956111915126e-12
form O 0 2.833904714626828e-13
of O 0 1.5424933465929547e-13
the O 0 9.490433439118817e-11
Schwartz B-Disease 0 0.3458835780620575
- I-Disease 1 0.9998301267623901
Jampel I-Disease 1 0.9996581077575684
syndrome I-Disease 1 0.9999858140945435
( O 0 1.1702820934544889e-09
SJS B-Disease 0 0.13767749071121216
) O 0 4.550928731084092e-11
of O 0 1.608944574793547e-11
myotonia B-Disease 1 0.8774195909500122
and O 0 8.387275762800073e-09
skeletal B-Disease 1 0.9851744771003723
dysplasia I-Disease 1 0.9996771812438965
, O 0 1.0840819353319375e-09
which O 0 1.9947639373629755e-10
we O 0 2.4922020003259604e-10
called O 0 1.0438288011727082e-09
SJS B-Disease 1 0.5781199932098389
type I-Disease 0 3.9277374526136555e-06
2 I-Disease 0 2.453719893935613e-09
. O 0 6.8671255348817795e-09

This O 0 1.3778461704916367e-09
disorder O 0 0.0014700432075187564
is O 0 4.568043512898079e-11
reminiscent O 0 8.342185275900249e-10
of O 0 1.6966262379389252e-13
another O 0 9.109447571264973e-12
rare O 0 6.046958489491772e-10
condition O 0 1.5550525631624623e-06
, O 0 1.3108124828631329e-11
the O 0 3.0794183175641976e-11
Stuve B-Disease 1 0.9914976954460144
- I-Disease 1 0.9999992847442627
Wiedemann I-Disease 1 0.9999996423721313
syndrome I-Disease 1 0.9999994039535522
( O 0 3.5027764022643737e-10
SWS B-Disease 0 0.00014544882287736982
) O 0 2.213757128999294e-11
, O 0 4.240433525148912e-12
which O 0 2.050226741850958e-12
comprises O 0 3.675114726431339e-11
campomelia B-Disease 0 3.67659254152386e-08
at O 0 2.34404440302427e-10
birth O 0 1.3476237903375932e-09
with O 0 1.16283163653641e-11
skeletal B-Disease 0 0.1036309227347374
dysplasia I-Disease 1 0.9905722737312317
, O 0 6.461580159822233e-10
contractures B-Disease 0 3.4569478884804994e-05
, O 0 1.806962579564697e-09
and O 0 2.0257093225062306e-10
early B-Disease 0 9.596907712960956e-10
death I-Disease 0 3.4534700432686805e-08
. O 0 1.6051789897275626e-09

To O 0 1.1507286235001857e-09
test O 0 5.614389508856732e-10
for O 0 2.42897498989314e-13
possible O 0 1.2844254826394064e-10
nosologic O 0 3.824361101578688e-06
identity O 0 5.644254841286056e-08
between O 0 8.870335715949196e-11
these O 0 7.656207612338761e-11
disorders O 0 1.6979795418592403e-06
, O 0 9.147490924454882e-12
we O 0 2.7801925692183538e-11
reviewed O 0 4.6229239880624107e-10
the O 0 7.901087553316422e-13
literature O 0 5.220062229693845e-12
and O 0 1.0565747495666633e-12
obtained O 0 9.299303948412385e-13
a O 0 2.26782763575184e-12
follow O 0 1.281308253942015e-10
- O 0 4.0424474434530566e-08
up O 0 3.1257263444217642e-09
of O 0 1.1084128813355562e-13
the O 0 6.61582442475217e-13
only O 0 7.112220101052058e-12
two O 0 6.821395119767371e-13
surviving O 0 4.965845512572287e-10
patients O 0 1.2197205918884624e-11
, O 0 2.6006218120828983e-13
one O 0 7.174180954166998e-13
with O 0 2.7179491296491776e-12
SJS B-Disease 0 0.007446497678756714
type I-Disease 0 5.420264642452821e-06
2 I-Disease 0 1.4451488616895602e-10
at O 0 3.7726785251379624e-08
age O 0 9.026992486838026e-09
10 O 0 1.9688325622602143e-11
years O 0 1.2398740020791443e-11
and O 0 8.175396123966117e-12
another O 0 2.0511587220384264e-11
with O 0 9.563622463404364e-12
SWS B-Disease 0 1.1763376278395299e-05
at O 0 6.967395549395405e-09
age O 0 1.9162584852239206e-09
7 O 0 3.3430738732853627e-10
years O 0 3.7372943628710686e-10
. O 0 9.923307731085629e-10

Patients O 0 2.1830230707564624e-06
reported O 0 4.841707550440333e-07
as O 0 1.2390638515213936e-10
having O 0 1.394034554458301e-09
either O 0 2.038198587683837e-08
neonatal O 1 0.9999837875366211
SJS B-Disease 1 0.9999979734420776
or O 0 1.1537483260326553e-05
SWS B-Disease 0 0.08932531625032425
presented O 0 2.857797887223512e-10
a O 0 6.471009492137192e-12
combination O 0 1.0595904362253883e-11
of O 0 9.414193193448342e-14
a O 0 5.681846312888261e-11
severe O 0 1.4539367931831748e-08
, O 0 7.128793388933019e-11
prenatal O 0 0.1900673359632492
- O 1 0.9975690245628357
onset O 1 0.9996976852416992
neuromuscular B-Disease 1 0.9999978542327881
disorder I-Disease 1 0.9999725818634033
( O 0 2.4756119376689867e-09
with O 0 8.301618059647353e-09
congenital B-Disease 1 0.9999992847442627
joint I-Disease 1 0.8386111259460449
contractures I-Disease 1 0.9999922513961792
, O 0 1.0938279046968091e-05
respiratory O 1 0.9999507665634155
and O 0 1.6715672757072753e-07
feeding O 0 0.0009830202907323837
difficulties O 0 6.821983333793469e-07
, O 0 1.7984268588233654e-11
tendency O 0 1.0951569651140858e-09
to O 0 9.39389885323827e-12
hyperthermia B-Disease 0 5.1982791774207726e-05
, O 0 4.2386025245200187e-10
and O 0 2.6512811390766444e-10
frequent O 0 5.200396344662295e-07
death O 0 4.993899551664072e-07
in O 0 9.082923996261982e-11
infancy O 0 4.733307790161234e-08
) O 0 2.401131160220671e-12
with O 0 4.457448136725023e-13
a O 0 1.9780619850418013e-11
distinct O 0 1.6037070560415145e-09
campomelic B-Disease 0 3.734221900231205e-05
- I-Disease 0 0.00015604037616867572
metaphyseal I-Disease 0 0.0002490610349923372
skeletal I-Disease 0 0.47203680872917175
dysplasia I-Disease 1 0.9911839962005615
. O 0 1.7609346514291246e-07

The O 0 3.1640828845880264e-11
similarity O 0 5.066618791182975e-10
of O 0 2.1947351434067203e-13
the O 0 1.2389443854524118e-12
clinical O 0 1.5529052488361117e-09
and O 0 4.034984499301508e-11
radiographic O 0 1.0033480975835118e-05
findings O 0 8.615206326112457e-10
is O 0 2.416450026188066e-11
so O 0 3.218895636147856e-12
extensive O 0 3.289505889902955e-10
that O 0 4.816981535871179e-11
these O 0 1.212683287121763e-10
disorders O 0 5.083370524516795e-07
appear O 0 6.339741925875941e-11
to O 0 4.2774860042893437e-11
be O 0 3.7839456568100616e-10
a O 0 1.2599429832782505e-10
single O 0 3.716214891369418e-08
entity O 0 4.442517092684284e-05
. O 0 3.637517309584837e-08

The O 0 2.2427348866926877e-10
follow O 0 5.602237562740697e-10
- O 0 1.8742903762358765e-07
up O 0 1.4908529966106698e-09
observation O 0 1.2433019946911372e-07
of O 0 2.887792815205875e-13
an O 0 8.426095108107767e-13
identical O 0 2.039286295385523e-09
and O 0 4.750274392589793e-12
unique O 0 9.267153884551238e-12
pattern O 0 2.452364000760099e-08
of O 0 1.3073412795036599e-12
progressive O 0 2.637057150423061e-07
bone B-Disease 1 0.5420095920562744
dysplasia I-Disease 1 0.9986937642097473
in O 0 2.809212584775622e-10
the O 0 1.207895450328067e-10
two O 0 1.8237755750050155e-10
patients O 0 8.601688805676133e-11
( O 0 5.674064191586725e-13
one O 0 5.376078748842161e-11
with O 0 1.9554392827192402e-10
SJS B-Disease 1 0.970170259475708
type I-Disease 0 3.8578014937229455e-05
2 I-Disease 0 2.838626556034285e-10
, O 0 3.01217731313308e-11
one O 0 2.42660180144183e-11
with O 0 4.6444868784245585e-11
SWS B-Disease 0 0.0002610767842270434
) O 0 8.932594941502003e-11
surviving O 0 1.458678333676744e-08
beyond O 0 3.5489380323383557e-09
infancy O 0 1.1106609854039107e-08
adds O 0 3.6861386165654153e-10
to O 0 8.356966919691178e-13
the O 0 5.994512476464528e-14
evidence O 0 1.2389142663160602e-11
in O 0 1.3904998571838412e-13
favor O 0 3.738944483883122e-12
of O 0 5.935490272022947e-13
identity O 0 9.417899349273284e-09
. O 0 2.2812365330082685e-09

The O 0 6.216764603106384e-11
hypothesis O 0 5.983695205991069e-10
that O 0 1.7146737155138148e-11
SWS B-Disease 0 1.7409101928933524e-05
and O 0 5.73235681144979e-10
SJS B-Disease 1 0.6779922246932983
type I-Disease 0 3.867784471367486e-06
2 I-Disease 0 6.636520499814225e-11
are O 0 4.713738514100507e-12
the O 0 9.906084199456933e-13
same O 0 7.243780575372227e-10
disorder O 0 0.00012131389667047188
should O 0 4.901667405299293e-10
be O 0 3.0898597482703627e-12
testable O 0 3.141274393381188e-11
by O 0 2.3241574409384874e-14
molecular O 0 1.6034262676281608e-12
methods O 0 5.1941229095575636e-11
. O 0 3.389706224043998e-11
. O 0 5.042824491319209e-10

A O 0 5.1835584713444405e-09
mouse O 0 4.2517643805695116e-07
model O 0 9.53639087697411e-08
of O 0 1.0492422486407804e-09
severe O 1 0.9995825886726379
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.9436332583427429
defects O 1 0.9999998807907104
in O 0 2.8202410362609953e-07
hemostasis O 1 0.9998621940612793
and O 0 7.230097708088579e-06
thrombosis B-Disease 0 5.535526361200027e-05
. O 0 4.3275921512986315e-08

von B-Disease 0 0.03994850069284439
Willebrand I-Disease 0 0.0431000217795372
factor I-Disease 0 3.945705884689232e-06
( I-Disease 0 4.8887407899655955e-08
vWf I-Disease 0 0.010844591073691845
) I-Disease 0 5.827575660077855e-05
deficiency I-Disease 1 0.9999977350234985
causes O 1 0.8740073442459106
severe O 1 0.9999980926513672
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 1.1534533683743575e-07
humans O 0 1.6181866158149205e-07
. O 0 3.7940093733368485e-08

We O 0 2.1000350347577523e-09
generated O 0 2.98943751697589e-11
a O 0 7.698524109867044e-12
mouse O 0 9.75654543822202e-08
model O 0 3.921825530994738e-09
for O 0 2.280649085383002e-13
this O 0 5.710805634807914e-13
disease O 0 2.220627459692537e-09
by O 0 3.639609433606604e-14
using O 0 6.1455293978718295e-12
gene O 0 1.1655889586847934e-08
targeting O 0 1.5539022513166856e-07
. O 0 9.896792718677716e-09

vWf B-Disease 0 0.003341125091537833
- I-Disease 1 0.9835926294326782
deficient I-Disease 1 0.8848949074745178
mice O 0 7.533076859544963e-05
appeared O 0 9.330505434945735e-08
normal O 0 1.12550786468546e-08
at O 0 9.130103895138575e-10
birth O 0 4.0050374128242083e-10
; O 0 2.9186824398313993e-12
they O 0 7.414026857721634e-12
were O 0 1.0257104193778233e-10
viable O 0 5.172713812839902e-09
and O 0 4.50635848081582e-11
fertile O 0 1.1884536021966596e-08
. O 0 2.3128601256416914e-09

Neither O 0 8.272828608824057e-07
vWf O 0 5.6878507166402414e-05
nor O 0 5.023398898629239e-06
vWf O 0 0.0001388389355270192
propolypeptide O 0 0.0003996380546595901
( O 0 5.228073618468443e-08
von B-Disease 1 0.9935470223426819
Willebrand I-Disease 1 0.9946742057800293
antigen O 0 0.00010203349665971473
II O 0 3.77772594220005e-05
) O 0 7.926775902333816e-10
were O 0 7.130238621755325e-10
detectable O 0 4.938797815157159e-08
in O 0 6.611926175840999e-13
plasma O 0 3.5880609594585167e-09
, O 0 4.99087013036692e-12
platelets O 0 3.8354933118434076e-10
, O 0 3.961983519040757e-12
or O 0 1.0827045857086937e-11
endothelial O 0 2.6231880556615295e-10
cells O 0 7.587402928166398e-11
of O 0 5.630198455890134e-13
the O 0 8.690703538760669e-12
homozygous O 0 5.9284676723336815e-08
mutant O 0 1.8274673152518517e-07
mice O 0 2.138000354534597e-06
. O 0 6.953203346427017e-09

The O 0 4.6364523331732244e-10
mutant O 0 1.8324340089748148e-06
mice O 0 0.00012052293459419161
exhibited O 0 3.565652514225803e-05
defects O 1 0.9993870258331299
in O 0 1.1262690086111249e-10
hemostasis O 0 0.0017979179974645376
with O 0 1.9292545339055778e-10
a O 0 3.7923489348834494e-10
highly O 0 4.172564516125021e-09
prolonged O 0 9.138836503552739e-06
bleeding O 0 0.06488668918609619
time O 0 2.3650270630781733e-09
and O 0 4.804220909981893e-10
spontaneous O 0 4.528308394924352e-09
bleeding O 0 1.2360151231405325e-06
events O 0 1.5573269063207107e-10
in O 0 4.372486313991564e-12
approximately O 0 5.261349689256178e-10
10 O 0 7.786244565766154e-11
% O 0 4.947442629188448e-12
of O 0 1.1306140051958735e-11
neonates O 0 6.42294435238e-06
. O 0 1.5170950717902087e-08

As O 0 4.183016988346111e-10
in O 0 1.8535756696885786e-12
the O 0 2.73672658970478e-13
human O 0 5.390970447827215e-10
disease O 0 7.836433724150993e-07
, O 0 1.1240189551689483e-12
the O 0 7.159468737262184e-14
factor O 0 9.238250442411555e-11
VIII O 0 4.720028243809793e-07
level O 0 2.289074529926438e-08
in O 0 9.373240031362862e-13
these O 0 3.478140084972603e-12
mice O 0 9.720192650775061e-09
was O 0 1.9595761124868716e-10
reduced O 0 7.438645185930959e-12
strongly O 0 8.028627762612928e-11
as O 0 9.479136225953866e-13
a O 0 9.925431787224936e-13
result O 0 2.5451227497058637e-12
of O 0 1.0160936762121375e-13
the O 0 4.2644173782468986e-12
lack O 0 6.560729043370017e-11
of O 0 4.020905787147089e-13
protection O 0 3.7030864485920745e-10
provided O 0 7.789613572228848e-12
by O 0 2.310785417181105e-11
vWf O 0 4.5789983005306567e-07
. O 0 8.446257027117099e-09

Defective O 1 0.8606151938438416
thrombosis B-Disease 0 2.7837848392664455e-05
in O 0 4.0088432573526234e-10
mutant O 0 8.472454737784574e-07
mice O 0 6.060530267859576e-06
was O 0 1.1375224318044275e-08
also O 0 2.80296147403547e-10
evident O 0 2.2631892193647474e-10
in O 0 3.3053627109674855e-13
an O 0 9.723541823060053e-14
in O 0 4.3565758639507735e-13
vivo O 0 4.5056094677420333e-07
model O 0 5.047002815672386e-09
of O 0 2.7915104255926693e-11
vascular B-Disease 1 0.8586260080337524
injury I-Disease 0 0.0035381733905524015
. O 0 1.8256331202337606e-07

In O 0 6.005851371782e-11
this O 0 1.847857153750021e-12
model O 0 2.0084285345944863e-09
, O 0 4.708617176718555e-12
the O 0 1.591349014368193e-12
exteriorized O 0 9.25768404158589e-08
mesentery O 0 5.072145086160162e-07
was O 0 2.915999219865739e-09
superfused O 0 3.491886957363022e-08
with O 0 1.1006990457973487e-11
ferric O 0 1.3907606621899049e-08
chloride O 0 9.971403702735415e-10
and O 0 3.462362341277725e-11
the O 0 8.518007263078053e-13
accumulation O 0 1.3405865306737041e-09
of O 0 6.765307064560133e-12
fluorescently O 0 9.260115803044755e-06
labeled O 0 9.029387229020358e-07
platelets O 0 5.506075950734157e-08
was O 0 8.026396769444943e-10
observed O 0 2.988350122912209e-10
by O 0 5.503019914754326e-12
intravital O 0 1.4227563127633402e-08
microscopy O 0 7.9672659580865e-09
. O 0 1.6777368383458224e-09

We O 0 4.82985695882121e-09
conclude O 0 9.528831890204259e-11
that O 0 1.5911841885329209e-13
these O 0 3.5807707981453524e-14
mice O 0 7.907593330136464e-11
very O 0 2.4685023990167476e-12
closely O 0 1.198466437202228e-09
mimic O 0 3.7896229514444713e-06
severe O 0 9.602546924725175e-06
human O 0 0.0023174546658992767
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 0.003386835101991892
will O 0 8.728003990654543e-07
be O 0 2.8878965885326124e-10
very O 0 5.691561371506948e-12
useful O 0 6.545426960852252e-12
for O 0 7.64423179161304e-14
investigating O 0 3.592556113707346e-11
the O 0 1.5844668784480154e-13
role O 0 1.3159176873167588e-11
of O 0 1.2294147904573505e-13
vWf O 0 5.615206521980554e-09
in O 0 1.0688240223433176e-11
normal O 0 6.957860065881505e-09
physiology O 0 9.64040625106577e-10
and O 0 1.1707101954527843e-10
in O 0 7.994150480472584e-12
disease O 0 2.469019193540589e-07
models O 0 1.1975920699569542e-08
. O 0 7.138943602935655e-11
. O 0 7.90732646027692e-10

Oral O 0 7.07096489804826e-07
contraceptives O 0 0.00013463411596603692
and O 0 3.472226284273461e-09
the O 0 7.684502340010724e-11
risk O 0 3.480800160104991e-06
of O 0 2.6763116167671797e-08
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 5.430159717434435e-07

Hereditary B-Disease 1 0.9999995231628418
Ovarian I-Disease 1 0.9999972581863403
Cancer I-Disease 0 0.08213943243026733
Clinical O 0 2.6403236574878974e-07
Study O 0 1.4063381570394995e-09
Group O 0 1.868088794765299e-08
. O 0 2.3640438495675653e-09

BACKGROUND O 0 2.401125675532967e-05
Women O 0 2.38770642146946e-10
with O 0 6.520801151647937e-13
mutations O 0 3.145641247481734e-10
in O 0 1.1871280868047673e-12
either O 0 6.138527186561049e-11
the O 0 1.6338298769458248e-11
BRCA1 O 0 4.622602602921688e-07
or O 0 6.806056829233853e-10
the O 0 4.417207051521377e-12
BRCA2 O 0 9.009156087813608e-09
gene O 0 2.8920486006001056e-09
have O 0 4.038356801738807e-11
a O 0 2.4036342360922447e-11
high O 0 3.1511733222799876e-09
lifetime O 0 5.923516965822273e-08
risk O 0 4.991514651919715e-05
of O 0 2.458936705806991e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 5.421807713901217e-07

Oral O 0 2.2090380298323e-06
contraceptives O 0 0.4074224829673767
protect O 0 0.011670448817312717
against O 0 0.08523572981357574
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 8.342960350349315e-11
general O 0 2.4122651098856807e-10
, O 0 8.103891169231048e-11
but O 0 4.92813845287543e-11
it O 0 3.386481720046852e-11
is O 0 9.344807913591602e-12
not O 0 3.3743374847766683e-13
known O 0 7.048488312108581e-13
whether O 0 3.329376704885867e-12
they O 0 3.126699637048813e-12
also O 0 1.5215264811963003e-11
protect O 0 9.789157262574122e-10
against O 0 4.890741145402444e-10
hereditary B-Disease 0 0.0014056720538064837
forms I-Disease 0 4.00234384869691e-05
of I-Disease 0 0.001932564307935536
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 1.23430424991966e-07

METHODS O 0 9.622594632219261e-08
We O 0 1.0119876048264587e-09
enrolled O 0 2.0545623535817015e-10
207 O 0 6.83187773020677e-09
women O 0 4.3583630038313e-09
with O 0 3.828985200016177e-07
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.2261467929874925e-07
161 O 0 5.394336533015576e-09
of O 0 1.4750291266185656e-11
their O 0 6.109958650135638e-10
sisters O 0 1.836423990653202e-08
as O 0 1.206702099354473e-11
controls O 0 3.5023265354539035e-07
in O 0 4.964050438066581e-12
a O 0 4.862063529564864e-11
case O 0 6.562284049493883e-10
- O 0 8.77455050840581e-08
control O 0 7.111297861683852e-08
study O 0 5.882124232137187e-10
. O 0 8.098333115214018e-10

All O 0 8.594887024315767e-10
the O 0 8.811228656424586e-12
patients O 0 4.865542344023588e-11
carried O 0 2.5981267137709096e-10
a O 0 7.999886343645901e-12
pathogenic O 0 2.0109045539840054e-09
mutation O 0 3.715644458779366e-10
in O 0 5.1091742598805e-13
either O 0 7.44980951927765e-11
BRCA1 O 0 3.6335787712005185e-08
( O 0 1.4441699572320665e-11
179 O 0 2.7966666760192993e-09
women O 0 3.973845211224791e-11
) O 0 2.2157891840790533e-11
or O 0 5.653388868154252e-09
BRCA2 O 0 3.034571136595332e-07
( O 0 5.821237936132206e-11
28 O 0 7.463911266825107e-09
women O 0 3.7856041218420344e-11
) O 0 7.15911080417797e-11
. O 0 7.314727157314849e-10

The O 0 3.640525936265959e-10
control O 0 5.986509563626896e-07
women O 0 1.3888559746710882e-10
were O 0 2.2855852627179374e-11
enrolled O 0 9.748230868356078e-12
regardless O 0 1.0089722460304706e-11
of O 0 2.7006915380802833e-14
whether O 0 5.1459617816940195e-11
or O 0 4.224308680633726e-10
not O 0 1.0326423049988875e-09
they O 0 3.667482290081736e-11
had O 0 2.401912280181051e-10
either O 0 5.171761630062832e-11
mutation O 0 3.3721823111676485e-09
. O 0 9.14997799750239e-10

Lifetime O 0 4.6425984123743547e-07
histories O 0 7.287550261025899e-07
of O 0 2.0549100615552263e-11
oral O 0 1.0049980403437075e-08
- O 0 1.1411749255785253e-05
contraceptive O 0 5.73567604078562e-07
use O 0 1.0776821796065761e-10
were O 0 5.43820283943619e-12
obtained O 0 2.9245167485619783e-12
by O 0 8.71413672557525e-13
interview O 0 1.684817107161507e-06
or O 0 1.7333784407824737e-10
by O 0 8.014726577722231e-13
written O 0 2.3489708442236967e-11
questionnaire O 0 4.645514528611727e-11
and O 0 2.2222256586962308e-12
were O 0 1.516333933415659e-12
compared O 0 2.7539673666532316e-11
between O 0 1.1482543214869079e-11
patients O 0 1.7638918103912715e-10
and O 0 3.962454322992137e-11
control O 0 3.311010686957161e-06
women O 0 5.0019849373583725e-11
, O 0 1.9075617821440183e-12
after O 0 1.694120971978963e-12
adjustment O 0 3.7504907512975194e-10
for O 0 4.1049452790924146e-13
year O 0 8.263308657122104e-13
of O 0 7.936229798333194e-14
birth O 0 1.015192929720854e-09
and O 0 3.6943595405070084e-10
parity O 0 8.181589095102026e-08
. O 0 1.4651717616942506e-09

RESULTS O 0 1.735828547566598e-08
The O 0 1.7795947007681612e-11
adjusted O 0 2.1106750409671804e-06
odds O 0 1.0774595466500614e-05
ratio O 0 0.0001951565354829654
for O 0 4.2689538531703874e-05
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 2.1838299346654821e-07
with O 0 3.477604662571743e-11
any O 0 4.472955617007557e-10
past O 0 1.6052678075695326e-09
use O 0 3.747685495270048e-11
of O 0 9.647639674995045e-13
oral O 0 1.6160600635473088e-09
contraceptives O 0 1.5748227042422513e-06
was O 0 3.1960038171519045e-08
0 O 0 5.42534073222356e-10
. O 0 6.561082788181238e-10

5 O 0 2.481715277724561e-09
( O 0 6.674145264229381e-11
95 O 0 1.100394264597071e-08
percent O 0 1.6101248547784053e-06
confidence O 0 1.517943672979527e-07
interval O 0 3.5788663699243273e-10
, O 0 1.2786237997206018e-12
0 O 0 4.929428176411732e-14
. O 0 1.2666170704238224e-14
3 O 0 4.2315899184209096e-14
to O 0 2.402004918751477e-13
0 O 0 9.191594967788985e-13
. O 0 1.4064352980847072e-12
8 O 0 1.6959971621544057e-11
) O 0 5.710275134684917e-12
. O 0 9.460433131325274e-11

The O 0 4.92100193927314e-10
risk O 0 3.764455414057011e-08
decreased O 0 4.043488388560945e-08
with O 0 7.536240728689414e-12
increasing O 0 6.866502505475935e-11
duration O 0 3.1032123537499956e-09
of O 0 5.31094753678657e-13
use O 0 6.120896151040611e-11
( O 0 2.4610933950508507e-12
P O 0 2.4705425261117853e-08
for O 0 1.3344840098412913e-13
trend O 0 4.6065551373430935e-09
, O 0 8.042106477285094e-13
< O 0 8.755279140570948e-11
0 O 0 4.478736717432319e-13
. O 0 2.3176512792266735e-13
001 O 0 1.5118123766755254e-11
) O 0 2.2935165322913315e-14
; O 0 4.561687043592088e-15
use O 0 4.101681830553233e-13
for O 0 6.311912797984931e-13
six O 0 2.8060717811861924e-12
or O 0 5.900636750044708e-12
more O 0 4.343549445898903e-13
years O 0 2.3811642761717433e-12
was O 0 2.5786739063504704e-11
associated O 0 1.9923330346616197e-11
with O 0 2.660826474518846e-13
a O 0 7.294532165802448e-12
60 O 0 2.432033741062156e-10
percent O 0 1.4132568448843585e-09
reduction O 0 4.0621683794483943e-10
in O 0 1.5274181919266994e-10
risk O 0 1.6384328205276688e-07
. O 0 2.1622303947310684e-09

Oral O 0 1.4998000779087306e-06
- O 0 3.2162017305381596e-05
contraceptive O 0 1.1030419955204707e-05
use O 0 1.3809488663696357e-08
protected O 0 0.09067660570144653
against O 0 0.008452027104794979
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 8.745761059802959e-12
for O 0 3.152064330033677e-12
carriers O 0 6.691480702869512e-11
of O 0 1.5747804807137583e-13
the O 0 1.2267222827822e-11
BRCA1 O 0 1.1172544134296913e-07
mutation O 0 3.0218058610920195e-10
( O 0 2.311445522831801e-12
odds O 0 2.3057158404782285e-09
ratio O 0 1.0387641857789731e-09
, O 0 4.610512058939031e-12
0 O 0 3.410279328895649e-13
. O 0 1.3045359063823536e-13
5 O 0 1.6973351706344592e-13
; O 0 1.066304095259478e-13
95 O 0 2.864155024262516e-10
percent O 0 2.9014631763857324e-07
confidence O 0 1.3136080667663919e-07
interval O 0 3.8916897482366153e-10
, O 0 1.1194168422073991e-12
0 O 0 9.496703011653562e-14
. O 0 2.307469875438041e-14
3 O 0 5.633686605329563e-14
to O 0 1.7234953427532756e-13
0 O 0 4.969533356873057e-13
. O 0 6.041968683180576e-13
9 O 0 1.0845399231462771e-11
) O 0 2.5765620106227294e-13
and O 0 9.320861140207914e-13
for O 0 1.26822041908968e-13
carriers O 0 4.437312930288817e-12
of O 0 4.459869702277269e-14
the O 0 3.3441994833072197e-12
BRCA2 O 0 1.9917358429211163e-08
mutation O 0 5.7595005154009726e-11
( O 0 3.631989999551555e-13
odds O 0 1.3041403512659144e-09
ratio O 0 6.177454658917725e-10
, O 0 5.075308662921829e-12
0 O 0 7.829962264498114e-13
. O 0 8.077228935612218e-14
4 O 0 4.4639145895322696e-13
; O 0 7.595098053085614e-13
95 O 0 1.3610926830054382e-09
percent O 0 1.502525833529944e-06
confidence O 0 8.197896761430457e-08
interval O 0 1.296456414445757e-10
, O 0 6.821954568088373e-13
0 O 0 8.584580664600452e-14
. O 0 5.35549964022098e-14
2 O 0 1.3100638466840425e-13
to O 0 8.181880737159752e-13
1 O 0 1.6501804263324704e-12
. O 0 2.559015282663224e-12
1 O 0 3.1392844053457214e-12
) O 0 9.4868999808706e-12
. O 0 1.8105668353474158e-10

CONCLUSIONS O 0 6.359297799463093e-08
Oral O 0 5.349288301204069e-08
- O 0 1.8578675735625438e-06
contraceptive O 0 1.5754402227230457e-07
use O 0 7.678554320156294e-11
may O 0 1.537272913132437e-11
reduce O 0 5.805447789164475e-11
the O 0 1.1824306291041697e-11
risk O 0 5.3855859732721e-05
of O 0 4.701384455074731e-07
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 2.338792493006281e-10
women O 0 1.2600816223784506e-11
with O 0 1.522306586343447e-12
pathogenic O 0 5.146203019279483e-09
mutations O 0 3.788085400913133e-09
in O 0 1.7652565607179094e-12
the O 0 1.4223687332115542e-11
BRCA1 O 0 2.7878812147719145e-07
or O 0 9.034968329046933e-09
BRCA2 O 0 2.4874852897482924e-06
gene O 0 6.327867140498711e-06

A O 0 1.443288244473706e-08
Japanese O 0 2.1988048715115838e-08
family O 0 8.518576954941182e-09
with O 0 1.4540713078048384e-10
adrenoleukodystrophy B-Disease 1 1.0
with O 0 1.7776957683679484e-10
a O 0 6.378725325717483e-11
codon O 0 1.6330565344446768e-08
291 O 0 3.334675868771342e-09
deletion O 0 1.783300973556834e-08
: O 0 3.326160527561406e-11
a O 0 1.2853462218187506e-11
clinical O 0 9.589259386544313e-10
, O 0 1.3651471446329833e-11
biochemical O 0 5.228111277233438e-09
, O 0 1.8814522856347438e-11
pathological O 0 3.9824325170911834e-08
, O 0 2.7246354478149826e-11
and O 0 2.5398287639699646e-11
genetic O 0 2.501390916620494e-08
report O 0 2.9531605605370714e-08
. O 0 5.370652367275852e-09

We O 0 1.2579055130856887e-08
report O 0 1.147935219103502e-10
a O 0 1.2715182205746967e-11
Japanese O 0 3.504148082811298e-09
family O 0 3.6065246344918478e-09
with O 0 1.0374059389306467e-09
adrenoleukodystrophy B-Disease 1 1.0
( O 0 2.9996547823429864e-07
ALD B-Disease 1 1.0
) O 0 2.009006017100745e-10
with O 0 7.979648192213418e-12
a O 0 2.948220140241986e-11
three O 0 2.037752258599035e-11
base O 0 1.0349004320175936e-08
pair O 0 9.378333665210903e-10
deletion O 0 7.146812475156139e-09
( O 0 2.0665129329966447e-11
delGAG O 0 1.061141308156266e-08
291 O 0 4.457880453667684e-10
) O 0 3.4516326428979394e-12
in O 0 2.0063159033439915e-12
the O 0 7.040245469935869e-11
ALD B-Disease 1 0.9999988079071045
gene O 0 1.4971448081269045e-06
. O 0 8.250411021037962e-09

A O 0 5.988505247245257e-09
variety O 0 7.728014339569711e-10
of O 0 1.520997520640388e-12
phenotypes O 0 1.764691148764541e-08
were O 0 1.1333847749206427e-10
observed O 0 1.4143786142284398e-09
within O 0 6.334058277879251e-12
this O 0 5.296241743779628e-12
family O 0 5.794777990786315e-09
. O 0 1.2506322644156853e-09

While O 0 3.6947769288531163e-09
the O 0 2.2751162065404174e-11
proband O 0 2.1994893018018047e-07
( O 0 5.769814140355045e-11
patient O 0 6.487037040869836e-08
1 O 0 1.1712411422670765e-11
) O 0 4.68916875814851e-12
was O 0 4.852886981154825e-09
classified O 0 1.399430544779534e-07
as O 0 1.8841421478565934e-11
having O 0 9.846149069681065e-12
a O 0 8.3521389674171e-13
rare O 0 1.1298272213633442e-11
intermediate O 0 3.583659410888451e-11
type O 0 2.330596693411735e-08
of O 0 2.2586980029382087e-12
adult O 0 1.299419409406255e-06
cerebral O 0 6.148057582322508e-05
and O 0 1.1149847267688529e-08
cerebello O 0 0.005316563416272402
- O 1 0.6197306513786316
brain O 0 0.0020977677777409554
stem O 0 4.4621124573041016e-08
forms O 0 8.787274907717801e-09
, O 0 1.0549211504340406e-09
his O 0 5.639450018080083e-10
younger O 0 3.1296758518095658e-09
brother O 0 7.715149052955894e-08
( O 0 3.670435136382544e-11
patient O 0 5.576071089308243e-07
2 O 0 1.3977986823565658e-10
) O 0 2.584495395474562e-10
and O 0 1.9158136410624138e-08
nephew O 0 0.00015345189603976905
( O 0 1.0143180739774493e-09
patient O 0 9.653065717429854e-06
3 O 0 2.754977634911171e-10
) O 0 3.289116756732824e-10
had O 0 1.0395321936584878e-07
a O 0 6.093807236595694e-09
childhood O 0 0.06811807304620743
ALD B-Disease 1 1.0
type O 0 0.22530964016914368
. O 0 1.1025943535969418e-07

Another O 0 1.575256192154484e-08
nephew O 0 4.17108185502002e-06
( O 0 1.3196440606932924e-09
patient O 0 2.371538585066446e-06
4 O 0 1.094603019335949e-10
) O 0 2.493493952981929e-11
of O 0 2.631259619911841e-11
patient O 0 3.27960224240087e-05
1 O 0 1.993626513874247e-10
was O 0 1.1995759905403247e-06
classified O 0 4.527802957454696e-06
as O 0 4.4367670648526314e-10
having O 0 3.610473309212381e-10
an O 0 4.5690608414805656e-12
adolescent O 0 3.1952662737921855e-08
form O 0 1.5929296770522683e-10
. O 0 2.4317425850739482e-09

The O 0 2.965614975813935e-10
tau O 0 3.620702182516311e-09
level O 0 3.535208237259724e-10
in O 0 2.513202753545718e-12
the O 0 5.3721631310121865e-11
cerebrospinal O 0 9.774661884875968e-05
fluid O 0 9.27300618513982e-08
( O 0 1.409880545644171e-09
CSF O 0 0.07395633310079575
) O 0 4.883486670603787e-11
in O 0 2.5608475409666376e-11
patient O 0 1.1426634927147461e-07
1 O 0 4.360194497121661e-12
was O 0 5.936524516414465e-08
as O 0 2.425704082043012e-11
high O 0 3.2287051504598097e-11
as O 0 2.2284509849403167e-13
that O 0 1.254583730739972e-13
of O 0 1.7261964969407517e-13
patients O 0 8.436431553349166e-10
with O 0 3.639616386053035e-10
Alzheimers B-Disease 1 0.9999736547470093
disease I-Disease 0 0.4091539978981018
( O 0 2.1839148545144127e-10
AD B-Disease 0 8.318044820043724e-06
) O 0 3.961121208817531e-09
. O 0 3.1034963487996947e-09

His O 0 2.2082773387666066e-09
brain O 0 2.7061759055868606e-08
magnetic O 0 1.106833380504213e-08
resonance O 0 2.9420007763292233e-08
image O 0 1.3079777261282288e-07
( O 0 2.3401836024561362e-11
MRI O 0 9.29691381656994e-08
) O 0 4.896796509945567e-11
showed O 0 6.485119570243114e-07
abnormalities B-Disease 0 0.007922657765448093
in I-Disease 0 3.1665624983245877e-12
the I-Disease 0 4.5433573570008434e-11
bilateral I-Disease 0 1.4553106666426174e-05
cerebellar I-Disease 0 0.02096780762076378
hemispheres I-Disease 0 0.00020695182320196182
and O 0 1.3574559254436736e-08
brain O 0 2.2894005269336049e-07
stem O 0 7.206186758423883e-10
, O 0 6.766739078789552e-12
but O 0 4.897578870233232e-12
not O 0 4.044722022589209e-12
in O 0 3.343126285786785e-13
the O 0 2.5269545570610896e-12
cerebral O 0 6.364090410215795e-08
white O 0 3.723845953818028e-10
matter O 0 1.0235582346973526e-11
, O 0 3.404917407051622e-13
where O 0 5.110216720269345e-13
marked O 0 2.5791362101568183e-11
reductions O 0 2.035671214928314e-10
of O 0 5.156528416067063e-13
the O 0 4.492850189108388e-11
cerebral O 0 2.262724592583254e-06
blood O 0 1.3436359580509816e-08
flow O 0 2.2711308389489204e-08
and O 0 1.7370231919500156e-09
oxygen O 0 5.190448765235445e-11
metabolism O 0 5.123009239049736e-10
were O 0 1.9981061943896705e-11
clearly O 0 5.230828617475147e-11
demonstrated O 0 4.472712131220469e-12
by O 0 7.884207745218266e-14
positron O 0 3.8443334626769854e-10
emission O 0 8.74557037899848e-10
tomography O 0 3.646047375127637e-08
( O 0 4.6331816161426786e-10
PET O 0 2.7617312525762827e-07
) O 0 2.8921301464812643e-10
. O 0 7.110165789470102e-10

In O 0 5.45672340646064e-10
patients O 0 1.5075178882995033e-09
2 O 0 4.059036787240622e-11
and O 0 1.7588726308748193e-10
3 O 0 2.7129003904446947e-11
, O 0 4.135714774117227e-12
the O 0 3.359176001596631e-13
autopsy O 0 4.7887155233183876e-05
findings O 0 6.598090962484093e-10
showed O 0 4.928804031578693e-08
massive O 0 2.0486562846144807e-07
demyelination B-Disease 1 1.0
of I-Disease 0 3.135326165359942e-10
the I-Disease 0 1.892610790310556e-10
cerebral I-Disease 0 6.789945814489329e-07
white I-Disease 0 7.635969634378625e-10
matter I-Disease 0 4.981702116796383e-12
with O 0 2.0218153323411925e-13
sparing O 0 5.6007819909664747e-11
of O 0 1.4798358935821931e-12
the O 0 2.5805827960634353e-11
U O 0 0.014792381785809994
- O 0 5.703380338673014e-06
fibers O 0 4.8109011885344444e-08
, O 0 4.7771508970839704e-12
compatible O 0 5.134314848276311e-11
with O 0 6.785255950852997e-13
the O 0 6.749772182151892e-13
findings O 0 5.426103663608295e-11
of O 0 2.0378067289161805e-11
childhood O 0 0.0001843159698182717
ALD B-Disease 1 0.9999992847442627
. O 0 7.651956224208334e-08

Oleic O 0 0.0007892667199485004
and O 0 1.5297230149258212e-08
erucic O 0 2.9860239010304213e-05
acids O 0 2.808505372708936e-10
( O 0 7.598812204467897e-12
Lorenzos O 0 2.232749629627051e-08
Oil O 0 3.3420349820900697e-10
) O 0 6.33758345282287e-13
were O 0 6.897407991979243e-13
administered O 0 1.5479259584186278e-12
to O 0 2.577353478208644e-13
patients O 0 1.0904015537716027e-11
1 O 0 1.078610616621345e-12
and O 0 1.0204456724061117e-10
4 O 0 2.2672927771361095e-11
, O 0 1.0611051967646112e-11
but O 0 8.169379235589691e-12
sufficient O 0 9.803909420402768e-12
effectiveness O 0 1.7356446835314898e-10
was O 0 8.216768376811956e-10
not O 0 1.601538172912864e-11
obtained O 0 7.802479495833126e-11
. O 0 1.060456833457124e-09

The O 0 2.2099783114626348e-10
findings O 0 2.6301921751681334e-10
in O 0 2.56121106311305e-13
this O 0 5.4385705330504616e-14
family O 0 2.7603358834782377e-11
suggest O 0 2.2333510041327997e-11
that O 0 1.4911834787800782e-12
delGAG291 O 0 5.298695260336217e-09
is O 0 1.1947587884308941e-11
part O 0 7.349766628639287e-12
of O 0 7.751781258991813e-14
the O 0 1.239790713668254e-12
cause O 0 2.1559862228848203e-10
of O 0 9.473933790249411e-12
Japanese O 0 2.015276186284609e-05
ALD B-Disease 1 0.9999997615814209
with O 0 5.7362038730079945e-11
phenotypic O 0 3.6073931397595516e-08
variations O 0 3.5458077718431014e-07
. O 0 2.3185148023685542e-08

Moreover O 0 2.0970341907400325e-08
, O 0 1.9338145668124085e-11
although O 0 7.742283376910297e-13
the O 0 6.634864641204274e-14
scale O 0 5.821634658786934e-07
of O 0 1.2545215246403257e-13
the O 0 1.1505003221813637e-13
study O 0 1.398623946692601e-12
is O 0 2.9177862383156228e-12
limited O 0 1.2564433000961106e-11
, O 0 1.396829808937572e-12
there O 0 7.95818706073037e-12
is O 0 1.9108464810457804e-12
a O 0 1.5968331529021135e-13
possibility O 0 3.176555806588821e-12
that O 0 2.7936930113020564e-12
PET O 0 1.1919086162492931e-08
can O 0 6.322446472611931e-12
detect O 0 4.3226071611002226e-09
an O 0 4.182207531677751e-12
insidious B-Disease 0 1.1445340533100534e-05
lesion I-Disease 1 0.999832272529602
which O 0 4.97564442980547e-08
is O 0 1.9084818170256312e-09
undetectable O 0 1.0967609043177617e-08
by O 0 4.4069462705811913e-13
computed O 0 5.089272892000452e-10
tomogram O 0 3.13836885368346e-08
( O 0 7.101687293786796e-12
CT O 0 2.7316966111357033e-07
) O 0 4.408352155538253e-12
or O 0 6.19036332610845e-12
MRI O 0 1.5684855636521888e-09
analysis O 0 3.980756002608388e-11
, O 0 7.267035497665608e-12
and O 0 1.689119872617939e-12
that O 0 6.400766418626636e-13
the O 0 6.181284596586817e-14
higher O 0 9.622209279358529e-12
level O 0 1.0301291070158314e-11
of O 0 6.093277195740737e-15
tau O 0 1.841794295201482e-12
reflects O 0 8.163502426133951e-13
the O 0 9.524288333646793e-15
process O 0 1.018754742024286e-12
of O 0 1.4228231765521515e-13
neuronal B-Disease 0 7.049366246292266e-08
degeneration I-Disease 0 7.85934753366746e-05
in O 0 6.481916869915949e-08
ALD B-Disease 1 0.9999998807907104
. O 0 3.1783628173798206e-07

Lorenzos O 0 7.0437467911688145e-06
Oil O 0 1.8010767632858915e-07
should O 0 1.661814991171795e-10
be O 0 5.752501339856275e-13
given O 0 2.3387609665755094e-14
in O 0 1.1166412473763866e-14
the O 0 1.7671480666042912e-14
early O 0 1.5409071588146084e-11
stage O 0 6.250382877937e-09
. O 0 1.6202589617209107e-11
. O 0 1.0483614670819819e-10

Nonsense O 0 1.714682366582565e-05
mutation O 0 1.0257232396782001e-08
in O 0 1.8059261768302304e-12
exon O 0 1.2685665851108752e-09
4 O 0 1.2145860706080924e-10
of O 0 1.91588281697741e-12
human O 0 9.33804700231633e-10
complement O 0 2.45738696058595e-09
C9 O 0 1.630467139079883e-08
gene O 0 1.0173334175078708e-08
is O 0 3.7391319207547014e-11
the O 0 3.578806088283537e-13
major O 0 6.515237654936001e-11
cause O 0 2.5748711496298426e-10
of O 0 1.0428705642107072e-11
Japanese O 0 9.526203029963654e-06
complement B-Disease 0 9.516142199572641e-06
C9 I-Disease 0 0.003679306013509631
deficiency I-Disease 1 0.7801589965820312
. O 0 1.3503183460272794e-08

Deficiency B-Disease 1 0.9998944997787476
of I-Disease 0 7.454613315527325e-11
the I-Disease 0 1.4141695627023498e-11
ninth I-Disease 0 3.351233179849089e-10
component I-Disease 0 2.410359201121537e-08
of I-Disease 0 2.9660759525568237e-12
human I-Disease 0 1.0095796421083492e-09
complement I-Disease 0 4.5316242425208486e-10
( O 0 3.4754677434578607e-12
C9 O 0 6.160581489389472e-10
) O 0 7.582982093808088e-13
is O 0 9.824870951524733e-13
the O 0 5.4453488295075694e-14
most O 0 7.75093184079978e-12
common O 0 1.6221818555095524e-08
complement B-Disease 1 0.9999997615814209
deficiency I-Disease 1 1.0
in O 0 1.2070266661168283e-11
Japan O 0 1.5396218744356815e-09
but O 0 5.521461326346566e-12
is O 0 7.240909803175877e-13
rare O 0 1.2292020699911088e-12
in O 0 4.055906272729809e-13
other O 0 3.924722959819382e-12
countries O 0 1.2349978678605211e-11
. O 0 1.8454990313720998e-10

We O 0 3.613857879614102e-09
studied O 0 1.7117361347795956e-11
the O 0 6.642956177542805e-14
molecular O 0 3.9040218974273344e-11
basis O 0 2.198513315843087e-10
of O 0 6.034074628846753e-11
C9 B-Disease 0 0.010545273311436176
deficiency I-Disease 1 0.9008556008338928
in O 0 2.4916731872215436e-11
four O 0 1.08977424306822e-10
Japanese O 0 4.033282507975855e-08
C9 B-Disease 0 9.436572554477607e-07
- I-Disease 0 0.00015543834888376296
deficient I-Disease 0 8.990435890154913e-05
patients O 0 2.6234458161411567e-08
who O 0 1.3805458998206177e-08
had O 0 8.894149345906044e-07
suffered O 0 0.0019157659262418747
from O 0 1.1359553298007086e-07
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 3.2080939149636833e-07

Direct O 0 7.977910776446606e-09
sequencing O 0 5.03253616557231e-09
of O 0 1.4402995289486409e-11
amplified O 0 1.8655105904485936e-08
C9 O 0 2.3127730841565608e-08
cDNA O 0 1.8380735822276506e-09
and O 0 2.3513377009343195e-11
DNA O 0 8.648661231624999e-10
revealed O 0 9.16558842711801e-11
a O 0 3.642633937539497e-12
nonsense O 0 1.2765470902564857e-09
substitution O 0 2.956046865620898e-11
( O 0 4.076709456124483e-12
CGA O 0 1.4445220131165115e-08
- O 0 2.1621865187171352e-07
- O 0 6.689511877766563e-08
> O 0 2.201278465063794e-10
TGA O 0 1.2371049962212055e-08
) O 0 1.372048308301288e-12
at O 0 7.41602092235727e-12
codon O 0 5.3417863882243566e-11
95 O 0 1.2372187475906404e-11
in O 0 9.892408344303744e-14
exon O 0 1.3803680420920728e-10
4 O 0 3.97235994098466e-11
in O 0 6.5144270186556774e-12
the O 0 7.212807608125704e-12
four O 0 2.0825591251494302e-10
C9 B-Disease 0 5.575624868470186e-07
- I-Disease 0 5.6887187383836135e-05
deficient I-Disease 0 1.6539148418814875e-05
individuals O 0 9.147465007686151e-10
. O 0 5.708505890211768e-10

An O 0 1.9724004374221948e-10
allele O 0 4.048234103493087e-08
- O 0 7.02670632790614e-08
specific O 0 3.67113728305668e-10
polymerase O 0 5.112920931082954e-08
chain O 0 3.035920030924899e-07
reaction O 0 5.128523161701537e-10
system O 0 1.1928438271857633e-11
designed O 0 6.420470405332779e-11
to O 0 3.987013356184649e-13
detect O 0 2.2083783690618475e-09
exclusively O 0 3.0450576088414394e-11
only O 0 5.351583759471978e-12
one O 0 2.3238628903132774e-12
of O 0 3.0532647672101496e-14
the O 0 1.9421367725841465e-13
normal O 0 1.182722114689838e-10
and O 0 1.6752401332462141e-12
mutant O 0 7.893719011775602e-10
alleles O 0 4.3761765045058354e-11
indicated O 0 2.4865292047593357e-09
that O 0 1.883490759191364e-12
all O 0 3.9863744900545117e-13
the O 0 1.6730009304993798e-13
four O 0 1.7277289625014514e-12
patients O 0 6.200230433239806e-12
were O 0 2.185195817697161e-12
homozygous O 0 1.9889775937365073e-10
for O 0 2.188510738734481e-13
the O 0 1.6946921567884826e-13
mutation O 0 1.8264273773938022e-11
in O 0 1.3803212316632757e-13
exon O 0 1.6496816412914228e-10
4 O 0 2.1308925457486083e-10
and O 0 4.143282661406289e-10
that O 0 2.7960718809727503e-11
the O 0 6.853372036541572e-13
parents O 0 1.8117472799783485e-11
of O 0 1.8616068430711563e-13
patient O 0 1.364118507041212e-08
2 O 0 5.514948914209228e-11
were O 0 7.783476085876373e-09
heterozygous O 0 2.6425101395943784e-07
. O 0 2.258843334601579e-09

The O 0 1.7588054623818294e-10
common O 0 9.468917316901582e-11
mutation O 0 1.5384381268912506e-10
at O 0 2.5230454878122366e-11
codon O 0 3.903733447607749e-10
95 O 0 1.4671061587812062e-10
in O 0 3.9323340590702305e-13
exon O 0 2.6325860935649814e-10
4 O 0 3.797580305775483e-11
might O 0 1.1889353390692747e-10
be O 0 8.832088706223207e-13
responsible O 0 1.0499904418148631e-10
for O 0 2.104506673095141e-12
most O 0 7.119281553169543e-11
Japanese O 0 4.07418440317997e-07
C9 B-Disease 0 1.5097137293196283e-05
deficiency I-Disease 0 2.1989613742334768e-05
. O 0 1.9582188301447978e-11
. O 0 4.5214015864658563e-10

BRCA1 O 0 3.1481827136303764e-06
required O 0 1.4457333941120254e-10
for O 0 2.358626531931418e-12
transcription O 0 5.024822371524351e-07
- O 0 1.3776329069514759e-05
coupled O 0 8.861521649805582e-08
repair O 0 2.643249899847433e-05
of O 0 4.109114524336599e-12
oxidative O 0 1.2165213547632447e-07
DNA O 0 9.146823686023708e-06
damage O 0 0.0005266206571832299
. O 0 7.678272595512681e-08

The O 0 3.191812325553656e-08
breast B-Disease 1 0.9999960660934448
and I-Disease 1 0.9999814033508301
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
susceptibility O 0 0.00012290901213418692
gene O 0 1.8339937014388852e-05
BRCA1 O 0 1.573473127791658e-06
encodes O 0 1.3033876200552186e-08
a O 0 8.10910982806945e-09
zinc O 0 0.003401172114536166
finger O 0 0.016834571957588196
protein O 0 1.5585380097604684e-08
of O 0 8.598076244037411e-12
unknown O 0 9.513006382633193e-09
function O 0 1.7964820742122356e-08
. O 0 6.0917622057843346e-09

Association O 0 1.2597519472024032e-08
of O 0 4.341067002394672e-12
the O 0 1.761597053125119e-12
BRCA1 O 0 9.637211917379318e-09
protein O 0 7.231900408383174e-12
with O 0 1.774769160843917e-13
the O 0 2.0457103350711436e-13
DNA O 0 2.2278914713069753e-08
repair O 0 1.264165916836646e-06
protein O 0 1.1531894328342673e-09
Rad51 O 0 7.906247390110366e-08
and O 0 2.7178194590693483e-12
changes O 0 6.528579218033348e-13
in O 0 3.1225720522731065e-14
the O 0 1.6337463066423696e-14
phosphorylation O 0 3.917266684638765e-12
and O 0 3.296782334974435e-12
cellular O 0 2.8855084988066437e-09
localization O 0 1.3291978628870993e-09
of O 0 2.382903173826084e-13
the O 0 2.566889029890357e-13
protein O 0 5.066729154290517e-12
after O 0 8.843618112125418e-13
exposure O 0 5.4266834081939663e-11
to O 0 1.938551749680606e-12
DNA O 0 2.0506500675310235e-07
- O 0 1.8650841582257272e-07
damaging O 0 6.925330922058492e-07
agents O 0 1.4186908314783864e-09
are O 0 1.962701268870548e-12
consistent O 0 8.55557985568467e-11
with O 0 1.8631804269992475e-13
a O 0 1.1503670195242566e-12
role O 0 3.408644200231237e-11
for O 0 8.300224114791976e-13
BRCA1 O 0 6.248508377382223e-10
in O 0 6.01235586924348e-13
DNA O 0 2.9316938210399712e-08
repair O 0 2.7082443921244703e-05
. O 0 6.2669638367651714e-09

Here O 0 6.965880317011397e-09
, O 0 9.137987241891743e-12
it O 0 6.84016916458613e-13
is O 0 2.1761025869714706e-13
shown O 0 1.0760009419921723e-12
that O 0 4.538502820089496e-13
mouse O 0 6.529852214498533e-08
embryonic O 0 1.7352888903587882e-08
stem O 0 3.808393955750944e-08
cells O 0 1.4207008014466282e-08
deficient B-Disease 0 6.264647822717961e-07
in I-Disease 0 3.53608136695327e-12
BRCA1 I-Disease 0 5.071699860081935e-08
are O 0 7.408245024376203e-12
defective O 0 2.230994198271219e-07
in O 0 3.104380034285592e-12
the O 0 1.7525684679539633e-12
ability O 0 1.6044802986225903e-10
to O 0 2.984012559617555e-12
carry O 0 2.623678774238414e-10
out O 0 8.153924757614561e-11
transcription O 0 1.510154667982988e-08
- O 0 1.7539807117827877e-07
coupled O 0 4.647610740704522e-09
repair O 0 1.946085603776737e-06
of O 0 3.7646182829073616e-13
oxidative O 0 2.974839485858638e-09
DNA O 0 3.2522092396902735e-07
damage O 0 8.110139606287703e-05
, O 0 1.3631963613480735e-10
and O 0 5.796585433870405e-11
are O 0 1.37071768865904e-11
hypersensitive O 0 1.024538232741179e-05
to O 0 4.611508744312154e-11
ionizing O 0 1.3680138799543329e-08
radiation O 0 1.9396539485683206e-08
and O 0 8.028781112168204e-11
hydrogen O 0 7.162033466290296e-11
peroxide O 0 8.787996108594598e-09
. O 0 1.091728263347136e-09

These O 0 3.4621197575468443e-10
results O 0 2.992124256695483e-11
suggest O 0 2.1820992235355163e-10
that O 0 3.0185769248763927e-12
BRCA1 O 0 4.164923517180341e-09
participates O 0 6.271585334394203e-11
, O 0 1.969282376057535e-12
directly O 0 2.5194291097818677e-11
or O 0 8.055578426535703e-11
indirectly O 0 2.4130442088932114e-09
, O 0 1.0576761688696479e-11
in O 0 6.768774993629045e-13
transcription O 0 1.99722194338392e-07
- O 0 1.9900705865438795e-06
coupled O 0 7.3344432749422594e-09
repair O 0 6.89947091814247e-06
of O 0 3.049646310222115e-13
oxidative O 0 6.457542944815486e-09
DNA O 0 1.376806039843359e-06
damage O 0 5.195385165279731e-05
. O 0 1.2838848872931408e-09
. O 0 4.674842735141738e-09

Truncation O 0 3.3475298550911248e-06
mutations O 0 4.716338537491538e-07
in O 0 7.653127437334817e-11
the O 0 1.4742413886881245e-11
transactivation O 0 4.828814053325914e-05
region O 0 1.3901003903526998e-08
of O 0 2.1416608070312648e-11
PAX6 O 0 4.6039581320656e-06
result O 0 6.802445412512625e-11
in O 0 2.520119746565741e-12
dominant O 0 5.8855420093095745e-08
- O 0 5.859007501385349e-07
negative O 0 6.21362019614935e-08
mutants O 0 2.1410553330269977e-08
. O 0 2.0987216409196208e-09

PAX6 O 0 5.632020111079328e-05
is O 0 3.4943084536998015e-10
a O 0 7.141186947334788e-12
transcription O 0 2.683220756694027e-09
factor O 0 7.54279194659091e-10
with O 0 2.7241731440086348e-11
two O 0 9.239374022806945e-12
DNA O 0 2.701880021049874e-06
- O 0 6.27332065050723e-06
binding O 0 1.4458836794517538e-08
domains O 0 2.6459794355560007e-08
( O 0 2.4335311543666194e-11
paired O 0 1.1607984573558383e-09
box O 0 2.0801797973035718e-07
and O 0 1.3158078793207295e-10
homeobox O 0 8.443740151520274e-10
) O 0 7.72617538523368e-13
and O 0 9.545139201608266e-13
a O 0 4.825070898384354e-12
proline O 0 1.347709712717915e-07
- O 0 4.2400863264902e-08
serine O 0 1.6359409471533581e-07
- O 0 2.1106936642922847e-08
threonine O 0 3.361216016628532e-08
( O 0 5.182522379992838e-12
PST O 0 3.560703731864123e-08
) O 0 4.770688011301871e-11
- O 0 1.3935248510676956e-08
rich O 0 3.4490563183275924e-10
transactivation O 0 1.0141657185158692e-06
domain O 0 3.53779547879185e-08
. O 0 1.1459800886015614e-09

PAX6 O 0 0.0004682283033616841
regulates O 0 4.7606513362552505e-06
eye O 0 3.21704828820657e-05
development O 0 1.2048773090356235e-09
in O 0 1.7003558934122753e-12
animals O 0 3.956714469954825e-11
ranging O 0 2.357999351332296e-10
from O 0 7.1905377702422e-13
jellyfish O 0 1.6767273333662125e-11
to O 0 2.7544321532825544e-13
Drosophila O 0 1.2433742403727965e-11
to O 0 1.4504660493519506e-12
humans O 0 8.411795565654856e-11
. O 0 1.9319942867745965e-10

Heterozygous O 0 3.191544965375215e-05
mutations O 0 1.2043889796586882e-07
in O 0 7.742789916165282e-12
the O 0 4.312866470207455e-12
human O 0 3.3894234641174137e-10
PAX6 O 0 2.1220300823188154e-06
gene O 0 3.953958938041069e-08
result O 0 3.6423024318832375e-11
in O 0 7.529843176930229e-13
various O 0 4.938420332389892e-12
phenotypes O 0 4.678722742568198e-09
, O 0 1.30409424578537e-11
including O 0 4.3989581421932655e-10
aniridia B-Disease 1 1.0
, O 0 2.466188789185253e-06
Peters B-Disease 1 1.0
anomaly I-Disease 1 0.9999994039535522
, O 0 8.722584432518943e-09
autosomal B-Disease 0 0.007507575210183859
dominant I-Disease 0 2.327130459889304e-05
keratitis I-Disease 1 0.994992196559906
, O 0 7.940887059021406e-08
and O 0 4.035391043544223e-08
familial B-Disease 1 0.8934478759765625
foveal I-Disease 1 0.9826207756996155
dysplasia I-Disease 1 0.9999086856842041
. O 0 1.380361027258914e-06

It O 0 8.652670802078433e-10
is O 0 1.40875557747e-11
believed O 0 1.7426894996508402e-11
that O 0 3.763848160551718e-14
the O 0 2.2910025385038807e-14
mutated O 0 5.172918760010248e-10
allele O 0 1.4398395808967734e-09
of O 0 3.4125653691763347e-12
PAX6 O 0 6.11339601164218e-06
produces O 0 2.3755712064144063e-08
an O 0 6.7975269510411884e-12
inactive O 0 3.270850923442481e-09
protein O 0 7.038691851590784e-10
and O 0 1.1114297260306216e-09
aniridia B-Disease 1 1.0
is O 0 1.7066595248138583e-08
caused O 0 2.1086081769539078e-09
due O 0 5.065466102127658e-11
to O 0 2.1294774971147845e-11
genetic O 0 4.5357708700066723e-07
haploinsufficiency O 0 3.3581927709747106e-05
. O 0 4.443987577928965e-08

However O 0 3.4164504558731323e-10
, O 0 4.371477572290283e-12
several O 0 9.883322459047772e-13
truncation O 0 7.271608204462154e-09
mutations O 0 7.002276447565237e-08
have O 0 5.982232070822491e-11
been O 0 1.8284769531806688e-11
found O 0 5.2479847724440365e-12
to O 0 6.821147921672044e-13
occur O 0 5.917068484490029e-12
in O 0 2.7588066379979903e-13
the O 0 4.637173024041319e-12
C O 0 5.581285336120345e-07
- O 0 2.936714906809357e-07
terminal O 0 2.7711859473811273e-08
half O 0 7.225324071685746e-12
of O 0 1.0220491309829646e-13
PAX6 O 0 3.23284474745833e-08
in O 0 1.882161961008766e-12
patients O 0 9.018293056772819e-11
with O 0 1.5156929530912855e-11
Aniridia B-Disease 1 0.9999998807907104
resulting O 0 2.654470421248334e-09
in O 0 3.157630407146783e-12
mutant O 0 1.922580983304556e-09
proteins O 0 6.164030657423991e-12
that O 0 1.990372276716723e-12
retain O 0 8.516277266723549e-11
the O 0 1.5238462618485937e-12
DNA O 0 6.411521979998724e-08
- O 0 1.4383799928907592e-08
binding O 0 5.359475641064648e-10
domains O 0 5.708440942164827e-10
but O 0 7.328856271859863e-11
have O 0 2.2315670145101052e-11
lost O 0 5.535192790229182e-11
most O 0 1.5358000244811154e-13
of O 0 2.960985948617656e-14
the O 0 1.989005965138957e-12
transactivation O 0 9.717143711895915e-07
domain O 0 2.9678814073008652e-08
. O 0 2.8803561757939633e-09

It O 0 1.2268428495332273e-09
is O 0 4.522995519784523e-11
not O 0 1.7421068927714334e-12
clear O 0 1.080583214053965e-12
whether O 0 6.779524858169239e-13
such O 0 2.406801971263639e-13
mutants O 0 6.272940500373636e-10
really O 0 2.5554729443655333e-09
behave O 0 9.673076228899902e-11
as O 0 4.678624566760436e-13
loss O 0 7.486573166959332e-11
- O 0 3.6224101052084734e-08
of O 0 4.921992067391523e-12
- O 0 2.273966259735971e-07
function O 0 1.0094776126123861e-09
mutants O 0 2.579904900823493e-10
as O 0 8.423829125567273e-13
predicted O 0 1.846083425016687e-10
by O 0 7.97362349758135e-12
haploinsufficiency O 0 8.673132469994016e-07
. O 0 3.3656668563253334e-09

Contrary O 0 1.3675024668202695e-08
to O 0 4.2594829573194826e-12
this O 0 1.9722094237676485e-13
theory O 0 3.805800726647268e-12
, O 0 1.654356122579581e-12
our O 0 1.5429649745379859e-12
data O 0 2.021697566301217e-11
showed O 0 5.255653134916827e-10
that O 0 1.0819334794395785e-13
these O 0 5.246568153885467e-14
mutants O 0 1.1990392186078669e-11
are O 0 2.6718013110098304e-13
dominant O 0 7.705480142838894e-10
- O 0 1.7772331162291266e-08
negative O 0 8.06802713526622e-09
in O 0 4.477620097614876e-12
transient O 0 1.572745600419978e-09
transfection O 0 1.106536089423571e-07
assays O 0 5.3361399743323545e-09
when O 0 1.2363459214737027e-11
they O 0 1.1431141406711975e-12
are O 0 7.810418300611618e-14
coexpressed O 0 9.090069252870592e-10
with O 0 1.1357359280469992e-12
wild O 0 1.6379471112770716e-09
- O 0 2.543674418120645e-05
type O 0 0.00013193010818213224
PAX6 O 0 6.7718698119279e-05
. O 0 1.5726984159414314e-08

We O 0 5.8826659099509016e-09
found O 0 1.9559194541773905e-11
that O 0 2.5572767644796435e-13
the O 0 3.2745758416028586e-14
dominant O 0 4.475201986764432e-09
- O 0 4.803382580575999e-08
negative O 0 1.4215789434501858e-08
effects O 0 3.136093384981109e-09
result O 0 7.401677361296155e-12
from O 0 1.0817024088515675e-13
the O 0 2.7010520353026347e-14
enhanced O 0 3.3293527657018984e-11
DNA O 0 5.672503577969223e-10
binding O 0 3.738133413921929e-11
ability O 0 2.4965826281309056e-11
of O 0 9.372055676014693e-14
these O 0 4.414957982534773e-12
mutants O 0 2.047181979492052e-09
. O 0 5.867266117398628e-10

Kinetic O 0 1.8992846406717945e-08
studies O 0 3.257283331947747e-10
of O 0 1.3162484340314973e-12
binding O 0 3.718382934891906e-09
and O 0 1.183263625970099e-10
dissociation O 0 3.452401697856544e-09
revealed O 0 4.879754933462266e-10
that O 0 1.566177607525629e-13
various O 0 1.2634689030687624e-13
truncation O 0 6.525277540525565e-10
mutants O 0 8.114908744971672e-10
have O 0 2.5263777181372404e-11
3 O 0 3.765323556420563e-12
- O 0 8.427497988350297e-08
5 O 0 1.3834704215565097e-10
- O 0 3.8610181718468084e-08
fold O 0 4.388083230111306e-09
higher O 0 1.7919337888527842e-12
affinity O 0 6.155897189566439e-13
to O 0 1.9914259585980532e-14
various O 0 9.410746785792554e-14
DNA O 0 4.467975989186357e-10
- O 0 8.853449917634038e-11
binding O 0 7.392563124153373e-12
sites O 0 2.514581598500598e-10
when O 0 8.898303643402328e-13
compared O 0 7.597898872557796e-12
with O 0 8.833768948540016e-14
the O 0 1.8221456787002877e-13
wild O 0 7.849877414756179e-10
- O 0 1.8318677348361234e-06
type O 0 6.032511009834707e-06
PAX6 O 0 1.6621468603261746e-05
. O 0 7.561794745924999e-09

These O 0 1.8340393648230702e-09
results O 0 2.1632440283525511e-10
provide O 0 4.8528334128938866e-12
a O 0 2.1195324141631833e-12
new O 0 2.570226800488462e-12
insight O 0 5.269190986312289e-11
into O 0 2.3703285970295973e-13
the O 0 3.5896895807414897e-13
role O 0 2.0497900252158807e-11
of O 0 2.6631214594674546e-13
mutant O 0 4.023884869752692e-08
PAX6 O 0 1.881058665276214e-06
in O 0 8.980940990888087e-11
causing O 0 8.453014288534177e-08
aniridia B-Disease 1 0.9999986886978149
. O 0 8.0254975998173e-09
. O 0 6.20106810345078e-09

Reversal O 0 1.9263904960098444e-06
of O 0 2.2303052737981943e-09
severe O 0 0.0012656492181122303
hypertrophic B-Disease 1 0.9999873638153076
cardiomyopathy I-Disease 1 1.0
and O 0 9.720860134621034e-07
excellent O 0 1.9190214572972764e-07
neuropsychologic O 0 2.8225515507074306e-06
outcome O 0 2.348830019371917e-09
in O 0 1.082915267874851e-11
very B-Disease 0 9.39294197976892e-10
- I-Disease 0 1.0958859093079809e-05
long I-Disease 0 2.658026403423719e-07
- I-Disease 0 4.36763411926222e-06
chain I-Disease 0 2.012648656091187e-05
acyl I-Disease 0 3.3887804562482415e-08
- I-Disease 0 7.29465767790316e-08
coenzyme I-Disease 0 2.3743028876310746e-08
A I-Disease 0 1.4101656509168947e-09
dehydrogenase I-Disease 0 0.0005695869331248105
deficiency I-Disease 1 0.9270761013031006
. O 0 1.3483778538159186e-08

Very B-Disease 0 5.0156732100958834e-08
- I-Disease 0 7.259372796397656e-05
long I-Disease 0 2.6303007416572655e-07
- I-Disease 0 1.0158451914321631e-05
chain I-Disease 0 3.578072437449009e-06
acyl I-Disease 0 7.064060891792678e-09
- I-Disease 0 6.823048348536531e-09
coenzyme I-Disease 0 4.975848066912647e-10
A I-Disease 0 1.3056124757715448e-11
dehydrogenase I-Disease 0 3.4997396092251165e-09
( I-Disease 0 1.2629377578454726e-11
VLCAD I-Disease 0 6.7993423726875335e-06
) I-Disease 0 7.9407425079836e-10
deficiency I-Disease 0 0.00438014417886734
is O 0 8.853006001896535e-12
a O 0 2.464439242955141e-11
disorder O 0 0.0022049888502806425
of O 0 1.2910902815604919e-12
fatty O 0 1.5009771203722266e-08
acid O 0 1.2001197258193486e-10
beta O 0 2.5799369151452423e-12
oxidation O 0 2.48589950707645e-12
that O 0 3.283372271983831e-12
reportedly O 0 3.1462683125482727e-08
has O 0 5.462836294434226e-10
high O 0 1.1113894249348277e-09
rates O 0 1.1128642896096608e-08
of O 0 9.206513156001517e-12
morbidity O 0 0.0036578751169145107
and O 0 1.573536252408303e-07
mortality O 0 2.0454268451430835e-05
. O 0 4.715355661488729e-09

We O 0 3.551409832880381e-09
describe O 0 2.579993718665463e-10
the O 0 1.3858266747698855e-13
outcome O 0 8.504391635355546e-12
of O 0 7.049265007439895e-14
a O 0 2.6742153630410215e-11
5 O 0 1.8437459892162167e-11
- O 0 7.250947220427406e-08
year O 0 3.6087521859684557e-10
- O 0 8.374249773623887e-07
old O 0 5.719987825614226e-07
girl O 0 1.9747792975977063e-05
with O 0 5.083008236539399e-09
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 1.542949656929693e-09
was O 0 5.889407017622972e-11
first O 0 1.1701263872773704e-12
seen O 0 4.744051818050821e-09
at O 0 4.8350046188971874e-11
5 O 0 5.484899643845575e-13
months O 0 3.4266534922056113e-12
of O 0 1.2264051807518023e-13
age O 0 9.710792170380955e-10
with O 0 9.717554538823947e-10
severe O 0 0.015368493273854256
hypertrophic B-Disease 1 0.9999929666519165
cardiomyopathy I-Disease 1 1.0
, O 0 0.004081360064446926
hepatomegaly B-Disease 1 1.0
, O 0 3.689345976454206e-05
encephalopathy B-Disease 0 0.1796400099992752
, O 0 3.1013189794038e-09
and O 0 2.1009414652439773e-08
hypotonia B-Disease 1 0.9669308066368103
. O 0 6.977092681381691e-08

Biochemical O 0 1.5812631318112835e-05
studies O 0 1.2660852632961905e-07
indicated O 1 0.8727148175239563
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 5.846482622473559e-07
by O 0 6.892601767116702e-11
a O 0 3.131884973583965e-09
stable O 0 0.00022694423387292773
yet O 0 6.445877165361935e-09
inactive O 0 1.5445049683648904e-08
enzyme O 0 6.9654819689901615e-09
. O 0 5.107613221255747e-10

Molecular O 0 1.1946512223914851e-08
genetic O 0 2.0098090303122262e-08
analysis O 0 1.8629637832390245e-09
of O 0 2.2884555361812886e-11
her O 0 1.0157862107007531e-08
VLCAD O 0 1.7046746506821364e-05
gene O 0 9.116712362811086e-08
revealed O 0 1.8034548077139334e-08
a O 0 1.5030038325036799e-10
T1372C O 0 3.256833380760327e-08
( O 0 3.0756674984644405e-11
F458L O 0 1.1574761593635685e-08
) O 0 2.823818089081609e-11
missense O 0 7.805941777405678e-07
mutation O 0 1.568330887380398e-08
and O 0 1.8281359759342308e-10
a O 0 1.1814691447398218e-09
1668 O 0 0.0004066457331646234
ACAG O 0 0.0002899274695664644
1669 O 0 2.2174174318934092e-06
splice O 0 3.288622247055173e-05
site O 0 4.152871042606421e-06
mutation O 0 2.3318291653140477e-07
. O 0 6.180746137118831e-09

After O 0 6.58521681629054e-10
initial O 0 1.3829591916092454e-09
treatment O 0 2.3968063089796487e-09
with O 0 3.8292705811793226e-11
intravenous O 0 1.2121935677456008e-09
glucose O 0 9.963159754988737e-07
and O 0 3.8472158792046685e-10
carnitine O 0 1.5550853049717261e-07
, O 0 2.862236662959372e-11
the O 0 5.793885336780047e-12
patient O 0 3.026094219649167e-08
has O 0 4.162324374057391e-10
thrived O 0 5.782997192227413e-09
on O 0 4.564481431712508e-11
a O 0 8.949546659309249e-11
low O 0 2.974818436030091e-08
- O 0 6.719678680155994e-08
fat O 0 2.8770508198050493e-09
diet O 0 1.3628252970576682e-09
supplemented O 0 2.2910333352665901e-10
with O 0 5.639798957707276e-12
medium O 0 3.3076794636599516e-08
- O 0 2.484320020812447e-07
chain O 0 3.132747679046588e-07
triglyceride O 0 2.286299505271927e-08
oil O 0 3.1995622817859726e-10
and O 0 1.6140582793922054e-12
carnitine O 0 4.645164697336668e-09
and O 0 1.1022684501260649e-11
avoidance O 0 2.8794224782302535e-09
of O 0 8.574231602498372e-12
fasting O 0 5.8594661567212825e-08
. O 0 8.202894474784728e-10

Her O 0 2.538056094181229e-07
ventricular O 0 0.0005459157400764525
hypertrophy O 0 0.0005736729362979531
resolved O 0 7.072421794873662e-07
significantly O 0 3.4937919224375946e-08
over O 0 5.170807670928923e-10
1 O 0 1.8193623690931915e-11
year O 0 4.1133433464901614e-11
, O 0 1.7374454305829623e-11
and O 0 6.039152511405632e-11
cognitively O 0 3.59910465874691e-08
, O 0 2.4759824399089858e-11
she O 0 2.8750743452654604e-10
is O 0 9.02611839437295e-12
in O 0 2.307616174968691e-13
the O 0 1.3966452506227606e-13
superior O 0 1.4747739141007798e-10
range O 0 1.086224710178385e-08
for O 0 1.4137144233039578e-10
age O 0 1.333380605927914e-08
. O 0 3.2059355170588333e-09

Clinical O 0 9.77822764980374e-07
recognition O 0 9.989744853555749e-08
of O 0 2.840151864802465e-07
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 1.3607196258647036e-08
important O 0 1.2225068179994025e-10
because O 0 1.7305762725627893e-11
it O 0 5.1932386342656844e-12
is O 0 1.4477683375063721e-12
one O 0 1.3774281736912697e-13
of O 0 7.575313802892641e-15
the O 0 7.641858608582741e-13
few O 0 1.1793798160297797e-09
directly O 0 7.740748486639859e-09
treatable O 0 1.4328454653877998e-06
causes O 0 4.773749173736519e-10
of O 0 8.384121175097903e-10
cardiomyopathy B-Disease 1 1.0
in O 0 8.001607376684206e-09
children O 0 5.421880899803e-08
. O 0 2.713254065866977e-10
. O 0 1.0575159636871945e-09

Cloning O 0 5.59222371521173e-07
of O 0 1.4075148165038076e-11
a O 0 3.6922020996144056e-11
novel O 0 1.3645673480056075e-10
member O 0 2.3064646980514025e-12
of O 0 5.342664719377825e-14
the O 0 1.0065556244401308e-12
low O 0 5.7601464931167357e-08
- O 0 7.020603902674338e-07
density O 0 8.907257864620988e-08
lipoprotein O 0 1.887768848973792e-05
receptor O 0 3.646659507694494e-08
family O 0 9.155118618764391e-08
. O 0 5.2901723002207746e-09

A O 0 1.5596315350308032e-09
gene O 0 1.1485912665420983e-08
encoding O 0 2.4921984476122816e-09
a O 0 3.4460051479001663e-10
novel O 0 4.99207786219813e-09
transmembrane O 0 1.747975097998733e-08
protein O 0 6.632372984149981e-10
was O 0 3.020635963579821e-10
identified O 0 1.7280471498182237e-10
by O 0 9.253685193328157e-14
DNA O 0 8.178722282758955e-11
sequence O 0 1.7633124127502953e-11
analysis O 0 2.384040881375782e-12
within O 0 7.483781931834355e-13
the O 0 4.136266849863457e-12
insulin B-Disease 0 4.3057429138571024e-05
- I-Disease 1 0.997477114200592
dependent I-Disease 1 0.9998606443405151
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 3.938334103281704e-08
IDDM B-Disease 0 2.4029855921980925e-05
) O 0 1.8767365439487094e-10
locus O 0 7.14264487555738e-08
IDDM4 O 0 2.502250936231576e-06
on O 0 2.910964358449064e-09
chromosome O 0 1.336192053713603e-05
11q13 O 0 6.019443844706984e-06
. O 0 2.3496241396969708e-08

Based O 0 5.141042258571815e-09
on O 0 4.276215492815538e-10
its O 0 4.098620054460156e-11
chromosomal O 0 0.013354155234992504
position O 0 2.957422964300349e-07
, O 0 3.0815729742256215e-12
this O 0 5.075361450015102e-14
gene O 0 6.933609242310013e-11
is O 0 5.8901794032506505e-12
a O 0 8.708570431621709e-13
candidate O 0 1.8496634779374688e-11
for O 0 1.1420637656064936e-12
conferring O 0 1.464289023367371e-09
susceptibility O 0 1.8789717159961583e-06
to O 0 1.0710259346069506e-07
diabetes B-Disease 1 0.9943739175796509
. O 0 1.2846673769217887e-07

The O 0 3.069502291230819e-11
gene O 0 2.598271819920228e-09
, O 0 6.5358829459682966e-12
termed O 0 5.134065172995861e-09
low O 0 3.460875319660772e-08
- O 0 2.122727380537981e-07
density O 0 6.229225135712113e-08
lipoprotein O 0 8.977835932455491e-06
receptor O 0 5.334074071328132e-09
related O 0 1.4536650994045885e-08
protein O 0 9.836941261553989e-10
5 O 0 1.4102449243102999e-11
( O 0 1.2724029729155317e-12
LRP5 O 0 2.834647361282805e-08
) O 0 8.88067072137011e-13
, O 0 1.2353147476294735e-13
encodes O 0 3.3176809823703968e-12
a O 0 1.1240532159575989e-12
protein O 0 3.123053551878918e-11
of O 0 1.1621297457339863e-13
1615 O 0 1.1026171087280545e-08
amino O 0 5.174097261750887e-12
acids O 0 1.5024454933214998e-13
that O 0 1.3510227177715873e-14
contains O 0 3.734516764841017e-13
conserved O 0 1.2227207094039905e-11
modules O 0 4.380653131907941e-11
which O 0 3.735451618164243e-12
are O 0 1.1087363801587716e-13
characteristic O 0 1.0861712571030857e-11
of O 0 3.773472826524779e-14
the O 0 1.8783676870859356e-12
low O 0 3.014578453530703e-08
- O 0 2.0787243215636408e-07
density O 0 1.005306984325216e-07
lipoprotein O 0 1.4028090845386032e-05
( O 0 8.922041994097185e-10
LDL O 0 1.7216245851159329e-07
) O 0 4.101388673127815e-11
receptor O 0 6.340107883140433e-10
family O 0 8.328039591276593e-09
. O 0 2.294432421834358e-09

These O 0 1.8249517175217278e-10
modules O 0 2.9657507005786954e-10
include O 0 3.4356194104911975e-12
a O 0 6.028389159390413e-12
putative O 0 2.52690068869299e-09
signal O 0 2.8066113877400767e-09
peptide O 0 4.541052950335356e-11
for O 0 1.006948193717997e-14
protein O 0 5.598629199132787e-13
export O 0 3.025362599329284e-11
, O 0 1.3222212766946656e-13
four O 0 1.041209897164122e-13
epidermal O 0 1.9263763917365395e-09
growth O 0 2.61125365774717e-09
factor O 0 9.847999082879255e-10
( O 0 3.8828055354267477e-11
EGF O 0 1.2005256166958134e-07
) O 0 3.3712786035033915e-11
repeats O 0 1.6573849848100508e-08
with O 0 3.4762965075985086e-12
associated O 0 8.632329850932763e-10
spacer O 0 1.0103740351041779e-06
domains O 0 2.5878037490656425e-07
, O 0 2.0336726747061107e-10
three O 0 2.226193361598572e-11
LDL O 0 7.230894283338785e-08
- O 0 2.850033808954322e-07
receptor O 0 7.790705858212732e-10
( O 0 6.792795492760462e-12
LDLR O 0 7.179194483342144e-08
) O 0 8.478526040966994e-12
repeats O 0 1.1803705568524947e-08
, O 0 5.994929812985772e-12
a O 0 6.536020422803768e-12
single O 0 2.6247648499122533e-10
transmembrane O 0 1.516052949845914e-09
spanning O 0 1.997216614313402e-09
domain O 0 1.4265360448462161e-08
, O 0 1.2467873955479547e-10
and O 0 8.865346651232286e-11
a O 0 1.4147367999317595e-10
cytoplasmic O 0 4.044344237286168e-08
domain O 0 1.8974222371070937e-07
. O 0 5.251366896885656e-09

The O 0 3.768774528567498e-11
encoded O 0 2.906907214939025e-10
protein O 0 9.448480886575794e-10
has O 0 3.0570223435999466e-11
a O 0 1.126100406499686e-12
unique O 0 4.906311034530431e-12
organization O 0 9.615567890530752e-12
of O 0 4.79993594783984e-13
EGF O 0 3.3456231562922767e-07
and O 0 6.348179204529458e-10
LDLR O 0 1.966454419743968e-06
repeats O 0 4.906424067030457e-08
; O 0 3.4345646986178036e-12
therefore O 0 2.933539262200968e-12
, O 0 6.684738483239694e-13
LRP5 O 0 2.391482922803334e-08
likely O 0 3.788117736158725e-11
represents O 0 4.106865889030864e-12
a O 0 2.5754973240893486e-12
new O 0 2.56284108518523e-11
category O 0 3.0183568977548703e-09
of O 0 2.122161821271895e-12
the O 0 6.385054984736627e-11
LDLR O 0 6.249141006264836e-05
family O 0 9.978547410582905e-08
. O 0 4.511445883537135e-09

Both O 0 7.233370014070317e-10
human O 0 5.551943904613665e-10
and O 0 1.131048171787441e-10
mouse O 0 1.5490211353608174e-06
LRP5 O 0 4.872167096436897e-07
cDNAs O 0 1.4882739485244656e-08
have O 0 6.182532263920848e-11
been O 0 4.3740403660175176e-11
isolated O 0 1.4588499652745668e-07
and O 0 6.386635144350894e-12
the O 0 3.422215039561999e-14
encoded O 0 1.2337852961508133e-11
mature O 0 1.3239791207819707e-11
proteins O 0 9.611487495654603e-14
are O 0 1.1105226032379414e-13
95 O 0 1.1378504041759108e-11
% O 0 6.200463861967542e-13
identical O 0 5.760020238554375e-10
, O 0 1.2241535042589735e-11
indicating O 0 1.876669486478022e-09
a O 0 8.243811883135166e-11
high O 0 1.192135390404303e-09
degree O 0 3.4978124997114834e-12
of O 0 3.7892679581119984e-14
evolutionary O 0 1.9247990354354094e-11
conservation O 0 1.1158132751099004e-10
. O 0 8.03248439984472e-12
. O 0 2.86480533739919e-10

The O 0 7.083242881122942e-10
APC B-Disease 0 7.544051072727598e-08
variants O 0 3.6715732676384505e-09
I1307K O 0 2.3943995230979453e-08
and O 0 1.024834384022455e-10
E1317Q O 0 7.485410513652369e-09
are O 0 1.885511712040877e-11
associated O 0 1.7275554853313224e-07
with O 0 0.03478569537401199
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 2.593219051050255e-06
but O 0 1.3202130499934128e-09
not O 0 2.253712494404425e-10
always O 0 4.994579749784123e-10
with O 0 3.4984379759447903e-13
a O 0 2.5813507581462503e-11
family O 0 3.4450606811731177e-09
history O 0 1.894020051906864e-09
. O 0 2.166812951287511e-09

Classical O 0 0.0017823880771175027
familial B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 0.999996542930603
polyposis I-Disease 1 1.0
( O 0 1.3249655239633285e-07
FAP B-Disease 0 4.044931642965821e-07
) O 0 1.3692470768322806e-10
is O 0 3.634023637566486e-11
a O 0 1.193313226011128e-10
high O 0 8.912200541999482e-07
- O 1 0.9999600648880005
penetrance O 1 0.9999761581420898
autosomal B-Disease 1 0.9999955892562866
dominant I-Disease 1 0.552557110786438
disease I-Disease 0 0.2129473090171814
that O 0 6.916540257195791e-12
predisposes O 0 5.147164916508018e-09
to O 0 2.796689095585503e-12
hundreds O 0 9.586963167773632e-12
or O 0 3.369002993247605e-11
thousands O 0 1.5336186487413528e-10
of O 0 5.207026276821125e-08
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.18211300671100616
carcinoma I-Disease 1 1.0
and O 0 3.643635579919646e-07
that O 0 5.169653594094825e-10
results O 0 5.132650207628764e-11
from O 0 5.704622429818229e-13
truncating O 0 4.617456639266493e-08
mutations O 0 2.262223519622353e-09
in O 0 1.7316352345086994e-12
the O 0 2.6067661484246996e-12
APC B-Disease 0 1.1404508448720208e-08
gene O 0 2.1598779653686506e-08
. O 0 1.287133621907799e-09

A O 0 7.238742938397991e-09
variant O 0 2.471483355748205e-07
of O 0 1.3644345375762867e-10
FAP B-Disease 0 1.1646970961010084e-05
is O 0 2.038144657490193e-07
attenuated B-Disease 1 0.999889612197876
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 0.9999943971633911
coli I-Disease 1 0.9999998807907104
, O 0 4.9274664348786246e-09
which O 0 1.3386107500235056e-10
results O 0 1.0260626376323856e-10
from O 0 1.136919811767223e-11
germ O 0 0.00042252481216564775
- O 0 1.1599463505262975e-05
line O 0 2.835632244568842e-07
mutations O 0 2.0350199303464933e-09
in O 0 8.3506888470114e-13
the O 0 2.3051924410120994e-13
5 O 0 2.4473220758963743e-12
and O 0 5.4831343458683346e-12
3 O 0 1.4576073638014608e-12
regions O 0 1.9711810309019917e-11
of O 0 1.0298176428367306e-13
the O 0 4.159082366700373e-12
APC B-Disease 0 3.3973346358351364e-09
gene O 0 2.581905134135809e-09
. O 0 5.009071490924555e-10

Attenuated B-Disease 1 0.999864935874939
adenomatous I-Disease 1 0.9999995231628418
polyposis I-Disease 1 0.9999967813491821
coli I-Disease 1 0.9999998807907104
patients O 0 0.11192160099744797
have O 0 1.7920195105602943e-08
" O 0 1.9092807690412883e-07
multiple O 0 4.3941388867096975e-05
" O 1 0.9998019337654114
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 6.022418674866969e-10
typically O 0 8.349534952323268e-11
fewer O 0 3.076547350211456e-11
than O 0 2.5726852939667033e-11
100 O 0 6.010045933146912e-11
) O 0 2.4755091639766524e-12
without O 0 1.1608016631248219e-11
the O 0 1.1904118316086176e-11
florid O 0 9.074492481886409e-07
phenotype O 0 6.198678903501786e-09
of O 0 5.8701368418900834e-12
classical O 0 3.854709884620888e-09
FAP B-Disease 0 4.165085272234137e-07
. O 0 3.6262310931789443e-09

Another O 0 3.6359342203695633e-09
group O 0 6.327423585084091e-10
of O 0 8.925194567785399e-13
patients O 0 6.445517453101957e-10
with O 0 1.7229714183164546e-11
multiple O 0 4.3446107156341895e-06
adenomas B-Disease 1 0.9920231103897095
has O 0 2.0972751372028142e-05
no O 0 9.412673307451769e-09
mutations O 0 1.6834136307153358e-09
in O 0 6.458022051153423e-13
the O 0 1.0794749425932504e-12
APC B-Disease 0 2.893404404957778e-10
gene O 0 2.3225579792729434e-10
, O 0 8.443216611975224e-12
and O 0 1.3187368731737426e-11
their O 0 2.454521178321678e-12
phenotype O 0 1.327118082095069e-09
probably O 0 1.3685795829943004e-09
results O 0 7.1340260088259555e-12
from O 0 8.508649920703146e-14
variation O 0 3.067467113648803e-10
at O 0 3.4400966519854137e-09
a O 0 5.680133793872777e-11
locus O 0 3.60410412625356e-09
, O 0 1.1049443304766982e-10
or O 0 2.9219088953924555e-11
loci O 0 6.246455436231813e-11
, O 0 6.573251491726051e-12
elsewhere O 0 8.534326717546392e-11
in O 0 3.198666917274273e-13
the O 0 9.70007819726948e-13
genome O 0 3.023739036933648e-09
. O 0 2.395727394244318e-09

Recently O 0 3.6571952932717977e-07
, O 0 9.597451999798778e-11
however O 0 2.678680844844794e-12
, O 0 2.2162982983141982e-13
a O 0 1.192238148484126e-12
missense O 0 6.133526397889e-08
variant O 0 1.0914877179857285e-07
of O 0 3.5046993085430245e-11
APC B-Disease 0 1.864155585451499e-08
( O 0 5.014533926983589e-12
I1307K O 0 9.62405488635909e-10
) O 0 1.075758731226839e-12
was O 0 3.095182096735094e-11
described O 0 1.0169774050661218e-10
that O 0 7.042656388622781e-13
confers O 0 2.204478960488032e-11
an O 0 4.45762675903294e-13
increased O 0 2.5526585289981085e-08
risk O 0 0.002025129972025752
of O 0 0.0031375058460980654
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 5.968985306026298e-07
including O 0 8.541235496650756e-10
multiple O 0 2.7178049322174047e-07
adenomas B-Disease 0 0.00010474574810359627
, O 0 2.372545049311725e-09
in O 0 2.267328269578428e-10
Ashkenazim O 0 7.517974609072553e-06
. O 0 1.4401040360212392e-08

We O 0 3.013612470681437e-08
have O 0 2.4599623553445138e-12
studied O 0 1.843794214528849e-12
a O 0 2.770449614077769e-13
set O 0 5.650502201554053e-12
of O 0 2.1215536651682937e-13
164 O 0 7.202123786242964e-09
patients O 0 5.669421598852864e-10
with O 0 1.1155579238142366e-10
multiple O 1 0.99105304479599
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 7.451236888300627e-05
/ I-Disease 1 0.999890923500061
or I-Disease 0 0.1460052728652954
carcinoma I-Disease 1 1.0
and O 0 5.210065978644707e-07
analyzed O 0 1.1430656599031863e-07
codons O 0 1.4377633306139614e-07
1263 O 0 1.513530492047721e-06
- O 0 5.610262974187208e-07
1377 O 0 1.0877136702447388e-07
( O 0 1.3488163363994943e-10
exon O 0 7.076359942459476e-09
15G O 0 1.3239412055554567e-07
) O 0 1.50719419583778e-11
of O 0 1.3509100793302614e-13
the O 0 5.855619266380285e-13
APC B-Disease 0 2.485044114930446e-10
gene O 0 2.589864156465893e-10
for O 0 8.77583943015292e-12
germ O 0 4.429180535225896e-06
- O 0 4.99211228088825e-06
line O 0 1.417667021996749e-06
variants O 0 1.1085302986657553e-07
. O 0 3.7242813277771347e-09

Three O 0 6.079400094449738e-09
patients O 0 3.8323504369941475e-09
with O 0 9.933253221697247e-13
the O 0 1.2047696824543652e-12
I1307K O 0 8.516188643170608e-09
allele O 0 3.353376465398128e-09
were O 0 8.214883634449777e-11
detected O 0 8.41722869182604e-09
, O 0 1.5144090408786282e-12
each O 0 2.6454275510630343e-13
of O 0 2.0476903592886453e-12
Ashkenazi O 0 3.294098860351369e-08
descent O 0 1.854927518252225e-07
. O 0 9.812380241669416e-09

Four O 0 1.1509355246630548e-08
patients O 0 1.602854560189826e-08
had O 0 2.9215316277309e-10
a O 0 1.5679345322094917e-10
germ O 0 0.0013277331599965692
- O 0 0.00012032587255816907
line O 0 4.7100284064072184e-06
E1317Q O 0 1.962396964927393e-07
missense O 0 1.9420792796154274e-07
variant O 0 8.523989514230834e-09
of O 0 7.864386767676701e-13
APC O 0 3.0344374235546923e-10
that O 0 1.2208861309079277e-12
was O 0 7.725829004323614e-11
not O 0 2.7646973252415386e-12
present O 0 4.641031049051891e-12
in O 0 3.407853968635799e-13
controls O 0 1.5745555401736056e-06
; O 0 4.0010017868241654e-12
one O 0 2.5240981180174593e-12
of O 0 2.1706296699300354e-14
these O 0 9.191227423252513e-13
individuals O 0 4.721765513304721e-12
had O 0 1.1132793298340715e-10
an O 0 1.4790166975257174e-13
unusually O 0 8.944495144547204e-11
large O 0 3.799304620910604e-11
number O 0 9.778833298668133e-11
of O 0 1.2736857575579297e-11
metaplastic B-Disease 0 7.530872244387865e-05
polyps I-Disease 0 4.194220309727825e-05
of I-Disease 0 3.473792781205631e-11
the I-Disease 0 3.8583122807800407e-10
colorectum I-Disease 0 8.54751851875335e-06
. O 0 1.2867365839497324e-08

There O 0 1.863152299108606e-09
is O 0 1.200808289608668e-11
increasing O 0 9.295601614833782e-12
evidence O 0 6.203049185415921e-11
that O 0 7.930457505966881e-12
there O 0 4.373756565256848e-11
exist O 0 5.07874187150037e-10
germ O 0 1.6184843616429134e-06
- O 0 3.5389939512242563e-07
line O 0 2.5160618477571006e-08
variants O 0 2.5282106963508966e-10
of O 0 7.470757411136286e-14
the O 0 4.990989175765459e-14
APC B-Disease 0 2.3860937531372528e-11
gene O 0 3.915145551508514e-12
that O 0 6.161955982356832e-14
predispose O 0 1.945641564526923e-12
to O 0 1.0685355188557247e-13
the O 0 8.01356119591208e-14
development O 0 3.659390498955695e-11
of O 0 4.54004819849807e-11
multiple O 1 0.9999403953552246
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.19545862078666687
carcinoma I-Disease 1 1.0
, O 0 1.7726492274050543e-08
but O 0 3.095567135957822e-10
without O 0 1.7475590419202547e-11
the O 0 2.59991876118415e-12
florid O 0 9.476308377998066e-07
phenotype O 0 5.493862698102703e-09
of O 0 1.7966044504966888e-13
classical O 0 4.471127981742207e-11
FAP B-Disease 0 6.392723017611956e-10
, O 0 8.708936349854923e-13
and O 0 1.0804384324063568e-13
possibly O 0 6.970584049206807e-13
with O 0 2.805893538349036e-13
importance O 0 1.8661006073728004e-09
for O 0 2.265696275571827e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 9.444501301913988e-06
in O 0 6.364770689659682e-12
the O 0 2.277155460722602e-12
general O 0 8.62766594278419e-11
population O 0 6.788965223325505e-11
. O 0 4.513851445397954e-11
. O 0 1.3564561696099986e-09

Genomic O 0 7.80445574832811e-08
structure O 0 1.92557569889118e-09
of O 0 7.336708822934523e-13
the O 0 1.6196873703355763e-11
human O 0 5.550086257244402e-07
congenital B-Disease 1 0.9999998807907104
chloride I-Disease 1 0.9999502897262573
diarrhea I-Disease 1 1.0
( O 0 4.5709140295002726e-07
CLD B-Disease 0 0.005065293982625008
) O 0 8.949089802534616e-10
gene O 0 1.378156184728141e-07
. O 0 1.1859649262646599e-08

Congenital B-Disease 1 0.9999998807907104
chloride I-Disease 1 0.9999905824661255
diarrhea I-Disease 1 1.0
( O 0 7.068227887430112e-07
CLD B-Disease 1 0.5859664082527161
) O 0 1.1706705604908052e-09
is O 0 1.3234394136141248e-10
caused O 0 2.1609265765665242e-10
by O 0 1.4891058221569442e-12
mutations O 0 3.692100181140745e-09
in O 0 4.963300278583438e-13
a O 0 3.5992003648288584e-12
gene O 0 7.431112170053211e-09
which O 0 9.957657615133897e-11
encodes O 0 3.2244309444706687e-09
an O 0 3.783296176340656e-10
intestinal O 0 0.051166243851184845
anion O 0 7.980552254593931e-06
transporter O 0 0.0002881555410567671
. O 0 9.688544366781571e-08

We O 0 2.7287640591566742e-08
report O 0 3.3309871527720247e-10
here O 0 1.3708248945698553e-11
the O 0 4.904462727324359e-14
complete O 0 2.135039974676678e-12
genomic O 0 9.538637657513505e-10
organization O 0 2.7034477087517494e-11
of O 0 4.641043951057744e-14
the O 0 2.594676047368988e-13
human O 0 7.979606558849994e-11
CLD B-Disease 0 1.8939944368412398e-07
gene O 0 3.38959327272903e-09
which O 0 2.5812869203223343e-11
spans O 0 2.9240134757912983e-09
approximately O 0 6.106928851501436e-10
39kb O 0 5.977199180051684e-07
, O 0 3.8865419216271846e-10
and O 0 1.4599767228506977e-10
comprises O 0 1.365810131659373e-09
21 O 0 1.5529704189276572e-09
exons O 0 2.8050072486962563e-08
. O 0 7.290105852320039e-09

All O 0 1.190294973696382e-09
exon O 0 4.917606020171661e-07
/ O 0 0.00022689382603857666
intron O 0 0.00011927876039408147
boundaries O 0 2.7496939836169076e-08
conform O 0 1.8320883699018964e-09
to O 0 2.4318086606911482e-12
the O 0 1.336657672566799e-12
GT O 0 2.7980661343462998e-08
/ O 0 2.3974416762939654e-05
AG O 0 0.0003588951367419213
rule O 0 2.975885315947835e-08
. O 0 1.0663672167510185e-09

An O 0 1.2638461457936678e-11
analysis O 0 5.0352000346975956e-11
of O 0 4.178274208826299e-13
the O 0 1.1249861719270227e-12
putative O 0 4.080551008200928e-09
promoter O 0 4.788472551808809e-07
region O 0 2.4751776184217533e-09
sequence O 0 3.4900671241899772e-09
shows O 0 3.115442837042792e-08
a O 0 7.222586417832133e-11
putative O 0 3.811138515885659e-09
TATA O 0 5.517724588344208e-08
box O 0 7.399740820090983e-09
and O 0 3.146683608123979e-11
predicts O 0 7.943443236513303e-09
multiple O 0 1.234887747614266e-10
transcription O 0 5.229347621593661e-09
factor O 0 8.770728032736486e-10
binding O 0 4.589094437790209e-09
sites O 0 4.015490162601054e-07
. O 0 7.694909598399136e-09

The O 0 7.371193933014553e-11
genomic O 0 6.254711859554618e-09
structure O 0 2.6562836374921517e-09
was O 0 8.305094806315694e-11
determined O 0 8.88125076953239e-12
using O 0 5.281332662865346e-12
DNA O 0 5.124494717456685e-10
from O 0 3.181368471612267e-13
several O 0 2.6428151659284305e-13
sources O 0 1.573073160447691e-12
including O 0 1.2576198762936919e-12
multiple O 0 4.5873685405872777e-10
large O 0 9.339062856383862e-10
- O 0 5.731658347940538e-06
insert O 0 3.851383496566996e-07
libaries O 0 1.2521875305537833e-06
and O 0 7.004483798533911e-11
genomic O 0 3.2371623159832552e-09
DNA O 0 7.161822690449071e-09
from O 0 3.872967918594483e-11
Finnish O 0 1.615326539194939e-07
CLD B-Disease 0 0.00021487809135578573
patients O 0 2.602241089277868e-08
and O 0 2.741521731852714e-10
controls O 0 1.9757400878006592e-05
. O 0 7.497430942748906e-08

Exon O 0 4.46350168203935e-06
- O 0 6.352694072120357e-06
specific O 0 4.163763556164213e-09
primers O 0 1.5467220393361458e-08
developed O 0 1.997421394950294e-10
in O 0 3.185155589800759e-14
this O 0 1.1057644125973994e-14
study O 0 1.6417563922926925e-13
will O 0 1.8851933902830353e-13
facilitate O 0 1.7957281711958317e-12
mutation O 0 8.706017677606592e-12
screening O 0 1.7599522533773282e-11
studies O 0 9.817396461747618e-13
of O 0 2.0107740884671432e-13
patients O 0 2.2407679878266862e-10
with O 0 2.2305742322648037e-12
the O 0 1.8042616012348134e-10
disease O 0 0.0019953970331698656
. O 0 1.8553125258335967e-08

Genomic O 0 8.214550462071202e-08
sequencing O 0 5.9219664727550025e-09
of O 0 4.049942672890161e-11
a O 0 5.816567782979121e-10
BAC O 0 1.6475110896863043e-05
clone O 0 0.0005618470022454858
H O 1 0.9999997615814209
_ O 0 4.894109562059157e-10
RG364P16 O 0 2.5551853966021554e-09
revealed O 0 2.701016632578046e-10
the O 0 1.3530942046067335e-13
presence O 0 2.1222275672916346e-11
of O 0 1.675541961578507e-14
another O 0 7.655211534118855e-12
, O 0 5.729396991560609e-13
highly O 0 5.485600038449001e-13
homologous O 0 2.047117510228791e-11
gene O 0 3.4916769475756837e-10
3 O 0 1.978676120520384e-12
of O 0 1.247477869701502e-13
the O 0 1.128466070587919e-11
CLD B-Disease 0 1.6689642734490917e-06
gene O 0 2.521191033721948e-09
, O 0 5.47567243283642e-12
with O 0 2.405305772265609e-13
a O 0 1.514778862239663e-12
similar O 0 7.753401219667833e-12
genomic O 0 1.7142275376968996e-09
structure O 0 1.2896358647651596e-08
, O 0 8.231787647361433e-12
recently O 0 4.74256578453236e-10
identified O 0 1.4530655567668305e-09
as O 0 1.946707899047606e-11
the O 0 3.6227123523246973e-09
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 2.4370708615606418e-06
( O 0 9.765845909726067e-10
PDS B-Disease 0 6.489048018920585e-07
) O 0 7.264627788217126e-11
. O 0 3.345642859975406e-11
. O 0 3.9385028571814473e-10

The O 0 1.3366902029687822e-09
APCI1307K O 0 9.179593689623289e-06
allele O 0 1.9930373582610628e-06
and O 0 8.217932112586368e-09
cancer B-Disease 0 1.5065840671013575e-05
risk O 0 8.227957692952259e-08
in O 0 5.858358936849939e-12
a O 0 1.1866131688353931e-10
community O 0 6.824242282377213e-10
- O 0 4.8917350170540885e-08
based O 0 7.724723638524722e-11
study O 0 1.2666720970722078e-11
of O 0 1.060524064400159e-12
Ashkenazi O 0 5.759956955841972e-09
Jews O 0 2.461790771235428e-10
. O 0 2.6148108678292203e-10

Mutations O 0 1.7453752434448688e-06
in O 0 2.0431942249210522e-10
APC O 0 1.9826850916615513e-07
are O 0 6.315026279679614e-11
classically O 0 2.3141337806009687e-06
associated O 0 2.120320687026833e-06
with O 0 8.536944733350538e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 0.9999995231628418
polyposis I-Disease 1 1.0
( O 0 6.248620820770157e-08
FAP B-Disease 0 7.947840003907913e-07
) O 0 7.823178216348481e-11
, O 0 1.4082130427028883e-11
a O 0 1.5880637083132143e-10
highly O 0 1.2332365031397785e-06
penetrant O 1 0.9999608993530273
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999996423721313
disorder I-Disease 1 1.0
characterized O 0 0.00039281658246181905
by O 0 1.4380782786815871e-08
multiple O 0 0.00017947166634257883
intestinal O 1 0.9998481273651123
polyps B-Disease 1 0.9918505549430847
and O 0 4.375966256020547e-08
, O 0 3.582770885524056e-11
without O 0 1.0645696997546583e-11
surgical O 0 6.3360010571500425e-09
intervention O 0 8.455747213531595e-10
, O 0 2.3034618917144867e-12
the O 0 2.410638149600436e-13
development O 0 1.861042653317213e-09
of O 0 1.1179194814303628e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 6.734341528868981e-09
CRC B-Disease 0 7.678139581912546e-07
) O 0 1.1128254984171804e-09
. O 0 3.2756706236369837e-09

APC B-Disease 0 1.0546439170866506e-06
is O 0 4.1700801145516664e-10
a O 0 4.50203957447215e-10
tumour O 1 1.0
- O 0 8.470495231449604e-06
suppressor O 0 5.745409907831345e-07
gene O 0 3.113209601224298e-08
, O 0 1.8937797510720777e-11
and O 0 5.075618311062291e-12
somatic O 0 1.686450645799198e-09
loss O 0 3.348723520701924e-09
occurs O 0 2.1312756004476796e-09
in O 0 1.7658855488988934e-09
tumours B-Disease 1 0.9999998807907104
. O 0 3.737494296274235e-07

The O 0 3.8807490554404467e-10
germline O 0 1.4584356904379092e-06
T O 0 5.1539387641241774e-05
- O 0 6.936079444130883e-08
to O 0 6.083047954241749e-11
- O 0 1.6444245076741026e-08
A O 0 4.9937581847459e-11
transversion O 0 1.116005954315824e-08
responsible O 0 3.1464691963023483e-10
for O 0 2.8985979740568657e-13
the O 0 3.4401222647438556e-13
APC O 0 8.589904898492762e-10
I1307K O 0 5.657517232471321e-10
allele O 0 4.5137567294961656e-11
converts O 0 3.369875342315587e-12
the O 0 1.7656900518515234e-13
wild O 0 4.145731674620734e-11
- O 0 4.961397959135638e-09
type O 0 2.512219321459952e-09
sequence O 0 2.2649543698904928e-11
to O 0 1.7383429765094327e-12
a O 0 6.902797777819103e-11
homopolymer O 0 3.762574851862155e-05
tract O 1 0.9990779161453247
( O 0 2.189767700500056e-09
A8 O 0 0.0001318339054705575
) O 0 1.9312933197124238e-11
that O 0 4.658253383721389e-12
is O 0 4.892117093369119e-12
genetically O 0 1.0684561013718508e-09
unstable O 0 1.8308150174561888e-05
and O 0 1.2316023756397954e-09
prone O 0 1.7253241821890697e-06
to O 0 1.3065790636923591e-11
somatic O 0 7.969655513306861e-08
mutation O 0 1.8499349607736804e-07
. O 0 1.1660982401906494e-08

The O 0 3.5151984101311484e-10
I1307K O 0 1.6972252581126668e-07
allele O 0 4.4870677839981e-08
was O 0 3.4327489739638395e-09
found O 0 9.888009161462818e-11
in O 0 2.2214966411554515e-12
6 O 0 4.731182112749366e-10
. O 0 1.4429407668714589e-09

1 O 0 7.082908481947925e-09
% O 0 6.810806085777443e-11
of O 0 1.0703922557336876e-12
unselected O 0 2.7218120521865785e-06
Ashkenazi O 0 3.4173858409758395e-08
Jews O 0 1.6276067993370447e-10
and O 0 3.2473131822419177e-11
higher O 0 9.341831995468564e-12
proportions O 0 9.926564015216854e-10
of O 0 1.925098969124406e-12
Ashkenazim O 0 1.0948530615451091e-07
with O 0 2.978311000600975e-11
family O 0 1.655912740261556e-08
or O 0 6.511641892359421e-09
personal O 0 2.947230655081512e-07
histories O 0 9.993095773097593e-07
of O 0 2.8471924470863108e-11
CRC B-Disease 0 8.039655199354456e-07
( O 0 2.0693924004944186e-11
ref O 0 2.4600012693554163e-06
. O 0 4.3603211319354074e-11
2 O 0 1.41346838747336e-11
) O 0 2.985989927539734e-11
. O 0 4.247107665555916e-10

To O 0 5.90393012256385e-10
evaluate O 0 6.772456817571992e-09
the O 0 2.4430032649624955e-12
role O 0 1.0662121185944784e-10
of O 0 3.86543661662353e-13
I1307K O 0 1.0320304610900166e-08
in O 0 7.225392593263047e-12
cancer B-Disease 0 8.5031226504384e-09
, O 0 2.1357946661249017e-11
we O 0 5.986914297650969e-10
genotyped O 0 5.363571276006951e-08
5 O 0 1.1157280654927604e-10
, O 0 1.1680470479724647e-10
081 O 0 6.275997748161899e-07
Ashkenazi O 0 7.023782888637697e-09
volunteers O 0 3.427511746645351e-11
in O 0 1.2259725840849806e-13
a O 0 4.130149347525425e-12
community O 0 7.675537982976266e-11
survey O 0 6.554822107318614e-08
. O 0 1.5684408216642964e-09

Risk O 0 7.47074977880402e-07
of O 0 3.044256166595538e-11
developing O 0 9.333492016594391e-06
colorectal B-Disease 1 1.0
, I-Disease 0 1.1490467386465752e-06
breast I-Disease 0 0.4014054238796234
and I-Disease 0 1.2739208798961954e-08
other I-Disease 0 5.154124349537881e-11
cancers I-Disease 0 3.617298034441774e-07
were O 0 4.0138622980911975e-10
compared O 0 8.706407816916339e-10
between O 0 1.259769927264287e-10
genotyped O 0 6.091311774980568e-07
I1307K O 0 9.099357356490145e-08
carriers O 0 2.6507869232972325e-09
and O 0 5.1286377922288295e-11
non O 0 5.716677686784521e-10
- O 0 3.4290869166397897e-07
carriers O 0 2.22476503886071e-09
and O 0 2.6835710736916596e-11
their O 0 1.027383473434229e-12
first O 0 1.9889426911001706e-11
- O 0 2.75739324706592e-08
degree O 0 1.713213459986207e-10
relatives O 0 1.6337442509950506e-09
. O 0 2.068170218416654e-10

Sperm O 0 2.8140529906295342e-08
DNA O 0 3.5428850964080993e-09
analysis O 0 1.5307079215265418e-10
in O 0 5.272566237779497e-12
a O 0 1.3746017657467746e-09
Friedreich B-Disease 1 0.9997977614402771
ataxia I-Disease 1 0.9999699592590332
premutation O 0 0.02233114093542099
carrier O 0 3.593813516999944e-06
suggests O 0 2.5938597936203678e-09
both O 0 6.265531930088608e-12
meiotic O 0 5.2102649306107196e-08
and O 0 5.1642308485089217e-11
mitotic O 0 5.338797404164097e-09
expansion O 0 6.070579594563696e-10
in O 0 3.412304726974069e-12
the O 0 4.09614833371541e-12
FRDA B-Disease 0 2.5809274006860505e-07
gene O 0 2.3472770394050713e-08
. O 0 1.4221884780951655e-09

Friedreich B-Disease 1 0.9999505281448364
ataxia I-Disease 1 0.9999983310699463
is O 0 2.8513551342257415e-07
usually O 0 4.214074422748126e-09
caused O 0 6.606175606549414e-10
by O 0 4.917448284506853e-13
an O 0 4.2354520498472104e-13
expansion O 0 2.5629072197830283e-09
of O 0 2.736875656661475e-11
a O 0 3.405691062496885e-09
GAA O 0 1.6081685316748917e-07
trinucleotide O 0 3.3158596579596633e-07
repeat O 0 1.477559941065465e-08
in O 0 3.3837615869003468e-12
intron O 0 2.2539452970704588e-07
1 O 0 6.750354615558951e-12
of O 0 2.5248721299483967e-13
the O 0 5.197618811042526e-12
FRDA B-Disease 0 2.8202057933413016e-07
gene O 0 2.809285426508268e-08
. O 0 1.1360365981261111e-09

Occasionally O 0 1.873125228257777e-07
, O 0 7.72042221819369e-11
a O 0 3.345879129312834e-11
fully O 0 4.616465265616654e-10
expanded O 0 7.116444239452235e-11
allele O 0 9.0371399252831e-09
has O 0 1.2696219631180838e-09
been O 0 1.216052692570857e-11
found O 0 2.4301485303246384e-12
to O 0 3.177026784012549e-13
arise O 0 2.6678154043530133e-12
from O 0 2.2609755593368946e-14
a O 0 1.3381754471880614e-12
premutation O 0 2.3196549125970023e-09
of O 0 4.3018797617026816e-13
100 O 0 4.1871821981898094e-11
or O 0 1.0838085290343358e-10
less O 0 2.0132293054864192e-10
triplet O 0 2.9999095204402693e-05
repeats O 0 2.7703579689841717e-05
. O 0 8.87885853728676e-09

We O 0 2.2800893617613838e-08
have O 0 2.3983677890915267e-11
examined O 0 1.241623470704667e-10
the O 0 1.2396599588862522e-13
sperm O 0 1.1715851379323627e-11
DNA O 0 1.0640180403420629e-10
of O 0 2.5602978938332743e-13
a O 0 1.794186049730584e-10
premutation O 0 3.8295106605801266e-06
carrier O 0 1.747350552250282e-06
. O 0 6.712528310970356e-09

This O 0 7.515692512782834e-10
mans O 0 1.4696009031922586e-07
leucocyte O 0 1.2307526731092366e-06
DNA O 0 3.9834284848438983e-07
showed O 0 3.8290426829235e-08
one O 0 7.293210306513753e-12
normal O 0 7.440607158182289e-11
allele O 0 1.0788755444579579e-09
and O 0 1.1573330835346063e-11
one O 0 9.089708694932919e-13
allele O 0 4.090552549462778e-11
of O 0 2.487378250419503e-13
approximately O 0 2.6817521536770528e-09
100 O 0 7.256118372822584e-09
repeats O 0 1.3315009255165933e-06
. O 0 9.022294022997812e-09

His O 0 7.095930509848358e-09
sperm O 0 2.859425585199915e-08
showed O 0 6.548508846293544e-09
an O 0 8.968812563285578e-13
expanded O 0 2.162423157203719e-10
allele O 0 2.1119408444292276e-09
in O 0 9.587951092793201e-12
a O 0 2.7456975582040855e-10
tight O 0 2.7609562636143892e-08
range O 0 9.579848914142985e-09
centering O 0 1.2492851197976051e-09
on O 0 1.0487394980218667e-10
a O 0 4.545513705017656e-12
size O 0 1.28386704045802e-10
of O 0 3.034908695881411e-12
approximately O 0 1.4393350511454628e-08
320 O 0 4.818197112399503e-07
trinucleotide O 0 2.1971754904370755e-05
repeats O 0 9.789156138140243e-06
. O 0 1.8761120657018182e-08

His O 0 1.3589247060963316e-08
affected O 0 2.537978502914484e-07
son O 0 3.1668540032114834e-05
has O 0 1.8552771763324927e-08
repeat O 0 8.110239591019308e-09
sizes O 0 6.197044544187236e-10
of O 0 2.4428729438613628e-12
1040 O 0 4.341680082120547e-08
and O 0 9.59357704388708e-10
540 O 0 1.2665562110214523e-07
. O 0 1.1188187043487119e-09

These O 0 1.6224886018045837e-11
data O 0 4.631474023741866e-11
suggest O 0 3.735458990739016e-12
that O 0 3.0610743432211984e-13
expansion O 0 8.190883388214942e-11
occurs O 0 5.208647402277222e-11
in O 0 2.381562828890349e-13
two O 0 4.834317625032614e-13
stages O 0 3.2047109410626717e-10
, O 0 3.279391515287333e-12
the O 0 5.32876253702113e-14
first O 0 4.685205673947423e-13
during O 0 5.673764409686033e-12
meiosis O 0 3.6767623667888216e-11
followed O 0 1.5859160772818681e-12
by O 0 1.3007989325443392e-13
a O 0 1.763896754353178e-12
second O 0 2.0988636176277886e-11
mitotic O 0 4.6312955248595244e-08
expansion O 0 3.0124116534580025e-08
. O 0 1.1436092961503164e-08

We O 0 1.3622829087012178e-08
also O 0 3.3045843839119016e-11
show O 0 4.298591704809951e-09
that O 0 1.033750775952802e-11
in O 0 6.070732024715531e-13
all O 0 2.2008228572900634e-12
informative O 0 9.315280991017971e-09
carrier O 0 3.1553051282884326e-09
father O 0 1.2000785087895594e-10
to O 0 1.3642796744747776e-12
affected O 0 7.517785838295765e-10
child O 0 8.377843307982857e-09
transmissions O 0 1.4434568583965302e-05
, O 0 4.809820250417651e-11
with O 0 5.660833130374798e-13
the O 0 1.2086013613521462e-13
notable O 0 2.356105414935694e-11
exception O 0 1.281571463535025e-11
of O 0 1.174864513401458e-13
the O 0 2.2022589914877377e-12
premutation O 0 1.4629301325896904e-08
carrier O 0 1.0130691840970485e-09
, O 0 2.28950105402026e-13
the O 0 2.665096672537816e-14
expansion O 0 3.040803372988954e-11
size O 0 2.7154916093508064e-09
decreases O 0 2.0701534708678082e-08
. O 0 1.559776474646668e-10
. O 0 2.497366091702702e-09

The O 0 6.019904019716193e-10
R496H O 0 1.1569544966505418e-07
mutation O 0 2.806236798491568e-09
of O 0 1.777202408674572e-12
arylsulfatase O 0 4.3659289872266527e-07
A O 0 5.675371839153343e-10
does O 0 3.008654658742671e-09
not O 0 1.1757457230032742e-09
cause O 0 6.750805141564342e-07
metachromatic B-Disease 1 0.9999998807907104
leukodystrophy I-Disease 1 0.9999995231628418
. O 0 1.1737564591385308e-06

Deficiency B-Disease 1 0.9999468326568604
of I-Disease 0 5.894770782610692e-10
arylsulfatase I-Disease 0 3.09827591991052e-05
A I-Disease 0 1.7782197048177295e-08
( O 0 3.8567968263514274e-10
ARSA O 0 0.0018096304265782237
) O 0 1.1518128811838224e-10
enzyme O 0 1.2585822162236582e-08
activity O 0 1.1315681831547408e-06
causes O 0 1.1605151485127863e-05
metachromatic B-Disease 1 0.9999998807907104
leukodystrophy I-Disease 1 0.9999998807907104
( O 0 7.53076562887145e-07
MLD B-Disease 1 0.9999938011169434
) O 0 1.1625716389573881e-08
. O 0 6.598358748277633e-09

A O 0 1.7188799272815913e-09
number O 0 8.145391305891536e-11
of O 0 1.1223141339888887e-11
ARSA O 0 0.35373786091804504
gene O 0 4.6078406512606307e-07
mutations O 0 6.347664083250493e-08
responsible O 0 1.7417715270084955e-08
for O 0 7.919370714759566e-10
MLD B-Disease 1 0.9999994039535522
have O 0 1.8208613283832165e-08
been O 0 2.453036440641654e-09
identified O 0 2.7390104406777027e-08
. O 0 9.57613544017022e-10

Recently O 0 8.895862606550509e-07
, O 0 1.132030164052722e-10
the O 0 1.031969323363191e-12
R496H O 0 2.0670196665406593e-09
mutation O 0 2.4332261205906036e-10
of O 0 4.1656221115744796e-13
ARSA O 0 3.189542985637672e-05
was O 0 2.2661264531542713e-10
proposed O 0 5.575103746713328e-12
to O 0 2.7587448384741586e-12
be O 0 8.284301196426203e-12
a O 0 7.940083486535077e-12
cause O 0 1.0508124370645078e-09
of O 0 3.0974806053407633e-10
MLD B-Disease 1 1.0
( O 0 8.338863821677478e-09
Draghia O 0 1.276846342079807e-05
et O 0 4.287067440600367e-06
al O 0 2.1116711650392972e-05
. O 0 2.25366086903378e-10
, O 0 4.304075498784421e-11
1997 O 0 3.687381303074666e-11
) O 0 2.5633592470875044e-11
. O 0 1.794230597429447e-10

We O 0 1.7802728180527083e-08
have O 0 8.64222148705407e-12
investigated O 0 7.809819457804679e-11
the O 0 4.3583629001815727e-13
R496H O 0 4.411875309529023e-09
mutation O 0 2.8978561217307686e-10
and O 0 1.2272997288592657e-12
found O 0 6.27477345256644e-13
this O 0 2.1431653042416725e-14
mutation O 0 5.770757569717455e-12
at O 0 5.726056781507616e-12
a O 0 1.6009631771327082e-12
relatively O 0 4.661053227411616e-12
high O 0 3.9769138503176205e-12
frequency O 0 3.24605148316337e-10
in O 0 3.671161898782804e-12
an O 0 3.7384009191239465e-13
African O 0 1.085247126539346e-12
American O 0 6.258661124081133e-13
population O 0 1.6559092421916666e-12
( O 0 7.84371428485392e-13
f O 0 1.1213742254767567e-06
= O 0 3.5141695775564585e-08
0 O 0 1.9383160007602207e-11
. O 0 8.578288253346944e-12
09 O 0 2.788552999621885e-10
, O 0 1.3169296382564699e-11
n O 0 8.706997789431625e-08
= O 0 2.94471590223111e-07
61 O 0 4.75080685902185e-09
subjects O 0 2.123209608129173e-09
) O 0 1.486797213123836e-10
. O 0 5.547773351821661e-10

The O 0 1.184036424461965e-09
ARSA O 0 8.280769543489441e-05
enzyme O 0 5.8484985743234574e-09
activity O 0 2.1859131393853204e-08
in O 0 7.109164602489559e-13
subjects O 0 4.864023073203327e-10
with O 0 2.007587672492317e-11
and O 0 1.4062140341053464e-10
without O 0 4.099884928082664e-12
the O 0 2.5484537982504996e-13
R496H O 0 5.642515898962586e-10
mutation O 0 2.5276693932374528e-11
was O 0 3.1136204725612515e-11
determined O 0 1.5353690541175524e-10
and O 0 3.789734585174509e-12
found O 0 9.0141965072843e-12
to O 0 2.58182212588276e-12
be O 0 5.5765208423208534e-11
normal O 0 2.630690110194678e-09
. O 0 7.518761169222898e-10

It O 0 9.878927675899263e-10
is O 0 2.6785341306068133e-11
therefore O 0 1.0252419573031357e-12
concluded O 0 6.074152032048419e-12
that O 0 8.85316600303214e-14
the O 0 8.538465480446497e-14
R496H O 0 1.889106204799873e-09
mutation O 0 2.1489166002197635e-10
of O 0 2.080369296969531e-12
ARSA O 0 6.608768308069557e-05
does O 0 4.867048986056943e-10
not O 0 1.361459339363491e-12
negatively O 0 1.5117029156241912e-11
influence O 0 2.0699440425597793e-12
the O 0 2.6531993832859535e-13
activity O 0 1.3383415264911491e-08
of O 0 3.551709057067476e-12
ARSA O 0 0.005014493595808744
and O 0 5.972908279083811e-10
is O 0 5.062664870658651e-11
not O 0 8.190847305966642e-12
a O 0 2.577267566028496e-11
cause O 0 3.442091722760665e-09
of O 0 7.119451694848067e-09
MLD B-Disease 1 0.9999995231628418

Down O 0 1.6545334801776335e-05
- O 0 1.816925646380696e-06
regulation O 0 1.3319640945752553e-09
of O 0 4.3793137519121395e-12
transmembrane O 0 6.322820667037377e-08
carbonic O 0 2.2615603612052837e-08
anhydrases O 0 1.721346848171379e-06
in O 0 1.2647131120147037e-09
renal B-Disease 1 0.9999494552612305
cell I-Disease 1 0.9999920129776001
carcinoma I-Disease 1 1.0
cell O 1 0.9993246793746948
lines O 0 0.0003262145910412073
by O 0 7.845012972573784e-10
wild O 0 3.082920159158675e-07
- O 0 0.11519549787044525
type O 1 0.8245970606803894
von B-Disease 1 0.9995607733726501
Hippel I-Disease 1 0.9987987279891968
- I-Disease 1 0.9947758913040161
Lindau I-Disease 1 0.7907528281211853
transgenes O 0 0.0010720528662204742
. O 0 1.302719567775057e-07

To O 0 3.02665115192724e-10
discover O 0 1.461136323044343e-09
genes O 0 1.2917350522556603e-09
involved O 0 9.205258222344526e-10
in O 0 4.212449000728924e-10
von B-Disease 1 0.9999450445175171
Hippel I-Disease 1 0.9999933242797852
- I-Disease 1 0.9999915361404419
Lindau I-Disease 1 0.9999390840530396
( O 0 9.084150320859408e-08
VHL B-Disease 0 1.5601817722199485e-05
) O 0 6.140099539919674e-10
- O 0 1.9379328932700446e-06
mediated O 0 6.495685056506773e-07
carcinogenesis O 0 4.8887777666095644e-06
, O 0 5.969625488377872e-11
we O 0 5.5485536304411553e-11
used O 0 3.2297244878520814e-09
renal B-Disease 1 0.9685161709785461
cell I-Disease 1 0.9999403953552246
carcinoma I-Disease 1 1.0
cell O 1 0.9999475479125977
lines O 1 0.9971926808357239
stably O 0 0.29574236273765564
transfected O 0 4.496605833992362e-05
with O 0 1.1934913057842778e-09
wild O 0 6.016086473437099e-08
- O 0 0.002569065196439624
type O 0 0.0020395475439727306
VHL O 0 3.5192901123082265e-05
- O 0 3.458999117356143e-06
expressing O 0 9.529205868830104e-09
transgenes O 0 1.9078843251918443e-06
. O 0 4.379454132674709e-09

Large O 0 2.377992025515141e-08
- O 0 3.5503255730873207e-06
scale O 0 1.2253325394340209e-06
RNA O 0 1.8193302864233374e-08
differential O 0 1.9330235190295753e-09
display O 0 1.7301554633419869e-09
technology O 0 1.9472798373776357e-11
applied O 0 6.544550058135146e-13
to O 0 2.0727716147205671e-13
these O 0 9.648761824243568e-13
cell O 0 4.3131713312050124e-08
lines O 0 8.19430141518751e-08
identified O 0 6.348352066254392e-09
several O 0 2.888235223902358e-12
differentially O 0 9.641715870145617e-09
expressed O 0 2.286308989352115e-11
genes O 0 1.6750309472790548e-10
, O 0 1.8808268744535672e-12
including O 0 1.2500078012608884e-12
an O 0 1.2661811703285064e-12
alpha O 0 7.793495709895737e-11
carbonic O 0 7.081054631541406e-10
anhydrase O 0 4.7643822220777565e-09
gene O 0 2.2606103655675724e-09
, O 0 6.540962216305957e-11
termed O 0 1.0383412529790803e-07
CA12 O 0 6.901552842464298e-05
. O 0 2.5230011857502177e-08

The O 0 6.750564690571892e-11
deduced O 0 1.4781172952282873e-09
protein O 0 1.0653278953443035e-10
sequence O 0 2.3215658562225627e-10
was O 0 2.4177698731975283e-10
classified O 0 1.7459782508666422e-09
as O 0 7.56871041535101e-12
a O 0 5.053557919354468e-11
one O 0 5.240051059729467e-09
- O 0 0.02556172013282776
pass O 0 5.347299136815309e-08
transmembrane O 0 4.267379694056217e-08
CA O 0 1.5029098676677677e-07
possessing O 0 4.1571357467518055e-10
an O 0 7.915613694023382e-13
apparently O 0 4.916629881002166e-10
intact O 0 1.9898163672316116e-10
catalytic O 0 1.2879244337682394e-09
domain O 0 4.6376751328125465e-09
in O 0 8.21849966553545e-12
the O 0 8.446084109881014e-12
extracellular O 0 8.840233078899473e-08
CA O 0 0.00012478919234126806
module O 0 1.5383859590656357e-06
. O 0 4.251908158892093e-09

Reintroduced O 0 2.5230789901797834e-07
wild O 0 1.3066537007944135e-07
- O 0 4.247816832503304e-05
type O 0 1.1107627869932912e-05
VHL B-Disease 0 9.886642828860204e-07
strongly O 0 7.10076053511699e-10
inhibited O 0 8.149762531495242e-10
the O 0 5.35747390461444e-13
overexpression O 0 4.109885001768454e-11
of O 0 5.936200695496469e-14
the O 0 9.538892028690404e-14
CA12 O 0 9.538789313978668e-09
gene O 0 1.8818192837333214e-10
in O 0 5.171598826264612e-13
the O 0 1.5980747974930765e-11
parental O 0 0.07312317937612534
renal B-Disease 1 0.9999661445617676
cell I-Disease 1 0.9999911785125732
carcinoma I-Disease 1 1.0
cell O 1 0.999503493309021
lines O 1 0.7572165727615356
. O 0 1.019823912429274e-06

Similar O 0 3.293965322725967e-09
results O 0 3.6577313400343314e-10
were O 0 1.0408058963295996e-11
obtained O 0 3.0748344842512765e-11
with O 0 1.335305217092797e-11
CA9 O 0 1.9941473510698415e-05
, O 0 4.450215196349916e-11
encoding O 0 1.435682239758762e-09
another O 0 2.45115172603505e-09
transmembrane O 0 2.3829455741974925e-08
CA O 0 3.9452766031899955e-06
with O 0 3.70145841060987e-12
an O 0 2.6367042230135418e-12
intact O 0 8.267455164912008e-09
catalytic O 0 1.697440552561602e-07
domain O 0 6.585171945516777e-07
. O 0 7.45723749417948e-09

Although O 0 1.7383422479255728e-09
both O 0 4.150051136075916e-11
domains O 0 2.4264377174176843e-09
of O 0 1.924497020078242e-12
the O 0 6.9619249601360345e-12
VHL B-Disease 0 2.767446360962822e-08
protein O 0 1.1003085595429063e-11
contribute O 0 1.8906857416484124e-12
to O 0 3.9661099382991283e-13
regulation O 0 5.384922542595039e-12
of O 0 6.823554850494962e-13
CA12 O 0 7.751905855002406e-07
expression O 0 4.320115931655266e-10
, O 0 3.015757348706627e-12
the O 0 1.2928614884395728e-13
elongin O 0 1.3727133207908082e-08
binding O 0 1.2256032855262333e-09
domain O 0 9.390688227028932e-09
alone O 0 1.3099198170607451e-08
could O 0 1.394948878630231e-10
effectively O 0 7.5110246910981e-09
regulate O 0 3.952870315515611e-07
CA9 O 0 0.00035055787884630263
expression O 0 3.5781977203441784e-07
. O 0 1.2564596474362588e-08

We O 0 1.3164235213025677e-07
mapped O 0 1.1311675734759774e-05
CA12 O 0 7.943237869767472e-05
and O 0 2.9361746367584374e-09
CA9 O 0 4.356812951300526e-06
loci O 0 1.2868512921926367e-09
to O 0 5.113397986283852e-12
chromosome O 0 3.09770271655907e-08
bands O 0 4.2379819653604045e-09
15q22 O 0 1.871539723197202e-07
and O 0 5.935329450146298e-10
17q21 O 0 2.244740500145781e-07
. O 0 2.501112872366207e-09

2 O 0 6.1829039665894925e-09
respectively O 0 1.3003351728713142e-09
, O 0 7.011755759345206e-11
regions O 0 2.9965192549497033e-09
prone O 0 9.136972039414104e-06
to O 0 3.962013876701587e-12
amplification O 0 7.664394119366591e-10
in O 0 8.976034433956503e-13
some O 0 7.37006549539343e-12
human O 0 1.982078723372638e-09
cancers B-Disease 0 1.2421349993019248e-06
. O 0 3.4287117589570926e-09

Additional O 0 6.774364957884416e-10
experiments O 0 5.728709506769292e-09
are O 0 4.869318923766963e-12
needed O 0 4.088077966424297e-12
to O 0 7.725291218362018e-13
define O 0 5.553406068337097e-10
the O 0 5.064497432538673e-12
role O 0 1.78880521506386e-09
of O 0 8.33769078084634e-12
CA O 0 1.7607997506274842e-05
IX O 0 5.279379706735199e-07
and O 0 1.1989244264043464e-08
CA O 0 6.638417289650533e-06
XII O 0 1.959316620059326e-08
enzymes O 0 1.6209792189081362e-11
in O 0 5.21118284429415e-14
the O 0 1.757601497068967e-14
regulation O 0 6.692112142214768e-13
of O 0 2.2706920436814382e-13
pH O 0 1.702586445162524e-07
in O 0 8.418351736191876e-13
the O 0 1.99837195402619e-12
extracellular O 0 7.733292894940291e-10
microenvironment O 0 1.1248022957488502e-07
and O 0 7.367510768130359e-11
its O 0 2.3932713449914544e-12
potential O 0 2.4090534254950224e-12
impact O 0 1.6474703545821257e-11
on O 0 3.7616237902327043e-10
cancer B-Disease 0 5.802213109973309e-08
cell O 0 1.5456713242656406e-07
growth O 0 6.864547685836442e-07
. O 0 6.708201993887997e-09

A O 0 1.7996879542181432e-09
gene O 0 2.2525544096652084e-08
encoding O 0 1.5225207761204729e-09
a O 0 4.581876544840213e-10
transmembrane O 0 1.2304547603037008e-08
protein O 0 1.058932830311221e-09
is O 0 3.798759050377409e-12
mutated O 0 7.852513084216639e-10
in O 0 2.797192165393536e-11
patients O 0 4.1216978274860594e-08
with O 0 3.227221895940602e-06
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9216151833534241
optic B-Disease 1 0.9999998807907104
atrophy I-Disease 1 0.9999303817749023
( O 0 0.0017618453130126
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 2.7007411418367155e-08
. O 0 1.7348057212984713e-08

Wolfram B-Disease 1 0.9999995231628418
syndrome I-Disease 1 1.0
( O 0 9.203315016748093e-07
WFS B-Disease 0 0.007394091691821814
; O 0 1.1216054751628235e-08
OMIM O 0 0.0007167083094827831
222300 O 0 2.201974211857305e-07
) O 0 4.341044537725658e-11
is O 0 2.857501908704041e-11
an O 0 1.6243226208523254e-10
autosomal B-Disease 1 0.999998927116394
recessive I-Disease 1 0.9999985694885254
neurodegenerative I-Disease 1 0.999998927116394
disorder I-Disease 1 0.9999908208847046
defined O 0 4.00281976453698e-07
by O 0 5.839912442517914e-10
young O 0 1.6822589543608046e-08
- O 0 0.00020322883210610598
onset O 0 0.002581163076683879
non O 0 2.6856374461203814e-05
- O 1 0.9702489972114563
immune O 1 0.6553575396537781
insulin B-Disease 1 0.8739806413650513
- I-Disease 1 0.9999045133590698
dependent I-Disease 1 0.9999452829360962
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 8.60816908243578e-06
progressive O 0 0.0027405426371842623
optic B-Disease 1 0.9999916553497314
atrophy I-Disease 1 0.8099645972251892
. O 0 3.8158253801157116e-07

Linkage O 0 3.934196683985647e-06
to O 0 6.096896876250923e-10
markers O 0 1.975683517230209e-06
on O 0 9.318747551390061e-09
chromosome O 0 0.0034983300138264894
4p O 0 0.0013370946981012821
was O 0 3.8373266875169065e-07
confirmed O 0 7.133944279757998e-08
in O 0 6.183802168241437e-12
five O 0 9.25800616724537e-11
families O 0 2.607091764694758e-10
. O 0 3.595437281234126e-10

On O 0 2.412464450429752e-09
the O 0 3.823546947806511e-12
basis O 0 2.6805373892768714e-11
of O 0 3.910478982727811e-13
meiotic O 0 1.818266355257947e-05
recombinants O 0 0.0026115665677934885
and O 0 1.1229625229702833e-08
disease O 0 0.00021663738880306482
- O 0 1.5365181752713397e-05
associated O 0 1.3047161928625428e-07
haplotypes O 0 3.064382951833977e-07
, O 0 1.1785920850382325e-10
the O 0 2.323885008037596e-12
WFS B-Disease 0 4.3558806339660805e-08
gene O 0 4.583957102788361e-10
was O 0 9.372427139942019e-11
localized O 0 1.1286910295282837e-09
to O 0 6.427650772744542e-11
a O 0 1.7900372295542866e-09
BAC O 0 1.1685087883961387e-05
/ O 0 4.946975877828663e-06
P1 O 0 6.077623311284697e-07
contig O 0 3.790725244812165e-08
of O 0 3.0832294725148535e-13
less O 0 2.4740741139811506e-12
than O 0 1.1648271756869999e-11
250 O 0 1.1189467130634512e-09
kb O 0 1.8059525928038056e-06
. O 0 1.5798267583022607e-08

Mutations O 0 9.473389468439564e-07
in O 0 2.8976170421413094e-11
a O 0 1.3812100768673119e-11
novel O 0 2.3063743970208606e-10
gene O 0 9.527151512145338e-09
( O 0 1.3601725648570984e-11
WFS1 O 0 2.2080303097027354e-07
) O 0 1.4423723500300856e-11
encoding O 0 2.0321254401434174e-10
a O 0 1.9848241106235065e-10
putative O 0 2.0192537419916334e-08
transmembrane O 0 1.2906982149729629e-09
protein O 0 5.525298968356296e-11
were O 0 7.164407522103344e-12
found O 0 5.7186677268616926e-12
in O 0 2.590457958816933e-13
all O 0 1.1572022637004742e-12
affected O 0 1.8056661721388423e-10
individuals O 0 2.9857435968061452e-12
in O 0 3.964024854891113e-12
six O 0 3.820437854962222e-10
WFS B-Disease 0 1.1581280290329232e-07
families O 0 5.162251182078137e-11
, O 0 2.285819537123368e-12
and O 0 1.0155574298176262e-12
these O 0 2.9212149734759996e-13
mutations O 0 4.1798727673514335e-11
were O 0 2.158938609483907e-12
associated O 0 4.5269569343142635e-11
with O 0 1.0484269702404347e-11
the O 0 2.5819923976655446e-10
disease O 0 2.2239732061279938e-05
phenotype O 0 2.3946034843902453e-07
. O 0 1.2632986212679498e-08

WFS1 O 0 9.653046618041117e-06
appears O 0 1.3982027091685723e-08
to O 0 1.539326652255646e-11
function O 0 3.488827560182983e-10
in O 0 1.4699672685677956e-12
survival O 0 2.3175246610662725e-08
of O 0 2.7419058776928518e-12
islet O 0 0.011050382629036903
beta O 0 7.376911970169431e-09
- O 0 4.808374001186166e-07
cells O 0 1.3053796932283035e-09
and O 0 2.1296806332338214e-11
neurons O 0 3.7948813536026194e-10
. O 0 1.706250071786819e-11
. O 0 3.1402339062402973e-10

Stable O 0 7.529166850872571e-06
interaction O 0 1.2807126470448793e-09
between O 0 9.58056550759423e-12
the O 0 2.3752617169144064e-13
products O 0 1.1446060765862853e-09
of O 0 1.2864878704433452e-13
the O 0 1.1496481717998552e-11
BRCA1 O 0 8.41626729197742e-07
and O 0 4.31468111239397e-10
BRCA2 O 0 2.55244515301456e-07
tumor B-Disease 0 2.820791600299799e-08
suppressor O 0 4.45180958763558e-08
genes O 0 4.379913320917694e-09
in O 0 1.4815395438239065e-11
mitotic O 0 4.807635605175165e-07
and O 0 1.1317090597984247e-09
meiotic O 0 1.4722319974680431e-05
cells O 0 1.879013495909021e-07
. O 0 7.810066371405355e-09

BRCA1 O 0 0.0021710433065891266
and O 0 2.4859378555674994e-08
BRCA2 O 0 1.1788719120886526e-06
account O 0 4.095949690530176e-10
for O 0 6.368446351864843e-13
most O 0 1.4900773757237085e-12
cases O 0 2.5954609988998456e-11
of O 0 2.42715488549608e-13
familial O 0 7.123555860744091e-07
, O 0 4.430946581868156e-11
early O 0 1.103268698621207e-09
onset O 0 5.329355190042406e-06
breast B-Disease 0 0.002757496200501919
and I-Disease 0 6.505749297502916e-06
/ I-Disease 1 0.9999998807907104
or I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 3.390936698099978e-10
encode O 0 1.9725059086095342e-10
products O 0 2.2640334051970967e-08
that O 0 1.7569898444133591e-12
each O 0 4.173224808258491e-13
interact O 0 2.0588333121684954e-11
with O 0 8.227596555443473e-12
hRAD51 O 0 6.541339985233208e-07
. O 0 6.7657688340716504e-09

Results O 0 1.4354967881047287e-08
presented O 0 3.76969649940051e-10
here O 0 3.618095753554762e-11
show O 0 2.234239460108256e-09
that O 0 5.3029365620904656e-11
BRCA1 O 0 2.2116256559456815e-07
and O 0 5.009357928464908e-10
BRCA2 O 0 5.393484343585442e-07
coexist O 0 4.211599513581632e-09
in O 0 5.374781565994913e-13
a O 0 2.410758875512342e-12
biochemical O 0 1.6810585146131984e-09
complex O 0 1.4697564276744401e-09
and O 0 7.136806423613251e-11
colocalize O 0 8.242928117851989e-08
in O 0 7.483843406097535e-12
subnuclear O 0 4.903168928649393e-07
foci O 0 2.2552024248057023e-08
in O 0 6.956571820329605e-13
somatic O 0 2.2584199788067139e-10
cells O 0 1.9394781614057166e-10
and O 0 6.408404189250927e-12
on O 0 1.6473478831047217e-11
the O 0 3.828675386712693e-13
axial O 0 1.7245141425981103e-10
elements O 0 5.466930033670714e-11
of O 0 6.323950694706038e-13
developing O 0 1.0505959435747059e-09
synaptonemal O 0 2.805901715419168e-07
complexes O 0 2.1418952655949397e-07
. O 0 3.174676965755907e-09

Like O 0 6.868935997772496e-08
BRCA1 O 0 2.953272996819578e-06
and O 0 1.6592124341130443e-09
RAD51 O 0 6.989043322391808e-05
, O 0 1.403831634272379e-10
BRCA2 O 0 5.161176375167997e-08
relocates O 0 7.149048020238524e-09
to O 0 5.6357266076112467e-11
PCNA O 0 2.7667185804602923e-06
+ O 0 1.739696564584392e-08
replication O 0 8.23001045091587e-09
sites O 0 1.1163934665603392e-08
following O 0 6.851206667962684e-12
exposure O 0 2.4577762047783835e-09
of O 0 1.4296192268198338e-12
S O 0 2.0381614831421757e-06
phase O 0 9.49983869347193e-10
cells O 0 1.64460473017769e-10
to O 0 1.078534917625662e-11
hydroxyurea O 0 1.2733651999496942e-07
or O 0 8.274408380692932e-10
UV O 0 4.110613360808202e-07
irradiation O 0 8.09395501732979e-08
. O 0 3.871790443810141e-09

Thus O 0 1.1086863871412334e-08
, O 0 4.773266781832319e-10
BRCA1 O 0 1.212622464663582e-07
and O 0 2.041659341589508e-10
BRCA2 O 0 1.0140400519276227e-08
participate O 0 2.0942331202533637e-11
, O 0 9.988239402236587e-12
together O 0 3.285904881522583e-11
, O 0 6.889180632213554e-12
in O 0 3.217887382337553e-13
a O 0 1.4387180682917666e-11
pathway O 0 7.316080519181867e-10
( O 0 1.125160641740619e-11
s O 0 1.8368009477853775e-06
) O 0 1.3125682181772125e-12
associated O 0 1.1702772084731805e-10
with O 0 1.0369453776540305e-12
the O 0 4.0834780760772016e-13
activation O 0 1.0804606515035786e-10
of O 0 1.5172222202555763e-12
double O 0 5.117896506590114e-08
- O 0 1.9378328488528496e-06
strand O 0 6.800729579481413e-08
break O 0 1.0625590185497913e-08
repair O 0 2.5203393306583166e-05
and O 0 1.3417343625032885e-10
/ O 0 3.1769499031497617e-08
or O 0 3.914259194548464e-11
homologous O 0 1.1861611692864926e-09
recombination O 0 2.6363222715986012e-08
. O 0 2.2473263250333275e-09

Dysfunction O 0 0.0035480456426739693
of O 0 1.3009589933110632e-11
this O 0 9.652060400933138e-12
pathway O 0 6.438197530655998e-09
may O 0 1.211702960191019e-10
be O 0 1.5476838560735118e-12
a O 0 1.401411755738713e-12
general O 0 5.990837600305943e-12
phenomenon O 0 1.863077692121351e-09
in O 0 3.489374587883898e-13
the O 0 1.2216937802112665e-13
majority O 0 3.3691812360847617e-12
of O 0 1.2513193335238898e-13
cases O 0 2.0354461172100713e-10
of O 0 8.122720378256343e-12
hereditary B-Disease 1 0.8861790299415588
breast I-Disease 1 0.9994751811027527
and I-Disease 0 0.01955985836684704
/ I-Disease 1 0.9999998807907104
or I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.900594514050226e-09
. O 0 5.633572275343113e-09

A O 0 1.2675948291018813e-08
novel O 0 9.155236568858527e-09
Arg362Ser O 0 8.35611672300729e-07
mutation O 0 1.5028439603881338e-09
in O 0 1.845356333018966e-12
the O 0 1.729004743197815e-12
sterol O 0 1.4856810821584077e-06
27 O 0 2.5806803805039635e-08
- O 0 4.07047400585725e-06
hydroxylase O 0 1.105348019336816e-05
gene O 0 1.7039663902096436e-08
( O 0 9.048026217151062e-12
CYP27 O 0 4.648871865242654e-08
) O 0 3.257945128953832e-12
: O 0 6.948933616024444e-13
its O 0 3.076743775119045e-13
effects O 0 1.4586935825899872e-10
on O 0 2.3031611340318392e-10
pre O 0 4.6742030690438696e-07
- O 0 1.9018975283557893e-09
mRNA O 0 6.494465121936743e-12
splicing O 0 1.6683692621866086e-11
and O 0 9.908389213275637e-13
enzyme O 0 2.7505657473891887e-11
activity O 0 6.11883321788298e-10
. O 0 5.3005193983990395e-11

A O 0 5.899329025282896e-09
novel O 0 9.60194257437763e-10
C O 0 3.228322142945217e-08
to O 0 1.5930738716044002e-12
A O 0 4.756167248237686e-12
mutation O 0 5.471968711479036e-11
in O 0 3.134197274542311e-13
the O 0 1.9833158552973185e-12
sterol O 0 7.828024308764725e-07
27 O 0 8.729076128588531e-09
- O 0 5.239354550212738e-07
hydroxylase O 0 1.6796448107925244e-06
gene O 0 1.127590021354763e-08
( O 0 7.803472278078427e-12
CYP27 O 0 1.3887673233625719e-08
) O 0 9.610172900520464e-13
was O 0 1.0281543845469532e-11
identified O 0 9.223368596655845e-12
by O 0 2.7082536788267803e-14
sequencing O 0 9.098841818877546e-11
amplified O 0 1.6449694939524306e-09
CYP27 O 0 1.3011693944520175e-08
gene O 0 1.7818992947837842e-09
products O 0 9.837579639793148e-10
from O 0 6.637336622157541e-13
a O 0 6.447788136743071e-11
patient O 0 4.515761133916385e-07
with O 0 5.6430571326870904e-09
cerebrotendinous B-Disease 1 0.9999997615814209
xanthomatosis I-Disease 1 0.999998927116394
( O 0 3.001457216100789e-08
CTX B-Disease 0 8.083641296252608e-05
) O 0 1.0207867884304278e-09
. O 0 1.4854798502383915e-09

The O 0 3.9889872655018976e-11
mutation O 0 1.1066132454828903e-09
changed O 0 1.9009968599270621e-10
the O 0 3.937670502163204e-13
adrenodoxin O 0 2.741868065925246e-09
cofactor O 0 8.702805143201431e-10
binding O 0 4.0994665995164326e-10
residue O 0 7.045855010545665e-09
362Arg O 0 3.393890679603828e-08
to O 0 5.4383088310405725e-11
362Ser O 0 1.1764129936864265e-07
( O 0 1.0114429432883654e-10
CGT O 0 2.44846916075403e-07
362Arg O 0 6.766907034716496e-08
to O 0 4.542109743876921e-11
AGT O 0 9.034971526489244e-08
362Ser O 0 1.0786332715895242e-08
) O 0 8.08610123304021e-12
, O 0 4.2863369104084725e-12
and O 0 2.178080415679573e-12
was O 0 2.4358684513892115e-10
responsible O 0 1.4526784219981437e-08
for O 0 1.4258735858696525e-10
deficiency O 0 0.00010365711204940453
in O 0 6.907914453131714e-13
the O 0 3.572574311036525e-12
sterol O 0 9.785037491383264e-07
27 O 0 1.708671648614768e-09
- O 0 1.1600952198875802e-08
hydroxylase O 0 1.0885085544032336e-07
activity O 0 2.2580561420681988e-08
, O 0 2.5012273068697466e-13
as O 0 4.09866876495326e-14
confirmed O 0 1.0109062024976634e-11
by O 0 8.280674729894619e-14
expression O 0 2.9478531161225563e-12
of O 0 2.95275719294167e-14
mutant O 0 1.8890260189419195e-10
cDNA O 0 3.9846700938817037e-10
into O 0 4.3963388485224186e-11
COS O 0 7.982668648764957e-06
- O 0 6.453974066289447e-08
1 O 0 1.6347463313581834e-11
cells O 0 7.586060668529626e-10
. O 0 3.1568567204764975e-10

Quantitative O 0 8.382079030866407e-09
analysis O 0 8.448621247048038e-10
showed O 0 7.0141301655723964e-09
that O 0 8.042535821345398e-13
the O 0 6.860496600067517e-14
expression O 0 5.886677950650565e-11
of O 0 4.65022660135761e-13
CYP27 O 0 3.7942697872495046e-08
gene O 0 3.202547949054946e-10
mRNA O 0 1.9577558324490596e-11
in O 0 3.0450717902058555e-13
the O 0 6.05117193332172e-13
patient O 0 1.39199396453904e-09
represented O 0 2.3584479855176532e-11
52 O 0 9.028215508521953e-09
. O 0 2.808962396017023e-09

5 O 0 2.812151844722166e-09
% O 0 1.766301514771751e-11
of O 0 4.984493720550098e-13
the O 0 1.512256639357723e-11
normal O 0 8.234190573830347e-08
level O 0 1.7468986257540564e-08
. O 0 1.8491220776795103e-09

As O 0 1.317503189879332e-10
the O 0 9.691903312888939e-13
mutation O 0 8.901334530575511e-11
occurred O 0 1.7899885740302324e-10
at O 0 4.1927603749991604e-11
the O 0 1.3835368397815961e-13
penultimate O 0 1.5421779131497004e-10
nucleotide O 0 1.2267066529236814e-10
of O 0 6.164027079556822e-13
exon O 0 4.39555308817674e-10
6 O 0 8.862489214722657e-11
( O 0 6.9913332935434e-12
- O 0 2.910949348233771e-08
2 O 0 4.158908026991037e-12
position O 0 4.626167851573548e-11
of O 0 3.2811042294592085e-13
exon O 0 2.5400441749923175e-09
6 O 0 1.396062154768174e-09
- O 0 2.751835154413129e-06
intron O 0 8.615117621957324e-06
6 O 0 1.9703624842826173e-10
splice O 0 2.226094863999606e-08
site O 0 1.0524536797618111e-08
) O 0 2.6862876072869524e-13
of O 0 1.83281687929067e-15
the O 0 3.17115117056733e-15
gene O 0 1.462381084282871e-11
, O 0 2.149409393959606e-13
we O 0 1.848892675244962e-13
hypothesized O 0 6.258613419185544e-13
that O 0 2.147507838874338e-13
the O 0 1.3395129460930938e-13
mutation O 0 2.3088039813323746e-10
may O 0 9.327873543019116e-12
partially O 0 9.021171032408404e-10
affect O 0 3.080704788493982e-11
the O 0 5.767890505492534e-14
normal O 0 4.210316123520741e-12
splicing O 0 7.2627161229466e-11
efficiency O 0 9.657129956819333e-11
in O 0 3.9729393277836145e-13
exon O 0 6.836175514557397e-10
6 O 0 2.9387112188139497e-10
and O 0 1.574346729371623e-11
cause O 0 1.4543117578258435e-11
alternative O 0 3.2765404972545653e-12
splicing O 0 3.892343114486607e-10
elsewhere O 0 3.2921046444478463e-10
, O 0 5.852012667853512e-13
which O 0 3.031424395359694e-13
resulted O 0 2.206455070735691e-12
in O 0 8.895724326433985e-13
decreased O 0 1.3698545409113194e-08
transcript O 0 3.9366515380834244e-08
in O 0 2.484308071759589e-11
the O 0 2.5054075133978948e-11
patient O 0 6.810413566427087e-08
. O 0 1.3321674874333667e-09

Transfection O 0 1.2270900697330944e-05
of O 0 9.728992611535148e-11
constructed O 0 1.72219856153788e-08
minigenes O 0 1.512806079517759e-06
, O 0 1.5525994379039787e-10
with O 0 7.366467678904254e-12
or O 0 2.100218332579118e-10
without O 0 6.619298859034117e-12
the O 0 8.302816848762204e-14
mutation O 0 2.358753817266468e-11
, O 0 5.8228969606125e-13
into O 0 1.5141866710130514e-12
COS O 0 6.376270903274417e-05
- O 0 1.4902857969900651e-07
1 O 0 1.2752311142824602e-12
cells O 0 2.404303665881624e-11
confirmed O 0 1.4686851734779793e-10
that O 0 3.2604859567450517e-13
the O 0 1.291877981543857e-13
mutant O 0 2.4559108080524084e-09
minigene O 0 3.292685590849942e-08
was O 0 3.6831798722047893e-10
responsible O 0 3.140407656143651e-10
for O 0 2.6518129597578877e-13
a O 0 1.9893398994080824e-12
mRNA O 0 9.700267498968795e-12
species O 0 4.377532949843832e-13
alternatively O 0 2.2652050374327715e-11
spliced O 0 1.5685403198517633e-08
at O 0 1.3072982696371582e-09
an O 0 4.193206112196313e-12
activated O 0 1.1297362156881263e-08
cryptic O 0 9.528005939785089e-09
5 O 0 2.250013023119557e-11
splice O 0 4.177973877972363e-08
site O 0 1.2176427333088213e-07
88 O 0 8.286459296513726e-10
bp O 0 3.124921654773516e-09
upstream O 0 2.926746067721808e-10
from O 0 1.6068919198725107e-12
the O 0 6.189474930848315e-13
3 O 0 2.390565826890234e-12
end O 0 9.930345434838728e-11
of O 0 1.1287410893109917e-12
exon O 0 9.902174191722679e-09
6 O 0 2.9596549655508397e-09
. O 0 1.6827074178493717e-09

Our O 0 1.4790422220301025e-09
data O 0 9.092977759639354e-11
suggest O 0 2.679545821338003e-11
that O 0 4.961624644125862e-13
the O 0 9.779079401719265e-14
C O 0 4.255565067001754e-10
to O 0 1.2280320261116168e-13
A O 0 3.330411901120156e-12
mutation O 0 6.465978447112164e-11
at O 0 2.5669945336037614e-11
the O 0 1.5122492559409284e-13
penultimate O 0 1.0073190892523343e-10
nucleotide O 0 5.287321969138503e-11
of O 0 1.0674253635937353e-13
exon O 0 9.74332906023001e-11
6 O 0 1.104922750516657e-11
of O 0 1.2508800961187616e-13
the O 0 6.297950442407663e-13
CYP27 O 0 8.458009403966571e-09
gene O 0 1.0299200381425067e-09
not O 0 1.5690464552631234e-11
only O 0 2.3646761632134528e-12
causes O 0 2.425140921413771e-10
the O 0 1.1199795951766234e-10
deficiency B-Disease 0 0.0060708229430019855
in I-Disease 0 5.103265032779802e-12
the I-Disease 0 1.938042434868059e-11
sterol I-Disease 0 6.223456693987828e-06
27 I-Disease 0 6.745950464903672e-09
- I-Disease 0 7.480203834120402e-08
hydroxylase I-Disease 0 3.739751548437198e-07
activity I-Disease 0 7.609689589571644e-08
, O 0 6.414004743993118e-12
but O 0 4.300889505648442e-12
also O 0 1.202025111390892e-11
partially O 0 2.7966986504424085e-09
leads O 0 4.325883401490316e-12
to O 0 3.559391008930296e-13
alternative O 0 4.9861632184233784e-11
pre O 0 1.0699579888751032e-07
- O 0 1.9925174843393734e-09
mRNA O 0 7.584505939961517e-12
splicing O 0 2.4481916494067946e-11
of O 0 3.762512897813666e-14
the O 0 2.0192099945207098e-13
gene O 0 4.944334941470174e-10
. O 0 1.4005527293470266e-10

To O 0 3.522777847209113e-09
our O 0 3.7003961006476516e-10
knowledge O 0 1.739348769180804e-11
, O 0 3.7585055510588883e-13
this O 0 4.6582485454691944e-14
is O 0 7.023526725491447e-13
the O 0 9.43532869836141e-15
first O 0 3.147256760760442e-13
report O 0 1.3499145377904309e-11
regarding O 0 3.5969836050669945e-12
effects O 0 4.85894213753113e-10
on O 0 4.411704612738987e-10
pre O 0 7.981176395333023e-07
- O 0 3.741311704885675e-09
mRNA O 0 4.913466335187966e-12
splicing O 0 4.613538717723742e-12
of O 0 2.126081327321911e-14
a O 0 2.6327881931867414e-13
mutation O 0 1.896316220370564e-12
at O 0 2.922542850086751e-12
the O 0 5.471347658790593e-13
- O 0 3.928244041162543e-07
2 O 0 1.759636707177048e-11
position O 0 5.068813146991147e-10
of O 0 8.46445987303171e-14
a O 0 1.3017135112869394e-11
5 O 0 1.1549250271414291e-11
splice O 0 2.829629863754235e-07
site O 0 1.7238834288946236e-06
. O 0 3.556324124076582e-09

ATM O 0 2.547891199355945e-05
germline O 0 2.354618573008338e-06
mutations O 0 8.942153328916902e-08
in O 0 1.206559990807321e-10
classical O 0 0.0007021893979981542
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9576433300971985
in O 0 1.720729114751407e-10
the O 0 6.293022353220934e-11
Dutch O 0 2.1483535306288104e-07
population O 0 1.7535943808155707e-09
. O 0 1.8373514931724344e-09

Germline O 0 2.419578959234059e-05
mutations O 0 5.393463879954652e-07
in O 0 1.2546185444717306e-11
the O 0 3.296801416932671e-12
ATM O 0 1.2497959112067747e-08
gene O 0 6.969784194232886e-10
are O 0 1.0882818084201329e-12
responsible O 0 1.3658588149390027e-10
for O 0 2.1026460086948084e-11
the O 0 1.0552566891419701e-06
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.7879486680030823
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 4.449285828656002e-09
. O 0 1.5740240222328339e-09

In O 0 1.762607948485595e-09
our O 0 1.3080483918237462e-10
study O 0 1.258935121949134e-12
, O 0 9.561046615882973e-13
we O 0 4.727514820584977e-12
have O 0 1.1775522505870495e-13
determined O 0 4.231933380116626e-12
the O 0 2.2441476574177471e-13
ATM O 0 3.849008667344833e-09
mutation O 0 5.260143362550984e-11
spectrum O 0 9.906830217287776e-11
in O 0 5.145547182783261e-12
19 O 0 1.624483603190896e-10
classical O 0 1.0675135442284045e-08
A B-Disease 1 0.9999994039535522
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
patients O 0 1.4695161532074508e-08
, O 0 3.9697880941692854e-13
including O 0 1.306921693262908e-13
some O 0 3.1197996117927895e-13
immigrant O 0 1.1932996257790762e-10
populations O 0 6.569606664230676e-11
, O 0 1.9941570096604355e-12
as O 0 2.0283594682340977e-12
well O 0 1.5089488686337305e-11
as O 0 9.330293482268104e-12
12 O 0 2.661157752492649e-12
of O 0 4.747889364650759e-13
Dutch O 0 1.032617618079712e-07
ethnic O 0 1.6177500450353932e-09
origin O 0 1.2506918833921077e-09
. O 0 9.153591218336032e-10

Both O 0 2.7654226131268445e-10
the O 0 6.488642631009844e-13
protein O 0 1.025291396922201e-11
truncation O 0 3.4375056134905435e-09
test O 0 4.2263095245687055e-09
( O 0 9.895848246746497e-13
PTT O 0 7.151731429289043e-10
) O 0 3.0816771660543973e-13
and O 0 1.300270519510524e-13
the O 0 3.448128487923939e-14
restriction O 0 7.829657061586559e-11
endonuclease O 0 1.1476249284214646e-07
fingerprinting O 0 2.072547466980268e-08
( O 0 7.694134392111085e-12
REF O 0 8.750880908792169e-09
) O 0 1.126499338689052e-13
method O 0 3.212833916011598e-13
were O 0 1.6533962512912254e-13
used O 0 9.419604853067032e-13
and O 0 2.0050265701204717e-12
compared O 0 1.0003396548607935e-11
for O 0 1.1995596573347034e-13
their O 0 9.863054925736414e-14
detection O 0 6.892295761895539e-12
efficiency O 0 1.0321667132107137e-11
, O 0 3.350205312821486e-13
identifying O 0 6.580329336980384e-11
76 O 0 1.102147054177216e-10
% O 0 1.430890453867073e-12
and O 0 3.702441478403706e-11
60 O 0 5.806525260609874e-10
% O 0 1.1083162382644063e-12
of O 0 9.683288106901097e-14
the O 0 9.264396541586173e-12
mutations O 0 4.364594019534707e-09
, O 0 1.2919734726501986e-10
respectively O 0 1.475649602511453e-09
. O 0 3.1501337094397286e-09

Most O 0 2.1336510336311676e-09
patients O 0 1.936326432527835e-09
were O 0 9.576802025013098e-12
found O 0 9.080286869633802e-12
to O 0 1.1066221723698977e-12
be O 0 2.4382097035813288e-11
compound O 0 1.1943394895297388e-07
heterozygote O 0 1.0545554687269032e-06
. O 0 9.024926583833803e-09

Seventeen O 0 3.673221016242678e-08
mutations O 0 6.321180734403242e-08
were O 0 9.344082452233948e-11
distinct O 0 1.752442461977477e-11
, O 0 1.508223754220772e-11
of O 0 1.3726469776358802e-13
which O 0 7.799388912488325e-10
10 O 0 5.2418947654730985e-11
were O 0 1.1719479553473633e-10
not O 0 5.355939580731217e-10
reported O 0 1.2085049547749804e-06
previously O 0 7.954101377549705e-09
. O 0 1.0891284540903712e-09

Mutations O 0 4.069066505962837e-07
are O 0 1.1828478301001422e-11
small O 0 3.427727199301067e-11
deletions O 0 5.0022592290588364e-08
or O 0 1.2401597970779221e-08
point O 0 5.2894555402360766e-09
mutations O 0 1.618746949816341e-07
frequently O 0 4.4084855765902375e-09
affecting O 0 6.268374708184865e-09
splice O 0 2.7072734155808575e-05
sites O 0 1.647250246605836e-05
. O 0 2.281951516636127e-08

Moreover O 0 6.922505946249657e-08
, O 0 1.1881554073944756e-10
a O 0 1.1141332301178863e-10
16 O 0 7.040544813818883e-10
. O 0 1.556157869231356e-09

7 O 0 2.5047597773664165e-07
- O 0 3.7545783015957568e-06
kb O 0 1.1961900554524618e-06
genomic O 0 2.150612132822971e-08
deletion O 0 4.235608130898072e-08
of O 0 8.986882418793307e-12
the O 0 4.250620688761586e-12
3 O 0 7.555411157822434e-12
end O 0 1.359535123368616e-10
of O 0 3.860321486299015e-14
the O 0 3.052239857343972e-14
gene O 0 1.5589874877153242e-11
, O 0 3.521487572030746e-13
most O 0 6.255614787026992e-14
likely O 0 1.0249037946455375e-12
a O 0 4.277954672362444e-13
result O 0 7.045329489079044e-13
of O 0 1.9926871906565148e-14
recombination O 0 2.0138707368388964e-10
between O 0 8.574040089026624e-11
two O 0 3.1846622561282345e-11
LINE O 0 8.611302746430738e-07
elements O 0 1.5853679480315463e-09
, O 0 9.668814360264122e-11
was O 0 3.3095457485643465e-09
identified O 0 1.0732770228116806e-08
. O 0 4.5130960080186355e-10

The O 0 1.1074762634732949e-10
most O 0 1.546893863002552e-11
frequently O 0 4.4739456583897663e-10
found O 0 6.417014922904807e-12
mutation O 0 7.374526683756599e-11
, O 0 1.7661355234191434e-12
identified O 0 5.68481928198139e-10
in O 0 1.2747958071102072e-12
three O 0 2.9587769734273905e-11
unrelated O 0 6.285497988756106e-08
Turkish O 0 0.00016663133283145726
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999996423721313
T I-Disease 1 1.0
individuals O 0 2.809632082545477e-09
, O 0 2.5361350172725672e-11
was O 0 7.103944099640103e-10
previously O 0 4.0055261885107996e-10
described O 0 3.1744634698682717e-10
to O 0 7.924863022756856e-12
be O 0 3.108398607953866e-11
a O 0 1.6031129201898864e-10
Turkish O 0 2.8511096843431005e-06
A B-Disease 1 0.9999995231628418
- I-Disease 1 0.9999990463256836
T I-Disease 1 0.9999998807907104
founder O 0 2.411348418718262e-07
mutation O 0 1.8087117581444545e-08
. O 0 1.0090425162090355e-09

The O 0 1.5617114546007116e-10
presence O 0 1.5336369951768347e-09
of O 0 7.064397352686547e-13
a O 0 1.284620760461097e-11
founder O 0 1.2286038852948877e-09
mutation O 0 4.701872780010774e-10
among O 0 7.532127048806569e-13
relatively O 0 3.3465474315319543e-12
small O 0 1.2604782669012327e-11
ethnic O 0 3.5407465154291273e-11
population O 0 1.3190588378508838e-11
groups O 0 3.721172675552609e-12
in O 0 5.292745408613797e-13
Western O 0 1.8899258893978477e-11
Europe O 0 1.2388960690667972e-10
could O 0 2.6613114489926204e-11
indicate O 0 5.3402480354458604e-11
a O 0 2.6056676347835372e-12
high O 0 4.466491065890921e-11
carrier O 0 1.6107723488367753e-10
frequency O 0 1.4474495213523397e-10
in O 0 9.4111459077173e-13
such O 0 1.892162294903077e-11
communities O 0 7.235164134478111e-10
. O 0 1.3884832172905703e-09

In O 0 1.3886420902053942e-09
patients O 0 2.6163402111478717e-08
of O 0 2.3687163341890027e-12
Dutch O 0 5.288359261612641e-07
ethnic O 0 8.917482863246562e-10
origin O 0 7.515029570859255e-11
, O 0 8.228036307844633e-12
however O 0 1.611993958455793e-12
, O 0 7.637647567344807e-13
no O 0 4.174038718829376e-12
significant O 0 3.396649064443813e-12
founder O 0 5.312110751276578e-10
effect O 0 5.997978780314384e-10
could O 0 1.4555620042600026e-09
be O 0 1.5626828997472586e-10
identified O 0 1.181803277461313e-08
. O 0 9.952003665603115e-10

The O 0 8.304904680622727e-11
observed O 0 7.305134830382087e-10
genetic O 0 1.1768136465306611e-09
heterogeneity O 0 7.867054230281667e-10
including O 0 4.4183299380273766e-11
the O 0 1.6416455000944907e-11
relative O 0 4.2569552327620386e-09
high O 0 2.50502774079564e-09
percentage O 0 1.4912199253203084e-09
of O 0 2.065542615420357e-12
splice O 0 5.289217006065883e-05
- O 0 1.5778113038322772e-06
site O 0 1.0923495210590772e-06
mutations O 0 5.3937117883151586e-08
had O 0 3.4540614812783588e-09
no O 0 7.006755592398051e-11
reflection O 0 6.970232724334835e-11
on O 0 1.1838008351361395e-10
the O 0 4.1786452770198323e-11
phenotype O 0 7.062528339929486e-08
. O 0 1.527052040373178e-09

All O 0 2.1310043507583032e-08
patients O 0 6.7547829551983796e-09
manifested O 0 1.7510342065207851e-09
classical O 0 8.976398646609596e-08
A B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999992847442627
T I-Disease 1 1.0
and O 0 6.851383349548712e-10
increased O 0 1.7148742148531682e-10
cellular O 0 4.626827987408433e-08
radioresistant O 0 1.2118225356516632e-07
DNA O 0 5.927922153148302e-09
synthesis O 0 5.194960461807341e-09
. O 0 8.336203949355081e-10

Determination O 0 2.2808337973856396e-07
of O 0 3.591033503544394e-12
the O 0 6.683412503982744e-13
genomic O 0 9.013998436557813e-10
structure O 0 9.945779755327067e-10
of O 0 2.1855366366500817e-13
the O 0 8.282306589689481e-13
COL4A4 O 0 1.707812380402629e-08
gene O 0 9.207962725632513e-10
and O 0 2.7845746541910188e-12
of O 0 4.68044494220804e-13
novel O 0 4.7541817593810265e-08
mutations O 0 0.0007612025365233421
causing O 0 0.00011326926323818043
autosomal B-Disease 1 0.999998927116394
recessive I-Disease 1 0.9999998807907104
Alport I-Disease 1 1.0
syndrome I-Disease 1 0.9999998807907104
. O 0 1.937075830937829e-05

Autosomal B-Disease 1 0.9999990463256836
recessive I-Disease 1 0.9999996423721313
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 4.296233058198595e-08
a O 0 6.820160436404876e-09
progressive O 0 0.00022861563775222749
hematuric B-Disease 1 0.9999035596847534
glomerulonephritis I-Disease 1 1.0
characterized O 0 0.0010352545650675893
by O 0 2.1192132493297322e-08
glomerular B-Disease 1 0.9998321533203125
basement I-Disease 1 0.9320889711380005
membrane I-Disease 0 0.0005444140988402069
abnormalities I-Disease 1 0.9998526573181152
and O 0 9.418397173277526e-10
associated O 0 3.990216601579277e-09
with O 0 1.7077901592887912e-11
mutations O 0 6.984386402564269e-09
in O 0 6.9373096676927926e-12
either O 0 7.616503261420604e-11
the O 0 1.2584363238976604e-11
COL4A3 O 0 4.3646773519867565e-06
or O 0 3.6359321109458165e-10
the O 0 1.3751556317276314e-12
COL4A4 O 0 1.123339554709446e-08
gene O 0 2.9219213160125435e-10
, O 0 1.375837703314342e-12
which O 0 2.345566232561658e-13
encode O 0 3.882204020061453e-12
the O 0 1.0947690236989827e-12
alpha3 O 0 1.1477201411480564e-07
and O 0 3.8325825846285966e-10
alpha4 O 0 7.094146781128075e-07
type O 0 1.4686002032249235e-05
IV O 0 4.429907221492613e-06
collagen O 0 2.802203016472049e-05
chains O 0 3.5550932807382196e-05
, O 0 1.3718018943009724e-09
respectively O 0 1.773412638961247e-09
. O 0 4.982279921961208e-09

To O 0 1.397932047897399e-10
date O 0 7.847407168526388e-10
, O 0 2.643149371248099e-12
mutation O 0 6.391790742521497e-12
screening O 0 6.984578887481163e-11
in O 0 4.058630601738722e-13
the O 0 2.1188441084139809e-13
two O 0 2.559350843235608e-13
genes O 0 5.4205799571160895e-11
has O 0 1.4270924719728129e-10
been O 0 1.222077855578263e-10
hampered O 0 3.2284803719306865e-09
by O 0 1.4062260470654175e-12
the O 0 1.3384179832140464e-12
lack O 0 3.81689428327614e-12
of O 0 2.578384723881267e-14
genomic O 0 2.163282442069203e-09
structure O 0 4.252769869594886e-08
information O 0 2.36605259829048e-08
. O 0 1.7596217816162607e-09

We O 0 4.263848651930857e-08
report O 0 3.917920987639434e-10
here O 0 4.2268753601415465e-12
the O 0 9.981672572636959e-15
complete O 0 1.931852464456818e-12
characterization O 0 3.65093066889699e-09
of O 0 4.035195842830991e-13
the O 0 6.839947445241856e-13
48 O 0 2.064783413691096e-11
exons O 0 3.504412038335403e-11
of O 0 1.322685450749761e-13
the O 0 1.0338409815735528e-12
COL4A4 O 0 2.8729504109037407e-08
gene O 0 1.3612068139323696e-09
, O 0 2.0940003203628876e-12
a O 0 4.936478201038319e-13
comprehensive O 0 6.123535706281658e-11
gene O 0 6.443221955976242e-09
screen O 0 5.333412445907015e-06
, O 0 1.530621185352743e-09
and O 0 4.4076315514063324e-11
the O 0 3.067169727834912e-13
subsequent O 0 1.8630900641691817e-11
detection O 0 9.565894742991077e-10
of O 0 4.0620379781163007e-13
10 O 0 2.752553393547963e-12
novel O 0 2.9732934864190597e-11
mutations O 0 6.66106225732932e-10
in O 0 1.2454456953595039e-12
eight O 0 3.511043955573001e-10
patients O 0 1.4679922166749293e-08
diagnosed O 0 8.666609937790781e-05
with O 0 3.8784708067396423e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 0.9999998807907104
. O 0 1.5203243492578622e-05

Furthermore O 0 3.079798815974755e-08
, O 0 1.7676032859625934e-10
we O 0 1.5824329693825412e-11
identified O 0 2.5481453752584926e-11
a O 0 1.6002601804440686e-13
glycine O 0 1.1308302211299193e-10
to O 0 5.230584303357599e-13
alanine O 0 4.5111422930510514e-10
substitution O 0 1.253853011001782e-11
in O 0 7.236008667255156e-13
the O 0 3.3850637679196105e-13
collagenous O 0 5.6165163186960854e-08
domain O 0 1.1296020785422911e-09
that O 0 1.8225575562635932e-11
is O 0 4.432561262479595e-11
apparently O 0 3.3869953508514072e-09
silent O 0 8.729546152608236e-08
in O 0 2.342075752087558e-12
the O 0 2.5340109784804943e-12
heterozygous O 0 9.902248798709934e-09
carriers O 0 4.5708611895456386e-10
, O 0 1.1456619507244081e-11
in O 0 8.753104144276769e-12
11 O 0 6.400910357307055e-10
. O 0 8.348392532830928e-10

5 O 0 2.3889514810804258e-09
% O 0 3.93951503363521e-11
of O 0 1.3179240684890736e-12
all O 0 2.156717165968658e-11
control O 0 2.5595579700166127e-07
individuals O 0 1.5028718547416275e-10
, O 0 4.24870971738045e-11
and O 0 7.810073421321562e-11
in O 0 3.5201665801037896e-12
one O 0 1.814718340875654e-11
control O 0 2.2653077635936825e-08
individual O 0 3.2088914858618978e-12
homozygous O 0 5.802160488177499e-11
for O 0 8.383576358085218e-14
this O 0 1.8582650609250129e-13
glycine O 0 4.312393775407486e-10
substitution O 0 2.522974607011008e-10
. O 0 3.9501635296090853e-10

There O 0 3.5247289531525894e-08
has O 0 2.672285726035284e-09
been O 0 3.1386890309015314e-10
no O 0 2.0259025013125154e-10
previous O 0 8.178582117102096e-11
finding O 0 7.0402290767990205e-12
of O 0 9.591630841085299e-15
a O 0 2.0708589465630312e-13
glycine O 0 1.457922324532568e-11
substitution O 0 1.0998967578737529e-12
that O 0 2.6599385129395803e-13
is O 0 1.9438935866793877e-13
not O 0 6.041493667103756e-14
associated O 0 2.089336516297724e-12
with O 0 7.376643783654768e-13
any O 0 6.115344897139607e-10
obvious O 0 2.851521241353794e-09
phenotype O 0 1.321485942895606e-08
in O 0 8.783609256601821e-12
homozygous O 0 1.3573891521900805e-07
individuals O 0 1.162903773277435e-09
. O 0 2.3938089288577657e-09

Founder O 0 2.7229256374994293e-05
BRCA1 O 0 7.675359665881842e-05
and O 0 7.836282733819644e-09
BRCA2 O 0 1.9556557617761428e-06
mutations O 0 4.682489951335356e-09
in O 0 1.7233591290133354e-11
French O 0 7.26778409898543e-07
Canadian O 0 4.828638702747412e-05
breast B-Disease 1 0.9999996423721313
and I-Disease 1 0.9999990463256836
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 3.074323444707261e-07
. O 0 8.312376564845181e-09

We O 0 8.065045165039919e-08
have O 0 5.124276697410224e-11
identified O 0 1.7504724059147492e-10
four O 0 1.7116233289645594e-13
mutations O 0 3.2404950250919384e-11
in O 0 7.870295398466204e-14
each O 0 2.8862234325612024e-13
of O 0 2.7814041217780194e-13
the O 0 2.24089191647181e-10
breast B-Disease 0 0.16916243731975555
cancer I-Disease 0 7.552346505690366e-05
- O 0 0.002125559840351343
susceptibility O 0 3.331427797093056e-05
genes O 0 3.306216740384116e-07
, O 0 4.964614275237977e-10
BRCA1 O 0 2.031686250347775e-07
and O 0 6.434585086978473e-10
BRCA2 O 0 3.722983166198901e-08
, O 0 1.9916263083175068e-11
in O 0 6.695192143746365e-12
French O 0 4.788061502836172e-08
Canadian O 0 1.8424819359097455e-07
breast B-Disease 1 0.990477442741394
cancer I-Disease 1 0.9190693497657776
and O 0 0.0005612748791463673
breast B-Disease 1 0.9999997615814209
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.9364311754088703e-07
from O 0 2.764679041256102e-10
Quebec O 0 5.265908953333565e-07
. O 0 5.671287439668049e-08

To O 0 1.2397192161728299e-09
identify O 0 4.845801981900877e-09
founder O 0 8.54950421569356e-09
effects O 0 2.2205819405485272e-08
, O 0 2.0959443902679453e-10
we O 0 4.1078024315410744e-10
examined O 0 2.1631473501315668e-08
independently O 0 1.0619312718063156e-07
ascertained O 0 1.6329029222106328e-06
French O 0 5.939083891348673e-08
Canadian O 0 4.834926681240859e-09
cancer B-Disease 0 2.9192514716669393e-07
families O 0 2.2021886050827e-11
for O 0 1.8990298428830238e-13
the O 0 1.9072154337600178e-13
distribution O 0 3.6407482584266404e-10
of O 0 4.1835691811861753e-13
these O 0 6.47062655192987e-12
eight O 0 2.7271051736277307e-11
mutations O 0 8.106419535636178e-09
. O 0 8.730853262584048e-10

Mutations O 0 2.279950876982184e-07
were O 0 1.9784932026034596e-10
found O 0 2.1315947271172142e-11
in O 0 5.058278015196427e-13
41 O 0 1.5005632847397976e-10
of O 0 1.3191740451737322e-12
97 O 0 2.386862263392686e-08
families O 0 9.029559322470959e-09
. O 0 4.330430236620941e-09

Six O 0 8.104580118128979e-09
of O 0 3.611489145932678e-12
eight O 0 2.4828444855629073e-11
mutations O 0 5.229375266146974e-10
were O 0 3.4221354916486035e-11
observed O 0 1.7623995596238728e-09
at O 0 2.0709263193197103e-09
least O 0 3.870193610033823e-10
twice O 0 1.0636127534269235e-09
. O 0 1.4004386539312463e-09

The O 0 9.041997151015835e-10
BRCA1 O 0 9.402661476087815e-07
C4446T O 0 2.8296126330928928e-08
mutation O 0 3.911121204680512e-09
was O 0 2.050142833276425e-10
the O 0 1.7231240035091994e-13
most O 0 2.5558727226662747e-13
common O 0 1.5283695533122033e-12
mutation O 0 6.049066803015535e-11
found O 0 2.140847915610422e-11
, O 0 2.3848731149633817e-12
followed O 0 5.043781364788558e-12
by O 0 8.518868119603007e-13
the O 0 3.3522157272258823e-11
BRCA2 O 0 5.78923504690465e-07
8765delAG O 0 1.8599793349949323e-07
mutation O 0 3.871127773891203e-08
. O 0 3.978642304502955e-09

Together O 0 1.165335650199495e-08
, O 0 4.0242319893080136e-11
these O 0 3.3355149154853936e-13
mutations O 0 4.590753471811482e-11
were O 0 1.497463264499288e-11
found O 0 2.8399465071271557e-11
in O 0 9.805063662035596e-13
28 O 0 5.730757882127513e-11
of O 0 8.98452590537141e-14
41 O 0 9.682162849244946e-10
families O 0 1.15624749358334e-11
identified O 0 7.619457287333375e-10
to O 0 1.192823270712573e-11
have O 0 6.538068003658637e-11
a O 0 4.919441937145663e-11
mutation O 0 1.628524515240315e-08
. O 0 1.4956379468245018e-09

The O 0 2.1697812990773002e-10
odds O 0 7.439649785112579e-09
of O 0 2.0449962524152904e-13
detection O 0 1.829489476579127e-10
of O 0 4.2917749974551167e-13
any O 0 1.1651389575373372e-10
of O 0 6.136484007567e-13
the O 0 5.553484755393967e-12
four O 0 4.712572346243782e-11
BRCA1 O 0 2.408617305604821e-08
mutations O 0 1.4121170899272784e-09
was O 0 1.541567762330942e-08
18 O 0 1.655343417894528e-09
. O 0 2.40521424998974e-09

7x O 0 9.534223499940708e-05
greater O 0 4.19540446827682e-09
if O 0 5.518255852265952e-10
one O 0 2.3483784361566507e-12
or O 0 1.4179264533342728e-11
more O 0 7.105589554246006e-12
cases O 0 1.3334187975999612e-08
of O 0 1.635068883842905e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 6.799847795946334e-08
also O 0 6.395296514583038e-10
present O 0 1.2875797650302445e-10
in O 0 7.595377451985463e-12
the O 0 2.04149093463446e-11
family O 0 1.705419627739957e-08
. O 0 1.911319769121178e-09

The O 0 1.4194967423719618e-10
odds O 0 1.0567623220936184e-08
of O 0 2.219310211949363e-13
detection O 0 1.368098551113306e-10
of O 0 2.648840890552562e-13
any O 0 1.4719551966191347e-10
of O 0 6.194612422842638e-13
the O 0 2.6584297263543277e-11
four O 0 2.6929866669966884e-10
BRCA2 O 0 8.238275484018232e-08
mutations O 0 1.4858283492458213e-09
was O 0 5.987945694840846e-09
5 O 0 6.091364079807704e-10
. O 0 1.8520410760558548e-09

3x O 0 6.609208412555745e-06
greater O 0 5.813398651355328e-09
if O 0 9.48365275199592e-10
there O 0 4.909281314802172e-11
were O 0 7.088371556385198e-12
at O 0 1.3370790585831571e-11
least O 0 3.738730679214708e-12
five O 0 3.1797912285018437e-13
cases O 0 1.799353201159537e-11
of O 0 4.532622107505935e-12
breast B-Disease 0 0.006745762657374144
cancer I-Disease 0 1.8391483536106534e-05
in O 0 4.019637053764846e-11
the O 0 1.2007654592860462e-10
family O 0 3.39022932394073e-07
. O 0 1.216441969376092e-08

Interestingly O 0 3.174212537260246e-08
, O 0 2.1761295890265764e-11
the O 0 1.305974913715785e-13
presence O 0 4.144245016601822e-11
of O 0 2.528477102171911e-13
a O 0 6.230918003780062e-10
breast B-Disease 0 0.0020550612825900316
cancer I-Disease 0 3.4998497540073004e-06
case O 0 8.954877950273499e-10
< O 0 4.171731049495975e-08
36 O 0 9.204906836757232e-10
years O 0 3.1776241360415014e-11
of O 0 3.9909696099120484e-13
age O 0 2.3257142045540746e-10
was O 0 2.3135825200082394e-10
strongly O 0 1.5741884185072053e-10
predictive O 0 3.182091035114354e-09
of O 0 1.6971181946746905e-13
the O 0 3.361944782894616e-13
presence O 0 9.991217575500144e-11
of O 0 3.376704975745562e-14
any O 0 1.576976396688856e-11
of O 0 1.0801251657411443e-13
the O 0 8.778278668200579e-13
eight O 0 2.441290399002316e-11
mutations O 0 1.0950483853022774e-09
screened O 0 5.260652713445779e-08
. O 0 4.2173469161355115e-09

Carriers O 0 4.6345828508265186e-08
of O 0 5.239073931628813e-12
the O 0 6.963873379860208e-13
same O 0 6.415998808628753e-12
mutation O 0 8.250339994519962e-11
, O 0 9.020537680530516e-13
from O 0 3.810009762111183e-14
different O 0 5.517437093142952e-13
families O 0 1.1316798192995137e-11
, O 0 1.188251645516114e-12
shared O 0 1.555808325053032e-12
similar O 0 2.7074249960012953e-12
haplotypes O 0 3.912641044490073e-10
, O 0 4.1795360575247464e-12
indicating O 0 3.1825631019444245e-10
that O 0 8.083228097283124e-13
the O 0 6.954511836201882e-14
mutant O 0 3.725195707460216e-10
alleles O 0 2.6429742075451124e-11
were O 0 1.6305267899752174e-11
likely O 0 9.368204129112101e-12
to O 0 1.5148365417952392e-12
be O 0 3.7640907751823605e-11
identical O 0 1.5361019123361075e-09
by O 0 6.470700277677599e-12
descent O 0 1.1415978384832215e-08
for O 0 3.2811496575302357e-12
a O 0 2.0233410433223575e-11
mutation O 0 3.1603628047882637e-10
in O 0 2.4030371876399004e-12
the O 0 2.7690458433149434e-12
founder O 0 5.066021824262634e-09
population O 0 6.964880339133117e-10
. O 0 1.7823309494957584e-09

The O 0 2.765078270516863e-11
identification O 0 1.9958371066941538e-10
of O 0 3.457943295853e-13
common O 0 3.2105110236990697e-10
BRCA1 O 0 6.2934063862485345e-06
and O 0 1.885984923788442e-09
BRCA2 O 0 3.1834986202738946e-07
mutations O 0 1.7795149798160992e-09
will O 0 1.4800454264940477e-11
facilitate O 0 4.685400400994411e-10
carrier O 0 2.867158954700244e-08
detection O 0 2.9855486971541723e-09
in O 0 1.8994519498938267e-11
French O 0 1.1879588157626131e-07
Canadian O 0 1.5002734699010034e-07
breast B-Disease 1 0.9925861954689026
cancer I-Disease 1 0.9571947455406189
and O 0 0.00046158008626662195
breast B-Disease 1 0.9999995231628418
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 4.901816737401532e-06
. O 0 2.3044947283779038e-08

Are O 0 5.280363257753606e-09
Dp71 O 0 2.7589564979280112e-06
and O 0 3.0289455388299302e-09
Dp140 O 0 1.0758378721220652e-06
brain O 0 4.321571225318621e-07
dystrophin O 0 2.572525659161329e-07
isoforms O 0 2.083135886010723e-09
related O 0 6.564252696961148e-09
to O 0 1.1880421646459638e-10
cognitive B-Disease 0 2.3191589207272045e-05
impairment I-Disease 0 0.0001368637167615816
in O 0 9.984788107431086e-09
Duchenne B-Disease 1 0.9995482563972473
muscular I-Disease 1 0.9862939715385437
dystrophy I-Disease 1 0.9991984963417053
? O 0 0.0011192881502211094

Molecular O 0 1.5809089148888233e-08
study O 0 2.082706090922315e-10
and O 0 1.4627968975000627e-11
neuropsychological O 0 3.6335077169269425e-09
analysis O 0 6.30928295719535e-11
were O 0 4.022183280882885e-11
performed O 0 3.847685781099841e-10
concurrently O 0 8.172078985735354e-11
on O 0 8.069607759786379e-10
49 O 0 4.804042319506152e-08
patients O 0 8.843665799673772e-10
with O 0 1.321814879773342e-10
Duchenne B-Disease 0 0.007344003766775131
muscular I-Disease 0 0.009901512414216995
dystrophy I-Disease 1 0.6998435854911804
( O 0 9.689764368658871e-08
DMD B-Disease 1 1.0
) O 0 4.230365835411476e-09
in O 0 1.5289448526689675e-11
order O 0 7.025178615921446e-12
to O 0 6.395921119117798e-13
find O 0 5.276589928882025e-12
a O 0 1.731667245577842e-13
molecular O 0 4.120007720403995e-12
explanation O 0 7.048034898760047e-12
for O 0 3.3194451419353566e-13
the O 0 2.7322582130812068e-12
cognitive B-Disease 0 2.1807331052059453e-07
impairment I-Disease 0 2.9678247415176884e-08
observed O 0 7.787704370265658e-10
in O 0 1.5637286604475165e-11
most O 0 4.9082000685984895e-09
DMD B-Disease 1 0.9999998807907104
patients O 0 1.7040823649949743e-06
. O 0 3.756735811322187e-09

Complete O 0 2.312061875286986e-09
analysis O 0 2.8932831130923375e-10
of O 0 4.560508871584434e-13
the O 0 4.551158712048919e-13
dystrophin O 0 5.8489337817491105e-09
gene O 0 1.8318613292933605e-09
was O 0 2.2979350366991724e-10
performed O 0 1.4983295160142518e-10
to O 0 4.722339598355052e-13
define O 0 1.491270440467929e-10
the O 0 1.256164768557999e-12
localization O 0 1.8264152412683643e-09
of O 0 1.8860959885916295e-13
deletions O 0 6.699507171248342e-09
and O 0 2.40702124898462e-10
duplications O 0 1.12171667510097e-08
in O 0 5.414728561359272e-12
relation O 0 1.8088031072949207e-10
to O 0 3.5716885178616042e-12
the O 0 2.164067102600198e-12
different O 0 4.931431929477981e-10
DMD B-Disease 1 0.9999924898147583
promoters O 0 6.334251452244644e-07
. O 0 1.2143787309071286e-08

Qualitative O 0 4.1570050512973467e-08
analysis O 0 3.498429879122966e-10
of O 0 4.3020114922666386e-13
the O 0 8.72388153470155e-13
Dp71 O 0 1.5848154788500324e-08
transcript O 0 4.205861969808211e-08
and O 0 1.7755396111707178e-11
testing O 0 4.539701947692265e-11
for O 0 8.777231532189865e-15
the O 0 4.602641510108307e-15
specific O 0 2.1969171002788473e-13
first O 0 1.545452947473297e-13
exon O 0 1.4788687635602926e-11
of O 0 9.28625882787304e-13
Dp140 O 0 5.666829228090364e-09
were O 0 6.857253098679905e-10
also O 0 3.2437613706193247e-10
carried O 0 2.593000658634992e-08
out O 0 1.0158438534801917e-09
. O 0 4.163062949924523e-10

Neuropsychological O 0 3.226329499739222e-05
analysis O 0 3.396429093527331e-08
assessed O 0 4.691513026955363e-07
verbal O 0 1.4859311704640277e-05
and O 0 4.429666855543246e-09
visuospatial O 0 0.00018413395446259528
intelligence O 0 1.2971692342489405e-07
, O 0 9.010556190069963e-11
verbal O 0 9.644993781421363e-08
memory O 0 7.436481155309593e-07
, O 0 1.2179962594061067e-10
and O 0 2.0464001326825354e-10
reading O 0 9.456405081209596e-08
skills O 0 4.906031136897582e-08
. O 0 1.532794779990354e-09

Comparison O 0 6.932769469614186e-09
of O 0 2.09414798869878e-12
molecular O 0 4.95879393103138e-10
and O 0 3.968588305203191e-11
psychometric O 0 1.692297018962563e-06
findings O 0 3.1248548193474335e-10
demonstrated O 0 3.9346487873404e-11
that O 0 2.787474569741766e-13
deletions O 0 5.458972163197018e-10
and O 0 7.029172816724882e-12
duplications O 0 1.056713383462693e-09
that O 0 2.088297763880309e-11
were O 0 5.7580147247437985e-12
localized O 0 1.4900968237085976e-09
in O 0 5.657079839294088e-12
the O 0 3.2274148089282695e-13
distal O 0 2.0161902369864038e-08
part O 0 8.288687514124149e-10
of O 0 3.8292302271744627e-13
the O 0 1.2898343959739933e-13
gene O 0 2.2270778277100334e-10
seemed O 0 3.168612247583802e-11
to O 0 2.220368664320252e-13
be O 0 1.163197034352581e-12
preferentially O 0 4.0373115961500616e-10
associated O 0 1.950404060480082e-09
with O 0 2.857301895087261e-10
cognitive B-Disease 0 1.7754053260432556e-05
impairment I-Disease 0 2.1961321181152016e-05
. O 0 1.5489865390350133e-08

Two O 0 3.7348998893627083e-10
altered O 0 2.3534365567456916e-08
Dp71 O 0 7.177482643783151e-07
transcripts O 0 5.692354676511968e-08
and O 0 8.39756042481099e-11
two O 0 8.563130131193641e-13
deleted O 0 3.323094688312267e-09
Dp140 O 0 1.2667096260798871e-09
DNA O 0 4.536127376497667e-11
sequences O 0 1.1875068636757469e-11
were O 0 1.0663920918183023e-12
found O 0 7.347323704304243e-13
in O 0 9.47508130982877e-14
four O 0 3.0139974717402485e-12
patients O 0 4.351066382191071e-11
with O 0 7.219390363299993e-11
severe O 0 0.00017322869098279625
cerebral B-Disease 1 0.9930758476257324
dysfunction I-Disease 0 0.47729915380477905
. O 0 2.74130314892318e-07

These O 0 1.1504339147982989e-10
findings O 0 2.1150912618561613e-11
suggest O 0 8.94670795781316e-12
that O 0 1.2621682670375944e-13
some O 0 2.2353506103967892e-14
sequences O 0 1.3155212162663243e-11
located O 0 6.353605974673826e-10
in O 0 5.25103615103828e-13
the O 0 6.917984387384488e-14
distal O 0 6.3134790728724965e-09
part O 0 8.931628214803311e-10
of O 0 4.3334292317703804e-13
the O 0 1.8930266154539716e-13
gene O 0 1.7585237432893308e-10
and O 0 1.0920312397411092e-11
, O 0 2.2865902422376794e-13
in O 0 1.0174118458253136e-14
particular O 0 1.8044456987637014e-12
, O 0 6.153326546215476e-13
some O 0 7.011698513470499e-12
DMD B-Disease 1 0.9999827146530151
isoforms O 0 7.206623492406194e-11
expressed O 0 2.6054601184877235e-11
in O 0 2.0643165996037105e-13
the O 0 8.925534465166474e-13
brain O 0 4.4142601041130547e-07
may O 0 1.979171514177036e-11
be O 0 1.0420170585764832e-12
related O 0 1.6243474620925014e-10
to O 0 5.711178925615901e-12
the O 0 4.046568288784691e-11
cognitive B-Disease 0 5.481939751916798e-06
impairment I-Disease 0 3.2132211345015094e-06
associated O 0 1.2255810588612803e-07
with O 0 4.714989287890603e-08
DMD B-Disease 1 0.9999998807907104
. O 0 2.5820639848461724e-08
. O 0 1.734957955079608e-08

I1307K O 0 7.083849141054088e-06
APC O 0 1.099773157875461e-06
and O 0 1.4250144120264707e-10
hMLH1 O 0 2.890814876366221e-08
mutations O 0 1.6975361116777776e-09
in O 0 2.9584032706225782e-12
a O 0 4.9884936459410056e-11
non O 0 5.053292895240702e-09
- O 0 1.6721445206258068e-07
Jewish O 0 4.8047548162344356e-09
family O 0 1.893963208488003e-08
with O 0 1.745897454386025e-10
hereditary B-Disease 1 0.9918701648712158
non I-Disease 1 0.9993258714675903
- I-Disease 1 0.9999996423721313
polyposis I-Disease 1 0.9999997615814209
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 9.570023848937126e-07

We O 0 1.5989522594850314e-08
describe O 0 1.3624751993290829e-08
a O 0 1.5539897146865655e-09
French O 0 7.335831497812251e-08
Canadian O 0 8.13262701626627e-08
hereditary B-Disease 1 0.9997283816337585
non I-Disease 1 0.9997678399085999
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 8.826214070722926e-07
HNPCC B-Disease 0 0.019592000171542168
) O 0 4.938738307203039e-09
kindred O 0 2.9068834805912047e-07
which O 0 3.951362015364168e-10
carries O 0 1.422755580016144e-09
a O 0 2.2815520306362913e-11
novel O 0 9.437404191459109e-10
truncating O 0 2.9219700081739575e-07
mutation O 0 2.0625311236699417e-08
in O 0 5.018325685557379e-11
hMLH1 O 0 1.4072962812861078e-06
. O 0 4.0874055251549635e-09

Interestingly O 0 7.349717066063022e-07
, O 0 4.729070468556529e-10
the O 0 6.94302818363135e-12
I1307K O 0 2.055407222201211e-08
APC O 0 5.1432982317578535e-09
polymorphism O 0 9.296657887958304e-10
, O 0 1.0256800834010371e-12
associated O 0 2.0461689634321267e-11
with O 0 6.788932480419896e-13
an O 0 2.749106064320328e-12
increased O 0 2.845723656719201e-07
risk O 0 0.03233766183257103
of O 0 1.0786203347379342e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 1.1976170277705478e-08
is O 0 3.2906416480571465e-10
also O 0 9.256170829807786e-11
present O 0 1.975984306734624e-11
in O 0 1.7609387255659859e-12
this O 0 2.136393492668809e-11
family O 0 1.6955047144051605e-08
. O 0 1.5558343502419802e-09

The O 0 2.565307133384209e-10
I1307K O 0 2.702889823069654e-08
polymorphism O 0 4.626810223840039e-08
has O 0 1.97023952708264e-09
previously O 0 2.0373881748358968e-10
only O 0 4.379564419454418e-12
been O 0 2.408553911870115e-11
identified O 0 4.2087067164686687e-10
in O 0 5.02990607064574e-13
individuals O 0 3.0366054722813507e-12
of O 0 1.3454232302909097e-12
self O 0 0.0011537782847881317
- O 0 0.049612294882535934
reported O 0 0.01470467634499073
Ashkenazi O 0 1.1443090386364929e-07
Jewish O 0 1.392368442765246e-09
origins O 0 1.689596906828683e-08
. O 0 1.2791843140291803e-09

In O 0 6.490555315430413e-11
addition O 0 2.169747020941415e-11
, O 0 2.5193029086489904e-12
in O 0 3.9722399496197255e-14
this O 0 4.178521135871083e-13
family O 0 2.9176555615961774e-10
, O 0 3.613680101682837e-12
there O 0 4.783332584190614e-12
appears O 0 1.3166012724497023e-10
to O 0 5.149052191566472e-12
be O 0 8.97645360820043e-11
no O 0 2.482391237013104e-10
relationship O 0 7.581992672589521e-11
between O 0 6.465145801527739e-13
the O 0 1.6967492948855023e-13
I1307K O 0 6.910850780528222e-10
polymorphism O 0 7.580565064557732e-10
and O 0 1.2094902336612368e-11
the O 0 2.7275810733293215e-13
presence O 0 7.030869220159275e-10
or O 0 3.0387695137967796e-10
absence O 0 6.490716297768984e-11
of O 0 1.1613592032500009e-12
cancer B-Disease 0 1.4210801424496822e-08
. O 0 2.2877748306893153e-11
. O 0 1.1880902928140813e-09

Identification O 0 3.669824977237113e-08
of O 0 9.61063607168855e-12
a O 0 5.1511173798646226e-11
novel O 0 7.532569568091674e-10
mutation O 0 2.608864013708967e-09
of O 0 4.329232014110146e-13
the O 0 1.1232879860642586e-12
CPO O 0 5.369517452891159e-07
gene O 0 1.1070354632991553e-09
in O 0 3.826684195212815e-12
a O 0 2.3230807555396638e-10
Japanese O 0 1.8560953662927204e-07
hereditary B-Disease 0 8.871395402820781e-05
coproporphyria I-Disease 0 0.0006180960917845368
family O 0 4.7414218897756655e-06
. O 0 1.9463767486627148e-08

Hereditary B-Disease 1 0.9735861420631409
coproporphyria I-Disease 0 0.0010950706200674176
( O 0 3.2045781583889266e-09
HCP B-Disease 0 2.743954064499121e-05
) O 0 1.2297590723520102e-10
is O 0 1.2270785776369308e-10
an O 0 8.046472516065606e-11
autosomal B-Disease 1 0.9999985694885254
dominant I-Disease 1 0.9998989105224609
disease I-Disease 1 0.9998840093612671
characterized O 0 8.638703548058402e-06
by O 0 9.034498149596004e-10
a O 0 3.241297577005753e-07
deficiency B-Disease 1 0.9976988434791565
of I-Disease 0 2.89184162727274e-11
coproporphyrinogen I-Disease 0 0.000157461196067743
oxidase I-Disease 0 2.518744076951407e-05
( O 0 8.782005678220628e-11
CPO O 0 1.905563976833946e-06
) O 0 8.772173959448182e-12
caused O 0 4.689770100041457e-11
by O 0 3.292670769285827e-13
a O 0 5.314618536922389e-12
mutation O 0 1.8020192282808267e-10
in O 0 1.7028971548843641e-12
the O 0 1.0102509107046131e-11
CPO O 0 9.618513104214799e-06
gene O 0 5.3633360863614143e-08
. O 0 2.049459713049373e-09

Only O 0 3.384922342419827e-09
11 O 0 1.7292670073665306e-10
mutations O 0 5.295752170120238e-10
of O 0 1.652267596829668e-13
the O 0 2.3833487809189757e-13
gene O 0 1.6924280865637797e-09
have O 0 3.7647440720434133e-11
been O 0 1.4262352410199242e-10
reported O 0 1.9972847553617612e-07
in O 0 3.20861184843757e-11
HCP B-Disease 0 0.0006797644309699535
patients O 0 1.5616206994195636e-08
. O 0 1.2392132875405082e-09

We O 0 1.599788213013653e-08
report O 0 2.2243480668482363e-10
another O 0 4.285903663220347e-12
mutation O 0 1.0642799141979964e-10
in O 0 7.560107596372989e-13
a O 0 1.0315590742715486e-10
Japanese O 0 5.7164655231645156e-08
family O 0 1.5949803255921324e-08
. O 0 1.137756222568953e-09

Polymerase O 0 4.915359568258282e-06
chain O 0 2.1575860955636017e-06
reaction O 0 4.729063807218381e-09
- O 0 1.5763202299012846e-08
single O 0 1.843788142996683e-11
strand O 0 4.062354341805019e-10
conformational O 0 8.977579964153382e-12
polymorphism O 0 4.1114786575313644e-10
and O 0 1.5828971163325822e-12
direct O 0 9.433238044864733e-12
sequence O 0 4.959551103134174e-10
analyses O 0 2.5467195019501787e-09
demonstrated O 0 2.6741135347729816e-11
a O 0 1.0443650068012178e-12
C O 0 1.5524513619080693e-10
to O 0 7.457307341085517e-13
T O 0 1.3354338745941163e-09
substitution O 0 4.3362649625525163e-13
in O 0 7.863752915981612e-14
exon O 0 6.728903545472065e-11
1 O 0 1.0591393213854605e-12
of O 0 4.0360560894922223e-14
the O 0 1.0109843057116638e-13
CPO O 0 1.7621518466626185e-08
gene O 0 4.692543922879544e-11
at O 0 1.9688202890916218e-12
nucleotide O 0 3.9705492366204354e-11
position O 0 6.491050058565762e-11
85 O 0 3.639809287303564e-11
, O 0 2.3688518594605634e-12
which O 0 2.199246167122748e-11
lies O 0 2.8149225173024206e-08
in O 0 1.6023195140504876e-12
the O 0 6.965626534773117e-13
putative O 0 1.5520397467216895e-10
presequence O 0 2.7274045244496392e-09
for O 0 4.786131885779754e-13
targeting O 0 6.7201721964949e-10
to O 0 2.4174919011077378e-11
mitochondria O 0 3.84054610336193e-09
. O 0 1.4722675301115373e-09

This O 0 5.206472059038347e-11
mutation O 0 2.8782676242400385e-10
changes O 0 1.7822466592820607e-12
the O 0 3.9087619452997727e-14
codon O 0 1.3029952984633386e-11
for O 0 1.0797127284584672e-14
glutamine O 0 3.1015034290815535e-12
to O 0 7.76227091501061e-14
a O 0 1.2939599478706265e-12
termination O 0 1.4357225130989804e-10
codon O 0 1.132296256756149e-09
at O 0 7.102951560256088e-11
amino O 0 2.118345429624746e-11
acid O 0 7.759925514660981e-12
position O 0 1.0572229203198447e-10
29 O 0 6.578901867726472e-10
. O 0 2.3522495062877624e-10

MaeI O 0 3.1810998279979685e-06
restriction O 0 2.4207347237847898e-08
analysis O 0 1.962112916586989e-09
showed O 0 1.183459019671318e-08
two O 0 1.3387319681631982e-12
other O 0 3.218691589298994e-13
carriers O 0 2.0253913129986145e-11
in O 0 8.827422842173915e-13
the O 0 2.1691719601091286e-11
family O 0 7.804604251759883e-08
. O 0 4.077477910868765e-09

The O 0 2.8871711688083224e-09
C O 0 2.5314246158814058e-05
- O 0 0.07310549169778824
T O 0 0.00018760681268759072
mutation O 0 1.0776004533141759e-09
is O 0 5.633595586557183e-12
located O 0 1.8186657735341782e-10
within O 0 1.651499791956168e-12
a O 0 1.3844886175007343e-11
recently O 0 3.3514073738416528e-09
proposed O 0 1.3249094876766065e-10
putative O 0 3.1354518981174806e-10
alternative O 0 2.598254424113211e-11
translation O 0 1.0660698018805093e-10
initiation O 0 3.147710217477062e-11
codon O 0 6.414891950967672e-10
( O 0 5.743481645142934e-12
TIC O 0 1.2133882876241842e-07
- O 0 1.604325738924217e-08
1 O 0 8.54115768996605e-13
) O 0 1.6134881245747495e-13
, O 0 7.608563573017341e-14
supporting O 0 1.0659798564682799e-11
that O 0 2.6261592726839478e-12
TIC O 0 4.7502342681582377e-07
- O 0 9.990636762324812e-09
1 O 0 5.788668155926047e-13
is O 0 1.757690347437002e-12
the O 0 9.832982545603455e-14
real O 0 3.78378689491754e-10
TIC O 0 1.3717056823736584e-08
rather O 0 4.030044527258969e-12
than O 0 2.139340571014059e-12
TIC O 0 1.4640327172799061e-08
- O 0 3.453086483418133e-09
2 O 0 2.5171895817743817e-12
. O 0 1.2520218152164975e-12
. O 0 4.2226794977340276e-11

Human B-Disease 0 6.267958951866603e-08
complement I-Disease 0 4.634711103790323e-07
factor I-Disease 0 0.00011555756645975634
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999971389770508
associated O 0 0.0014616803964599967
with O 0 0.006634909193962812
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 0.9999998807907104
. O 0 4.257101863913704e-06

This O 0 1.2423809377104522e-11
study O 0 4.7567297323247715e-12
reports O 0 1.1559967566521223e-10
on O 0 1.6831230853497914e-11
six O 0 9.775153776703238e-12
cases O 0 7.568021209714004e-11
of O 0 5.029035781561886e-12
deficiency B-Disease 0 0.12419393658638
in I-Disease 0 8.265452124817108e-13
the I-Disease 0 1.8578503535940372e-13
human I-Disease 0 1.8510398075433088e-11
complement I-Disease 0 2.4367499337762943e-11
regulatory I-Disease 0 4.0658167804741296e-11
protein I-Disease 0 4.1517156379455855e-10
Factor I-Disease 0 9.6870254040482e-09
H I-Disease 1 0.9999994039535522
( O 0 1.8421721093009324e-10
FH O 0 8.615585102234036e-06
) O 0 4.8440110429759375e-12
in O 0 7.861953140375286e-14
the O 0 1.880014529199569e-14
context O 0 1.1331593649521743e-11
of O 0 9.272735574175628e-13
an O 0 2.7348796560744404e-09
acute B-Disease 1 0.9999715089797974
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 4.2522001422184985e-06

Five O 0 1.7032280030804259e-09
of O 0 1.2376665447719204e-12
the O 0 3.0647722857810034e-13
cases O 0 1.0877655547136822e-11
were O 0 3.5052659559664523e-12
observed O 0 2.2863407000972558e-10
in O 0 6.515802979632779e-13
children O 0 4.9410517344306015e-11
presenting O 0 5.086751908578435e-09
with O 0 2.5109684997914883e-07
idiopathic O 1 0.9999997615814209
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 8.2637579907896e-06
HUS B-Disease 1 0.9999858140945435
) O 0 3.4922439340334677e-07
. O 0 1.0570933284270723e-07

Two O 0 3.1175678705253063e-10
of O 0 1.8510531649140738e-12
the O 0 5.926126776800711e-12
children O 0 5.382350676264025e-10
exhibited O 0 4.3400206095611793e-07
a O 0 4.308408740882896e-09
homozygous O 1 0.7592636346817017
deficiency O 0 0.22866986691951752
characterized O 0 3.1086448970540914e-09
by O 0 2.22423659351767e-11
the O 0 1.029408329411563e-11
absence O 0 1.3125493747434547e-10
of O 0 6.657098917256521e-14
the O 0 8.973809108997477e-13
150 O 0 5.280267542651096e-11
- O 0 7.345458130636473e-10
kD O 0 5.986849238581726e-09
form O 0 1.1687813260621849e-12
of O 0 1.2802802709047795e-13
Factor O 0 8.747738644565572e-10
H O 1 0.9999997615814209
and O 0 1.0670381245247995e-10
the O 0 3.6164916005464176e-13
presence O 0 1.023349877060653e-10
, O 0 8.674730042363549e-14
upon O 0 3.58431004061216e-14
immunoblotting O 0 2.3126220938252118e-09
, O 0 2.0003586460870526e-12
of O 0 2.8573125040055186e-14
the O 0 8.621488939430932e-13
42 O 0 1.1517029691043845e-10
- O 0 1.952983996744706e-09
kD O 0 1.7479625569194468e-07
Factor O 0 1.577610575509425e-08
H O 1 0.9999969005584717
- O 0 5.279520678413974e-07
like O 0 1.7143901576144316e-10
protein O 0 1.045749320471856e-10
1 O 0 1.6190626313597467e-12
( O 0 1.0503540311818105e-12
FHL O 0 2.3412139782408303e-08
- O 0 2.0231240682733187e-08
1 O 0 2.7496082667666233e-13
) O 0 8.241220612837871e-14
and O 0 1.1212304549439514e-13
other O 0 1.582811572781173e-13
FH O 0 6.655951438006014e-06
- O 0 2.107905494597162e-08
related O 0 3.4350349231715427e-09
protein O 0 1.2236966995260445e-10
( O 0 3.4876199150879472e-12
FHR O 0 1.9537932161028948e-08
) O 0 6.487432986646002e-12
bands O 0 5.06927722021544e-10
. O 0 3.8332770291304996e-10

Southern O 0 7.347566821636065e-08
blot O 0 2.2234057723835576e-06
and O 0 2.1676788836133554e-11
PCR O 0 2.6825233701011086e-10
analysis O 0 2.0856018734943804e-12
of O 0 1.7986299095614812e-14
DNA O 0 4.903815548074064e-11
of O 0 5.604908830353188e-14
one O 0 2.618827377176558e-11
patient O 0 1.639707747358443e-08
with O 0 2.665061504814048e-10
homozygous O 0 0.044167377054691315
deficiency O 1 0.6386061906814575
ruled O 0 5.6663782999066825e-08
out O 0 1.3102039453372072e-09
the O 0 6.875393808968011e-13
presence O 0 3.806935322536731e-11
of O 0 1.2195327111716187e-14
a O 0 5.255304112890269e-13
large O 0 2.034279428936303e-12
deletion O 0 4.676534715031266e-10
of O 0 2.727289693995466e-13
the O 0 1.9470336801163945e-12
FH O 0 4.864668312620779e-07
gene O 0 5.516729850718605e-10
as O 0 2.3931117504316646e-12
the O 0 2.522802116950579e-13
underlying O 0 2.8518043482250732e-09
defect O 0 5.306596904119942e-07
for O 0 3.001338066965786e-11
the O 0 9.272896228651462e-09
deficiency O 1 0.9496707320213318
. O 0 1.3482131855369062e-08

The O 0 8.891425096191341e-11
other O 0 6.939294625030179e-12
four O 0 3.279491695568071e-12
children O 0 2.8258060821850783e-11
presented O 0 3.611862892105577e-11
with O 0 7.555304160078435e-10
heterozygous O 0 0.32054901123046875
deficiency O 1 0.9351609349250793
and O 0 1.7551964048845292e-10
exhibited O 0 1.837253194025834e-07
a O 0 1.2712982055962385e-10
normal O 0 1.5446612877667576e-08
immunoblotting O 0 4.889100182481343e-07
pattern O 0 7.419600933644688e-08
of O 0 1.5170593188791603e-13
proteins O 0 4.656388122303845e-12
of O 0 2.872855490824999e-13
the O 0 4.9472852897691766e-11
FH O 0 0.000784886593464762
family O 0 1.0345338097295098e-07
. O 0 2.757680972464982e-09

Factor B-Disease 0 0.05139291658997536
H I-Disease 1 1.0
deficiency I-Disease 1 0.999996542930603
is O 0 3.6164438110830588e-09
the O 0 1.275996391880696e-10
only O 0 1.3564578011937556e-06
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 5.377204388423706e-07
with O 0 8.373289617225055e-09
HUS B-Disease 1 0.9997814297676086
. O 0 2.1781268344511773e-07

These O 0 5.033071182047877e-10
observations O 0 1.6321620721626573e-09
suggest O 0 9.306624221272486e-11
a O 0 3.1437424278385473e-12
role O 0 3.8604747870651934e-11
for O 0 4.470579722387624e-12
FH O 0 9.15570926736109e-05
and O 0 3.3121583253858944e-10
/ O 0 6.26725704933051e-06
or O 0 9.291911240438822e-09
FH O 0 5.6870587286539376e-05
receptors O 0 3.413536814322882e-11
in O 0 1.9897714660828403e-13
the O 0 2.2293651028969935e-13
pathogenesis O 0 5.910377520734755e-09
of O 0 1.7141930236386216e-11
idiopathic O 0 0.019238747656345367
HUS B-Disease 1 0.9998157620429993
. O 0 2.8571413679401303e-08
. O 0 2.4105384355266324e-08

Further O 0 1.0566206798401367e-09
evidence O 0 7.04211272628541e-11
for O 0 1.775503978866319e-13
a O 0 1.3311951367611652e-12
major O 0 1.9423056912826198e-11
ancient O 0 2.2142241373757088e-09
mutation O 0 4.466030986804981e-06
underlying O 0 9.553263225825503e-05
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 0.9999997615814209
from O 0 5.651111245619234e-10
linkage O 0 2.160843678211677e-06
disequilibrium O 0 2.177543194648024e-07
studies O 0 9.6237927349474e-11
in O 0 1.9273770947292324e-12
the O 0 1.3918963637921111e-12
Japanese O 0 2.3784172409335724e-09
population O 0 1.422768292069776e-10
. O 0 4.636187267426095e-10

The O 0 1.0758804336319372e-07
myotonic B-Disease 1 0.9999992847442627
dystrophy I-Disease 1 0.9999998807907104
( O 0 1.4298888117991737e-06
DM B-Disease 1 1.0
) O 0 2.4062971615279594e-09
mutation O 0 1.7111641881228934e-08
is O 0 1.1178902248332179e-10
an O 0 9.254258817592564e-12
unstable O 0 4.1816558223217726e-05
( O 0 2.1202785360774357e-10
CTG O 0 1.1142384209961165e-05
) O 0 1.0276236805939476e-10
n O 0 1.8436226412177348e-07
repeat O 0 4.8024482168784743e-08
, O 0 9.029269519567062e-12
present O 0 3.210213778831461e-12
at O 0 1.3070476992393942e-11
a O 0 7.784247421996349e-13
copy O 0 1.2697042306442086e-09
number O 0 1.3961405816165229e-11
of O 0 3.7430526885449955e-13
5 O 0 4.680066056916843e-11
- O 0 7.978581493262027e-07
37 O 0 6.979934408235522e-10
repeats O 0 7.181793826305238e-09
on O 0 8.053996358725612e-11
normal O 0 1.7761062065524413e-10
chromosomes O 0 3.1300545488832654e-11
but O 0 8.637190897393954e-13
amplified O 0 1.6577681935525668e-11
to O 0 1.6853773151387363e-12
50 O 0 1.5943421929898172e-11
- O 0 7.048606698312199e-10
3000 O 0 1.3937653808859807e-10
copies O 0 2.9035213122696746e-10
on O 0 1.270588541046891e-07
DM B-Disease 1 0.9999998807907104
chromosomes O 0 1.0901266023211065e-06
. O 0 7.413981428783245e-09

Previous O 0 5.818016290959349e-08
findings O 0 1.1789165199616036e-09
in O 0 6.179946745316078e-12
Caucasian O 0 1.2134480087411248e-08
populations O 0 2.6292390487014927e-10
of O 0 4.668411057034971e-12
a O 0 4.106498252554047e-08
DM B-Disease 1 1.0
founder O 0 5.23330982105108e-06
chromosome O 0 3.293156987638213e-05
raise O 0 3.2682316852827853e-09
a O 0 2.339567602149817e-11
question O 0 9.710898057901929e-11
about O 0 2.690628449208976e-11
the O 0 6.25722550487949e-14
molecular O 0 7.591365903947267e-12
events O 0 3.5280710644625124e-12
involved O 0 1.0783683841719682e-11
in O 0 3.8184725021685184e-13
the O 0 5.604708862815e-13
expansion O 0 4.793386132462274e-09
mutation O 0 1.754324685521169e-08
. O 0 2.0728154748184124e-09

To O 0 3.882126009546738e-10
investigate O 0 6.843223765429229e-09
whether O 0 4.212189971819491e-11
a O 0 8.866339953894631e-12
founder O 0 2.379751284919962e-09
chromosome O 0 3.6786272517019825e-07
for O 0 2.3437481122545734e-11
the O 0 4.5561249217840327e-10
DM B-Disease 1 1.0
mutation O 0 3.747505843421095e-07
exists O 0 1.0818258094902333e-10
in O 0 1.77319245983458e-13
the O 0 3.2513986484737287e-14
Japanese O 0 4.792613181314742e-11
population O 0 3.648354676092508e-13
, O 0 5.570562457493655e-13
we O 0 1.0586813543878026e-11
genotyped O 0 3.5060315761725747e-10
families O 0 2.9092380631270953e-13
using O 0 9.838560088154535e-13
polymorphic O 0 1.5158853061691957e-09
markers O 0 1.3409295434030355e-06
near O 0 2.8439078505471116e-06
the O 0 3.39138786498161e-11
( O 0 1.84443536832557e-11
CTG O 0 4.046799233492493e-07
) O 0 1.2214160238777083e-10
n O 0 8.896541885405895e-07
repeat O 0 8.05190097707964e-07
region O 0 3.4017585193169e-08
and O 0 1.750974143455153e-09
constructed O 0 8.170639489435416e-07
haplotypes O 0 2.0355780634417897e-06
. O 0 7.883039998546337e-09

Six O 0 4.1900301006592144e-09
different O 0 1.3425067481309672e-11
haplotypes O 0 3.905120227187808e-09
were O 0 1.2124982962102848e-10
found O 0 2.927862952084581e-10
and O 0 2.2791839526803415e-09
DM B-Disease 1 1.0
alleles O 0 4.887444760015569e-08
were O 0 8.057595701771447e-10
always O 0 1.1840340929936133e-09
haplotype O 0 4.909625772597792e-08
A O 0 2.1020227780610412e-09
. O 0 1.6911695377430647e-09

To O 0 8.804366680159603e-10
find O 0 1.4670110959347227e-10
an O 0 4.77495952120547e-14
origin O 0 7.310211463940064e-13
of O 0 1.0263097067076538e-13
the O 0 1.0839727553058065e-12
( O 0 1.556170448578642e-12
CTG O 0 2.3542499150153162e-07
) O 0 6.887328814902949e-12
n O 0 5.750113629687803e-08
repeat O 0 7.066055296434115e-09
mutation O 0 3.9595249301527247e-10
and O 0 1.6231626502952179e-12
to O 0 2.320097239327801e-13
investigate O 0 4.43327145827066e-11
the O 0 1.3762726852259433e-13
mechanism O 0 1.6684202630568024e-11
of O 0 1.0605835904875602e-14
the O 0 3.50284275055842e-14
expansion O 0 3.959273534026586e-11
mutation O 0 5.310324749374651e-11
in O 0 1.149127451180454e-13
the O 0 4.7279515643251085e-14
Japanese O 0 7.7961123667869e-11
population O 0 2.0544613373810888e-13
we O 0 1.1116428090540698e-11
have O 0 7.497350857548282e-14
studied O 0 9.624205729238944e-13
90 O 0 1.1500691891874748e-11
Japanese O 0 1.0225626567716972e-08
DM B-Disease 1 1.0
families O 0 1.0542769435240018e-10
comprising O 0 2.194485045070582e-12
190 O 0 7.233035698162027e-11
affected O 0 4.535947728534495e-10
and O 0 8.331416112561385e-11
130 O 0 3.923172453568213e-09
unaffected O 0 5.750398486270569e-07
members O 0 6.195741836245716e-11
. O 0 3.3663521969984345e-10

The O 0 4.126617936250909e-10
results O 0 1.5745335590899856e-10
suggest O 0 1.039643718336869e-10
that O 0 9.354576575165696e-13
a O 0 9.948876575002763e-13
few O 0 5.3689335963169604e-12
common O 0 1.1828111190145818e-12
ancestral O 0 1.788001036118203e-08
mutations O 0 5.001293601480938e-09
in O 0 5.643834358193267e-12
both O 0 6.437413969939687e-12
Caucasian O 0 1.0711971754062688e-08
and O 0 1.1563539709102955e-10
Japanese O 0 1.7734734791829965e-09
populations O 0 1.2247117382735428e-11
have O 0 7.599542333315903e-14
originated O 0 5.693162548380329e-14
by O 0 5.24488433708962e-15
expansion O 0 1.9681745382776894e-12
of O 0 3.131913131615427e-14
an O 0 2.622168703957789e-13
ancestral O 0 2.375612666583038e-07
n O 0 2.202142604801338e-05
= O 0 8.071244792517973e-07
5 O 0 2.0252764743045049e-10
repeat O 0 1.0453195642412538e-08
to O 0 6.928982387854887e-11
n O 0 3.3296061019427725e-07
= O 0 9.81466712346446e-08
19 O 0 2.623214312436062e-09
- O 0 5.0132058504459565e-08
37 O 0 7.26592008781779e-10
copies O 0 8.216141100803043e-10
. O 0 5.154018878350541e-10

These O 0 3.687950986264177e-11
data O 0 9.521383681487805e-11
support O 0 9.030768320650306e-12
multistep O 0 4.4696149004153085e-09
models O 0 9.354006458295316e-09
of O 0 3.431133632422756e-12
triplet O 0 1.5338271168729989e-06
repeat O 0 4.111943230356019e-09
expansion O 0 3.1936786548669716e-10
that O 0 6.630140013397234e-12
have O 0 3.35191808120347e-13
been O 0 1.243448974428546e-13
proposed O 0 5.631347710192969e-13
for O 0 3.387208319816787e-13
both O 0 2.1650975456921628e-10
DM B-Disease 1 1.0
and O 0 7.274621225406008e-07
Friedreichs B-Disease 0 0.0003050867235288024
ataxia I-Disease 1 0.9703897833824158
. O 0 1.2182664876903004e-09
. O 0 3.0948661411400735e-09

The O 0 2.4624517702687143e-11
molecular O 0 7.274364999254601e-10
basis O 0 4.943017106739944e-09
of O 0 1.3932803355487522e-08
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 9.190621874655136e-11
the O 0 3.2943877660562837e-12
western O 0 1.7543529129415703e-10
Cape O 0 5.47411449502988e-09
, O 0 5.1886175911342036e-11
South O 0 7.395504209029014e-10
Africa O 0 2.1751431211747274e-10
. O 0 9.971588832424771e-11

Deficiency B-Disease 1 0.9998040795326233
of I-Disease 0 4.377495588236968e-11
the I-Disease 0 6.939983310250142e-12
sixth I-Disease 0 2.396475795585218e-10
component I-Disease 0 4.880725601452696e-09
of I-Disease 0 9.231618290986288e-13
human I-Disease 0 6.024383214509044e-10
complement I-Disease 0 9.714274940009204e-10
( O 0 7.67450946542736e-12
C6 O 0 1.3951684252333507e-08
) O 0 9.318538128633147e-12
has O 0 7.83040368657062e-11
been O 0 1.1194109007794939e-11
reported O 0 6.045370426477348e-09
in O 0 1.496410959554717e-13
a O 0 1.8103681531309035e-12
number O 0 6.824118527204437e-12
of O 0 1.9157502732618237e-13
families O 0 4.543719133581758e-12
from O 0 1.025012729858818e-13
the O 0 3.954794120224897e-13
western O 0 6.302704191885056e-11
Cape O 0 6.825922049813471e-10
, O 0 1.6854682580169644e-11
South O 0 2.9727054151607035e-10
Africa O 0 5.03717900723899e-11
. O 0 4.151412547059863e-11

Meningococcal B-Disease 1 0.9992823004722595
disease I-Disease 1 0.6054727435112
is O 0 9.047500526548902e-10
endemic O 0 2.1230892599533036e-08
in O 0 1.1798015689401531e-11
the O 0 4.810551696571297e-12
Cape O 0 2.517598041151814e-08
and O 0 1.621963535702875e-10
almost O 0 1.5961922755769464e-11
all O 0 6.845350566768438e-13
pedigrees O 0 2.0796742106199417e-09
of O 0 7.550254692290093e-12
total O 0 0.0010298470733687282
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 8.764886733070298e-11
C6Q0 O 0 2.2687459022563417e-07
) O 0 8.239139405452622e-12
have O 0 7.57795475675449e-12
been O 0 7.244228654446072e-12
ascertained O 0 1.0258323079881393e-09
because O 0 4.478072860442106e-12
of O 0 2.6765360761071832e-12
recurrent O 1 0.9617942571640015
disease O 1 0.9657201170921326
. O 0 3.6610856568586314e-08

We O 0 2.5488882116064815e-08
have O 0 1.6195175409072782e-11
sequenced O 0 1.4723622321355379e-10
the O 0 3.77923712290007e-13
expressed O 0 2.052112603109779e-12
exons O 0 7.322568940093532e-11
of O 0 1.0047271039237068e-13
the O 0 2.7809373727427644e-13
C6 O 0 2.6576618683549214e-09
gene O 0 1.0872122646610194e-10
from O 0 2.586094045072679e-13
selected O 0 1.84710298271884e-12
cases O 0 3.4928272080181344e-11
and O 0 4.78013392757326e-11
have O 0 2.484507218014631e-11
found O 0 2.112845315371814e-11
three O 0 1.9011727955819957e-12
molecular O 0 2.2390516107861913e-09
defects O 0 0.003990003373473883
leading O 0 3.755181054998502e-09
to O 0 1.3245411434326115e-09
total O 0 1.7338813904643757e-06
deficiency O 1 0.9754160046577454
879delG O 0 3.2063398975878954e-06
, O 0 3.3725022774433455e-10
which O 0 3.4270475346431795e-11
is O 0 8.591665573431939e-12
the O 0 1.1029844843458286e-13
common O 0 9.007252409209965e-12
defect O 0 1.4391612523922959e-07
in O 0 5.821420277253575e-13
the O 0 6.494759157565921e-13
Cape O 0 2.955711675411976e-09
and O 0 3.5906107948013855e-11
hitherto O 0 1.034607843841684e-09
unreported O 0 5.753190701618394e-10
, O 0 1.572746967382077e-11
and O 0 8.981553348275106e-12
1195delC O 0 1.6981132944238198e-08
and O 0 6.408994168705107e-11
1936delG O 0 2.9002089618757054e-08
, O 0 1.5397200875399975e-11
which O 0 6.1819507846117006e-12
have O 0 5.173071606495716e-12
been O 0 8.982427648906999e-12
previously O 0 2.0594352612146594e-10
reported O 0 3.8630849985565874e-07
in O 0 7.959355396991441e-12
African O 0 1.4092883804384115e-10
- O 0 7.853671490920533e-07
Americans O 0 7.294524984047257e-10
. O 0 2.791384068334679e-10

We O 0 3.4779613855562275e-08
also O 0 1.4037827324175911e-11
show O 0 8.112896465739539e-10
that O 0 5.058895468333657e-13
the O 0 7.74434769784671e-14
879delG O 0 9.890395169520616e-09
and O 0 3.725207989302426e-11
1195delC O 0 7.194402655841259e-07
defects O 0 0.0006978215533308685
are O 0 9.19494298409762e-13
associated O 0 1.9323553868133558e-10
with O 0 5.555574750237824e-11
characteristic O 0 2.158359848181135e-06
C6 O 0 0.00044225764577277005
/ O 0 0.030719522386789322
C7 O 0 7.121883754734881e-06
region O 0 1.6788611389984e-08
DNA O 0 9.046076598906438e-08
marker O 0 3.290357142304856e-07
haplotypes O 0 1.2108770874874608e-08
, O 0 8.12729224197728e-12
although O 0 2.1360664972935872e-12
small O 0 8.397508383106711e-12
variations O 0 9.453473559517533e-10
were O 0 5.589984586329422e-10
observed O 0 2.248832409179613e-08
. O 0 1.0716767473439859e-09

The O 0 7.77440667398821e-10
1936delG O 0 3.5173525247955695e-06
defect O 0 1.2155199328844901e-05
was O 0 7.816902125590275e-10
observed O 0 1.668848281788371e-09
only O 0 4.2120772147935526e-11
once O 0 9.746191353965372e-11
in O 0 1.1235767362078458e-13
the O 0 1.484825175139537e-13
Cape O 0 4.6364523331732244e-10
, O 0 1.8884043634370684e-12
but O 0 6.107967864127373e-13
its O 0 7.036479146745045e-13
associated O 0 1.3342697779972212e-10
haplotype O 0 4.687917254386775e-08
could O 0 2.780386143541591e-09
be O 0 3.8014064118740976e-11
deduced O 0 3.9020009445778214e-09
. O 0 3.3314573322229535e-10

The O 0 1.080710035350485e-10
data O 0 4.884783688652305e-10
from O 0 4.70312157274666e-13
the O 0 9.011058365411204e-14
haplotypes O 0 3.0070770318246787e-09
indicate O 0 1.0406183692523996e-09
that O 0 3.282357675590819e-12
these O 0 4.854247429367242e-13
three O 0 3.424064417417716e-13
molecular O 0 2.699874324108009e-09
defects O 0 0.0024932604283094406
account O 0 3.316052155089011e-10
for O 0 1.723313158841222e-11
the O 0 1.6213325126912537e-10
defects O 1 0.9970709085464478
in O 0 1.4933729600152823e-11
all O 0 9.926401714488442e-12
the O 0 1.7223724616682867e-12
38 O 0 2.0109650056276962e-10
unrelated O 0 7.293133874597402e-10
C6Q0 O 0 2.95654871251827e-07
individuals O 0 1.0776615710916815e-10
we O 0 5.811843784009341e-10
have O 0 4.767465502236723e-12
studied O 0 1.098425690682081e-11
from O 0 4.786761807241968e-13
the O 0 1.6075112161534344e-12
Cape O 0 5.492919452620981e-09
. O 0 7.253721512334721e-10

We O 0 2.525822750953921e-08
have O 0 2.164138659943582e-11
also O 0 7.951203714537391e-13
observed O 0 1.2554946665632727e-11
the O 0 1.2490826244420522e-13
879delG O 0 7.902719545427317e-08
defect O 0 6.686309461656492e-07
in O 0 4.753917745570213e-12
two O 0 2.585249792019795e-10
Dutch O 1 0.6515966057777405
C6 B-Disease 1 1.0
- I-Disease 1 0.9999991655349731
deficient I-Disease 1 0.9999998807907104
kindreds O 0 1.177639660454588e-05
, O 0 2.2228286919445672e-11
but O 0 9.402802972000024e-13
the O 0 1.9929316443650924e-13
879delG O 0 5.589286544704919e-08
defect O 0 6.972429105189804e-07
in O 0 1.0714748316029143e-12
the O 0 4.362388271797468e-13
Cape O 0 3.563431494324476e-10
probably O 0 8.922246275133716e-10
did O 0 6.804404956151089e-11
not O 0 1.0923785747490866e-12
come O 0 4.650545898897407e-13
from O 0 5.714453568542513e-14
The O 0 1.204309682577634e-13
Netherlands O 0 2.2592644421948194e-10
. O 0 4.576596913941078e-12
. O 0 1.022378362525167e-10

Complement B-Disease 1 0.9989646673202515
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 1.0426587371270557e-09
seven O 0 4.445224570381878e-12
further O 0 6.699343770705246e-12
molecular O 0 1.7327064938399417e-07
defects O 1 0.9999538660049438
and O 0 1.89355775503941e-09
their O 0 6.617371234307612e-11
associated O 0 4.990394941728482e-08
marker O 0 0.00013927968393545598
haplotypes O 0 3.2555963116465136e-06
. O 0 2.1106533409920303e-08

Seven O 0 7.779064614688025e-10
further O 0 2.1941681110915212e-11
molecular O 0 1.021451034866061e-09
bases O 0 3.086303195232176e-07
of O 0 4.655464636016404e-08
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 2.0064145900278163e-09
described O 0 7.845229532676967e-08
. O 0 3.6354210752875815e-09

All O 0 1.920956310685895e-10
these O 0 1.3489486220749636e-12
new O 0 4.6808043552282186e-12
molecular O 0 5.206546749292329e-09
defects O 0 0.00012854186934418976
involve O 0 6.2536470446517e-10
single O 0 4.3817016681657606e-09
- O 0 3.8861128359712893e-07
nucleotide O 0 2.8876061541893705e-09
events O 0 1.348602757245132e-10
, O 0 1.2492213210049674e-12
deletions O 0 2.636872664663059e-10
and O 0 9.360488079090956e-12
substitutions O 0 3.146095536865623e-11
, O 0 9.92087054868529e-13
some O 0 1.208437646824101e-13
of O 0 1.0039602849965575e-14
which O 0 4.4922568269434304e-12
alter O 0 1.749562805741789e-08
splice O 0 2.0033358794080414e-07
sites O 0 5.862976308890211e-07
, O 0 7.271018509502625e-11
and O 0 3.2474991445985424e-11
others O 0 3.4610352778186027e-11
codons O 0 4.2998133942262484e-09
. O 0 5.656039525625545e-10

They O 0 3.0166478204307623e-09
are O 0 3.6285848457884295e-12
distributed O 0 9.255812262465302e-12
along O 0 9.0489116200132e-11
the O 0 9.519611661457095e-13
C7 O 0 4.517731522213353e-09
gene O 0 4.1463185662671265e-10
, O 0 1.1977174894234333e-12
but O 0 1.6698257089119845e-13
predominantly O 0 5.898832854470126e-13
towards O 0 1.890948985935892e-12
the O 0 8.713288879476366e-13
3 O 0 1.8744925750491248e-11
end O 0 7.664938905804775e-09
. O 0 1.1206895411675077e-09

All O 0 7.123699963251795e-10
were O 0 2.1358312687902448e-11
found O 0 1.862840177252467e-12
in O 0 1.8356139091374457e-13
compound O 0 1.3556783251544857e-08
heterozygous O 0 8.230516357343731e-08
individuals O 0 9.397331801608289e-10
. O 0 8.542099805275427e-10

The O 0 9.554320890003964e-09
C6 O 0 0.0007037959876470268
/ O 0 0.008775508031249046
C7 O 0 0.00019554731261450797
marker O 0 2.4642402422614396e-05
haplotypes O 0 1.6426961337856483e-06
associated O 0 4.9957186831761646e-08
with O 0 2.0102211562011973e-10
most O 0 1.7654814277179298e-09
C7 B-Disease 0 0.07125238329172134
defects I-Disease 1 0.9998076558113098
are O 0 9.853298177375791e-10
tabulated O 0 1.0037761200010209e-07
. O 0 6.218377895939042e-11
. O 0 5.547244330550427e-10

A O 0 1.9324827960076618e-08
genome O 0 6.282692766035325e-08
- O 0 7.733078177807329e-07
wide O 0 6.397886664899488e-09
search O 0 1.2786598446723474e-09
for O 0 1.813727661982567e-12
chromosomal O 0 8.171591616701335e-05
loci O 0 5.80480374878789e-08
linked O 0 4.436727067513857e-06
to O 0 5.982919160096856e-10
mental O 0 0.00012127318768762052
health O 0 3.381871493957078e-08
wellness O 0 1.647967025064645e-07
in O 0 8.742008852924421e-12
relatives O 0 6.524717433009641e-10
at O 0 2.1078029599497228e-10
high O 0 3.879101040382693e-09
risk O 0 1.0619454826610308e-07
for O 0 3.669352321988839e-10
bipolar B-Disease 1 0.9999911785125732
affective I-Disease 1 0.9995620846748352
disorder I-Disease 1 0.9990484118461609
among O 0 3.2027128171741026e-10
the O 0 2.1830181759496803e-11
Old O 0 1.4945200064175879e-06
Order O 0 1.4158471062231115e-09
Amish O 0 4.325158045048738e-07
. O 0 2.084125538814874e-09

Bipolar B-Disease 1 0.9999443292617798
affective I-Disease 1 0.999862551689148
disorder I-Disease 1 0.9999595880508423
( O 0 3.933247626264347e-06
BPAD B-Disease 1 1.0
; O 0 1.3353819667827338e-05
manic B-Disease 1 0.9999992847442627
- I-Disease 1 0.9999998807907104
depressive I-Disease 1 1.0
illness I-Disease 1 0.9999294281005859
) O 0 1.1700093671684897e-10
is O 0 7.046291328194343e-11
characterized O 0 1.5084583582236633e-09
by O 0 5.7134344998155395e-12
episodes O 0 1.6063497199070298e-08
of O 0 5.242405121119731e-11
mania B-Disease 0 0.021983155980706215
and O 0 5.160553318006578e-09
/ O 0 0.004740378353744745
or O 0 2.498664173344878e-07
hypomania B-Disease 0 0.015347786247730255
interspersed O 0 3.951354301534593e-06
with O 0 9.959633118228339e-11
periods O 0 8.20915957433499e-09
of O 0 7.387999240160426e-11
depression B-Disease 0 1.5947650808811886e-06
. O 0 1.738932553507766e-09

Compelling O 0 1.2893825562798611e-08
evidence O 0 3.3396196918999976e-10
supports O 0 3.862008490784774e-10
a O 0 1.9654059196100304e-12
significant O 0 2.573004136141588e-11
genetic O 0 1.3897213158031718e-08
component O 0 1.9102964543549206e-08
in O 0 4.137458604891453e-12
the O 0 2.57605720609122e-12
susceptibility O 0 4.7911399292388523e-08
to O 0 2.3152966210915338e-09
develop O 0 1.6034275176934898e-05
BPAD B-Disease 1 0.9999996423721313
. O 0 2.6409128395243897e-07

To O 0 1.3882442417845198e-10
date O 0 1.2448396757847036e-09
, O 0 7.449194039388374e-12
however O 0 1.0541230431940218e-12
, O 0 2.742401303875569e-13
linkage O 0 1.072232969079323e-09
studies O 0 8.765082409878389e-12
have O 0 1.6569455226281282e-12
attempted O 0 1.3497684914209884e-10
only O 0 9.872339491040494e-13
to O 0 9.98255948389537e-13
identify O 0 1.4451717600394431e-09
chromosomal O 0 1.4469024790741969e-05
loci O 0 3.3509661712116667e-09
that O 0 1.6559140170180342e-10
cause O 0 1.010891925723456e-09
or O 0 2.135807919412258e-10
increase O 0 3.6383257517869083e-10
the O 0 1.6548878933875244e-10
risk O 0 2.9028001335973386e-07
of O 0 9.076084328540901e-11
developing O 0 9.74346312432317e-06
BPAD B-Disease 1 0.9999994039535522
. O 0 1.7449146128001303e-07

To O 0 5.760478205552033e-11
determine O 0 6.274636366043751e-11
whether O 0 1.4255573284327472e-11
there O 0 8.543263319005234e-12
could O 0 3.6212146562603076e-12
be O 0 7.029289802139294e-13
protective O 0 1.8650667815700572e-11
alleles O 0 2.4539125072220447e-12
that O 0 5.623490497048966e-13
prevent O 0 3.1412522583096347e-10
or O 0 4.5296366657510134e-10
reduce O 0 1.4264727177248915e-09
the O 0 1.767811418085241e-11
risk O 0 2.0485423135596648e-08
of O 0 1.7932399272099775e-12
developing O 0 1.44587332329138e-07
BPAD B-Disease 1 1.0
, O 0 4.718715695961606e-11
similar O 0 1.2547087934605683e-12
to O 0 2.8436619920781114e-13
what O 0 6.6843048023707e-13
is O 0 2.314899032011819e-13
observed O 0 8.637903760322363e-12
in O 0 1.8905370162154017e-13
other O 0 5.281798956535688e-11
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 3.420027802625292e-11
we O 0 9.867228561999397e-11
used O 0 2.402628318520783e-09
mental O 0 2.003204463107977e-05
health O 0 2.184125236226464e-08
wellness O 0 1.4329422981518292e-07
( O 0 5.539575742563585e-11
absence O 0 3.594950448437828e-10
of O 0 3.353217876977954e-12
any O 0 2.737104978223215e-07
psychiatric B-Disease 1 0.9658568501472473
disorder I-Disease 0 0.08136610686779022
) O 0 1.705524436956818e-11
as O 0 1.9342203186334395e-11
the O 0 3.188477910517906e-12
phenotype O 0 1.9286311214727903e-08
in O 0 8.65888610812604e-12
our O 0 2.531361786850539e-10
genome O 0 3.3392328901982182e-09
- O 0 2.3288858841397087e-08
wide O 0 2.4352004857064458e-09
linkage O 0 1.1500045360435251e-07
scan O 0 2.2605893263971666e-06
of O 0 2.3255345132228156e-12
several O 0 5.305968771990299e-12
large O 0 3.247759006175244e-11
multigeneration O 0 1.0383828197291223e-07
Old O 0 1.7322397738439577e-08
Order O 0 2.503172148726751e-11
Amish O 0 2.5438952278022953e-08
pedigrees O 0 5.908148992261886e-08
exhibiting O 0 1.6755118181777107e-08
an O 0 3.0083002061642716e-12
extremely O 0 2.246679065009971e-09
high O 0 4.292626698543245e-09
incidence O 0 0.00022257969249039888
of O 0 1.2715104524829712e-08
BPAD B-Disease 1 1.0
. O 0 4.95004826461809e-07

We O 0 6.851428935306103e-08
have O 0 2.8748536537448466e-11
found O 0 2.5854689483101323e-12
strong O 0 9.559459343902454e-13
evidence O 0 2.3658672677201453e-12
for O 0 1.1756895912547194e-13
a O 0 5.285514647485057e-12
locus O 0 7.177206828856697e-09
on O 0 9.115492360933786e-09
chromosome O 0 9.992613195208833e-05
4p O 0 2.1552667021751404e-05
at O 0 5.586981099980903e-09
D4S2949 O 0 2.5237133272071333e-08
( O 0 2.323628962852542e-11
maximum O 0 6.733272273073965e-10
GENEHUNTER O 0 8.545706009499554e-07
- O 0 1.6958647108822333e-07
PLUS O 0 4.241718087882873e-09
nonparametric O 0 1.655951251677834e-07
linkage O 0 2.1236769498500507e-07
score O 0 2.2403332522458186e-09
= O 0 2.247167563140806e-09
4 O 0 9.590402257064756e-12
. O 0 1.131448342135688e-12
05 O 0 1.0213842271955542e-10
, O 0 9.112593492288656e-12
P O 0 5.668994162988383e-07
= O 0 8.174780297132145e-10
5 O 0 2.8794893986577863e-12
. O 0 9.499661257281189e-13
22 O 0 7.477436204939014e-12
x O 0 2.493911743783883e-08
10 O 0 8.694140546383622e-11
( O 0 2.5594398562339693e-12
- O 0 3.638694181518076e-07
4 O 0 8.875391740992278e-12
) O 0 2.351133610717371e-13
; O 0 1.493587968148108e-13
SIBPAL O 0 1.3285692546105565e-09
Pempirical O 0 9.938195821845852e-10
value O 0 1.2718948116940965e-10
< O 0 1.6222768683959998e-09
3 O 0 9.649703779091023e-12
x O 0 4.1648778648095686e-08
10 O 0 7.011100033871287e-11
( O 0 8.656244124272128e-12
- O 0 1.7556072862134897e-07
5 O 0 4.1958298814537276e-12
) O 0 1.1478896988752901e-13
) O 0 4.731172322403748e-14
and O 0 2.2028627294674863e-13
suggestive O 0 5.271387326644117e-09
evidence O 0 8.429796791165067e-12
for O 0 1.9950299143820308e-14
a O 0 1.323051911084061e-12
locus O 0 9.055010630198979e-10
on O 0 1.555362616478817e-09
chromosome O 0 0.00011213684774702415
4q O 0 0.0009201794164255261
at O 0 2.242583008182919e-08
D4S397 O 0 3.16962669444365e-08
( O 0 2.945741220394815e-11
maximum O 0 2.7052611262234905e-09
GENEHUNTER O 0 3.3239507502003107e-06
- O 0 4.930143404635601e-07
PLUS O 0 6.891636150641034e-09
nonparametric O 0 1.504154454323725e-07
linkage O 0 2.347398577740023e-07
score O 0 6.849110167905792e-10
= O 0 1.1298714186480652e-09
3 O 0 3.2794164519373004e-12
. O 0 5.366320452240836e-13
29 O 0 3.686698862859217e-11
, O 0 3.7632271430998454e-12
P O 0 3.7417206044665363e-07
= O 0 3.0438801479348854e-10
2 O 0 5.393595184192967e-13
. O 0 4.5383380213592783e-13
57 O 0 5.511846881689486e-11
x O 0 2.0736941053201008e-08
10 O 0 5.6959954114477185e-11
( O 0 5.159856483055725e-12
- O 0 7.934149692800929e-08
3 O 0 7.477023340751732e-12
) O 0 2.27513564628537e-13
; O 0 1.4186040037979242e-13
SIBPAL O 0 6.772543637012518e-10
Pempirical O 0 8.415346197665485e-10
value O 0 2.4341485424517195e-11
< O 0 6.375104333322668e-10
1 O 0 2.1513012725404845e-12
x O 0 5.997446095307168e-08
10 O 0 1.7141220387539846e-10
( O 0 1.866988681709092e-11
- O 0 6.84099541103933e-06
3 O 0 5.107529850445491e-12
) O 0 1.2772362377802549e-13
) O 0 2.5496291411681096e-14
that O 0 7.439814958759908e-14
are O 0 9.01485713877305e-14
linked O 0 1.3973781021192622e-09
to O 0 4.0302310100326366e-11
mental O 0 1.4823756828263868e-05
health O 0 3.573617490815195e-08
wellness O 0 2.8565339107444743e-06
. O 0 7.828902859330356e-09

These O 0 2.1271526207122804e-10
findings O 0 9.432865599734441e-11
are O 0 2.1834795256581163e-12
consistent O 0 6.889135928389578e-10
with O 0 9.253636268705123e-13
the O 0 8.203222037197686e-14
hypothesis O 0 1.4186406389893325e-11
that O 0 1.4493424906406038e-13
certain O 0 2.48335829981447e-13
alleles O 0 6.754373102491051e-12
could O 0 1.5299891562015056e-11
prevent O 0 1.0272341866013335e-09
or O 0 1.2941444582637018e-09
modify O 0 1.1857211035248838e-07
the O 0 4.6774781964353807e-11
clinical O 0 1.28756152406595e-08
manifestations O 0 4.397936681499459e-09
of O 0 8.863909606304787e-11
BPAD B-Disease 1 1.0
and O 0 7.190918971389237e-10
perhaps O 0 1.928157286612553e-11
other O 0 3.676045579048548e-12
related O 0 4.8762711202243736e-08
affective B-Disease 0 0.22239388525485992
disorders I-Disease 1 0.8634812235832214
. O 0 7.187647810269482e-08

Segregation O 0 1.9799595975200646e-05
distortion O 0 8.4328705270309e-05
in O 0 9.737972561651986e-08
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 0.9999997615814209
. O 0 4.440221914592257e-07

Myotonic B-Disease 1 0.9999983310699463
dystrophy I-Disease 1 0.9999997615814209
( O 0 3.375799224158982e-06
DM B-Disease 1 1.0
) O 0 3.502998779936206e-09
is O 0 9.627121322353105e-10
an O 0 9.150601804064351e-11
autosomal B-Disease 1 0.9999867677688599
dominant I-Disease 1 0.9983550906181335
disease I-Disease 1 0.9999520778656006
which O 0 1.3658524977699926e-08
, O 0 7.839205673487726e-11
in O 0 6.457849663007997e-13
the O 0 4.1870177572463085e-13
typical O 0 4.780730922249177e-09
pedigree O 0 2.4774655571491166e-07
, O 0 5.361800847064613e-12
shows O 0 4.950043708262797e-10
a O 0 1.5210159520773203e-11
three O 0 3.4928655020388666e-12
generation O 0 4.440754708401329e-10
anticipation O 0 2.1037391828571117e-09
cascade O 0 1.2936767745941324e-07
. O 0 1.3899988937637886e-09

This O 0 8.388931910241482e-11
results O 0 4.4496656359527265e-10
in O 0 2.9329424305890583e-11
infertility B-Disease 1 0.749045729637146
and O 0 1.7801879948819987e-05
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 3.813845594891063e-08
CDM B-Disease 0 3.651842064300581e-07
) O 0 1.3703804584153101e-11
with O 0 2.96153076020933e-12
the O 0 8.81134195555161e-13
disappearance O 0 3.1211289552857124e-08
of O 0 1.181373887604309e-10
DM B-Disease 1 1.0
in O 0 1.9899233372200342e-09
that O 0 8.541936602490807e-10
pedigree O 0 7.969014745867753e-07
. O 0 7.350419162222011e-10

The O 0 2.8610959088015697e-11
concept O 0 4.275822057531187e-11
of O 0 2.722492641483304e-13
segregation O 0 1.9980472831804263e-09
distortion O 0 4.4299646617673716e-08
, O 0 1.9839147685773995e-11
where O 0 2.3269454939300882e-12
there O 0 4.869985166001956e-13
is O 0 4.53006176407561e-13
preferential O 0 6.723400308716876e-11
transmission O 0 2.5105975964834215e-07
of O 0 1.8511791221014623e-13
the O 0 3.030557304672249e-13
larger O 0 8.484608848835506e-12
allele O 0 7.209390306961438e-10
at O 0 4.5864234632375656e-10
the O 0 1.558652235056357e-10
DM B-Disease 1 1.0
locus O 0 8.836153853053474e-08
, O 0 1.5506440576018576e-09
has O 0 3.504460333036974e-10
been O 0 2.1598662094945986e-11
put O 0 2.2439017657860383e-11
forward O 0 1.763325943593408e-11
to O 0 1.2249681520873357e-12
explain O 0 2.820723932206448e-10
partially O 0 1.7405884511489944e-09
the O 0 5.111951985846408e-13
maintenance O 0 3.630752232197665e-08
of O 0 2.8009398619910364e-11
DM B-Disease 1 1.0
in O 0 5.912663136875551e-10
the O 0 2.839112452079906e-11
population O 0 5.33630029053711e-10
. O 0 8.632641823602683e-10

In O 0 2.3247385960711853e-10
a O 0 1.3048065405918408e-10
survey O 0 4.3937806282201564e-08
of O 0 1.842849484123832e-11
DM B-Disease 1 1.0
in O 0 1.4529796255047245e-09
Northern O 0 5.159571969670651e-08
Ireland O 0 2.383776287473438e-09
, O 0 1.1163299451499853e-11
59 O 0 1.7344004010766412e-10
pedigrees O 0 5.382629897354718e-09
were O 0 8.403284734725958e-10
ascertained O 0 5.6985470564541174e-08
. O 0 1.3771996876243975e-09

Sibships O 0 1.9704020814970136e-05
where O 0 3.3795100051747795e-09
the O 0 1.5749315913915485e-12
status O 0 6.579500833048257e-11
of O 0 3.885097809869925e-13
all O 0 3.3233114610925485e-12
the O 0 1.3355789185102301e-13
members O 0 9.712587315359802e-14
had O 0 7.655079695134681e-12
been O 0 1.9263405974523362e-12
identified O 0 1.817004012527601e-11
were O 0 3.7537700270200147e-13
examined O 0 5.5247403873970313e-11
to O 0 3.5592619888717703e-13
determine O 0 1.5299541147872908e-11
the O 0 5.870660403119177e-13
transmission O 0 5.935318085903418e-07
of O 0 9.328722690160607e-13
the O 0 5.833496879992239e-11
DM B-Disease 1 1.0
expansion O 0 7.476407049011868e-09
from O 0 1.740510340020318e-11
affected O 0 1.3504386497942278e-09
parents O 0 3.583262853101843e-11
to O 0 2.413924312175131e-12
their O 0 4.631217631612117e-11
offspring O 0 5.292634774889393e-09
. O 0 7.32788163482212e-10

Where O 0 1.2784533431897671e-08
the O 0 3.925167135765406e-11
transmitting O 0 4.829320459975861e-05
parent O 0 4.613362989402958e-07
was O 0 1.1413778366886618e-08
male O 0 7.135847468475731e-09
, O 0 8.29755777975727e-11
58 O 0 2.0549553170212675e-09
. O 0 1.5165388944637925e-09

3 O 0 2.2217627737575185e-09
% O 0 1.6265662428072147e-11
of O 0 2.6033710777417784e-13
the O 0 1.1912607402256303e-12
offspring O 0 2.8586810696396014e-10
were O 0 4.8663406637672324e-11
affected O 0 4.33426239343504e-10
, O 0 6.018692488840571e-12
and O 0 9.869462885836455e-12
in O 0 2.1141533077147223e-13
the O 0 2.0530902282087093e-13
case O 0 2.477980841353311e-11
of O 0 3.7954380849129776e-14
a O 0 2.060278857241027e-11
female O 0 8.356484948457421e-10
transmitting O 0 1.1806399015767965e-05
parent O 0 1.2141848060309712e-07
, O 0 1.9672494189215683e-10
68 O 0 1.3238246054925185e-08
. O 0 2.4146371568889435e-09

7 O 0 1.2376354163734504e-07
% O 0 9.73666480774682e-10
were O 0 1.6009472636469013e-09
affected O 0 6.063930868549505e-08
. O 0 4.392286534482537e-09

Studies O 0 1.797252457969023e-09
on O 0 2.1675641836971238e-10
meiotic O 0 5.079677407593408e-07
drive O 0 3.240178898522572e-07
in O 0 5.24381760236281e-10
DM B-Disease 1 1.0
have O 0 6.997917245676888e-10
shown O 0 1.3197969106482077e-10
increased O 0 9.461353228656932e-11
transmission O 0 9.602625823390554e-07
of O 0 5.816614551124033e-13
the O 0 2.5882209786845523e-13
larger O 0 8.933697531743334e-12
allele O 0 2.921174691028483e-10
at O 0 4.0466630046864793e-10
the O 0 1.2293532858365097e-10
DM B-Disease 1 0.9999998807907104
locus O 0 3.378023620825843e-07
in O 0 2.457982262171754e-09
non O 0 7.555368028988596e-07
- O 0 0.03760262951254845
DM O 1 0.9999997615814209
heterozygotes O 0 6.527650384668959e-06
for O 0 3.652161628675543e-10
CTGn O 0 2.0763318389072083e-06
. O 0 2.9094766595960664e-09

This O 0 8.568395125363448e-12
study O 0 5.924228121956254e-12
provides O 0 1.342926095847241e-12
further O 0 1.1203496084414427e-13
evidence O 0 5.375625292125541e-12
that O 0 1.3069772044141392e-12
the O 0 8.44856476445166e-12
DM B-Disease 1 1.0
expansion O 0 1.1315757220131673e-08
tends O 0 3.094541733972278e-09
to O 0 8.338041194988488e-12
be O 0 2.2758539844347503e-11
transmitted O 0 3.320752028912466e-08
preferentially O 0 4.108355255993956e-08
. O 0 1.1507418351541787e-09

Diagnosis O 0 0.012993835844099522
of O 0 1.088390177983456e-07
hemochromatosis B-Disease 1 0.9999997615814209
. O 0 3.4389681786706205e-06

If O 0 1.1366260821432661e-07
untreated O 0 9.503553883405402e-06
, O 0 1.43634579785612e-08
hemochromatosis B-Disease 1 1.0
can O 0 1.301197971770307e-05
cause O 0 1.70156522472098e-06
serious O 0 6.465519254561514e-05
illness O 0 0.02835942804813385
and O 0 9.089393127048595e-10
early B-Disease 0 1.348564926395568e-09
death I-Disease 0 2.1291070240181398e-08
, O 0 1.975449144542285e-11
but O 0 1.0264477635912872e-11
the O 0 9.530967595011708e-13
disease O 0 2.470649178576423e-07
is O 0 6.83669371115414e-11
still O 0 1.846640729219473e-09
substantially O 0 1.2670848370532894e-08
under O 0 4.09556077940465e-09
- O 1 0.9548239707946777
diagnosed O 1 0.6721755862236023
. O 0 1.776687419408063e-08

The O 0 3.873271148258084e-11
cornerstone O 0 1.0776600722905982e-09
of O 0 1.294220942438598e-13
screening O 0 7.930386208832019e-11
and O 0 1.3132642759719482e-12
case O 0 3.8439534216262727e-13
detection O 0 5.592538151327764e-12
is O 0 8.669094630521512e-13
the O 0 1.69208248215931e-13
measurement O 0 9.195962213937037e-09
of O 0 4.492111110171448e-12
serum O 0 8.276906271476037e-09
transferrin O 0 2.349555661140812e-09
saturation O 0 1.0568993680237782e-08
and O 0 3.4603106491282176e-10
the O 0 7.446981920011808e-11
serum O 0 1.2712490615740535e-07
ferritin O 0 1.6126820128192776e-06
level O 0 7.071340402120541e-09
. O 0 1.03401209816667e-09

Once O 0 2.0997237726305684e-08
the O 0 6.2687233876035364e-12
diagnosis O 0 2.556196534442279e-07
is O 0 1.0019537283190161e-10
suspected O 0 3.712372347308701e-07
, O 0 1.0195016705849547e-11
physicians O 0 2.4011964291914545e-11
must O 0 1.4695426819866242e-10
use O 0 3.5344616122756634e-09
serum O 0 1.6780320947873406e-05
ferritin O 0 0.0006227600388228893
levels O 0 1.0858709487138185e-07
and O 0 5.07568154173299e-10
hepatic O 0 1.144468660640996e-05
iron O 0 3.6075145999348024e-06
stores O 0 2.73707627229669e-07
on O 0 1.898027068847341e-09
liver O 0 9.804600864526947e-08
biopsy O 0 3.191185840023536e-07
specimens O 0 3.0154495567202844e-10
to O 0 1.2040628043219481e-11
assess O 0 1.637963542577836e-08
patients O 0 2.0659306210202288e-10
for O 0 5.469656845502602e-13
the O 0 4.678876643765539e-12
presence O 0 1.0120808191516062e-08
of O 0 7.280787778229936e-11
iron B-Disease 0 0.005163675174117088
overload I-Disease 0 0.000697970564942807
. O 0 2.2531128962555158e-08

Liver O 0 0.0005449039163067937
biopsy O 0 0.010528524406254292
is O 0 2.2863244630855206e-09
also O 0 1.9867472250689744e-11
used O 0 5.512642859556438e-12
to O 0 6.328982476988543e-13
establish O 0 9.742269491130884e-11
the O 0 1.5928916172192054e-12
presence O 0 3.033404638586035e-08
or O 0 5.565603089507931e-09
absence O 0 1.0051393051213608e-09
of O 0 1.5797452321969496e-12
cirrhosis B-Disease 0 3.0928551950637484e-06
, O 0 3.490168657555026e-12
which O 0 1.3040794138996503e-11
can O 0 1.9627070801941926e-10
affect O 0 1.3671087373268165e-08
prognosis O 0 1.9451094885880593e-06
and O 0 4.1171993592215017e-10
management O 0 1.8260053025187517e-08
. O 0 1.5583766499460694e-09

A O 0 3.6573286621433e-09
DNA O 0 1.8438367277440193e-08
- O 0 2.4480131699533558e-08
based O 0 7.117122863276037e-11
test O 0 7.297110138360097e-11
for O 0 3.964867036033645e-14
the O 0 1.6144977878478767e-13
HFE O 0 4.16323366891902e-08
gene O 0 5.599140040501993e-10
is O 0 2.9444534917905107e-12
commercially O 0 1.1876540549626835e-11
available O 0 5.347105137137875e-12
, O 0 2.4496758788128403e-12
but O 0 1.3285443708696554e-12
its O 0 4.960565378603343e-13
place O 0 4.1356197980069176e-12
in O 0 1.3155099297217088e-13
the O 0 1.15390661435677e-13
diagnosis O 0 6.636516758362632e-08
of O 0 1.1509645667096002e-11
hemochromatosis B-Disease 1 1.0
is O 0 1.006638612466304e-07
still O 0 2.5224271560375655e-09
being O 0 8.675289653314877e-11
evaluated O 0 2.2064079452377428e-09
. O 0 4.197122926985486e-10

Currently O 0 4.971887435090139e-08
, O 0 6.703437110955335e-11
the O 0 1.031754231204697e-13
most O 0 8.187122312562634e-14
useful O 0 2.8894419409203342e-12
role O 0 2.4589117634393753e-12
for O 0 3.7791631938644335e-14
this O 0 2.3694110909411314e-13
test O 0 1.9947323307012432e-11
is O 0 1.579548395292535e-13
in O 0 2.5952574931356305e-15
the O 0 6.906747733009507e-15
detection O 0 4.946407519690332e-11
of O 0 2.6222002000308997e-12
hemochromatosis B-Disease 1 1.0
in O 0 1.1475455308218585e-10
the O 0 2.8941189722520022e-12
family O 0 3.027869621696766e-10
members O 0 1.525485602638446e-13
of O 0 1.3717205268794913e-13
patients O 0 3.949596552588197e-11
with O 0 3.1933085190873067e-13
a O 0 3.33260571916405e-11
proven O 0 4.9217767639220256e-08
case O 0 1.0249751047908262e-10
of O 0 2.760965013472866e-13
the O 0 1.626287993161668e-10
disease O 0 0.00012227155093569309
. O 0 5.120178947493059e-09

It O 0 2.68239042089391e-10
is O 0 1.6032467020643537e-11
crucial O 0 1.1719680781396846e-10
to O 0 1.180450959203938e-09
diagnose O 1 0.9999786615371704
hemochromatosis B-Disease 1 1.0
before O 0 0.4767235219478607
hepatic B-Disease 1 0.9999977350234985
cirrhosis I-Disease 1 0.9999785423278809
develops O 0 0.0015461487928405404
because O 0 5.060160290781823e-09
phlebotomy O 0 0.0009187668329104781
therapy O 0 7.513257969549159e-06
can O 0 2.242745544833724e-08
avert O 0 3.669569923658855e-05
serious O 0 0.022076301276683807
chronic O 1 0.9999970197677612
disease O 1 0.9999884366989136
and O 0 6.377202055318776e-08
can O 0 2.4264112497007773e-08
even O 0 6.497655746784403e-10
lead O 0 1.1140906946982554e-10
to O 0 2.0394748390106798e-11
normal O 0 1.532193394382375e-08
life O 0 4.5731307629637286e-09
expectancy O 0 3.770340484265944e-08
. O 0 8.562987992288829e-12
. O 0 2.0493530483722822e-10

Prevalence O 0 0.0009492916869930923
of O 0 2.3349580949294513e-11
the O 0 2.402515686394935e-11
I1307K O 0 5.7455423529972904e-08
APC B-Disease 0 7.433550219815288e-09
gene O 0 1.6213148601451621e-09
variant O 0 3.1817997125926922e-09
in O 0 5.0952506103207895e-12
Israeli O 0 1.881067568376693e-08
Jews O 0 7.072719146461459e-12
of O 0 1.5268332659388456e-13
differing O 0 1.4120590981214765e-11
ethnic O 0 1.5666909436440335e-10
origin O 0 3.091761291429407e-10
and O 0 1.4761845079647173e-09
risk O 0 1.809380023587437e-07
for O 0 1.6031060567911481e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.2232385415700264e-07

BACKGROUND O 0 1.1007102330040652e-05
& O 0 4.2340255390627135e-07
AIMS O 0 2.216735737192721e-07
Israeli O 0 1.0261913274689505e-07
Jews O 0 7.294229803500585e-11
of O 0 1.2335657668949285e-12
European O 0 4.0868619252676375e-12
birth O 0 1.655709680470352e-09
, O 0 1.0283647544628849e-10
i O 0 2.335371362960359e-08
. O 0 5.050757988928067e-13
e O 0 2.9054714190124287e-10
. O 0 6.681500513451566e-13
, O 0 9.123579712902452e-13
Ashkenazim O 0 5.123517166083502e-10
, O 0 4.9836597522390225e-12
have O 0 2.864869452778862e-11
the O 0 1.542413280430921e-10
highest O 1 0.9295053482055664
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 0.1766161024570465
of O 0 4.460820948737343e-11
any O 0 3.473446952284576e-08
Israeli O 0 0.00043287361040711403
ethnic O 0 5.295727589782473e-08
group O 0 2.151252154192207e-08
. O 0 1.588643216976493e-09

The O 0 6.656324935683244e-10
I1307K O 0 4.949199023940309e-07
APC B-Disease 0 4.3258179260874385e-08
gene O 0 2.3065604981553633e-09
variant O 0 3.44606121416291e-08
was O 0 4.683794685433895e-09
found O 0 4.694041266795068e-10
in O 0 1.132807216086551e-11
6 O 0 1.2968675022762e-09
. O 0 1.4831101902146315e-09

1 O 0 6.447029576861496e-10
% O 0 3.797013484879708e-12
of O 0 4.4695523053039227e-14
American O 0 2.3711935193126976e-12
Jews O 0 1.8713239291479056e-11
, O 0 8.520935693145937e-12
28 O 0 1.062164245446695e-11
% O 0 4.0582435415631446e-13
of O 0 2.8756803795854102e-12
their O 0 2.775111397568253e-06
familial O 1 0.9999998807907104
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 1.0662924978532828e-06
, O 0 1.8132106927026825e-10
but O 0 1.3756344674487053e-10
not O 0 5.367513031262483e-11
in O 0 2.6753976638260735e-12
non O 0 5.144809023249763e-09
- O 0 8.721954714019375e-07
Jews O 0 8.07578626194072e-09
. O 0 1.8421800751511341e-09

We O 0 2.3783911728969542e-08
assessed O 0 7.1620407382511075e-09
the O 0 5.024836449707415e-12
I1307K O 0 4.0868933126603224e-08
prevalence O 0 3.3465803994658927e-07
in O 0 3.0815790457577874e-12
Israeli O 0 4.141137921465088e-08
Jews O 0 1.9130100281650186e-11
of O 0 1.310156274919247e-13
differing O 0 1.1843243399867198e-11
ethnic O 0 4.9066223306581946e-11
origin O 0 4.6453549340519373e-11
and O 0 1.725300458055301e-10
risk O 0 2.959882294817362e-08
for O 0 1.6907092614815156e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.4494462163838762e-07

METHODS O 0 1.267684268668745e-08
DNA O 0 2.805043308740096e-09
samples O 0 3.043106738820356e-11
from O 0 1.0149644118868581e-13
500 O 0 5.7459028854345284e-12
unrelated O 0 1.1325673905659972e-11
Jews O 0 6.094158597896859e-12
of O 0 6.634134431041105e-13
European O 0 5.834431549001096e-11
or O 0 1.8318123684579746e-09
non O 0 1.9188927780078302e-08
- O 0 2.3545327110241487e-07
European O 0 7.305350768760377e-12
origin O 0 6.208940479812686e-12
, O 0 1.3832948458566974e-12
with O 0 2.1161987906383878e-13
or O 0 1.2437015826927134e-11
without O 0 1.7644250860718302e-12
a O 0 4.2478971729043025e-12
personal O 0 2.8189990342042393e-09
and O 0 4.666270703168607e-10
/ O 0 0.00012019606219837442
or O 0 4.826065946872404e-08
family O 0 2.849136393479057e-08
history O 0 4.0996228634071485e-10
of O 0 2.1446312607753537e-12
neoplasia B-Disease 0 8.678165386299952e-08
, O 0 6.338118831855644e-12
were O 0 8.137716195344424e-12
examined O 0 1.4337776521600176e-09
for O 0 5.487578165312701e-13
the O 0 7.024544791331411e-13
I1307K O 0 1.4581296170490532e-09
variant O 0 5.282889126156931e-10
by O 0 1.9419453024804856e-12
the O 0 9.10414538896065e-13
allele O 0 1.244163105873497e-09
- O 0 6.994290924211555e-09
specific O 0 1.2943660032682658e-10
oligonucleotide O 0 2.2962197476772417e-08
( O 0 1.6908430211515224e-10
ASO O 0 1.6438542616015184e-06
) O 0 1.6698805966469665e-12
method O 0 6.341181052471612e-11
. O 0 3.6094405242437233e-10

RESULTS O 0 1.1200511629283483e-08
In O 0 2.1477383673612627e-12
persons O 0 2.7091568571835367e-11
at O 0 1.4499364209275e-10
average O 0 2.7692345838659094e-07
risk O 0 0.00010841811308637261
for O 0 8.02729027782334e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 1.4658985136861702e-09
I1307K O 0 1.668772853236078e-08
was O 0 1.6983522366231796e-09
found O 0 1.170750441037427e-10
in O 0 6.32835841021806e-12
5 O 0 2.2612217653872335e-10
. O 0 2.4836286360852e-09

0 O 0 3.136422233041003e-09
% O 0 2.8805621082872435e-11
of O 0 7.899957814652692e-13
120 O 0 8.222788006051474e-10
European O 0 3.487887756392638e-11
and O 0 2.1306242881102833e-10
1 O 0 5.0537796170146976e-11
. O 0 8.954502694891175e-10

6 O 0 3.6513643664193296e-08
% O 0 1.3000318876965622e-10
of O 0 3.7063754843025265e-12
188 O 0 1.0148043294577747e-08
non O 0 6.808829056126342e-08
- O 0 1.4498446034849621e-06
European O 0 1.521097137135996e-11
Jews O 0 5.729293428569093e-11
( O 0 1.470719726559544e-11
P O 0 9.89508521342941e-07
= O 0 1.4257981462151292e-09
0 O 0 4.7461084541622345e-12
. O 0 1.3586990690525602e-12
08 O 0 2.7315821479745317e-11
) O 0 3.208469297535932e-12
. O 0 2.1452135207100653e-11

It O 0 1.0585430310072752e-09
occurred O 0 1.3230092577032337e-08
in O 0 3.02394324858124e-11
15 O 0 4.5127518388810017e-10
. O 0 4.7093490218586e-10

4 O 0 6.213890291206781e-09
% O 0 2.2649240122296632e-11
of O 0 6.189545403989527e-13
52 O 0 1.063085508512529e-09
Ashkenazi O 0 1.3026768108659326e-08
Israelis O 0 4.275314680057818e-08
with O 0 5.4633547685867256e-11
familial O 0 0.0001184470602311194
cancer B-Disease 0 3.31385490426328e-05
( O 0 2.1226265189966398e-09
P O 1 0.9210984110832214
= O 0 1.3100930118525866e-06
0 O 0 9.910591097783694e-11
. O 0 4.002469189412494e-11
02 O 0 1.0112158888020417e-09
) O 0 2.7056631132608977e-13
and O 0 2.0813815081177633e-12
was O 0 8.096444348293375e-11
not O 0 4.513608237166622e-12
detected O 0 1.3885627092591335e-09
in O 0 1.407557122072578e-12
51 O 0 2.5526232239059254e-09
non O 0 4.205803705303879e-09
- O 0 2.5988729390746812e-08
European O 0 3.1283461064679496e-12
Jews O 0 9.68239290827233e-12
at O 0 6.068967550731941e-11
increased O 0 5.481529674611352e-10
cancer B-Disease 0 1.0175197076023323e-06
risk O 0 7.773702037638941e-08
. O 0 3.1023128510554443e-09

Colorectal B-Disease 1 0.7570016384124756
neoplasia I-Disease 0 0.0015519652515649796
occurred O 0 5.064923698228085e-07
personally O 0 4.206835455988767e-06
or O 0 6.6148664323861794e-09
in O 0 5.883689369046152e-12
the O 0 8.556635434919801e-12
families O 0 8.309784110815954e-11
of O 0 7.911855307192461e-13
13 O 0 8.477980817378494e-11
of O 0 6.649614669659853e-13
20 O 0 8.046886768031669e-11
Ashkenazi O 0 1.6584562612109721e-09
I1307K O 0 3.6209439890910744e-09
carriers O 0 2.3492677247993754e-10
, O 0 2.9767761606375176e-12
8 O 0 2.567629919444925e-12
of O 0 1.27488514536922e-13
whom O 0 3.1744651352028086e-09
also O 0 6.3820544404791235e-09
had O 0 7.171366434022275e-08
a O 0 2.1099427760518097e-10
personal O 0 4.1698149289004505e-07
or O 0 5.0391662398396875e-08
family O 0 1.9683399798964274e-08
history O 0 7.147135661078607e-10
of O 0 7.646663857663327e-11
noncolonic O 0 0.00011328589607728645
neoplasia B-Disease 0 8.82383537827991e-05
. O 0 2.0198390515702158e-08

CONCLUSIONS O 0 1.0740739497805407e-07
The O 0 1.0588736831795842e-10
I1307K O 0 1.7084778392018052e-07
APC O 0 5.337954789297328e-08
variant O 0 8.773061921374392e-08
may O 0 9.945699125379903e-11
represent O 0 1.3537918615996736e-12
a O 0 1.2277236519087076e-12
susceptibility O 0 4.7269357317247795e-09
gene O 0 1.2567812746056006e-07
for O 0 1.231536539414435e-09
colorectal B-Disease 1 1.0
, I-Disease 0 1.1934099930499542e-08
or I-Disease 0 1.8290192693726226e-09
other I-Disease 0 3.8292632953407235e-11
, I-Disease 0 5.467015729010427e-10
cancers I-Disease 0 1.5955804144596186e-07
in O 0 1.049753166337819e-12
Ashkenazi O 0 6.984875455806616e-10
Jews O 0 1.7326834411690584e-11
, O 0 1.8870623813560528e-11
and O 0 2.0190888891380432e-11
partially O 0 5.8683662373937295e-09
explains O 0 1.2849014074944876e-09
the O 0 4.592894532577663e-13
higher O 0 2.065607684897941e-10
incidence O 0 0.002116738585755229
of O 0 1.1418423127906863e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 9.08240926911219e-10
European O 0 3.1166699776541407e-10
Israelis O 0 4.104564652607223e-07
. O 0 3.953218641328249e-09

Systematic O 0 3.317010666137321e-08
analysis O 0 9.823760693805639e-10
of O 0 3.415822832919524e-11
coproporphyrinogen O 0 9.198978659696877e-06
oxidase O 0 0.00016936470638029277
gene O 0 0.00014466042921412736
defects O 1 0.9994032382965088
in O 0 2.522680953020995e-10
hereditary B-Disease 0 0.019617807120084763
coproporphyria I-Disease 0 0.007312601897865534
and O 0 3.7396210572637756e-09
mutation O 0 5.551282811211422e-08
update O 0 1.416310198010251e-07
. O 0 7.85190312768691e-09

Hereditary B-Disease 1 0.8564150929450989
coproporphyria I-Disease 0 0.0020481026731431484
( O 0 4.772840789257771e-09
HC B-Disease 0 0.00014964195725042373
) O 0 7.202916596504849e-10
is O 0 3.5114677832126517e-09
an O 0 8.96602525557455e-09
acute O 1 0.9998444318771362
hepatic B-Disease 1 0.9999990463256836
porphyria I-Disease 1 0.9999998807907104
with O 0 1.0602252586977556e-05
autosomal O 1 0.9999899864196777
dominant O 0 0.004423308186233044
inheritance O 0 1.5383538993773982e-05
caused O 0 7.250075100273534e-07
by O 0 3.8264325041836855e-10
deficient B-Disease 0 1.6787780623417348e-05
activity I-Disease 0 8.053237934291246e-07
of I-Disease 0 1.7941818170053025e-11
coproporphyrinogen I-Disease 0 1.6780000805738382e-05
III I-Disease 0 1.91738272405928e-05
oxidase I-Disease 0 2.5624556656111963e-05
( O 0 8.0040146732685e-10
CPO O 0 7.726289368292782e-06
) O 0 2.9487220998269947e-10
. O 0 4.763071603797187e-10

Clinical O 0 1.002100088953739e-05
manifestations O 0 5.1435556258638826e-08
of O 0 1.4880504814462903e-11
the O 0 6.089154180877188e-11
disease O 0 8.258420712081715e-05
are O 0 8.358198681779339e-12
characterized O 0 1.0616798107321301e-08
by O 0 2.649587771408335e-10
acute O 0 2.133471571141854e-05
attacks O 0 0.00023265910567715764
of O 0 5.684323234333988e-09
neurological B-Disease 1 0.9999953508377075
dysfunction I-Disease 1 0.7062464356422424
often O 0 6.933563057032188e-09
precipitated O 0 3.4785501146217257e-09
by O 0 1.9913556480871675e-12
drugs O 0 7.352966846507769e-11
, O 0 7.074618126566568e-13
fasting O 0 1.3761645989429638e-10
, O 0 9.544301113328935e-13
cyclical O 0 2.2253651366099803e-07
hormonal O 0 5.050684137586359e-08
changes O 0 3.558290051497437e-10
, O 0 1.0814667911196452e-10
or O 0 1.9515587368346132e-08
infectious B-Disease 0 1.4066521316635772e-06
diseases I-Disease 0 5.000113742426038e-05
. O 0 5.906568567581871e-09

Skin O 1 0.998904824256897
photosensitivity O 1 0.9980892539024353
may O 0 6.6944271566171665e-06
also O 0 4.267735498331149e-09
be O 0 1.973702590252202e-10
present O 0 5.602067143506417e-10
. O 0 1.6434015259747525e-09

The O 0 1.9769741399500163e-09
seven O 0 1.0832380825664956e-10
exons O 0 1.6952195203145948e-09
, O 0 4.527006373933329e-12
the O 0 7.779348996581059e-13
exon O 0 6.146851916355445e-09
/ O 0 1.0146649401576724e-05
intron O 0 1.0351469427405391e-05
boundaries O 0 6.200289703883755e-08
and O 0 1.3744462512566002e-10
part O 0 3.1563255481481534e-11
of O 0 3.143764816613409e-13
3 O 0 2.2980027169355877e-12
noncoding O 0 1.3477086113766745e-09
sequence O 0 1.545523153900774e-10
of O 0 1.0038574382561019e-13
the O 0 5.541176241810608e-13
CPO O 0 9.443315462931423e-09
gene O 0 1.29898355960556e-10
were O 0 3.8550720775354375e-12
systematically O 0 1.0135349226558787e-09
analyzed O 0 3.165525827575344e-11
by O 0 1.375931568117425e-13
an O 0 7.128619119696825e-14
exon O 0 2.789553033011316e-10
- O 0 1.327113707816352e-08
by O 0 1.168189711631129e-10
- O 0 4.4767242002308194e-07
exon O 0 4.824114512302913e-07
denaturing O 0 4.791361061506905e-05
gradient O 0 1.2292935025470797e-06
gel O 0 6.197133757268602e-07
electrophoresis O 0 1.391299253583611e-08
( O 0 1.7544757313636694e-11
DGGE O 0 1.0544991546623805e-08
) O 0 1.00539281761014e-12
strategy O 0 3.747964438804985e-11
followed O 0 4.672390946369731e-13
by O 0 2.2192752803106182e-14
direct O 0 1.2948782671107217e-12
sequencing O 0 4.350352716953054e-11
in O 0 2.381173383469992e-12
seven O 0 7.824576923887161e-12
unrelated O 0 2.5471762477025095e-09
heterozygous O 0 3.762259552786418e-07
HC B-Disease 0 2.0285962818888947e-05
patients O 0 1.612431503872358e-07
from O 0 1.5270774922360175e-10
France O 0 6.630961593145912e-07
, O 0 6.427163801170366e-10
Holland O 0 1.7103276377383736e-06
, O 0 1.826395212845e-08
and O 0 1.5901194672096608e-07
Czech O 0 3.070500315516256e-05
Republic O 0 2.852361262739578e-07
. O 0 1.2812116700899878e-08

Seven O 0 7.128596379857299e-09
novel O 0 1.594371301649744e-09
mutations O 0 1.1106589425935454e-08
and O 0 2.138105664739598e-11
two O 0 2.0192408942826257e-13
new O 0 3.99741654708019e-12
polymorphisms O 0 4.07073521557777e-08
were O 0 1.4025905992198773e-09
detected O 0 4.296454676477879e-07
. O 0 1.6106502798152178e-09

Among O 0 1.125595283646419e-09
these O 0 7.64931520902401e-12
mutations O 0 6.382562256490587e-10
two O 0 4.9205279607777985e-12
are O 0 8.984636819253655e-12
missense O 0 1.8003410318101487e-08
( O 0 6.8930586065441e-12
G197W O 0 9.687062707541827e-09
, O 0 5.675182112446775e-12
W427R O 0 3.3615463190805883e-10
) O 0 9.89522591469949e-13
, O 0 4.005323416683693e-12
two O 0 5.731211403896264e-13
are O 0 5.11804270839078e-12
nonsense O 0 8.707727516821251e-08
( O 0 1.0267115933479398e-12
Q306X O 0 8.385416250256128e-10
, O 0 2.63794671870321e-12
Q385X O 0 1.8622027531112195e-10
) O 0 6.683016770189787e-13
, O 0 6.704684008505823e-13
two O 0 5.766152393884769e-14
are O 0 9.292383756995953e-14
small O 0 1.154997104901856e-12
deletions O 0 4.738406333970602e-10
( O 0 7.253907544080285e-12
662de14bp O 0 2.682340571880104e-09
; O 0 8.302651101355085e-12
1168del3bp O 0 7.0127792461960325e-09
removing O 0 1.3249049635177812e-09
a O 0 1.3598353346133685e-11
glycine O 0 9.763666541928728e-10
at O 0 3.806552295593235e-10
position O 0 1.4177324592079543e-10
390 O 0 1.377645775235692e-10
) O 0 6.281910755467912e-13
, O 0 1.3914982447543744e-12
and O 0 2.3568412846342035e-12
one O 0 6.496927561910892e-13
is O 0 5.110294782825764e-13
a O 0 3.967191972067269e-13
splicing O 0 7.650650668544756e-10
mutation O 0 2.0774888753738452e-10
( O 0 9.045110146987945e-12
IVS1 O 0 3.8834934912301833e-07
- O 0 2.9663374334631953e-07
15c O 0 6.12731810178957e-07
- O 0 2.070708205792471e-06
- O 0 1.0849594218598213e-06
> O 0 5.568520089482831e-10
g O 0 6.311440814421587e-10
) O 0 4.3999079011279585e-13
which O 0 1.146419981515323e-12
creates O 0 1.0988300547243313e-11
a O 0 9.885982006976879e-13
new O 0 2.8405027895778145e-12
acceptor O 0 3.456865696471745e-11
splice O 0 4.119968721738587e-08
site O 0 1.4763716649213166e-07
. O 0 1.9555446151287015e-09

The O 0 6.963269544302264e-11
pathological O 0 1.8201355089786375e-08
significance O 0 4.372449624590047e-10
of O 0 3.722448510459081e-13
the O 0 1.2491093229205497e-12
point O 0 1.463339033280775e-10
mutations O 0 4.949807785870064e-10
G197W O 0 1.277786987330387e-09
, O 0 1.0642482988626467e-12
W427R O 0 4.161935518443016e-10
, O 0 3.896454339735733e-12
and O 0 1.8313660050256475e-12
the O 0 1.5863841544647844e-13
in O 0 2.038707744289603e-12
- O 0 5.574061106017325e-07
frame O 0 5.350295850803377e-06
deletion O 0 2.44605757870886e-08
390delGly O 0 2.578102353822942e-08
were O 0 8.2167016246526e-11
assessed O 0 5.018960247404891e-10
by O 0 1.1854542521227973e-11
their O 0 2.989745603865224e-11
respective O 0 5.871383240707573e-11
expression O 0 1.5730619931653145e-11
in O 0 5.6041712340627187e-14
a O 0 8.181397182990824e-13
prokaryotic O 0 4.313008283851616e-11
system O 0 3.1113154587425473e-12
using O 0 7.39362043811198e-12
site O 0 4.316513013691292e-07
- O 0 2.442545508074545e-07
directed O 0 8.546373386764117e-09
mutagenesis O 0 5.602702231044532e-07
. O 0 3.972386419803797e-09

These O 0 4.0601386142036233e-10
mutations O 0 3.371372292448882e-09
resulted O 0 2.5718574492294977e-10
in O 0 5.9167302134122135e-12
the O 0 3.908907485888902e-12
absence O 0 1.3994713721210417e-10
or O 0 6.362588927943946e-11
a O 0 1.5529688646154227e-11
dramatic O 0 5.059233476600866e-09
decrease O 0 2.46211726562251e-08
of O 0 1.5281109710940655e-11
CPO O 0 0.00046725900028832257
activity O 0 3.141188926747418e-06
. O 0 2.5816488946617255e-09

The O 0 5.524487464714234e-11
two O 0 6.472650974226335e-12
polymorphisms O 0 1.2385358516553424e-08
were O 0 1.6260886734342783e-11
localized O 0 1.0390936999726819e-08
in O 0 2.7608085088892675e-12
noncoding O 0 4.2921868725898094e-08
part O 0 1.9317843158450643e-10
of O 0 1.5722414147510688e-13
the O 0 6.75708539685585e-14
gene O 0 3.203181817013068e-11
1 O 0 1.7609210530705743e-13
) O 0 1.6041413531710236e-13
a O 0 6.3494201216207635e-12
C O 0 1.582915309938926e-08
/ O 0 2.97573848229149e-07
G O 0 3.6435428008019244e-09
polymorphism O 0 2.8008357855213717e-09
in O 0 3.839156423324219e-12
the O 0 1.168765713550901e-12
promotor O 0 9.485977159329195e-08
region O 0 2.374382079839421e-10
, O 0 1.5382604044711368e-12
142 O 0 2.875231996934957e-11
bp O 0 9.41967281953282e-10
upstream O 0 1.1152366530264857e-10
from O 0 5.091439964945155e-13
the O 0 1.0417561317711474e-13
transcriptional O 0 8.288825875668593e-11
initiation O 0 4.370502224015915e-12
site O 0 1.5085993565477906e-09
( O 0 1.961919125423317e-12
- O 0 3.808246606951116e-09
142C O 0 5.8671578706537275e-09
/ O 0 6.490477488796387e-08
G O 0 9.90764803532329e-10
) O 0 4.912226766844163e-13
, O 0 9.046813862281788e-13
and O 0 7.177123478863123e-13
2 O 0 1.9944259460093205e-13
) O 0 8.148828969456803e-14
a O 0 9.053217702413574e-13
6 O 0 3.642967438127753e-12
bp O 0 4.04322214597741e-10
deletion O 0 7.754143854787898e-11
polymorphism O 0 1.117679726547749e-09
in O 0 5.174147135050822e-12
the O 0 8.979682232165831e-13
3 O 0 2.182018021129606e-12
noncoding O 0 1.2630039236682933e-09
part O 0 5.0239475773983244e-11
of O 0 2.0749076285256352e-13
the O 0 1.8830336595554442e-13
CPO O 0 5.59297319568941e-09
gene O 0 3.870523693216832e-11
, O 0 1.1627223706414669e-12
574 O 0 4.595563166120975e-11
bp O 0 9.84315406959979e-10
downstream O 0 1.9941742701590215e-10
of O 0 1.2803851674649674e-13
the O 0 7.370286564216399e-13
last O 0 2.984054323085239e-11
base O 0 1.1577553499231286e-10
of O 0 4.759193188738457e-14
the O 0 7.323203458572958e-13
normal O 0 2.0085049179385805e-09
termination O 0 1.9791472904984175e-09
codon O 0 3.063042708362218e-09
( O 0 5.4034547669612465e-11
+ O 0 1.0770688341210644e-08
574 O 0 1.9936665651698604e-08
delATTCTT O 0 6.372617633587652e-08
) O 0 7.5197936766358e-10
. O 0 2.637709162200963e-09

Five O 0 5.568884464679513e-09
intragenic O 0 5.984385893498256e-07
dimorphisms O 0 4.460623870272684e-07
are O 0 3.044941382368549e-11
now O 0 5.848481421377727e-11
well O 0 5.360693985066722e-13
characterized O 0 2.965518941522305e-10
and O 0 3.0170071302348944e-11
the O 0 5.891502021480866e-13
high O 0 1.6995374552131182e-10
degree O 0 1.740044740239366e-12
of O 0 5.907480450997871e-13
allelic O 0 1.9143742591154478e-08
heterogeneity O 0 1.0852762244439873e-08
in O 0 8.743847312864261e-11
HC B-Disease 0 4.252173675922677e-05
is O 0 2.303386148483355e-09
demonstrated O 0 9.53623624511124e-10
with O 0 8.832964199477489e-13
seven O 0 2.814625431595691e-13
new O 0 1.0742573958210169e-13
different O 0 2.2215366888731977e-14
mutations O 0 4.559832546269238e-12
making O 0 5.5258441052086216e-12
a O 0 8.754223040918774e-12
total O 0 4.210318205188912e-11
of O 0 4.267281406705736e-12
nineteen O 0 8.873255907815292e-09
CPO O 0 0.00012416696699801832
gene B-Disease 0 8.989795787783805e-06
defects I-Disease 0 0.13726404309272766
reported O 0 1.1797131946877926e-06
so O 0 6.250951978259423e-10
far O 0 5.110877832059657e-10
. O 0 2.7893017756630556e-11
. O 0 4.098176520361818e-10

Coincidence O 0 6.779606565032736e-08
of O 0 3.2503371522052404e-11
two O 0 5.255267141596187e-12
novel O 0 1.8095001885765072e-10
arylsulfatase O 0 9.827292046793445e-08
A O 0 3.551365798659667e-11
alleles O 0 8.189383199352918e-11
and O 0 6.257303702961181e-12
mutation O 0 1.8035125615156744e-09
459 O 0 1.703387830787051e-08
+ O 0 1.3352007499634055e-07
1G O 0 4.070419890922494e-06
> O 0 1.2309265606802455e-08
A O 0 3.3809394173189844e-10
within O 0 2.795389440757301e-11
a O 0 8.393413741814015e-11
family O 0 3.3647799568825576e-07
with O 0 9.859603977702136e-08
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 0.9999997615814209
: O 0 4.137373776913478e-11
molecular O 0 3.428224371049282e-11
basis O 0 1.573464102067046e-11
of O 0 2.375095129250604e-12
phenotypic O 0 1.2121265058340214e-07
heterogeneity O 0 1.2725289479931234e-06
. O 0 7.428592851965732e-08

In O 0 8.474282386927712e-10
a O 0 2.500572526820122e-10
family O 0 2.1623138835025202e-08
with O 0 9.291140079525917e-11
three O 0 4.0031106901539104e-11
siblings O 0 9.096456032864353e-09
, O 0 6.247727162012051e-12
one O 0 1.0222076006830005e-12
developed O 0 3.08198015719352e-11
classical O 0 1.1279119860319042e-09
late O 0 2.7311675694363657e-06
infantile O 1 0.99994957447052
metachromatic B-Disease 1 0.9999998807907104
leukodystrophy I-Disease 1 0.9999996423721313
( O 0 4.035344502995031e-08
MLD B-Disease 1 0.9999731779098511
) O 0 1.4815090820796684e-10
, O 0 8.820830350864117e-12
fatal O 0 2.330670989536543e-09
at O 0 4.198021930079676e-09
age O 0 1.801779614396537e-09
5 O 0 2.8723542641606592e-11
years O 0 2.5533998526672264e-11
, O 0 9.956854785109215e-12
with O 0 1.1549801046117913e-11
deficient O 0 6.563917054336343e-07
arylsulfatase O 0 5.377686917995561e-08
A O 0 3.585719221543826e-10
( O 0 5.436740467545942e-12
ARSA O 0 1.301938709730166e-06
) O 0 2.3670813573128946e-12
activity O 0 4.437912259902532e-09
and O 0 1.979062053125702e-11
increased O 0 6.30227425801877e-10
galactosylsulfatide O 0 2.9511134016502183e-06
( O 0 8.267313056364856e-09
GS O 1 0.9999991655349731
) O 0 9.319738314417236e-10
excretion O 0 1.545406824732254e-08
. O 0 1.6163036464789116e-09

The O 0 5.981481421279966e-10
two O 0 5.0985392990865464e-11
other O 0 8.318978318710979e-12
siblings O 0 1.6399790414567406e-09
, O 0 3.53116980100765e-11
apparently O 0 4.189998570325315e-09
healthy O 0 2.7945070701917984e-09
at O 0 5.122872126506195e-10
12 O 0 1.0176151588048299e-11
( O 0 4.971438300090114e-13
1 O 0 4.685663749365299e-12
/ O 0 3.2975347608044103e-07
2 O 0 1.0523598485689956e-11
) O 0 3.113357661954641e-12
and O 0 2.601239536270672e-11
15 O 0 3.295481075527018e-12
years O 0 1.8345333932523467e-12
, O 0 4.3921520608870834e-13
respectively O 0 4.126448748670297e-12
, O 0 3.146413685151117e-11
and O 0 1.1904510710536442e-10
their O 0 5.069252309586325e-12
father O 0 7.434231008573988e-09
, O 0 2.3934357100408032e-12
apparently O 0 1.3960294031889475e-10
healthy O 0 1.052920389765788e-10
as O 0 7.113722046321602e-13
well O 0 3.5793267221667646e-12
, O 0 1.4087978830387704e-12
presented O 0 1.8082167707600405e-10
ARSA O 0 0.011594792827963829
and O 0 3.9408894281223183e-07
GS O 1 0.9999994039535522
values O 0 2.296949963564998e-09
within O 0 4.068878914353924e-12
the O 0 7.624402953605725e-13
range O 0 4.242802109644117e-09
of O 0 8.731015216367766e-11
MLD B-Disease 1 0.9999970197677612
patients O 0 4.414966880972315e-08
. O 0 1.3543027810314356e-09

Mutation O 0 7.086249098620101e-08
screening O 0 2.1063732980053373e-09
and O 0 8.259767002305463e-12
sequence O 0 3.436814027812929e-11
analysis O 0 5.008562314889886e-11
disclosed O 0 7.45359685083713e-09
the O 0 6.154816782101558e-13
involvement O 0 1.6151388004814748e-09
of O 0 1.3285849200309063e-12
three O 0 1.0194024444021288e-11
different O 0 2.0473440651147534e-11
ARSA O 0 0.0006205885438248515
mutations O 0 7.051568662319596e-09
being O 0 8.30722816924645e-12
the O 0 2.6409796116504125e-14
molecular O 0 2.0740935011143158e-12
basis O 0 1.1115388991178587e-11
of O 0 1.4257795248259764e-12
intrafamilial O 0 6.911001264597871e-07
phenotypic O 0 1.0260479257340194e-06
heterogeneity O 0 2.0448842406040058e-06
. O 0 7.915089383914165e-08

The O 0 3.8987330031048373e-10
late O 0 4.1676351258956856e-08
infantile O 1 0.9993195533752441
patient O 0 0.057136863470077515
inherited O 0 0.004505100194364786
from O 0 7.729989426330519e-10
his O 0 1.7486186720816477e-08
mother O 0 1.307608670231275e-07
the O 0 3.3517969216106946e-13
frequent O 0 1.6786555478986998e-09
0 O 0 2.0615968654436045e-10
- O 0 6.226028972378117e-07
type O 0 7.670640115975402e-06
mutation O 0 5.223518684260853e-08
459 O 0 2.451377412171496e-08
+ O 0 3.039236418089786e-08
1G O 0 3.998653141934483e-07
> O 0 2.898554063435199e-09
A O 0 1.4641018397654193e-09
, O 0 1.0444655557106941e-10
and O 0 5.215814932735263e-11
from O 0 4.86381421249682e-12
his O 0 6.413926056936248e-10
father O 0 3.081495281165303e-09
a O 0 2.5298771324372415e-12
novel O 0 5.500399441471515e-11
, O 0 3.5747826140214434e-12
single O 0 3.711357263180837e-11
basepair O 0 1.016867834380264e-08
microdeletion O 0 6.615800351994494e-09
of O 0 8.478537425089805e-13
guanine O 0 4.48785092421744e-10
at O 0 1.7764408000164877e-11
nucleotide O 0 1.2200331023226596e-10
7 O 0 2.2239142818958335e-11
in O 0 1.173051456318519e-12
exon O 0 2.0839665548777475e-09
1 O 0 1.951169781300166e-10
( O 0 9.264007963527554e-12
7delG O 0 5.1719275973027834e-08
) O 0 7.74812713988382e-11
. O 0 2.458712677899655e-10

The O 0 6.480662118057978e-10
two O 0 3.3717048597559085e-10
clinically O 0 4.1625709854997694e-05
unaffected O 0 2.5027160518220626e-05
siblings O 0 1.452502971233116e-07
carried O 0 7.67996866102294e-09
the O 0 3.2535857688587022e-12
maternal O 0 2.4573654400228406e-07
mutation O 0 1.7586161860094762e-08
459 O 0 3.0983642318460625e-08
+ O 0 7.875604524087976e-08
1G O 0 4.385809688756126e-07
> O 0 2.890714112524506e-09
A O 0 9.45235667515476e-10
and O 0 1.9274229434707024e-10
, O 0 2.048578320867911e-11
on O 0 7.429818427162616e-10
their O 0 3.807284001955402e-11
paternal O 0 2.0387195931448332e-08
allele O 0 6.299726851288767e-10
, O 0 1.180404190191664e-12
a O 0 7.066391200481748e-13
novel O 0 1.9299860321009277e-11
cytosine O 0 3.9142533658775847e-10
to O 0 5.181828273762012e-13
thymidine O 0 1.4604230047510214e-09
transition O 0 7.777535837583116e-10
at O 0 6.570873012368139e-11
nucleotide O 0 1.1297486279815416e-09
2435 O 0 4.8611809688736685e-08
in O 0 1.3406382124228622e-12
exon O 0 4.633685102284346e-10
8 O 0 7.596757944927646e-11
, O 0 7.668564134394318e-13
resulting O 0 1.0216385029626629e-12
in O 0 5.405229622180638e-14
substitution O 0 9.496241466788735e-12
of O 0 9.843496460645862e-13
alanine O 0 3.313532914717143e-08
464 O 0 2.0015602508749453e-09
by O 0 3.244644483646475e-11
valine O 0 5.510414666787256e-07
( O 0 3.938898859856543e-11
A464V O 0 2.225368689323659e-08
) O 0 4.6358952787706187e-10
. O 0 3.530996606215808e-10

The O 0 3.9195673373626505e-09
fathers O 0 2.3008581706562836e-08
genotype O 0 2.9269948242927057e-08
thus O 0 1.178688813219253e-10
was O 0 2.5086044352917725e-09
7delG O 0 1.6361201460313168e-06
/ O 0 4.098988210898824e-05
A464V O 0 3.2733294119680068e-06
. O 0 1.3849291491396798e-08

Mutation O 0 3.7676380770790274e-07
A464V O 0 1.5290498822650989e-07
was O 0 1.3828116429692727e-09
not O 0 6.882981597872151e-12
found O 0 1.352509142009406e-12
in O 0 3.1710815613997245e-13
18 O 0 7.401666779482952e-11
unrelated O 0 8.960233799371053e-08
MLD B-Disease 1 0.9999998807907104
patients O 0 2.288128825966851e-06
and O 0 7.101085275351693e-10
50 O 0 2.5750885868092155e-09
controls O 0 1.3977267371956259e-05
. O 0 7.593624928858844e-08

A464V O 0 6.70934298341308e-07
, O 0 1.9090742875427225e-10
although O 0 1.2616977775048444e-11
clearly O 0 3.770257717139458e-10
modifying O 0 9.14534510343401e-08
ARSA O 1 0.8478084802627563
and O 0 6.3872594182612374e-06
GS O 1 1.0
levels O 0 9.081166929547635e-09
, O 0 4.449559644348344e-12
apparently O 0 1.771308932863036e-10
bears O 0 7.067786633729867e-11
little O 0 4.508583176937586e-12
significance O 0 1.2982323549515229e-11
for O 0 8.182926992256201e-13
clinical O 0 4.5411766014247235e-10
manifestation O 0 4.456436997202218e-09
of O 0 1.7821941145079734e-10
MLD B-Disease 1 0.9999991655349731
, O 0 6.409670016971347e-10
mimicking O 0 1.1654516640646762e-07
the O 0 1.7920724626474538e-10
frequent O 0 1.2247063523318502e-06
ARSA O 0 0.2558750808238983
pseudodeficiency O 0 2.5273626306443475e-05
allele O 0 1.5824585943846614e-06
. O 0 8.741621648766795e-09

Our O 0 1.407817773468878e-08
results O 0 1.3693358946742507e-10
demonstrate O 0 4.0853674609930835e-11
that O 0 1.8947713678000438e-13
in O 0 3.090853040090685e-14
certain O 0 1.9853333386998795e-12
genetic O 0 9.06452228832677e-08
conditions O 0 1.1811564490926685e-06
MLD B-Disease 1 0.9999997615814209
- O 0 0.1406829059123993
like O 0 4.1770979919419915e-07
ARSA O 1 0.858194887638092
and O 0 4.5418829586196807e-07
GS O 1 0.9999984502792358
values O 0 1.5973207201369632e-09
need O 0 5.403122393943249e-12
not O 0 4.3769152256560584e-13
be O 0 7.482350920491945e-14
paralleled O 0 2.789430630922851e-10
by O 0 6.87505694735302e-12
clinical O 0 4.027562994224354e-08
disease O 0 2.466306341375457e-06
, O 0 4.1148399791690604e-12
a O 0 4.107453526608351e-12
finding O 0 4.945520729049413e-11
with O 0 2.8280058850249645e-11
serious O 0 2.90739254893424e-08
diagnostic O 0 1.7251054487132933e-06
and O 0 2.8111115657480923e-09
prognostic O 0 2.2327030819724314e-05
implications O 0 2.1366010116707912e-07
. O 0 1.4307405038493926e-08

Moreover O 0 1.0721643661781854e-07
, O 0 9.247704824133507e-10
further O 0 3.156725991715348e-09
ARSA O 1 0.8900154829025269
alleles O 0 3.992670016828015e-08
functionally O 0 1.500238511198404e-08
similar O 0 1.2644062186151217e-10
to O 0 1.1067957314536692e-11
A464V O 0 3.783112134669864e-08
might O 0 6.800373042459285e-10
exist O 0 3.897377559569648e-11
which O 0 5.726865162647421e-12
, O 0 3.8458602621971316e-13
together O 0 3.514006305990053e-13
with O 0 4.81155913722997e-13
0 O 0 7.915259420121501e-11
- O 0 5.454561232909327e-06
type O 0 2.7276271794107743e-05
mutations O 0 2.5023261684964382e-08
, O 0 1.0425264818092472e-11
may O 0 3.6051040624984765e-11
cause O 0 2.6919746987097426e-10
pathological O 0 6.211490926943952e-06
ARSA O 1 0.9998891353607178
and O 0 0.0003207419940736145
GS O 1 1.0
levels O 0 4.5807279747123175e-08
, O 0 3.329033880158927e-12
but O 0 2.815501954842037e-12
not O 0 3.0769800769825384e-12
clinical O 0 5.7663266522789414e-11
outbreak O 0 4.330834801891115e-09
of O 0 2.988847233945102e-13
the O 0 8.321362349184014e-11
disease O 0 4.075026299688034e-05
. O 0 1.5817155918362857e-10
. O 0 3.0174704956920095e-09

Human O 0 0.00010503480734769255
MLH1 O 1 0.9993464350700378
deficiency O 1 0.9992432594299316
predisposes O 0 9.244968532584608e-05
to O 0 6.070281610703887e-09
hematological B-Disease 1 0.9584509134292603
malignancy I-Disease 1 0.9376296997070312
and O 0 1.9106323634332512e-07
neurofibromatosis B-Disease 1 0.9892907738685608
type I-Disease 0 0.0006189582054503262
1 I-Disease 0 3.27614699813239e-08
. O 0 3.2750161693684277e-08

Heterozygous O 0 0.00022599803924094886
germ O 0 0.001850247965194285
- O 0 0.0005649708327837288
line O 0 8.124562214106845e-07
mutations O 0 5.241200806693769e-09
in O 0 3.3238800709219085e-13
the O 0 2.882262842025113e-13
DNA O 0 1.377242586642069e-08
mismatch O 0 9.673860859038541e-07
repair O 0 2.150790714949835e-05
genes O 0 4.9733483109548615e-08
lead O 0 2.708369084558626e-09
to O 0 1.739059563021783e-08
hereditary B-Disease 1 0.999997615814209
nonpolyposis I-Disease 1 0.9999997615814209
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 5.715261067962274e-06

The O 0 5.745393605316451e-10
disease O 0 1.8658756744116545e-06
susceptibility O 0 2.04421638727581e-07
of O 0 5.6731397357623337e-11
individuals O 0 5.347482812112503e-08
who O 0 5.479558922161232e-07
constitutionally O 0 1.725671609165147e-05
lack O 0 5.144867643025464e-09
both O 0 1.0688953194781803e-11
wild O 0 3.750306731831188e-09
- O 0 7.207731414382579e-06
type O 0 6.330100404738914e-06
alleles O 0 4.289165023152464e-09
is O 0 1.8253425437819715e-09
unknown O 0 3.222428546223455e-08
. O 0 2.6648798723272193e-09

We O 0 5.1093525854639665e-08
have O 0 4.875836193130034e-11
identified O 0 2.6149107879014366e-10
three O 0 8.073952205596424e-13
offspring O 0 1.1645812092453411e-10
in O 0 7.777617092030731e-12
a O 0 2.2041376723791473e-08
hereditary B-Disease 1 0.999998927116394
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.020785972476005554
who O 0 1.4682868254567438e-07
developed O 0 8.421745434361583e-08
hematological B-Disease 0 0.006447222549468279
malignancy I-Disease 0 0.00011327563697705045
at O 0 3.246969582093584e-09
a O 0 2.4522762293033296e-11
very O 0 8.424877982748935e-12
early O 0 5.8314694219296914e-12
age O 0 8.916491156529815e-11
, O 0 1.445665744233271e-12
and O 0 9.481268851627145e-13
at O 0 3.637088893948537e-11
least O 0 6.462190157985326e-12
two O 0 3.001901841253457e-13
of O 0 6.570738148459904e-14
them O 0 7.546050589946063e-12
displayed O 0 1.524427872823253e-08
signs O 0 2.886914387545403e-07
of O 0 1.0885022917739295e-11
neurofibromatosis B-Disease 0 0.0013616228243336082
type I-Disease 0 1.2503101970651187e-05
1 I-Disease 0 7.738619745012443e-10
( O 0 4.365274808293407e-10
NF1 B-Disease 0 9.005153515317943e-06
) O 0 1.5113988949266854e-09
. O 0 2.0846067094737464e-09

DNA O 0 2.9572806425903764e-08
sequence O 0 6.252096618197811e-10
analysis O 0 7.396981638319033e-11
and O 0 3.650033834207145e-12
allele O 0 1.1678761291378237e-09
- O 0 3.835085138348404e-09
specific O 0 6.448477168907729e-11
amplification O 0 1.4369314627060703e-09
in O 0 4.1339084932978665e-12
two O 0 6.386196692992341e-12
siblings O 0 1.2748463396050624e-09
revealed O 0 2.465226689452038e-09
a O 0 2.5953877935691594e-10
homozygous O 0 4.7708367674204055e-06
MLH1 O 0 0.0005303495563566685
mutation O 0 2.188541259329213e-08
( O 0 9.409289319917136e-11
C676T O 0 7.799931012186789e-08
- O 0 0.0001180642211693339
- O 0 3.060508242924698e-05
> O 0 3.287809491325788e-08
Arg226Stop O 0 5.827372433486744e-07
) O 0 2.82349088553957e-10
. O 0 6.054182710713008e-10

Thus O 0 4.296566658013035e-09
, O 0 5.971971528406783e-11
a O 0 3.450061070164878e-11
homozygous O 0 2.6030457433989795e-07
germ O 0 0.0013173418119549751
- O 0 0.0007817682926543057
line O 0 0.00018198566976934671
MLH1 O 0 0.059322796761989594
mutation O 0 5.6737000875273225e-08
and O 0 9.173843629195488e-11
consequent O 0 1.3206297921897203e-07
mismatch O 1 0.509010910987854
repair O 1 0.9999617338180542
deficiency O 1 0.9999616146087646
results O 0 2.3672066529201174e-09
in O 0 8.85456031413101e-12
a O 0 8.292119213493265e-10
mutator O 0 0.01747644692659378
phenotype O 0 6.856539584987331e-07
characterized O 0 1.091905854622155e-08
by O 0 1.5433844480217118e-10
leukemia B-Disease 0 0.04933984950184822
and O 0 4.1843939868613234e-08
/ O 1 0.9999939203262329
or O 1 0.9998993873596191
lymphoma B-Disease 1 1.0
associated O 0 0.0003173541044816375
with O 0 1.8406531410164462e-08
neurofibromatosis B-Disease 1 0.997374415397644
type I-Disease 0 0.004233202897012234
1 I-Disease 0 2.231224316417979e-09
. O 0 7.399624246673397e-10
. O 0 3.959950145571156e-09

Missense O 0 0.00024644003133289516
mutations O 0 3.2141545602826227e-07
in O 0 9.460644073699953e-12
the O 0 5.709259020408863e-13
most O 0 2.0445633846979255e-13
ancient O 0 1.7657078056620978e-12
residues O 0 5.587766915837733e-10
of O 0 4.177461328247478e-13
the O 0 4.920565691013401e-12
PAX6 O 0 2.0877566839772044e-06
paired O 0 6.634814919692644e-10
domain O 0 7.075762198383018e-10
underlie O 0 1.272273952857006e-09
a O 0 1.5085632396050208e-11
spectrum O 0 7.022921688637496e-10
of O 0 7.464469146956088e-12
human O 0 4.7260095925594214e-07
congenital B-Disease 1 0.9999943971633911
eye I-Disease 1 0.9996498823165894
malformations I-Disease 1 0.9996224641799927
. O 0 1.1982965588686056e-06

Mutations O 0 8.622280915915326e-07
of O 0 1.1387797822781653e-11
the O 0 7.519384420673347e-12
human O 0 9.56002166319081e-10
PAX6 O 0 9.817557292990386e-05
gene O 0 1.4141700376057997e-05
underlie O 0 0.0015400309348478913
aniridia B-Disease 1 0.9999998807907104
( O 0 2.6979098493029596e-06
congenital B-Disease 1 0.9999996423721313
absence I-Disease 0 2.663184659468243e-07
of I-Disease 0 1.6045468773095983e-11
the I-Disease 0 3.606046364290627e-11
iris I-Disease 0 1.5884515960351564e-05
) O 0 2.4469683224115357e-11
, O 0 5.1140320277143214e-12
a O 0 7.81668653415668e-12
rare O 0 3.871192255644473e-09
dominant O 0 0.0003992693964391947
malformation B-Disease 1 0.9965409636497498
of I-Disease 0 2.8794702733314637e-10
the I-Disease 0 1.5723197188677318e-09
eye I-Disease 0 0.30937135219573975
. O 0 2.0389437338508287e-07

The O 0 1.7624793291481922e-10
spectrum O 0 2.207443339230508e-09
of O 0 1.2108428842916297e-11
PAX6 O 0 1.633496503927745e-05
mutations O 0 8.081105562496305e-08
in O 0 2.3396001802566957e-10
aniridia B-Disease 1 1.0
patients O 0 2.4941263632172195e-07
is O 0 3.717882945952766e-11
highly O 0 3.977174145575191e-11
biased O 0 1.660295900762776e-08
, O 0 7.173325822229515e-11
with O 0 3.347588048777106e-12
92 O 0 1.564743751236719e-10
% O 0 4.542113755424959e-13
of O 0 1.1218037268426531e-13
all O 0 2.6852247855813083e-11
reported O 0 1.481340632381034e-06
mutations O 0 4.5936920933797865e-09
leading O 0 1.2488438061453166e-10
to O 0 6.44601472893358e-12
premature O 0 8.44552761058992e-10
truncation O 0 7.819903835581954e-09
of O 0 1.578026424808865e-11
the O 0 1.1032843041935969e-11
protein O 0 1.8769798215689804e-10
( O 0 1.1608033327961675e-12
nonsense O 0 8.809645457574788e-09
, O 0 1.1363787921726473e-13
splicing O 0 6.931199104248664e-12
, O 0 3.348448363200973e-13
insertions O 0 1.2471086663357056e-10
and O 0 1.3557273793179947e-12
deletions O 0 4.012267948438897e-11
) O 0 3.6791529024748915e-12
and O 0 2.572999278915855e-11
just O 0 8.239320337111167e-10
2 O 0 2.31677741227565e-12
% O 0 1.6978822861557497e-13
leading O 0 2.4288696054419745e-12
to O 0 9.924119902596229e-14
substitution O 0 2.752269983100075e-12
of O 0 7.399637136753026e-14
one O 0 1.6437438432950757e-12
amino O 0 5.808177831918837e-13
acid O 0 4.513965292047076e-14
by O 0 2.490282116531916e-14
another O 0 1.0704132892558338e-11
( O 0 5.4870366063275444e-12
missense O 0 3.2028811602913265e-08
) O 0 1.3136815246728162e-10
. O 0 9.081542740041471e-10

The O 0 7.667592255566902e-11
extraordinary O 0 6.030887594876688e-11
conservation O 0 1.0281033836767595e-11
of O 0 4.982732637408803e-14
the O 0 3.2393174514283585e-13
PAX6 O 0 5.37667155242616e-08
protein O 0 7.772431309671646e-11
at O 0 2.089660389170689e-11
the O 0 1.4561449105960494e-13
amino O 0 7.740752483442748e-12
acid O 0 1.7850770774735514e-12
level O 0 8.770413323540283e-13
amongst O 0 1.6871870382999948e-13
vertebrates O 0 1.0627316734956871e-11
predicts O 0 4.48258319352135e-09
that O 0 1.3519062605493737e-11
pathological O 0 1.0574119357897871e-07
missense O 0 6.467451839853311e-06
mutations O 0 2.7305088678986067e-07
should O 0 3.588957575573204e-09
in O 0 3.2489471182839402e-12
fact O 0 3.6821594384672807e-11
be O 0 2.6780322751052132e-12
common O 0 1.6727496124357977e-12
even O 0 5.6990787956900935e-12
though O 0 1.0934422638164687e-11
they O 0 4.386913141779525e-12
are O 0 5.21952218859173e-13
hardly O 0 2.778146462878439e-11
ever O 0 1.1169162816848655e-10
seen O 0 1.2416413674998239e-08
in O 0 1.1366536878387734e-10
aniridia B-Disease 1 0.9999988079071045
patients O 0 1.0790246562919492e-07
. O 0 2.2241923858246082e-09

This O 0 6.872582364314539e-11
indicates O 0 5.470666697426907e-10
that O 0 1.5255822863671775e-12
there O 0 6.012565011842552e-12
is O 0 8.879671086967078e-13
a O 0 1.6697245799543459e-12
heavy O 0 6.536656371736171e-08
ascertainment O 0 2.6335792426834814e-06
bias O 0 1.6128127526826574e-06
in O 0 3.107484105105418e-12
the O 0 3.960951710938257e-14
selection O 0 2.8904214633730663e-13
of O 0 7.943316414783103e-14
patients O 0 1.1361588753144858e-11
for O 0 1.1010464729625108e-13
PAX6 O 0 1.1377593978068035e-07
mutation O 0 1.81081205585798e-10
analysis O 0 6.477050840114629e-11
and O 0 2.231000974239894e-11
that O 0 2.1922845483413056e-12
the O 0 4.177009432781986e-12
missing O 0 1.4444559326420858e-08
PAX6 O 0 0.00017658610886428505
missense O 0 2.3511998733738437e-05
mutations O 0 6.978129931667354e-07
frequently O 0 3.807914339404306e-08
may O 0 1.1667518062807858e-09
underlie O 0 1.5760758742544567e-06
phenotypes O 0 1.6130850326590007e-06
distinct O 0 1.3933866505055903e-08
from O 0 2.1540143002596324e-09
textbook O 0 0.001549609238281846
aniridia B-Disease 1 0.9999984502792358
. O 0 3.758254081276391e-07

Here O 0 6.464076562906484e-08
we O 0 1.0010049455999592e-09
present O 0 3.9609881347102416e-11
four O 0 6.69048150214735e-12
novel O 0 1.5491362637121142e-09
PAX6 O 0 4.559028093353845e-05
missense O 0 3.0887226785125677e-06
mutations O 0 5.567792982219544e-08
, O 0 1.5258806718154716e-10
two O 0 2.4275635755049985e-12
in O 0 3.80030252059016e-12
association O 0 1.5185982679688514e-11
with O 0 1.0213836720840419e-11
atypical O 0 8.160344577845535e-07
phenotypes O 0 1.6320590248142253e-06
ectopia B-Disease 0 2.290685188199859e-05
pupillae I-Disease 0 1.7267977455048822e-05
( O 0 5.433542504817979e-10
displaced B-Disease 0 9.608876183619941e-08
pupils I-Disease 0 5.6460391917312336e-09
) O 0 3.6516184520607453e-10
and O 0 1.3843460067164415e-07
congenital B-Disease 1 0.9999984502792358
nystagmus I-Disease 0 0.005796243902295828
( O 0 5.48132039757121e-10
searching B-Disease 0 4.416883427893481e-07
gaze I-Disease 0 3.0708238227816764e-06
) O 0 3.112278490480236e-11
, O 0 5.846752942906264e-11
and O 0 3.9754900760247125e-11
two O 0 1.0658939009200452e-12
in O 0 1.4611982413967328e-12
association O 0 2.5940096425036696e-12
with O 0 6.801646919296633e-13
more O 0 2.0553333340833646e-11
recognizable O 0 9.72589805314783e-06
aniridia B-Disease 1 0.999997615814209
phenotypes O 0 2.5405905034858733e-05
. O 0 2.682178212864983e-08

Strikingly O 0 2.483223227045528e-07
, O 0 5.179779938302431e-10
all O 0 5.886832254303753e-12
four O 0 4.738200391936342e-13
mutations O 0 7.076123020866021e-11
are O 0 1.151796214828027e-12
located O 0 2.2488784168217535e-09
within O 0 1.7094521978511246e-11
the O 0 1.0705969964719397e-11
PAX6 O 0 3.0381233955267817e-06
paired O 0 8.699817533042165e-10
domain O 0 3.4483214061964418e-09
and O 0 3.7892591842059176e-11
affect O 0 1.6496941313004498e-10
amino O 0 4.377426806451146e-12
acids O 0 2.282877391898003e-13
which O 0 3.801177851214116e-13
are O 0 3.9878324709259616e-14
highly O 0 7.487961666734558e-14
conserved O 0 3.7147476934784596e-12
in O 0 7.123131294875518e-13
all O 0 2.29008739055514e-12
known O 0 5.6674939047374195e-11
paired O 0 1.0384091503334858e-10
domain O 0 1.3358568695664985e-09
proteins O 0 2.043131913653795e-10
. O 0 5.418742676788213e-10

Our O 0 9.209006179844437e-08
results O 0 2.89204743486593e-10
support O 0 1.0094111310698928e-11
the O 0 3.666364493904936e-14
hypothesis O 0 8.273279630821584e-12
that O 0 2.226220781071514e-13
the O 0 3.6691695282130635e-14
under O 0 1.956698475122365e-12
- O 0 2.933258302917352e-09
representation O 0 1.8813877539214374e-11
of O 0 1.3797559015454874e-12
missense O 0 2.60965521192702e-06
mutations O 0 2.3658765613276955e-08
is O 0 7.792247402882424e-11
caused O 0 2.0767240704877565e-10
by O 0 3.952420855879435e-12
ascertainment O 0 1.203540819005866e-06
bias O 0 9.564873835188337e-06
and O 0 1.8497985088128388e-10
suggest O 0 1.3365596129855106e-10
that O 0 5.977412575325358e-13
a O 0 6.178246391048969e-13
substantial O 0 1.225359674839055e-10
burden O 0 9.025804992290887e-09
of O 0 1.329338548961001e-11
PAX6 B-Disease 0 0.07431549578905106
- I-Disease 0 0.003308718791231513
related I-Disease 0 0.00020640513685066253
disease I-Disease 1 0.9271378517150879
remains O 0 2.654262232226756e-07
to O 0 4.483946894340285e-11
be O 0 1.1733145011127988e-10
uncovered O 0 6.180713398862281e-07
. O 0 1.19729837155802e-10
. O 0 4.6219719718187946e-10

The O 0 2.2275747912914312e-10
chromosomal O 0 3.393541192053817e-05
order O 0 4.736536163285621e-10
of O 0 2.2043055315085214e-12
genes O 0 1.4683478433141772e-08
controlling O 0 4.320163498050533e-06
the O 0 2.2893506534948926e-11
major O 0 1.174551012006475e-09
histocompatibility O 0 6.07947185926605e-08
complex O 0 3.0596620792522344e-09
, O 0 6.697452488435562e-12
properdin O 0 1.4038009865657841e-08
factor O 0 2.5028976669005942e-09
B O 0 4.29631290899124e-06
, O 0 9.559979891049508e-11
and O 0 3.759538458325551e-09
deficiency B-Disease 0 0.00025875287246890366
of I-Disease 0 2.0874513055602062e-13
the I-Disease 0 2.5167812712362236e-12
second I-Disease 0 5.982117579073076e-11
component I-Disease 0 6.341296376888295e-09
of I-Disease 0 2.966149461464118e-12
complement I-Disease 0 3.4358473843809634e-09
. O 0 1.1538099364827303e-09

The O 0 1.0576485520719103e-10
relationship O 0 1.8700627713030826e-09
of O 0 1.0224294148949639e-13
the O 0 7.671852519583466e-14
genes O 0 2.2585480360937105e-11
coding O 0 1.72877240300906e-10
for O 0 1.3239153696942285e-12
HLA O 0 4.5866904940794484e-08
to O 0 7.737416610198444e-12
those O 0 8.899695758991799e-13
coding O 0 8.438648391173587e-11
for O 0 4.740225681594545e-13
properdin O 0 9.49192724419845e-09
Factor O 0 1.2321569320405956e-09
B O 0 4.7068844821751554e-08
allotypes O 0 2.8095586301901676e-08
and O 0 4.649822887836663e-11
for O 0 1.5294873006999055e-11
deficiency B-Disease 0 1.6817441064631566e-05
of I-Disease 0 2.2501998094698328e-13
the I-Disease 0 1.7709086150632936e-12
second I-Disease 0 4.543296641679184e-11
component I-Disease 0 1.5021942800785837e-08
of I-Disease 0 1.519576782113563e-12
complement I-Disease 0 1.4503326317694132e-09
( O 0 1.5169886180554926e-11
C2 O 0 6.3723839538454286e-09
) O 0 2.962275065000741e-13
was O 0 1.1137756515677832e-11
studied O 0 3.1719665956331244e-12
in O 0 4.031624413112188e-14
families O 0 5.203577369342072e-13
of O 0 2.4380245882576514e-14
patients O 0 7.170015275947961e-11
with O 0 4.80002357305942e-11
connective O 1 0.9815726280212402
tissue O 1 0.999977707862854
disorders O 1 0.9974109530448914
. O 0 1.0660875915391443e-07

Patients O 0 1.845928863986046e-06
were O 0 1.4434795025941582e-10
selected O 0 7.602305937548515e-12
because O 0 3.1470542317946215e-12
they O 0 7.119830983462472e-13
were O 0 6.32992790128295e-12
heterozygous O 0 3.78927778044158e-09
or O 0 1.6478710618272885e-09
homozygous O 0 1.127803716372e-05
for O 0 1.9085222447756678e-05
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
. O 0 8.843201726449479e-08

12 O 0 7.497573051296058e-08
families O 0 2.8347109104487345e-09
with O 0 2.5053886049120067e-11
15 O 0 3.023408468028066e-10
matings O 0 0.00013317292905412614
informative O 0 0.3447534441947937
for O 0 0.005361825693398714
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 4.818079712975987e-09
found O 0 1.4973505768622886e-09
. O 0 3.847406837564904e-10

Of O 0 4.5575243579065727e-10
57 O 0 4.940980957712782e-09
informative O 0 2.854831748777542e-08
meioses O 0 3.5037362522416515e-07
, O 0 1.1459220725096309e-11
two O 0 1.6197259462488733e-13
crossovers O 0 3.8423247916696823e-10
were O 0 9.966474173728201e-11
noted O 0 2.521257091991913e-10
between O 0 1.5741732917184947e-10
the O 0 1.1332977578604186e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999995231628418
gene O 0 2.721890712820141e-09
and O 0 1.1950618446221473e-11
the O 0 1.3528857938441274e-12
HLA O 0 7.897633622633293e-06
- O 0 2.7133398816658882e-06
B O 0 1.453903486492436e-08
gene O 0 1.5064047231838629e-10
, O 0 2.2716622691005411e-13
with O 0 4.553568232792656e-15
a O 0 5.1304009733013287e-14
recombinant O 0 8.874235981476408e-13
fraction O 0 6.624755431727802e-12
of O 0 5.798614084555342e-13
0 O 0 1.545879951825313e-10
. O 0 2.7261717328030954e-09

035 O 0 0.004618636332452297
. O 0 1.0125346534550772e-06

A O 0 3.243962964916136e-08
lod O 0 2.026662514253985e-05
score O 0 2.2602613114486303e-09
of O 0 2.998045334125926e-13
13 O 0 3.004131448811065e-12
was O 0 4.835306200573486e-12
calculated O 0 3.499315420762983e-11
for O 0 1.348769273351591e-11
linkage O 0 0.0004893955774605274
between O 0 3.455200931057334e-05
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 2.229657708463506e-10
HLA O 0 1.0376842510595452e-05
- O 0 2.508176066839951e-06
B O 0 3.6798901703605225e-08
at O 0 7.949144814611842e-12
a O 0 4.588849374272119e-13
maximum O 0 2.0022980669331947e-12
likelihood O 0 2.828943459695643e-12
value O 0 5.217195599149793e-12
of O 0 6.470369911111247e-15
the O 0 1.1924007212117584e-14
recombinant O 0 2.1310123804463288e-12
fraction O 0 1.4380431741234379e-11
of O 0 1.4776358305337856e-12
0 O 0 2.6965690791413977e-10
. O 0 1.1111838116306672e-09

04 O 0 0.00023936030629556626
. O 0 3.097682395036827e-07

18 O 0 2.1191290500155446e-07
families O 0 4.6713037882284425e-09
with O 0 3.1944082795609674e-11
21 O 0 8.353199382193921e-11
informative O 0 2.968026935334933e-09
matings O 0 3.989115171521007e-08
for O 0 9.35078056651939e-12
both O 0 2.482989942126368e-12
properdin O 0 3.661644143448939e-08
Factor O 0 3.2107514424950523e-09
B O 0 5.991946494532385e-08
allotype O 0 5.302438665921727e-08
and O 0 3.4348365818281934e-10
HLA O 0 0.00022666742734145373
- O 0 0.001507649547420442
B O 0 6.154366474220296e-06
were O 0 1.5903128813832268e-10
found O 0 3.9901004722509015e-10
. O 0 1.812076738660906e-10

Of O 0 1.8420114322736936e-09
72 O 0 7.29897138285196e-08
informative O 0 2.7513996769812366e-07
meioses O 0 6.3298348322859965e-06
, O 0 1.2348666533767982e-10
three O 0 4.0285824806293724e-13
recombinants O 0 2.1347053014153516e-09
were O 0 1.6809895489466875e-11
found O 0 1.1629114338163049e-11
, O 0 3.82730786896001e-14
giving O 0 1.1441731215906456e-14
a O 0 4.020520149986863e-14
recombinant O 0 9.336269821483278e-13
fraction O 0 1.331429324430422e-11
of O 0 1.6775294261334173e-12
0 O 0 3.0868824163476916e-10
. O 0 1.7816105257750792e-09

042 O 0 0.0002669910900294781
. O 0 3.126247065665666e-07

A O 0 1.0584370357946682e-07
lod O 0 1.652850551181473e-05
score O 0 1.1823940937460975e-08
of O 0 1.851413120035339e-12
16 O 0 1.0130486727266685e-11
between O 0 3.239312897779234e-12
HLA O 0 1.406191131536616e-05
- O 0 1.2202633115521166e-05
B O 0 1.3233088225206302e-07
and O 0 3.3877785559494056e-12
Factor O 0 6.581119676996039e-11
B O 0 1.0373425451959406e-09
allotypes O 0 9.30801324905417e-10
was O 0 1.5272835079960245e-11
calculated O 0 7.59216509105265e-11
at O 0 4.623272251147448e-12
a O 0 1.3678617158223438e-13
maximum O 0 1.951837779942678e-12
likelihood O 0 5.236296639343774e-12
value O 0 1.6306855171732693e-11
of O 0 1.0207901520321427e-14
the O 0 1.0872225225688238e-14
recombinant O 0 7.991433578248552e-13
fraction O 0 9.501858501403948e-12
of O 0 1.4285833800642411e-12
0 O 0 2.0457913141314066e-10
. O 0 9.92777526853672e-10

04 O 0 0.00028540362836793065
. O 0 5.587841656051751e-07

A O 0 5.824294380118999e-10
crossover O 0 7.772854360155179e-09
was O 0 3.0977127529752124e-09
shown O 0 6.196403112834759e-11
to O 0 1.1301197607935243e-12
have O 0 1.0927349520031826e-12
occurred O 0 2.5578258261438336e-11
between O 0 2.5118919598954466e-14
genes O 0 2.2504370329051726e-12
for O 0 8.175886589923895e-14
Factor O 0 1.5259360441888248e-10
B O 0 2.7041377137493328e-08
and O 0 7.58348245311069e-11
HLA O 0 4.8075535232783295e-06
- O 0 7.142193226172822e-06
D O 0 1.3587101932444057e-07
, O 0 6.0396904491555325e-12
in O 0 1.511764753095099e-13
which O 0 2.9930717626580616e-11
HLA O 0 1.1422768693591934e-05
- O 0 1.1546886753421859e-06
D O 0 2.255004538653793e-08
segregared O 0 9.281071022826382e-09
with O 0 9.828867754413384e-12
HLA O 0 2.330133611394558e-06
- O 0 2.0481963929341873e-06
A O 0 1.0488906632133421e-08
and O 0 1.3242228424914515e-09
B O 0 2.1102754033108795e-07
. O 0 1.9879725643434654e-10

These O 0 4.926850594166865e-11
studies O 0 1.721991364604658e-12
suggest O 0 6.823272849509898e-12
that O 0 2.6354042713849953e-14
the O 0 5.526405054472007e-15
genes O 0 5.121392025742022e-12
for O 0 1.2624457685836421e-12
Factor O 0 7.36667900014254e-08
B O 1 0.9993495345115662
and O 1 0.83855140209198
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 1.8212997082711624e-11
located O 0 2.5015376436954284e-09
outside O 0 9.218699692503662e-10
those O 0 1.8752916428922684e-13
for O 0 8.717972768386775e-14
HLA O 0 1.3889903982544638e-07
, O 0 1.0598410170314931e-11
that O 0 1.2308066892063874e-12
the O 0 3.2195556306678294e-14
order O 0 6.735637980530285e-13
of O 0 7.491347765644502e-14
genese O 0 1.3867158976665905e-08
is O 0 2.6984367518245733e-10
HLA O 0 2.461423719068989e-06
- O 0 2.2162686263982323e-07
A O 0 1.7305811228496282e-09
, O 0 1.682918387979626e-10
- O 0 4.714935357696959e-07
B O 0 5.7101452455299295e-08
, O 0 1.0694948399114779e-11
- O 0 1.0770585312513958e-08
D O 0 1.527588056049467e-09
, O 0 1.3826353256751744e-12
Factor O 0 3.464458164792461e-10
B O 0 5.077498030914285e-07
allotype O 0 0.0003093140840064734
, O 0 3.537696102284826e-05
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 3.143436899666341e-12
that O 0 1.6255567855325004e-13
the O 0 5.538944276113275e-14
genes O 0 1.8316411720675774e-09
coding O 0 5.916035661357455e-06
for O 0 1.8888874819822377e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 5.609979147891409e-10
Factor O 0 1.956798278968108e-09
B O 0 2.467486694968102e-07
allotypes O 0 3.9873579993354724e-08
are O 0 3.840364658225237e-12
approximately O 0 6.469938473863124e-11
3 O 0 9.769288156213918e-11
- O 0 2.7264909476798493e-06
- O 0 3.4873283993874793e-07
5 O 0 7.57552701124986e-12
centimorgans O 0 6.578425026937396e-10
from O 0 1.2232141027076343e-13
the O 0 9.08246053235931e-14
HLA O 0 1.326002863066833e-08
- O 0 4.713887058471755e-10
A O 0 3.1298276470526076e-11
and O 0 3.018613137228954e-11
HLA O 0 1.305521891481476e-06
- O 0 5.268927907309262e-07
B O 0 2.1610595535292987e-09
loci O 0 1.344985234297269e-11
, O 0 5.762208744007624e-13
and O 0 4.49100338081182e-13
that O 0 1.2864781126237929e-13
the O 0 6.983769031826403e-14
apparent O 0 3.931065195583727e-10
lack O 0 3.24020281092241e-12
of O 0 1.7120795747912684e-14
recombinants O 0 1.9542618634460496e-09
between O 0 1.117170700566661e-12
the O 0 6.133558288004548e-13
Factor O 0 8.015809682682118e-10
B O 0 1.1873012226715218e-06
gene O 0 6.505004876089515e-06
and O 0 0.0020534906070679426
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
gene O 0 6.878989378122924e-09
suggests O 0 7.529179502085981e-10
that O 0 5.386596550749356e-12
these O 0 1.0819897495323305e-12
two O 0 1.0293625760798841e-12
genes O 0 3.6823457616463884e-09
lie O 0 2.7979760375274054e-07
in O 0 6.099403100645606e-12
close O 0 1.3841104262724002e-08
proximity O 0 4.714537205074976e-09
to O 0 1.5170617539972397e-10
one O 0 8.468799966854235e-11
another O 0 1.0189408206073836e-09
. O 0 2.8953990316438194e-09

Distribution O 0 2.8208667401941057e-08
of O 0 4.0142122265107716e-11
emerin O 0 1.3480967027135193e-05
and O 0 2.957471156861402e-09
lamins O 0 7.563899544038577e-06
in O 0 7.0008204962335174e-12
the O 0 3.910525982891988e-12
heart O 0 2.15111253254463e-08
and O 0 1.1494354947017005e-11
implications O 0 2.9502116027924075e-11
for O 0 3.815977048238217e-12
Emery B-Disease 0 3.345470759086311e-05
- I-Disease 1 0.9983838796615601
Dreifuss I-Disease 1 0.9998098015785217
muscular I-Disease 1 0.6150869131088257
dystrophy I-Disease 0 0.38329070806503296
. O 0 9.87805108820794e-08

Emerin O 0 1.4444951375480741e-05
is O 0 1.7073455982341557e-09
a O 0 7.991791950434646e-11
nuclear O 0 9.154751978712738e-08
membrane O 0 5.318680496024797e-10
protein O 0 3.865516240431077e-10
which O 0 2.2420921022558993e-11
is O 0 4.2052861193297986e-11
missing O 0 1.9180566857013304e-10
or O 0 2.4510182078385512e-11
defective O 0 4.407242926163235e-08
in O 0 6.802065855016082e-12
Emery B-Disease 0 0.000290919269900769
- I-Disease 1 0.9997908473014832
Dreifuss I-Disease 1 0.9999370574951172
muscular I-Disease 1 0.9228410124778748
dystrophy I-Disease 1 0.9807063341140747
( O 0 1.0240503200975581e-07
EDMD B-Disease 1 0.9999995231628418
) O 0 4.13007867905435e-08
. O 0 5.588920881649528e-09

It O 0 7.183013295275487e-09
is O 0 2.0793083921333277e-10
one O 0 4.242196871562243e-12
member O 0 2.3005276611649805e-13
of O 0 1.494157140407345e-14
a O 0 7.650817479554206e-12
family O 0 1.6220694787349998e-09
of O 0 1.670785471780123e-12
lamina O 0 2.6860905563808046e-05
- O 0 0.0003375239612068981
associated O 0 1.7206586377938038e-08
proteins O 0 3.7431707039514706e-11
which O 0 6.380937445094048e-12
includes O 0 4.7544281012168454e-11
LAP1 O 0 1.4755974575564323e-07
, O 0 4.9392046008733814e-11
LAP2 O 0 3.3680032629490597e-07
and O 0 4.673788578379856e-10
lamin O 0 1.1279682439635508e-05
B O 0 7.407407792925369e-06
receptor O 0 9.832313629942746e-09
( O 0 7.083404973684537e-10
LBR O 0 6.382780702551827e-05
) O 0 2.4712103474655578e-09
. O 0 4.215231719228996e-09

A O 0 4.1390983973599305e-09
panel O 0 1.4885542798381834e-09
of O 0 1.929131333844314e-12
16 O 0 1.2214906863761144e-10
monoclonal O 0 6.240129124535088e-08
antibodies O 0 7.967676296516402e-09
( O 0 2.1870138078999846e-12
mAbs O 0 1.0962416530091446e-09
) O 0 2.4589633714627857e-12
has O 0 1.3215520691667315e-11
been O 0 5.094512051800892e-12
mapped O 0 2.1090716728622283e-08
to O 0 7.249619741328539e-12
six O 0 1.1083838924799694e-12
specific O 0 1.3778440194345265e-12
sites O 0 9.859087990449211e-10
throughout O 0 2.915861345778592e-12
the O 0 2.440030870496518e-13
emerin O 0 1.0271460348931782e-09
molecule O 0 4.1168496563159795e-12
using O 0 6.8168201118601335e-12
phage O 0 3.0335476353116064e-09
- O 0 1.852335351770762e-08
displayed O 0 8.067960743929348e-10
peptide O 0 3.346906779500003e-11
libraries O 0 1.970041317578275e-12
and O 0 1.1076737400569914e-12
has O 0 1.5488681301065177e-12
been O 0 1.7534770564795604e-13
used O 0 4.3566338687670014e-13
to O 0 5.983446702516326e-13
localize O 0 3.761965103876719e-07
emerin O 0 1.02650994904252e-06
in O 0 1.120598752679669e-11
human O 0 1.2945245986273335e-09
and O 0 4.984881951664022e-10
rabbit O 0 0.0010105818510055542
heart O 0 1.9464347133180127e-05
. O 0 7.235485099954531e-09

Several O 0 3.817548055451425e-09
mAbs O 0 2.971875687762804e-07
against O 0 3.983338311974727e-11
different O 0 2.6990838383755822e-11
emerin O 0 2.1714153319862817e-07
epitopes O 0 1.189287900160707e-06
did O 0 4.346939697086327e-09
not O 0 4.670568792830565e-11
recognize O 0 5.403849034912867e-10
intercalated O 0 2.1092989854754052e-10
discs O 0 2.8191730052640196e-06
in O 0 3.7070416181173016e-11
the O 0 7.683237726596737e-12
heart O 0 9.420759283784719e-08
, O 0 5.479036495337208e-12
though O 0 2.2590306361647272e-11
they O 0 6.618743313840936e-12
recognized O 0 8.577307267221279e-12
cardiomyocyte O 0 6.4841279012739506e-09
nuclei O 0 2.4739339049562048e-11
strongly O 0 1.5106198236747304e-10
, O 0 2.6657656117257122e-12
both O 0 2.6511759909815524e-13
at O 0 3.467313935967553e-10
the O 0 9.453862172270622e-12
rim O 0 2.2941782162888558e-07
and O 0 3.200068821040958e-10
in O 0 8.570667613116978e-12
intranuclear O 0 3.444622791448637e-07
spots O 0 2.306601913915074e-07
or O 0 4.745454695864737e-09
channels O 0 2.524041349261097e-07
. O 0 7.416753433631129e-09

A O 0 5.0072614499185875e-08
polyclonal O 0 7.652636668353807e-06
rabbit O 0 7.076246674841968e-06
antiserum O 0 2.517363782317261e-06
against O 0 1.1061210281049227e-10
emerin O 0 4.825366204386228e-07
did O 0 8.619134850285093e-10
recognize O 0 2.015274169764325e-09
both O 0 1.3194815899619794e-11
nuclear O 0 1.2825972817154252e-07
membrane O 0 2.485973094046301e-10
and O 0 1.1431277799345274e-11
intercalated O 0 3.0381884508212664e-11
discs O 0 4.3305480090793935e-08
but O 0 1.1628188689716268e-10
, O 0 1.9843707840111469e-13
after O 0 8.785543635907861e-14
affinity O 0 7.463525782645808e-13
purification O 0 1.5994738086083649e-12
against O 0 2.544946946323595e-13
a O 0 1.9610398374614313e-12
pure O 0 4.7985861811872255e-11
- O 0 2.2129627907929716e-08
emerin O 0 1.1088724605201605e-08
band O 0 1.4522107474879142e-11
on O 0 1.550701581032321e-11
a O 0 4.972190627977602e-12
western O 0 4.039057630023102e-11
blot O 0 3.753704731934704e-06
, O 0 2.454644126848038e-11
it O 0 2.2084686510104312e-11
stained O 0 9.869670947182385e-08
only O 0 8.348464280993895e-12
the O 0 3.795290037106325e-12
nuclear O 0 6.269895891364285e-08
membrane O 0 1.4823748895054223e-09
. O 0 5.699117289204025e-10

These O 0 2.362307294223598e-10
results O 0 1.4520010194196686e-10
would O 0 1.2405695394568372e-11
not O 0 1.9413711090099373e-12
be O 0 5.704099844371091e-13
expected O 0 2.357638390071415e-11
if O 0 7.299904604407548e-12
immunostaining O 0 7.452516825878774e-09
at O 0 1.1167160252067987e-10
intercalated O 0 5.063785502024132e-11
discs O 0 7.924847977847094e-08
were O 0 2.2904654561894944e-10
due O 0 9.386054433679902e-12
to O 0 7.365621242268194e-13
a O 0 6.461722216327681e-12
product O 0 6.604399249710013e-10
of O 0 2.1435576499028407e-14
the O 0 1.628858994299348e-13
emerin O 0 3.2520335313535043e-09
gene O 0 1.0462086752482946e-09
and O 0 9.068245460097657e-11
, O 0 1.9469371861230433e-12
therefore O 0 2.0715909456597847e-12
, O 0 5.104177714168601e-13
cast O 0 3.802486797654936e-11
some O 0 4.68613732887424e-12
doubt O 0 1.908469042521954e-11
upon O 0 1.0143432318046597e-13
the O 0 5.4002317889786586e-14
hypothesis O 0 1.0000254097031203e-10
that O 0 4.081403270905781e-11
cardiac B-Disease 0 1.5730045561213046e-05
defects I-Disease 1 0.9834629893302917
in O 0 1.7961455656134717e-09
EDMD B-Disease 1 1.0
are O 0 2.895089723509159e-09
caused O 0 2.82142509355765e-09
by O 0 1.1052094135710622e-11
absence O 0 2.973601365141576e-10
of O 0 2.728279624789054e-12
emerin O 0 5.226677899372589e-07
from O 0 1.0332564664983224e-10
intercalated O 0 5.13747444585988e-09
discs O 0 1.2421857718436513e-05
. O 0 2.0710301029680522e-08

Although O 0 2.952364797081941e-09
emerin O 0 3.2845755981725233e-07
was O 0 6.151141818122596e-10
abundant O 0 1.646863895254924e-11
in O 0 1.426944066379443e-12
the O 0 1.2634718575196824e-12
membranes O 0 3.8981828875961355e-10
of O 0 4.301215687872034e-13
cardiomyocyte O 0 1.7378855687866235e-08
nuclei O 0 5.514854545252135e-11
, O 0 4.793086500615162e-12
it O 0 1.6781799908049955e-11
was O 0 9.782513687994765e-10
absent O 0 4.624809216147163e-11
from O 0 2.5685738800663993e-13
many O 0 2.43862601553152e-13
non O 0 3.943621817992238e-10
- O 0 1.563096532208874e-07
myocyte O 0 5.7387137530895416e-06
cells O 0 3.068234999403785e-09
in O 0 8.246717544957427e-12
the O 0 3.323484196182669e-11
heart O 0 2.4995316039166937e-07
. O 0 1.7413621655748557e-09

This O 0 1.628348150761738e-11
distribution O 0 1.5766311867171368e-10
of O 0 7.490365207425687e-13
emerin O 0 9.551244772865175e-08
was O 0 2.3570323470778476e-10
similar O 0 1.3945830167755302e-12
to O 0 1.0600749878603155e-12
that O 0 2.2840587927952516e-12
of O 0 1.5888974706258774e-13
lamin O 0 4.743321824207669e-07
A O 0 3.920148650138344e-10
, O 0 5.496935805843206e-12
a O 0 2.0818737359040718e-12
candidate O 0 6.023036236424417e-11
gene O 0 5.300512251338318e-10
for O 0 2.9258559550854324e-12
an O 0 1.4940196649271265e-11
autosomal O 0 9.683393000159413e-05
form O 0 8.435635123760221e-08
of O 0 1.1559377099956691e-07
EDMD B-Disease 1 1.0
. O 0 1.6598659158262308e-06

In O 0 4.842731771148578e-10
contrast O 0 8.634721382350108e-09
, O 0 7.447453764797274e-10
lamin O 0 0.002900035586208105
B1 O 0 0.44000253081321716
was O 0 1.5070988013121678e-08
absent O 0 1.211800659817186e-09
from O 0 1.5639216267501754e-12
cardiomyocyte O 0 1.3017578126550688e-08
nuclei O 0 5.5448510366540305e-11
, O 0 5.232323255222049e-12
showing O 0 3.570749029790932e-08
that O 0 6.613525838083945e-10
lamin O 0 0.0002832796308211982
B1 O 0 0.00020306282385718077
is O 0 3.1674822487115506e-11
not O 0 2.00899626795481e-12
essential O 0 9.06335987163609e-13
for O 0 7.923010663345165e-14
localization O 0 2.1867949118181684e-10
of O 0 1.606615367003364e-13
emerin O 0 1.8857734929156322e-08
to O 0 3.8476472008497353e-11
the O 0 5.683819040425142e-11
nuclear O 0 2.759066774160601e-06
lamina O 0 2.2749640038455254e-07
. O 0 1.7682447728262218e-09

Lamin O 1 0.9142459630966187
B1 O 1 0.9790710210800171
is O 0 1.3161983503096053e-08
also O 0 1.5888613758008319e-09
almost O 0 4.431523481507327e-10
completely O 0 3.684237270817903e-08
absent O 0 2.6793542939884674e-09
from O 0 1.8244149246893215e-11
skeletal O 0 0.00047459223424084485
muscle O 0 1.0262025398333208e-06
nuclei O 0 4.1389505156530504e-08
. O 0 4.391331742681359e-09

In O 0 2.665123899348032e-09
EDMD B-Disease 1 0.9999985694885254
, O 0 1.2859649456409272e-10
the O 0 2.877291775064267e-13
additional O 0 1.3685859737155859e-11
absence O 0 2.0163921921056982e-10
of O 0 1.0575349623787034e-11
lamin O 0 0.10458548367023468
B1 O 0 0.0027625493239611387
from O 0 3.656348834812917e-11
heart O 0 6.903241569489182e-07
and O 0 2.0765982267079153e-09
skeletal O 0 0.050475966185331345
muscle O 0 5.449406330626516e-07
nuclei O 0 1.1382097486745124e-09
which O 0 4.68717897827986e-10
already O 0 2.287401823508617e-09
lack O 0 4.911135387253296e-11
emerin O 0 3.565856161458214e-07
may O 0 2.3044485764067701e-10
offer O 0 4.834236309869677e-12
an O 0 3.19662204421433e-14
alternative O 0 3.643968373573392e-12
explanation O 0 1.7548438396852717e-11
of O 0 7.077907595957889e-14
why O 0 4.589869456728124e-11
these O 0 3.1782993663125036e-13
tissues O 0 5.2399556915716516e-11
are O 0 5.992411970280609e-13
particularly O 0 4.875768191969776e-12
affected O 0 3.916844903972816e-10
. O 0 1.3852652532009291e-11
. O 0 4.5629083844644924e-10

Genetic O 0 6.743412086507306e-07
mapping O 0 8.174585275355639e-08
of O 0 1.1400337271427752e-11
the O 0 6.366898674947663e-11
copper B-Disease 0 1.43798445151333e-06
toxicosis I-Disease 0 1.7973950889427215e-05
locus O 0 9.358235963929928e-09
in O 0 1.2071970159621692e-11
Bedlington O 0 2.5321617158624576e-07
terriers O 0 3.991885222376368e-08
to O 0 5.5526826192586753e-11
dog O 0 7.030405413388507e-07
chromosome O 0 8.023325790418312e-07
10 O 0 4.367789740999939e-10
, O 0 8.621181026013947e-12
in O 0 4.567037394966056e-13
a O 0 3.234301368393311e-11
region O 0 8.442955667931074e-09
syntenic O 0 2.3603247427672613e-06
to O 0 3.013969976373154e-11
human O 0 6.945048425244238e-10
chromosome O 0 9.107020559895318e-06
region O 0 1.827774127605153e-07
2p13 O 0 4.644964519684436e-06
- O 0 8.81253981788177e-06
p16 O 0 2.6911209261015756e-06
. O 0 9.184182303556554e-09

Abnormal O 1 0.9974026083946228
hepatic B-Disease 1 0.9961393475532532
copper I-Disease 0 0.00023492831678595394
accumulation I-Disease 0 2.689442681003129e-06
is O 0 2.4223267836021023e-09
recognized O 0 1.4733518849396887e-09
as O 0 2.6013546872150073e-10
an O 0 2.1550508932932644e-08
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 6.39500719046282e-09
man O 0 6.901569236106297e-07
, O 0 1.3296680596852628e-11
mouse O 0 1.4887800148244423e-07
, O 0 4.3564141877228124e-11
rat O 0 1.8474082708053174e-06
and O 0 1.7853999390027298e-09
dog O 0 2.2075886590755545e-05
. O 0 9.815487089781527e-09

The O 0 1.9118255589756217e-10
major O 0 2.0003578793392762e-09
cause O 0 2.6480593717792544e-08
of O 0 1.1594016718907696e-10
hepatic B-Disease 1 0.6940948367118835
copper I-Disease 0 0.008722452446818352
accumulation I-Disease 0 1.8077033701047185e-06
in O 0 2.1368266878152298e-10
man O 0 2.3144593797042035e-07
is O 0 1.0504050407256216e-10
a O 0 1.85589009438214e-11
dysfunctional O 0 8.660141759264661e-08
ATP7B O 0 5.985116331430618e-07
gene O 0 5.43064722080544e-08
, O 0 1.685205447410354e-10
causing O 0 1.0055543953058077e-07
Wilson B-Disease 0 8.016547508304939e-05
disease I-Disease 0 0.20721901953220367
( O 0 1.4843844375889148e-08
WD B-Disease 1 0.9805052876472473
) O 0 7.392630507752074e-09
. O 0 1.8070185348051382e-08

Mutations O 0 1.2194291230116505e-06
in O 0 3.043623339471502e-11
the O 0 2.0034822325459833e-12
ATP7B O 0 3.416649860810139e-07
genes O 0 5.361110999579921e-10
have O 0 1.795506625323906e-11
also O 0 6.2063357925135065e-12
been O 0 2.532746408434594e-11
demonstrated O 0 4.81137144014987e-11
in O 0 6.557469411222483e-13
mouse O 0 1.8181355017077294e-06
and O 0 1.6537624603074619e-09
rat O 0 9.594446055416483e-06
. O 0 5.127117397307757e-09

The O 0 2.341689342433284e-10
ATP7B O 0 1.8378963773102441e-07
gene O 0 5.154260662720844e-08
has O 0 1.50366974427385e-09
been O 0 3.405661516686642e-11
excluded O 0 4.746047305159706e-11
in O 0 6.007286410935481e-14
the O 0 4.3548704816960895e-14
much O 0 3.0746921935581595e-12
rarer O 0 1.136949201452353e-09
human O 0 2.0816268708756525e-09
copper B-Disease 0 2.7790847525466233e-05
overload I-Disease 0 0.0015787362353876233
disease O 0 0.013163144700229168
non B-Disease 0 3.930307684640866e-06
- I-Disease 1 0.965298056602478
Indian I-Disease 0 3.679188864680327e-07
childhood I-Disease 0 0.00037538044853135943
cirrhosis I-Disease 0 0.0002868168521672487
, O 0 4.8654752102250676e-12
indicating O 0 1.4496164268962275e-09
genetic O 0 2.0866087524495924e-08
heterogeneity O 0 3.640183194875135e-07
. O 0 1.2380114711163515e-08

By O 0 5.874754849255481e-11
investigating O 0 3.6027070215993717e-10
the O 0 5.927483330558925e-12
common O 0 3.2638214353397643e-09
autosomal O 1 0.9149853587150574
recessive O 1 0.8058668971061707
copper B-Disease 0 0.0006189466803334653
toxicosis I-Disease 0 0.0004745881597045809
( O 0 1.4619941368643197e-10
CT B-Disease 0 4.2408892113598995e-06
) O 0 1.409502809607277e-11
in O 0 2.272747094689276e-12
Bedlington O 0 5.107657230496443e-08
terriers O 0 2.2896733753441367e-07
, O 0 1.5877456294166592e-10
we O 0 7.589197326129948e-11
have O 0 2.5517321545695526e-13
identified O 0 2.8508152869616277e-12
a O 0 7.149820693179779e-14
new O 0 5.830799168146661e-13
locus O 0 6.459288659499407e-10
involved O 0 9.857583638250844e-10
in O 0 5.763262089786281e-10
progressive O 1 0.896019697189331
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 3.868555893404846e-07

We O 0 7.137399116174947e-09
examined O 0 3.117902380722626e-09
whether O 0 3.3005279065356774e-11
the O 0 4.210765850581888e-12
WD B-Disease 0 4.116593117942102e-05
gene O 0 1.3677294852243449e-08
ATP7B O 0 2.7501144472807937e-07
was O 0 9.88435666648968e-10
also O 0 6.643305263537291e-12
causative O 0 7.937699386673103e-10
for O 0 4.902819686694593e-13
CT B-Disease 0 1.7489729486896977e-07
by O 0 4.481824199958906e-12
investigating O 0 3.5792827035585617e-10
the O 0 3.907961194232756e-12
chromosomal O 0 0.008062982931733131
co O 0 6.888573989272118e-05
- O 0 1.1495312719489448e-06
localization O 0 8.167945253489961e-08
of O 0 3.4462842735810684e-12
ATP7B O 0 1.3451852964863065e-07
and O 0 4.246689805365023e-12
C04107 O 0 3.805897264008706e-11
, O 0 9.559961126220408e-15
using O 0 2.053794349757103e-14
fluorescence O 0 5.497373389840021e-13
in O 0 4.3324352894287543e-14
situ O 0 1.6597877239288295e-10
hybridization O 0 2.2425455589725196e-11
( O 0 3.0025849428322315e-12
FISH O 0 2.2740544169952415e-10
) O 0 3.701671955069763e-11
. O 0 2.588812497705817e-10

C04107 O 0 7.38561129765003e-06
is O 0 1.3006427046491353e-09
an O 0 9.675525138030938e-12
anonymous O 0 4.788695551205535e-10
microsatellite O 0 8.33999911264982e-06
marker O 0 1.0479692718945444e-05
closely O 0 7.257366974044999e-08
linked O 0 2.3177705088528455e-07
to O 0 3.031856987689707e-10
CT B-Disease 0 0.00030703796073794365
. O 0 2.648170571717401e-08

However O 0 5.036973060867922e-09
, O 0 1.3223980799281776e-09
BAC O 0 2.1118971744726878e-06
clones O 0 2.6891865445577423e-07
containing O 0 1.2781947944517924e-08
ATP7B O 0 3.183172566423309e-06
and O 0 5.905784888904364e-11
C04107 O 0 4.3988093167968145e-09
mapped O 0 6.435069366261814e-08
to O 0 2.3100892726501954e-11
the O 0 6.9962555714064845e-12
canine O 0 5.741345603382797e-07
chromosome O 0 4.592674486048054e-06
regions O 0 3.421690664140442e-08
CFA22q11 O 0 1.0799160008900799e-05
and O 0 1.7241598149198012e-09
CFA10q26 O 0 1.8849937077902723e-07
, O 0 1.034748935840879e-11
respectively O 0 4.599243728919955e-12
, O 0 5.640355803943065e-13
demonstrating O 0 3.467775372412163e-11
that O 0 2.7566633004072472e-11
WD B-Disease 0 0.0031250640749931335
cannot O 0 5.399246827408888e-09
be O 0 2.0142798019817665e-12
homologous O 0 1.4619691568462656e-10
to O 0 4.3970771468337944e-11
CT B-Disease 0 7.994851330295205e-06
. O 0 7.129031587282952e-09

The O 0 7.241542920866095e-10
copper O 0 1.0799610983269758e-08
transport O 0 1.0249795456829247e-09
genes O 0 7.550723379878832e-10
CTR1 O 0 2.6316459411646065e-07
and O 0 1.0715167642061374e-10
CTR2 O 0 3.01867572716219e-07
were O 0 2.6640450956350037e-10
also O 0 2.7292805168666057e-11
excluded O 0 3.636071166379651e-10
as O 0 2.0095940970327186e-12
candidate O 0 3.0823726817480468e-12
genes O 0 2.317758398401315e-12
for O 0 2.7036395515499072e-14
CT B-Disease 0 4.829163913200318e-07
since O 0 2.2738505522923447e-10
they O 0 6.36825574912292e-12
both O 0 2.1709205071628046e-13
mapped O 0 7.36125755906869e-08
to O 0 4.0486008989759625e-10
canine O 0 7.225678473332664e-06
chromosome O 0 9.603479702491313e-05
region O 0 3.2276068395731272e-06
CFA11q22 O 0 6.42060476820916e-05
. O 0 2.1163655716804897e-08

2 O 0 4.864547804572794e-07
- O 0 0.000659709854517132
22 O 0 9.88325297157644e-08
. O 0 3.761223776876932e-09

5 O 0 1.7635866811360756e-07
. O 0 1.3066259185734452e-08

A O 0 6.163523025293216e-09
transcribed O 0 5.6160981642960905e-08
sequence O 0 3.0900648706477796e-09
identified O 0 2.2995496617994604e-09
from O 0 7.756207243310442e-13
the O 0 7.530719212285597e-13
C04107 O 0 2.7367073940354203e-08
- O 0 3.963835837339502e-08
containing O 0 5.20310905471888e-10
BAC O 0 1.2224130330196203e-07
was O 0 5.11314934836804e-10
found O 0 6.069496467919766e-12
to O 0 1.0639960998847994e-13
be O 0 6.133064704965524e-14
homologous O 0 1.6614457205854638e-12
to O 0 5.611861954410609e-14
a O 0 7.0095280491414e-13
gene O 0 1.0565884833724226e-09
expressed O 0 4.617403247947349e-12
from O 0 2.787586242565532e-13
human O 0 3.359634445643245e-11
chromosome O 0 5.838514880451839e-07
2p13 O 0 2.401823735453945e-07
- O 0 3.689202117129753e-07
p16 O 0 3.800252201813237e-08
, O 0 2.1405580433175864e-11
a O 0 9.257754285396658e-12
region O 0 3.993031461035912e-10
devoid O 0 1.3928358466586133e-09
of O 0 8.03871780339499e-13
any O 0 1.343255368047025e-10
positional O 0 7.771389931576778e-08
candidate O 0 3.2957139239897515e-08
genes O 0 3.5781596352535416e-08
. O 0 6.424630161205869e-09

Molecular O 0 4.031357914158207e-09
analysis O 0 3.9650568939286757e-10
of O 0 1.0104989761616778e-12
the O 0 1.1293117049143708e-12
APC B-Disease 0 8.071593948777434e-10
gene O 0 1.821213735375693e-10
in O 0 1.079594313252441e-12
205 O 0 1.6654259915593883e-10
families O 0 5.0368140214196444e-11
: O 0 2.167371967662368e-12
extended O 0 7.035014792933225e-10
genotype O 0 7.685347895858285e-07
- O 0 9.589552973920945e-06
phenotype O 0 9.006890877572005e-08
correlations O 0 5.31499899647514e-10
in O 0 8.651832505632284e-13
FAP B-Disease 0 4.114530383070303e-10
and O 0 1.7020075670018397e-12
evidence O 0 2.4083781843819985e-12
for O 0 5.2482896636474666e-14
the O 0 9.634706362804737e-14
role O 0 1.2824370038133637e-11
of O 0 1.6209684419385417e-13
APC B-Disease 0 6.310044153856609e-10
amino O 0 2.295059324877724e-12
acid O 0 8.649340466938826e-13
changes O 0 3.039475615640441e-11
in O 0 1.2575144481274947e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 0 0.03340105339884758
. O 0 1.471729831337143e-07

BACKGROUND O 0 1.1481791943879216e-06
/ O 0 3.2399550491390983e-06
AIMS O 0 3.4366617995829074e-08
The O 0 1.1692540382093886e-12
development O 0 3.845961327186842e-10
of O 0 8.60269810942782e-09
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 4.062999270360024e-09
a O 0 1.1934452037731802e-10
variable O 0 8.31708657500485e-09
range O 0 1.8435095228142018e-08
of O 0 2.5249085808254357e-11
extracolonic O 0 7.096118497429416e-05
manifestations O 0 2.0682744434452616e-05
in O 0 1.8461949480297335e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 0.9999923706054688
polyposis I-Disease 1 1.0
( O 0 7.699402004845979e-09
FAP B-Disease 0 9.759393293506946e-08
) O 0 4.629804525868586e-11
is O 0 2.4082047120344008e-11
the O 0 1.1481481455681564e-13
result O 0 1.2863512338645577e-12
of O 0 6.774377743880636e-14
the O 0 3.927606070236456e-12
dominant O 0 2.5082641741391853e-07
inheritance O 0 7.094802754181728e-07
of O 0 1.6115890844048408e-07
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 0.9999927282333374
coli I-Disease 1 0.9999996423721313
( O 0 1.0678088635529548e-08
APC B-Disease 0 7.967983606249618e-08
) O 0 1.119648540548468e-10
gene O 0 3.570401574393145e-08
mutations O 0 1.448014899096961e-07
. O 0 6.656544648819818e-09

In O 0 6.19965103559883e-12
this O 0 4.308676692884629e-14
study O 0 2.1084590779048284e-13
, O 0 5.371765722126873e-14
direct O 0 2.5446324734834658e-12
mutation O 0 1.14132016337809e-10
analysis O 0 1.8441574656247184e-11
of O 0 9.47714197158285e-14
the O 0 9.948117633482023e-13
APC B-Disease 0 1.9862556044358826e-10
gene O 0 9.317226851157656e-11
was O 0 1.1261444554655498e-10
performed O 0 9.099709874504924e-11
to O 0 1.7330227964490463e-12
determine O 0 8.781926297274367e-10
genotype O 0 5.873004056411446e-07
- O 0 1.1068766070820857e-05
phenotype O 0 1.5971394873304234e-07
correlations O 0 7.2042114496184695e-09
for O 0 1.4182862349831904e-11
nine O 0 8.083483188370266e-11
extracolonic O 0 4.806654629874174e-08
manifestations O 0 4.142613363455894e-09
and O 0 6.824691419632378e-12
to O 0 6.150885465024125e-13
investigate O 0 3.889715771698832e-10
the O 0 1.3319443204623527e-12
incidence O 0 4.004010634162114e-07
of O 0 7.38885602008521e-12
APC B-Disease 0 3.230551826050032e-08
mutations O 0 2.0280916945836225e-09
in O 0 3.7763875360141697e-11
non O 0 3.698336740853847e-06
- O 1 0.9997597336769104
FAP O 1 0.9997296929359436
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 5.5760233408364e-07

METHODS O 0 1.1847599346026527e-08
The O 0 7.404035717861746e-12
APC B-Disease 0 1.3260528231029411e-09
gene O 0 5.471501585141425e-10
was O 0 5.86784509870597e-11
analysed O 0 2.0874385553426578e-10
in O 0 1.026263275749617e-12
190 O 0 1.3618683958327438e-10
unrelated O 0 8.736266710052121e-10
FAP B-Disease 0 4.788454432969047e-08
and O 0 2.8822672026862506e-10
15 O 0 1.1645306940977207e-09
non O 0 1.8185933186032344e-06
- O 1 0.9995181560516357
FAP O 1 0.9996057152748108
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 8.074033530647284e-08
using O 0 2.546020061444665e-09
denaturing O 0 5.12100086780265e-05
gradient O 0 2.361409997320152e-06
gel O 0 1.3648299272972508e-06
electrophoresis O 0 2.378785879386669e-08
, O 0 2.5139567511045513e-11
the O 0 7.183392335824434e-14
protein O 0 4.0199952741626355e-12
truncation O 0 2.080348560085099e-09
test O 0 5.843491912571608e-09
, O 0 5.148079879058187e-12
and O 0 1.6923802853910375e-12
direct O 0 8.949170571259657e-11
sequencing O 0 7.095335430307159e-09
. O 0 4.939821884875073e-09

RESULTS O 0 1.338131937700382e-06
Chain O 0 4.1139246604871005e-06
terminating O 0 5.0918217198159255e-08
signals O 0 2.8551038866453382e-08
were O 0 4.5411570337439144e-11
only O 0 7.330638374970777e-13
identified O 0 1.9602527934203806e-10
in O 0 2.662273342318028e-13
patients O 0 6.341335442860974e-12
belonging O 0 3.34182265193661e-11
to O 0 3.4148313517168294e-12
the O 0 1.66635531328313e-12
FAP B-Disease 0 5.118538481951873e-09
group O 0 4.248182708388448e-11
( O 0 2.166685667687185e-12
105 O 0 2.810617016901773e-10
patients O 0 2.68268213199363e-10
) O 0 4.9674344498873424e-11
. O 0 1.3672384335805532e-09

Amino O 0 1.2386562886490537e-08
acid O 0 6.364021115645713e-11
changes O 0 9.996968530767703e-12
were O 0 7.1122608670537435e-12
identified O 0 1.575104352502521e-10
in O 0 7.141183261047401e-13
four O 0 9.531717429234199e-12
patients O 0 1.246642372665363e-10
, O 0 7.01429365979056e-12
three O 0 2.398421522151195e-12
of O 0 7.552410845150515e-13
whom O 0 7.719970773756302e-10
belonged O 0 2.398754306298656e-09
to O 0 1.495465209999658e-11
the O 0 7.794755292611644e-12
non O 0 5.286974857909854e-09
- O 0 1.0659696414450082e-07
FAP O 0 1.9244568605358836e-08
group O 0 9.393246180877668e-10
of O 0 1.8708155025137785e-09
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 7.891196219134144e-06
. O 0 9.326535099773992e-09

Genotype O 0 0.001941292081028223
- O 0 0.0012905960902571678
phenotype O 0 1.7427572629458155e-06
correlations O 0 2.294661172186352e-08
identified O 0 8.608804336063258e-09
significant O 0 2.1105546477162562e-10
differences O 0 3.055744102198332e-08
in O 0 2.2157511936349295e-11
the O 0 2.0960063112224203e-12
nature O 0 1.2962220186096829e-09
of O 0 5.092090486248646e-13
certain O 0 4.7804343816792993e-11
extracolonic O 0 2.1626732404911309e-07
manifestations O 0 6.052754741858735e-09
in O 0 1.911445481062035e-11
FAP B-Disease 0 5.124773494458168e-08
patients O 0 6.213816128308736e-10
belonging O 0 7.195127826875591e-11
to O 0 3.728490172855148e-12
three O 0 1.3212445026944408e-11
mutation O 0 7.611399510665251e-09
subgroups O 0 2.025116252468706e-08
. O 0 9.63673407738952e-09

CONCLUSIONS O 0 3.8280504099930113e-07
Extended O 0 2.5308187545647343e-08
genotype O 0 5.332517503120471e-06
- O 0 0.0001014301014947705
phenotype O 0 5.068363861937542e-07
correlations O 0 3.567753381616967e-08
made O 0 2.7810783190251875e-11
in O 0 1.3872785570041152e-13
this O 0 3.587346823134656e-14
study O 0 4.946826910774693e-13
may O 0 4.914881002182625e-12
have O 0 3.0441716313521494e-13
the O 0 1.2189839185250927e-14
potential O 0 8.988986855210102e-13
to O 0 2.130303989851881e-13
determine O 0 9.167332691573105e-12
the O 0 9.559764275763466e-14
most O 0 1.1961051181626214e-13
appropriate O 0 4.555277596102192e-12
surveillance O 0 3.890684396878896e-08
and O 0 3.693242326546775e-12
prophylactic O 0 2.1484871659538385e-09
treatment O 0 1.7080516168110904e-10
regimens O 0 2.61824451008863e-10
for O 0 3.4881968732740354e-13
those O 0 9.75874242525876e-12
patients O 0 1.2782684633005914e-11
with O 0 2.2249174345349149e-13
mutations O 0 5.3446762571240924e-09
associated O 0 8.901682946316214e-09
with O 0 2.260441278600922e-10
life O 0 2.422106888388953e-07
threatening O 0 0.008979957550764084
conditions O 0 6.3364541347255e-06
. O 0 1.7142284036708588e-08

This O 0 1.3199725167056808e-11
study O 0 4.9944315176631005e-12
also O 0 1.1307450201863967e-12
provided O 0 2.825420561576586e-13
evidence O 0 3.1549272742903423e-12
for O 0 9.697722903575026e-14
the O 0 2.289007742031779e-13
pathological O 0 7.994928807875112e-08
nature O 0 4.839343370477422e-10
of O 0 2.39804974922625e-13
amino O 0 2.626946923878215e-11
acid O 0 8.189984064196909e-13
changes O 0 2.6043444202421273e-13
in O 0 1.141359820240953e-13
APC O 0 2.686589006817286e-10
associated O 0 6.101105037847887e-11
with O 0 1.5700666678233888e-12
both O 0 3.255385978145897e-12
FAP B-Disease 0 1.8529147993717743e-08
and O 0 8.257995398608386e-10
non O 0 5.547685304918559e-06
- O 1 0.9999337196350098
FAP O 1 0.9999293088912964
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 1.3577895288108266e-06
. O 0 2.2897446438907565e-10
. O 0 1.907161095715537e-09

Inherited B-Disease 1 0.9999377727508545
colorectal I-Disease 1 1.0
polyposis I-Disease 1 0.9999855756759644
and O 0 4.520683069131337e-05
cancer B-Disease 0 0.08448994904756546
risk O 0 1.060224690263567e-06
of O 0 1.0636969603738944e-11
the O 0 8.213975333237755e-11
APC O 0 2.2213026795725455e-07
I1307K O 0 8.50585166745077e-08
polymorphism O 0 1.1508043229468967e-07
. O 0 3.0020281815978933e-09

Germ O 0 0.0007149550365284085
- O 0 0.0003122148918919265
line O 0 1.949471879925113e-06
and O 0 1.2964909701373983e-10
somatic O 0 3.920696656223299e-09
truncating O 0 5.174473116653644e-08
mutations O 0 5.528793867171089e-09
of O 0 6.827044355187106e-13
the O 0 4.2474089024559236e-13
APC B-Disease 0 1.574599756137829e-10
gene O 0 4.954423676872821e-11
are O 0 3.5470023728063904e-13
thought O 0 2.826958285517822e-12
to O 0 4.9409452224091766e-12
initiate O 0 3.9694609768048394e-06
colorectal B-Disease 1 1.0
tumor I-Disease 1 0.9020956158638
formation O 0 1.7190305925396387e-06
in O 0 2.106032297888305e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 0.9999997615814209
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 2.2194371922523715e-05
sporadic O 1 0.9999723434448242
colorectal O 1 1.0
carcinogenesis O 1 0.9015216827392578
, O 0 6.835504251512248e-08
respectively O 0 3.024686279218258e-08
. O 0 1.5630092775609228e-08

Recently O 0 5.665594358106318e-07
, O 0 1.679881372895764e-10
an O 0 1.0978056137755932e-11
isoleucine O 0 0.017972871661186218
- O 0 0.010767458006739616
- O 0 7.856979937059805e-05
> O 0 6.75638034408621e-09
lysine O 0 1.1417393253054797e-08
polymorphism O 0 3.48797080107488e-09
at O 0 2.5153923388643307e-10
codon O 0 1.2463410303809042e-09
1307 O 0 6.032032651148711e-09
( O 0 1.89368139225099e-12
I1307K O 0 1.846900549162811e-10
) O 0 2.403164201924407e-13
of O 0 1.0001988657876854e-14
the O 0 1.6054083789348444e-13
APC B-Disease 0 3.5532168873864123e-10
gene O 0 8.409308666079696e-11
has O 0 3.6062867969643975e-11
been O 0 1.2117000111611098e-11
identified O 0 1.6119433565719987e-10
in O 0 4.4375389322316716e-13
6 O 0 3.6192555896708e-11
% O 0 1.805018114142687e-11
- O 0 2.7136297831020784e-06
7 O 0 6.317414369405583e-10
% O 0 2.643653525258305e-12
of O 0 1.6479746983277116e-13
the O 0 6.497091926960241e-12
Ashkenazi O 0 1.753239886603808e-09
Jewish O 0 2.98120556019299e-10
population O 0 1.2303479068886958e-10
. O 0 3.466983089506215e-10

To O 0 5.750063758469537e-10
assess O 0 4.0340982110365076e-08
the O 0 7.115042062466603e-12
risk O 0 8.220295000249678e-10
of O 0 1.1900104789379015e-14
this O 0 3.0878904576543686e-13
common O 0 1.773167203344972e-11
APC B-Disease 0 6.526314155763657e-09
allelic O 0 7.248870392828621e-09
variant O 0 1.6534453095573554e-07
in O 0 4.4448561498100503e-10
colorectal O 1 0.9999998807907104
carcinogenesis O 0 0.00024886353639885783
, O 0 5.885044895848068e-09
we O 0 2.951441313570058e-09
have O 0 2.8028302335308952e-12
analyzed O 0 2.189364835258889e-11
a O 0 1.489810228308408e-12
large O 0 5.948458739468698e-12
cohort O 0 2.258118553255528e-10
of O 0 8.104316371639053e-13
unselected O 0 4.042316845698224e-07
Ashkenazi O 0 1.689091178036506e-08
Jewish O 0 1.3528879128088533e-09
subjects O 0 2.722586378567371e-09
with O 0 3.161036710164211e-11
adenomatous B-Disease 0 6.648338512604823e-06
polyps I-Disease 0 6.396465323632583e-05
and O 0 2.913953078831355e-09
. O 0 1.2390289905184204e-09
or O 1 0.8124560713768005
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 3.4287361838636343e-10
for O 0 3.371707860827522e-12
the O 0 2.5956984825437068e-11
APC O 0 4.499288763781806e-08
I1307K O 0 5.533101088417425e-08
polymorphism O 0 2.3710926200237736e-07
. O 0 5.622075693878514e-09

The O 0 2.412450461619642e-09
APC O 0 1.1778173103493828e-07
I1307K O 0 5.910031219968914e-08
allele O 0 7.619722630636261e-09
was O 0 3.10374365097843e-10
identified O 0 9.787439747555027e-10
in O 0 2.427702570223511e-12
48 O 0 1.9039797516384738e-10
( O 0 3.0105429325681665e-13
10 O 0 5.222292650403082e-12
. O 0 6.23816211360595e-13
1 O 0 3.784972281341975e-13
% O 0 2.5939226962657e-14
) O 0 3.937645768801144e-14
of O 0 4.308030169576649e-13
476 O 0 9.611016871247102e-09
patients O 0 5.67981484067559e-09
. O 0 6.41920017141473e-10

Compared O 0 1.4939024239879473e-08
with O 0 1.422813776519316e-11
the O 0 2.0182820529863338e-13
frequency O 0 1.6655286039224393e-09
in O 0 5.9780652650331945e-12
two O 0 1.538680099132106e-12
separate O 0 9.18129634819298e-12
population O 0 6.509694259332344e-12
control O 0 8.325752531845865e-09
groups O 0 2.281713012974862e-11
, O 0 2.2527387941173593e-12
the O 0 3.301210487697409e-13
APC O 0 9.386958987889216e-10
I1307K O 0 6.85976497827312e-10
allele O 0 1.6052884022066394e-10
is O 0 2.4119499800190347e-12
associated O 0 1.7546832042913962e-11
with O 0 1.4384484272114695e-12
an O 0 1.2250078338868486e-12
estimated O 0 8.285340413749509e-09
relative O 0 3.7790456985931087e-07
risk O 0 4.975070737600618e-07
of O 0 1.9740027321080156e-11
1 O 0 1.014265893495292e-09
. O 0 1.1827504309280812e-08

5 O 0 1.5512607376422238e-07
- O 0 0.00018933879618998617
1 O 0 6.179696754315955e-09
. O 0 5.243770306861961e-09

7 O 0 2.0187864890885976e-07
for O 0 1.6043076200844553e-08
colorectal B-Disease 1 0.9999998807907104
neoplasia I-Disease 0 0.03535815700888634
( O 0 2.806225918305927e-09
both O 0 7.038266414127747e-09
P O 1 0.9716956615447998
= O 0 3.789406264331774e-06
. O 0 1.077567590712647e-09
01 O 0 1.4159475369979191e-08
) O 0 3.252284205834677e-11
. O 0 2.3146771999105198e-10

Furthermore O 0 2.5740488851511145e-08
, O 0 8.597867556803251e-11
compared O 0 2.599663539992747e-10
with O 0 1.062123739653531e-11
noncarriers O 0 5.849611284247658e-07
, O 0 5.3207271921706933e-11
APC O 0 5.057014806908455e-09
I1307K O 0 2.410417643261553e-09
carriers O 0 3.682603666455009e-10
had O 0 2.250996090913393e-11
increased O 0 1.5190617860816324e-11
numbers O 0 8.587230926337952e-11
of O 0 4.939069986331646e-12
adenomas B-Disease 0 0.05658364295959473
and O 0 3.464584733592346e-05
colorectal B-Disease 1 1.0
cancers I-Disease 0 0.08703864365816116
per O 0 1.0931019644999651e-08
patient O 0 4.794244887307286e-05
( O 0 5.176642225990236e-09
P O 1 0.9998083710670471
= O 0 2.305460839124862e-05
. O 0 1.170418206797308e-09
03 O 0 1.0938168149010608e-09
) O 0 2.7645602820869364e-12
, O 0 2.8498477449429016e-12
as O 0 8.619368239981551e-13
well O 0 4.473795899712085e-12
as O 0 7.379387357252243e-13
a O 0 2.6499540409230526e-12
younger O 0 4.58206667053318e-11
age O 0 9.468881234653281e-11
at O 0 7.025091619539126e-10
diagnosis O 0 1.0900143934122752e-06
. O 0 2.894156692079264e-09

We O 0 7.085300346432177e-09
conclude O 0 5.354203191920703e-10
that O 0 1.6964684865228286e-12
the O 0 4.449820232340501e-13
APC O 0 1.0789187321336158e-09
I1307K O 0 4.490582072858018e-10
variant O 0 1.993931686428141e-09
leads O 0 5.495879792927205e-11
to O 0 7.254253621413742e-12
increased O 0 6.539499253221948e-08
adenoma B-Disease 1 1.0
formation O 0 5.012478965227274e-08
and O 0 1.78052919630467e-10
directly O 0 7.2243218351975e-11
contributes O 0 9.686447199896975e-10
to O 0 1.4522993918575366e-11
3 O 0 2.8538255092414033e-11
% O 0 8.766670549220645e-12
- O 0 4.4139946453469747e-07
4 O 0 3.939259335394851e-11
% O 0 3.279071079335255e-13
of O 0 4.0136877111837665e-13
all O 0 1.9985378629794326e-10
Ashkenazi O 0 6.154483799036825e-06
Jewish O 0 0.0004056878387928009
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 3.8777788091692855e-08

The O 0 7.298028154023584e-11
estimated O 0 1.7790093842506849e-09
relative O 0 9.598156935908264e-09
risk O 0 1.4152025329394746e-08
for O 0 4.740173531470049e-12
carriers O 0 2.1761650259577436e-09
may O 0 2.935527862457654e-11
justify O 0 2.4416233479485072e-09
specific O 0 1.9794178796050943e-10
clinical O 0 1.3776614571359147e-10
screening O 0 9.607030448943732e-11
for O 0 3.412569977035568e-13
the O 0 4.762610119647681e-13
360 O 0 4.5550996308207914e-10
, O 0 3.994215548586144e-12
000 O 0 7.549908614956635e-12
Americans O 0 9.394162964887487e-13
expected O 0 1.2817596810321685e-11
to O 0 1.6923802853910375e-12
harbor O 0 2.597344006538549e-10
this O 0 9.029432881729402e-14
allele O 0 1.1647188769003947e-10
, O 0 1.4895943636558662e-12
and O 0 6.78715872566571e-13
genetic O 0 8.954002123084948e-11
testing O 0 5.64612245845808e-10
in O 0 2.660811295688431e-13
the O 0 4.69025751397012e-13
setting O 0 9.988364579882614e-10
of O 0 1.3425316630968909e-12
long O 0 1.0810945916261971e-08
- O 0 9.498157851339784e-07
term O 0 3.1588156534922973e-09
- O 0 1.241285518815971e-09
outcome O 0 6.271618207404073e-12
studies O 0 9.21518720706227e-13
may O 0 2.3238350263174445e-13
impact O 0 5.494106038173019e-12
significantly O 0 3.7183047751909726e-09
on O 0 0.04898226261138916
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 1.6660145263358572e-07
in O 0 1.4478374011847595e-12
this O 0 2.1972074767256933e-12
population O 0 1.0240919223747369e-10
. O 0 1.2294759654807308e-09

Localization O 0 7.270008950399642e-07
of O 0 2.5718462082213733e-11
human O 0 1.1313788794709012e-09
BRCA1 O 0 2.4510973162250593e-07
and O 0 3.196732045740447e-10
its O 0 1.0784141635244993e-10
loss O 0 5.246461043384443e-09
in O 0 2.6661381435921783e-11
high O 0 3.0084214586167946e-07
- O 0 0.0026430890429764986
grade O 0 7.354194167419337e-06
, O 0 1.3917490770953833e-10
non B-Disease 0 1.7285836406699673e-07
- I-Disease 1 0.507550060749054
inherited I-Disease 1 0.9998300075531006
breast I-Disease 1 0.999946117401123
carcinomas I-Disease 1 1.0
. O 0 1.910571654661908e-06

Although O 0 2.8835869803067737e-10
the O 0 2.4801972541704798e-12
link O 0 6.5774998780909755e-09
between O 0 3.383505281506771e-11
the O 0 5.6622210392598404e-11
BRCA1 O 0 0.0005057920352555811
tumour B-Disease 1 0.9999998807907104
- O 0 2.8484735139500117e-06
suppressor O 0 1.1909245358765475e-06
gene O 0 8.223725671996363e-06
and O 0 1.4996827530922019e-06
hereditary B-Disease 1 0.9999948740005493
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 5.25507708459827e-08
established O 0 3.3741878735504827e-10
, O 0 1.0647889688020218e-11
the O 0 3.347145965341275e-13
role O 0 1.702937929559667e-10
, O 0 8.474694036808561e-12
if O 0 2.4728708664101262e-12
any O 0 4.458777097537947e-12
, O 0 7.202603856219791e-13
of O 0 3.4144629940287274e-14
BRCA1 O 0 1.664652771182773e-08
in O 0 8.026588074749874e-12
non B-Disease 0 1.186396957564284e-06
- I-Disease 1 0.8948720693588257
familial I-Disease 1 0.9731853008270264
cancers I-Disease 1 0.8877682089805603
is O 0 1.5722305235499334e-08
unclear O 0 2.095119100431475e-08
. O 0 3.132118120419136e-09

BRCA1 O 0 7.121526141418144e-05
mutations O 0 2.0810608702959144e-07
are O 0 7.730232252922686e-12
rare O 0 4.884501830781929e-11
in O 0 9.933030960251887e-12
sporadic B-Disease 1 0.5709902048110962
cancers I-Disease 0 0.08705414086580276
, O 0 7.387281064641371e-11
but O 0 2.6828903681996863e-11
loss O 0 1.1868961369287945e-10
of O 0 2.5740241101773753e-12
BRCA1 O 0 3.6444836837290495e-07
resulting O 0 9.826266189616462e-11
from O 0 9.927499794448735e-12
reduced O 0 6.979335442913737e-10
expression O 0 2.0410177992147283e-09
or O 0 1.5252356044825888e-09
incorrect O 0 4.002773721367703e-07
subcellular O 0 4.365869608591311e-05
localization O 0 1.1611416539381025e-07
is O 0 3.344747872766063e-12
postulated O 0 2.355556071378939e-12
to O 0 1.5663657166025552e-13
be O 0 1.722713226411099e-13
important O 0 2.416567651281759e-13
in O 0 1.0045571145755883e-12
non B-Disease 0 5.258385371575969e-08
- I-Disease 0 0.3285422623157501
familial I-Disease 1 0.9999649524688721
breast I-Disease 1 0.9999995231628418
and I-Disease 1 0.9999978542327881
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 7.710617921929952e-08

Epigenetic O 0 3.5797584132524207e-06
loss O 0 2.786310346891696e-07
, O 0 3.2289712570410245e-10
however O 0 3.150430957776784e-11
, O 0 3.610237456208587e-11
has O 0 2.4649809970966885e-10
not O 0 3.7428046772980395e-12
received O 0 2.697876915359193e-13
general O 0 1.7974381748622759e-12
acceptance O 0 8.725138667120547e-11
due O 0 3.7671051174303916e-12
to O 0 7.268112977784624e-13
controversy O 0 2.4393029263158894e-11
regarding O 0 6.474604880013501e-11
the O 0 4.184577163945935e-12
subcellular O 0 5.7586807997722644e-06
localization O 0 4.259637975678743e-08
of O 0 6.983079479244703e-13
BRCA1 O 0 1.5365532179956176e-09
proteins O 0 3.9027093189092366e-12
, O 0 4.958795418556761e-13
reports O 0 1.885070433083058e-10
of O 0 1.021955550782952e-13
which O 0 1.0313033066422506e-10
have O 0 1.130969970453144e-11
ranged O 0 9.827785113492027e-11
from O 0 1.141324990246162e-13
exclusively O 0 1.1878942274279325e-11
nuclear O 0 8.546344787419002e-08
, O 0 2.0505854501397247e-13
to O 0 6.987420082642248e-14
conditionally O 0 1.6273655756293692e-09
nuclear O 0 1.0146170126290599e-07
, O 0 1.6043890933674365e-13
to O 0 9.702182362635731e-14
the O 0 6.967819333666969e-13
ER O 0 3.8164074567248463e-07
/ O 0 1.288562003765037e-07
golgi O 0 5.49606360422672e-09
, O 0 2.122065717591326e-11
to O 0 2.6453383754343474e-12
cytoplasmic O 0 2.575859969766725e-09
invaginations O 0 6.972369703817094e-08
into O 0 2.4246956872864267e-11
the O 0 5.399238781761406e-12
nucleus O 0 5.632945776490317e-10
. O 0 4.4071712945736863e-10

In O 0 1.0399393152171754e-10
an O 0 1.1944642323846733e-12
attempt O 0 2.5986471308137027e-10
to O 0 2.56734702941408e-11
resolve O 0 2.7163049587386467e-09
this O 0 2.314807416928244e-12
issue O 0 9.544989243437385e-10
, O 0 3.732944942741456e-12
we O 0 2.2980303424069426e-11
have O 0 1.3793428205177705e-12
comprehensively O 0 2.315372782391023e-08
characterized O 0 9.477739704166765e-10
19 O 0 4.1042155785042667e-10
anti O 0 2.8725020229103393e-07
- O 0 0.00010905017552431673
BRCA1 O 0 6.197704806254478e-06
antibodies O 0 2.3127775250486593e-08
. O 0 7.179762895326292e-10

These O 0 3.611988763640994e-10
reagents O 0 1.299145235833521e-09
detect O 0 2.184548986150503e-09
a O 0 2.416081397449421e-11
220 O 0 8.593674105661364e-10
- O 0 4.423142740961339e-08
kD O 0 7.201411449386796e-07
protein O 0 6.548604991607476e-10
localized O 0 8.782043425803465e-10
in O 0 6.012229559690385e-13
discrete O 0 1.3097873008405259e-08
nuclear O 0 5.550648893404286e-06
foci O 0 4.666862452040732e-08
in O 0 5.852696799424351e-12
all O 0 3.0801979890304754e-12
epithelial O 0 3.751016564024212e-08
cell O 0 1.4492111404251773e-05
lines O 0 3.784505679504946e-06
, O 0 2.9837410320254776e-11
including O 0 9.656199451146819e-13
those O 0 8.439895375460249e-13
derived O 0 2.4517278398444864e-12
from O 0 8.823539121571855e-12
breast B-Disease 0 3.13466216539382e-06
malignancies I-Disease 0 5.078435151517624e-06
. O 0 5.4920629821708644e-08

Immunohistochemical O 0 0.00010599992674542591
staining O 0 1.609253104106756e-06
of O 0 2.082609605602581e-11
human O 0 1.561548446105121e-09
breast O 0 4.149616870563477e-06
specimens O 0 2.3317927144717032e-08
also O 0 4.185589208560714e-09
revealed O 0 1.0277519777446287e-06
BRCA1 O 0 4.029671345051611e-06
nuclear O 0 4.3460136112116743e-07
foci O 0 1.1289892398735901e-07
in O 0 3.658043659648946e-11
benign O 0 0.05188816785812378
breast O 0 0.0004663272120524198
, O 0 1.0372793735058394e-09
invasive B-Disease 0 0.00012698248610831797
lobular I-Disease 1 0.9997772574424744
cancers I-Disease 1 0.9972782731056213
and O 0 3.3549699764989782e-06
low B-Disease 0 0.294900506734848
- I-Disease 1 0.9998924732208252
grade I-Disease 1 0.89848393201828
ductal I-Disease 1 0.9997608065605164
carcinomas I-Disease 1 0.9999997615814209
. O 0 5.704762315872358e-06

Conversely O 0 4.7551156967529096e-07
, O 0 1.4409742288279404e-09
BRCA1 O 0 2.3387308090150327e-07
expression O 0 2.15757500754421e-09
was O 0 8.809292850742168e-09
reduced O 0 2.9677214019585563e-09
or O 0 6.064693991447712e-08
undetectable O 0 2.318872475370881e-06
in O 0 4.235422342707684e-12
the O 0 1.7527390129556952e-12
majority O 0 3.915715321434199e-11
of O 0 8.364813290813455e-13
high O 0 5.0918217198159255e-08
- O 0 3.5781464248429984e-05
grade O 0 2.2427441592753894e-07
, O 0 4.584864432555236e-11
ductal B-Disease 0 0.0018644938245415688
carcinomas I-Disease 1 1.0
, O 0 5.249601864321107e-10
suggesting O 0 4.4674499655172895e-09
that O 0 5.179214696005019e-11
absence O 0 5.09109560065113e-11
of O 0 3.9354402982944015e-13
BRCA1 O 0 2.6688130816410194e-08
may O 0 6.815754557965015e-12
contribute O 0 2.0833157247934775e-12
to O 0 8.228706886888315e-13
the O 0 1.6293997401328753e-13
pathogenesis O 0 2.0564637492892501e-10
of O 0 3.1094196634813207e-14
a O 0 5.497205338503286e-13
significant O 0 1.5598173794262316e-11
percentage O 0 2.822512445987968e-09
of O 0 2.0393154179232376e-11
sporadic B-Disease 1 0.9996713399887085
breast I-Disease 1 0.9997351765632629
cancers I-Disease 0 0.04897022619843483
. O 0 2.1792012638854885e-09
. O 0 4.157090227607796e-09

